PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Keimer, B				Keimer, B			Physics - Quasi-particles survive - for now	SCIENCE			English	Editorial Material							MAGNETORESISTIVE OXIDE; FERMI-SURFACE; STATE; SUPERCONDUCTIVITY; PHOTOEMISSION		Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany	Max Planck Society	Keimer, B (corresponding author), Max Planck Inst Festkorperforsch, Heisenbergstr 1, D-70569 Stuttgart, Germany.			Keimer, Bernhard/0000-0001-5220-9023				Adams CP, 2000, PHYS REV LETT, V85, P3954, DOI 10.1103/PhysRevLett.85.3954; Anderson PW, 2000, SCIENCE, V288, P480, DOI 10.1126/science.288.5465.480; Chuang YD, 2001, SCIENCE, V292, P1509, DOI 10.1126/science.1059255; Dessau DS, 1998, PHYS REV LETT, V81, P192, DOI 10.1103/PhysRevLett.81.192; Joynt R, 1999, SCIENCE, V284, P777, DOI 10.1126/science.284.5415.777; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Moreo A, 1999, SCIENCE, V283, P2034, DOI 10.1126/science.283.5410.2034; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Savrasov SY, 1996, PHYS REV B, V54, P16487, DOI 10.1103/PhysRevB.54.16487; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tranquada JM, 1997, PHYS REV LETT, V78, P338, DOI 10.1103/PhysRevLett.78.338; Valla T, 1999, PHYS REV LETT, V83, P2085, DOI 10.1103/PhysRevLett.83.2085	12	1	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1498	1499		10.1126/science.1061205	http://dx.doi.org/10.1126/science.1061205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11326086				2022-12-28	WOS:000168963800030
J	de Lange, T				de Lange, T			Cell biology - Telomere capping - One strand fits all	SCIENCE			English	Editorial Material							OXYTRICHA MACRONUCLEAR DNA; BINDING-PROTEIN; CDC13; END; TRF2		Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; GOTTSCHLING DE, 1984, CELL, V38, P501, DOI 10.1016/0092-8674(84)90505-1; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Ishikawa F, 1999, MUTAT RES-DNA REPAIR, V434, P99, DOI 10.1016/S0921-8777(99)00017-8; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0	16	49	50	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1075	1076						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352055				2022-12-28	WOS:000168609200033
J	Johnson, N; Revenga, C; Echeverria, J				Johnson, N; Revenga, C; Echeverria, J			Ecology - Managing water for people and nature	SCIENCE			English	Article									World Resources Inst, Washington, DC 20002 USA		Johnson, N (corresponding author), World Resources Inst, Washington, DC 20002 USA.							Abramowitz J.N, 1996, 128 WORLDW I; BRAUTIGAM A, 1999, WORLD CONSERV BIOL, V30, P4; CONSTANCE P, 1999, IDB AM, V26, P2; Faeth P., 2000, FERTILE GROUND NUTR; FALKENMARK M, 1992, POPUL BULL, V47, P2; *FAO, 1999, REV WORLD FISH AQ 19; Gleick Peter H., 1998, WORLDS WATER 1998 19; Moyle Peter B., 1992, P127; OECD, 1997, ENV TAX GREEN TAX RE; POSTEL S, 1995, HAVE ALL RIVERS GONE; RAMESH B, 2000, SUMMARY WATER EC SES; REID WV, 2001, MONOGRAPHS SYSTEMATI, V84, P197; Revenga C., 2000, PILOT ANAL GLOBAL EC; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; ROSEGRANT MW, 1995, FOOD POLICY, V20, P203, DOI 10.1016/0306-9192(95)00014-6; Shiklomanov I.A., 1997, COMPREHENSIVE ASSESS; Solorzano R., 1995, VALORACION EC ECOLOG; *UNEP, 1996, GROUNDW THREAT RES; Vorosmarty C., 2001, EOS T AM GEOPHYS UN, V82, P54, DOI [DOI 10.1029/01EO00031, 10.1029/01EO00031, 10.1029/01-o00031]; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; *WMO, 1997, COMPR ASS FRESHW RES; *WRI, 2000, WORLD RES 2000 01 PE	22	165	179	7	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1071	1072		10.1126/science.1058821	http://dx.doi.org/10.1126/science.1058821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352054				2022-12-28	WOS:000168609200030
J	Rudolf, MCJ; Sahota, P; Barth, JH; Walker, J				Rudolf, MCJ; Sahota, P; Barth, JH; Walker, J			Increasing prevalence of obesity in primary school children: cohort study	BRITISH MEDICAL JOURNAL			English	Article							BRITISH CHILDREN; UK		Leeds Community & Mental Hlth Trust, Community Paediat, Leeds LS2 9NP, W Yorkshire, England; Leeds Metropolitan Univ, Sch Hlth Sci, Leeds LS1 3HE, W Yorkshire, England; Gen Infirm, Reg Paediat Endocrinol Clin, Leeds LS1 3EX, W Yorkshire, England	Leeds Beckett University; Leeds General Infirmary	Rudolf, MCJ (corresponding author), Leeds Community & Mental Hlth Trust, Community Paediat, Leeds LS2 9NP, W Yorkshire, England.		Barth, Julian H/F-6028-2010					COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Reilly JJ, 1999, LANCET, V354, P1874, DOI 10.1016/S0140-6736(99)04555-9; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039; SAHOTA P, IN PRESS BMJ; TANNER JM, 1975, ARCH DIS CHILD, V50, P142, DOI 10.1136/adc.50.2.142	5	77	81	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1094	1095		10.1136/bmj.322.7294.1094	http://dx.doi.org/10.1136/bmj.322.7294.1094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337437	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168628300019
J	Ramanathan, R; Corwin, MJ; Hunt, CE; Lister, G; Tinsley, LR; Baird, T; Silvestri, JM; Crowell, DH; Hufford, D; Martin, RJ; Neuman, MR; Weese-Mayer, DE; Cupples, LA; Peucker, M; Willinger, M; Keens, TG				Ramanathan, R; Corwin, MJ; Hunt, CE; Lister, G; Tinsley, LR; Baird, T; Silvestri, JM; Crowell, DH; Hufford, D; Martin, RJ; Neuman, MR; Weese-Mayer, DE; Cupples, LA; Peucker, M; Willinger, M; Keens, TG		Collaborative Home Infant Monitori	Cardiorespiratory events recorded on home monitors - Comparison of healthy infants with those at increased risk for SIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEATH-SYNDROME; BIRTH-WEIGHT; APNEA; PLETHYSMOGRAPHY; PATTERN; AGE	Context Home monitors designed to identify cardiorespiratory events are frequently used in infants at increased risk for sudden infant death syndrome (SIDS), but the efficacy of such devices for this use is unproven. Objective To test the hypothesis that preterm infants, siblings of infants who died of SIDS, and infants who have experienced an idiopathic, apparent life-threatening event have a greater risk of cardiorespiratory events than healthy term infants. Design Longitudinal cohort study conducted from May 1994 through February 1998. Setting Five metropolitan medical centers in the United States. Participants A total of 1079 infants (classified as healthy term infants and 6 groups of those at risk for SIDS) who, during the first 6 months after birth, were observed with home cardiorespiratory monitors using respiratory inductance plethysmography to detect apnea and obstructed breathing. Main Outcome Measures Occurrence of cardiorespiratory events that exceeded predefined conventional and extreme thresholds as recorded by the monitors. Results During 718 358 hours of home monitoring, 6993 events exceeding conventional alarm thresholds occurred in 445 infants (41%), Of these, 653 were extreme events in 116 infants (10%), and of those events with apnea, 70% included at least 3 obstructed breaths. The frequency of at least 1 extreme event was similar in term infants in all groups, but preterm infants were at increased risk of extreme events until 43 weeks' postconceptional age. Conclusions In this study, conventional events are quite common, even in healthy term infants. Extreme events were common only in preterm infants, and their timing suggests that they are not likely to be immediate precursors to SIDS. The high frequency of obstructed breathing in study participants would likely preclude detection of many events by conventional techniques. These data should be important for designing future monitors and determining if an infant is likely to be at risk for a cardiorespiratory event.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Univ So Calif, Sch Med, Dept Pediat & Neonatol, Los Angeles, CA USA; Womens & Childrens Hosp, Los Angeles, CA USA; Good Samaritan Hosp, Los Angeles, CA USA; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Pediat, Boston, MA 02118 USA; Med Coll Ohio, Dept Pediat, Toledo, OH 43699 USA; Univ Hawaii Manoa, Kapiolani Med Ctr Women & Children, Dept Pediat, Honolulu, HI 96822 USA; Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Dept Pediat, Cleveland, OH USA; Rush Univ, Rush Med Coll, Rush Childrens Hosp, Dept Pediat, Chicago, IL 60612 USA; Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Metrohlth Med Ctr, Dept Obstet & Gynecol, Cleveland, OH USA; NICHHD, Ctr Res Mothers & Children, Pregnancy & Perinatol Branch, NIH, Bethesda, MD 20892 USA	Yale University; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Boston University; Boston University; Boston University; Boston University; University of Hawaii System; University of Hawaii Manoa; Case Western Reserve University; MetroHealth System; Rush University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; MetroHealth System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lister, G (corresponding author), Yale Univ, Sch Med, Dept Pediat, Box 208064, New Haven, CT 06520 USA.	george.lister@yale.edu		Ramanathan, Rangasamy/0000-0002-7358-601X; Corwin, Michael/0000-0002-6591-209X	NICHD NIH HHS [HD 29067, HD 34625, HD 29073, HD 29071, HD 28791, HD 29056, HD 29060] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD029071, U10HD029060, U10HD029067, U10HD029073, U10HD029056, U10HD034625] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1987, PEDIATRICS, V79, P292; Barrington KJ, 1996, J PEDIATR-US, V129, P934, DOI 10.1016/S0022-3476(96)70044-6; BROUILLETTE RT, 1987, J PEDIATR-US, V111, P377, DOI 10.1016/S0022-3476(87)80457-2; Corwin MJ, 1998, PEDIATR RES, V44, P682, DOI 10.1203/00006450-199811000-00010; Cote A, 1998, J PEDIATR-US, V132, P783, DOI 10.1016/S0022-3476(98)70304-X; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Eichenwald EC, 1997, PEDIATRICS, V100, P354, DOI 10.1542/peds.100.3.354; GUNTHEROTH WG, 1990, J PEDIATR-US, V116, P520, DOI 10.1016/S0022-3476(05)81596-3; HAGEMAN JR, 1988, PEDIATR PULM, V4, P78, DOI 10.1002/ppul.1950040204; HOPPENBROUWERS T, 1993, PEDIATR PULM, V15, P1, DOI 10.1002/ppul.1950150102; Hunt CE, 1999, J PEDIATR-US, V135, P580, DOI 10.1016/S0022-3476(99)70056-9; Hunt CE, 1996, PEDIATR RES, V39, P216, DOI 10.1203/00006450-199602000-00005; HUNT CE, 1992, RESP CONTROL DISORDE, P190; KAHN A, 1982, PEDIATRICS, V70, P852; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAWLESS JF, 1980, STAT MODELS METHODS; Leach CEA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e43; MALLOY MH, 1995, PEDIATRICS, V96, P464; Malloy MH, 2000, PEDIATRICS, V105, P1227, DOI 10.1542/peds.105.6.1227; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; SOUTHALL DP, 1982, PEDIATRICS, V70, P844; TOBIN MJ, 1987, J APPL PHYSIOL, V62, P497, DOI 10.1152/jappl.1987.62.2.497; Weese-Mayer DE, 2000, AM J RESP CRIT CARE, V162, P471, DOI 10.1164/ajrccm.162.2.9904029	23	195	203	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2199	2207		10.1001/jama.285.17.2199	http://dx.doi.org/10.1001/jama.285.17.2199			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325321	Bronze			2022-12-28	WOS:000168256100022
J	Lorenz, KA; Shapiro, MF; Asch, SM; Bozzette, SA; Hays, RD				Lorenz, KA; Shapiro, MF; Asch, SM; Bozzette, SA; Hays, RD			Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; OF-LIFE; SERVICES UTILIZATION; PALLIATIVE CARE; UNITED-STATES; COST; AIDS	Background: Health-related quality of life refers to how well people are able to perform daily activities (functioning) and how they feel about their lives (well-being). The relationship between symptoms and health-related quality of life has not been fully explored, Objective: To estimate the association of HIV symptoms with health-related quality of life and with disability days. Design: Prospective cohort study. Setting: HIV providers in 28 urban and 24 rural randomly selected sites throughout the United States. Patients: Nationally representative sample of 2267 adults with known HIV infection who were interviewed in 1996 and again between 1997 and 1998. Measurements: Symptoms, two single-item global measures of health-related quality of life (perceived health and perceived quality of life), and disability days. Results: White patches in the mouth; nausea or loss of appetite; persistent cough, difficulty breathing, or difficulty catching one's breath; and weight loss were associated with more disability days and worse scores on both health-related quality-of-life measures. Headache; pain in the mouth, lips, or gums; dry mouth; and sinus infection, pain, or discharge were associated with worse perceived health, Pain in the mouth, lips, or gums; trouble with eyes; pain, numbness, or tingling of hands or feet; and diarrhea or loose or watery stools were associated with worse perceived quality of life. Headache and fever, sweats, or chills were associated with more disability days. Conclusions: Several symptoms are associated with worse health-related quality of life and more disability days in persons with HIV infection. In such patients, targeting specific symptoms may improve health-related quality of life and reduce disability.	Vet Affairs Greater Los Angeles Healthcare Syst, Div Gen Internal Med, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Lorenz, KA (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Div Gen Internal Med, 11303 Wilshire Blvd,Code 111-G, Los Angeles, CA 90073 USA.	klorenz@ucla.edu	Hays, Ronald/D-5629-2013	Hays, Ronald/0000-0001-6697-907X	AHRQ HHS [HS08578] Funding Source: Medline; ASC OASH HHS [R01AS10227] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); ASC OASH HHS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 1992, AM HERITAGE DICT; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Crofton C, 1999, MED CARE, V37, pMS1, DOI 10.1097/00005650-199903001-00001; Cunningham WE, 1998, AM J MED, V104, P129, DOI 10.1016/S0002-9343(97)00349-5; DUAN N, 1060 RAND; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Grimes R M, 1998, Gastrointest Endosc Clin N Am, V8, P783; Hays RD, 2000, AM J MED, V108, P714, DOI 10.1016/S0002-9343(00)00387-9; Hays RD, 1997, KIDNEY DIS QUALITY L; Justice AC, 1999, J ACQ IMMUN DEF SYND, V21, P126; KALTON G, 1983, COMPENSATING MISSING; Kaplan RM, 1997, QUAL LIFE RES, V6, P507, DOI 10.1023/A:1018456031659; MATHEWS W, 1980, MED CARE, V38, P750; Meyer M, 1999, INT J STD AIDS, V10, P80, DOI 10.1258/0956462991913682; Meyer M, 1999, INT J STD AIDS, V10, P495, DOI 10.1258/0956462991914573; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; ROSK K, 2000, ARCH FAM MED, V9, P150; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	20	114	117	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			854	860		10.7326/0003-4819-134-9_Part_2-200105011-00009	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346321				2022-12-28	WOS:000168543100009
J	Ouyang, M; Huang, JL; Cheung, CL; Lieber, CM				Ouyang, M; Huang, JL; Cheung, CL; Lieber, CM			Energy gaps in "metallic" single-walled carbon nanotubes	SCIENCE			English	Article							DENSITY-OF-STATES; ELECTRONIC-STRUCTURE; BROKEN SYMMETRY; ROPES; PSEUDOGAPS	Metallic single-walled carbon nanotubes have been proposed to be good one-dimensional conductors. However, the finite curvature of the graphene sheet that forms the nanotubes and the broken symmetry due to the local environment may modify their electronic properties. We used Low-temperature atomically resolved scanning tunneling microscopy to investigate zigzag and armchair nanotubes, both thought to be metallic. "Metallic" zigzag nanotubes were found to have energy gaps with magnitudes that depend inversely on the square of the tube radius, whereas isolated armchair tubes do not have energy gaps. Additionally, armchair nanotubes packed in bundles have pseudogaps, which exhibit an inverse dependence on tube radius. These observed energy gaps suggest that most "metallic" single-walled nanotubes are not true metals, and they have implications for our understanding of the electronic properties and potential applications of carbon nanotubes.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.		Chu, Yung-Ming/C-6318-2009; Cheung, Chin Li/B-8270-2013	Cheung, Chin Li/0000-0001-8210-2833				BLASE X, 1994, PHYS REV LETT, V72, P1878, DOI 10.1103/PhysRevLett.72.1878; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; Delaney P, 1998, NATURE, V391, P466, DOI 10.1038/35099; Delaney P, 1999, PHYS REV B, V60, P7899, DOI 10.1103/PhysRevB.60.7899; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Hertel T, 1998, PHYS REV B, V58, P13870, DOI 10.1103/PhysRevB.58.13870; Kane CL, 1997, PHYS REV LETT, V78, P1932, DOI 10.1103/PhysRevLett.78.1932; Kim P, 1999, PHYS REV LETT, V82, P1225, DOI 10.1103/PhysRevLett.82.1225; Kwon YK, 1998, PHYS REV B, V58, P13314, DOI 10.1103/PhysRevB.58.R13314; Maarouf AA, 2000, PHYS REV B, V61, P11156, DOI 10.1103/PhysRevB.61.11156; McEuen PL, 1998, NATURE, V393, P15, DOI 10.1038/29874; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; MINTMIRE JW, 1993, J PHYS CHEM SOLIDS, V54, P1835, DOI 10.1016/0022-3697(93)90296-4; Mintmire JW, 1998, PHYS REV LETT, V81, P2506, DOI 10.1103/PhysRevLett.81.2506; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Odom TW, 2000, J PHYS CHEM B, V104, P2794, DOI 10.1021/jp993592k; OUYANG M, UNPUB; Rubio A, 1999, APPL PHYS A-MATER, V68, P275, DOI 10.1007/s003390050888; SAITO R, 1992, PHYS REV B, V46, P1804, DOI 10.1103/PhysRevB.46.1804; TERSOFF J, 1994, PHYS REV LETT, V73, P676, DOI 10.1103/PhysRevLett.73.676; WHITE CT, 1996, CLUSTERS NANOSTRUCTU, P231; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Yang L, 2000, PHYS REV LETT, V85, P154, DOI 10.1103/PhysRevLett.85.154	24	595	616	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					702	705		10.1126/science.1058853	http://dx.doi.org/10.1126/science.1058853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326093	Green Published			2022-12-28	WOS:000168478300044
J	Que, L; Watanabe, Y				Que, L; Watanabe, Y			Bioinorganic chemistry - Oxygenase pathways: Oxo, peroxo, and superoxo	SCIENCE			English	Editorial Material							CYTOCHROME P450CAM; HYDROXYLATION; DIOXYGEN; COMPLEX		Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Que, L (corresponding author), Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.	que@chem.umn.edu; yoshi@ims.ac.jp						Chavez FA, 2001, CHEM COMMUN, P111, DOI 10.1039/b006647h; Collman JP, 1999, J AM CHEM SOC, V121, P1387, DOI 10.1021/ja983351a; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Ghiladi RA, 1999, J AM CHEM SOC, V121, P9885, DOI 10.1021/ja992296i; Girerd JJ, 2000, STRUCT BOND, V97, P145; Itoh S, 2000, ANGEW CHEM INT EDIT, V39, P398, DOI 10.1002/(SICI)1521-3773(20000117)39:2<398::AID-ANIE398>3.0.CO;2-2; Jaron S, 1999, BIOCHEMISTRY-US, V38, P15086, DOI 10.1021/bi991341w; Lee D, 1999, J AM CHEM SOC, V121, P9893, DOI 10.1021/ja9923686; LIU AMF, UNPUB; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; Nam W, 2000, J AM CHEM SOC, V122, P10805, DOI 10.1021/ja0010554; Naruta Y, 2001, J INORG BIOCHEM, V83, P239, DOI 10.1016/S0162-0134(00)00170-7; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; *PAC BAS SOC, 2000, 2000 INT CHEM C PAC; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shiren K, 2000, J AM CHEM SOC, V122, P254, DOI 10.1021/ja990311d	18	23	23	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					651	653						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330325				2022-12-28	WOS:000168478300032
J	Besag, FMC				Besag, FMC			Lesson of the week - Tonic seizures are a particular risk factor for drowning in people with epilepsy	BRITISH MEDICAL JOURNAL			English	Review							CHILDREN		Twinwoods Hlth Resource Ctr, Bedfordshire & Luton Community Hlth Trust, Learning Disabil Serv, Bedford MK41 6AT, England		Besag, FMC (corresponding author), Twinwoods Hlth Resource Ctr, Bedfordshire & Luton Community Hlth Trust, Learning Disabil Serv, Bedford MK41 6AT, England.		Besag, FM/H-7031-2019					Cass DT, 1996, MED J AUSTRALIA, V165, P610, DOI 10.5694/j.1326-5377.1996.tb138663.x; DIEKEMA DS, 1993, PEDIATRICS, V91, P612; KEMP AM, 1993, ARCH DIS CHILD, V68, P684, DOI 10.1136/adc.68.5.684; Osamura T, 1997, BRAIN DEV-JPN, V19, P499, DOI 10.1016/S0387-7604(97)00064-8; RYAN CA, 1993, CAN MED ASSOC J, V148, P781; SENANAYAKE N, 1995, SEIZURE, V4, P273, DOI 10.1016/S1059-1311(95)80004-2; Spitz MC, 1998, EPILEPSIA, V39, P904, DOI 10.1111/j.1528-1157.1998.tb01189.x	7	12	12	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					975	976		10.1136/bmj.322.7292.975	http://dx.doi.org/10.1136/bmj.322.7292.975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312233	Green Published			2022-12-28	WOS:000168345100022
J	Wilkie, GS; Davis, I				Wilkie, GS; Davis, I			Drosophila wingless and pair-rule transcripts localize apically by dynein-mediated transport of RNA particles	CELL			English	Article							MATERNAL MESSENGER-RNA; CYTOPLASMIC DYNEIN; BICOID RNA; ASYMMETRIC LOCALIZATION; CELL-DIVISION; ANTERIOR POLE; IN-VIVO; PROTEIN; MICROTUBULES; DIFFUSION	Asymmetric mRNA localization targets proteins to their cytoplasmic site of function. We have elucidated the mechanism of apical localization of wingless and pair-rule transcripts in the Drosophila blastoderm embryo by directly visualizing intermediates along the entire path of transcript movement. After release from their site of transcription, mRNAs diffuse within the nucleus and are exported to all parts of the cytoplasm, regardless of their cytoplasmic destinations. Endogenous and injected apical RNAs assemble selectively into cytoplasmic particles that are transported apically along microtubules. Cytoplasmic dynein is required for correct localization of endogenous transcripts and apical movement of injected RNA particles. We propose that dynein-dependent movement of RNA particles is a widely deployed mechanism for mRNA localization.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Davis, I (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	ilan.davis@ed.ac.uk	Davis, Ilan/F-4975-2010	Davis, Ilan/0000-0002-5385-3053				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; BRENIERE Y, 1989, J MOTOR BEHAV, V21, P20; Carson JH, 1998, CURR OPIN NEUROBIOL, V8, P607, DOI 10.1016/S0959-4388(98)80088-3; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Davis I, 2000, PRACT APPROACH SER, V218, P133; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; DAVIS I, 1993, COLD SPRING HARB SYM, V58, P793, DOI 10.1101/SQB.1993.058.01.086; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Fischer JA, 2000, CURR OPIN GENET DEV, V10, P489, DOI 10.1016/S0959-437X(00)00117-9; Foe Victoria E., 1993, P149; FrancisLang H, 1996, EMBO J, V15, P640, DOI 10.1002/j.1460-2075.1996.tb00396.x; Gepner J, 1996, GENETICS, V142, P865; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hazelrigg T, 1998, CELL, V95, P451, DOI 10.1016/S0092-8674(00)81613-X; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; Joseph EM, 1998, DEVELOPMENT, V125, P2677; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; McGrail M, 1997, DEVELOPMENT, V124, P2409; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Pante N, 1997, RNA, V3, P498; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; STEPHENSON EC, 1988, GENE DEV, V2, P1655, DOI 10.1101/gad.2.12a.1655; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; SUNDELL CL, 1990, J CELL BIOL, V111, P2397, DOI 10.1083/jcb.111.6.2397; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; WILKIE GS, 1998, ELSEVIER TRENDS J TE; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZACHAR Z, 1993, J CELL BIOL, V121, P729, DOI 10.1083/jcb.121.4.729	62	185	191	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					209	219		10.1016/S0092-8674(01)00312-9	http://dx.doi.org/10.1016/S0092-8674(01)00312-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336671	Bronze			2022-12-28	WOS:000168384300008
J	Lyapina, S; Cope, G; Shevchenko, A; Serino, G; Tsuge, T; Zhou, CS; Wolf, DA; Wei, N; Shevchenko, A; Deshaies, RJ				Lyapina, S; Cope, G; Shevchenko, A; Serino, G; Tsuge, T; Zhou, CS; Wolf, DA; Wei, N; Shevchenko, A; Deshaies, RJ			Promotion of NEDD8-CUL1 conjugate cleavage by COP9 signalosome	SCIENCE			English	Article							UBIQUITIN-LIGASE; FISSION YEAST; COMPLEX; PROTEIN; DEGRADATION; P27(KIP1); SCF; ARABIDOPSIS; REGULATOR; SUBUNITS	SCF ubiquitin ligases control various processes by marking regulatory proteins for ubiquitin-dependent proteolysis. To illuminate how SCF complexes are regulated, we sought proteins that interact with the human SCF component CUL1. The COP9 signalosome (CSN), a suppressor of plant photomorphogenesis, associated with multiple cullins and promoted cleavage of the ubiquitin-like protein NEDD8 from Schizosaccharomyces pombe CUL1 in vivo and in vitro. Multiple NEDD8-modified proteins uniquely accumulated in CSN-deficient S. pombe cells. We propose that the broad spectrum of activities previously attributed to CSN subunits-including repression of photomorphogenesis, activation of JUN, and activation of p27 nuclear export-underscores the importance of dynamic cycles of NEDD8 attachment and removal in biological regulation.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; European Mol Biol Lab, Prot & Peptide Grp, D-69012 Heidelberg, Germany; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.		Deshaies, Raymond/B-8354-2014; Serino, Giovanna/W-4683-2019; Wolf, Dieter/AAE-5890-2021; Tsuge, Tomohiko/GVY-1467-2022	Deshaies, Raymond/0000-0002-3671-9354; Serino, Giovanna/0000-0001-8689-6132; Wolf, Dieter/0000-0002-3761-1070; Tsuge, Tomohiko/0000-0003-2736-0295				BLANCHI E, 2000, NATURE, V404, P617; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; COPE G, UNPUB; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; SCHWARZ S, UNPUB; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Shevchenko A, 2000, ANAL CHEM, V72, P2132, DOI 10.1021/ac9913659; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Verma R. P., UNPUB; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; ZHOU CS, UNPUB	28	543	578	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1382	1385		10.1126/science.1059780	http://dx.doi.org/10.1126/science.1059780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11337588				2022-12-28	WOS:000168862900048
J	Dolan, JF				Dolan, JF			Astronomy - How to find a stellar black hole	SCIENCE			English	Editorial Material									NASA, Goddard Space Flight Ctr, Astron & Solar Phys Lab, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Dolan, JF (corresponding author), NASA, Goddard Space Flight Ctr, Astron & Solar Phys Lab, Greenbelt, MD 20771 USA.							BAHCALL S, 1990, ASTROPHYS J, V362, P251, DOI 10.1086/169261; Blandford RD, 1999, MON NOT R ASTRON SOC, V303, pL1, DOI 10.1046/j.1365-8711.1999.02358.x; Chandrasekhar S, 1931, ASTROPHYS J, V74, P81, DOI 10.1086/143324; DOLAN JF, 1992, ASTROPHYS J, V384, P249, DOI 10.1086/170867; DOLAN JF, IN PRESS PUBL ASTRON; DOLAN JF, 2001, B AM ASTRON SOC, V32, P1602; GARCIA MR, 2001, B AM ASTRON SOC, V32, P1602; King AR, 1999, ASTROPHYS J, V519, pL169, DOI 10.1086/312126; ROSEN N, 1975, GEN RELAT GRAVIT, V6, P259, DOI 10.1007/BF00751570; Rosen N., 1973, General Relativity and Gravitation, V4, P435, DOI 10.1007/BF01215403; SHAPIRO SL, 1983, BLACK HOLES WHITE DW, P388; STOEGER WR, 1980, MON NOT R ASTRON SOC, V190, P715; YILMAZ H, 1992, NUOVO CIMENTO B, V107, P941, DOI 10.1007/BF02899296; [No title captured]	14	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1079	1080		10.1126/science.1061665	http://dx.doi.org/10.1126/science.1061665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352057				2022-12-28	WOS:000168609200035
J	Ke, YH; Su, B; Song, XF; Lu, DR; Chen, LF; Li, HY; Qi, CJ; Marzuki, S; Deka, R; Underhill, P; Xiao, CJ; Shriver, M; Lell, J; Wallace, D; Wells, RS; Seielstad, M; Oefner, P; Zhu, DL; Jin, JZ; Huang, W; Chakraborty, R; Chen, Z; Jin, L				Ke, YH; Su, B; Song, XF; Lu, DR; Chen, LF; Li, HY; Qi, CJ; Marzuki, S; Deka, R; Underhill, P; Xiao, CJ; Shriver, M; Lell, J; Wallace, D; Wells, RS; Seielstad, M; Oefner, P; Zhu, DL; Jin, JZ; Huang, W; Chakraborty, R; Chen, Z; Jin, L			African origin of modern humans in East Asia: A tale of 12,000 Y chromosomes	SCIENCE			English	Article							DNA-SEQUENCE VARIATION; HUMAN-EVOLUTION; MITOCHONDRIAL-DNA; NONCODING REGION; FOSSIL EVIDENCE; X-CHROMOSOME; HOMO-SAPIENS; POPULATIONS; PATTERNS; ANCESTRY	To test the hypotheses of modern human origin in East Asia, we sampled 12,127 male individuals from 163 populations and typed for three Y chromosome biallelic markers (YAP, M89, and M130). All the individuals carried a mutation at one of the three sites. These three mutations (YAP+, M89T, and M130T) coalesce to another mutation (M168T), which originated in Africa about 35,000 to 89,000 years ago. Therefore, the data do not support even a minimal in situ hominid contribution in the origin of anatomically modern humans in East Asia.	Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200443, Peoples R China; Morgan Tan Int Ctr Life Sci, Shanghai, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; Univ Texas, Ctr Human Genet, Houston, TX 77030 USA; Eijkman Inst Mol Biol, Jakarta, Indonesia; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Yunnan Univ, Dept Biol, Kunming 650091, Peoples R China; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Univ Oxford, WEllcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Shanghai Second Med Univ, Shanghai, Peoples R China; Natl Human Genome Ctr, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Texas System; Eijkman Institute; University System of Ohio; University of Cincinnati; Stanford University; Yunnan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Emory University; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard T.H. Chan School of Public Health; Shanghai Jiao Tong University	Jin, L (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200443, Peoples R China.		Seielstad, Mark/T-7841-2019; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; Shriver, Mark/0000-0003-0006-0479; Seielstad, Mark/0000-0001-5783-1401				Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROOKS AS, 1990, NATURE, V344, P288, DOI 10.1038/344288a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Etler DA, 1996, ANNU REV ANTHROPOL, V25, P275, DOI 10.1146/annurev.anthro.25.1.275; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; IGOR VO, 2000, NATURE, V404, P490; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; LI TY, 1992, NATURE, V357, P404; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Stoneking M, 1996, CURR OPIN GENET DEV, V6, P731, DOI 10.1016/S0959-437X(96)80028-1; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	28	138	180	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1151	1153		10.1126/science.1060011	http://dx.doi.org/10.1126/science.1060011			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349147				2022-12-28	WOS:000168609200056
J	Hargreaves, S				Hargreaves, S			Refugees: 50 years on	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Hargreaves, S (corresponding author), The Lancet, London WC1X 8RR, England.			Hargreaves, Sally/0000-0003-2974-4348					0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1384	1384		10.1016/S0140-6736(00)04621-3	http://dx.doi.org/10.1016/S0140-6736(00)04621-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356433				2022-12-28	WOS:000168478200007
J	Leonard, J; Grunewald, S; Clayton, P				Leonard, J; Grunewald, S; Clayton, P			Diversity of congenital disorders of glycosylation	LANCET			English	Editorial Material							DEFICIENT GLYCOPROTEIN SYNDROME		Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 1EH, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London WC1N 1EH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Leonard, J (corresponding author), Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 1EH, England.	j.leonard@ich.ucl.ac.uk	Clayton, Peter T/C-1523-2008	Clayton, Peter/0000-0001-7592-4302				de Lonlay P, 2001, J MED GENET, V38, P14, DOI 10.1136/jmg.38.1.14; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; Grunewald S, 2000, ANN NEUROL, V47, P776; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; Korner C, 1999, EMBO J, V18, P6816, DOI 10.1093/emboj/18.23.6816; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Tan J, 1996, AM J HUM GENET, V59, P810; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vestweber D, 2000, BLOOD, V95, P3642	10	19	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1382	1383		10.1016/S0140-6736(00)04618-3	http://dx.doi.org/10.1016/S0140-6736(00)04618-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356431				2022-12-28	WOS:000168478200005
J	Howard, ML				Howard, ML			Legal medicine: A professional option	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Kaiser Permanente Med Ctr, Dept Head & Neck Surg, Santa Rosa, CA USA	Kaiser Permanente								SANBAR SS, 1998, LEGAL MED	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2251	2251		10.1001/jama.285.17.2251	http://dx.doi.org/10.1001/jama.285.17.2251			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325332				2022-12-28	WOS:000168256100032
J	Aaron, LA; Buchwald, D				Aaron, LA; Buchwald, D			A review of the evidence for overlap among unexplained clinical conditions	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC-FATIGUE-SYNDROME; IRRITABLE-BOWEL-SYNDROME; MULTIPLE CHEMICAL SENSITIVITIES; HEALTH-CARE-SEEKING; PRIMARY FIBROMYALGIA; TEMPOROMANDIBULAR DISORDERS; INTERSTITIAL CYSTITIS; SYMPTOMS; DYSFUNCTION; PAIN	Purpose: Unexplained clinical conditions share features, including symptoms (fatigue, pain), disability out of proportion to physical examination findings, inconsistent demonstration of laboratory abnormalities, and an association with "stress" and psychosocial factors. This literature review examines the nature and extent of the overlap among these unexplained clinical conditions and the limitations of previous research. Data Sources: English-language articles were identified by a search of the MEDLINE database from 1966 to January 2001 by using individual syndromes and their hallmark symptoms as search terms. Study Selection: studies that assessed patients with at least one unexplained clinical condition and that included information on symptoms, overlap with other unexplained clinical conditions, or physiologic markers, Conditions examined were the chronic fatigue syndrome, fibromyalgia, the irritable bowel syndrome, multiple chemical sensitivity, temporomandibular disorder, tension headache, interstitial cystitis, and the postconcussion syndrome. Data Extraction: information on authorship, patient and control groups, eligibility criteria, case definitions, study methods, and major findings. Data Synthesis: Many similarities were apparent in case definition and symptoms, and the proportion of patients with one unexplained clinical condition meeting criteria for a second unexplained condition was striking, Tender points on physical examination and decreased pain threshold and tolerance were the most frequent and consistent objective findings. A major shortcoming of all proposed explanatory models is their inability to account for the occurrence of unexplained clinical conditions in many affected patients. Conclusions: Overlap between unexplained clinical conditions is substantial. Most studies are limited by methodologic problems, such as case definition and the selection and recruitment of case-patients and controls.	Harborview Med Ctr, Dept Med, Div Internal Med, Seattle, WA 98104 USA	Harborview Medical Center	Aaron, LA (corresponding author), Harborview Med Ctr, Dept Med, Div Internal Med, 325 9th Ave,Box 359780, Seattle, WA 98104 USA.	laaron@u.washington.edu	Winwood, Peter/A-6363-2008					Aaron LA, 1996, ARTHRITIS RHEUM-US, V39, P436, DOI 10.1002/art.1780390311; Aaron LA, 1997, ARTHRITIS RHEUM, V40, P453, DOI 10.1002/art.1780400311; Aaron LA, 2000, ARCH INTERN MED, V160, P221, DOI 10.1001/archinte.160.2.221; Aaron LA, 2001, J GEN INTERN MED, V16, P24, DOI 10.1046/j.1525-1497.2001.03419.x; ADAMS RD, 1977, HARRISONS TXB INTERN, P25; Alagiri M, 1997, UROLOGY, V49, P52, DOI 10.1016/S0090-4295(99)80332-X; ALMY TP, 1975, TXB MED, P1189; [Anonymous], 1992, GASTROENTEROL INT; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Bartha L, 1999, ARCH ENVIRON HEALTH, V54, P147; BELL IR, 1993, J AM COLL NUTR, V12, P693; Bombardier CH, 1996, MED CARE, V34, P924, DOI 10.1097/00005650-199609000-00005; Bradley L A, 2000, Curr Rev Pain, V4, P148; Buchwald D, 1996, J RHEUMATOL, V23, P739; Buchwald D, 1996, RHEUM DIS CLIN N AM, V22, P219, DOI 10.1016/S0889-857X(05)70270-2; BUCHWALD D, 1994, J GEN INTERN MED, V9, P397, DOI 10.1007/BF02629522; BUCHWALD D, 1994, ARCH INTERN MED, V154, P2049, DOI 10.1001/archinte.154.18.2049; BUCHWALD D, 1987, ARTHRITIS RHEUM, V30, P1132, DOI 10.1002/art.1780301007; CAMPBELL SM, 1983, ARTHRITIS RHEUM, V26, P817, DOI 10.1002/art.1780260701; Chang L, 2000, PAIN, V84, P297, DOI 10.1016/S0304-3959(99)00215-8; Chun A, 1999, DIGEST DIS SCI, V44, P631, DOI 10.1023/A:1026682113096; Cimino R, 1998, J OROFAC PAIN, V12, P35; Clauw DJ, 1997, J PSYCHIAT RES, V31, P125, DOI 10.1016/S0022-3956(96)00051-9; CULLEN MR, 1987, WORKERS MULTIPLE CHE; Dao Thuan T. T., 1997, Journal of Orofacial Pain, V11, P232; DELEEUW JRJ, 1994, J ORAL REHABIL, V21, P667; DeLuca J, 1997, J PSYCHIAT RES, V31, P83, DOI 10.1016/S0022-3956(96)00052-0; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; ERIKSSON PO, 1988, SWED DENT J, V12, P141; Fiedler N, 1996, PSYCHOSOM MED, V58, P38, DOI 10.1097/00006842-199601000-00007; Fischler B, 1997, NEUROPSYCHOBIOLOGY, V35, P115, DOI 10.1159/000119331; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GILLENWATER JY, 1988, J UROLOGY, V140, P203, DOI 10.1016/S0022-5347(17)41529-1; GOLDENBERG DL, 1990, ARTHRITIS RHEUM, V33, P381, DOI 10.1002/art.1780330311; Gomborone JE, 1996, J ROY COLL PHYS LOND, V30, P512; HAGBERG C, 1994, ACTA ODONTOL SCAND, V52, P170, DOI 10.3109/00016359409027592; Hedenberg-Magnusson B, 1997, ACTA ODONTOL SCAND, V55, P344, DOI 10.3109/00016359709059198; Helkimo M, 1974, Sven Tandlak Tidskr, V67, P101; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; HRUBEC Z, 1984, NEW ENGL J MED, V310, P435, DOI 10.1056/NEJM198402163100706; HUDSON JI, 1992, AM J MED, V92, P363, DOI 10.1016/0002-9343(92)90265-D; *INT ASS STUD PAIN, 1986, PAIN S, V3, pS59; Jason LA, 2000, PSYCHOSOM MED, V62, P655, DOI 10.1097/00006842-200009000-00009; KATON WJ, 1993, CIBA F SYMP, V173, P193; Korszun A, 1999, J RHEUMATOL, V26, P2675; Korszun A, 1998, ORAL SURG ORAL MED O, V86, P416, DOI 10.1016/S1079-2104(98)90366-3; Krogstad Berit Schie, 1996, Journal of Orofacial Pain, V10, P48; KRUIS W, 1984, GASTROENTEROLOGY, V87, P1; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Morriss RK, 1999, J AFFECT DISORDERS, V55, P143, DOI 10.1016/S0165-0327(98)00218-3; Nawab SS, 2000, PSYCHIAT RES, V95, P67, DOI 10.1016/S0165-1781(00)00148-7; Nicolodi M, 1998, CEPHALALGIA, V18, P41, DOI 10.1177/0333102498018S2111; OKESON JP, 1995, BELLS OROFACIAL PAIN, P9; Okifuji A, 1999, PSYCHOSOM MED, V61, P771, DOI 10.1097/00006842-199911000-00009; OSLER W, 1985, COLLECTED ESSAYS W O, V2, P239; Plesh O, 1996, J RHEUMATOL, V23, P1948; PLUM F, 1975, TXB MED, P616; PRESCOTT E, 1993, SCAND J RHEUMATOL, V22, P238, DOI 10.3109/03009749309095130; Raphael KG, 2000, J AM DENT ASSOC, V131, P161, DOI 10.14219/jada.archive.2000.0143; REYNOLDS MD, 1978, WESTERN J MED, V128, P285; Romano T J, 1988, W V Med J, V84, P16; SCHLUEDERBERG A, 1992, ANN INTERN MED, V117, P325, DOI 10.7326/0003-4819-117-4-325; Schulte John K., 1993, Journal of Orofacial Pain, V7, P247; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; SHORT D, 1994, BRIT J HOSP MED, V51, P128; Sivri A, 1996, CLIN RHEUMATOL, V15, P283, DOI 10.1007/BF02229708; Slotkoff AT, 1997, SCAND J RHEUMATOL, V26, P364, DOI 10.3109/03009749709065700; SMYTHE H, 1986, AM J MED, V81, P2, DOI 10.1016/0002-9343(86)90865-X; Smythe H. A, 1972, ARTHRITIS ALLIED CON, P874; Smythe HA, 1985, ARTHRITIS ALLIED CON, P1083; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Sperber AD, 1999, J MUSCULOSKELET PAIN, V7, P15, DOI 10.1300/J094v07n04_03; Sperber AD, 1999, AM J GASTROENTEROL, V94, P3541, DOI 10.1111/j.1572-0241.1999.01643.x; THOMPSON WG, 1993, LANCET, V341, P1569, DOI 10.1016/0140-6736(93)90705-L; Thompson WG., 1989, GASTROENTEROL INT, V2, P92; TRIADAFILOPOULOS G, 1991, DIGEST DIS SCI, V36, P59, DOI 10.1007/BF01300088; VEALE D, 1991, BRIT J RHEUMATOL, V30, P220; Walker EA, 1996, J PSYCHOSOM OBST GYN, V17, P39, DOI 10.3109/01674829609025662; WATSON D, 1991, MENTAL REPRESENTATIO, P60, DOI DOI 10.1007/978-1-4613-9074-9_4; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; White KP, 2000, SCAND J RHEUMATOL, V29, P44; WHORWELL PJ, 1986, GUT, V27, P37, DOI 10.1136/gut.27.1.37; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 1997, ARTHRITIS RHEUM, V40, P1560, DOI 10.1002/art.1780400904; Wright EF, 1997, J AM DENT ASSOC, V128, P738, DOI 10.14219/jada.archive.1997.0297; WYSENBEEK AJ, 1991, RHEUMATOL INT, V10, P227, DOI 10.1007/BF02274883; YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2; Yunus MB, 2000, J RHEUMATOL, V27, P485; Yunus MB, 2000, J INDIAN RHEUM ASS, V8, P27	93	321	333	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			868	881		10.7326/0003-4819-134-9_Part_2-200105011-00011	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00011			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346323				2022-12-28	WOS:000168543100011
J	Horne, AW; White, JO; Margara, RA; Williams, R; Winston, RML; Lalani, E				Horne, AW; White, JO; Margara, RA; Williams, R; Winston, RML; Lalani, E			MUC 1: a genetic susceptibility to infertility?	LANCET			English	Article								In man and some animals regulation of embryo Implantation by endometrial expression of the highly polymorphic MUC 1 mucin has been suggested. We assessed the polymorphism of MUC 1 in women known to be fertile and those with infertility due to suspected failure of embryo implantation. The median of the lower allele size in the infertile group was only 2.5 kb compared with 3.4 kb in the fertile group (p=0.0029, difference 0.9, [95% CI 0.1-1.3]). Woman with unexplained Infertility might have a genetic susceptibility to failure of embryo implantation due to small MUC 1 allele size.	Imperial Coll Sch Med, Inst Reprod & Dev Biol, London W12 0NN, England	Imperial College London	Lalani, E (corresponding author), Imperial Coll Sch Med, Inst Reprod & Dev Biol, Hammersmith Hosp Campus, London W12 0NN, England.			Lalani, El-Nasir/0000-0001-9733-459X; Horne, Andrew/0000-0002-9656-493X				Aplin JD, 1998, GLYCOBIOLOGY, V8, P269, DOI 10.1093/glycob/8.3.269; Carson DD, 1998, BIOESSAYS, V20, P577, DOI 10.1002/(SICI)1521-1878(199807)20:7<577::AID-BIES9>3.0.CO;2-H; Carvalho F, 1997, GLYCOCONJUGATE J, V14, P107, DOI 10.1023/A:1018573201347; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693	5	37	39	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1336	1337		10.1016/S0140-6736(00)04502-5	http://dx.doi.org/10.1016/S0140-6736(00)04502-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343742				2022-12-28	WOS:000168411400015
J	Lambeck, K; Chappell, J				Lambeck, K; Chappell, J			Sea level change through the last glacial cycle	SCIENCE			English	Review							ANTARCTIC ICE-SHEET; PAPUA-NEW-GUINEA; MUNGO 3 SKELETON; LATE PLEISTOCENE; HUON PENINSULA; MANTLE VISCOSITY; BRITISH-ISLES; MASS-SPECTROMETRY; MELTING HISTORY; YOUNGER DRYAS	Sea level change during the Quaternary is primarily a consequence of the cyclic growth and decay of ice sheets, resulting in a complex spatial and temporal pattern. Observations of this variability provide constraints on the timing, rates, and magnitudes of the changes in ice mass during a glacial cycle, as well as more limited information on the distribution of ice between the major ice sheets at any time. Observations of glacially induced sea level changes also provide information on the response of the mantle to surface loading on time scales of 10(3) to 10(5) years. Regional analyses indicate that the earth-response function is depth dependent as well as spatially variable. Comprehensive models of sea level change enable the migration of coastlines to be predicted during glacial cycles, including the anthropologically important period from about 60,000 to 20,000 years ago.	Australian Natl Univ, Res Sch Earth Sci, Camden, NSW 0200, Australia; Lund Univ, S-22100 Lund, Sweden	Australian National University; Lund University	Lambeck, K (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Camden, NSW 0200, Australia.							Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Bard E, 1998, RADIOCARBON, V40, P1085, DOI 10.1017/S0033822200019135; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BARD E, 1993, RADIOCARBON, V35, P191, DOI 10.1017/S0033822200013886; Bard E, 1999, SCIENCE, V284, P1133, DOI 10.1126/science.284.5417.1133; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; CHAPPELL J, 1991, NATURE, V349, P147, DOI 10.1038/349147a0; Chappell J, 1996, QUATERNARY SCI REV, V15, P7, DOI 10.1016/0277-3791(95)00062-3; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; CHAPPELL J, 1983, NATURE, V302, P406, DOI 10.1038/302406a0; CHAPPELL J, 1983, BMR J AUST GEOL GEOP, V8, P223; CHAPPELL J, IN PRESS QUAT SIC RE; CHURCH JA, IN PRESS INTERGOVERN, pCH11; COSGROVE R, 1990, ANTIQUITY, V64, P59, DOI 10.1017/S0003598X00077309; Denton G. H., 1981, LAST GREAT ICE SHEET; DENTON GH, 1989, QUATERNARY RES, V31, P151, DOI 10.1016/0033-5894(89)90004-5; DYKE AS, 1991, GEOL SURV CAN B, V397, P56; Dyke AS, 1989, QUATERNARY GEOLOGY C, V1, P178; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Ekman M, 1999, GLOBAL PLANET CHANGE, V21, P215, DOI 10.1016/S0921-8181(99)00045-4; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Forte AM, 1996, GEOPHYS RES LETT, V23, P1147, DOI 10.1029/96GL00964; Galewsky J, 1996, GEOLOGY, V24, P819, DOI 10.1130/0091-7613(1996)024<0819:FTACPD>2.3.CO;2; Gibb J. G., 1986, R SOC NZ B, V24, P377; Grun R, 2000, J HUM EVOL, V38, P733, DOI 10.1006/jhev.2000.0399; HAGER BH, 1984, J GEOPHYS RES, V89, P6003, DOI 10.1029/JB089iB07p06003; HALLAM A, 1984, ANNU REV EARTH PL SC, V12, P205, DOI 10.1146/annurev.ea.12.050184.001225; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; HEYWORTH A, 1982, Proceedings of the Geologists' Association, V93, P91; HUYBRECHTS P, 1994, ANN GLACIOL, V20, P336, DOI 10.3189/172756494794587221; JACOBSON TW, 1976, SCI AM, V234, P343; JOHNSTON P, 1993, GEOPHYS J INT, V114, P615, DOI 10.1111/j.1365-246X.1993.tb06992.x; Johnston PJ, 2000, J GEOPHYS RES-SOL EA, V105, P13179, DOI 10.1029/2000JB900074; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; Kaufmann G, 2000, PHYS EARTH PLANET IN, V121, P301, DOI 10.1016/S0031-9201(00)00174-6; Lambeck K, 2000, EARTH PLANET SC LETT, V181, P513, DOI 10.1016/S0012-821X(00)00223-5; LAMBECK K, 1995, J GEOL SOC LONDON, V152, P437, DOI 10.1144/gsjgs.152.3.0437; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; LAMBECK K, 1993, TECTONOPHYSICS, V223, P15, DOI 10.1016/0040-1951(93)90155-D; LAMBECK K, 1995, GEOPHYS J INT, V122, P1022, DOI 10.1111/j.1365-246X.1995.tb06853.x; LAMBECK K, 1990, GLOBAL PLANET CHANGE, V89, P143, DOI 10.1016/0921-8181(90)90060-P; Lambeck K, 1996, EARTH PLANET SC LETT, V142, P43, DOI 10.1016/0012-821X(96)00069-6; Lambeck K, 1996, GEOPHYS J INT, V125, P340, DOI 10.1111/j.1365-246X.1996.tb00003.x; Lambeck K, 1996, ANTIQUITY, V70, P588, DOI 10.1017/S0003598X00083733; LAMBECK K, IN PRESS QUAT SCI RE; Lambeck K., 1998, EARTHS MANTLE COMPOS, P461, DOI DOI 10.1017/CBO9780511573101.013; LAMBECK K, IN PRESS GLACIAL ISO; Liden R., 1938, GEOL FOREN STOCK FOR, V60, P397; Lighty R.G., 1982, Coral Reefs, V1, P125, DOI 10.1007/BF00301694; Milne GA, 1999, GEOPHYS J INT, V139, P464, DOI 10.1046/j.1365-246x.1999.00971.x; Milne GA, 1998, GEOPHYS J INT, V133, P1, DOI 10.1046/j.1365-246X.1998.1331455.x; MITROVICA JX, 1992, GEOPHYS RES LETT, V19, P1185, DOI 10.1029/92GL01285; MITROVICA JX, 1994, J GEOPHYS RES-SOL EA, V99, P7075, DOI 10.1029/93JB03401; Mitrovica JX, 1996, J GEOPHYS RES-SOL EA, V101, P555, DOI 10.1029/95JB03208; Montaggioni LF, 1997, GEOLOGY, V25, P555, DOI 10.1130/0091-7613(1997)025<0555:CRORGO>2.3.CO;2; NAKADA M, 1987, GEOPHYS J INT, V90, P171, DOI 10.1111/j.1365-246X.1987.tb00680.x; NAKADA M, 1989, GEOPHYS J INT, V96, P497, DOI 10.1111/j.1365-246X.1989.tb06010.x; Nakada M, 2000, MAR GEOL, V167, P85, DOI 10.1016/S0025-3227(00)00018-9; NAKADA M, 1991, NATO ADV SCI I C-MAT, V334, P79; NAKADA M, 1988, NATURE, V333, P36, DOI 10.1038/333036a0; O'Connell JF, 1998, EVOL ANTHROPOL, V6, P132, DOI 10.1002/(SICI)1520-6505(1998)6:4<132::AID-EVAN3>3.0.CO;2-F; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; RICARD Y, 1993, J GEOPHYS RES-SOL EA, V98, P21895, DOI 10.1029/93JB02216; Romanowicz B, 1998, PURE APPL GEOPHYS, V153, P257, DOI 10.1007/s000240050196; Roux G., 1992, ANCIENT IRAQ, V3rd ed.; ROUX G, 1992, INITIATION ORIENT AN, P37; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shennan I, 2000, QUATERNARY SCI REV, V19, P1103, DOI 10.1016/S0277-3791(99)00089-X; Stirling CH, 2001, SCIENCE, V291, P290, DOI 10.1126/science.291.5502.290; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Sutton, 1987, LANDSCAPES PEOPLE FR, P3; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; Vail P.R., 1984, INTERREGIONAL UNCONF, VVolume 36, P129; VORREN KD, 1986, NORSK GEOL TIDSSKR, V66, P135; WOODROFFE C, 1990, NATURE, V344, P531, DOI 10.1038/344531a0; Woodworth PL, 1999, GEOPHYS J INT, V136, P651, DOI 10.1046/j.1365-246x.1999.00751.x; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035; Yokoyama Y, 2000, RADIOCARBON, V42, P383, DOI 10.1017/S0033822200030320; ZWARTZ D, 1997, ANTARCTIC REGION GEO; [No title captured], DOI DOI 10.1016/0277-3791(86)90192-7	89	1314	1395	9	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					679	686		10.1126/science.1059549	http://dx.doi.org/10.1126/science.1059549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326090				2022-12-28	WOS:000168478300040
J	Mandelbrot, L; Landreau-Mascaro, A; Rekacewicz, C; Berrebi, A; Benifla, JL; Burgard, M; Lachassine, E; Barret, B; Chaix, ML; Bongain, A; Ciraru-Vigneron, N; Crenn-Hebert, C; Delfraissy, JF; Rouzioux, C; Mayaux, MJ; Blanche, S				Mandelbrot, L; Landreau-Mascaro, A; Rekacewicz, C; Berrebi, A; Benifla, JL; Burgard, M; Lachassine, E; Barret, B; Chaix, ML; Bongain, A; Ciraru-Vigneron, N; Crenn-Hebert, C; Delfraissy, JF; Rouzioux, C; Mayaux, MJ; Blanche, S		Agence Natl Rech SIDA	Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SELECTIVE VERTICAL TRANSMISSION; PERINATAL TRANSMISSION; RESISTANCE; THERAPY; WOMEN; EXPOSURE; MUTATION; TRIALS; SAFETY	Context Zidovudine reduces maternal-infant transmission of human immunodeficiency virus 1 (HIV-1) infection by two thirds. Combination antiretroviral therapies are potentially more effective prevention, Objectives To assess the safety of perinatal lamivudine-zidovudine therapy, especially in children, and its effects on viral load, acquisition of drug resistance, and maternal-infant transmission of HIV-1 in a nonbreastfeeding population. Design and Setting The Agence Nationale de Recherches sur le SIDA (ANRS) 075 Study, an open-label, nonrandomized intervention trial conducted in the context of an ongoing observational cohort study in 48 sites in France. Patients A total of 445 HIV-1-infected pregnant women were enrolled as the study cohort from February 1997 to September 1998; controls consisted of 899 pregnant women who had received zidovudine monotherapy in May 1994 to February 1997 as standard care. Intervention The study cohort received lamivudine in addition to the standard Pediatric AIDS Clinical Trial Group 076 Study zidovudine prophylaxis regimen. Lamivudine was initiated in women at 32 weeks' gestation through delivery at 150 mg twice per day orally; children received lamivudine, 2 mg/kg twice per day for 6 weeks. Main Outcome Measures HIV-1 infection status and tolerance of therapy in children through age 18 months; maternal plasma HIV-1 RNA levels through 6 weeks after delivery. Results The transmission rate in the study group was 1.6% (7/437; 95% confidence interval [CI], 0.7%-3.3%). In a multivariable analysis, transmission in the study group was 5-fold lower than in controls. In the study group, maternal plasma HIV-1 RNA level was less than 500 copies/mL at delivery in 74%; the median decrease was 1.24 (range, -1.63 to 3.40) log(10) copies/mL. The M184V lamivudine resistance mutation was detected at 6 weeks after delivery in specimens from 52 of 132 women. The most frequent serious adverse events in children were neutropenia and anemia, requiring blood transfusion in 9 children and premature treatment discontinuation in 19. Two uninfected children died at age 1 year from neurologic complications related to mitochondrial dysfunction. Conclusions Lamivudine-zidovudine may be effective in preventing maternal-infant HIV transmission. However, severe adverse effects and emergence of resistance to lamivudine occurred, Thus, the role of this combination therapy in this setting is as yet unclear, and further research involving a variety of strategies is needed to definitively ascertain its utility for preventing maternal-infant HIV transmission.	Hop Cochin, Dept Obstet Gynecol, Serv Gynecol Obstet, F-75014 Paris, France; Hop Bichat Claude Bernard, Dept Obstet Gynecol, F-75877 Paris, France; Hop Necker Enfants Malad, Dept Virol, Paris, France; Hop Necker Enfants Malad, Dept Pediat Immunol, Paris, France; Hop Lariboisiere, Dept Obstet Gynecol, F-75475 Paris, France; INSERM, U292, Le Kremlin Bicetre, France; Hop Kremlin Bicetre, Dept Internal Med, Le Kremlin Bicetre, France; Hop Grave Toulouse, Dept Obstet Gynecol, Toulouse, France; Hop Jean Verdier, Dept Obstet Gynecol, Bondy, France; Hop Archet 2, Dept Obstet Gynecol, Nice, France; Hop Louis Mourier, Dept Obstet Gynecol, F-92701 Colombes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU de Toulouse; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite	Mandelbrot, L (corresponding author), Hop Cochin, Dept Obstet Gynecol, Serv Gynecol Obstet, 123 Blvd Port Royal, F-75014 Paris, France.	laurent.mandelbrot@cch.ap-hop-paris.fr	Mandelbrot, Laurent/AAD-3554-2019	Mandelbrot, Laurent/0000-0002-5883-7597				Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Catucci M, 1999, J ACQ IMMUN DEF SYND, V21, P203, DOI 10.1097/00126334-199907010-00004; Clarke JR, 1999, J MED VIROL, V59, P364, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;364::AID-JMV17&gt;3.0.CO;2-V; Colgrove RC, 1998, AIDS, V12, P2281, DOI 10.1097/00002030-199817000-00009; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Eastman PS, 1998, J INFECT DIS, V177, P557, DOI 10.1086/514228; Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483; Grubert TA, 1999, AIDS, V13, P1430, DOI 10.1097/00002030-199907300-00034; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118; Koch N, 1999, J VIROL METHODS, V80, P25, DOI 10.1016/S0166-0934(99)00030-0; Luzzati R, 1999, LANCET, V353, P901, DOI 10.1016/S0140-6736(99)00523-1; Mandelbrot L, 1998, JAMA-J AM MED ASSOC, V280, P55, DOI 10.1001/jama.280.1.55; MAYAUX MJ, 1995, J ACQ IMMUN DEF SYND, V8, P188; Mayaux MJ, 1997, J PEDIATR-US, V131, P857, DOI 10.1016/S0022-3476(97)70033-7; Mayaux MJ, 1997, J INFECT DIS, V175, P172, DOI 10.1093/infdis/175.1.172; Minkoff H, 1997, AM J OBSTET GYNECOL, V176, P478, DOI 10.1016/S0002-9378(97)70519-2; Mofenson LM, 2000, NEW ENGL J MED, V343, P803, DOI 10.1056/NEJM200009143431110; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Moodley J, 1998, J INFECT DIS, V178, P1327, DOI 10.1086/314431; Newschaffer CJ, 2000, J ACQ IMMUN DEF SYND, V24, P249; Niehues T, 1999, AIDS, V13, P2482, DOI 10.1097/00002030-199912030-00025; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Scalfaro P, 1998, INTENS CARE MED, V24, P247, DOI 10.1007/s001340050558; Silverman N S, 1998, Infect Dis Obstet Gynecol, V6, P237, DOI 10.1155/S1064744998000490; Sperling RS, 1998, AIDS, V12, P1805, DOI 10.1097/00002030-199814000-00012; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Tovo PA, 1999, PRENAT NEONAT MED, V4, P3; Uusimaa J, 2000, PEDIATRICS, V105, P598, DOI 10.1542/peds.105.3.598; [No title captured]; [No title captured]; [No title captured]	37	249	262	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2083	2093		10.1001/jama.285.16.2083	http://dx.doi.org/10.1001/jama.285.16.2083			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311097	Bronze			2022-12-28	WOS:000168131600028
J	Freemantle, N				Freemantle, N			Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?	BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; MORTALITY		Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Freemantle, N (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.			Freemantle, Nick/0000-0001-5807-5740				Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Cleland JGF, 1999, BRIT MED J, V318, P824, DOI 10.1136/bmj.318.7187.824; *DEP HHS FDA, 1998, FED REGISTER, V63, P49583; Fisher LD, 1999, CONTROL CLIN TRIALS, V20, P16, DOI 10.1016/S0197-2456(98)00054-3; FREEMANTLE N, 1994, HEALTH ECON, V3, P63, DOI 10.1002/hec.4730030202; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Moye LA, 1999, CONTROL CLIN TRIALS, V20, P40, DOI 10.1016/S0197-2456(98)00051-8; *NAT I CLIN EXC, 2001, INT GUID MAN SPONS; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; POCOCK SJ, 1990, STAT MED, V9, P657, DOI 10.1002/sim.4780090612; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; TEMPLE R, 1980, NEW ENGL J MED, V303, P1488, DOI 10.1056/NEJM198012183032534	16	121	122	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					989	991		10.1136/bmj.322.7292.989	http://dx.doi.org/10.1136/bmj.322.7292.989			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312237	Green Published			2022-12-28	WOS:000168345100026
J	Sagasti, A; Hisamoto, N; Hyodo, J; Tanaka-Hino, M; Matsumoto, K; Bargmann, CI				Sagasti, A; Hisamoto, N; Hyodo, J; Tanaka-Hino, M; Matsumoto, K; Bargmann, CI			The CaMKII UNC-43 activates the MAPKKK NSY-1 to execute a lateral signaling decision required for asymmetric olfactory neuron fates	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROTEIN-KINASE CASCADE; C-ELEGANS; REGULATING KINASE-1; APOPTOSIS; ASK1; TRANSDUCTION; EXPRESSION; PATHWAY; MORPHOGENESIS	A stochastic cell fate decision mediated by axon contact and calcium signaling causes one of the two bilaterally symmetric AWC neurons, either AWCL or AWCR, to express the candidate olfactory receptor str-2 nsy-1 mutants express str-2 in both neurons, disrupting AWC asymmetry, nsy-1 encodes a homolog of the human MAP kinase kinase kinase (MAPKKK) ASK1, an activator of JNK and p38 kinases. Based on genetic epistasis analysis, nsy-1 appears to act downstream of the CaMKII unc-43, and NSY-1 associates with UNC-43, suggesting that UNC-43/CaMKII activates the NSY-1 MAP kinase cassette. Mosaic analysis demonstrates that UNC-43 and NSY-1 act primarily in a cell-autonomous execution step that represses str-2 expression in one AWC cell, downstream of the initial lateral signaling pathway that coordinates the fates of the two cells.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nagoya University; Japan Science & Technology Agency (JST)	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; HERMAN RK, 1984, GENETICS, V108, P165; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Watt WC, 2001, J BIOL CHEM, V276, P2047, DOI 10.1074/jbc.M006703200; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams BD, 1995, METHOD CELL BIOL, V48, P81; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	35	158	166	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					221	232		10.1016/S0092-8674(01)00313-0	http://dx.doi.org/10.1016/S0092-8674(01)00313-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336672	Bronze			2022-12-28	WOS:000168384300009
J	Redelmeier, DA; Singh, SM				Redelmeier, DA; Singh, SM			Survival in academy award-winning actors and actresses	ANNALS OF INTERNAL MEDICINE			English	Article							LEAD TIME; MORTALITY; BIAS; INEQUALITIES	Background: Social status is an important predictor of poor health. Most studies of this issue have focused on the lower echelons of society. Objective: To determine whether the increase in status from winning an academy award is associated with long-term mortality among actors and actresses. Design: Retrospective cohort analysis. Setting: Academy of Motion picture Arts and Sciences. Participants: All actors and actresses ever nominated for an academy award in a leading or a supporting role were identified (n = 762). For each, another cast member of the same sex who was in the same film and was born in the same era was identified (n = 887). Measurements: Life expectancy and all-cause mortality rates. Results: All 1649 performers were analyzed; the median duration of follow-up time from birth was 66 years, and 772 deaths occurred (primarily from ischemic heart disease and malignant disease). Life expectancy was 3.9 years longer for Academy Award winners than for other, less recognized performers (79.7 vs. 75.8 years; P = 0.003). This difference was equal to a 28% relative reduction in death rates (95% CI, 10% to 42%). Adjustment for birth year, sex, and ethnicity yielded similar results, as did adjustments for birth country, possible name change, age at release of first film, and total films in career. Additional wins were associated with a 22% relative reduction in death rates (CI, 5% to 35%), whereas additional films and additional nominations were not associated with a significant reduction in death rates. Conclusion: The association of high status with increased longevity that prevails in the public also extends to celebrities, contributes to a large survival advantage, and is partially explained by factors related to success.	Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Toronto, ON M4N 3M5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Redelmeier, DA (corresponding author), Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Room G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dar@ices.on.ca	Hegele, Robert/G-3301-2011; Staud, Roland/A-8442-2008					*BUR CENS, 1996, STAT ABSTR US 1996, P88; *BUR CENS, 1997, STAT ABSTR US 1997, P287; COX DR, 1984, ANAL SURVIVAL DATA, P112; Detsky AS, 1998, NEW ENGL J MED, V339, P402, DOI 10.1056/NEJM199808063390611; Evans R. G., 1994, WHY ARE SOME PEOPLE, P3; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; FULLER G, 1983, ILLUSTRATED WHOS WHO; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; KATZ E, 1979, FILM ENCY; KATZ MH, 1999, MULTIVARIABLE ANAL P, P173; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; MARMOT MG, 1984, LANCET, V1, P1003; MEDVEC VH, 1995, J PERS SOC PSYCHOL, V69, P603, DOI 10.1037/0022-3514.69.4.603; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; PELIKAN S, 1993, CANCER, V71, P1998, DOI 10.1002/1097-0142(19930315)71:6<1998::AID-CNCR2820710613>3.0.CO;2-P; SMITH GD, 1992, BRIT MED J, V305, P1554, DOI 10.1136/bmj.305.6868.1554; Syme SL, 1997, LANCET, V350, P231, DOI 10.1016/S0140-6736(05)62220-9; TAYLOR R, 1998, HDB PUBLIC HLTH METH, P57; TRUITT EM, 1979, WHO WAS WHO SCREEN; Tunnell RD, 1998, ANAESTHESIA, V53, P1045, DOI 10.1046/j.1365-2044.1998.00566.x; WALKER J, 1997, HALLIWELLS FILMGOERS	22	121	126	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					955	962		10.7326/0003-4819-134-10-200105150-00009	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352696				2022-12-28	WOS:000168682500003
J	Macintyre, K; Stewart, S; Chalmers, J; Pell, C; Finlayson, A; Boyd, J; Redpath, A; McMurray, J; Capewell, S				Macintyre, K; Stewart, S; Chalmers, J; Pell, C; Finlayson, A; Boyd, J; Redpath, A; McMurray, J; Capewell, S			Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis	BRITISH MEDICAL JOURNAL			English	Article							SURVIVAL		Univ Glasgow, Clin Res Initiat Heart Failure, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8QQ, Lanark, Scotland; Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Greater Glasgow Hlth Board, Glasgow G3 8RH, Lanark, Scotland; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Glasgow; University of Glasgow; University of Liverpool	McMurray, J (corresponding author), Univ Glasgow, Clin Res Initiat Heart Failure, Glasgow G12 8QQ, Lanark, Scotland.		mcmurray, John/B-2467-2013; Macintyre, Kate/J-7174-2014; Stewart, Simon/M-3316-2016	mcmurray, John/0000-0002-6317-3975; Macintyre, Kate/0000-0003-2741-0467; Stewart, Simon/0000-0001-9032-8998; Boyd, James/0000-0002-8925-8811; Pell, Jill/0000-0002-8898-7035				BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; *NAT HEART FOR, 1999, SOC INEQ COR HEART D; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981	5	60	60	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1152	1153		10.1136/bmj.322.7295.1152	http://dx.doi.org/10.1136/bmj.322.7295.1152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348909	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000168748900015
J	Marsh, AG; Mullineaux, LS; Young, CM; Manahan, DT				Marsh, AG; Mullineaux, LS; Young, CM; Manahan, DT			Larval dispersal potential of the tubeworm Riftia pachyptila at deep-sea hydrothermal vents	NATURE			English	Article							EAST PACIFIC RISE; FUCA RIDGE; ECOLOGICAL IMPLICATIONS; ENERGY-METABOLISM; LIPID-METABOLISM; PLUMES; EVENT; JUAN; CURRENTS; STORAGE	Hydrothermal vents are ephemeral because of frequent volcanic and tectonic activities associated with crust formation(1-3). Although the larvae of hydrothermal vent fauna can rapidly colonize new vent sites separated by tens to hundreds of kilometres(4,5), the mechanisms by which these larvae disperse and recruit are not understood. Here we integrate physiological, developmental and hydrodynamic data to estimate the dispersal potential of larvae of the giant tubeworm Riftia pachyptila. At in situ temperatures and pressures (2 degreesC and 250 atm), we estimate that the metabolic lifespan for a larva of R. pachyptila averages 38 days. In the measured flow regime at a fast-spreading ridge axis (9 degrees 50' N; East Pacific Rise), this lifespan results in potential along-ridge dispersal distances that rarely exceed 100 km. This limited dispersal results not from the physiological performance of the embryos and larvae, but instead from transport limitations imposed by periodic reversals in along-ridge flows and sustained episodes of across-ridge flow. The lifespan presented for these larvae can now be used to predict dispersal under current regimes at other hydrothermal vent sites.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Harbor Branch Oceanog Inst Inc, Div Marine Sci, Ft Pierce, FL 34946 USA	University of Southern California; Woods Hole Oceanographic Institution; Harbor Branch Oceanographic Institute Foundation	Manahan, DT (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.		Huffstickler, John/H-1745-2011	Mullineaux, Lauren/0000-0002-8932-2625				BAKER ET, 1994, EARTH PLANET SC LETT, V128, P1, DOI 10.1016/0012-821X(94)90022-1; Cannon GA, 1997, J GEOPHYS RES-OCEANS, V102, P24965, DOI 10.1029/97JC01910; CANNON GA, 1991, J GEOPHYS RES-OCEANS, V96, P12815, DOI 10.1029/91JC01023; CARY SC, 1989, MAR ECOL PROG SER, V52, P89, DOI 10.3354/meps052089; Chevaldonne P, 1997, LIMNOL OCEANOGR, V42, P67, DOI 10.4319/lo.1997.42.1.0067; CRANE K, 1988, MAR GEOPHYS RES, V9, P211, DOI 10.1007/BF00309974; Evanson M, 2000, MAR ECOL PROG SER, V192, P239, DOI 10.3354/meps192239; FOMARI DJ, 1995, PHYSICAL CHEM BIOL G, P1; Fornari DJ, 1998, EARTH PLANET SC LETT, V160, P419, DOI 10.1016/S0012-821X(98)00101-0; Hagen W, 1998, LIMNOL OCEANOGR, V43, P1894; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; Jannasch HW, 1996, APPL ENVIRON MICROB, V62, P1593, DOI 10.1128/AEM.62.5.1593-1596.1996; Kattner G, 1998, MAR ECOL PROG SER, V170, P203, DOI 10.3354/meps170203; KIM SL, 1994, J GEOPHYS RES-OCEANS, V99, P12655, DOI 10.1029/94JC00644; Lupton JE, 1998, SCIENCE, V280, P1052, DOI 10.1126/science.280.5366.1052; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Marsh AG, 1999, MAR ECOL PROG SER, V184, P1, DOI 10.3354/meps184001; Marsh AG, 1999, J EXP BIOL, V202, P2041; Miller CB, 1998, LIMNOL OCEANOGR, V43, P488, DOI 10.4319/lo.1998.43.3.0488; Mullineaux LS, 2000, OECOLOGIA, V123, P275, DOI 10.1007/s004420051014; MULLINEAUX LS, 1995, MAR BIOL, V122, P585, DOI 10.1007/BF00350680; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; THOMSON RE, 1989, J GEOPHYS RES-OCEANS, V94, P4709, DOI 10.1029/JC094iC04p04709; THOMSON RE, 1990, J GEOPHYS RES, V95, P12961; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0	26	173	182	2	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					77	80		10.1038/35075063	http://dx.doi.org/10.1038/35075063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333980				2022-12-28	WOS:000168432800046
J	Palmer, TD; Schwartz, PH; Taupin, P; Kaspar, B; Stein, SA; Gage, FH				Palmer, TD; Schwartz, PH; Taupin, P; Kaspar, B; Stein, SA; Gage, FH			Cell culture - Progenitor cells from human brain after death	NATURE			English	Article							NEURAL STEM-CELLS; IN-VITRO; TRANSPLANTATION; PROLIFERATION; NEURONS		Salk Inst, Genet Lab, La Jolla, CA 92122 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Childrens Hosp Orange Cty, Brain & Tissue Bank Dev Disorders, Orange, CA 92868 USA	Salk Institute; Stanford University; Childrens Hospital of Orange County	Palmer, TD (corresponding author), Salk Inst, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92122 USA.		Kaspar, Brian/E-3349-2011; Palmer, Theo/GSI-6635-2022	Palmer, Theo/0000-0002-6266-1862				Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7	10	361	392	1	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					42	43		10.1038/35075141	http://dx.doi.org/10.1038/35075141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333968				2022-12-28	WOS:000168432800034
J	Obuobie, K; Roach, H; Harvey, J; Lazarus, JH				Obuobie, K; Roach, H; Harvey, J; Lazarus, JH			An abnormal venous clot	LANCET			English	Editorial Material									Llandough Hosp, Dept Med, Penarth CF64 2XX, S Glam, Wales; Llandough Hosp, Dept Radiol, Penarth CF64 2XX, S Glam, Wales; Llandough Hosp, Dept Surg, Penarth CF64 2XX, S Glam, Wales		Lazarus, JH (corresponding author), Llandough Hosp, Dept Med, Penarth CF64 2XX, S Glam, Wales.		Lazarus, John H/H-5108-2017	Lazarus, John H/0000-0001-8852-704X				DZINSICH C, 1992, J VASC SURG, V15, P592; Perl L, 1871, ARCH F PATH ANAT, V53, P378; Reix T, 1998, ANN VASC SURG, V12, P589, DOI 10.1007/s100169900205; ROY C, 1993, AM J ROENTGENOL, V160, P112	4	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1334	1334		10.1016/S0140-6736(00)04521-9	http://dx.doi.org/10.1016/S0140-6736(00)04521-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343740				2022-12-28	WOS:000168411400013
J	Toulokhonov, I; Artsimovitch, I; Landick, R				Toulokhonov, I; Artsimovitch, I; Landick, R			Allosteric control of RNA polymerase by a site that contacts nascent RNA hairpins	SCIENCE			English	Article							INTRINSIC TRANSCRIPTION TERMINATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DNA HYBRID; ELONGATION; MECHANISM; INVITRO; BINDING; PAUSE; MODEL	DNA, RNA, and regulatory molecules control gene expression through interactions with RNA polymerase (RNAP). We show that a short or helix at the tip of the flaplike domain that covers the RNA exit channel of RNAP contacts a nascent RNA stem-loop structure (hairpin) that inhibits transcription, and that this flap-tip helix is required for activity of the regulatory protein NusA. Protein-RNA cross-linking, molecular modeling, and effects of alterations in RNAP and RNA all suggest that a tripartite interaction of RNAP, NusA, and the hairpin inhibits nucleotide addition in the active site, which is located 65 angstroms away. These findings favor an allosteric model for regulation of transcript elongation.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.		Artsimovitch, Irina/L-3467-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R01GM038660, R29GM038660] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Ennifar E, 2000, J MOL BIOL, V304, P35, DOI 10.1006/jmbi.2000.4204; FARNHAM PJ, 1980, CELL, V20, P739, DOI 10.1016/0092-8674(80)90320-7; Finn RD, 2000, EMBO J, V19, P6833, DOI 10.1093/emboj/19.24.6833; GRUBER T, UNPUB; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; LEE DN, 1992, J MOL BIOL, V228, P759, DOI 10.1016/0022-2836(92)90862-E; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; SAGITOV V, 1993, J BIOL CHEM, V268, P2195; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; SIGMUND CD, 1988, BIOCHEMISTRY-US, V27, P5622, DOI 10.1021/bi00415a034; Wang DG, 1997, P NATL ACAD SCI USA, V94, P8433, DOI 10.1073/pnas.94.16.8433; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	25	174	178	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					730	733		10.1126/science.1057738	http://dx.doi.org/10.1126/science.1057738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326100				2022-12-28	WOS:000168478300052
J	Bloch, G; Robinson, GE				Bloch, G; Robinson, GE			Chronobiology - Reversal of honeybee behavioural rhythms	NATURE			English	Article							DIVISION-OF-LABOR; BEE COLONIES; SLEEP; DROSOPHILA		Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bloch, G (corresponding author), Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.		Bloch, Guy/I-5861-2019	Bloch, Guy/0000-0003-1624-4926				Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; STUSSI T, 1966, CR ACAD SCI D NAT, V262, P2066; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Turek F, 1999, REGULATION SLEEP CIR; VONFIRSCH K, 1967, DANCE LANGUAGE ORIEN	12	90	94	0	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1048	1048		10.1038/35074183	http://dx.doi.org/10.1038/35074183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323660	Bronze			2022-12-28	WOS:000168285500036
J	Mysterud, A; Stenseth, NC; Yoccoz, NG; Langvatn, R; Steinheim, G				Mysterud, A; Stenseth, NC; Yoccoz, NG; Langvatn, R; Steinheim, G			Nonlinear effects of large-scale climatic variability on wild and domestic herbivores	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; RED DEER; PLANT PHENOLOGY; POPULATION-DYNAMICS; BODY-MASS; CONSEQUENCES; DENSITY; SEX	Large-scale climatic fluctuations, such as the North Atlantic Oscillation (NAO)(1,2), have been shown to affect many ecological processes(3-6). Such effects have been typically assumed to be linear. Only one study has reported a nonlinear relation(7); however, that nonlinear relation was monotonic (that is, no reversal). Here we show that there is a strong nonlinear and non-monotonic (that is, reversed) effect of the NAO on body weight during the subsequent autumn for 23,838 individual wild red deer (Cervus elaphus) and 139,485 individual domestic sheep (Ovis aries) sampled over several decades on the west coast of Norway. These relationships are, at least in part, explained by comparable nonlinear and nonmonotonic relations between the NAO and local climatic variables (temperature, precipitation and snow depth). The similar patterns observed for red deer and sheep, the latter of which live indoors during winter and so experience a stable energy supply in winter, suggest that the (winter) climatic variability (for which the index is a proxy) must influence the summer foraging conditions directly or indirectly.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway; Polar Environm Ctr, Norwegian Inst Nat Res, Dept Arctic Ecol, N-9296 Tromso, Norway; Univ Courses Svalbard UNIS, N-9170 Longyearbyen, Spitsbergen, Norway; Agr Univ Norway, Dept Anim Sci, N-1432 As, Norway	University of Oslo; Norwegian Institute Nature Research; University Centre Svalbard (UNIS); Norwegian University of Life Sciences	Stenseth, NC (corresponding author), Univ Oslo, Dept Biol, Div Zool, POB 1050 Blindern, N-0316 Oslo, Norway.	n.c.stenseth@bio.uio.no	Yoccoz, Nigel/C-8561-2014; Yoccoz, Nigel Gille/A-1493-2008; Stenseth, Nils Chr./G-5212-2016; Mysterud, Atle/AAQ-2864-2020	Yoccoz, Nigel/0000-0003-2192-1039; Stenseth, Nils Chr./0000-0002-1591-5399; Mysterud, Atle/0000-0001-8993-7382				ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gaillard JM, 2000, P ROY SOC B-BIOL SCI, V267, P471, DOI 10.1098/rspb.2000.1024; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HOBBS NT, 1989, WILDLIFE MONOGR, P1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Kettlewell PS, 1999, J CEREAL SCI, V29, P205, DOI 10.1006/jcrs.1999.0258; LAMB PJ, 1987, B AM METEOROL SOC, V68, P1218, DOI 10.1175/1520-0477(1987)068<1218:NAOCAA>2.0.CO;2; LANGVATN R, 1986, HOLARCTIC ECOL, V9, P285; Langvatn R, 1996, J ANIM ECOL, V65, P653, DOI 10.2307/5744; Loison A, 1999, ECOGRAPHY, V22, P20, DOI 10.1111/j.1600-0587.1999.tb00451.x; Mysterud A, 2000, J ANIM ECOL, V69, P959, DOI 10.1046/j.1365-2656.2000.00454.x; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Venables W.N., 2013, MODERN APPL STAT S; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; [No title captured]; [No title captured]; [No title captured]; [No title captured]	30	177	182	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1096	1099		10.1038/35074099	http://dx.doi.org/10.1038/35074099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323672				2022-12-28	WOS:000168285500048
J	Niu, FL; Wen, LX				Niu, FL; Wen, LX			Hemispherical variations in seismic velocity at the top of the Earth's inner core	NATURE			English	Article							DIFFERENTIAL TRAVEL-TIMES; ANISOTROPY; MODEL; HETEROGENEITY; PHASES; PKIKP; IRON; PKP	Knowledge of the seismic velocity structure at the top of the Earth's inner core is important for deciphering the physical processes responsible for inner-core growth(1-3). Previous global seismic studies(4-9) have focused on structures found 100 km or deeper within the inner core, with results for the uppermost 100 km available for only isolated regions(10-12). Here we present constraints on seismic velocity variations just beneath the inner-core boundary, determined from the difference in travel time between waves reflected at the inner-core boundary and those transmitted through the inner core. We found that these traveltime residuals-observed on both global seismograph stations and several regional seismic networks-are systematically larger, by about 0.8 s, for waves that sample the 'eastern hemisphere' of the inner core (40 degrees E to 180 degrees E) compared to those that sample the 'western hemisphere' (180 degrees W to 40 degrees E). These residuals show no correlation with the angle at which the waves traverse the inner core; this indicates that seismic anisotropy is not strong in this region and that the isotropic seismic velocity of the eastern hemisphere is about 0.8% higher than that of the western hemisphere.	Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Carnegie Institution for Science; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Niu, FL (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.		Niu, Fenglin/A-2548-2011	Wen, Lianxing/0000-0002-5344-6212				ANDERSON OL, 1995, REV GEOPHYS, V33, P429, DOI 10.1029/95RG00877; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; CORMIER VF, 1986, GEOPHYS RES LETT, V13, P1553, DOI 10.1029/GL013i013p01553; Creager KC, 1999, J GEOPHYS RES-SOL EA, V104, P23127, DOI 10.1029/1999JB900162; CREAGER KC, 1992, NATURE, V356, P309, DOI 10.1038/356309a0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Helmberger D., 1983, EARTHQUAKES OBSERVAT, V37, P173; HIRAHARA K, 1993, J GEOMAGN GEOELECTR, V45, P1265; Kaneshima S, 1996, GEOPHYS RES LETT, V23, P3075, DOI 10.1029/96GL03026; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; SHEARER PM, 1988, NATURE, V333, P228, DOI 10.1038/333228a0; SONG XD, 1995, J GEOPHYS RES-SOL EA, V100, P9805, DOI 10.1029/95JB00244; Sumita I, 1999, SCIENCE, V286, P1547, DOI 10.1126/science.286.5444.1547; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; TROMP J, 1993, NATURE, V366, P678, DOI 10.1038/366678a0; WEN L, UNPUB J GEOPHYS RES; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700	17	176	179	2	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1081	1084		10.1038/35074073	http://dx.doi.org/10.1038/35074073			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323668				2022-12-28	WOS:000168285500044
J	Tung, CH; Sattler, JI				Tung, CH; Sattler, JI			Leprosy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Northwestern Univ, Sch Med, Chicago, IL 60611 USA	Northwestern University	Tung, CH (corresponding author), Northwestern Univ, Sch Med, Chicago, IL 60611 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1293	1293		10.1056/NEJM200104263441705	http://dx.doi.org/10.1056/NEJM200104263441705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320388				2022-12-28	WOS:000168252400005
J	Smith, D; Bartolo, R; Pickles, RM; Tedman, BM				Smith, D; Bartolo, R; Pickles, RM; Tedman, BM			Requests for electroencephalography in a district general hospital: retrospective and prospective audit	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPILEPTIFORM ABNORMALITIES	Objectives To determine the number of inappropriate requests for electroencephalography (EEG) and whether guidelines an use could reduce this number. Design Audit with retrospective and prospective components. Setting EEG department in district general hospital and centre for neurology and neurosurgery. Participants Retrospective: 368 at the general hospital and 143 patients at the neurology centre. Prospective: 241 patients undergoing EEG at the general hospital. Interventions Guidelines for EEG issued to users of service at the general hospital. Outcomes Retrospective: differences in requesting practice, result in different clinical scenarios, relative roles of procedure, clinical acumen in establishing diagnosis, usefulness of procedure. Prospective: change of requesting practice, impact on use. Results There were considerable differences in requesting practice. Non-specialists seem to use EEG as a diagnostic tool, especially in patients with "funny turns," when it is much more likely to yield potentially misleading than clinically useful information. The cn el all proportion of procedures considered to influence management, to be justifiable, and to be inappropriate were 16% (59), 28.3% (104), and 55.7% (205), respectively. In the prospective study the total number of requests was significantly reduced (chi (2) = 33.85, df = 5, P < 0.0001), mainly because of fewer requests in patients with non-specific "funny turns" (<chi>(2) = 21.90, df = 6, P = 0.0013). There was a concomitant change in the usefulness of EEG (chi (2) 26.99, df = 2, P < 0.0001). Conclusions This original audit informed clinical practice and had potential benefits for patients, clinicians, and provision of service. Systematic replication of this project possibly on a regional basis, could result in financial savings, which would allow development of accessible local neurophysiology services.	Walton Ctr Neurol & Neurosurg, Dept Neurol, Liverpool L9 7LJ, Merseyside, England; Wrexham Maelor Hosp, EEG Dept, Wrexham LL13 7TD, Wales; Walton Ctr Neurol & Neurosurg, Dept Neurophysiol, Liverpool L9 7LJ, Merseyside, England	Walton Centre; Walton Centre	Smith, D (corresponding author), Walton Ctr Neurol & Neurosurg, Dept Neurol, Liverpool L9 7LJ, Merseyside, England.	brown-s@wcnn-tr.nwest.nhs.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; [Anonymous], 1993, BMJ, V306, P1374; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; BINNIE C D, 1990, Electroencephalography and Clinical Neurophysiology, V76, p29P; BINNIE CD, 1994, J NEUROL NEUROSUR PS, V57, P1308, DOI 10.1136/jnnp.57.11.1308; Binnie CD, 1992, TXB EPILEPSY, P277; BRIDGERS SL, 1987, ARCH NEUROL-CHICAGO, V44, P312, DOI 10.1001/archneur.1987.00520150056022; Fowle AJ, 2000, EPILEPSIA, V41, pS10, DOI 10.1111/j.1528-1157.2000.tb01529.x; Gibbs J, 1992, Seizure, V1, P15, DOI 10.1016/1059-1311(92)90049-7; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; MARSAN CA, 1970, EPILEPSIA, V11, P361, DOI 10.1111/j.1528-1157.1970.tb03903.x; NICOLAIDES P, 1995, ARCH DIS CHILD, V72, P522, DOI 10.1136/adc.72.6.522; RILEY TL, 1983, PSEUDOEPILEPSY, P25; SMITH D, 1999, Q J MED, P15	15	35	36	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2001	322	7292					954	957		10.1136/bmj.322.7292.954	http://dx.doi.org/10.1136/bmj.322.7292.954			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312226	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000168345100016
J	Farhi, E; Goldstone, J; Gutmann, S; Lapan, J; Lundgren, A; Preda, D				Farhi, E; Goldstone, J; Gutmann, S; Lapan, J; Lundgren, A; Preda, D			A quantum adiabatic evolution algorithm applied to random instances of an NP-complete problem	SCIENCE			English	Article								A quantum system will stay near its instantaneous ground state if the Hamiltonian that governs its evolution varies slowly enough. This quantum adiabatic behavior is the basis of a new class of algorithms for quantum computing. We tested one such algorithm by applying it to randomly generated hard instances of an NP-complete problem. For the small examples that we could simulate, the quantum adiabatic algorithm worked well, providing evidence that quantum computers (if large ones can be built) may be able to outperform ordinary computers on hard sets of instances of NP-complete problems.	MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA; Northeastern Univ, Dept Math, Boston, MA 02115 USA; MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northeastern University; Massachusetts Institute of Technology (MIT)	Farhi, E (corresponding author), MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA.							Bennett CH, 1997, SIAM J COMPUT, V26, P1510, DOI 10.1137/S0097539796300933; Farhi E, 1998, PHYS REV A, V57, P2403, DOI 10.1103/PhysRevA.57.2403; Farhi E., UNPUB; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; JOHNSON DS, 1985, TRAVELING SALESMAN P, P37; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; Mitchell D., 1992, P 10 NAT C ART INT, P459; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]	9	1238	1259	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					472	476		10.1126/science.1057726	http://dx.doi.org/10.1126/science.1057726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313487	Green Submitted			2022-12-28	WOS:000168187300037
J	Wang, L; Brock, A; Herberich, B; Schultz, PG				Wang, L; Brock, A; Herberich, B; Schultz, PG			Expanding the genetic code of Escherichia coli	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; IN-VIVO; PROTEINS; EXPANSION; EVOLUTION; ORGANISM; PAIR	A unique transfer RNA (tRNA)/aminoacyl-tRNA synthetase pair has been generated that expands the number of genetically encoded amino acids in Escherichia coli, When introduced into E, coli, this pair leads to the in vivo incorporation of the synthetic amino acid O-methyl-L-tyrosine into protein in response to an amber nonsense codon, The fidelity of translation is greater than 99%, as determined by analysis of dihydrofolate reductase containing the unnatural amino acid. This approach should provide a general method for increasing the genetic repertoire of Living cells to include a variety of amino acids with novel structural, chemical, and physical properties not found in the common 20 amino acids.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Novartis	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526				BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; Budisa N, 1999, FASEB J, V13, P41, DOI 10.1096/fasebj.13.1.41; GRAY GDP, 1993, FEBS LETT, V318, P167; Hamano-Takaku F, 2000, J BIOL CHEM, V275, P40324, DOI 10.1074/jbc.M003696200; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kowal AK, 2001, P NATL ACAD SCI USA, V98, P2268, DOI 10.1073/pnas.031488298; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.bb.24.060195.002251; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; Moore B, 2000, J MOL BIOL, V298, P195, DOI 10.1006/jmbi.2000.3658; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Pastrnak M, 2000, HELV CHIM ACTA, V83, P2277, DOI 10.1002/1522-2675(20000906)83:9<2277::AID-HLCA2277>3.0.CO;2-L; Steer BA, 1999, J BIOL CHEM, V274, P35601, DOI 10.1074/jbc.274.50.35601; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L., UNPUB; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006	23	1079	1274	17	414	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					498	500		10.1126/science.1060077	http://dx.doi.org/10.1126/science.1060077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313494				2022-12-28	WOS:000168187300045
J	Yaffe, K; Krueger, K; Sarkar, S; Grady, D; Barrett-Connor, E; Cox, DA; Nickelsen, T				Yaffe, K; Krueger, K; Sarkar, S; Grady, D; Barrett-Connor, E; Cox, DA; Nickelsen, T		Multiple Outcomes Raloxifene Evalu	Cognitive function in postmenopausal women treated with raloxifene.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTROGEN REPLACEMENT THERAPY; VERBAL MEMORY; IMPAIRMENT; DEMENTIA; DECLINE; BRAIN; TRIAL; MOOD; RATS	Background: In postmenopausal women, estrogen may have a beneficial effect on cognition or reduce the risk of decline in cognitive function. Whether raloxifene, a selective estrogen-receptor modulator, might have similar actions is not known. Methods: As part of the Multiple Outcomes of Raloxifene Evaluation trial, we studied 7478 postmenopausal women with osteoporosis (mean age, 66 years), who were enrolled at 178 sites in 25 countries. The women were randomly assigned to receive raloxifene (60 mg or 120 mg) or placebo daily for three years. We compared the mean scores of the groups on six tests of cognitive function, which were administered at base line and at six months and one, two, and three years. Women were classified as having a decline in cognitive function if the change in their scores at three years was in the worst 10 percent. Results: The mean cognitive scores in the three groups of women were similar at base line. The scores improved slightly in all three groups during the three-year study period, with no significant differences among the groups. The risk of decline in the cognitive function, as measured by four of the six tests, did not differ significantly between the two raloxifene groups combined and the placebo group, but there was a trend toward less decline in the combined raloxifene group on the two tests of verbal memory (relative risk, 0.77) and attention (relative risk, 0.87). Newly reported or worsening hot flashes did not negatively influence test scores or the effect of treatment on test performance. Conclusions: Raloxifene treatment for three years does not affect overall cognitive scores in postmenopausal women with osteoporosis. (N Engl J Med 2001;344:1207-13.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA USA; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; Univ Calif San Diego, Dept Community & Family Med, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Eli Lilly; University of California System; University of California San Diego	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 111G,4150 Clement St, San Francisco, CA 94121 USA.				NATIONAL INSTITUTE ON AGING [K23AG000888] Funding Source: NIH RePORTER; NIA NIH HHS [K23-AG00888] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Birge SJ, 1998, GERIATRICS, V53, pS28; CALDWELL BM, 1952, J GERONTOL, V7, P228; CAMPBELL S, 1977, CLIN OBSTET GYNAECOL, V4, P31; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fedor-Freybergh P, 1977, Acta Obstet Gynecol Scand Suppl, V64, P1; GANGULI M, 1993, J GERONTOL, V48, pM152, DOI 10.1093/geronj/48.4.M152; Hackman B W, 1976, Curr Med Res Opin, V4, P303, DOI 10.1185/03007997609109322; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; McEwen BS, 1997, NEUROLOGY, V48, pS8, DOI 10.1212/WNL.48.5_Suppl_7.8S; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Morris MC, 1999, AM J EPIDEMIOL, V149, P789, DOI 10.1093/oxfordjournals.aje.a009893; Nickelsen T, 1999, PSYCHONEUROENDOCRINO, V24, P115, DOI 10.1016/S0306-4530(98)00041-9; Nilsen J, 1998, MENOPAUSE, V5, P211; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Polo-Kantola P, 1998, OBSTET GYNECOL, V91, P459, DOI 10.1016/S0029-7844(97)00700-X; PoloKantola P, 1997, MATURITAS, V27, P13, DOI 10.1016/S0378-5122(97)01116-X; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resnick SM, 1997, NEUROLOGY, V49, P1491, DOI 10.1212/WNL.49.6.1491; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; SHERWIN BB, 1988, PSYCHONEUROENDOCRINO, V13, P345, DOI 10.1016/0306-4530(88)90060-1; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; SINGH M, 1994, BRAIN RES, V644, P305, DOI 10.1016/0006-8993(94)91694-2; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; Wolf OT, 1999, PSYCHONEUROENDOCRINO, V24, P727, DOI 10.1016/S0306-4530(99)00025-6; Wu X, 1999, BRAIN RES, V847, P98, DOI 10.1016/S0006-8993(99)02062-4; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688	32	177	186	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1207	1213		10.1056/NEJM200104193441604	http://dx.doi.org/10.1056/NEJM200104193441604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309635				2022-12-28	WOS:000168127600004
J	Arendt, D; Technau, U; Wittbrodt, J				Arendt, D; Technau, U; Wittbrodt, J			Evolution of the bilaterian larval foregut	NATURE			English	Article							BRACHYURY GENE-EXPRESSION; HEMICHORDATE EMBRYOS; DROSOPHILA; SPECIFICATION; PATTERN; DEUTEROSTOMES; CONSERVATION; VERTEBRATES; HOMOLOG	Bilateria are subdivided into Protostomia and Deuterostomia(1,2). Indirect development through primary, ciliary larvae occurs in both of these branches; however, the closing blastopore develops into mouth and anus in Protostomia and into anus only in Deuterostomia. Because of this important difference in larval gut ontogeny, the tube-shaped guts in protostome and deuterostome primary larvae are thought to have evolved independently(2,3). To test this hypothesis, we have analysed the expression of brachyury, otx and goosecoid homologues in the polychaete Platynereis dumerilii(4), which develops by means of a trochophora larva-the primary, ciliary larva prototypic for Protostomia(2). Here we show that brachyury expression in the ventral portion of the developing foregut in Platynereis and also otx expression along ciliated bands in the mouth region of the trochophora larva parallels expression in primary larvae in Deuterostomia(5-9). In addition, goosecoid expression in the foregut of Platynereis mirrors the function in higher Deuterostomia(10). We present molecular evidence for the evolutionary conservation of larval foreguts and mouth regions of Protostomia and Deuterostomia. Our data indicate that Urbilateria, the common bilaterian ancestors, developed through a primary, ciliary larva that already possessed a tripartite tube-shaped gut.	European Mol Biol Lab, Dev Biol Programme, D-69012 Heidelberg, Germany; Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany	European Molecular Biology Laboratory (EMBL); Technical University of Darmstadt	Wittbrodt, J (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69012 Heidelberg, Germany.	technau@bio.tu-darmstadt.de; Jochen.Wittbrodt@EMBL-Heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377; Technau, Ulrich/0000-0003-4472-8258				Arendt D, 1997, MECH DEVELOP, V61, P7, DOI 10.1016/S0925-4773(96)00620-X; Arendt D, 1999, DEVELOPMENT, V126, P2309; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P260, DOI 10.1007/BF00363215; Goriely A, 1996, DEVELOPMENT, V122, P1641; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; HAECKEL E, 1896, SYSTEMATISCHE PHYLOG, V2, P259; Hahn M, 1996, EMBO J, V15, P3077, DOI 10.1002/j.1460-2075.1996.tb00670.x; Harada Y, 2000, MECH DEVELOP, V91, P337, DOI 10.1016/S0925-4773(99)00279-8; Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.3.CO;2-#; Holland PWH, 1995, DEVELOPMENT, V121, P4283; KISPERT A, 1994, GENE DEV, V8, P2137, DOI 10.1101/gad.8.18.2137; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kusch T, 1999, DEVELOPMENT, V126, P3991; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Nielsen C., 1995, ANIMAL EVOLUTION INT; Peterson KJ, 2000, DEV BIOL, V219, P1, DOI 10.1006/dbio.1999.9475; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Shoguchi E, 2000, GENESIS, V27, P58, DOI 10.1002/1526-968X(200006)27:2<58::AID-GENE20>3.0.CO;2-8; Shoguchi E, 1999, MECH DEVELOP, V82, P185, DOI 10.1016/S0925-4773(99)00008-8; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; STEINBEISSER H, 1993, CR ACAD SCI III-VIE, V316, P966; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Willmer P., 1990, INVERTEBRATE RELATIO; Wilson EB, 1892, J MORPHOL, V6, P361; Woollard A, 2000, GENE DEV, V14, P596; Wu LH, 1998, DEVELOPMENT, V125, P2433; Yasuo H, 1998, DEV BIOL, V200, P158, DOI 10.1006/dbio.1998.8958	30	187	191	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					81	85		10.1038/35051075	http://dx.doi.org/10.1038/35051075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343117				2022-12-28	WOS:000166175600043
J	Wexler, M; Panerai, F; Lamouret, I; Droulez, J				Wexler, M; Panerai, F; Lamouret, I; Droulez, J			Self-motion and the perception of stationary objects	NATURE			English	Article							NONVISUAL INFORMATION; DEPTH-PERCEPTION; RIGID MOTION; PARALLAX; ORIENTATION; STEREOPSIS; CUE	One of the ways that we perceive shape is through seeing motion(1-3). Visual motion may be actively generated (for example, in locomotion), or passively observed. In the study of the perception of three-dimensional structure from motion, the nonmoving, passive observer in an environment of moving rigid objects has been used as a substitute(1) for an active observer moving in an environment of stationary objects; this 'rigidity hypothesis' has played a central role in computational and experimental studies of structure from motion(4,5). Here we show that this is not an adequate substitution because active and passive observers can perceive three-dimensional structure differently, despite experiencing the same visual stimulus: active observers' perception of three-dimensional structure depends on extraretinal information about their own movements. The visual system thus treats objects that are stationary (in an allocentric, earth-fixed reference frame) differently from objects that are merely rigid. These results show that action makes an important contribution to depth perception, and argue for a revision of the rigidity hypothesis to incorporate the special case of stationary objects.	Coll France, Lab Physiol Percept & Act, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France	Wexler, M (corresponding author), Coll France, Lab Physiol Percept & Act, 11 Pl Marcelin Berthelot, F-75005 Paris, France.		Wexler, Mark/AAH-2232-2022; Wexler, Mark/AFL-9963-2022					ADELSON EH, 1985, INVEST OPHTHAL VIS S, V26; AMES A, 1951, PSYCHOL MONOGR, V65; ATTNEAVE F, 1969, PERCEPT PSYCHOPHYS, V6, P391, DOI 10.3758/BF03212797; BRAUNSTEIN ML, 1962, J EXP PSYCHOL, V64, P415, DOI 10.1037/h0048140; DIJKSTRA TMH, 1995, VISION RES, V35, P453, DOI 10.1016/0042-6989(94)00147-E; Gibson J.J., 1986, ECOLOGICAL APPROACH; Ittelson W.H., 1952, AMES DEMONSTRATIONS; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P210; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; O'Brien J, 2000, PERCEPTION, V29, P437, DOI 10.1068/p2955; ONO H, 1990, PERCEPT PSYCHOPHYS, V48, P179, DOI 10.3758/BF03207085; Panerai F, 1999, J NEUROSCI METH, V90, P97, DOI 10.1016/S0165-0270(99)00054-0; Papathomas TV, 2000, P SOC PHOTO-OPT INS, V3959, P506, DOI 10.1117/12.387205; REINHARDTRUTLAND AH, 1993, PERCEPTION, V22, P335, DOI 10.1068/p220335; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; ROGERS S, 1992, PERCEPT PSYCHOPHYS, V52, P446, DOI 10.3758/BF03206704; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Sparrow JE, 1998, VISION RES, V38, P541, DOI 10.1016/S0042-6989(97)00164-8; TODD JT, 1982, J EXP PSYCHOL HUMAN, V8, P238, DOI 10.1037/0096-1523.8.2.238; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; vanDamme WJM, 1996, VISION RES, V36, P3119, DOI 10.1016/0042-6989(96)00060-0; Wade NJ, 1999, PERCEPTION, V28, P1115, DOI 10.1068/p2852; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WALLACH H, 1956, AM J PSYCHOL, V69, P48, DOI 10.2307/1418114; WALLACH H, 1987, ANNU REV PSYCHOL, V38, P1, DOI 10.1146/annurev.ps.38.020187.000245	29	94	95	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					85	88		10.1038/35051081	http://dx.doi.org/10.1038/35051081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	388HT	11343118	Green Accepted, Green Submitted			2022-12-28	WOS:000166175600044
J	Luh, DA; Miller, T; Paggel, JJ; Chou, MY; Chiang, TC				Luh, DA; Miller, T; Paggel, JJ; Chou, MY; Chiang, TC			Quantum electronic stability of atomically uniform films	SCIENCE			English	Article							SHELL STRUCTURE; GOLD NANOWIRES; PHOTOEMISSION; METALS; WELLS	We have studied the structural stability of thin silver films with thicknesses of N = 1 to 15 monolayers, deposited on an Fe(100) substrate. Photoemission spectroscopy results show that films of N = 1, 2, and 5 monolayer thicknesses are structurally stable for temperatures above 800 kelvin, whereas films of other thicknesses are unstable and bifurcate into a film with N +/- 1 monolayer thicknesses at temperatures around 400 kelvin, The results are in agreement with theoretical predictions that consider the electronic energy of the quantum well associated with a particular film thickness as a significant contribution-to the film stability.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Free University of Berlin; University System of Georgia; Georgia Institute of Technology	Chiang, TC (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.		Chou, Mei-Yin/D-3898-2012; LUH, DAH-AN/B-3921-2008; Chiang, Tai C/H-5528-2011	Chou, Mei-Yin/0000-0003-0113-7191; 				Chiang TC, 2000, SURF SCI REP, V39, P181, DOI 10.1016/S0167-5729(00)00006-6; EVANS DA, 1997, SURF SCI, V376, P1; KNIGHT WD, 1984, PHYS REV LETT, V52, P2141, DOI 10.1103/PhysRevLett.52.2141; Kondo Y, 2000, SCIENCE, V289, P606, DOI 10.1126/science.289.5479.606; KUMIKOV VK, 1983, J APPL PHYS, V54, P1346, DOI 10.1063/1.332209; Paggel JJ, 2000, PHYS REV B, V61, P1804, DOI 10.1103/PhysRevB.61.1804; Paggel JJ, 1998, PHYS REV LETT, V81, P5632, DOI 10.1103/PhysRevLett.81.5632; Paggel JJ, 1999, SCIENCE, V283, P1709, DOI 10.1126/science.283.5408.1709; Roco M. C., 1999, NANOTECHNOLOGY RES D; Smith AR, 1996, SCIENCE, V273, P226, DOI 10.1126/science.273.5272.226; SMITH NV, 1974, PHYS REV B, V9, P1341, DOI 10.1103/PhysRevB.9.1341; Tosatti E, 2000, SCIENCE, V289, P561, DOI 10.1126/science.289.5479.561; Yanson AI, 1999, NATURE, V400, P144, DOI 10.1038/22074; Zhang ZY, 1998, PHYS REV LETT, V80, P5381, DOI 10.1103/PhysRevLett.80.5381	14	158	161	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1131	1133		10.1126/science.292.5519.1131	http://dx.doi.org/10.1126/science.292.5519.1131			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349141				2022-12-28	WOS:000168609200049
J	Eremets, ML; Hemley, RJ; Mao, H; Gregoryanz, E				Eremets, ML; Hemley, RJ; Mao, H; Gregoryanz, E			Semiconducting non-molecular nitrogen up to 240 GPa and its low-pressure stability	NATURE			English	Article							MOLECULAR-HYDROGEN; PHASE; TRANSITION	The triple bond of diatomic nitrogen has among the greatest binding energies of any molecule. At low temperatures and pressures, nitrogen forms a molecular crystal in which these strong bonds co-exist with weak van der Waals interactions between molecules, producing an insulator with a large band gap(1). As the pressure is raised on molecular crystals, intermolecular interactions increase and the molecules eventually dissociate to form monoatomic metallic solids, as was first predicted for hydrogen(2). Theory predicts that, in a pressure range between 50 and 94 GPa, diatomic nitrogen can be transformed into a non-molecular framework or polymeric structure with potential use as a high-energy-density material(3-5). Here we show that the non-molecular phase of nitrogen is semiconducting up to at least 240 GPa, at which pressure the energy gap has decreased to 0.4 eV. At 300 K, this transition from insulating to semiconducting behaviour starts at a pressure of approximately 140 GPa, but shifts to much higher pressure with decreasing temperature. The transition also exhibits remarkably large hysteresis with an equilibrium transition estimated to be near 100 GPa. Moreover, we have succeeded in recovering the non-molecular phase of nitrogen at ambient pressure (at temperatures below 100 K), which could be of importance for practical use.	Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Carnegie Inst Sci, Ctr High Pressure Res, Washington, DC 20015 USA	Carnegie Institution for Science; Carnegie Institution for Science	Hemley, RJ (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	hemley@gl.ciw.edu		Gregoryanz, Eugene/0000-0001-9080-8756				BELL PM, 1986, PHYSICA B & C, V139, P16, DOI 10.1016/0378-4363(86)90517-6; BROVMAN EG, 1972, SOV PHYS JETP-USSR, V34, P1300; Christe KO, 1999, ANGEW CHEM INT EDIT, V38, P2004, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2004::AID-ANIE2004>3.0.CO;2-7; Eremets MI, 2000, PHYS REV LETT, V85, P2797, DOI 10.1103/PhysRevLett.85.2797; EREMETS MI, 1996, EXPT HIGH PRESSURE T, P16; FREIMAN YA, 1997, PHYSICS CRYOCRYSTALS, P538; Goncharov AF, 2000, PHYS REV LETT, V85, P1262, DOI 10.1103/PhysRevLett.85.1262; HELMY AA, 1994, J PHYS-CONDENS MAT, V6, P985, DOI 10.1088/0953-8984/6/5/008; HEMLEY RJ, 1988, PHYS REV LETT, V61, P857, DOI 10.1103/PhysRevLett.61.857; Johnson KA, 2000, NATURE, V403, P632, DOI 10.1038/35001024; LEWIS SP, 1992, PHYS REV B, V46, P11117, DOI 10.1103/PhysRevB.46.11117; MAILHIOT C, 1992, PHYS REV B, V46, P14419, DOI 10.1063/1.46314; MAO HK, 1986, J GEOPHYS RES-SOLID, V91, P4673, DOI 10.1029/JB091iB05p04673; MARTIN RM, 1986, PHYS REV B, V34, P5082, DOI 10.1103/PhysRevB.34.5082; MCMAHAN AK, 1985, PHYS REV LETT, V54, P1929, DOI 10.1103/PhysRevLett.54.1929; MITAS L, 1994, PHYS REV LETT, V72, P2438, DOI 10.1103/PhysRevLett.72.2438; Narayana C, 1998, NATURE, V393, P46, DOI 10.1038/29949; NELLIS WJ, 1984, PHYS REV LETT, V53, P1661, DOI 10.1103/PhysRevLett.53.1661; Olijnyk H, 1999, PHYS REV LETT, V83, P332, DOI 10.1103/PhysRevLett.83.332; REICHLIN R, 1985, PHYS REV LETT, V55, P1464, DOI 10.1103/PhysRevLett.55.1464; Shimizu K, 1998, NATURE, V393, P767, DOI 10.1038/31656; Stadele M, 2000, PHYS REV LETT, V84, P6070, DOI 10.1103/PhysRevLett.84.6070; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590; Yakub ES, 1998, J LOW TEMP PHYS, V111, P357, DOI 10.1023/A:1022235703345	24	260	266	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					170	174		10.1038/35075531	http://dx.doi.org/10.1038/35075531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346788				2022-12-28	WOS:000168563000043
J	Reich, DE; Cargill, M; Bolk, S; Ireland, J; Sabeti, PC; Richter, DJ; Lavery, T; Kouyoumjian, R; Farhadian, SF; Ward, R; Lander, ES				Reich, DE; Cargill, M; Bolk, S; Ireland, J; Sabeti, PC; Richter, DJ; Lavery, T; Kouyoumjian, R; Farhadian, SF; Ward, R; Lander, ES			Linkage disequilibrium in the human genome	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON DISEASE GENES; MODERN HUMAN ORIGINS; SEQUENCE VARIATION; POPULATIONS; REGIONS; LOCUS; ASSOCIATION; EXTENT	With the availability of a dense genome-wide map of single nucleotide polymorphisms (SNPs)(1), a central issue in human genetics is whether it is now possible to use linkage disequilibrium (LD) to map genes that cause disease. LD refers to correlations among neighbouring alleles, reflecting 'haplotypes' descended from single, ancestral chromosomes. The size of LD blocks has been the subject of considerable debate. Computer simulations(2) and empirical data(3) have suggested that LD extends only a few kilobases (kb) around common SNPs, whereas other data have suggested that it can extend much further, in some cases greater than 100 kb(4-6). It has been difficult to obtain a systematic picture of LD because past studies have been based on only a few (1-3) loci and different populations. Here, we report a large-scale experiment using a uniform protocol to examine 19 randomly selected genomic regions. LD in a United States population of north-European descent typically extends 60 kb from common alleles, implying that LD mapping is likely to be practical in this population. By contrast, LD in a Nigerian population extends markedly less far. The results illuminate human history, suggesting that LD in northern Europeans is shaped by a marked demographic event about 27,000-53,000 years ago.	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Oxford	Reich, DE (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reich@genome.wi.mit.edu; lander@genome.wi.mit.edu		Richter, Daniel/0000-0002-9238-5571				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chen XN, 1999, GENOME RES, V9, P492; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eaves IA, 2000, NAT GENET, V25, P320; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEWONTIN RC, 1988, GENETICS, V120, P849; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Mateu E, 2001, AM J HUM GENET, V68, P103, DOI 10.1086/316940; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHNEIDER S, 2000, VER 2 0 SOFTWARE POP; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; [No title captured]	35	1234	1318	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					199	204		10.1038/35075590	http://dx.doi.org/10.1038/35075590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346797				2022-12-28	WOS:000168563000052
J	[Anonymous]				[Anonymous]			Dealing with job dissatisfaction in medicine	LANCET			English	Editorial Material																			0	0	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1377	1377						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356427				2022-12-28	WOS:000168478200001
J	Jepson, P; Jarvie, JK; MacKinnon, K; Monk, KA				Jepson, P; Jarvie, JK; MacKinnon, K; Monk, KA			The end for Indonesia's lowland forests?	SCIENCE			English	Editorial Material									Univ Oxford, Sch Geog & Environm, Oxford OX3 1TB, England; World Bank, Dept Environm, Washington, DC 20433 USA	University of Oxford; The World Bank	MacKinnon, K (corresponding author), Leuser Management Unit, Jl D Mansyur 68, Medan 20154, Indonesia.		Monk, Kathryn/GRR-2773-2022					*EIA TEL, 2000, FIN CUT ILL LOGG IND; EIA Telepak, 1999, FIN CUT ILL LOGG IND; Holmes D, 2000, DEFORESTATION INDONE; Human Factors International, 2000, NEWSLETTER; MCCARTHY F, 31 CIFOR; Schweithelm J., 2000, TRIAL FIRE	6	138	141	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					859	+		10.1126/science.1061727	http://dx.doi.org/10.1126/science.1061727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341279				2022-12-28	WOS:000168514900024
J	Smith, MD; Schnell, DJ				Smith, MD; Schnell, DJ			Peroxisomal protein import: The paradigm shifts	CELL			English	Review							TRANSLOCATION; BIOGENESIS; TRANSPORT; MEMBRANES		Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Schnell, DJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.		Smith, Matthew/M-4726-2014	Smith, Matthew/0000-0002-2855-5126				Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Chen K, 2000, BIOCHEM SOC T, V28, P485, DOI 10.1042/0300-5127:0280485; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LAZAROW PB, 1989, DISORDERS PEROXISOME, P1479; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Terlecky SR, 2000, TRAFFIC, V1, P465, DOI 10.1034/j.1600-0854.2000.010604.x; Terlecky SR, 2001, EXP CELL RES, V263, P98, DOI 10.1006/excr.2000.5111; van der Klei IJ, 1997, TRENDS MICROBIOL, V5, P502, DOI 10.1016/S0966-842X(97)01156-6; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675	18	19	23	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2001	105	3					293	296		10.1016/S0092-8674(01)00337-3	http://dx.doi.org/10.1016/S0092-8674(01)00337-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348588	Bronze			2022-12-28	WOS:000168515900001
J	Aronowitz, RA				Aronowitz, RA			When do symptoms become a disease?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								When do symptoms become a disease? Are there rules or norms, currently or in the past, that tell us when a particular collection of largely symptom-based criteria has enough specificity, utility, or plausibility to justify the appellation disease? The history of numerous symptom-based diagnoses in use today suggests partial answers to these questions. The 19th-century shift to understanding ill health as a result of specific diseases, increasingly defined more by signs than symptoms, led to a loss of status for illnesses that possessed little clinical or laboratory specificity. Nevertheless, clinicians then and now have used symptom-based diagnoses. Some of these diagnoses owe their existence as specific diseases to the norms and practices of an older era much different from our own. Others have not only thrived but have resisted plausible redefinition done by using more "objective" criteria. Many strategies, such as response-to-treatment arguments, quantitative methods (for example, factor analysis), and consensus conferences, have been used to find or confer specificity in symptom-based diagnoses. These strategies are problematic and have generally been used after symptom-based diagnoses have been recognized and defined. These historical observations emphasize that although biological and clinical factors have set boundaries for which symptoms might plausibly be linked in a disease concept, social influences have largely determined which symptom clusters have become diseases.	Univ Penn, Dept Hist & Sociol Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Aronowitz, RA (corresponding author), Univ Penn, Dept Hist & Sociol Sci, 325 Logan Hall,249 S 36th St, Philadelphia, PA 19104 USA.							[Anonymous], 1992, OXFORD ENGLISH DICT, V2nd; ARONOWITZ TA, 1998, MAKINS SENSE ILLNESS; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Keen JH, 1998, BRIT J RHEUMATOL, V37, P1247; Kleinman A., 1988, ILLNESS NARRATIVES; Kramer P. D., 1993, LISTENING PROZAC; Kyle R A, 1982, JAMA, V247, P1925, DOI 10.1001/jama.247.14.1925; Reiter Hans, 1881, JAMA-J AM MED ASSOC, V211, P821	8	82	84	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			803	808		10.7326/0003-4819-134-9_Part_2-200105011-00002	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346314				2022-12-28	WOS:000168543100002
J	Fritsche, A; Stefan, N; Haring, H; Gerich, J; Stumvoll, M				Fritsche, A; Stefan, N; Haring, H; Gerich, J; Stumvoll, M			Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							DEFECTIVE GLUCOSE COUNTERREGULATION; INSULIN-INDUCED HYPOGLYCEMIA; DEFICIENT COUNTERREGULATION; ANTECEDENT HYPOGLYCEMIA; AUTONOMIC NEUROPATHY; UNAWARENESS; SYMPTOMS; RESPONSES; IDDM; THERAPY	Background: Lack of awareness of hypoglycemia is a major limiting factor in the management of type 1 diabetes. Objective: To examine whether reduction in the number of episodes of hypoglycemia restores hypoglycemia awareness by influencing beta -adrenergic sensitivity in patients with type 1 diabetes. Design: Controlled interventional study. Setting: Research unit and outpatient diabetes clinic of a university hospital. Patients: 10 men with type 1 diabetes and hypoglycemia unawareness (mean age[+/-SD], 46+/-6 years; mean duration of diabetes, 20 +/- 10 years). Intervention: Strict avoidance of hypoglycemia. Measurements: beta -Adrenergic sensitivity was measured by isoproterenol testing before and at 2 and 4 months after strict avoidance of hypoglycemia. Hypoglycemia awareness and catecholamine response were measured by performing hypoglycemic clamp (glucose level, 3 mmol/L [54 mg/dL]) before and after 4 months of avoidance of hypoglycemia. Results: After 4 months, the mean (+/-SE) number of episodes of hypoglycemia (glucose level < 3.9 mmol/L [70 mg/dL]) decreased from 8.4 +/- 0.9 to 1.4 +/- 0.3 per week (P < 0.001). Hemoglobin A(1c) values increased from 0.068 +/- 0.003 (6.8% +/- 0.3%) to 0.077 +/- 0.003 (7.7% +/- 0.3%) (P < 0.001). Autonomic symptom scores during hypoglycemic clamp increased from 1.8 +/- 0.6 to 3.3 +/- 0.7 (P = 0.004) and did not significantly differ from those of normal participants (4.7+/-0.8) (P>0.2). Although catecholamine responses to hypoglycemia were unchanged, the dose of isoproterenol necessary to increase heart rate by 25 beats/min (IC25) decreased from 1.96 +/- 0.43 mug before treatment to 1.09 +/- 0.17 mug after 4 months of treatment (P = 0.01), a value similar to that in normal participants (0.85 +/- 0.20 mug) (P > 0.2). Improvements in beta -adrenergic sensitivity (change in IC25-1) were correlated with improvements in autonomic symptoms (r = 0.65; P = 0.04). Conclusions: Avoidance of hypoglycemia in patients with type 1 diabetes who have hypoglycemia unawareness seems to restore hypoglycemia awareness, primarily by increasing beta -adrenergic sensitivity.	Univ Tubingen, Med Klin, D-72076 Tubingen, Germany; Univ Rochester, Sch Med, Rochester, NY USA	Eberhard Karls University of Tubingen; University of Rochester	Stumvoll, M (corresponding author), Univ Tubingen, Med Klin, Otfried Muller Str 10, D-72076 Tubingen, Germany.		Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Stefan, Norbert/0000-0002-2186-9595	NCRR NIH HHS [5MO1-RR 00044] Funding Source: Medline; NIDDK NIH HHS [DK-20411] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020411, R37DK020411] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amiel SA, 1998, LANCET, V352, P502, DOI 10.1016/S0140-6736(05)79244-8; AMIEL SA, 1994, DIABETIC MED, V11, P918, DOI 10.1111/j.1464-5491.1994.tb00248.x; BERLIN I, 1987, DIABETES CARE, V10, P742, DOI 10.2337/diacare.10.6.742; Bolinder J, 1996, DIABETOLOGIA, V39, P845, DOI 10.1007/s001250050519; Bottini P, 1997, DIABETES, V46, P814, DOI 10.2337/diabetes.46.5.814; BOYLE PJ, 1994, P NATL ACAD SCI USA, V91, P9352, DOI 10.1073/pnas.91.20.9352; CLARKE WL, 1991, DIABETES, V40, P680, DOI 10.2337/diabetes.40.6.680; COLLINS S, 1988, J BIOL CHEM, V263, P9067; CRANSTON I, 1994, LANCET, V344, P283, DOI 10.1016/S0140-6736(94)91336-6; CRYER PE, 1994, DIABETES, V43, P1378, DOI 10.2337/diabetes.43.11.1378; DAGOGOJACK S, 1994, DIABETES, V43, P1426, DOI 10.2337/diabetes.43.12.1426; Davis SN, 1996, J CLIN INVEST, V98, P680, DOI 10.1172/JCI118839; Davis SN, 2000, J CLIN ENDOCR METAB, V85, P2148, DOI 10.1210/jc.85.6.2148; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Fanelli C, 1997, DIABETES, V46, P1172, DOI 10.2337/diabetes.46.7.1172; FANELLI C, 1994, DIABETOLOGIA, V37, P1265, DOI 10.1007/BF00399801; FANELLI CG, 1993, DIABETES, V42, P1683, DOI 10.2337/diabetes.42.11.1683; Frische A, 1998, DIABETES CARE, V21, P1505, DOI 10.2337/diacare.21.9.1505; Fritsche A, 2000, J CLIN ENDOCR METAB, V85, P523, DOI 10.1210/jc.85.2.523; GERICH JE, 1988, DIABETES, V37, P1608, DOI 10.2337/diabetes.37.12.1608; GERICH JE, 1991, ENDOCR REV, V12, P356, DOI 10.1210/edrv-12-4-356; GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697; HEPBURN DA, 1991, DIABETES CARE, V14, P949, DOI 10.2337/diacare.14.11.949; Kanc K, 1998, DIABETOLOGIA, V41, P322, DOI 10.1007/s001250050910; Kendall DM, 1997, DIABETES, V46, P249, DOI 10.2337/diabetes.46.2.249; Korytkowski MT, 1998, DIABETES CARE, V21, P1939, DOI 10.2337/diacare.21.11.1939; Liu DT, 1996, CLIN INVEST MED, V19, P71; Meyer C, 1998, TRANSPLANTATION, V66, P233, DOI 10.1097/00007890-199807270-00017; MITRAKOU A, 1993, NEW ENGL J MED, V329, P834, DOI 10.1056/NEJM199309163291203; MOKAN M, 1994, DIABETES CARE, V17, P1397, DOI 10.2337/diacare.17.12.1397; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; TOWLER DA, 1993, DIABETES, V42, P1791, DOI 10.2337/diabetes.42.12.1791; Vea H, 1997, DIABETIC MED, V14, P979, DOI 10.1002/(SICI)1096-9136(199711)14:11<979::AID-DIA506>3.0.CO;2-6; ZIEGLER D, 1992, DIABETIC MED, V9, P166, DOI 10.1111/j.1464-5491.1992.tb01754.x	34	72	73	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					729	736		10.7326/0003-4819-134-9_Part_1-200105010-00009	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329230				2022-12-28	WOS:000168470700002
J	Cunha, BA				Cunha, BA			Effective antibiotic-resistance control strategies	LANCET			English	Editorial Material							ANTIMICROBIAL RESISTANCE; GUIDELINES		Winthrop Univ Hosp, Div Infect Dis, Mineola, NY 11501 USA; SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cunha, BA (corresponding author), Winthrop Univ Hosp, Div Infect Dis, Mineola, NY 11501 USA.	llusardi@winthrop.org						Cunha BA, 1998, CRIT CARE CLIN, V14, P309, DOI 10.1016/S0749-0704(05)70397-3; Cunha BA, 1998, DRUGS TODAY, V34, P691, DOI 10.1358/dot.1998.34.8.485267; Cunha BA, 2000, MED CLIN N AM, V84, P1407, DOI 10.1016/S0025-7125(05)70295-9; Gross PA, 1997, INFECT DIS CLIN N AM, V11, P803, DOI 10.1016/S0891-5520(05)70391-3; KREMERY V, 2000, J CHEMOTHER, V12, P471; Levy S.B, 1984, ANTIMICROBIALS AGR, P525; Levy SB, 1997, CIBA F SYMP, V207, P1; LEVY SB, 1988, ANTIMICROB AGENTS CH, V32, P1801, DOI 10.1128/AAC.32.12.1801; Mainardi JL, 1998, CRIT CARE CLIN, V14, P199, DOI 10.1016/S0749-0704(05)70392-4; McGowan JE, 2000, INFECT CONT HOSP EP, V21, pS36, DOI 10.1086/503172; MONNET D, 1995, INFECT CONT HOSP E S, V4, P19; Reinert RR, 2001, J CLIN MICROBIOL, V39, P1187, DOI 10.1128/JCM.39.3.1187-1189.2001; Rice LB, 1999, PHARMACOTHERAPY, V19, p120S, DOI 10.1592/phco.19.12.120S.31699; Shlaes DM, 1997, CLIN INFECT DIS, V25, P584, DOI 10.1086/513766; Smith DW, 1999, PHARMACOTHERAPY, V19, p129S, DOI 10.1592/phco.19.12.129S.31702	15	55	60	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1307	1308		10.1016/S0140-6736(00)04527-X	http://dx.doi.org/10.1016/S0140-6736(00)04527-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343730				2022-12-28	WOS:000168411400004
J	Shakespeare, TP; Gebski, VJ; Veness, MJ; Simes, J				Shakespeare, TP; Gebski, VJ; Veness, MJ; Simes, J			Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours	LANCET			English	Article							ACUTE COUGH; STATISTICAL SIGNIFICANCE; INTERVALS; TRIALS; PLACEBO; DISSECTION; ADULTS; NODES	The process of interpreting the results of clinical studies and translating them into clinical practice is being debated, Here we examine the role of p values and confidence intervals in clinical decision-making, and draw attention to confusion in their interpretation. To improve result reporting, we propose the use of confidence levels and plotting of clinical significance curves and risk-benefit contours. These curves and contours provide degrees of probability of both the potential benefit of treatment and the detriment due to toxicity, Additionally, they provide clinicians with a mechanism of translating the results of studies into treatment for individual patients, thus improving the clinical decision-making process. We illustrate the application of these curves and contours by reference to published studies. Confidence levels, clinical significance curves, and risk-benefit contours can be easily calculated with a hand calculator or standard statistical packages. We advocate their incorporation into the published results of clinical studies.	Natl Univ Singapore Hosp, Radiotherapy Ctr, Singapore 119074, Singapore; Westmead Hosp, Joint Ctr Radiat Oncol, Westmead, NSW 2145, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia	National University of Singapore; University of Sydney; University of Sydney	Shakespeare, TP (corresponding author), Natl Univ Singapore Hosp, Radiotherapy Ctr, Level 3,5 Lower Kent Ridge Rd, Singapore 119074, Singapore.	ThomasS@nuh.com.sg	Simes, Robert John/P-1497-2014					Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; ALTMAN DG, 1992, BRIT J OBSTET GYNAEC, V99, P90, DOI 10.1111/j.1471-0528.1992.tb14459.x; Atkins CD, 1998, LANCET, V351, P1884, DOI 10.1016/S0140-6736(05)78830-9; BERRY G, 1986, MED J AUSTRALIA, V144, P618, DOI 10.5694/j.1326-5377.1986.tb112339.x; BRAITMAN LE, 1988, ANN INTERN MED, V108, P296, DOI 10.7326/0003-4819-108-2-296; BRAITMAN LE, 1991, ANN INTERN MED, V114, P515, DOI 10.7326/0003-4819-114-6-515; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; BULPITT CJ, 1987, LANCET, V1, P494; Burton PR, 1998, J EPIDEMIOL COMMUN H, V52, P318, DOI 10.1136/jech.52.5.318; Cascinelli N, 1998, LANCET, V351, P793, DOI 10.1016/S0140-6736(97)08260-3; Cates CJ, 1998, BRIT MED J, V317, P1014, DOI 10.1136/bmj.317.7164.1014a; Clever L, 1997, NEW ENGL J MED, V336, P309; Fahey T, 1998, BRIT MED J, V316, P906, DOI 10.1136/bmj.316.7135.906; GARDNER MJ, 1986, BRIT MED J, V292, P810, DOI 10.1136/bmj.292.6523.810; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; POCOCK SJ, 1990, STAT MED, V9, P657, DOI 10.1002/sim.4780090612; Retsas S, 1998, LANCET, V351, P1884, DOI 10.1016/S0140-6736(98)26025-9; SACKETT DL, 1995, J PUBLIC HEALTH MED, V17, P330; Shakespeare TP, 1998, BRIT MED J, V317, P1014; Shakespeare TP, 1998, LANCET, V351, P1885, DOI 10.1016/S0140-6736(05)78831-0; SIMON R, 1986, ANN INTERN MED, V105, P429, DOI 10.7326/0003-4819-105-3-429; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505	23	97	99	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1349	1353		10.1016/S0140-6736(00)04522-0	http://dx.doi.org/10.1016/S0140-6736(00)04522-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343760				2022-12-28	WOS:000168411400035
J	Bouchon, A; Facchetti, F; Weigand, MA; Colonna, M				Bouchon, A; Facchetti, F; Weigand, MA; Colonna, M			TREM-1 amplifies inflammation and is a crucial mediator of septic shock	NATURE			English	Article							INNATE IMMUNITY; RECEPTOR ANTAGONIST; LETHAL ENDOTOXEMIA; MICE; CACHECTIN; INFECTION; CELLS; MONOCYTOGENES; PATHOGENESIS; PERITONITIS	Host innate responses to bacterial infections are primarily mediated by neutrophils and monocytes/macrophages(1,2). These cells express pattern recognition receptors (PRRs) that bind conserved molecular structures shared by groups of microorganisms(3,4). Stimulation of PRR signalling pathways initiates secretion of proinflammatory mediators(3,4), which promote the elimination of infectious agents and the induction of tissue repair. Excessive inflammation owing to bacterial infections can lead to tissue damage and septic shock(5-9). Here we show that inflammatory responses to microbial products are amplified by a pathway mediated by triggering receptor expressed on myeloid cells (TREM)-1. TREM-1 is an activating receptor expressed at high levels on neutrophils and monocytes that infiltrate human tissues infected with bacteria. Furthermore, it is upregulated on peritoneal neutrophils of patients with microbial sepsis and mice with experimental lipopolysaccaride (LPS)-induced shock. Notably, blockade of TREM-1 protects mice against LPS-induced shock, as well as microbial sepsis caused by live Escherichia coli or caecal ligation and puncture. These results demonstrate a critical function of TREM-1 in acute inflammatory responses to bacteria and implicate TREM-1 as a potential therapeutic target for septic shock.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Univ Brescia, Inst Pathol, Spedali Civili 1, Brescia, Italy; Univ Heidelberg, Clin Anaesthesiol, D-69120 Heidelberg, Germany; German Canc Res Inst DKFZ, Tumor Immunol Program, D-69120 Heidelberg, Germany	University of Brescia; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Colonna, M (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.		Facchetti, Fabio/E-7190-2010	Facchetti, Fabio/0000-0003-4975-2388; Colonna, Marco/0000-0001-5222-4987				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALEXANDER HR, 1991, J EXP MED, V173, P1029, DOI 10.1084/jem.173.4.1029; APPELMELK BJ, 1986, A VAN LEEUW J MICROB, V52, P537, DOI 10.1007/BF00423414; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; FACCHETTI F, 1992, AM J SURG PATHOL, V16, P955, DOI 10.1097/00000478-199210000-00005; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Peschon JJ, 1998, J IMMUNOL, V160, P943; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	27	783	892	2	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1103	1107		10.1038/35074114	http://dx.doi.org/10.1038/35074114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323674				2022-12-28	WOS:000168285500050
J	Forte, AM; Mitrovica, JX				Forte, AM; Mitrovica, JX			Deep-mantle high-viscosity flow and thermochemical structure inferred from seismic and geodynamic data	NATURE			English	Article							SHEAR-VELOCITY MODEL; CONVECTION; CONSTRAINTS; INVERSION; EARTH; RHEOLOGY; ANELASTICITY; ATTENUATION; ELASTICITY; DYNAMICS	Surface geophysical data that are related to the process of thermal convection in the Earth's mantle provide constraints on the rheological properties and density structure of the mantle. We show that these convection-related data imply the existence of a region of very high effective viscosity near 2,000 km depth. This inference is obtained using a viscous-flow model based on recent high-resolution seismic models of three-dimensional structure in the mantle. The high-viscosity layer near 2,000 km depth results in a re-organization of flow from short to long horizontal length scales, which agrees with seismic tomographic observations of very long wavelength structures in the deep mantle. The high-viscosity region also strongly suppresses flow-induced deformation and convective mixing in the deep mantle. Here we predict compositional and thermal heterogeneity in this region, using viscous-flow calculations based on the new viscosity profile, together with independent mineral physics data. These maps are consistent with the anti-correlation of anomalies in seismic shear and bulk sound velocity in the deep mantle. The maps also show that megaplumes in the lower mantle below the central Pacific and Africa are, despite the presence of compositional heterogeneity, buoyant and actively upwelling structures.	Univ Western Ontario, Dept Earth Sci, London, ON N6A 5B7, Canada; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	Western University (University of Western Ontario); University of Toronto	Forte, AM (corresponding author), Univ Western Ontario, Dept Earth Sci, Biol & Geol Bldg, London, ON N6A 5B7, Canada.	aforte@uwo.ca		Forte, Alessandro/0000-0002-3530-0455				ALBAREDE F, 1999, EOS T AM GEOPHYS UN, V80, P535; Bunge HP, 1996, GEOPHYS RES LETT, V23, P2987, DOI 10.1029/96GL02522; CONSTABLE SC, 1987, GEOPHYSICS, V52, P289, DOI 10.1190/1.1442303; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Durek JJ, 1996, B SEISMOL SOC AM, V86, P144; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Ekstrom G, 1998, NATURE, V394, P168, DOI 10.1038/28148; Forte AM, 2000, SCIENCE, V290, P1940, DOI 10.1126/science.290.5498.1940; Forte AM, 1994, ADV GEOPHYS, V36, P1, DOI 10.1016/S0065-2687(08)60537-3; FORTE AM, 1987, J GEOPHYS RES-SOLID, V92, P3645, DOI 10.1029/JB092iB05p03645; Forte AM, 1997, J GEOPHYS RES-SOL EA, V102, P17981, DOI 10.1029/97JB01276; FORTE AM, 2000, GEOPHYS MONOGR SER, V117, P3, DOI DOI 10.1029/GM117P0003; Grand SP., 1997, GSA TODAY, V7, P1; GURNIS M, 1986, GEOPHYS RES LETT, V13, P541, DOI 10.1029/GL013i006p00541; Gurnis M., 2000, GEOCHEM GEOPHY GEOSY, V1, DOI DOI 10.1029/1999GC000035; GWINN CR, 1986, J GEOPHYS RES-SOLID, V91, P4755, DOI 10.1029/JB091iB05p04755; HAGER BH, 1984, J GEOPHYS RES, V89, P6003, DOI 10.1029/JB089iB07p06003; HOFMANN AW, 1999, EOS T AGU S, V80, P1182; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; JACKSON I, 1992, GEOPHYS J INT, V108, P517, DOI 10.1111/j.1365-246X.1992.tb04633.x; Jackson I, 1998, GEOPHYS J INT, V134, P291, DOI 10.1046/j.1365-246x.1998.00560.x; KARATO S, 1992, SCIENCE, V255, P1238, DOI 10.1126/science.255.5049.1238; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; Karato S, 1998, PURE APPL GEOPHYS, V153, P239, DOI 10.1007/s000240050195; KELLOGG JB, 1999, EOS T AGU S, V80, P949; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kennett BLN, 1998, J GEOPHYS RES-SOL EA, V103, P12469, DOI 10.1029/98JB00150; KING SD, 1992, GEOPHYS RES LETT, V19, P1551, DOI 10.1029/92GL01700; Li XD, 1996, J GEOPHYS RES-SOL EA, V101, P22245, DOI 10.1029/96JB01306; Manga M, 1996, GEOPHYS RES LETT, V23, P403, DOI 10.1029/96GL00242; MARSH JG, 1990, J GEOPHYS RES-SOLID, V95, P22043, DOI 10.1029/JB095iB13p22043; Masters G, 1996, PHILOS T R SOC A, V354, P1385, DOI 10.1098/rsta.1996.0054; MASTERS G, 2000, GEOPHYS MONOGR SER, V117, P63, DOI DOI 10.1029/GM117P0063; MATHEWS P, 1999, EOS S, V80, P19; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Mitrovica JX, 1997, J GEOPHYS RES-SOL EA, V102, P2751, DOI 10.1029/96JB03175; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; OTTINO JM, 1989, KINEMATICS MIXING ST, pCH2; PANASYUK SV, 1998, THESIS MIT; RICARD Y, 1989, J GEOPHYS RES-SOLID, V94, P17543, DOI 10.1029/JB094iB12p17543; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; Robertson GS, 1996, EARTH PLANET SC LETT, V143, P197, DOI 10.1016/0012-821X(96)00134-3; Sinelnikov YD, 1998, PHYS CHEM MINER, V25, P515, DOI 10.1007/s002690050143; Stacey FD, 1998, PHYS EARTH PLANET IN, V106, P219, DOI 10.1016/S0031-9201(98)00084-3; STACEY FD, 1995, PHYS EARTH PLANET IN, V89, P219, DOI 10.1016/0031-9201(94)03005-4; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; Tackley PJ, 1998, GEODYNAMICS, V28, P231; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; van Keken PE, 1998, EARTH PLANET SC LETT, V156, P19, DOI 10.1016/S0012-821X(98)00023-5; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; WOODWARD RL, 1993, EVOLUTION EARTH PLAN, V74, P89; Zerr A, 1998, SCIENCE, V281, P243, DOI 10.1126/science.281.5374.243; Zhang JZ, 1999, SCIENCE, V284, P782, DOI 10.1126/science.284.5415.782	54	296	303	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1049	1056		10.1038/35074000	http://dx.doi.org/10.1038/35074000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323661				2022-12-28	WOS:000168285500037
J	Cohen, PJ				Cohen, PJ			Bedside rationing of health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Georgetown Univ, Ctr Law, Washington, DC 20057 USA	Georgetown University	Cohen, PJ (corresponding author), Georgetown Univ, Ctr Law, Washington, DC 20057 USA.							Bloche MG, 2000, JAMA-J AM MED ASSOC, V284, P2776, DOI 10.1001/jama.284.21.2776; BROUGHAM, 1821, TRIAL QUEEN CAROLINE, V2, P8	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2078	2078		10.1001/jama.285.16.2078	http://dx.doi.org/10.1001/jama.285.16.2078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311090				2022-12-28	WOS:000168131600020
J	Nansel, TR; Overpeck, M; Pilla, RS; Ruan, WJ; Simons-Morton, B; Scheidt, P				Nansel, TR; Overpeck, M; Pilla, RS; Ruan, WJ; Simons-Morton, B; Scheidt, P			Bullying behaviors among US youth - Prevalence and association with psychosocial adjustment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHOOL-AGE-CHILDREN; BULLY/VICTIM PROBLEMS; SELF-ESTEEM; BULLIES; VICTIMS; VICTIMIZATION; ADOLESCENTS; DEPRESSION; EXPERIENCE; STUDENTS	Context Although violence among US youth is a current major concern, bullying is infrequently addressed and no national data on the prevalence of bullying are available. Objectives To measure the prevalence of bullying behaviors among US youth and to determine the association of bullying and being bullied with indicators of psychosocial adjustment, including problem behavior, school adjustment, social/emotional adjustment, and parenting. Design, Setting, and Participants Analysis of data from a representative sample of 15686 students in grades 6 through 10 in public and private schools throughout the United States who completed the World Health Organization's Health Behaviour in School-aged Children survey during the spring of 1998. Main Outcome Measure Self-report of involvement in bullying and being bullied by others. Results A total of 29.9% of the sample reported moderate or frequent involvement in bullying, as a bully (13.0%), one who was bullied (10.6%), or both (6.3%). Males were more likely than females to be both perpetrators and targets of bullying. The frequency of bullying was higher among 6th- through 8th-grade students than among 9th- and 10th-grade students. Perpetrating and experiencing bullying were associated with poorer psychosocial adjustment (P<.001); however, different patterns of association occurred among bullies, those bullied, and those who both bullied others and were bullied themselves. Conclusions The prevalence of bullying among US youth is substantial. Given the concurrent behavioral and emotional difficulties associated with bullying, as well as the potential long-term negative outcomes for these youth, the issue of bullying merits serious attention, both for future research and preventive intervention.	NICHHD, Div Epidemiol Stat & Prevent Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nansel, TR (corresponding author), NICHHD, Div Epidemiol Stat & Prevent Res, 6100 Execut Blvd,Room 7805,MSC 7510, Bethesda, MD 20892 USA.		Fahimifar, Sepideh/M-5303-2019	Simons-Morton, Bruce/0000-0003-1099-6617; Nansel, Tonja/0000-0002-8298-7595	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002525, Z01HD002110] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Austin S, 1996, BRIT J EDUC PSYCHOL, V66, P447, DOI 10.1111/j.2044-8279.1996.tb01211.x; Baldry AC, 1998, SCHOOL PSYCHOL INT, V19, P361, DOI 10.1177/0143034398194007; Bijttebier P, 1998, BRIT J EDUC PSYCHOL, V68, P387, DOI 10.1111/j.2044-8279.1998.tb01299.x; Borg MG, 1999, EDUC RES, V41, P137, DOI 10.1080/0013188990410202; BOULTON MJ, 1992, BRIT J EDUC PSYCHOL, V62, P73, DOI 10.1111/j.2044-8279.1992.tb01000.x; BYRNE BJ, 1994, IRISH J PSYCHOL, V15, P574, DOI 10.1080/03033910.1994.10558031; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; FARRINGTON DP, 1996, CHILD AGGRESSION ADU, P5; Forero R, 1999, BRIT MED J, V319, P344, DOI 10.1136/bmj.319.7206.344; Haynie DL, 2001, J EARLY ADOLESCENCE, V21, P29, DOI 10.1177/0272431601021001002; Hazler R. J., 1992, SCHOOL PSYCHOL INT, V13, P5, DOI [10.1177/0143034392131001, DOI 10.1177/0143034392131001]; Hoover J.H., 1993, J HUMANISTIC ED DEV, V32, P76, DOI [DOI 10.1002/J.2164-4683.1993.TB00133.X, 10.1002/j.2164-4683.1993.tb00133.x]; Huttunen A, 1996, ANN NY ACAD SCI, V794, P355, DOI 10.1111/j.1749-6632.1996.tb32541.x; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; KING A, 1994, WHO REG PUBLICATION, V69; Kumpulainen K, 1998, CHILD ABUSE NEGLECT, V22, P705, DOI 10.1016/S0145-2134(98)00049-0; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Menesini E, 1997, AGGRESSIVE BEHAV, V23, P245, DOI 10.1002/(SICI)1098-2337(1997)23:4<245::AID-AB3>3.0.CO;2-J; O'Moore AM, 1997, IRISH J PSYCHOL, V18, P141; Olweus, 1978, AGGRESSION SCH BULLI; OLWEUS D, 1991, DEVELOPMENT AND TREATMENT OF CHILDHOOD AGGRESSION, P411; OLWEUS D, 1992, AGGRESSION AND VIOLENCE THROUGHOUT THE LIFE SPAN, P100; Olweus D, 1993, BULLYING SCH WHAT WE, DOI DOI 10.1007/978-1-4757-9116-7_5; Olweus D., 1999, NATURE SCH BULLYING; Olweus D., 1993, AGGRESSIVE BEHAV CUR; Pellegrini AD, 1999, J EDUC PSYCHOL, V91, P216, DOI 10.1037/0022-0663.91.2.216; Pellegrini AD, 1998, J APPL DEV PSYCHOL, V19, P165, DOI 10.1016/S0193-3973(99)80034-3; Rigby K, 1999, BRIT J EDUC PSYCHOL, V69, P95, DOI 10.1348/000709999157590; RIVERS I, 1994, AGGRESSIVE BEHAV, V20, P359, DOI 10.1002/1098-2337(1994)20:5<359::AID-AB2480200503>3.0.CO;2-J; Salmivalli C, 1998, AGGRESSIVE BEHAV, V24, P205, DOI 10.1002/(SICI)1098-2337(1998)24:3<205::AID-AB5>3.0.CO;2-J; Salmivalli C, 1999, PERS SOC PSYCHOL B, V25, P1268, DOI 10.1177/0146167299258008; Salmon G, 1998, BRIT MED J, V317, P924; Shah BV, 1997, SUDAAN USERS MANUAL; Sharp S., 1991, EARLY CHILD DEV CARE, V77, P47, DOI DOI 10.1080/0300443910770104; Slee P.T., 1995, CHILDRENS ENV, V12, P320; SLEE PT, 1993, PERS INDIV DIFFER, V14, P371, DOI 10.1016/0191-8869(93)90136-Q; SLEE PT, 1993, CHILD PSYCHIAT HUM D, V23, P273, DOI 10.1007/BF00707680; Smith PK, 1997, IRISH J PSYCHOL, V18, P191, DOI 10.1080/03033910.1997.10558139; *US DEP ED, 1999, 1999 ANN REP SCH SAF, P1; Whitney I., 1993, ED RES, V34, P3, DOI [10.1080/0013188930350101, DOI 10.1080/0013188930350101]; Williams K, 1996, BRIT MED J, V313, P17, DOI 10.1136/bmj.313.7048.17; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2001, HLTH BEHAV SCH AGED	43	2191	2245	24	780	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2094	2100		10.1001/jama.285.16.2094	http://dx.doi.org/10.1001/jama.285.16.2094			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422QW	11311098	Bronze, Green Accepted			2022-12-28	WOS:000168131600029
J	Edwards, TA; Pyle, SE; Wharton, RP; Aggarwal, AK				Edwards, TA; Pyle, SE; Wharton, RP; Aggarwal, AK			Structure of Pumilio reveals similarity between RNA and peptide binding motifs	CELL			English	Article							HUNCHBACK MESSENGER-RNA; CRYSTAL-STRUCTURE; TRANSLATIONAL REGULATION; DIFFRACTION DATA; PROTEIN; DROSOPHILA; DOMAIN; NANOS; REPRESSION; COMPLEX	Translation regulation plays an essential role in the differentiation and development of animal cells. One well-studied case is the control of hunchback mRNA during early Drosophila embryogenesis by the transacting factors Pumilio, Nanos, and Brain Tumor. We report here a crystal structure of the critical region of Pumilio, the Puf domain, that organizes a multivalent repression complex on the 3' untranslated region of hunchback mRNA. The structure reveals an extended, rainbow shaped molecule, with tandem helical repeats that bear unexpected resemblance to the armadillo repeats in beta -catenin and the HEAT repeats in protein phosphatase 2A. Based on the structure and genetic experiments, we identify putative interaction surfaces for hunchback mRNA and the cofactors Nanos and Brain Tumor. This analysis suggests that similar features in helical repeat proteins are used to bind extended peptides and RNA.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Duke University; Howard Hughes Medical Institute	Aggarwal, AK (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	aggarwal@inka.mssm.edu		edwards, thomas/0000-0002-1467-3674	NIGMS NIH HHS [R01 GM62947] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062947] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; DALBY B, 1993, EMBO J, V12, P1219, DOI 10.1002/j.1460-2075.1993.tb05763.x; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TA, 2000, J STRUCT BIOL, V132, P251, DOI 10.1006/jsbi.2000.4319; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR A, V47, P110; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Macdonald PM, 1996, CURR OPIN GENET DEV, V6, P403, DOI 10.1016/S0959-437X(96)80060-8; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; Wreden C, 1997, DEVELOPMENT, V124, P3015; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	53	196	204	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					281	289		10.1016/S0092-8674(01)00318-X	http://dx.doi.org/10.1016/S0092-8674(01)00318-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336677	Bronze			2022-12-28	WOS:000168384300014
J	Tromans, A				Tromans, A			Entomology - The alkaloid defence	NATURE			English	Editorial Material																		Conner WE, 2000, P NATL ACAD SCI USA, V97, P14406, DOI 10.1073/pnas.260503797	1	0	0	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					28	28		10.1038/35051196	http://dx.doi.org/10.1038/35051196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343096				2022-12-28	WOS:000166175600022
J	Larson, EB				Larson, EB			General internal medicine at the crossroads of prosperity and despair: Caring for patients with chronic diseases in an aging society	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; CONTINUITY; THROMBOSIS; THERAPY; HOME	During the past quarter century, general internal medicine has emerged as a vital discipline. In the realm of patient care, it is the integrating discipline par excellence. Ironically, as general internists face the challenge of integrating advances of dizzying speed and complexity, and as their clinical practice becomes increasingly effective, it has become much more difficult for them to earn a living. General internists find themselves at the crossroads of prosperity and despair. Although general medicine research leads the research agenda in many departments of medicine, it is particularly vulnerable. The necessary multidisciplinary "programmatic" infrastructure is expensive, and results often take many years to obtain, particularly in the study of chronic disease. The educational environment in many institutions is particularly difficult for general medicine, both because the current emphasis on technical skills obscures patients' and learners' real needs and because complex patients on general medicine services are now so ill and their turnover so rapid. General internal medicine and geriatrics are synergistic, especially in today's marketplace. A focus on geriatric medicine could help general medicine continue to flourish. General internists are ideally suited to the integrated care of elderly patients with multiple problems, research opportunities are enormous in the geriatric population, and the teaching of geriatrics requires a high level of generalist skills. Problems that plague current generalist practice have unique significance to older patients. Organizations that represent general internists would do well to join forces with many other advocacy groups, especially those representing the interests of elderly patients and geriatric medicine.	Univ Washington, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Larson, EB (corresponding author), Univ Washington, Med Ctr, Box 356330, Seattle, WA 98195 USA.	ebl@u.washington.edu						Burdi MD, 1999, HEALTH AFFAIR, V18, P134, DOI 10.1377/hlthaff.18.4.134; CAMPION EW, 1984, JAMA-J AM MED ASSOC, V252, P2459; Cunningham PJ, 2000, HEALTH AFFAIR, V19, P158, DOI 10.1377/hlthaff.19.3.158; EICHNA LW, 1980, NEW ENGL J MED, V303, P727, DOI 10.1056/NEJM198009253031304; Every NR, 1996, NEW ENGL J MED, V335, P1253, DOI 10.1056/NEJM199610243351701; FITZGERALD FT, 1990, WESTERN J MED, V152, P377; Grumbach K, 1999, NEW ENGL J MED, V341, P2008, DOI 10.1056/NEJM199912233412611; KASSIRER JP, 1983, NEW ENGL J MED, V309, P921, DOI 10.1056/NEJM198310133091511; KERN DC, 1985, JAMA-J AM MED ASSOC, V254, P70, DOI 10.1001/jama.254.1.70; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; LaCombe MA, 1997, ANN INTERN MED, V126, P217, DOI 10.7326/0003-4819-126-3-199702010-00007; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LEWIS CE, 1977, NEW ENGL J MED, V297, P423, DOI 10.1056/NEJM197708252970805; LOWRIE EG, 1981, NEW ENGL J MED, V305, P434, DOI 10.1056/NEJM198108203050805; *MA DEP PUBL HLTH, 1975, NEW ENGL J MED, V293, P775; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; Panzer RI, 1991, DIAGNOSTIC STRATEGIE; ROBACK G, 1977, PHYSICIAN DISTRIBUTI; ROBERG N, 1988, JAMA-J AM MED ASSOC, V260, P3645; SACKETT DL, 1987, J GEN INTERN MED, V2, P40, DOI 10.1007/BF02596250; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413	23	31	31	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					997	1000		10.7326/0003-4819-134-10-200105150-00013	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352700				2022-12-28	WOS:000168682500007
J	Ganzini, L; Nelson, HD; Lee, MA; Kraemer, DF; Schmidt, TA; Delorit, MA				Ganzini, L; Nelson, HD; Lee, MA; Kraemer, DF; Schmidt, TA; Delorit, MA			Oregon physicians' attitudes about and experiences with end-of-life care since passage of the Oregon Death with Dignity Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSISTED SUICIDE; PATIENT REQUESTS; EUTHANASIA; PAIN; DIE	Context The Oregon Death with Dignity Act, passed by ballot measure in 1994 and enacted in October 1997, legalized physician-assisted suicide for competent, terminally ill Oregonians, but little is known about the effects of the act on clinical practice or physician perspective. Objective To examine Oregon physicians' attitudes toward and practices regarding care of dying patients since the passage of the Death with Dignity Act. Design, Setting, and Participants A self-administered questionnaire was mailed in February 1999 to Oregon physicians eligible to prescribe under the act. Of 3981 eligible physicians, 2641 (66%) returned the questionnaire by August 1999. Main Outcome Measures Physicians' reports of their efforts to improve care for dying patients since 1994, their attitudes, concerns, and sources of information about participating in the Death with Dignity Act, and their conversations with patients regarding assisted suicide. Results A total of 791 respondents (30%) reported that they had increased referrals to hospice. Of the 2094 respondents who cared for terminally ill patients, 76% reported that they made efforts to improve their knowledge of the use of pain medications in the terminally ill. Nine hundred forty-nine responding physicians (36%) had been asked by a patient if they were potentially willing to prescribe a lethal medication, Seven percent of all survey participants reported that 1 or more patients became upset after learning the physician's position on assisted suicide, and 2% reported that 1 or more patients left their care after learning the physician's position on assisted suicide. Of the 73 physicians who were willing to write a lethal prescription and who had received a request from a patient, 20 (27%) were not confident they could determine when a patient had less than 6 months to live. Conclusion Most Oregon physicians who care for terminally ill patients report that since 1994 they have made efforts to improve their ability to care for these patients acid many have had conversations with patients about assisted suicide.	Dept Vet Affairs, Portland, OR USA; Oregon Hlth Sci Univ, Dept Psychiat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Ctr Eth & Hlth Care, Portland, OR 97201 USA; Providence Hlth Syst, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Ganzini, L (corresponding author), Vet Adm Med Ctr, Div Mental Hlth, P31DMH,POB 1034, Portland, OR 97207 USA.							ALPERS A, 1995, JAMA-J AM MED ASSOC, V274, P483, DOI 10.1001/jama.274.6.483; Bernat JL, 1997, SEMIN NEUROL, V17, P271, DOI 10.1055/s-2008-1040939; BLOCK SD, 1995, PSYCHOSOMATICS, V36, P445, DOI 10.1016/S0033-3182(95)71625-5; Caplan A L, 1997, Hosp J, V12, P17; *COMM PHYS ASS DEA, 1996, SUICIDE LIFE-THREAT, V26, P1; Emanuel EJ, 1996, ARCH INTERN MED, V156, P825, DOI 10.1001/archinte.156.8.825; Faber-Langendoen K, 1998, CANCER-AM CANCER SOC, V82, P35, DOI 10.1002/(SICI)1097-0142(19980101)82:1<35::AID-CNCR4>3.3.CO;2-#; FOLEY KM, 1991, J PAIN SYMPTOM MANAG, V6, P289, DOI 10.1016/0885-3924(91)90052-6; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; HALEY K, 1998, OREGON DEATH DIGNITY; Kelly BJ, 1996, AUST NZ J PSYCHIAT, V30, P3, DOI 10.3109/00048679609076068; MILES SH, 1994, JAMA-J AM MED ASSOC, V271, P1786, DOI 10.1001/jama.271.22.1786; Muskin PR, 1998, JAMA-J AM MED ASSOC, V279, P323, DOI 10.1001/jama.279.4.323; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Tolle SW, 2000, WESTERN J MED, V172, P374, DOI 10.1136/ewjm.172.6.374; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015	20	96	96	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2363	2369		10.1001/jama.285.18.2363	http://dx.doi.org/10.1001/jama.285.18.2363			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343484				2022-12-28	WOS:000168411200028
J	Crisci, C				Crisci, C			Internet therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1131	1131		10.1136/bmj.322.7294.1131	http://dx.doi.org/10.1136/bmj.322.7294.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337456	Green Published			2022-12-28	WOS:000168628300057
J	Kral, AH; Bluthenthal, RN; Lorvick, J; Gee, L; Bacchetti, P; Edlin, BR				Kral, AH; Bluthenthal, RN; Lorvick, J; Gee, L; Bacchetti, P; Edlin, BR			Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis	LANCET			English	Article							REPEAT ANONYMOUS TESTERS; CRACK COCAINE USERS; PREVENTION INTERVENTION; HARM REDUCTION; SEROCONVERSION; SEROPREVALENCE; BEHAVIOR; FEMALE; EXCHANGE; SYRINGE	Background Many new HIV-1 infections in the USA occur in injection drug users (IDUs). HIV-1 seroconversion of IDUs is mainly associated with injection-related risk factors. Harm-reduction programmes concentrate on injection-risk behaviour. We aimed to establish whether injection or sexual risk factors, or both, were associated with HIV-1 antibody seroconversion of street-recruited IDUs in San Francisco. from 1986 to 1998. Methods IDUs were enrolled every 6 months from four community sites. We did a nested case-control study comparing 58 respondents who seroconverted between Visits with 1134 controls who remained seronegative. Controls were matched with cases by sex and date. Adjusted odds ratios and 95% CI were calculated for men and women by use of conditional logistic regression. Findings Men who had sex with men were 8.8 times as likely to seroconvert (95% CI 3.7-20.5) as heterosexual men. Women who reported having traded sex for money in the past year were 5.1 times as likely as others to seroconvert (95% CI 1.9-13.7). Women younger than 40 years were more likely to seroconvert than those 40 years or older (2.8 [1.05-7.6]). and women who reported having a steady sex-partner who injected drugs were less likely to seroconvert than other women (0.32 [0.11-0.92]). Interpretation HIV-1 seroconversion of street-recruited IDUs in San Francisco is strongly associated with sexual behaviour. HIV-1. risk might be reduced by incorporation of innovative sexual-risk-reduction strategies into harm-reduction programmes.	Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Publ Hlth Biol & Epidemiol, Berkeley, CA 94720 USA; RAND Corp, Hlth Program, Los Angeles, CA USA; RAND Corp, Drug Policy Res Ctr, Los Angeles, CA USA; Charles R Drew Univ Med & Sci, Dept Psychiat, Los Angeles, CA 90059 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; RAND Corporation; RAND Corporation; Charles R. Drew University of Medicine & Science	Kral, AH (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, 3180 18th St, San Francisco, CA 94110 USA.	alkral@itsa.ucsf.edu	Bluthenthal, Ricky N/U-8203-2018; Edlin, Brian R/F-2966-2018	Bluthenthal, Ricky N/0000-0003-3491-1702; Edlin, Brian R/0000-0001-8172-8797; Kral, Alex/0000-0002-9092-3671; Lorvick, Jennifer/0000-0002-2836-3028	NIDA NIH HHS [R01-DA12109] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012109] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1997, NIH Consens Statement, V15, P1; ASTEMBORSKI J, 1994, AM J PUBLIC HEALTH, V84, P382, DOI 10.2105/AJPH.84.3.382; Bluthenthal RN, 1998, J ACQ IMMUN DEF SYND, V18, P505, DOI 10.1097/00042560-199808150-00013; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; CALSYN DA, 1992, AM J PUBLIC HEALTH, V82, P573, DOI 10.2105/AJPH.82.4.573; CALSYN DA, 1992, AIDS, V6, P1207, DOI 10.1097/00002030-199210000-00023; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P465; *CDCP, 1991, MMWR-MORBID MORTAL W, V40, P692; DESJARLAIS DC, 1995, AM J PUBLIC HEALTH, V85, P10, DOI 10.2105/AJPH.85.1.10; Downing M, 1999, AIDS EDUC PREV, V11, P243; EDLIN BR, 1994, NEW ENGL J MED, V331, P1422, DOI 10.1056/NEJM199411243312106; Elifson KW, 1999, J ACQ IMMUN DEF SYND, V20, P195, DOI 10.1097/00042560-199902010-00013; Fishbein M, 1999, AM J PUBLIC HEALTH, V89, P336, DOI 10.2105/AJPH.89.3.336; Fisher DG, 1998, J PSYCHOACTIVE DRUGS, V30, P299; FRIEDMAN SR, 1995, AM J EPIDEMIOL, V142, P864, DOI 10.1093/oxfordjournals.aje.a117726; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Kegeles SM, 1996, AM J PUBLIC HEALTH, V86, P1129, DOI 10.2105/AJPH.86.8_Pt_1.1129; Kellogg T, 1999, AIDS, V13, P2303, DOI 10.1097/00002030-199911120-00013; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kral AH, 1999, ADDICTION, V94, P675, DOI 10.1046/j.1360-0443.1999.9456755.x; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Kral AH, 2000, J ACQ IMMUN DEF SYND, V24, P162; KRAL AH, 1999, 127 M AM PUBL HLTH A; Latkin C A, 1998, Public Health Rep, V113 Suppl 1, P151; Lurie P, 1993, PUBLIC HLTH IMPACT N; McFarland W, 1997, AM J EPIDEMIOL, V146, P662, DOI 10.1093/oxfordjournals.aje.a009332; MOSS AR, 1994, AIDS, V8, P223, DOI 10.1097/00002030-199402000-00010; Nicolosi A, 1990, Epidemiology, V1, P453, DOI 10.1097/00001648-199011000-00007; NORMAND J, 1995, PREVENTING HIV TRANS; Paone D, 1995, J Am Med Womens Assoc (1972), V50, P109; Rhodes T, 1999, AIDS, V13, pS259; Rhodes T, 1996, SUBST USE MISUSE, V31, P375, DOI 10.3109/10826089609045817; *SAN FRANC DEP PUB, 1997, HIV PREV INC SAN FRA; SOLOMON L, 1993, AM J EPIDEMIOL, V137, P892, DOI 10.1093/oxfordjournals.aje.a116750; STRATHDEE SA, IN PRESS ARCH INTERN; VANAMEIJDEN EJC, 1992, AM J EPIDEMIOL, V136, P236, DOI 10.1093/oxfordjournals.aje.a116489; WATTERS JK, 1994, J ACQ IMMUN DEF SYND, V7, P1276; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; WEATHERBY NL, 1994, EVAL PROGRAM PLANN, V17, P347, DOI 10.1016/0149-7189(94)90035-3	40	299	303	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1397	1401		10.1016/S0140-6736(00)04562-1	http://dx.doi.org/10.1016/S0140-6736(00)04562-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	428TW	11356437				2022-12-28	WOS:000168478200011
J	Molokhia, M; McKeigue, PM; Cuadrado, M; Hughes, G				Molokhia, M; McKeigue, PM; Cuadrado, M; Hughes, G			Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK	LANCET			English	Article							POPULATIONS	SLE has a high prevalence in Afro-Caribbean populations but has been reported to be rare In west Africa. We assessed prevalence (per 100 000) of SLE in women in an area of south London and estimated it to be 177 (95% CI 135-220) in Afro-Caribbeans, 110 (58-163) in west Africans, and 35 (26-43) in Europeans. The high prevalence of SLE in recent migrants from west Africa suggests that the disease is not rare in west Africa, and that there is a genetic basis for the high risk of SLE in people of west African descent compared with other groups.	Univ London London Sch Hyg & Trop Med, Epidemiol Unit, London WC1E 7HT, England; St Thomas Hosp, Rayne Inst, London SE1 7EH, England	University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Molokhia, M (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol Unit, Keppel St, London WC1E 7HT, England.							ADELSTEIN AM, 1984, BRIT MED BULL, V40, P315, DOI 10.1093/oxfordjournals.bmb.a071997; Bae SC, 1998, ARTHRITIS RHEUM-US, V41, P2091, DOI 10.1002/1529-0131(199812)41:12<2091::AID-ART2>3.3.CO;2-4; GREENWOO.BM, 1968, LANCET, V2, P380; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Molokhia M, 2000, ARTHRITIS RES, V2, P115, DOI 10.1186/ar76	5	49	51	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1414	1415		10.1016/S0140-6736(00)04580-3	http://dx.doi.org/10.1016/S0140-6736(00)04580-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356443				2022-12-28	WOS:000168478200017
J	Thomas, M; McKinley, RK; Freeman, E; Foy, C				Thomas, M; McKinley, RK; Freeman, E; Foy, C			Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							HYPERVENTILATION PROVOCATION TEST; PANIC DISORDER; QUESTIONNAIRE; PLACEBO	Objectives To estimate the prevalence of dysfunctional breathing in adults with asthma treated in the community. Design Postal questionnaire survey using Nijmegen questionnaire. Setting One general practice with 7033 patients, Participants All adult patients aged 17-65 with diagnosed asthma who were receiving treatment. Main outcome measure Score greater than or equal to 23 on Nijmegen questionnaire. Results 227/307 patients returned completed questionnaires; 219 (71.3%) questionnaires were suitable for analysis, 63 participants scored greater than or equal to 23. Those scoring greater than or equal to 23 were more likely to be female than male (46/132 (35%) v 17/87 (20%), P=0.016) and were younger (mean (SD) age 44.8 (14.7) v 49.0 (13.8, (P=0.05). Patients at different treatment steps of the British Thoracic Society asthma guidelines were affected equally. Conclusions About a third of women and a fifth of men had scores suggestive of dysfunctional breathing. Although further studies are needed to confirm the validity of this screening tool and these findings, these prevalences suggest scope for therapeutic intervention and may explain the anecdotal success of the Buteyko method of nearing asthma.	Surgery, Stroud GL6 9JF, Glos, England; Univ Leicester, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England; Gloucestershire Hlth Author, Gloucestershire Res & Dev Support Unit, Gloucester GL1 2EL, England	University of Leicester	Thomas, M (corresponding author), Surgery, Stroud GL6 9JF, Glos, England.		McKinley, Robert Kee/H-9211-2013	McKinley, Robert Kee/0000-0002-3684-3435; Thomas, Mike/0000-0001-5939-1155				Bowler SD, 1998, MED J AUSTRALIA, V169, P575, DOI 10.5694/j.1326-5377.1998.tb123422.x; Britton J, 1998, BMJ-BRIT MED J, V317, P227, DOI 10.1136/bmj.317.7153.227; Carr RE, 1996, J ABNORM PSYCHOL, V105, P137, DOI 10.1037/0021-843X.105.1.137; Carr RE, 1998, J PSYCHOSOM RES, V44, P43, DOI 10.1016/S0022-3999(97)00137-2; DeGuire S, 1996, BIOFEEDBACK SELF-REG, V21, P191, DOI 10.1007/BF02284695; DEMETER SL, 1986, AM J MED, V81, P989, DOI 10.1016/0002-9343(86)90393-1; Dixhoorn J., 1997, BIOL PSYCHOL, V46, P90; Gardner WN, 1996, CHEST, V109, P516, DOI 10.1378/chest.109.2.516; GARDNER WN, 1986, LANCET, V1, P30; GARSSEN B, 1992, CLIN PSYCHOL REV, V12, P141, DOI 10.1016/0272-7358(92)90111-K; GROSSMAN P, 1985, J PSYCHOSOM RES, V29, P49, DOI 10.1016/0022-3999(85)90008-X; Han JN, 1999, AM J RESP CRIT CARE, V159, pA788; Han JN, 1997, EUR RESPIR J, V10, P167, DOI 10.1183/09031936.97.10010167; Hornsveld HK, 1996, LANCET, V348, P154, DOI 10.1016/S0140-6736(96)02024-7; HOWELL JBL, 1990, THORAX, V45, P287, DOI 10.1136/thx.45.4.287; HOWELL LBL, 1997, THORAX S, V52, pS30; LEWIS RA, 1986, B EUR PHYSIOPATH RES, V22, P201; LUM LC, 1994, BEHAV PSYCHOL APPROA; LUM LC, 1983, J DRUG RES, V8, P1867; *LUNG ASTHM INF AG, 1999, 991 LAIA; Malmberg LP, 2000, THORAX, V55, P295, DOI 10.1136/thorax.55.4.295; MARGARIAN GJ, 1982, MEDICINE, V61, P219; Maskell N, 1999, AM J RESP CRIT CARE, V159, pA832; McLean AN, 1999, AM J RESP CRIT CARE, V159, pA652; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; VANDIXHOORN J, 1998, ONTSPANNINGSINSTRUCT; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	27	127	129	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1098	1100		10.1136/bmj.322.7294.1098	http://dx.doi.org/10.1136/bmj.322.7294.1098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431JP	11337441	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168628300023
J	Whincup, PH; Gilg, JA; Odoki, K; Taylor, SJC; Cook, DG				Whincup, PH; Gilg, JA; Odoki, K; Taylor, SJC; Cook, DG			Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; Univ London Queen Mary & Westfield Coll, Dept Gen Practice & Primary Care Med Sci, London E1 4NS, England	St Georges University London; University of London; Queen Mary University London	Whincup, PH (corresponding author), St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England.			Cook, Derek/0000-0002-9723-5759; Whincup, Peter/0000-0002-5589-4107; Taylor, Stephanie/0000-0001-7454-6354	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ELLEN B, 2000, OBSERVER        0618, V1, P4; Eveleth PB, 1990, WORLDWIDE VARIATION; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Whincup PH, 1996, BMJ-BRIT MED J, V313, P79, DOI 10.1136/bmj.313.7049.79	4	105	109	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1095	1096		10.1136/bmj.322.7294.1095	http://dx.doi.org/10.1136/bmj.322.7294.1095			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337438	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168628300020
J	Edgar, BA; Orr-Weaver, TL				Edgar, BA; Orr-Weaver, TL			Endoreplication cell cycles: More for less	CELL			English	Review							TROPHOBLAST GIANT-CELLS; DNA-REPLICATION CONTROL; S-PHASE; FOLLICLE CELLS; DROSOPHILA EMBRYOGENESIS; ENDOREDUPLICATION CYCLES; SYSTEMIC ENDOPOLYPLOIDY; POLYTENE CHROMOSOMES; DOWN-REGULATION; ORIGIN		Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; MIT, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Fred Hutchinson Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	bedgar@fhcrc.org; weaver@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061805, R01GM057960] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57960, GM61805] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Britton JS, 1998, DEVELOPMENT, V125, P2149; BRITTON JS, 2000, THESIS U WASHINGTON; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DATAR SA, 2000, THESIS U WASHINGTON; de Nooij JC, 2000, MECH DEVELOP, V97, P73, DOI 10.1016/S0925-4773(00)00435-4; Dej KJ, 1999, DEVELOPMENT, V126, P293; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; DEROCHER EJ, 1990, SCIENCE, V250, P99, DOI 10.1126/science.250.4977.99; Donaldson AD, 1999, CURR OPIN GENET DEV, V9, P62, DOI 10.1016/S0959-437X(99)80009-4; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Duronio RJ, 1996, GENE DEV, V10, P2505, DOI 10.1101/gad.10.19.2505; Duronio RJ, 1998, MOL CELL BIOL, V18, P141, DOI 10.1128/MCB.18.1.141; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; Edgar BA, 2001, NOVART FDN SYMP, V237, P3, DOI 10.1002/0470846666.ch2; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; Galloni M, 1999, DEVELOPMENT, V126, P2365; GRAFI G, 1995, SCIENCE, V269, P1262, DOI 10.1126/science.269.5228.1262; Grafi G, 1996, P NATL ACAD SCI USA, V93, P8962, DOI 10.1073/pnas.93.17.8962; HAMMOND MP, 1985, CHROMOSOMA, V91, P267, DOI 10.1007/BF00328222; Hattori N, 2000, MOL BIOL CELL, V11, P1037, DOI 10.1091/mbc.11.3.1037; Hayashi S, 1996, DEVELOPMENT, V122, P1051; HAYASHI S, 1993, DEVELOPMENT, V118, P105; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Jones L, 2000, DEVELOPMENT, V127, P4619; KATO Y, 1987, DEVELOPMENT, V99, P137; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; LAIRD CD, 1980, CELL, V22, P869, DOI 10.1016/0092-8674(80)90563-2; LIANG C, 1993, GENE DEV, V7, P1072, DOI 10.1101/gad.7.6.1072; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795; MAHOWALD AP, 1979, EXP CELL RES, V118, P404, DOI 10.1016/0014-4827(79)90167-8; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; NAGL W, 1976, NATURE, V261, P614, DOI 10.1038/261614a0; NAGL W, 1978, ENDOPOLYPLOIDY POLYT; Nakayama H, 1998, DEV BIOL, V199, P150, DOI 10.1006/dbio.1998.8914; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Reed BH, 1997, DEVELOPMENT, V124, P3543; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; ROYZMAN I, 1997, MUTATIONS DROSOPHILA; SAUER K, 1995, GENE DEV, V9, P1327, DOI 10.1101/gad.9.11.1327; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; SMITH AV, 1991, DEVELOPMENT, V112, P997; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Su TT, 1998, J CELL BIOL, V140, P451, DOI 10.1083/jcb.140.3.451; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; URATA Y, 1995, J CELL BIOL, V131, P279, DOI 10.1083/jcb.131.2.279; VARMUZA S, 1988, DEVELOPMENT, V102, P127; WANG ZY, 1995, BLOOD, V86, P3783, DOI 10.1182/blood.V86.10.3783.bloodjournal86103783; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 1998, J BIOL CHEM, V273, P1387, DOI 10.1074/jbc.273.3.1387; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248; Zybina EV, 1996, INT REV CYTOL, V165, P53, DOI 10.1016/S0074-7696(08)62220-2	70	635	664	0	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					297	306		10.1016/S0092-8674(01)00334-8	http://dx.doi.org/10.1016/S0092-8674(01)00334-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348589	Bronze			2022-12-28	WOS:000168515900002
J	Paterson, L; MacDonald, MP; Arlt, J; Sibbett, W; Bryant, PE; Dholakia, K				Paterson, L; MacDonald, MP; Arlt, J; Sibbett, W; Bryant, PE; Dholakia, K			Controlled rotation of optically trapped microscopic particles	SCIENCE			English	Article							GAUSSIAN LASER MODES; ORBITAL ANGULAR-MOMENTUM; LIGHT; BEAM	We demonstrate controlled rotation of optically trapped objects in a spiral interference pattern. This pattern is generated by interfering an annular shaped laser beam with a reference beam. Objects are trapped in the spiral arms of the pattern. Changing the optical path length causes this pattern, and thus the trapped objects, to rotate. Structures of silica microspheres, microscopic glass rods, and chromosomes are set into rotation at rates in excess of 5 hertz. This technique does not depend on intrinsic properties of the trapped particle and thus offers important applications in optical and biological micromachines.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland	University of St Andrews; University of St Andrews	Dholakia, K (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		Arlt, Jochen/B-7435-2009; Dholakia, Kishan/C-9873-2009; MacDonald, Michael P/F-5880-2011	Arlt, Jochen/0000-0002-4152-5896; MacDonald, Michael P/0000-0003-4415-5437; Paterson, Lynn/0000-0003-0493-5041; Dholakia, Kishan/0000-0001-6534-9009				ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Beth RA, 1936, PHYS REV, V50, P115, DOI 10.1103/PhysRev.50.115; Clifford MA, 1998, OPT COMMUN, V156, P300, DOI 10.1016/S0030-4018(98)00464-7; Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566; Friese MEJ, 1996, PHYS REV A, V54, P1593, DOI 10.1103/PhysRevA.54.1593; Friese MEJ, 2001, APPL PHYS LETT, V78, P547, DOI 10.1063/1.1339995; Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; LIANG H, 1993, EXP CELL RES, V204, P110, DOI 10.1006/excr.1993.1015; Padgett M, 1996, AM J PHYS, V64, P77, DOI 10.1119/1.18283; Simpson NB, 1997, OPT LETT, V22, P52, DOI 10.1364/OL.22.000052	13	803	842	15	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					912	914		10.1126/science.1058591	http://dx.doi.org/10.1126/science.1058591			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340200				2022-12-28	WOS:000168514900038
J	He, T; Huang, Q; Ramirez, AP; Wang, Y; Regan, KA; Rogado, N; Hayward, MA; Haas, MK; Slusky, JS; Inumara, K; Zandbergen, HW; Ong, NP; Cava, RJ				He, T; Huang, Q; Ramirez, AP; Wang, Y; Regan, KA; Rogado, N; Hayward, MA; Haas, MK; Slusky, JS; Inumara, K; Zandbergen, HW; Ong, NP; Cava, RJ			Superconductivity in the non-oxide perovskite MgCNi3	NATURE			English	Article							TEMPERATURE	The interplay of magnetic interactions, the dimensionality of the crystal structure and electronic correlations in producing superconductivity is one of the dominant themes in the study of the electronic properties of complex materials. Although magnetic interactions and two-dimensional structures were long thought to be detrimental to the formation of a superconducting state, they are actually common features of both the high transition-temperature (T-c) copper oxides and low-T-c material Sr2RuO4, where they appear to be essential contributors to the exotic electronic states of these materials(1). Here we report that the perovskite-structured compound MgCNi3 is superconducting with a critical temperature of 8 K. This material is the three-dimensional analogue of the LnNi(2)B(2)C family of superconductors, which have critical temperatures up to 16 K (ref. 2). The itinerant electrons in both families of materials arise from the partial filling of the nickel d-states, which generally leads to ferromagnetism as is the case in metallic Ni. The high relative proportion of Ni in MgCNi3 suggests that magnetic interactions are important, and the lower T-c of this three-dimensional compound-when compared to the LnNi(2)B(2)C family-contrasts with conventional ideas regarding the origins of superconductivity.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Univ Maryland, Dept Mat & Nucl Engn, College Pk, MD 20742 USA; NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; Univ Calif Los Alamos Natl Lab, Condensed Matter & Thermal Phys Grp, Los Alamos, NM USA	Princeton University; Princeton University; Princeton University; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; United States Department of Energy (DOE); Los Alamos National Laboratory	Cava, RJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.		Hayward, Michael/B-8005-2008; Inumaru, Kei/J-9292-2015; Ong, N. Phuan/Z-1626-2019; Ramirez, Arthur/HGD-6619-2022	Hayward, Michael/0000-0002-6248-2063; Slusky, Joanna/0000-0003-0842-6340; Ong, N. Phuan/0000-0001-7166-1058				CAVA RJ, 1994, NATURE, V367, P252, DOI 10.1038/367252a0; CHAMBERLAND BL, 1992, CHEM SUPERCONDUCTOR, P2; HUETTER LJ, 1958, ACTA METALL MATER, V6, P367, DOI 10.1016/0001-6160(58)90074-9; KRESIN VZ, 1987, PHYS LETT A, V122, P434, DOI 10.1016/0375-9601(87)90744-4; KRESIN VZ, 1975, FIZ TVERD TELA, V16, P2180; Nohara M, 1997, J PHYS SOC JPN, V66, P1888, DOI 10.1143/JPSJ.66.1888; Rice TM, 2000, PHYSICA C, V341, P41, DOI 10.1016/S0921-4534(00)00386-5; SCHEIL E, 1953, Z METALLKD, V44, P387	8	552	561	10	158	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					54	56		10.1038/35075014	http://dx.doi.org/10.1038/35075014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333973	Green Submitted			2022-12-28	WOS:000168432800039
J	Yancy, CW; Fowler, MB; Colucci, WS; Gilbert, EM; Bristow, MR; Cohn, JN; Lukas, MA; Young, ST; Packer, M				Yancy, CW; Fowler, MB; Colucci, WS; Gilbert, EM; Bristow, MR; Cohn, JN; Lukas, MA; Young, ST; Packer, M		US Carvedilol Heart Failure Study	Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RACIAL-DIFFERENCES; BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; AFRICAN-AMERICANS; HOSPITALIZATION; NOREPINEPHRINE; SURVIVAL; PLACEBO; BLACKS; TRIAL	Background: The benefits of angiotensin-converting-enzyme inhibitors and beta-blockers may be smaller in black patients than in patients of other races, but it is unknown whether race influences the response to carvedilol in patients with chronic heart failure. Methods: In the U.S. Carvedilol Heart Failure Trials Program, 217 black and 877 nonblack patients (in New York Heart Association class II, III, or IV and with a left ventricular ejection fraction of no more than 0.35) were randomly assigned to receive placebo or carvedilol (at doses of 6.25 to 50 mg twice daily) for up to 15 months. The effects of carvedilol on ejection fraction, clinical status, and major clinical events were retrospectively compared between black and nonblack patients. Results: As compared with placebo, carvedilol lowered the risk of death from any cause or hospitalization for any reason by 48 percent in black patients and by 30 percent in nonblack patients. Carvedilol reduced the risk of worsening heart failure (heart failure leading to death, hospitalization, or a sustained increase in medication) by 54 percent in black patients and by 51 percent in nonblack patients. The ratios of the relative risks associated with carvedilol for these two outcome variables in black as compared with nonblack patients were 0.74 (95 percent confidence interval, 0.42 to 1.34) and 0.94 (95 percent confidence interval, 0.43 to 2.05), respectively. Carvedilol also improved functional class, ejection fraction, and the patients' and physicians' global assessments in both the black patients and the nonblack patients. For all these measures of outcome and clinical status, carvedilol was superior to placebo within each racial cohort (P<0.05 in all analyses), and there was no significant interaction between race and treatment (P>0.05 in all analyses). Conclusions: The benefit of carvedilol was apparent and of similar magnitude in both black and nonblack patients with heart failure. (N Engl J Med 2001;344:1358-65.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Texas, SW Med Ctr, Div Cardiol, Dallas, TX 75390 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Utah, Sch Med, Salt Lake City, UT USA; Univ Colorado, Sch Med, Denver, CO USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Glaxo SmithKline, King Of Prussia, PA USA; Columbia Univ, Coll Phys & Surg, New York, NY USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; Boston University; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Minnesota System; University of Minnesota Twin Cities; GlaxoSmithKline; Columbia University	Yancy, CW (corresponding author), Univ Texas, SW Med Ctr, Div Cardiol, CS7 102,5323 Harry Hines Blvd, Dallas, TX 75390 USA.		bristow, michael r/G-7850-2011	Colucci, Wilson/0000-0002-0576-9420				Afzal A, 1999, CLIN CARDIOL, V22, P791, DOI 10.1002/clc.4960221207; ALEXANDER M, 1995, JAMA-J AM MED ASSOC, V274, P1037, DOI 10.1001/jama.274.13.1037; *AM HEART ASS, 1999, BIOST FACT SHEET AFR; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Cohn J N, 1997, J Card Fail, V3, P173, DOI 10.1016/S1071-9164(97)90013-0; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Coughlin SS, 1997, J NATL MED ASSOC, V89, P277; CUBEDDU LX, 1986, JAMA-J AM MED ASSOC, V256, P2214, DOI 10.1001/jama.256.16.2214; DIMSDALE JE, 1987, HYPERTENSION, V10, P564, DOI 10.1161/01.HYP.10.6.564; Domanski MJ, 2000, J AM COLL CARDIOL, V35, p202A; Douglas J G, 1996, J Assoc Acad Minor Phys, V7, P16; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1999, NEW ENGL J MED, V341, P298; Duey W J, 1997, Ethn Health, V2, P127; EPSTEIN SE, 1966, ANN INTERN MED, V65, P20, DOI 10.7326/0003-4819-65-1-20; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Feuerstein G, 1998, PROG CARDIOVASC DIS, V41, P17, DOI 10.1016/S0033-0620(98)80027-3; FLAMENBAUM W, 1985, Journal of Clinical Hypertension, V1, P56; GAFFNEY TE, 1963, AM J MED, V34, P320, DOI 10.1016/0002-9343(63)90118-9; GHALI JK, 1990, ARCH INTERN MED, V150, P769, DOI 10.1001/archinte.150.4.769; Giugliano D, 1997, ANN INTERN MED, V126, P955, DOI 10.7326/0003-4819-126-12-199706150-00004; HAYWOOD LJ, 1990, AM J MED, V88, pS17, DOI 10.1016/0002-9343(90)90005-X; He J, 1999, ARCH INTERN MED, V159, P498, DOI 10.1001/archinte.159.5.498; Jacob S, 1996, J HYPERTENS, V14, P1382; Lang CC, 1997, HYPERTENSION, V30, P157, DOI 10.1161/01.HYP.30.2.157; LEVY SB, 1978, ANN INTERN MED, V88, P12, DOI 10.7326/0003-4819-88-1-12; LUFT FC, 1983, ANN INTERN MED, V98, P758, DOI 10.7326/0003-4819-98-5-758; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MATERSON BJ, 1994, NEW ENGL J MED, V330, P1689, DOI 10.1056/NEJM199406093302316; MAYET J, 1994, BMJ-BRIT MED J, V308, P1011, DOI 10.1136/bmj.308.6935.1011; MILLS PJ, 1995, HYPERTENSION, V25, P88, DOI 10.1161/01.HYP.25.1.88; *NAT HEART LUNG BL, 1996, DAT FACT SHEET CONG; Packer M, 1996, CIRCULATION, V94, P2793, DOI 10.1161/01.CIR.94.11.2793; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Philbin EF, 1998, AM J CARDIOL, V82, P76, DOI 10.1016/S0002-9149(98)00233-1; PRATT JH, 1992, J HYPERTENS, V10, P93, DOI 10.1097/00004872-199201000-00015; Saunders E, 1995, AM J HYPERTENS, V8, pS115, DOI 10.1016/0895-7061(95)00309-6; SHERWOOD A, 1993, AM J HYPERTENS, V6, P630, DOI 10.1093/ajh/6.7.630; Sudhir K, 1997, HYPERTENSION, V29, P1083, DOI 10.1161/01.HYP.29.5.1083; VOORS AW, 1979, SCIENCE, V204, P1091, DOI 10.1126/science.451554	41	191	200	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1358	1365		10.1056/NEJM200105033441803	http://dx.doi.org/10.1056/NEJM200105033441803			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333992	Bronze			2022-12-28	WOS:000168413500003
J	Yiangou, Y; Facer, P; Dyer, NHC; Chan, CLH; Knowles, C; Williams, NS; Anand, P				Yiangou, Y; Facer, P; Dyer, NHC; Chan, CLH; Knowles, C; Williams, NS; Anand, P			Vanilloid receptor 1 immunoreactivity in inflamed human bowel	LANCET			English	Article							NOCICEPTION; CAPSAICIN	Vanilloid receptor 1(VR1) is expressed by sensory neurons. Once activated, these neurons evoke the sensation of burning pain and release neuropeptides that induce neurogenic Inflammation. We used immunoblotting and immunostaining to estimate the density of VR1 in colonic tissues of patients with inflammatory bowel disease and of controls. Our study results indicate that VR1 immunoreactivity is greatly increased in colonic nerve fibres of patients with active inflammatory bowel disease. Thus, the discovery of new drugs that can bind the VRI receptor, or antagonise endogenous inflammatory substances that activate this receptor, could lead to new therapies for pain and dysmotility.	Hammersmith Hosp, Imperial Coll Sch Med, Peripheral Neuropathy Unit, London, England; Roche Biosci, Neurobiol Unit, Palo Alto, CA USA; St Bartholomews & Royal London Sch Med & Dent, Acad Dept Surg, London, England	Imperial College London; Roche Holding; University of London; Queen Mary University London	Anand, P (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Peripheral Neuropathy Unit, London, England.			Yiangou, Yiangos/0000-0003-3518-5474				Anand P, 1996, NAT MED, V2, P703, DOI 10.1038/nm0696-703; Baron R, 2000, LANCET, V356, P785, DOI 10.1016/S0140-6736(00)02649-0; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Yiangou Y, 2000, FEBS LETT, V467, P249, DOI 10.1016/S0014-5793(00)01166-2	5	292	319	2	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1338	1339		10.1016/S0140-6736(00)04503-7	http://dx.doi.org/10.1016/S0140-6736(00)04503-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343743				2022-12-28	WOS:000168411400016
J	Wei, WB; Unsworth, M; Jones, A; Booker, J; Tan, HD; Nelson, D; Chen, LS; Li, SH; Solon, K; Bedrosian, P; Jin, S; Deng, M; Ledo, J; Ray, D; Roberts, B				Wei, WB; Unsworth, M; Jones, A; Booker, J; Tan, HD; Nelson, D; Chen, LS; Li, SH; Solon, K; Bedrosian, P; Jin, S; Deng, M; Ledo, J; Ray, D; Roberts, B			Detection of widespread fluids in the Tibetan crust by magnetotelluric studies	SCIENCE			English	Article							SOUTHERN TIBET; ELECTRICAL-CONDUCTIVITY; SUBDUCTION; PLATEAU; MODELS; UPLIFT; ROCKS; MELT	Magnetotelluric exploration has shown that the middle and lower crust is anomalously conductive across most of the north-to-south width of the Tibetan plateau. The integrated conductivity (conductance) of the Tibetan crust ranges from 3000 to greater than 20,000 siemens. In contrast, stable continental regions typically exhibit conductances from 20 to 1000 siemens, averaging 100 siemens. Such pervasively high conductance suggests that partial melt and/or aqueous fluids are widespread within the Tibetan crust. In southern Tibet, the high-conductivity layer is at a depth of 15 to 20 kilometers and is probably due to partial melt and aqueous fluids in the crust. In northern Tibet, the conductive layer is at 30 to 40 kilometers and is due to partial melting. Zones of fluid may represent weaker areas that could accommodate deformation a nd lower crustal flow.	Univ Alberta, Inst Geophys Res, Edmonton, AB T6G 2J1, Canada; China Univ Geosci, Dept Appl Geophys, Beijing, Peoples R China; Geol Survey Canada, Ottawa, ON, Canada; Univ Washington, Geophys Program, Seattle, WA 98195 USA; Syracuse Univ, Syracuse, NY 13244 USA	University of Alberta; China University of Geosciences; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Washington; University of Washington Seattle; Syracuse University	Unsworth, M (corresponding author), Univ Alberta, Inst Geophys Res, Edmonton, AB T6G 2J1, Canada.		Jones, Alan G/A-3241-2009; Unsworth, Martyn J/A-6395-2012; Ledo, Juanjo/K-4420-2014	Jones, Alan G/0000-0002-3482-2518; Unsworth, Martyn J/0000-0001-8282-4174; Ledo, Juanjo/0000-0003-1548-1575; Bedrosian, Paul/0000-0002-6786-1038; Ming, Deng/0000-0002-2856-8269				Alsdorf D, 1999, GEOLOGY, V27, P943, DOI 10.1130/0091-7613(1999)027<0943:TSMLEF>2.3.CO;2; ARMIJO R, 1986, J GEOPHYS RES-SOLID, V91, P13803, DOI 10.1029/JB091iB14p13803; Brown LD, 1996, SCIENCE, V274, P1688, DOI 10.1126/science.274.5293.1688; Chen LH, 1996, SCIENCE, V274, P1694, DOI 10.1126/science.274.5293.1694; Egbert GD, 1997, GEOPHYS J INT, V130, P475, DOI 10.1111/j.1365-246X.1997.tb05663.x; FRANCHETEAU J, 1984, NATURE, V307, P32, DOI 10.1038/307032a0; FROST BR, 1989, NATURE, V340, P134, DOI 10.1038/340134a0; Hacker BR, 2000, SCIENCE, V287, P2463, DOI 10.1126/science.287.5462.2463; Hauck ML, 1998, TECTONICS, V17, P481, DOI 10.1029/98TC01314; Henry P, 1997, TECTONOPHYSICS, V273, P31, DOI 10.1016/S0040-1951(96)00287-9; Hochstein MP, 1998, J VOLCANOL GEOTH RES, V83, P75, DOI 10.1016/S0377-0273(98)00018-3; Holness MB, 1998, CONTRIB MINERAL PETR, V131, P86, DOI 10.1007/s004100050380; HYNDMAN RD, 1989, GEOPHYS J INT, V98, P343, DOI 10.1111/j.1365-246X.1989.tb03357.x; JONES AG, 1992, CONTINENTAL LOWER CR, pCH3; Kind R, 1996, SCIENCE, V274, P1692, DOI 10.1126/science.274.5293.1692; Lemonnier C, 1999, GEOPHYS RES LETT, V26, P3261, DOI 10.1029/1999GL008363; Li J., 1998, EOS, V79, pS344; Makovsky Y, 1999, J GEOPHYS RES-SOL EA, V104, P10795, DOI 10.1029/1998JB900074; McNeice GW, 2001, GEOPHYSICS, V66, P158, DOI 10.1190/1.1444891; Meyer B, 1998, GEOPHYS J INT, V135, P1, DOI 10.1046/j.1365-246X.1998.00567.x; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Nelson KD, 1996, SCIENCE, V274, P1684, DOI 10.1126/science.274.5293.1684; OLHOEFT GR, 1981, J GEOPHYS RES, V86, P931, DOI 10.1029/JB086iB02p00931; Owens TJ, 1997, NATURE, V387, P37, DOI 10.1038/387037a0; Partzsch GM, 2000, TECTONOPHYSICS, V317, P189, DOI 10.1016/S0040-1951(99)00320-0; Roberts JJ, 1999, J GEOPHYS RES-SOL EA, V104, P7055, DOI 10.1029/1998JB900111; Rodi W, 2001, GEOPHYSICS, V66, P174, DOI 10.1190/1.1444893; Schilling FR, 1997, PHYS EARTH PLANET IN, V103, P17, DOI 10.1016/S0031-9201(97)00011-3; TURNER S, 1993, NATURE, V364, P50, DOI 10.1038/364050a0; Van Ngoc P, 1986, NATURE, V319, P310; WANNAMAKER PE, 1984, GEOPHYSICS, V49, P1517, DOI 10.1190/1.1441777; WILLETT SD, 1994, NATURE, V369, P642, DOI 10.1038/369642a0	32	380	476	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					716	718		10.1126/science.1010580	http://dx.doi.org/10.1126/science.1010580			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326096				2022-12-28	WOS:000168478300048
J	Thomas, GD; Zhang, WG; Victor, RG				Thomas, GD; Zhang, WG; Victor, RG			Nitric oxide deficiency as a cause of clinical hypertension - Promising new drug targets for refractory hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; SUPEROXIDE-DISMUTASE; SYNTHASE; GENE; HYPOTENSION		Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypertens, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Victor, RG (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypertens, 5323 Harry Hines Blvd,Room J4-134, Dallas, TX 75390 USA.	ronald.victor@utsouthwestern.edu		Thomas, Gail/0000-0003-2731-6788	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064784, R13HL144010, R01HL044010] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64784, HL06296, HL44010] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balon TW, 1997, J APPL PHYSIOL, V82, P359, DOI 10.1152/jappl.1997.82.1.359; Benjafield AV, 2000, AM J HYPERTENS, V13, P994, DOI 10.1016/S0895-7061(00)00282-X; CALVER A, 1993, J HUM HYPERTENS, V7, P193; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; De Nicola L, 1999, KIDNEY INT, V56, P674, DOI 10.1046/j.1523-1755.1999.00582.x; Duffy SJ, 1999, LANCET, V354, P2048, DOI 10.1016/S0140-6736(99)04410-4; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Laursen JB, 1997, CIRCULATION, V95, P588, DOI 10.1161/01.CIR.95.3.588; Lin KF, 1997, HYPERTENSION, V30, P307, DOI 10.1161/01.HYP.30.3.307; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Ness AR, 1997, J HUM HYPERTENS, V11, P343, DOI 10.1038/sj.jhh.1000423; Ohashi Y, 1998, J CLIN INVEST, V102, P2061, DOI 10.1172/JCI4394; PETROS A, 1991, LANCET, V338, P1557, DOI 10.1016/0140-6736(91)92376-D; Sander M, 1999, HYPERTENSION, V33, P937, DOI 10.1161/01.HYP.33.4.937; Schnackenberg CG, 1998, HYPERTENSION, V32, P59, DOI 10.1161/01.HYP.32.1.59; VALLANCE P, 1992, LANCET, V339, P572; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; Wever R, 1999, ARTERIOSCL THROM VAS, V19, P1168, DOI 10.1161/01.ATV.19.5.1168	25	65	69	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2055	2057		10.1001/jama.285.16.2055	http://dx.doi.org/10.1001/jama.285.16.2055			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311074				2022-12-28	WOS:000168131600001
J	Bock, A				Bock, A			Molecular biology - Invading the genetic code	SCIENCE			English	Editorial Material							AMINO-ACIDS; SELECTION; ERRORS		Univ Munich, Inst Genet & Mikrobiol, D-80638 Munich, Germany	University of Munich	Bock, A (corresponding author), Univ Munich, Inst Genet & Mikrobiol, D-80638 Munich, Germany.	august.boeck@lrz.uni-muenchen.de						BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; KWOK Y, 1980, CAN J BIOCHEM CELL B, V58, P213, DOI 10.1139/o80-029; Lin L, 1996, BIOCHEMISTRY-US, V35, P5596, DOI 10.1021/bi960011y; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Osawa S., 1995, EVOLUTION GENETIC CO; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WONG JTF, 1988, MICROBIOL SCI, V5, P174	13	10	10	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					453	454		10.1126/science.1060637	http://dx.doi.org/10.1126/science.1060637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330299				2022-12-28	WOS:000168187300032
J	Burroughs, AK				Burroughs, AK			Assessment of value of consensus definitions in acute variceal bleeding	LANCET			English	Editorial Material							THERAPEUTIC STRATEGIES; PORTAL-HYPERTENSION; METHODOLOGY; WORKSHOP; BAVENO		Royal Free Hosp, Hepatobiliary & Liver Transplantat Unit, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Burroughs, AK (corresponding author), Royal Free Hosp, Hepatobiliary & Liver Transplantat Unit, Pond St, London NW3 2QG, England.	andrew.burroughs@talk21.com	Burroughs, Andrew K/C-5645-2009	Burroughs, Andrew K/0000-0001-6527-457X				BURROUGHS AK, 1990, GASTROENTEROLOGY, V99, P1388, DOI 10.1016/0016-5085(90)91166-4; Burroughs AK, 1996, PORTAL HYPERTENSION II, P10; Burroughs AK, 1996, HEPATOLOGY, V24, P737, DOI 10.1053/jhep.1996.v24.ajhep0240737; BURROUGHS AK, 1987, EXCERPTA MED C SERVI, V763; Cales P, 2000, J HEPATOL, V33, P738, DOI 10.1016/S0168-8278(00)80304-9; Cales P, 2001, NEW ENGL J MED, V344, P23, DOI 10.1056/NEJM200101043440104; de Franchis R, 2000, J HEPATOL, V33, P846; deFranchis R, 1996, J HEPATOL, V25, P390, DOI 10.1016/S0168-8278(96)80127-9; DEFRANCHIS R, 1992, J HEPATOL, V15, P256, DOI 10.1016/0168-8278(92)90044-P; Goulis J, 1999, EVIDENCE BASED GASTR, P389; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510	11	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1147	1148		10.1016/S0140-6736(00)04383-X	http://dx.doi.org/10.1016/S0140-6736(00)04383-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323039				2022-12-28	WOS:000168192100006
J	Moher, D; Schulz, KF; Altman, DG				Moher, D; Schulz, KF; Altman, DG		CONSORT Grp	The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials	LANCET			English	Article							CLINICAL-TRIALS; TREAT ANALYSIS; INTENTION	To comprehend the results of a randomised controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through total transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by use of a checklist and now diagram. The revised CONSORT statement presented here incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results, and Discussion. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting this information is associated with biased estimates of treatment effect, or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of a trial (enrolment, intervention allocation, followup, and analysis). The diagram explicitly shows the number of participants, for each intervention group, included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have done an intention-to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.	Univ Ottawa, Thomas C Chalmers Ctr Systemat Reviews, Ottawa, ON, Canada; Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; Univ N Carolina, Family Hlth Int, Chapel Hill, NC USA; Imperial Canc Res Fund, Med Stat Grp, Oxford, England; Inst Hlth Sci, Ctr Stat Med, Oxford, England	University of Ottawa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; University of Oxford	Moher, D (corresponding author), Childrens Hosp Eastern Ontario, Thomas C Chalmers Ctr Systemat Reviews, Res Inst, Room R235,401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.			Moher, David/0000-0003-2434-4206				Altman DG, 1996, BRIT MED J, V313, P570; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bentzen SM, 1998, RADIOTHER ONCOL, V46, P5, DOI 10.1016/S0167-8140(97)00226-0; Chalmers Iain, 2000, Curr Control Trials Cardiovasc Med, V1, P3, DOI 10.1186/CVM-1-1-003; Davidoff F, 2000, ANN INTERN MED, V133, P229, DOI 10.7326/0003-4819-133-3-200008010-00017; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; EGGER M, IN PRESS JAMA; ELBOURNE DR, IN PRESS STAT MED; Freemantle N, 1997, ANN INTERN MED, V126, P81, DOI 10.7326/0003-4819-126-1-199701010-00011; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Huston P, 1996, CAN MED ASSOC J, V155, P1277; JADAD AR, 2000, 11 MCM U; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOHER D, IN PRESS JAMA; Neumann PJ, 2000, ANN INTERN MED, V132, P964, DOI 10.7326/0003-4819-132-12-200006200-00007; OToole LB, 1997, BRIT MED J, V314, P1127; Ruiz-Canela M, 2000, BMJ-BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007; Schulz KF, 1997, ANN NEUROL, V41, P569, DOI 10.1002/ana.410410504; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181	29	2829	2925	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1191	1194		10.1016/S0140-6736(00)04337-3	http://dx.doi.org/10.1016/S0140-6736(00)04337-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323066	Green Submitted			2022-12-28	WOS:000168192100032
J	Osterblad, M; Norrdahl, K; Korpimaki, E; Huovinen, P				Osterblad, M; Norrdahl, K; Korpimaki, E; Huovinen, P			Antibiotic resistance - How wild are wild mammals?	NATURE			English	Article									Natl Publ Hlth Inst, Antimicrobial Res Lab, FIN-20520 Turku, Finland; Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	Osterblad, M (corresponding author), Natl Publ Hlth Inst, Antimicrobial Res Lab, Kiinamyllynkatu 13, FIN-20520 Turku, Finland.		Norrdahl, Kai/I-7193-2013; Huovinen, Pentti/C-9121-2019; Huovinen, Pentti/C-1917-2009	Norrdahl, Kai/0000-0002-4202-2043; Huovinen, Pentti/0000-0003-0003-1539; 				Baquero F, 1997, TRENDS ECOL EVOL, V12, P482, DOI 10.1016/S0169-5347(97)01223-8; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; LEVY SB, 1988, ANTIMICROB AGENTS CH, V32, P1801, DOI 10.1128/AAC.32.12.1801; Livermore DM, 1996, ANTIBIOTICS LAB MED, P502; Manninen Raija, 1997, Clin Microbiol Infect, V3, P408, DOI 10.1111/j.1469-0691.1997.tb00276.x; MURRAY BE, 1996, ANTIBIOTICS LAB MED, P453; Osterblad M, 2000, ANTIMICROB AGENTS CH, V44, P1479, DOI 10.1128/AAC.44.6.1479-1484.2000	8	88	97	2	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					37	38		10.1038/35051173	http://dx.doi.org/10.1038/35051173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343104				2022-12-28	WOS:000166175600030
J	Trautmann, A; Vivier, E				Trautmann, A; Vivier, E			Immunology - Agrin - A bridge between the nervous and immune systems	SCIENCE			English	Editorial Material							ANCHORED PROTEINS; PLASTICITY; RECEPTOR; DOMAINS; CELLS		ICGM, Lab Immunopharmacol, CNRS, UPR 415, Paris, France; Univ Med, CNRS, INSERM, Ctr Immunol Marseille, Marseille, France; Inst Univ France, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut Universitaire de France	Trautmann, A (corresponding author), ICGM, Lab Immunopharmacol, CNRS, UPR 415, Paris, France.		Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287				APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4	15	15	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1667	1668		10.1126/science.1061542	http://dx.doi.org/10.1126/science.1061542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11349139				2022-12-28	WOS:000169031800029
J	Toader, O; John, S				Toader, O; John, S			Proposed square spiral microfabrication architecture for large three-dimensional photonic band gap crystals	SCIENCE			English	Article							GROWTH	We present a blueprint for a three-dimensional photonic band gap (PBC) material that is amenable to Large-scale microfabrication on the optical scale using glancing angle deposition methods. The proposed chiral crystal consists of square spiral posts on a tetragonal Lattice. In the case of silicon posts in air (direct structure), the full PBC can be as Large as 15% of the gap center frequency, whereas for air posts in a silicon background (inverted structure) the maximum PEG is 24% of the center frequency. This PBC occurs between the fourth and fifth bands of the photon dispersion relation and is very robust to variations (disorder) in the geometrical parameters df the crystal.	Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	University of Toronto	Toader, O (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	ovi@physics.utoronto.ca; john@physics.utoronto.ca						Blanco A, 2000, NATURE, V405, P437, DOI 10.1038/35013024; Chutinan A, 1998, PHYS REV B, V57, pR2006, DOI 10.1103/PhysRevB.57.R2006; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; HO KM, 1990, PHYS REV LETT, V65, P3152, DOI 10.1103/PhysRevLett.65.3152; HO KM, 1994, SOLID STATE COMMUN, V89, P413, DOI 10.1016/0038-1098(94)90202-X; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; JOHN S, 1984, PHYS REV LETT, V53, P2169, DOI 10.1103/PhysRevLett.53.2169; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Palik E D, 1985, HDB OPTICAL CONSTANT; Robbie K, 1998, J VAC SCI TECHNOL B, V16, P1115, DOI 10.1116/1.590019; Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562; SOZUER HS, 1993, J OPT SOC AM B, V10, P296, DOI 10.1364/JOSAB.10.000296; SOZUER HS, 1994, J MOD OPTIC, V41, P231, DOI 10.1080/09500349414550291; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; TOADER O, UNPUB; Tsai YC, 1999, PHYS REV B, V59, P10401, DOI 10.1103/PhysRevB.59.R10401; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; YABLONOVITCH E, 1991, PHYS REV LETT, V67, P2295, DOI 10.1103/PhysRevLett.67.2295	18	227	241	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1133	1135		10.1126/science.1059479	http://dx.doi.org/10.1126/science.1059479			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349142				2022-12-28	WOS:000168609200050
J	Crowley, TJ; Berner, RA				Crowley, TJ; Berner, RA			Paleoclimate - CO2 and climate change	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; GLACIATION; RECORD		Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Texas A&M University System; Texas A&M University College Station; Yale University	Crowley, TJ (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	robert.berner@yale.edu						Barron E. J, 1985, CARBON CYCLE ATMOSPH, P546, DOI [10.1029/GM032p0546, DOI 10.1029/GM032P0546]; BERNER RA, IN PRESS AM J SCI; CROWLEY TJ, 1993, J GEOPHYS RES-ATMOS, V98, P16723, DOI 10.1029/93JD01415; CROWLEY TJ, 1995, J GEOPHYS RES-ATMOS, V100, P1093, DOI 10.1029/94JD02521; CROWLEY TJ, 2000, WARM CLIMATES EARTH, P425; Douglas R.G., 1981, SEA OCEANIC LITHOSPH, P1233; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; ENDAL AS, 1981, ASTROPHYS J, V243, P625, DOI 10.1086/158628; Gibbs MT, 1997, GEOLOGY, V25, P447, DOI 10.1130/0091-7613(1997)025<0447:AAPCTF>2.3.CO;2; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; ROYER DL, IN PRESS EARTH SCI R; ROYER DL, UNPUB; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; Tajika E, 1998, EARTH PLANET SC LETT, V160, P695, DOI 10.1016/S0012-821X(98)00121-6; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; WALLMANN K, IN PRESS GEOCHEM COS; YAPP CJ, 1992, NATURE, V355, P342, DOI 10.1038/355342a0; [No title captured]	24	181	198	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					870	872		10.1126/science.1061664	http://dx.doi.org/10.1126/science.1061664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341284				2022-12-28	WOS:000168514900031
J	Heuberger, M; Zach, M; Spencer, ND				Heuberger, M; Zach, M; Spencer, ND			Density fluctuations under confinement: When is a fluid not a fluid?	SCIENCE			English	Article							POROUS SILICA; PHASE-TRANSITIONS; ORGANIC NANOCRYSTALS; SOLVATION FORCES; REFRACTIVE-INDEX; LIQUID-CRYSTALS; MICA SURFACES; THIN-FILMS; CYCLOHEXANE; BEHAVIOR	Knowing the behavior of a fluid in small volumes is essential for the understanding of a vast array of common problems in science, such as biological interactions, fracture propagation, and molecular tribology and adhesion, as well as pressure solvation and other geophysical processes. When a fluid is confined, its phase behavior is altered and excluded-volume effects become apparent. Pioneering measurements performed with the surface forces apparatus have revealed so-called structural or oscillatory solvation forces as well as the occurrence of a finite shear stress, which was interpreted as a solidification transition. Here, we report measurements obtained with an extended surface forces apparatus, which makes use of fast spectral correlation to gain insight into the behavior of a thin film of cyclohexane confined within attoliter volumes, with simultaneous measurement of film thickness and refractive index. With decreasing pore width, cyclohexane is found to undergo a drastic transition from a three-dimensional bulk fluid to a two-dimensional adsorbate with strikingly different properties. Long-range density fluctuations of unexpected magnitude are observed.	ETH Zentrum, Surface Sci & Technol Lab, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Heuberger, M (corresponding author), ETH Zentrum, Surface Sci & Technol Lab, CH-8092 Zurich, Switzerland.		Zäch, Michael/B-8640-2008; Spencer, NIcholas D./A-5843-2008; Spencer, Nicholas/M-9647-2019; Heuberger, Manfred P/D-1582-2012	Spencer, NIcholas D./0000-0002-7873-7905; Spencer, Nicholas/0000-0002-7873-7905; 				Aksnes DW, 1999, J MOL STRUCT, V475, P27, DOI 10.1016/S0022-2860(98)00493-1; Booth HF, 1998, MOL PHYS, V93, P263, DOI 10.1080/00268979809482209; Booth HF, 1998, MAGN RESON IMAGING, V16, P501, DOI 10.1016/S0730-725X(98)00066-6; CHRISTENSON HK, 1983, J CHEM PHYS, V78, P6906, DOI 10.1063/1.444639; Christenson HK, 1997, COLLOID SURFACE A, V123, P355, DOI 10.1016/S0927-7757(96)03781-8; CHRISTENSON HK, 1982, J COLLOID INTERF SCI, V88, P79, DOI 10.1016/0021-9797(82)90156-4; DORE JC, 1989, COLLOID SURFACE, V36, P199, DOI 10.1016/0166-6622(89)80238-0; EVANS R, 1987, J CHEM PHYS, V86, P7138, DOI 10.1063/1.452363; Faivre C, 1999, EUR PHYS J B, V7, P19, DOI 10.1007/s100510050586; FARMAN H, 1992, PHYSICA B, V180, P857, DOI 10.1016/0921-4526(92)90492-B; GAUTHIERMANUEL B, 1995, J COLLOID INTERF SCI, V175, P476, DOI 10.1006/jcis.1995.1478; GEE ML, 1990, J CHEM PHYS, V93, P1895, DOI 10.1063/1.459067; Gladstone J., 1863, P R SOC LONDON, V12, P317, DOI DOI 10.1098/RSTL.1863.0014; GODBOUT G, 1968, J CHIM PHYS PCB, V65, P1944, DOI 10.1051/jcp/1968651944; Hassel O, 1938, Z PHYS CHEM B-CHEM E, V40, P391; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Heuberger M, 2001, REV SCI INSTRUM, V72, P1700, DOI 10.1063/1.1347978; Hill TL, 1994, THERMODYNAMICS SMALL; HORN RG, 1987, J COLLOID INTERF SCI, V115, P480, DOI 10.1016/0021-9797(87)90065-8; ISRAELAC.JN, 1973, J COLLOID INTERF SCI, V44, P259, DOI 10.1016/0021-9797(73)90218-X; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1990, J MATER RES, V5, P2223, DOI 10.1557/JMR.1990.2223; ISRAELACHVILI JN, 1991, INTERMOLECLAR SURFAC; JACKSON CL, 1990, J CHEM PHYS, V93, P9002, DOI 10.1063/1.459240; Janik J, 1997, LANGMUIR, V13, P4466, DOI 10.1021/la960452i; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; KEKICHEFF P, 1994, LANGMUIR, V10, P1584, DOI 10.1021/la00017a043; Kitaev V, 2000, J PHYS CHEM B, V104, P8822, DOI 10.1021/jp992996+; KLEIN J, 1995, SCIENCE, V269, P816, DOI 10.1126/science.269.5225.816; Kohonen MM, 2000, LANGMUIR, V16, P7285, DOI 10.1021/la991404b; Kumacheva E, 1998, J CHEM PHYS, V108, P7010, DOI 10.1063/1.476115; MAYER J, 1991, PHYS STATUS SOLIDI B, V166, P381, DOI 10.1002/pssb.2221660207; MU R, 1991, PHYS REV B, V44, P4296, DOI 10.1103/PhysRevB.44.4296; ROSS SM, 1976, MOL CRYST LIQ CRYST, V33, P321; SCHULTE L, 1987, J CHEM THERMODYN, V19, P363, DOI 10.1016/0021-9614(87)90119-4; Stapf S, 1997, APPL MAGN RESON, V12, P199, DOI 10.1007/BF03162187; Webb LM, 1996, HEALTH COMMUN, V8, P367, DOI 10.1207/s15327027hc0804_4; WISOTZKI KD, 1982, J PHYS CHEM SOLIDS, V43, P13, DOI 10.1016/0022-3697(82)90167-6; WOHLFARTH C, 1987, LANDOLTBORNSTEIN NUM, V38	39	148	149	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					905	908		10.1126/science.1058573	http://dx.doi.org/10.1126/science.1058573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340198				2022-12-28	WOS:000168514900036
J	Ogawa, H; Amagai, Y; Koike, I; Kaiser, K; Benner, R				Ogawa, H; Amagai, Y; Koike, I; Kaiser, K; Benner, R			Production of refractory dissolved organic matter by bacteria	SCIENCE			English	Article							AMINO-ACIDS; CARBON; SEAWATER; NITROGEN; RELEASE	Most of the oceanic reservoir of dissolved organic matter (DOM) is of marine origin and is resistant to microbial oxidation, but little is known about the mechanisms of its formation. In a laboratory study. natural assemblages of marine bacteria rapidly (in < 48 hours) utilized labile compounds (glucose, glutamate) and produced refractory DOM that persisted for more than a year. Only 10 to 15% of the bacterially derived DOM was identified as hydrolyzable amino acids and sugars, a feature consistent with marine DOM. These results suggest that microbial processes alter the molecular structure of DOM, making it resistant to further degradation and thereby preserving fixed carbon in the ocean.	Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA	University of Tokyo; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ogawa, H (corresponding author), Univ Tokyo, Ocean Res Inst, 1-5-1 Minamidai, Tokyo 1648639, Japan.	hogawa@ori.u-tokyo.ac.jp	Benner, Ronald/M-4412-2015; Kaiser, Karl/AHB-7688-2022	Benner, Ronald/0000-0002-1238-2777; 				Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Benner R, 1997, MAR CHEM, V57, P243, DOI 10.1016/S0304-4203(97)00013-3; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; BROPHY JE, 1989, DEEP-SEA RES, V36, P497, DOI 10.1016/0198-0149(89)90002-2; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; COWIE GL, 1992, LIMNOL OCEANOGR, V37, P703, DOI 10.4319/lo.1992.37.4.0703; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; FUHRMAN JA, 1986, MAR ECOL PROG SER, V33, P237, DOI 10.3354/meps033237; HARVEY GR, 1983, MAR CHEM, V12, P119, DOI 10.1016/0304-4203(83)90075-0; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HUBBERTEN U, 1994, MAR CHEM, V45, P121, DOI 10.1016/0304-4203(94)90096-5; Kaiser K, 2000, ANAL CHEM, V72, P2566, DOI 10.1021/ac991407t; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; McCarthy M, 1996, MAR CHEM, V55, P281, DOI 10.1016/S0304-4203(96)00041-2; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; NAGATA T, 1992, MAR ECOL PROG SER, V83, P233, DOI 10.3354/meps083233; NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL, P102; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ogawa H, 1999, DEEP-SEA RES PT I, V46, P1809, DOI 10.1016/S0967-0637(99)00027-8; OGAWA H, 1992, NATURE, V356, P696, DOI 10.1038/356696a0; OGURA N, 1972, MAR BIOL, V13, P89, DOI 10.1007/BF00366559; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rich JH, 1996, LIMNOL OCEANOGR, V41, P595, DOI 10.4319/lo.1996.41.4.0595; Skoog A, 1997, LIMNOL OCEANOGR, V42, P1803, DOI 10.4319/lo.1997.42.8.1803; Stoderegger K, 1998, LIMNOL OCEANOGR, V43, P877, DOI 10.4319/lo.1998.43.5.0877; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; TRANVIK LJ, 1993, FEMS MICROBIOL ECOL, V12, P177; TSUGITA A, 1987, J BIOCHEM-TOKYO, V102, P1593, DOI 10.1093/oxfordjournals.jbchem.a122209; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0; WILLIAMS PM, 1988, OCEANOGRAPHY, V1, P14	34	465	481	32	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					917	920		10.1126/science.1057627	http://dx.doi.org/10.1126/science.1057627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340202				2022-12-28	WOS:000168514900040
J	Forrest, CB; Weiner, JP; Fowles, J; Vogeli, C; Frick, KD; Lemke, KW; Starfield, B				Forrest, CB; Weiner, JP; Fowles, J; Vogeli, C; Frick, KD; Lemke, KW; Starfield, B			Self-referral in point-of-service health plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; MANAGED CARE; PHYSICIAN; EXPENDITURES; SATISFACTION; SPECIALISTS; CONTINUITY; ACCESS; MODELS	Context Most health maintenance organizations offer products with loosened restrictions on patients' access to specialty care. One such product is the point-of-service (POS) plan, which combines "gatekeeping" arrangements with the ability to self-refer at increased out-of-pocket costs. Few data are available from formal evaluations of this new type of plan. Objectives To comprehensively describe the self-referral process in POS plans by quantifying rates of self-referral, identifying patients most likely to self-refer, characterizing patients' reasons for self-referral, and assessing satisfaction with specialty care. Design Retrospective cohort analysis using administrative databases composed of members aged 0 to 64 years who were enrolled in 3 POS health plans in the Midwest (n =265 843), Northeast (n = 80292), and mid-Atlantic (n = 39 888) regions for 6 to 12 months in 1996, and a 1997 telephone survey of specialty care users (n = 606) in the midwestern plan. Main Outcome Measures Self-referred service use and charges, reasons for self-referral, and satisfaction with specialty care. Results Overall, 8.8% of enrollees in the midwestern POS plan, 16.7% in the northeastern plan, and 17.3% in the mid-Atlantic plan self-referred for at least 1 physician or nonphysician clinician visit. The proportions of enrollees self-referring to generalists (4.7%-8.5%) were slightly higher than the proportions self-referring to specialists (3.7%-7.2%) across all 3 plans. Nine percent to 16% of total charges were due to self-referral, The chances of self-referral to a specialist were increased for patients with chronic and orthopedic conditions, higher cost sharing for physician-approved services, and less continuity with their regular physician. Patients who self-referred to specialists preferred to access specialty care directly (38%), reported relationship problems with their regular physicians (28%), had an ongoing relationship with a specialist (23%), were confused about insurance rules (8%), and did not have a regular physician (3%), Compared with those referred to specialists by a physician, patients who self-referred were more satisfied with the specialty care they received. Conclusions Having the option to self-refer is enough for most POS plan enrollees; 93% to 96% of enrollees did not exercise their POS option to obtain specialty care via self-referral during al-year interval. The potential downside of uncoordinated, self-referred service use in POS health plans is limited and counterbalanced by higher patient satisfaction with specialist services.	Johns Hopkins Sch Publ Hlth, Hlth Serv Res & Dev Ctr, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Pk Nicollet Inst, Hlth Res Ctr, Minneapolis, MN USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Forrest, CB (corresponding author), Johns Hopkins Sch Publ Hlth, Hlth Serv Res & Dev Ctr, Dept Hlth Policy & Management, 624 N Broadway,Room 689, Baltimore, MD 21205 USA.		Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X; Frick, Kevin/0000-0002-0178-5319; Lemke, Klaus/0000-0001-6936-5946				*AM MED ASS, 1994, MED NAT LEV 2 COD HC; BERENSON R, 1992, JAMA-J AM MED ASSOC, V267, P687, DOI 10.1001/jama.267.5.687; BRESLAU N, 1975, J MED EDUC, V50, P965; BURRELL CE, 1992, AAPPO J          JAN, P25; *COUNC GRAD MED ED, 1999, AGOCME PHYS WORKF PO; Forrest CB, 1998, AM J PUBLIC HEALTH, V88, P1330, DOI 10.2105/AJPH.88.9.1330; Forrest CB, 2000, ARCH PEDIAT ADOL MED, V154, P499, DOI 10.1001/archpedi.154.5.499; Fowles J B, 1995, Health Care Financ Rev, V16, P189; GRAMLING A, 1995, MANAGED CARE     MAR, P33; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; Halm EA, 1997, JAMA-J AM MED ASSOC, V278, P1677, DOI 10.1001/jama.278.20.1677; HERRIE GN, 1992, MGM J            MAR, P10; *HLTH RES SERV ADM, 1995, AR RES FIL ARF SYST; *KAIS FAM F HLTH R, 2001, EMPL HLTH BEN 2000 A; Kapur K, 2000, MED CARE RES REV, V57, P161, DOI 10.1177/107755870005700202; Kerr EA, 1997, JAMA-J AM MED ASSOC, V278, P308, DOI 10.1001/jama.278.4.308; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; ROUSSEL HM, 1999, HMO PPO MEDICARE MED; Safran DG, 2000, ARCH INTERN MED, V160, P69, DOI 10.1001/archinte.160.1.69; SCHNEEWEISS R, 1983, MED CARE, V21, P105, DOI 10.1097/00005650-198301000-00008; Tabenkin H, 1998, JAMA-J AM MED ASSOC, V279, P1943, DOI 10.1001/jama.279.24.1943; *US DEP COMM NAT T, 1994, HCFA GROUP MED COD E; WEINER JP, 1994, JAMA-J AM MED ASSOC, V272, P222; Wong HS, 1999, MED CARE RES REV, V56, P85	24	47	47	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2223	2231		10.1001/jama.285.17.2223	http://dx.doi.org/10.1001/jama.285.17.2223			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	424WC	11325324	Bronze			2022-12-28	WOS:000168256100025
J	Steinberg, KK; Cogswell, ME; Chang, JC; Caudill, SP; McQuillan, GM; Bowman, BA; Grummer-Strawn, LM; Sampson, EJ; Khoury, MJ; Gallagher, ML				Steinberg, KK; Cogswell, ME; Chang, JC; Caudill, SP; McQuillan, GM; Bowman, BA; Grummer-Strawn, LM; Sampson, EJ; Khoury, MJ; Gallagher, ML			Prevalence of CY282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEREDITARY HEMOCHROMATOSIS; IRON OVERLOAD; POPULATION; CYS282TYR; HEALTH; EXPRESSION; PRODUCT; C282Y	Context Population-based estimates of the prevalence of disease-associated mutations. such as hemochromatosis (HFE) gene mutations, are needed to determine the usefulness of genetic screening. Objective To estimate the prevalence of the HFE mutations C282Y and H63D in the US population. Design Cross-sectional population-based study of samples in the DNA bank from phase 2 of the Third National Health and Nutrition Examination Survey conducted from 1992 to 1994. Setting and Participants Genotyped samples of cells from a total of 5171 participants, cross-classified by sex, age, and race/ethnicity in the analysis. Main Outcome Measures Estimates of the prevalence of C282Y and H63D mutations. Results The prevalence of C282Y homozygosity is estimated to be 0.26% (95% confidence interval [CI], 0.12%-0.49%); 1.89% (95% CI, 1.48%-2.43%) for H63D homozygosity; and 1.97% (95% CI, 1.54%-2.49%) for compound heterozygosity. The prevalence estimates for C282Y heterozygosity (C282Y/wild type) are 9.54% among non-Hispanic whites, 2.33% among non-Hispanic blacks, and 2.75% among Mexican-Americans. The prevalence estimates of the C282Y mutation in the US population are 5.4% (95% CI, 4.7%-6.2%) and 13.5% (95% CI, 12.5%-14.8%) for the H63D mutation. Conclusions Estimates of prevalence of HFE mutations are within the expected range for non-Hispanic whites and blacks but the estimated prevalence of the C282Y mutation among Mexican-Americans is less than expected. Mutation data now need to be linked to clinically relevant indices, such as transferrin saturation level.	Ctr Dis Control & Prevent, Mol Biol Branch, Div Sci Lab, Natl Ctr Environm Hlth, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Off Genet & Dis Prevent, Natl Ctr Environm Hlth, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Div Diabet Transplantat, Natl Ctr Chron Dis Prevent & Hlth Promot, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Rockville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Steinberg, KK (corresponding author), Ctr Dis Control & Prevent, Mol Biol Branch, Div Sci Lab, Natl Ctr Environm Hlth, Mailstop F-24, Chamblee, GA 30341 USA.							[Anonymous], VITAL HLTH STAT; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Beutler E, 2000, ANN INTERN MED, V133, P329, DOI 10.7326/0003-4819-133-5-200009050-00008; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Bradley LA, 1998, J MED SCREEN, V5, P34, DOI 10.1136/jms.5.1.34; Burke W, 1998, JAMA-J AM MED ASSOC, V280, P172, DOI 10.1001/jama.280.2.172; Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P991; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; Cogswell ME, 1998, ANN INTERN MED, V129, P971, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00008; Cullen LM, 1998, AM J HUM GENET, V62, P1403, DOI 10.1086/301878; Distante S, 1999, SCAND J GASTROENTERO, V34, P529, DOI 10.1080/003655299750026290; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Fabrega E, 1999, MED CLIN-BARCELONA, V112, P451; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gangaidzo IT, 1999, GUT, V45, P278, DOI 10.1136/gut.45.2.278; Jeffery S, 1999, GENET TEST, V3, P375, DOI 10.1089/gte.1999.3.375; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Looker AC, 1998, ANN INTERN MED, V129, P940, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00004; Lynas C, 1997, BLOOD, V90, P4235, DOI 10.1182/blood.V90.10.4235; Marshall DS, 1999, INT J MOL MED, V4, P389; McDonnell SM, 1999, AM J MED, V107, P30, DOI 10.1016/S0002-9343(99)00163-1; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Mortimore M, 1999, J GASTROEN HEPATOL, V14, P838, DOI 10.1046/j.1440-1746.1999.01980.x; *NAT CTR HLTH STAT, 1996, WEIGHT EST METH REP; *NAT CTR HTLH STAT, 1996, AN REP GUID 3 NAT HL; Nielsen P, 1998, BRIT J HAEMATOL, V103, P842; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; *PERK APPL BIOS DI, 1995, TAQMAN PROB DES SYNT; Powell LW, 1998, ANN INTERN MED, V129, P925, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00002; Rivard SR, 2000, BRIT J HAEMATOL, V108, P854, DOI 10.1046/j.1365-2141.2000.01954.x; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Sanchez M, 1998, J HEPATOL, V29, P725, DOI 10.1016/S0168-8278(98)80252-3; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938; Weisberg S., 1985, APPL LINEAR REGRESSI	40	172	177	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2216	2222		10.1001/jama.285.17.2216	http://dx.doi.org/10.1001/jama.285.17.2216			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325323	Bronze			2022-12-28	WOS:000168256100024
J	Kravitz, RL				Kravitz, RL			Measuring patients' expectations and requests	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIAL PSYCHOLOGICAL DETERMINANTS; PRIMARY-CARE; PATIENTS SATISFACTION; CLINICAL NEGOTIATION; MEDICAL OUTCOMES; PHYSICIANS; VISITS; COMMUNICATION; PERCEPTIONS; AWARENESS	Patients seeking help for symptoms frequently worry about the underlying causes of their symptoms; have specific expectations for care; and request (or demand) time, information, and services. Understanding patients' concerns, expectations, and requests is important for clinicians, health care policymakers, and researchers. One obstacle to progress in this area has been disagreement over the most appropriate methods for identifying, monitoring, and classifying these phenomena. This article reviews the conceptual relationships linking patients' expectations, requests, and satisfaction with care; surveys contemporary approaches to the measurement of expectations and requests; and highlights recent empirical findings. The literature reviewed supports the conclusion that patients' expectations are wide ranging, can be measured, and have potentially important clinical consequences. For clinicians and policymakers alike, learning to elicit, evaluate, and understand patients' expectations will be a major task for the early part of the new century.	Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Sacramento, CA 95817 USA	University of California System; University of California Davis	Kravitz, RL (corresponding author), Univ Calif Davis, Ctr Hlth Serv Res Primary Care, 4150 V St,PSSB Suite 2500, Sacramento, CA 95817 USA.	rlkravitz@ucdavis.edu	Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS009812] Funding Source: NIH RePORTER; AHRQ HHS [R03 HS09812-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BECKMAN HB, 1984, ANN INTERN MED, V101, P692, DOI 10.7326/0003-4819-101-5-692; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; BERTAKIS KD, 1995, MED CARE, V33, P407, DOI 10.1097/00005650-199504000-00007; BRESLAU N, 1975, MED CARE, V13, P562, DOI 10.1097/00005650-197507000-00004; BRODY DS, 1989, MED CARE, V27, P1027, DOI 10.1097/00005650-198911000-00004; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25; EISENTHAL S, 1976, J NERV MENT DIS, V162, P169, DOI 10.1097/00005053-197603000-00003; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; FRANCIS V, 1969, NEW ENGL J MED, V280, P535, DOI 10.1056/NEJM196903062801004; Froehlich GW, 1996, J GEN INTERN MED, V11, P470, DOI 10.1007/BF02599041; Gallagher TH, 1997, J GEN INTERN MED, V12, P663, DOI 10.1046/j.1525-1497.1997.07137.x; HALL JA, 1994, MED CARE, V32, P1216, DOI 10.1097/00005650-199412000-00005; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Hamm RM, 1996, J FAM PRACTICE, V43, P56; HICKSON GB, 1994, JAMA-J AM MED ASSOC, V272, P1583, DOI 10.1001/jama.272.20.1583; Hornberger J, 1997, J GEN INTERN MED, V12, P597, DOI 10.1046/j.1525-1497.1997.07119.x; Jackson JL, 1999, ARCH FAM MED, V8, P135, DOI 10.1001/archfami.8.2.135; KANE RL, 1977, J FAM PRACTICE, V4, P1119; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; KORSCH BM, 1968, PEDIATRICS, V42, P855; Kravitz RL, 1996, MED CARE RES REV, V53, P3, DOI 10.1177/107755879605300101; KRAVITZ RL, 1994, J GEN INTERN MED, V9, P75, DOI 10.1007/BF02600205; Kravitz RL, 1999, J FAM PRACTICE, V48, P872; Kravitz RL, 1996, ANN INTERN MED, V125, P730, DOI 10.7326/0003-4819-125-9-199611010-00004; Kravitz RL, 1997, J GEN INTERN MED, V12, P67, DOI 10.1007/s11606-006-0010-6; Lang F, 2000, ARCH FAM MED, V9, P222, DOI 10.1001/archfami.9.3.222; LAZARE A, 1975, COMPR PSYCHIAT, V16, P467, DOI 10.1016/0010-440X(75)90037-1; LAZARE A, 1975, ARCH GEN PSYCHIAT, V32, P553; Lazare A, 1995, MED INTERVIEW, P50; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; LIKE R, 1986, FAM PRACT, V3, P216, DOI 10.1093/fampra/3.4.216; LIKE R, 1987, SOC SCI MED, V24, P351, DOI 10.1016/0277-9536(87)90153-5; LINDERPELZ S, 1982, SOC SCI MED, V16, P583, DOI 10.1016/0277-9536(82)90312-4; LINDERPELZ S, 1982, SOC SCI MED, V16, P577, DOI 10.1016/0277-9536(82)90311-2; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; Marple RL, 1997, ARCH INTERN MED, V157, P1482, DOI 10.1001/archinte.157.13.1482; MECHANIC D, 1990, INQUIRY-J HEALTH CAR, V27, P14; NOYES RW, 1974, AM J OBSTET GYNECOL, V118, P809, DOI 10.1016/0002-9378(74)90493-1; O'Brien M K, 1992, Med Care Rev, V49, P435, DOI 10.1177/002570879204900403; OLIVER RL, 1993, J CONSUM RES, V20, P418, DOI 10.1086/209358; PENNEBAKER JW, 1981, J PERS SOC PSYCHOL, V41, P213, DOI 10.1037/0022-3514.41.2.213; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941; Skelton JA, 1991, MENTAL REPRESENTATIO; UHLMANN RF, 1984, MED CARE, V22, P681, DOI 10.1097/00005650-198407000-00011; Ware J E Jr, 1983, Eval Program Plann, V6, P291, DOI 10.1016/0149-7189(83)90009-5; WEBB S, 1994, BRIT J GEN PRACT, V44, P165; WHITE J, 1994, J GEN INTERN MED, V9, P24, DOI 10.1007/BF02599139	49	121	132	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			881	888		10.7326/0003-4819-134-9_Part_2-200105011-00012	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346324				2022-12-28	WOS:000168543100012
J	Evron, E; Dooley, WC; Umbricht, CB; Rosenthal, D; Sacchi, N; Gabrielson, E; Soito, AB; Hung, DT; Ljung, BM; Davidson, NE; Sukumar, S				Evron, E; Dooley, WC; Umbricht, CB; Rosenthal, D; Sacchi, N; Gabrielson, E; Soito, AB; Hung, DT; Ljung, BM; Davidson, NE; Sukumar, S			Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR	LANCET			English	Article								If detected early, breast cancer is curable. We tested cells collected from the breast ducts by methylation-specific PCR (MSP), Methylated alleles of Cyclln D2, RAR-beta and Twist genes were frequently detected in fluid from mammary ducts containing endoscopically visualised carcinomas (17 cases of 20), and ductal carcinoma in situ (two of seven), but rarely in ductal lavage fluid from healthy ducts (five of 45), Two of the women with healthy mammograms whose ductal lavage fluid contained methylated markers and cytologically abnormal cells were subsequently diagnosed with breast cancer. Carrying out MSP in these quid samples may provide a sensitive and powerful addition to mammographic screening for early detection of breast cancer.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; ProDuct Hlth, Menlo Pk, CA USA	Johns Hopkins University; University of California System; University of California San Francisco	Sukumar, S (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA.	saras@jhmi.edu	Dooley, William Chesnut/E-7660-2013	Dooley, William Chesnut/0000-0002-0223-5677; Evron, Ella/0000-0002-1003-5042	NCI NIH HHS [P50 CA88843] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA088843] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dooley WC, 2000, JAMA-J AM MED ASSOC, V284, P1518, DOI 10.1001/jama.284.12.1518-b; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Evron E, 2001, CANCER RES, V61, P2782; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456	5	269	292	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1335	1336		10.1016/S0140-6736(00)04501-3	http://dx.doi.org/10.1016/S0140-6736(00)04501-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343741				2022-12-28	WOS:000168411400014
J	Berners-Lee, T; Hendler, J				Berners-Lee, T; Hendler, J			Publishing on the semantic web - The coming Internet revolution will profoundly affect scientific information.	NATURE			English	Editorial Material									MIT, World Wide Web Consortium, Cambridge, MA 02139 USA; Univ Maryland, Dept Comp Sci, College Pk, MD 20853 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park	Berners-Lee, T (corresponding author), MIT, World Wide Web Consortium, 545 Technol Sq,Room NE43-356, Cambridge, MA 02139 USA.			Hendler, James/0000-0003-3056-1960				HARNAD S, 1995, SCHOLARLY J CROSSROA, P1; Odlyzko A, 1999, TECHNOLOGY AND SCHOLARLY COMMUNICATION, P380	2	138	147	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1023	1024		10.1038/35074206	http://dx.doi.org/10.1038/35074206			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323639				2022-12-28	WOS:000168285500018
J	Hillaire-Marcel, C; de Vernal, A; Bilodeau, G; Weaver, AJ				Hillaire-Marcel, C; de Vernal, A; Bilodeau, G; Weaver, AJ			Absence of deep-water formation in the Labrador Sea during the last interglacial period	NATURE			English	Article							NORTHERN NORTH-ATLANTIC; THERMOHALINE CIRCULATION; SURFACE SEDIMENTS; CLIMATE-CHANGE; OCEAN; ISOTOPES; TRACERS; PACIFIC; RECORD; RATES	The two main constituent water masses of the deep North Atlantic Ocean-North Atlantic Deep Water at the bottom and Labrador Sea Water at an intermediate level-are currently formed in the Nordic seas and the Labrador Sea, respectively(1). The rate of formation of these two water masses tightly governs the strength of the global ocean circulation and the associated heat transport across the North Atlantic Ocean(2). Numerical simulations have suggested a possible shut-down of Labrador Sea Water formation as a consequence of global warming(3). Here we use micropalaeontological data and stable isotope measurements in both planktonic and benthic foraminifera from deep Labrador Sea cores to investigate the density structure of the water column during the last interglacial period, which was thought to be about 2 degreesC warmer than present(4). Our results indicate that today's stratification between Labrador Sea Water and North Atlantic Deep Water never developed during the last interglacial period. Instead, a buoyant surface layer was present above a single water mass originating from the Nordic seas. Thus the present situation, with an active site of intermediate-water formation in the Labrador Sea, which settled some 7,000 years ago, has no analogue throughout the last climate cycle.	Univ Quebec, GEOTOP, Montreal, PQ H3C 3P8, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada	University of Quebec; University of Quebec Montreal; University of Victoria	Hillaire-Marcel, C (corresponding author), Univ Quebec, GEOTOP, CP 8888, Montreal, PQ H3C 3P8, Canada.		de Vernal, Anne/D-5602-2013; Weaver, Andrew J/E-7590-2011; Hillaire-Marcel, Claude/H-1441-2012; Hillaire-Marcel, Claude/C-9153-2013	de Vernal, Anne/0000-0001-5656-724X; Weaver, Andrew J/0000-0001-8919-3598; Hillaire-Marcel, Claude/0000-0002-3733-4632; Bilodeau, Guy/0000-0002-5419-9110				AAGAARD K, 1985, J GEOPHYS RES-OCEANS, V90, P4833, DOI 10.1029/JC090iC03p04833; Adkins JF, 1997, NATURE, V390, P154, DOI 10.1038/36540; Andreasen DJ, 1997, PALEOCEANOGRAPHY, V12, P395, DOI 10.1029/97PA00822; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; De Vernal A, 1997, GEOBIOS-LYON, V30, P905, DOI 10.1016/S0016-6995(97)80215-X; de Vernal A., 1991, QUATERN INT, V10-12, P95; DEVERNAL A, 2000, CAN GEOPH UN M; DICKSON RR, 1988, PROG OCEANOGR, V20, P103, DOI 10.1016/0079-6611(88)90049-3; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; DICKSON RR, 1996, PROG OCEANOGR, V38, P205; Faul KL, 2000, J FORAMIN RES, V30, P110, DOI 10.2113/0300110; HILLAIREMARCEL C, IN PRESS AM GEOPHYS; HILLAIREMARCEL C, 1994, CAN J EARTH SCI, V31; KEIGWIN LD, 1994, NATURE, V371, P323, DOI 10.1038/371323a0; Kohfeld KE, 1996, PALEOCEANOGRAPHY, V11, P679, DOI 10.1029/96PA02617; Marshall J, 1999, REV GEOPHYS, V37, P1, DOI 10.1029/98RG02739; MCCARTNEY MS, 1992, PROG OCEANOGR, V29, P283, DOI 10.1016/0079-6611(92)90006-L; MCCARTNEY MS, 1984, J PHYS OCEANOGR, V14, P922, DOI 10.1175/1520-0485(1984)014<0922:WTCWCI>2.0.CO;2; *NAT OC DAT CTR, 1994, WORLD OC ATL CR ROM; SCHMITZ WJ, 1993, REV GEOPHYS, V31, P29, DOI 10.1029/92RG02583; SHACKLETON NJ, 1987, QUATERNARY SCI REV, V6, P183, DOI 10.1016/0277-3791(87)90003-5; SHACKLETON NJ, 1974, METHODES QUANTITATIV, P203; Stoner JS, 1998, EARTH PLANET SC LETT, V159, P165, DOI 10.1016/S0012-821X(98)00069-7; TALLEY LD, 1982, J PHYS OCEANOGR, V12, P1189, DOI 10.1175/1520-0485(1982)012<1189:DACOLS>2.0.CO;2; Weaver AJ, 1999, ANNU REV EARTH PL SC, V27, P231, DOI 10.1146/annurev.earth.27.1.231; WHITE JWC, 1993, NATURE, V364, P186, DOI 10.1038/364186a0; Wood RA, 1999, NATURE, V399, P572, DOI 10.1038/21170; WU GP, 1994, GEOCHIM COSMOCHIM AC, V58, P1303, DOI 10.1016/0016-7037(94)90383-2; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	30	192	194	0	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1073	1077		10.1038/35074059	http://dx.doi.org/10.1038/35074059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323666				2022-12-28	WOS:000168285500042
J	Nauta, K; Moore, DT; Stiles, PL; Miller, RE				Nauta, K; Moore, DT; Stiles, PL; Miller, RE			Probing the structure of metal cluster-adsorbate systems with high-resolution infrared spectroscopy	SCIENCE			English	Article							LIQUID-HELIUM DROPLETS; SUPERFLUID-HELIUM; PENDULAR STATES; POLAR-MOLECULES; COMPLEXES; ATOMS; NANODROPLETS; RELAXATION; SOLVATION; MAGNESIUM	High-resolution infrared Laser spectroscopy was used to obtain rotationally resolved infrared spectra of adsorbate-metal complexes. The method involves forming the bare metal clusters in helium nanodroplets and then adding a molecular adsorbate (HCN) and recording the infrared spectrum associated with the C-H stretching vibration. Rotationally resolved spectra were obtained for MCN-Mg-n (n = 1 to 4). The results suggest a qualitative change in the adsorbate-metal cluster bonding with cluster size.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Miller, RE (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.		Moore, David/A-7393-2008					[Anonymous], COMMUNICATION; Ballone P., 1999, METAL CLUSTERS, P71; Bauschlicher CW, 1999, CHEM PHYS LETT, V300, P364, DOI 10.1016/S0009-2614(98)01381-5; BLOCK PA, 1992, PHYS REV LETT, V68, P1303, DOI 10.1103/PhysRevLett.68.1303; Callegari C, 1999, PHYS REV LETT, V83, P5058, DOI 10.1103/PhysRevLett.83.5058; Callegari C, 2000, J CHEM PHYS, V113, P4636, DOI 10.1063/1.1288604; CHABAL YJ, 1988, SURF SCI REP, V8, P211, DOI 10.1016/0167-5729(88)90011-8; Crepin-Gilbert C, 1999, INT REV PHYS CHEM, V18, P485, DOI 10.1080/014423599229901; Elhanine M, 2000, J CHEM PHYS, V112, P10912, DOI 10.1063/1.481762; Gough T. E., 1986, Proceedings of the SPIE - The International Society for Optical Engineering, V669, P129, DOI 10.1117/12.938947; GOYAL S, 1992, PHYS REV LETT, V69, P933, DOI 10.1103/PhysRevLett.69.933; Grebenev S, 2000, J CHEM PHYS, V112, P4485, DOI 10.1063/1.481011; Hartmann M, 1996, SCIENCE, V272, P1631, DOI 10.1126/science.272.5268.1631; HARTMANN M, 1995, PHYS REV LETT, V75, P1566, DOI 10.1103/PhysRevLett.75.1566; Higgins J, 1998, J PHYS CHEM A, V102, P4952, DOI 10.1021/jp981115g; Higgins J, 1996, PHYS REV LETT, V77, P4532, DOI 10.1103/PhysRevLett.77.4532; HUANG ZS, 1986, J CHEM PHYS, V85, P3338, DOI 10.1063/1.450955; IMIZU Y, 1984, INORG CHEM, V23, P3602, DOI 10.1021/ic00190a034; Kaplan IG, 2000, J CHEM PHYS, V113, P6245, DOI 10.1063/1.1287835; Kim C, 1997, Z PHYS D ATOM MOL CL, V40, P119, DOI 10.1007/s004600050173; Klabunde K.J., 1994, FREE ATOMS CLUSTERS; Kwon Y, 2000, J CHEM PHYS, V113, P6469, DOI 10.1063/1.1310608; Lanzisera DV, 1997, J PHYS CHEM A, V101, P9666, DOI 10.1021/jp972098i; Lehmann KK, 1998, SCIENCE, V279, P2065, DOI 10.1126/science.279.5359.2065; MOSKOVITS M, 1979, ACCOUNTS CHEM RES, V12, P229, DOI 10.1021/ar50139a002; Nauta K, 1999, PHYS REV LETT, V82, P4480, DOI 10.1103/PhysRevLett.82.4480; Nauta K, 1999, FARADAY DISCUSS, V113, P261, DOI 10.1039/a903027a; Nauta K, 1999, SCIENCE, V283, P1895, DOI 10.1126/science.283.5409.1895; Nauta K, 1999, J CHEM PHYS, V111, P3426, DOI 10.1063/1.479627; NAUTA K, UNPUB; NAUTA K, 2000, THESIS U N CAROLINA; ROST JM, 1992, PHYS REV LETT, V68, P1299, DOI 10.1103/PhysRevLett.68.1299; SIN JM, 2000, CLUSTER NANOSTRUCTUR, P345; STILES PL, UNPUB; WHITTEN JL, 1996, SURF SCI REP, V24, P55	35	58	58	5	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					481	484		10.1126/science.1058896	http://dx.doi.org/10.1126/science.1058896			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313489				2022-12-28	WOS:000168187300040
J	Fearon, P; Hotopf, M				Fearon, P; Hotopf, M			Relation between headache in childhood and physical and psychiatric symptoms in adulthood: national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL-PAIN; CHILDREN; SCHOOLCHILDREN; PREVALENCE; ADOLESCENTS; MIGRAINE; AGE; POPULATION; COMMUNITY; PARENTS	Objective To elucidate the associations between frequent headache and psychosocial factors in childhood and to determine whether such children are at an increased risk of headache, multiple physical symptoms, and psychiatric symptoms in adulthood. Design Population based birth cohort study. Setting General population. Participants People participating in the national child development study, a population based birth cohort study established in 1958. Main outcome measures Headache, multiple physical symptoms, and psychiatric morbidity at age 33. Results Headache in childhood was associated with several psychosocial factors. Prospectively, children with frequent headache had an increased risk in adulthood of headache (odds ratio 2.22, 95% confidence interval 1.62 to 3.06), multiple physical symptoms (1.75, 1.46 to 2.10), and psychiatric morbidity (1.41, 1.20 to 1.66). The outcomes of headache and multiple physical symptoms were not accounted for by psychiatric morbidity. Conclusion Children with headache are at an increased risk of recurring headache in adulthood and may complain of other physical and psychiatric symptoms. Strategies for coping with psychosocial adversity in childhood may improve the prognosis in adulthood.	Inst Psychiat, London SE5 8AF, England; Guys Kings & St Thomass Sch Med, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Fearon, P (corresponding author), Inst Psychiat, London SE5 8AF, England.		Hotopf, Matthew/E-4971-2010	Hotopf, Matthew/0000-0002-3980-4466				ANDRASIK F, 1988, PAIN, V34, P43, DOI 10.1016/0304-3959(88)90180-7; BILLE B, 1981, CEPHALALGIA, V1, P71, DOI 10.1111/j.1468-2982.1981.tb00012.x; BORGE AIH, 1994, ACTA PAEDIATR, V83, P433, DOI 10.1111/j.1651-2227.1994.tb18137.x; Carlsson J, 1996, ACTA PAEDIATR, V85, P692, DOI 10.1111/j.1651-2227.1996.tb14128.x; CUNNINGHAM SJ, 1987, HEADACHE, V27, P16, DOI 10.1111/j.1526-4610.1987.hed2701016.x; ECOB R, 1993, SOC SCI MED, V36, P1017, DOI 10.1016/0277-9536(93)90119-O; EGERMARKERIKSSON I, 1982, ACTA PAEDIATR SCAND, V71, P135, DOI 10.1111/j.1651-2227.1982.tb09384.x; Egger HL, 1998, J AM ACAD CHILD PSY, V37, P951, DOI 10.1097/00004583-199809000-00015; ESCOBAR JI, 1987, AM J PUBLIC HEALTH, V77, P837, DOI 10.2105/AJPH.77.7.837; Hotopf M, 1998, BRIT MED J, V316, P1196, DOI 10.1136/bmj.316.7139.1196; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; LARSSON BS, 1991, J CHILD PSYCHOL PSYC, V32, P821, DOI 10.1111/j.1469-7610.1991.tb01905.x; OSTER J, 1972, PEDIATRICS, V50, P429; PASSCHIER J, 1985, CEPHALALGIA, V5, P167, DOI 10.1046/j.1468-2982.1985.0503167.x; Power C., 1991, HLTH CLASS EARLY YEA; Rutter M., 1970, ED HLTH BEHAV; Scott SC, 1997, J CLIN EPIDEMIOL, V50, P45, DOI 10.1016/S0895-4356(96)00312-5; Sillanpaa M, 1996, HEADACHE, V36, P466, DOI 10.1046/j.1526-4610.1996.3608466.x; SILLANPAA M, 1991, CEPHALALGIA, V11, P239, DOI 10.1046/j.1468-2982.1991.1105239.x; Stott D. H., 1969, SOCIAL ADJUSTMENT CH; Sweeting H, 1998, ARCH DIS CHILD, V78, P427, DOI 10.1136/adc.78.5.427; WATERS W E, 1970, Headache, V9, P178, DOI 10.1111/j.1526-4610.1970.hed0904178.x; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; ZUCKERMAN B, 1987, PEDIATRICS, V79, P677	24	167	170	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1145	1148A		10.1136/bmj.322.7295.1145	http://dx.doi.org/10.1136/bmj.322.7295.1145			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433HH	11348907	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168748900013
J	Baranowski, E; Ruiz-Jarabo, CM; Domingo, E				Baranowski, E; Ruiz-Jarabo, CM; Domingo, E			Evolution of cell recognition by viruses	SCIENCE			English	Editorial Material							MOUTH-DISEASE-VIRUS; HEPATITIS-C VIRUS; SINGLE AMINO-ACID; GLY-ASP MOTIF; RECEPTOR-RECOGNITION; MEASLES-VIRUS; INTEGRIN ALPHA(V)BETA(3); POLIOVIRUS RECEPTOR; VIRAL PERSISTENCE; FEVER VIRUS	Evolution of receptor specificity by viruses has several implications for viral pathogenesis, host range, virus-mediated gene targeting, and viral adaptation after organ transplantation and xenotransplantation, as well as for the emergence of viral diseases. Recent evidence suggests that minimal changes in viral genomes may trigger a shift in receptor usage for virus entry, even into the same cell type. A capacity to exploit alternative entry pathways may reflect the-ancient evolutionary origins of viruses and a possible role as agents of horizontal gene transfers among cells.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Domingo, E (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Baranowski, Eric/I-2655-2013; Domingo, Esteban/K-3937-2014	Domingo, Esteban/0000-0002-0573-1676; Baranowski, Eric/0000-0003-0660-1854				ACHARYA R, 1989, NATURE, V337, P709, DOI 10.1038/337709a0; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; BAE YS, 1993, DIABETES, V42, P435, DOI 10.2337/diabetes.42.3.435; Baranowski E, 2000, J VIROL, V74, P1641, DOI 10.1128/JVI.74.4.1641-1647.2000; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; CARVALHO DS, 1997, J VIROL, V71, P5115; COLSTON EM, 1995, J VIROL, V69, P4823, DOI 10.1128/JVI.69.8.4823-4829.1995; CRANDALL KA, 1999, EVOLUTION HIV; CRAWFORD E. M., 1964, VIROLOGY, V22, P165, DOI 10.1016/0042-6822(64)90063-7; Crowell RL, 1986, VIRUS ATTACHMENT ENT; Curry S, 1996, STRUCTURE, V4, P135, DOI 10.1016/S0969-2126(96)00017-2; DOMINGO E, 2000, QUASISPECIES RNA VIR; Evans DJ, 1998, TRENDS MICROBIOL, V6, P198, DOI 10.1016/S0966-842X(98)01263-3; Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; Harber J, 1995, VIROLOGY, V214, P559, DOI 10.1006/viro.1995.0067; Hsu EC, 1998, J VIROL, V72, P2905, DOI 10.1128/JVI.72.4.2905-2916.1998; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; JENNINGS AD, 1994, J INFECT DIS, V169, P512, DOI 10.1093/infdis/169.3.512; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Lake JA, 1999, SCIENCE, V283, P2027, DOI 10.1126/science.283.5410.2027; LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9; LEDERBERG J, 1992, EMEGING INFECT MICRO; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Martinez MA, 1997, P NATL ACAD SCI USA, V94, P6798, DOI 10.1073/pnas.94.13.6798; MASON PW, 1994, P NATL ACAD SCI USA, V91, P1932, DOI 10.1073/pnas.91.5.1932; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; McCright IJ, 1999, J VIROL, V73, P2814, DOI 10.1128/JVI.73.4.2814-2824.1999; MCLAREN LC, 1959, J EXP MED, V109, P475, DOI 10.1084/jem.109.5.475; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; MURRAY MG, 1988, SCIENCE, V241, P213, DOI 10.1126/science.2838906; Neff S, 1998, J VIROL, V72, P3587, DOI 10.1128/JVI.72.5.3587-3594.1998; Nomoto Akio, 1994, Trends in Microbiology, V2, P47, DOI 10.1016/0966-842X(94)90125-2; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Pickrell J, 2001, SCIENCE, V291, P1677; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; Ruiz-Jarabo CM, 1999, J GEN VIROL, V80, P1899, DOI 10.1099/0022-1317-80-8-1899; RUIZJARABO CM, UNPUB; Sato S, 1996, VIROLOGY, V226, P327, DOI 10.1006/viro.1996.0660; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Stewart PL, 1997, TRENDS MICROBIOL, V5, P229, DOI 10.1016/S0966-842X(97)01049-4; Taboga O, 1997, J VIROL, V71, P2606, DOI 10.1128/JVI.71.4.2606-2614.1997; Taplitz RA, 1997, J VIROL, V71, P7814, DOI 10.1128/JVI.71.10.7814-7819.1997; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Urban S, 2000, EMBO J, V19, P1217, DOI 10.1093/emboj/19.6.1217; VERDAGUER N, 1995, EMBO J, V14, P1690, DOI 10.1002/j.1460-2075.1995.tb07158.x; Webster R.G., 1999, ORIGIN EVOLUTION VIR; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WIMMER E, 1994, CELLULAR RECEPTORS A; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	58	196	210	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1102	1105		10.1126/science.1058613	http://dx.doi.org/10.1126/science.1058613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352064				2022-12-28	WOS:000168609200042
J	Stevens, CF				Stevens, CF			An evolutionary scaling law for the primate visual system and its basis in cortical function	NATURE			English	Article							BRAIN STRUCTURE VOLUMES; GENICULATE NEURONS; CORTEX; INSECTIVORA; NEOCORTEX; NUCLEUS; SIZE; MAPS	A hallmark of mammalian brain evolution is the disproportionate increase in neocortical size as compared with subcortical structures(1). Because primary visual cortex (V1) is the most thoroughly understood cortical region, the visual system provides an excellent model in which to investigate the evolutionary expansion of neocortex. I have compared the numbers of neurons in the visual thalamus (lateral geniculate nucleus; LGN) and area V1 across primate species. Here I find that the number of V1 neurons increases as the 3/2 power of the number of LGN neurons. As a consequence of this scaling law, the human, for example, uses four times as many V1 neurons per LGN neuron (356) to process visual information as does a tarsier (87). I argue that the 3/2 power relationship is a natural consequence of the organization of V1, together with the requirement that spatial resolution in V1 should parallel the maximum resolution provided by the LGN. The additional observation that thalamus/ neocortex follows the same evolutionary scaling law as LGN/V1 may suggest that neocortex generally conforms to the same organizational principle as V1.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cfs@salk.edu						AHMAD A, 1993, J COMP NEUROL, V334, P631, DOI 10.1002/cne.903340410; Andrews TJ, 1997, J NEUROSCI, V17, P2859; ARMSTRONG E, 1979, AM J PHYS ANTHROPOL, V51, P365, DOI 10.1002/ajpa.1330510308; ARMSTRONG E, 1980, AM J PHYS ANTHROPOL, V52, P43, DOI 10.1002/ajpa.1330520107; ARMSTRONG E, 1981, AM J PHYS ANTHROPOL, V55, P369, DOI 10.1002/ajpa.1330550311; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FRAHM HD, 1982, J HIRNFORSCH, V23, P375; FRAHM HD, 1984, J HIRNFORSCH, V25, P537; FRITSCHY JM, 1986, DEV BRAIN RES, V29, P173, DOI 10.1016/0165-3806(86)90093-3; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; SCHEIN SJ, 1987, J NEUROSCI, V7, P996; Shulz H-D, 1967, THESIS JW GOETHE U F; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Swindale NV, 2000, CEREB CORTEX, V10, P633, DOI 10.1093/cercor/10.7.633	18	78	78	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					193	195		10.1038/35075572	http://dx.doi.org/10.1038/35075572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	430FC	11346795				2022-12-28	WOS:000168563000050
J	Go, AS; Hylek, EM; Phillips, KA; Chang, YC; Henault, LE; Selby, JV; Singer, DE				Go, AS; Hylek, EM; Phillips, KA; Chang, YC; Henault, LE; Selby, JV; Singer, DE			Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. Objective To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050, Design, Setting, and Patients Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997, Main Outcome Measures Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. Results A total of 17974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. Conclusions Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 3505 Boradway,12th Floor, Oakland, CA 94611 USA.	axg@dor.kaiser.org	Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NIA NIH HHS [AG15478] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; HOLLMAN FW, 2000, 38 US CENS BUR DEP C; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Langenberg M, 1996, BRIT MED J, V313, P1534, DOI 10.1136/bmj.313.7071.1534; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LIP GYH, 1994, BRIT HEART J, V71, P92; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; Psaty BM, 1997, CIRCULATION, V96, P2455; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; *US CENS BUR, 1999, RES POP EST US AG SE; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wolk R, 1996, INT J CARDIOL, V54, P207, DOI 10.1016/0167-5273(96)02631-9	17	4559	4812	1	179	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2370	2375		10.1001/jama.285.18.2370	http://dx.doi.org/10.1001/jama.285.18.2370			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343485	Bronze			2022-12-28	WOS:000168411200029
J	Barbour, RS				Barbour, RS			Checklists for improving rigour in qualitative research: a case of the tail wagging the dog?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland	University of Glasgow	Barbour, RS (corresponding author), Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland.	rsb2g@clinmed.gla.ac.uk						Armstrong D, 1997, SOCIOLOGY, V31, P597, DOI 10.1177/0038038597031003015; Atkinson P, 1997, QUAL HEALTH RES, V7, P325, DOI 10.1177/104973239700700302; Barbour R S, 1999, J Health Serv Res Policy, V4, P39; Barbour RS, 1998, QUAL HEALTH RES, V8, P352, DOI 10.1177/104973239800800306; Barbour RS, 1998, MEDDLING WITH MYTHOLOGY: AIDS AND THE SOCIAL CONSTRUCTION OF KNOWLEDGE, P183; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Bloor M, 1997, CONTEXT METHOD QUALI, P37; Bryman A., 1994, ANAL QUALITATIVE DAT; Frankland J, 1999, DEV FOCUS GROUP RES, P144; Glaser B.G., 1965, AWARENESS DYING; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Harding G, 1998, FAM PRACT, V15, P76, DOI 10.1093/fampra/15.1.76; Hoddinott P, 1997, FAM PRACT, V14, P313, DOI 10.1093/fampra/14.4.313; KUZEL AJ, 1992, RES METH PR, V3, P31; Mauthner NS, 1998, SOCIOLOGY, V32, P733, DOI 10.1177/0038038598032004006; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Melia K.M, 1997, CONTEXT METHOD QUALI, P26; Miller G., 1997, CONTEXT METHOD QUALI; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; RICHARDSON L, 1991, SOCIOLOGICAL THEORY, V9, P173; Seale C, 1997, EUR J PUBLIC HEALTH, V7, P379, DOI 10.1093/eurpub/7.4.379; Seale C., 1999, QUAL INQ, V5, P465, DOI [10.1177/107780049900500402, DOI 10.1177/107780049900500402]	23	1498	1501	2	117	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2001	322	7294					1115	1117		10.1136/bmj.322.7294.1115	http://dx.doi.org/10.1136/bmj.322.7294.1115			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431JP	11337448	Green Published, Green Accepted			2022-12-28	WOS:000168628300029
J	Schoeller, T; Schmutzhard, E				Schoeller, T; Schmutzhard, E			Waterhouse-Friderichsen syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Leopold Franzens Univ Hosp, A-6020 Innsbruck, Austria	University of Innsbruck	Schoeller, T (corresponding author), Leopold Franzens Univ Hosp, A-6020 Innsbruck, Austria.			Schmutzhard, Erich/0000-0003-3295-7491					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1372	1372		10.1056/NEJM200105033441805	http://dx.doi.org/10.1056/NEJM200105033441805			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333994				2022-12-28	WOS:000168413500005
J	Ramtoola, S; Home, P; Damry, H; Husnoo, A; Ah-Kion, S				Ramtoola, S; Home, P; Damry, H; Husnoo, A; Ah-Kion, S			Gestational impaired glucose tolerance does not increase perinatal mortality in a developing country: cohort study	BRITISH MEDICAL JOURNAL			English	Article									Univ Newcastle Upon Tyne, Human Diabet & Metab Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Dr AG Jeetoo Hosp, Port Louis, Mauritius	Newcastle University - UK	Ramtoola, S (corresponding author), Dr AG Jeetoo Hosp, Port Louis, Mauritius.							Alberti KG, 1999, DEFINITION DIAGNOS 1; Deerochanawong C, 1996, DIABETOLOGIA, V39, P1070; *INT DIAB I AUSTR, 1993, MAUR NONC DIS INT PR; ROBERTS RN, 1993, DIABETIC MED, V10, P438, DOI 10.1111/j.1464-5491.1993.tb00095.x; *WHO STUD GROUP, 1985, WHO TECHN REP SER, V727	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1025	1026		10.1136/bmj.322.7293.1025	http://dx.doi.org/10.1136/bmj.322.7293.1025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325766	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000168478700020
J	Davis, MB; Shaw, RG				Davis, MB; Shaw, RG			Range shifts and adaptive responses to Quaternary climate change	SCIENCE			English	Review							LIFE-HISTORY VARIATION; EASTERN NORTH-AMERICA; GENETIC DIVERSITY; GEOGRAPHIC PATTERNS; ALLOZYME VARIATION; VEGETATION CHANGE; PLANT MIGRATION; PINUS-CONTORTA; POPULATIONS; POLLEN	Tree taxa shifted latitude or elevation range in response to changes in Quaternary climate. Because many modern trees display adaptive differentiation in relation to latitude or elevation, it is likely that ancient trees were also so differentiated, with environmental sensitivities of populations throughout the range evolving in conjunction with migrations. Rapid climate changes challenge this process by imposing stronger selection and by distancing populations from environments to which they are adapted. The unprecedented rates of climate changes anticipated to occur in the future, coupled with land use changes that impede gene flow, can be expected to disrupt the interplay of adaptation and migration, likely affecting productivity and threatening the persistence of many species.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Davis, MB (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	mbdavis@ecology.umn.edu						ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; Austerlitz F, 2000, GENETICS, V154, P1309; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; BENNETT KD, 1990, PALEOBIOLOGY, V16, P11, DOI 10.1017/S0094837300009684; Betancourt J.L., 1990, PACKRAT MIDDENS LAST; BRADSHAW AD, 1991, PHILOS T R SOC B, V333, P289, DOI 10.1098/rstb.1991.0079; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Comps B, 2001, GENETICS, V157, P389; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Davis M.B., 1981, FOREST SUCCESSION CO, P132, DOI DOI 10.1007/978-1-4612-5950-3_10; ERIKSSON G, 1993, FOREST ECOL MANAG, V62, P15, DOI 10.1016/0378-1127(93)90039-P; Eriksson G., 1980, STUD FOREST SUECICA, V156, P1; ETTERSON JR, COMMUNICATION; Falconer DS, 1996, INTRO QUANTITATIVE G; FURNIER GR, 1991, CAN J FOREST RES, V21, P707, DOI 10.1139/x91-097; GULLBERG U, 1985, SILVAE GENET, V34, P193; Hamann A, 1998, CAN J FOREST RES, V28, P1557, DOI 10.1139/cjfr-28-10-1557; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HAMRICK JL, 1994, NATURAL HIST COLORAD, P147; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huntley B., 1983, ATLAS PRESENT POLLEN; Huntley B, 1988, VEGETATION HIST; HUNTLEY B, 1997, FUTURE RAPID ENV CHA, P487; Huntley Brian, 1993, P136; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jackson ST, 1999, P NATL ACAD SCI USA, V96, P13847, DOI 10.1073/pnas.96.24.13847; Jackson ST, 1997, QUATERNARY SCI REV, V16, P1, DOI 10.1016/S0277-3791(96)00047-9; JACOBSON GL, 1987, N AM ADJACENT OCEANS, P277; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kuser JE, 1997, AM J BOT, V84, P1536, DOI 10.2307/2446615; LAW R, 1977, EVOLUTION, V31, P233, DOI 10.1111/j.1558-5646.1977.tb01004.x; Lewontin R. C., 1974, The genetic basis of evolutionary change.; Lynch M., 1993, BIOTIC INTERACTIONS, P235; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; MATYAS C, 1997, FUTURE RAPID ENV CHA, P357; Melillo JM, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P445; Mikola J, 1982, SILVA FENNICA, V16, P178, DOI DOI 10.14214/SF.A15075; Miyoshi N, 1999, REV PALAEOBOT PALYNO, V104, P267, DOI 10.1016/S0034-6667(98)00058-X; Pitelka LF, 1997, AM SCI, V85, P464; Premoli AC, 2000, J BIOGEOGR, V27, P251, DOI 10.1046/j.1365-2699.2000.00402.x; PRENTICE IC, 1991, ECOLOGY, V72, P2038, DOI 10.2307/1941558; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; REINARTZ JA, 1984, J ECOL, V72, P897, DOI 10.2307/2259539; RITCHIE JC, 1986, J BIOGEOGR, V13, P527, DOI 10.2307/2844816; Scotti I, 2000, MOL ECOL, V9, P699, DOI 10.1046/j.1365-294x.2000.00911.x; Shugart H. H., 1984, A theory of forest dynamics. The ecological implications of forest succession models.; Spaulding W.G., 1983, LATE QUATERNARY ENV, V1, P259; Suyama Y, 1997, J PLANT RES, V110, P219, DOI 10.1007/BF02509310; Suyama Y, 1996, GENES GENET SYST, V71, P145, DOI 10.1266/ggs.71.145; Sykes MT, 1996, J BIOGEOGR, V23, P203; Tani N, 1996, CAN J FOREST RES, V26, P1454, DOI 10.1139/x26-162; TERAMURA AH, 1983, AM J BOT, V70, P53, DOI 10.1002/j.1537-2197.1983.tb12431.x; THOMPSON RS, 1988, VEGETATION HIST, P415; Tomaru N, 1997, HEREDITY, V78, P241, DOI 10.1038/hdy.1997.38; Tomaru N, 1998, AM J BOT, V85, P629, DOI 10.2307/2446531; TSUKADA M, 1982, BOT MAG TOKYO, V95, P203, DOI 10.1007/BF02488586; Tsukada M., 1988, VEGETATION HIST, P459; Turesson G, 1925, HEREDITAS, V6, P147; WALKER KV, COMMUNICATION; WEBB T, 1986, VEGETATIO, V67, P75, DOI 10.1007/BF00037359; WEBB T, 1987, VEGETATIO, V69, P177, DOI 10.1007/BF00038699; WEBB T, 1993, GLOBAL CLIMATES LAST, V1, P415; Yang RC, 1996, GENETICS, V142, P1045; [No title captured]	66	1526	1581	21	804	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					673	679		10.1126/science.292.5517.673	http://dx.doi.org/10.1126/science.292.5517.673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326089				2022-12-28	WOS:000168478300039
J	de Vegt, F; Dekker, JM; Jager, A; Hienkens, E; Kostense, PJ; Stehouwer, CDA; Nijpels, G; Bouter, LM; Heine, RJ				de Vegt, F; Dekker, JM; Jager, A; Hienkens, E; Kostense, PJ; Stehouwer, CDA; Nijpels, G; Bouter, LM; Heine, RJ			Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAUCASIAN POPULATION; NATURAL-HISTORY; HIGH-RISK; TOLERANCE; NIDDM; PROGRESSION; CONVERSION; MELLITUS; HYPERGLYCEMIA; DETERMINANTS	Context Persons with impaired glucose tolerance (IGT) are known to have an elevated risk of developing diabetes mellitus. Less is known about diabetes risk among persons with impaired fasting glucose (IFG) or with normal glucose levels. Objective To determine the incidence of diabetes in relation to baseline fasting and postload glucose levels and other risk factors. Design, Setting, and Participants Population-based cohort study conducted from October 1989 to February 1992 among 1342 nondiabetic white residents of Hoorn, the Netherlands, aged 50 to 75 years at baseline, in whom fasting plasma glucose (FPG) levels and glucose levels 2 hours after a 75-g oral glucose tolerance test were measured at baseline and at follow-up in 1996-1998. Main outcome Measures Cumulative incidence of diabetes, defined according to the diagnostic criteria of the World Health Organization (WHO-1985 and WHO-1999) and the American Diabetes Association (ADA-1997), during a mean follow-up of 6.4 years, compared among participants with IFG, IGT, and normal glucose levels at baseline. Results The cumulative incidence of diabetes was 6.1%, 8.3%, and 9.9% according to the WHO-1985, ADA, and WHO-1999 criteria, respectively. The cumulative incidence of diabetes (WHO-1999 criteria) for participants with both IFG and IGT was 64.5% compared with 4.5% for those with normal glucose levels at baseline. The odds ratios for diabetes (WHO-1999 criteria), adjusted for age, sex, and follow-up duration, were 10.0 (95% confidence interval [CI], 6.1-16.5), 10.9 (95% CI, 6.0-19.9), and 39.5 (95% CI, 17.0-92.1), respectively, for those having isolated IFG, isolated IGT, and both IFG and IGT. In addition to FPG and 2-hour postload glucose levels (P<.001 for both), the waist-hip ratio also was an important risk factor for developing diabetes (P=.002). Conclusion In this study, the cumulative incidence of diabetes was strongly related to both IFG and IGT at baseline and, in particular, to the combined presence of IFG and IGT.	Free Univ Amsterdam, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; Free Univ Amsterdam, Univ Hosp, Dept Internal Med, Amsterdam, Netherlands; Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Dekker, JM (corresponding author), Free Univ Amsterdam, Inst Res Extramural Med, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.		de Vegt, F./L-4704-2015; jager, agnes/V-6381-2017; Stehouwer, Coen/AAB-3435-2021	de Vegt, F./0000-0001-8728-3397; jager, agnes/0000-0002-7713-1450; Bouter, Lex/0000-0002-2659-5482				Alberti KGMM, 1996, DIABETIC MED, V13, P927, DOI 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E; Chou PS, 1998, DIABETES CARE, V21, P1183, DOI 10.2337/diacare.21.7.1183; de Vegt F, 2000, DIABETES CARE, V23, P40, DOI 10.2337/diacare.23.1.40; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Dinneen SF, 1998, DIABETES CARE, V21, P1408, DOI 10.2337/diacare.21.9.1408; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; FESKENS EJM, 1991, J CLIN EPIDEMIOL, V44, P947, DOI 10.1016/0895-4356(91)90058-H; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haffner SM, 1997, DIABETOLOGIA, V40, P62, DOI 10.1007/s001250050643; Harrison A, 1996, FAM PRACT, V13, P59, DOI 10.1093/fampra/13.1.59; HOSMER DW, 1989, APPL LOGISTIC REGRES; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; MOOY JM, 1995, DIABETES CARE, V18, P1270, DOI 10.2337/diacare.18.9.1270; MOTALA AA, 1993, DIABETES, V42, P556, DOI 10.2337/diabetes.42.4.556; Nijpels G, 1996, DIABETOLOGIA, V39, P113; Nijpels G, 1998, EUR J CLIN INVEST, V28, P8; NORUSIS MJ, 1990, SPSS WINDOWS; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Sinclair AJ, 1997, DIABETIC MED, V14, P639, DOI 10.1002/(SICI)1096-9136(199708)14:8<639::AID-DIA433>3.0.CO;2-C; Vaccaro O, 1999, DIABETES CARE, V22, P1490, DOI 10.2337/diacare.22.9.1490; Warram JH, 1996, DIABETIC MED, V13, pS40; *WHO, 1985, WHO TECHNICAL REPORT, V727; *WHO, 1999, PUBL WHO NCD NCS	29	431	442	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2109	2113		10.1001/jama.285.16.2109	http://dx.doi.org/10.1001/jama.285.16.2109			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311100	Bronze, Green Published			2022-12-28	WOS:000168131600031
J	Kaushal, R; Bates, DW; Landrigan, C; McKenna, DJ; Clapp, MD; Federico, F; Goldmann, DA				Kaushal, R; Bates, DW; Landrigan, C; McKenna, DJ; Clapp, MD; Federico, F; Goldmann, DA			Medication errors and adverse drug events in pediatric inpatients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN ORDER ENTRY; INTENSIVE-CARE UNIT; OF-MEDICINE REPORT; HOSPITALIZED-PATIENTS; PREVENTION; IMPROVEMENT; PHARMACISTS; MANAGEMENT	Context latrogenic injuries, including medication errors, are an important problem in all hospitalized populations. However, few epidemiological data are available regarding medication errors in the pediatric inpatient setting. Objectives To assess the rates of medication errors, adverse drug events (ADEs), and potential ADEs; to compare pediatric rates with previously reported adult rates; to analyze the major types of errors; and to evaluate the potential impact of prevention strategies. Design, Setting, and Patients Prospective cohort study of 1120 patients admitted to 2 academic institutions during 6 weeks in April and May of 1999. Main Outcome Measures Medication errors, potential ADEs, and ADEs were identified by clinical staff reports and review of medication order sheets, medication administration records, and patient charts. Results We reviewed 10778 medication orders and found 616 medication errors (5.7%), 115 potential ADEs (1.1%), and 26 ADEs (0.24%). Of the 26 ADEs, 5 (19%) were preventable. While the preventable ADE rate was similar to that of a previous adult hospital study, the potential ADE rate was 3 times higher. The rate of potential ADEs was significantly higher in neonates in the neonatal intensive care unit. Most potential ADEs occurred at the stage of drug ordering (79%) and involved incorrect dosing (34%), anti-infective drugs (28%), and intravenous medications (54%), Physician reviewers judged that computerized physician order entry could potentially have prevented 93% and ward-based clinical pharmacists 94% of potential ADEs. Conclusions Medication errors are common in pediatric inpatient settings, and further efforts are needed to reduce them.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Dept Qual Improvement & Risk Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Risk Management Fdn, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Goldmann, DA (corresponding author), Childrens Hosp, Dept Med, Enders 609,300 Longwood Ave, Boston, MA 02115 USA.	Don.Goldmann@tch.harvard.edu		Landrigan, Christopher/0000-0001-8386-4100	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000063] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS00063] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ALLAN EL, 1990, AM J HOSP PHARM, V47, P555, DOI 10.1093/ajhp/47.3.555; [Anonymous], 1999, ERR IS HUMAN BUILDIN; Ashton CM, 1999, MED CARE, V37, P798, DOI 10.1097/00005650-199908000-00009; BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; FOLLI HL, 1987, PEDIATRICS, V79, P718; FORRESTER JW, 1971, TECHNOL REV, V73, P52, DOI 10.1177/003754977101600202; Glauber J, 2000, PEDIATRICS, V105, P1330; *JOINT COMM ACCR H, 1999, COMPR ACCR MAN HOSP; KATONA BG, 1989, AM J HOSP PHARM, V46, P1179, DOI 10.1093/ajhp/46.6.1179; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Perrow C, 1984, NORMAL ACCIDENTS; REESON J, 1990, HUMAN ERROR; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003	31	1169	1213	1	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2114	2120		10.1001/jama.285.16.2114	http://dx.doi.org/10.1001/jama.285.16.2114			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311101	Bronze			2022-12-28	WOS:000168131600032
J	Dismukes, GC				Dismukes, GC			Photosynthesis - Splitting water	SCIENCE			English	Editorial Material							PHOTOSYSTEM-II; EARLY EVOLUTION; OXIDATION; ORIGIN		Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Dismukes, GC (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.		Dismukes, Gerard C/I-4905-2012	Dismukes, Gerard C/0000-0003-0155-0541				Ananyev GM, 2001, BBA-BIOENERGETICS, V1503, P52, DOI 10.1016/S0005-2728(00)00215-2; BABCOCK GT, 1996, OXYGENIC PHOTOSYNTHE, P213; Blankenship RE, 1998, TRENDS BIOCHEM SCI, V23, P94, DOI 10.1016/S0968-0004(98)01186-4; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Des Marais DJ, 2000, SCIENCE, V289, P1703; Diner BA, 1998, BIOCHEMISTRY-US, V37, P17931, DOI 10.1021/bi981894r; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; DISMUKES GC, 1988, CHEM SCRIPTA, V28A, P99; Dole F, 1997, J AM CHEM SOC, V119, P11540, DOI 10.1021/ja9717727; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Limburg J, 2001, J AM CHEM SOC, V123, P423, DOI 10.1021/ja001090a; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Ruettinger W, 2000, J AM CHEM SOC, V122, P10353, DOI 10.1021/ja0005587; RUETTINGER W, 1997, CHEM REV, V97, P1; Rutherford A. W., 1996, P143; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Westphal KL, 2000, CURR OPIN PLANT BIOL, V3, P236, DOI 10.1016/S1369-5266(00)80071-0; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; YAGI M, UNPUB; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	22	28	29	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					447	448		10.1126/science.1060222	http://dx.doi.org/10.1126/science.1060222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330297				2022-12-28	WOS:000168187300028
J	Radford, JA; Lieberman, BA; Brison, DR; Smith, ARB; Critchlow, JD; Russell, SA; Watson, AJ; Clayton, JA; Harris, M; Gosden, RG; Shalet, SM				Radford, JA; Lieberman, BA; Brison, DR; Smith, ARB; Critchlow, JD; Russell, SA; Watson, AJ; Clayton, JA; Harris, M; Gosden, RG; Shalet, SM			Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma	LANCET			English	Article							FERTILITY; TISSUE; SHEEP; LONG	Background Infertility is a common late effect of chemotherapy and radiotherapy, and has a substantial effect on the quality of life for young survivors of cancer. For men, semen cryopreservation is a simple way of preserving reproductive potential but for women, storage of mature eggs rarely proves successful, and the alternative-immediate in vitro fertilisation with cryopreservation of embryos-is not always appropriate. Reimplantation of cryopreserved ovarian tissue has been shown to restore natural fertility in animals. We applied this technique in a woman who had received sterilising chemotherapy for lymphoma. Methods A 36-year-old woman underwent a right oophorectomy with cryopreservation of ovarian cortical strips before receiving high-dose CBV chemotherapy for a third recurrence of Hodgkin's lymphoma. 19 months later, when serum sex steroid analysis confimed a postmenopausal state, two ovarian cortical strips were thawed and reimplanted-one onto the left ovary and another at the site of the right ovary. Findings 7 months after reimplantation of ovarian cortical strips, the patient reported resolution of hot flashes and, for the first time, oestradiol was detected in the serum. This finding was associated with a decrease in the concentrations of follicle-stimulating hormone and luteinising hormone, and ultrasonography revealed a 10 mm thick endometrium, a poorly visualised left ovary, and a 2 cm diameter follicular structure to the right of the midline, The patient had one menstrual period, but by 9 months after the implantation, her sex steroid concentrations had returned to those seen with ovarian failure. Interpretation Orthotopic reimplantation of frozen/thawed ovarian cortical strips is a well tolerated technique for restoring ovarian function in women treated with sterilising chemotherapy for cancer.	Christie Hosp, Dept Med Oncol, Canc Res Campaign, Manchester M20 4BX, Lancs, England; Christie Hosp, Dept Histopathol, Manchester M20 4BX, Lancs, England; Christie Hosp, Dept Endocrinol, Manchester M20 4BX, Lancs, England; St Marys Hosp, Dept Reprod Med, Manchester M13 0JH, Lancs, England; St Marys Hosp, Dept Diagnost Radiol, Manchester M13 0JH, Lancs, England; McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	Christie NHS Foundation Trust; Christie Hospital; Christie NHS Foundation Trust; Christie Hospital; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Manchester; McGill University	Radford, JA (corresponding author), Christie Hosp, Dept Med Oncol, Canc Res Campaign, Wilmslow Rd, Manchester M20 4BX, Lancs, England.		Radford, John A/N-1331-2015	Radford, John A/0000-0001-7898-2786				Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Fabbri R, 2001, HUM REPROD, V16, P411, DOI 10.1093/humrep/16.3.411; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Howell S, 1998, ENDOCRIN METAB CLIN, V27, P927, DOI 10.1016/S0889-8529(05)70048-7; KIMM SS, 1999, FERTIL STERIL S; Newton H, 1996, HUM REPROD, V11, P1487; Oktay K, 2000, FERTIL STERIL, V73, P599, DOI 10.1016/S0015-0282(99)00548-8; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Oktay K, 1998, FERTIL STERIL, V69, P1, DOI 10.1016/S0015-0282(97)00207-0; PARROTT DMV, 1960, J REPROD FERTIL, V1, P230, DOI 10.1530/jrf.0.0010230; Shaw JM, 1996, HUM REPROD, V11, P1668; TAN SL, 1994, AM J OBSTET GYNECOL, V171, P513, DOI 10.1016/0002-9378(94)90291-7	12	272	287	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1172	1175		10.1016/S0140-6736(00)04335-X	http://dx.doi.org/10.1016/S0140-6736(00)04335-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323045				2022-12-28	WOS:000168192100012
J	Rothwell, PM				Rothwell, PM			Carotid endarterectomy and prevention of stroke in the very elderly	LANCET			English	Editorial Material							SURGERY; AGE		Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; BurnsCox N, 1997, BRIT J SURG, V84, P496; DINH QC, 1995, 44 INSEE DEM SOC; DUNLOP WE, 1993, AM J SURG, V165, P577, DOI 10.1016/S0002-9610(05)80438-6; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Perler BA, 1998, J VASC SURG, V27, P25, DOI 10.1016/S0741-5214(98)70288-5; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; Rothwell PM, 2000, CEREBROVASC DIS, V10, P21, DOI 10.1159/000047601; ROTHWELL PM, 2000, CEREBROVASC DIS, V10, P108; STILLER CA, 1994, BRIT J CANCER, V70, P352, DOI 10.1038/bjc.1994.306; Thomas PC, 1996, AUST NZ J SURG, V66, P231, DOI 10.1111/j.1445-2197.1996.tb01172.x; VanDamme H, 1996, ACTA CHIR BELG, V96, P71	15	21	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1142	1143		10.1016/S0140-6736(00)04379-8	http://dx.doi.org/10.1016/S0140-6736(00)04379-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323035				2022-12-28	WOS:000168192100002
J	Webb, DJ; Suginohara, N				Webb, DJ; Suginohara, N			Oceanography - Vertical mixing in the ocean	NATURE			English	Article							CIRCULATION		Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, Tokyo 1538904, Japan	NERC National Oceanography Centre; University of Southampton; University of Tokyo	Webb, DJ (corresponding author), Southampton Oceanog Ctr, Empress Dock, Southampton SO14 3ZH, Hants, England.			Webb, David/0000-0001-7084-8566				Doos K., 1997, INT WOCE NEWSLETTER, P3; FOSTER TD, 1976, DEEP-SEA RES, V23, P301, DOI 10.1016/0011-7471(76)90872-X; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; SCHMITZ WJ, 1995, REV GEOPHYS, V33, P151, DOI 10.1029/95RG00879; Toggweiler JR, 1998, J PHYS OCEANOGR, V28, P1832, DOI 10.1175/1520-0485(1998)028<1832:OTOSLS>2.0.CO;2; Wunsch C, 2000, NATURE, V405, P743, DOI 10.1038/35015639	10	96	100	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					37	37		10.1038/35051171	http://dx.doi.org/10.1038/35051171			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343103	Bronze, Green Accepted			2022-12-28	WOS:000166175600029
J	Throop, HB; Bally, J; Esposito, LW; McCaughrean, MJ				Throop, HB; Bally, J; Esposito, LW; McCaughrean, MJ			Evidence for dust grain growth in young circumstellar disks	SCIENCE			English	Article							LIGHT-SCATTERING; ORION NEBULA; INTERSTELLAR; PARTICLES; ACCRETION; OBJECTS; IMAGES; STARS	Hundreds of circumstellar disks in the Orion nebula are being rapidly destroyed by the intense ultraviolet radiation produced by nearby bright stars. These young, million-year-old disks may not survive long enough to form planetary systems. Nevertheless, the first stage of planet formation-the growth of dust grains into larger particles-may have begun in these systems. Observational evidence for these large particles in Orion's disks is presented. A model of grain evolution in externally irradiated protoplanetary disks is developed and predicts rapid particle size evolution and sharp outer disk boundaries. We discuss implications for the formation rates of planetary systems.	Univ Colorado, Lab Atmospher & Planetary Sci, Boulder, CO 80309 USA; Univ Colorado, CASA, Boulder, CO 80309 USA; Astrophys Inst Potsdam, D-14482 Potsdam, Germany	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Throop, HB (corresponding author), SW Res Inst, 1050 Walnut St,Suite 426, Boulder, CO 80302 USA.	throop@boulder.swri.edu	ESPOSITO, LARRY W/AAB-3673-2021	ESPOSITO, LARRY W/0000-0003-3381-2016; McCaughrean, Mark/0000-0002-1452-5268				Bally J, 2000, ASTRON J, V119, P2919, DOI 10.1086/301385; Bally J, 1998, ASTRON J, V116, P854, DOI 10.1086/300469; Beckwith S. V. W., 2000, Protostars and planets 4, P533; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; CHURCHWELL E, 1987, ASTROPHYS J, V321, P516, DOI 10.1086/165648; DUBRULLE B, 1995, ICARUS, V114, P237, DOI 10.1006/icar.1995.1058; Farinella P., 2000, Protostars and planets 4, P1255; Henney WJ, 1999, ASTRON J, V118, P2350, DOI 10.1086/301087; Johnstone D, 1998, ASTROPHYS J, V499, P758, DOI 10.1086/305658; KIM SH, 1994, ASTROPHYS J, V422, P164, DOI 10.1086/173714; Lumme K, 1997, ICARUS, V126, P455, DOI 10.1006/icar.1996.5650; MANNINGS V, 1994, MON NOT R ASTRON SOC, V267, P361, DOI 10.1093/mnras/267.2.361; McCaughrean M. J., 2000, Protostars and planets 4, P485; McCaughrean MJ, 1996, ASTRON J, V111, P1977, DOI 10.1086/117934; McCaughrean MJ, 1998, ASTROPHYS J, V492, pL157, DOI 10.1086/311110; Mishchenko MI, 1996, J QUANT SPECTROSC RA, V55, P535, DOI 10.1016/0022-4073(96)00002-7; MIZUNO H, 1988, ASTRON ASTROPHYS, V195, P183; MUNDY LG, 1995, ASTROPHYS J, V452, pL137, DOI 10.1086/309734; ODELL CR, 1993, ASTROPHYS J, V410, P696, DOI 10.1086/172786; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Schneider G, 1999, ASTROPHYS J, V513, pL127, DOI 10.1086/311921; Storzer H, 1998, ASTROPHYS J, V495, P853, DOI 10.1086/305315; Storzer H, 1999, ASTROPHYS J, V515, P669, DOI 10.1086/307055; THROOP HB, 2000, THESIS U COLORADO BO; Visser AE, 1998, MON NOT R ASTRON SOC, V301, P585, DOI 10.1046/j.1365-8711.1998.02092.x; Walter F. M., 2000, Protostars and planets 4, P273; Watson A.M., UNPUB; WESTLEY MS, 1995, NATURE, V373, P405, DOI 10.1038/373405a0; YORKE HW, 1993, ASTROPHYS J, V411, P274, DOI 10.1086/172827	30	68	69	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1686	1689		10.1126/science.1059093	http://dx.doi.org/10.1126/science.1059093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11326083	Green Submitted			2022-12-28	WOS:000169031800035
J	Hooper, LV; Gordon, JI				Hooper, LV; Gordon, JI			Commensal host-bacterial relationships in the gut	SCIENCE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; ORAL TOLERANCE; MICE DEVELOP; DOUBLE-BLIND; COLITIS; BACTEROIDES; RESPONSES; SYSTEM; FLORA; IDENTIFICATION	One potential outcome of the adaptive coevolution of humans and bacteria is the development of commensal relationships, where neither partner is harmed, or symbiotic relationships, where unique metabolic traits or other benefits are provided. Our gastrointestinal tract is colonized by a vast community of symbionts and commensals that have important effects on immune function, nutrient processing, and a broad range of other host activities. The current genomic revolution offers an unprecedented opportunity to identify the molecular foundations of these relationships so that we can understand how they contribute to our normal physiology and how they can be exploited to develop new therapeutic strategies.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	jgordon@molecool.wustl.edu						Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Beninati C, 2000, NAT BIOTECHNOL, V18, P1060, DOI 10.1038/80250; Brant SR, 2000, GASTROENTEROLOGY, V119, P1483, DOI 10.1053/gast.2000.20245; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Contractor NV, 1998, J IMMUNOL, V160, P385; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dianda L, 1997, AM J PATHOL, V150, P91; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Ewald P. W., 1988, Oxford Surveys in Evolutionary Biology, V5, P215; EWALD PW, 1984, EVOLUTION INFECT DIS; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEDERBERG J, COMMUNICATION; LEVY SB, 1988, ANTIMICROB AGENTS CH, V32, P1801, DOI 10.1128/AAC.32.12.1801; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; MOREAU MC, 1988, INFECT IMMUN, V56, P2766, DOI 10.1128/IAI.56.10.2766-2768.1988; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nelson KE, 2000, NAT BIOTECHNOL, V18, P1049, DOI 10.1038/80235; Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492, DOI 10.1152/ajpgi.2000.279.3.G492; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shaw DM, 2000, IMMUNOLOGY, V100, P510, DOI 10.1046/j.1365-2567.2000.00069.x; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Steinert M, 2000, NATURWISSENSCHAFTEN, V87, P1, DOI 10.1007/s001140050001; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Sudo N, 1997, J IMMUNOL, V159, P1739; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; USHIJIMA T, 1983, MICROBIOL IMMUNOL, V27, P985, DOI 10.1111/j.1348-0421.1983.tb02929.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Visick KL, 2000, J BACTERIOL, V182, P1779, DOI 10.1128/JB.182.7.1779-1787.2000; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46; Xie H, 2000, J BACTERIOL, V182, P7067, DOI 10.1128/JB.182.24.7067-7069.2000	51	1594	1766	13	454	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1115	1118		10.1126/science.1058709	http://dx.doi.org/10.1126/science.1058709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352068				2022-12-28	WOS:000168609200046
J	Bertet, P; Osnaghi, S; Rauschenbeutel, A; Nogues, G; Auffeves, A; Brune, M; Raimond, JM; Haroche, S				Bertet, P; Osnaghi, S; Rauschenbeutel, A; Nogues, G; Auffeves, A; Brune, M; Raimond, JM; Haroche, S			A complementarity experiment with an interferometer at the quantum-classical boundary	NATURE			English	Article							WHICH-WAY INFORMATION; FRINGE VISIBILITY; SINGLE-PHOTON; COHERENCE; LIGHT; ERASER; FIELDS	To illustrate the quantum mechanical principle of complementarity, Bohr(1) described an interferometer with a microscopic slit that records the particle's path. Recoil of the quantum slit causes it to become entangled with the particle, resulting in a kind of Einstein-Podolsky-Rosen pair(2). As the motion of the slit can be observed, the ambiguity of the particle's trajectory is lifted, suppressing interference effects. In contrast, the state of a sufficiently massive slit does not depend on the particle's path; hence, interference fringes are visible. Although many experiments illustrating various aspects of complementarity have been proposed(3-9) and realized(10-18), none has addressed the quantum- classical limit in the design of the interferometer. Here we report an experimental investigation of complementarity using an interferometer in which the properties of one of the beam-splitting elements can be tuned continuously from being effectively microscopic to macroscopic. Following a recent proposal(19), we use an atomic double-pulse Ramsey interferometer(20), in which microwave pulses act as beam-splitters for the quantum states of the atoms. One of the pulses is a coherent field stored in a cavity, comprising a small, adjustable mean photon number. The visibility of the interference fringes in the final atomic state probability increases with this photon number, illustrating the quantum to classical transition.	Ecole Normale Super, Dept Phys, Lab Kastler Brossel, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Haroche, S (corresponding author), Ecole Normale Super, Dept Phys, Lab Kastler Brossel, 24 Rue Lhomond, F-75231 Paris 05, France.	haroche@lkb.ens.fr	Rauschenbeutel, Arno/C-1472-2013	Rauschenbeutel, Arno/0000-0003-2467-4029; RAIMOND, Jean-Michel/0000-0002-4289-3455				BADUREK G, 1986, PHYS REV A, V34, P2600, DOI 10.1103/PhysRevA.34.2600; Bohr N., 1949, A EINSTEIN PHILOS SC, V7, P199; Bohr N., 1983, QUANTUM THEORY MEASU, P9; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; BRUNE M, 1994, PHYS REV LETT, V72, P3339, DOI 10.1103/PhysRevLett.72.3339; Buks E, 1998, NATURE, V391, P871, DOI 10.1038/36057; CHAPMAN MS, 1995, PHYS REV LETT, V75, P3783, DOI 10.1103/PhysRevLett.75.3783; Durr S, 1998, NATURE, V395, P33, DOI 10.1038/25653; Durr S, 1998, PHYS REV LETT, V81, P5705, DOI 10.1103/PhysRevLett.81.5705; EICHMANN U, 1993, PHYS REV LETT, V70, P2359, DOI 10.1103/PhysRevLett.70.2359; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Englert BG, 1996, PHYS REV LETT, V77, P2154, DOI 10.1103/PhysRevLett.77.2154; ENGLERT BG, 1995, NATURE, V375, P367, DOI 10.1038/375367b0; Gerry CC, 1996, PHYS REV A, V53, P1179, DOI 10.1103/PhysRevA.53.1179; GRANGIER P, 1986, EUROPHYS LETT, V1, P173, DOI 10.1209/0295-5075/1/4/004; HAROCHE S, 1992, APPL PHYS B-PHOTO, V54, P355, DOI 10.1007/BF00325380; HAROCHE S, 1992, CAVITY QUANTUM ELECT, P123; HERZOG TJ, 1995, PHYS REV LETT, V75, P3034, DOI 10.1103/PhysRevLett.75.3034; Kim JI, 1999, PHYS REV LETT, V82, P4737, DOI 10.1103/PhysRevLett.82.4737; KWIAT PG, 1992, PHYS REV A, V45, P7729, DOI 10.1103/PhysRevA.45.7729; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; PFAU T, 1994, PHYS REV LETT, V73, P1223, DOI 10.1103/PhysRevLett.73.1223; Ramsey N. F., 1985, MOL BEAMS; Rauschenbeutel A, 1999, PHYS REV LETT, V83, P5166, DOI 10.1103/PhysRevLett.83.5166; Scully M.O., 1997, QUANTUM OPT; SCULLY MO, 1982, PHYS REV A, V25, P2208, DOI 10.1103/PhysRevA.25.2208; SCULLY MO, 1991, NATURE, V351, P111, DOI 10.1038/351111a0; STOREY EP, 1995, NATURE, V375, P368, DOI 10.1038/375368a0; Wiseman HM, 1997, PHYS REV A, V56, P55, DOI 10.1103/PhysRevA.56.55; Zheng SB, 2000, OPT COMMUN, V173, P265, DOI 10.1016/S0030-4018(99)00600-8	31	161	165	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					166	170		10.1038/35075517	http://dx.doi.org/10.1038/35075517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346787				2022-12-28	WOS:000168563000042
J	Maher, BA; Dennis, PF				Maher, BA; Dennis, PF			Evidence against dust-mediated control of glacial-interglacial changes in atmospheric CO2	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; SOUTHERN-OCEAN; EXPORT PRODUCTION; IRON; CLIMATE; ANTARCTICA; DEPOSITION; SEDIMENTS; ORIGIN; VOSTOK	The low concentration of atmospheric CO2 inferred to have been present during glacial periods is thought to have been partly caused by an increased supply of iron-bearing dust to the ocean surface(1). This is supported by a recent model(2) that attributes half of the CO2 reduction during past glacial stages to iron-stimulated uptake of CO2 by phytoplankton in the Southern Ocean. But atmospheric dust fluxes to the Southern Ocean, even in glacial periods, are thought to be relatively low and therefore it has been proposed that Southern Ocean productivity might be influenced by iron deposited elsewhere-for example, in the Northern Hemisphere(3,4) -which is then transported south via ocean circulation (similar to the distal supply of iron to the equatorial Pacific Ocean(5-7)). Here we examine the timing of dust fluxes to the North Atlantic Ocean, in relation to climate records from the Vostok ice core in Antarctica around the time of the penultimate deglaciation (about 130 kyr ago). Two main dust peaks occurred 155 kyr and 130 kyr ago, but neither was associated with the CO2 rise recorded in the Vostok ice core. This mismatch, together with the low dust flux supplied to the Southern Ocean, suggests that dust-mediated iron fertilization of the Southern Ocean did not significantly influence atmospheric CO2 at the termination of the penultimate glaciation.	Univ E Anglia, Ctr Environm Magnetism & Palaeomagnetism, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Stable Isotope Lab, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Maher, BA (corresponding author), Univ E Anglia, Ctr Environm Magnetism & Palaeomagnetism, Norwich NR4 7TJ, Norfolk, England.		Maher, Barbara A/K-6234-2012	Maher, Barbara A/0000-0002-8759-8214; Dennis, Paul/0000-0002-0307-4406				BAREILLE G, 1994, PALEOCEANOGRAPHY, V9, P799, DOI 10.1029/94PA01946; Basile I, 1997, EARTH PLANET SC LETT, V146, P573, DOI 10.1016/S0012-821X(96)00255-5; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Chapman MR, 1998, EARTH PLANET SC LETT, V159, P57, DOI 10.1016/S0012-821X(98)00068-5; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; DEMENOCAL PB, 1993, PALEOCEANOGRAPHY, V8, P209, DOI 10.1029/93PA02688; Diekmann B, 2000, PALAEOGEOGR PALAEOCL, V162, P357, DOI 10.1016/S0031-0182(00)00138-3; DUCE R, 1991, LIMNOL OCEANOGR, V42, P405; Hovan SA, 1991, PALEOCEANOGRAPHY, V6, P349, DOI 10.1029/91PA00559; HUSAR RB, 1997, NOAA J GEOPHYS RES, V102, P16889; JICKELLS TD, IN PRESS BIOGEOCHEMI; KIDD RB, 1983, I OCEANOGR SCI REP, V166, P1; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; Loubere P, 2000, NATURE, V406, P497, DOI 10.1038/35020041; Maher B.A., 1999, QUATERNARY CLIMATES, P1, DOI DOI 10.1017/CB09780511535635.002; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; Measures CI, 2000, GLOBAL BIOGEOCHEM CY, V14, P317, DOI 10.1029/1999GB001188; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; REIFF J, 1986, J CLIM APPL METEOROL, V25, P1543, DOI 10.1175/1520-0450(1986)025<1543:ADRNEA>2.0.CO;2; ROBINSON SG, 1986, PHYS EARTH PLANET IN, V42, P22, DOI 10.1016/S0031-9201(86)80006-1; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Watson AJ, 1999, TELLUS B, V51, P453, DOI 10.1034/j.1600-0889.1999.00022.x; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Wells ML, 1999, NATURE, V398, P601, DOI 10.1038/19281	27	48	51	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					176	180		10.1038/35075543	http://dx.doi.org/10.1038/35075543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346790	Green Accepted			2022-12-28	WOS:000168563000045
J	Miura, A; Yonebayashi, S; Watanabe, K; Toyama, T; Shimada, H; Kakutani, T				Miura, A; Yonebayashi, S; Watanabe, K; Toyama, T; Shimada, H; Kakutani, T			Mobilization of transposons by a mutation abolishing full DNA methylation in Arabidopsis	NATURE			English	Article							CYTOSINE METHYLATION; DDM1 MUTATION; GENE; THALIANA; ELEMENT; RETROTRANSPOSONS; MAINTENANCE; HOMOLOGY; MUTANTS; VIRUS	A major component of the large genomes of higher plants and vertebrates comprises transposable elements and their derivatives, which potentially reduce the stability of the genome(1). It has been proposed that methylation of cytosine residues may suppress transposition, but experimental evidence for this has been limited(2-5). Reduced methylation of repeat sequences results from mutations in the Arabidopsis gene DDM1 (decrease in DNA methylation)(6), which encodes a protein similar to the chromatin-remodelling factor SWI2/SNF2 (ref. 7). In the ddm1-induced hypomethylation background, silent repeat sequences are often reactivated transcriptionally, but no transposition of endogenous elements has been observed(8-11). A striking feature of the ddm1 mutation is that it induces developmental abnormalities by causing heritable changes in other loci(12,13). Here we report that one of the ddm1-induced abnormalities is caused by insertion of CAC1, an endogenous CACTA family transposon. This class of Arabidopsis elements transposes and increases in copy number at high frequencies specifically in the ddm1 hypomethylation background. Thus the DDM1 gene not only epigenetically ensures proper gene expression(13-16), but also stabilizes transposon behaviour, possibly through chromatin remodelling or DNA methylation.	Natl Inst Genet, Shizuoka 4118540, Japan; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 3058602, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1010062, Japan; Tokyo Univ Sci, Chiba 2788510, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Agrobiological Sciences - Japan; Japan Science & Technology Agency (JST); Tokyo University of Science	Kakutani, T (corresponding author), Natl Inst Genet, Shizuoka 4118540, Japan.	tkakutan@lab.nig.ac.jp	Hu, Ruogu/B-2203-2008					Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; CHANDLER VL, 1986, P NATL ACAD SCI USA, V83, P1767, DOI 10.1073/pnas.83.6.1767; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fedoroff N., 1996, Epigenetic mechanisms of gene regulation., P575; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Furner IJ, 1998, GENETICS, V149, P651; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1999, GENETICS, V151, P831; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; LAWSON EJR, 1994, MOL GEN GENET, V245, P608, DOI 10.1007/BF00282223; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Matzke MA, 1999, GENETICA, V107, P271, DOI 10.1023/A:1003921710672; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MCCLINTOCK B, 1958, CARNEGIE I WASHINGTO, V57, P415; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NACKEN WKF, 1991, MOL GEN GENET, V228, P201, DOI 10.1007/BF00282466; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Scortecci KC, 1997, PLANT CELL PHYSIOL, V38, P336, DOI 10.1093/oxfordjournals.pcp.a029171; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	33	437	464	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					212	214		10.1038/35075612	http://dx.doi.org/10.1038/35075612			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346800				2022-12-28	WOS:000168563000055
J	Emmerson, MC; Solan, M; Emes, C; Paterson, DM; Raffaelli, D				Emmerson, MC; Solan, M; Emes, C; Paterson, DM; Raffaelli, D			Consistent patterns and the idiosyncratic effects of biodiversity in marine ecosystems	NATURE			English	Article							SPECIES-DIVERSITY; PLANT DIVERSITY; PRODUCTIVITY; STABILITY; COMPLEMENTARITY; COMPETITION; COMMUNITIES; BIOMASS	Revealing the consequences of species extinctions for ecosystem function has been a chief research goal(1-7) and has been accompanied by enthusiastic debate(8-11). Studies carried out predominantly in terrestrial grassland and soil ecosystems have demonstrated that as the number of species in assembled communities increases, so too do certain ecosystem processes, such as productivity, whereas others such as decomposition can remain unaffected(12). Diversity can influence aspects of ecosystem function, but questions remain as to how generic the patterns observed are, and whether they are the product of diversity, as such, or of the functional roles and traits that characterize species in ecological systems. Here we demonstrate variable diversity effects for species representative of marine coastal systems at both global and regional scales. We provide evidence for an increase in complementary resource use as diversity increases and show strong evidence for diversity effects in naturally assembled com-munities at a regional scale. The variability among individual species responses is consistent with a positive but idiosyncratic pattern of ecosystem function with increased diversity.	Univ Aberdeen, Culterty Field Stn, Newburgh AB41 6AA, Ellon, Scotland; Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland	University of Aberdeen; University of St Andrews	Emmerson, MC (corresponding author), Univ Aberdeen, Culterty Field Stn, Newburgh AB41 6AA, Ellon, Scotland.		Paterson, David M/D-5202-2013; Ross, Donald J/F-7607-2012; Emmerson, Mark Charles/ABD-6274-2021; Solan, Martin/E-9338-2012	Paterson, David M/0000-0003-1174-6476; Ross, Donald J/0000-0002-8659-3833; Solan, Martin/0000-0001-9924-5574; Emmerson, Mark/0000-0003-1034-8572				Emmerson MC, 2000, OIKOS, V91, P195; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HECTOR A, 2000, SCIENCE, V289, P1257; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Hughes JB, 2000, AM NAT, V155, P618, DOI 10.1086/303348; Huston M A, 2000, Science, V289, P1255; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Lawton JH, 1998, FUNCT ECOL, V12, P848; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; McGrady-Steed J, 2000, ECOLOGY, V81, P361; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nedwell DB, 1999, ADV ECOL RES, V29, P43; Nixon SW, 1981, ESTUARIES NUTRIENTS, P111, DOI DOI 10.1007/978-1-4612-5826-1_6; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Wardle DA, 1997, OIKOS, V80, P470, DOI 10.2307/3546620; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; [No title captured]	25	234	242	0	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					73	77		10.1038/35075055	http://dx.doi.org/10.1038/35075055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333979				2022-12-28	WOS:000168432800045
J	Emery, J; Hayflick, S				Emery, J; Hayflick, S			The challenge of integrating genetic medicine into primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMOGLOBIN DISORDERS; FAMILY HISTORY; SERVICES; DISEASE; CANCER; RISK; BREAST		Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Cambridge; Oregon Health & Science University	Emery, J (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Gen Practice & Primary Care Res Unit, Cambridge CB2 2SR, England.	jde10@medschl.cam.ac.uk						Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; Bernstein T, 1994, RADON RENTAL HOUSING; Chou WH, 2000, J CLIN PSYCHOPHARM, V20, P246, DOI 10.1097/00004714-200004000-00019; Emery J, 1999, FAM PRACT, V16, P426, DOI 10.1093/fampra/16.4.426; Emery J, 2000, BMJ-BRIT MED J, V321, P28, DOI 10.1136/bmj.321.7252.28; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Hallman D M, 1997, J Cardiovasc Risk, V4, P325, DOI 10.1097/00043798-199710000-00002; Harper PS, 1996, J ROY COLL PHYS LOND, V30, P296; HARRIS H, 1993, BRIT MED J, V306, P1580, DOI 10.1136/bmj.306.6892.1580; Hayflick S J, 1998, Community Genet, V1, P18, DOI 10.1159/000016131; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Jarman P, 1999, BRIT MED J, V318, P1641, DOI 10.1136/bmj.318.7199.1641; Kumar S, 1999, LANCET, V354, P1992, DOI 10.1016/S0140-6736(99)04073-8; Leggatt V, 1999, BRIT MED J, V319, P757, DOI 10.1136/bmj.319.7212.757; McDonnell SM, 1998, ANN INTERN MED, V129, P962, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00007; Modell B, 1997, BRIT MED J, V315, P779, DOI 10.1136/bmj.315.7111.779; Modell M, 1998, BMJ-BRIT MED J, V317, P788, DOI 10.1136/bmj.317.7161.788; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; *RCGP NW ENGL FAC, 1998, 77 RCGP NW ENGL FAC; Richard F, 1997, LANCET, V349, P539, DOI 10.1016/S0140-6736(97)80089-X; Ridker PM, 1999, LANCET, V353, P687, DOI 10.1016/S0140-6736(99)00067-7; Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; Watson EK, 1999, FAM PRACT, V16, P420, DOI 10.1093/fampra/16.4.420; Wolf CR, 2000, BRIT MED J, V320, P987, DOI 10.1136/bmj.320.7240.987; YkiJarvinen H, 1997, LANCET, V349, P516, DOI 10.1016/S0140-6736(97)80078-5	29	134	135	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2001	322	7293					1027	1030		10.1136/bmj.322.7293.1027	http://dx.doi.org/10.1136/bmj.322.7293.1027			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325768	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000168478700022
J	Poinar, H; Kuch, M; Paabo, S				Poinar, H; Kuch, M; Paabo, S			Molecular analyses of oral polio vaccine samples	SCIENCE			English	Article							MONKEYS	It has been suggested that the human immunodeficiency virus (HIV), and thus the acquired immunodeficiency syndrome (AIDS) it causes, was inadvertently introduced to humans by the use of an oral polio vaccine (OPV) during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959. The "OPV/AIDS hypothesis" suggests that the OBV used in this campaign was produced in chimpanzee kidney epithelial cell cultures rather than in monkey kidney cell cultures, as stated by H. Koprowski and co-workers, who produced the OPV. If chimpanzee cells were indeed used, this would lend support to the OPV/AIDS hypothesis, since chimpanzees harbor a simian immunodeficiency virus, widely accepted to be the origin of HIV-1. We analyzed several early OPV pools and found no evidence for the presence of chimpanzee DNA; by contrast, monkey DNA is present.	Max Planck Inst Evolut Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolut Anthropol, Inselstr 22, D-04103 Leipzig, Germany.							COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Curtis Tom, 1992, ROLLING STONE, P108; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Hooper Edward, 1999, RIVER JOURNEY SOURCE; MORIN PA, IN PRESS MOL ECOL; PLOTKIN SA, 1961, VIROLOGY, V15, P473, DOI 10.1016/0042-6822(61)90114-3; Plotkin SA, 2001, CLIN INFECT DIS, V32, P1068, DOI 10.1086/319612; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111	8	19	19	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					743	744		10.1126/science.1058463	http://dx.doi.org/10.1126/science.1058463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326104				2022-12-28	WOS:000168478300056
J	Mellman, I				Mellman, I			Setting logical priorities - A boycott is not the best route to free exchange of scientific information.	NATURE			English	Editorial Material									Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, POB 208002, New Haven, CT 06520 USA.		Mellman, Ira/ABG-5896-2020						0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1026	1026		10.1038/35074213	http://dx.doi.org/10.1038/35074213			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323641	Bronze			2022-12-28	WOS:000168285500020
J	Alter, DA; Naylor, CD; Austin, PC; Tu, JV				Alter, DA; Naylor, CD; Austin, PC; Tu, JV			Long term MI outcomes at hospitals with or without on-site revascularization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC-CATHETERIZATION FACILITIES; UNITED-STATES; HEART-FAILURE; ELDERLY PATIENTS; ST ELEVATION; MANAGEMENT; IMPACT; CANADA; ANGIOGRAPHY	Context Many studies have found that patients with acute myocardial infarction (AMI) who are admitted to hospitals with on-site revascularization facilities have higher rates of invasive cardiac procedures and better outcomes than patients in hospitals without such facilities. Whether such differences are due to invasive procedure rates alone or to other patient, physician, and hospital characteristics is unknown. Objective To determine whether invasive procedural rate Variations alone account for outcome differences in patients with AMI admitted to hospitals with or without on-site revascularization facilities. Design Retrospective, observational cohort study using linked population-based administrative data from a universal health insurance system. Setting One hundred ninety acute care hospitals in Ontario, 9 of which offered invasive procedures. Patients A total of 25697 patients hospitalized with AMI between April 1, 1992, and December 31, 1993, of whom 2832 (11%) were in invasive hospitals. Main Outcome Measures Mortality, recurrent cardiac hospitalizations, and emergency department Visits in the 5 years following the index admission, adjusted for patient age, sex, socioeconomic status, illness severity, and index revascularization procedures; attending physician specialty; and hospital volume, teaching status, and geographical proximity to invasive-procedure centers and compared by hospital type. Results Patients admitted to invasive-procedure hospitals were much more likely to undergo revascularization (11.4% vs 3.2% at other hospitals; P<.001). However, many other clinical and process-related factors differed between the 2 groups. Although mortality rates were similar between the 2 institution types, the nonfatal composite 5-year event rate tie, recurrent cardiac hospitalization and emergency department visits) was lower for patients initially admitted to invasive-procedure hospitals (71.3% vs 80.4%; unadjusted odds ratio [OR], 0.65; 95% confidence interval [CI], 0.52-0.82; P<.001). This advantage persisted after adjustment for sociodemographic and clinical factors and procedure utilization (adjusted OR, 0.68; 95% CI, 0.53-0.89; P<.001). However, the nonfatal outcome advantages of invasive-procedure hospitals were explained by their teaching status (adjusted OR, 0.98; 95% CI, 0.73-1.30; P=.87). Conclusions In this sample of patients admitted with AMI, the differing outcomes of apparently similar patients treated in 2 different practice settings were explained by multiple competing factors. Researchers conducting observational studies should be cautious about attributing patient outcome differences to any single factor.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; Univ Toronto, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Deans Off, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto	Alter, DA (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca		Austin, Peter/0000-0003-3337-233X; Tu, Jack/0000-0003-0111-722X				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; [Anonymous], CARDIOVASCULAR HLTH; Batchelor WB, 1999, J AM COLL CARDIOL, V34, P12, DOI 10.1016/S0735-1097(99)00174-6; BLUSTEIN J, 1993, JAMA-J AM MED ASSOC, V270, P344, DOI 10.1001/jama.270.3.344; BRYK A, 1996, HIERARCHICAL LINEAR; COS JL, 1994, J GEN INTERN MED, V9, P674, DOI 10.1007/BF02599007; DiSalvo TG, 1996, J AM COLL CARDIOL, V27, P262, DOI 10.1016/0735-1097(95)00488-2; EVERY NR, 1993, NEW ENGL J MED, V329, P546, DOI 10.1056/NEJM199308193290807; Every NR, 1997, CIRCULATION, V96, P1770, DOI 10.1161/01.CIR.96.6.1770; FEIT F, 1990, J AM COLL CARDIOL, V16, P1529, DOI 10.1016/0735-1097(90)90295-Z; Fonarow GC, 1997, J AM COLL CARDIOL, V30, P725, DOI 10.1016/S0735-1097(97)00208-8; Fox J., 1991, QUANTITATIVE APPL SO; Fu YL, 2000, CIRCULATION, V102, P1375, DOI 10.1161/01.CIR.102.12.1375; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; MARK DB, 1994, NEW ENGL J MED, V331, P1130, DOI 10.1056/NEJM199410273311706; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; ROULEAU JL, 1993, NEW ENGL J MED, V328, P779, DOI 10.1056/NEJM199303183281108; Scull GS, 2000, J AM COLL CARDIOL, V35, P895, DOI 10.1016/S0735-1097(99)00643-9; Snijders T.A., 1999, INTRO BASIC ADV MULT; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; Tu JV., 1999, CARDIOVASCULAR HLTH, P83; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X	29	77	79	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2101	2108		10.1001/jama.285.16.2101	http://dx.doi.org/10.1001/jama.285.16.2101			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311099	Bronze			2022-12-28	WOS:000168131600030
J	Beevers, G; Lip, GYH; O'Brien, E				Beevers, G; Lip, GYH; O'Brien, E			ABC of hypertension - Blood pressure measurement - Part I - Sphygmomanometry: factors common to all techniques	BRITISH MEDICAL JOURNAL			English	Review							PREGNANCY; ACCURACY											*BRIT HYP SOC, 1998, BLOOD PRESS MEAS CD; DAHLOFF B, 1991, LANCET, V394, P405; de Swiet M, 1999, HYPERTENS PREGNANCY, V18, pIII, DOI 10.3109/10641959909016191; DESWIET M, 1989, BRIT MED J, V299, P497, DOI 10.1136/bmj.299.6697.497; O'Brien E., 1997, BLOOD PRESSURE MEASU; OBrien E, 1996, J HUM HYPERTENS, V10, P565; OBRIEN E, 1994, HYPERTENSION ELDERLY, P13; OCALLAGHAN WG, 1983, BRIT MED J, V286, P1545, DOI 10.1136/bmj.286.6377.1545-a; Shennan A, 1996, LANCET, V347, P139, DOI 10.1016/S0140-6736(96)90338-4; Shennan AH, 1999, BEST PRACT RES CL OB, V13, P1, DOI 10.1053/beog.1999.0003; SPENCE JD, 1978, CLIN SCI MOL MED, V55, pS399, DOI 10.1042/cs055399s; STAESSEN J, 1988, J HUM HYPERTENS, V2, P207; STEWART MJ, 1995, J HYPERTENS, V13, P297	13	157	162	0	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					981	985		10.1136/bmj.322.7292.981	http://dx.doi.org/10.1136/bmj.322.7292.981			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312235	Green Published			2022-12-28	WOS:000168345100024
J	Cheng, AF; Barnouin-Jha, O; Zuber, MT; Veverka, J; Smith, DE; Neumann, GA; Robinson, M; Thomas, P; Garvin, JB; Murchie, S; Chapman, C; Prockter, L				Cheng, AF; Barnouin-Jha, O; Zuber, MT; Veverka, J; Smith, DE; Neumann, GA; Robinson, M; Thomas, P; Garvin, JB; Murchie, S; Chapman, C; Prockter, L			Laser altimetry of small-scale features on 433 Eros from NEAR-Shoemaker	SCIENCE			English	Article							SHAPE	During the Near Earth Asteroid Rendezvous (NEAR)-Shoemaker's Low-altitude flyover of asteroid 433 Eros, observations by the NEAR Laser Rangefinder (NLR) have helped to characterize small-scale surface features. On scales from meters to hundreds of meters, the surface has a fractal structure with roughness dominated by blocks, structural features, and walls of small craters, This fractal structure suggests that a single process, possibly impacts, dominates surface morphology on these scales.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; NASA, Goddard Space Flight Ctr, Earth Sci Directorate, Greenbelt, MD 20771 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Cornell Univ, Ithaca, NY 14853 USA; Northwestern Univ, Dept Geol Sci, Evanston, IL 60208 USA; SW Res Inst, Boulder, CO 80302 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Cornell University; Northwestern University	Cheng, AF (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.		Murchie, Scott L/E-8030-2015; Barnouin, Olivier S/I-7475-2015; Neumann, Gregory A/I-5591-2013	Murchie, Scott L/0000-0002-1616-8751; Barnouin, Olivier S/0000-0002-3578-7750; Neumann, Gregory A/0000-0003-0644-9944; Garvin, James/0000-0003-1606-5645				BARNOUINJHA O, 2000, LUNAR PLANET SCI, V31; Cheng AF, 1997, J GEOPHYS RES-PLANET, V102, P23695, DOI 10.1029/96JE03364; Cheng AF, 2000, ICARUS, V148, P572, DOI 10.1006/icar.2000.6487; Cole TD, 1997, SPACE SCI REV, V82, P217, DOI 10.1023/A:1005056828065; Greenberg R, 1996, ICARUS, V120, P106, DOI 10.1006/icar.1996.0040; HARTMANN WK, 1985, ICARUS, V63, P69, DOI 10.1016/0019-1035(85)90021-1; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Michel P, 1998, ASTRON J, V116, P2023, DOI 10.1086/300562; Murchie S, 1999, ICARUS, V140, P66, DOI 10.1006/icar.1999.6118; QUAIDE WL, 1968, J GEOPHYS RES, V73, P5247, DOI 10.1029/JB073i016p05247; Shepard MK, 1998, ICARUS, V134, P279, DOI 10.1006/icar.1998.5958; THOMAS PC, 1994, ICARUS, V107, P23, DOI 10.1006/icar.1994.1004; Turcotte D. L., 1997, FRACTALS CHAOS GEOLO; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651; Yeomans DK, 2000, SCIENCE, V289, P2085, DOI 10.1126/science.289.5487.2085; Zuber MT, 1997, J GEOPHYS RES-PLANET, V102, P23761, DOI 10.1029/97JE00890; Zuber MT, 2000, SCIENCE, V289, P2097, DOI 10.1126/science.289.5487.2097	19	31	31	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					488	491		10.1126/science.1058330	http://dx.doi.org/10.1126/science.1058330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313491				2022-12-28	WOS:000168187300042
J	Watanabe, T; Wu, T; Catalano, PJ; Ueki, T; Satriano, R; Benson, AB; Hamilton, SR				Watanabe, T; Wu, T; Catalano, PJ; Ueki, T; Satriano, R; Benson, AB; Hamilton, SR			Molecular predictors of survival after adjuvant chemotherapy for colon cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							18Q ALLELIC LOSS; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; MISMATCH REPAIR; CHROMOSOME 18Q; DCC PROTEIN; STAGE-II; FAMILIAL PREDISPOSITION; PROGNOSTIC-SIGNIFICANCE; INTERNATIONAL CRITERIA	Background: Adjuvant chemotherapy improves survival among patients with stage III colon cancer, but no reliable molecular predictors of outcome have been identified. Methods: We evaluated loss of chromosomal material (also called loss of heterozygosity or allelic loss) from chromosomes 18q, 17p, and 8p; cellular levels of p53 and p21(WAF1/CIP1) proteins; and microsatellite instability as molecular markers. We analyzed tumor tissue from 460 patients with stage III and high-risk stage II colon cancer who had been treated with various combinations of adjuvant fluorouracil, leucovorin, and levamisole to determine the ability of these markers to predict survival. Results: Loss of heterozygosity at 18q was present in 155 of 319 cancers (49 percent). High levels of microsatellite instability were found in 62 of 298 tumors (21 percent), and 38 of these 62 tumors (61 percent) had a mutation of the gene for the type II receptor for transforming growth factor beta1 (TGF-beta1). Among patients with microsatellite-stable stage III cancer, five-year overall survival after fluorouracil-based chemotherapy was 74 percent in those whose cancer retained 18q alleles and 50 percent in those with loss of 18q alleles (relative risk of death with loss at 18q, 2.75; 95 percent confidence interval, 1.34 to 5.65; P = 0.006). The five-year survival rate among patients whose cancer had high levels of microsatellite instability was 74 percent in the presence of a mutated gene for the type II receptor for TGF-beta1 and 46 percent if the tumor did not have this mutation (relative risk of death, 2.90; 95 percent confidence interval, 1.14 to 7.35; P = 0.03). Conclusions: Retention of 18q alleles in microsatellite-stable cancers and mutation of the gene for the type II receptor for TGF-beta1 in cancers with high levels of microsatellite instability point to a favorable outcome after adjuvant chemotherapy with fluorouracil-based regimens for stage III colon cancer. (N Engl J Med 2001;344:1196-206.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Div Gastrointestinal Liver Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21205 USA; Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA; Univ Penn, Ctr Canc, Dept Hematol Oncol, Philadelphia, PA 19104 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; Eastern Cooperat Oncol Grp, Brookline, MA USA	University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Hamilton, SR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, 1515 Holcombe Blvd,Box 85,G1-3754, Houston, TX 77030 USA.				NATIONAL CANCER INSTITUTE [P50CA062924, U01CA060100, U10CA023318, U10CA021115] Funding Source: NIH RePORTER; NCI NIH HHS [CA60100, U10 CA023318, CA21115, P50 CA062924, CA62924, U10 CA021115] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Ahnen DJ, 1998, CANCER RES, V58, P1149; Akhurst RJ, 1999, J PATHOL, V187, P82, DOI 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8; Arai T, 1998, INT J CANCER, V79, P418, DOI 10.1002/(SICI)1097-0215(19980821)79:4<418::AID-IJC18>3.0.CO;2-0; BAAS IO, 1994, J PATHOL, V172, P5, DOI 10.1002/path.1711720104; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boland CR, 1998, CANCER RES, V58, P5248; Boulaire J, 2000, PATHOL BIOL, V48, P190; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Carethers JM, 1998, GASTROENTEROLOGY, V114, P1188, DOI 10.1016/S0016-5085(98)70424-X; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Cheng JD, 1999, CLIN CANCER RES, V5, P1057; Chu E, 1999, MOL CELL BIOL, V19, P1582; Chung DC, 1998, GASTROENTEROLOGY, V114, P1330, DOI 10.1016/S0016-5085(98)70441-X; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Cohn KH, 1997, CANCER, V79, P233; COX DR, 1972, J R STAT SOC B, V34, P187; Cox LS, 1997, J PATHOL, V183, P134, DOI 10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D; Dietmaier W, 1997, CANCER RES, V57, P4749; Doglioni C, 1996, J PATHOL, V179, P248, DOI 10.1002/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO;2-6; El-Deiry WS, 1998, CANCER J - FRANCE, V11, P229; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; Elsaleh H, 2000, ONCOLOGY-BASEL, V58, P52, DOI 10.1159/000012079; FEARON ER, 1996, BIOCHIM BIOPHYS ACTA, V1288, P17; Fujiwara T, 1998, AM J PATHOL, V153, P1063, DOI 10.1016/S0002-9440(10)65651-9; Galanis E, 2000, Surg Oncol Clin N Am, V9, P813; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Haller DG, 1998, P AN M AM SOC CLIN, V17, p256a; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; IINO H, 1994, CANCER, V73, P1324, DOI 10.1002/1097-0142(19940301)73:5<1324::AID-CNCR2820730503>3.0.CO;2-W; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; ITOH F, 1993, INT J CANCER, V53, P260, DOI 10.1002/ijc.2910530215; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Jernvall P, 1999, EUR J CANCER, V35, P197, DOI 10.1016/S0959-8049(98)00306-2; Jernvall P, 1999, BRIT J CANCER, V79, P903, DOI 10.1038/sj.bjc.6690144; Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6; Johannsdottir JT, 1999, ANTICANCER RES, V19, P1821; Kane MF, 1997, CANCER RES, V57, P808; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kato M, 1996, CANCER, V77, P1729, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1729::AID-CNCR47>3.0.CO;2-Z; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Lanza G, 1998, INT J CANCER, V79, P390, DOI 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.3.CO;2-M; Laurent-Puig P, 1999, EUR J CANCER PREV, V8, pS39; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LOTHE RA, 1993, CANCER RES, V53, P5849; Lukish JR, 1998, ANN SURG, V227, P51, DOI 10.1097/00000658-199801000-00008; Macdonald JS, 1999, CA-CANCER J CLIN, V49, P202, DOI 10.3322/canjclin.49.4.202; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Martinez-Lopez E, 1998, GASTROENTEROLOGY, V114, P1180, DOI 10.1016/S0016-5085(98)70423-8; McLeod HL, 1999, BRIT J CANCER, V79, P191, DOI 10.1038/sj.bjc.6690033; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Moskaluk CA, 1996, HUM PATHOL, V27, P1211, DOI 10.1016/S0046-8177(96)90317-2; Moskaluk CA, 1997, AM J PATHOL, V150, P1547; Nita ME, 1998, BRIT J CANCER, V78, P986, DOI 10.1038/bjc.1998.617; North S, 2000, PATHOL BIOL, V48, P255; OCONNELL MJ, 1992, CANCER-AM CANCER SOC, V70, P1732, DOI 10.1002/1097-0142(19920915)70:4+<1732::AID-CNCR2820701614>3.0.CO;2-#; OConnor PM, 1997, CANCER RES, V57, P4285; Ogunbiyi OA, 1998, J CLIN ONCOL, V16, P427, DOI 10.1200/JCO.1998.16.2.427; OOKAWA K, 1993, INT J CANCER, V53, P382, DOI 10.1002/ijc.2910530307; Perucho M, 1999, CANCER RES, V59, P249; Pirollo KF, 2000, ANTI-CANCER DRUG, V11, P419, DOI 10.1097/00001813-200007000-00002; Prolla TA, 1998, CURR OPIN CELL BIOL, V10, P311, DOI 10.1016/S0955-0674(98)80005-7; Reymond MA, 1998, DIS COLON RECTUM, V41, P755, DOI 10.1007/BF02236264; RIEGERCHRIST KM, 1997, FRONTIERS BIOSCI, V2, P438; Saito M, 1999, ONCOLOGY-BASEL, V56, P134, DOI 10.1159/000011954; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Save V, 1998, J PATHOL, V184, P348; Shibata D, 1996, NEW ENGL J MED, V335, P1727, DOI 10.1056/NEJM199612053352303; Smith DM, 2000, INT J MOL MED, V6, P503; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Valassiadou KE, 1997, ANTICANCER RES, V17, P2571; Wu TT, 1998, AM J PATHOL, V153, P287, DOI 10.1016/S0002-9440(10)65570-8	78	674	702	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1196	1206		10.1056/NEJM200104193441603	http://dx.doi.org/10.1056/NEJM200104193441603			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309634	Green Accepted			2022-12-28	WOS:000168127600003
J	Macfarlane, GJ				Macfarlane, GJ			Identification and prevention of work-related carpal-tunnel syndrome	LANCET			English	Editorial Material							HEALTH INTERVIEW SURVEY; RISK-FACTORS; PREVALENCE; POPULATION		Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England.		Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314				Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Davis L, 2001, AM J IND MED, V39, P58, DOI 10.1002/1097-0274(200101)39:1<58::AID-AJIM6>3.3.CO;2-V; Ferry S, 2000, AM J EPIDEMIOL, V151, P566, DOI 10.1093/oxfordjournals.aje.a010244; Harrington JM, 1998, OCCUP ENVIRON MED, V55, P264, DOI 10.1136/oem.55.4.264; Leclerc A, 1998, OCCUP ENVIRON MED, V55, P180, DOI 10.1136/oem.55.3.180; Lincoln AE, 2000, AM J PREV MED, V18, P37, DOI 10.1016/S0749-3797(00)00140-9; *NAT I OCC SAF HLT, DEP HLTH HUM SERV PU; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Sluiter J, 2000, CRITERIA DOCUMENT EV; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; TANAKA S, 1995, AM J IND MED, V27, P451, DOI 10.1002/ajim.4700270402; TANAKA S, 1994, AM J PUBLIC HEALTH, V84, P1846, DOI 10.2105/AJPH.84.11.1846; Tanaka S, 1997, AM J IND MED, V32, P550, DOI 10.1002/(SICI)1097-0274(199711)32:5<550::AID-AJIM18>3.0.CO;2-1	13	9	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1146	1147		10.1016/S0140-6736(00)04382-8	http://dx.doi.org/10.1016/S0140-6736(00)04382-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323038				2022-12-28	WOS:000168192100005
J	Mindel, A; Estcourt, C				Mindel, A; Estcourt, C			Sexual health education for male sex workers	LANCET			English	Editorial Material							MALE PROSTITUTES; TRANSMITTED INFECTIONS; HIV; BEHAVIOR; PROGRAM; CLIENTS		Westmead Hosp, Sexually Transmitted Infect Res Ctr, Sydney, NSW 2145, Australia; St Bartholomews Hosp, Barts Sexual Hlth Ctr, London EC1A 7BE, England	University of Sydney; University of London; Queen Mary University London	Mindel, A (corresponding author), Westmead Hosp, Sexually Transmitted Infect Res Ctr, Sydney, NSW 2145, Australia.			Mindel, Adrian/0000-0002-8780-9982				Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; COUTINHO RA, 1988, GENITOURIN MED, V64, P207; DEGRAAF R, 1994, AIDS CARE, V6, P277, DOI 10.1080/09540129408258640; Estcourt CS, 2000, SEX TRANSM INFECT, V76, P294, DOI 10.1136/sti.76.4.294; Ford K, 2000, INT J STD AIDS, V11, P731, DOI 10.1258/0956462001915156; Leonard L, 2000, AIDS EDUC PREV, V12, P21; Limpakarnjanarat K, 1999, SEX TRANSM INFECT, V75, P30, DOI 10.1136/sti.75.1.30; MINDEL A, 2000, CONDOMS, P112; PLEAK RR, 1990, J SEX RES, V27, P557, DOI 10.1080/00224499009551580; Tichonova L, 1997, LANCET, V350, P210, DOI 10.1016/S0140-6736(97)01382-2; TOMLINSON DR, 1991, GENITOURIN MED, V67, P103; Walden VM, 1999, HEALTH EDUC RES, V14, P545, DOI 10.1093/her/14.4.545; ZEKENG L, 1993, AIDS, V7, P725, DOI 10.1097/00002030-199305000-00018; Ziersch A, 2000, SEX TRANSM INFECT, V76, P447, DOI 10.1136/sti.76.6.447	14	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1148	1148		10.1016/S0140-6736(00)04384-1	http://dx.doi.org/10.1016/S0140-6736(00)04384-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423RX	11323040				2022-12-28	WOS:000168192100007
J	Brickley, SG; Revilla, V; Cull-Candy, SG; Wisden, W; Farrant, M				Brickley, SG; Revilla, V; Cull-Candy, SG; Wisden, W; Farrant, M			Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance	NATURE			English	Article							CEREBELLAR GRANULE NEURONS; DOMAIN K+ CHANNEL; GABA(A) RECEPTORS; RAT CEREBELLUM; SYNAPTIC INTEGRATION; ALPHA-6 SUBUNIT; GOLGI CELLS; CURRENTS; INHIBITION; ACTIVATION	Many neurons receive a continuous, or 'tonic', synaptic input, which increases their membrane conductance, and so modifies the spatial and temporal integration of excitatory signals(1-3). In cerebellar granule cells, although the frequency of inhibitory synaptic currents is relatively low, the spillover of synaptically released GABA (gamma -aminobutyric acid)(4) gives rise to a persistent conductance mediated by the GABA(A) receptor(5-7) that also modifies the excitability of granule cells(8). Here we show that this tonic conductance is absent in granule cells that lack the alpha6 and delta -subunits of the GABAA receptor. The response of these granule cells to excitatory synaptic input remains unaltered, owing to an increase in a 'leak' conductance, which is present at rest, with properties characteristic of the two-pore-domain K(+) channel TASK-1 (refs 9- 12). Our results highlight the importance of tonic inhibition mediated by GABAA receptors, loss of which triggers a form of homeostatic plasticity leading to a change in the magnitude of a voltage-independent K(+) conductance that maintains normal neuronal behaviour.	UCL, Dept Pharmacol, London WC1E 6BT, England; MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England; UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London	Farrant, M (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	m.farrant@ucl.ac.uk	Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Cull-Candy, Stuart G/0000-0002-0831-8326; Brickley, Stephen/0000-0002-0930-7346; Farrant, Mark/0000-0002-9918-0376				BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; DEDSAI NS, 1999, NAT NEUROSCI, V2, P515; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Jones A, 1997, J NEUROSCI, V17, P1350; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tia S, 1996, J NEUROSCI, V16, P3630; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224	29	446	455	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					88	92		10.1038/35051086	http://dx.doi.org/10.1038/35051086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343119				2022-12-28	WOS:000166175600045
J	Papadopoulos, P; Ivison, R; Carilli, C; Lewis, G				Papadopoulos, P; Ivison, R; Carilli, C; Lewis, G			A massive reservoir of low-excitation molecular gas at high redshift	NATURE			English	Article							ABSORPTION-LINE QUASAR; APM 08279+5255; DUST EMISSION; CO 4-3; GALAXIES	Molecular hydrogen (H-2) is an important component of galaxies because it fuels star formation and the accretion of gas onto active galactic nuclei (AGN), the two processes that can generate the large infrared luminosities of gas-rich galaxies(1,2). Observations of spectral-line emission from the tracer molecule carbon monoxide (CO) are used to probe the properties of this gas. But the lines that have been studied in the local Universe-mostly the lower rotational transitions of J = 1 --> 0 and J = 2 --> 1 - have hitherto been unobservable in high-redshift galaxies. Instead, higher transitions have been used, although the densities and temperatures required to excite these higher transitions may not be reached by much of the gas. As a result, past observations may have underestimated the total amount of molecular gas by a substantial amount. Here we report the discovery of large amounts of low-excitation molecular gas around the infrared-luminous quasar APM08279+5255 at redshift z = 3.91, using the two lowest excitation lines of (CO)-C-12 (J = 1 --> 0 and J = 2 --> 1). The maps confirm the presence of hot and dense gas near the nucleus(3), and reveal an extended reservoir of molecular gas with low excitation that is 10 to 100 times more massive than the gas traced by the higher-excitation observations. This raises the possibility that significant amounts of low-excitation molecular gas may exist in the environments of high-redshift (z> 3) galaxies.	UCL, Dept Phys & Astron, London WC1E 6BT, England; Leiden Observ, NL-2300 RA Leiden, Netherlands; Natl Radio Astron Observ, Socorro, NM 87801 USA; Anglo Australian Observ, Epping, NSW 1710, Australia	University of London; University College London; Leiden University; Leiden University - Excl LUMC; National Radio Astronomy Observatory (NRAO)	Ivison, R (corresponding author), UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England.	rji@star.ucl.ac.uk	Lewis, Geraint/F-9069-2015; Ivison, R. J./G-4450-2011; Papadopoulos, Panagiotis/B-2822-2012	Lewis, Geraint/0000-0003-3081-9319; Ivison, R. J./0000-0001-5118-1313; Papadopoulos, Panagiotis/0000-0001-9913-9771				AALTO S, 1995, ASTRON ASTROPHYS, V300, P369; Carilli CL, 1999, RADIO SCI, V34, P817, DOI 10.1029/1999RS900048; Carilli CL, 1999, ASTROPHYS J, V521, pL25, DOI 10.1086/312179; DICKMAN RL, 1986, ASTROPHYS J, V309, P326, DOI 10.1086/164604; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Downes D, 1999, ASTROPHYS J, V513, pL1, DOI 10.1086/311896; Egami E, 2000, ASTROPHYS J, V535, P561, DOI 10.1086/308862; HUGHES DH, 1994, MON NOT R ASTRON SOC, V270, P641, DOI 10.1093/mnras/270.3.641; Ibata RA, 1999, ASTRON J, V118, P1922, DOI 10.1086/301111; Irwin MJ, 1998, ASTROPHYS J, V505, P529, DOI 10.1086/306213; Ivison RJ, 1996, MON NOT R ASTRON SOC, V278, P669; Ivison RJ, 2000, ASTROPHYS J, V542, P27, DOI 10.1086/309536; JACKSON JM, 1995, ASTROPHYS J, V438, P695, DOI 10.1086/175113; Lewis GF, 1998, ASTROPHYS J, V505, pL1, DOI 10.1086/311603; Paglione TAD, 1997, ASTROPHYS J, V484, P656, DOI 10.1086/304356; Papadopoulos PP, 2000, ASTROPHYS J, V528, P626, DOI 10.1086/308215; Papadopoulos PP, 2000, ASTROPHYS J, V537, P631, DOI 10.1086/309066; Plume R, 2000, ASTROPHYS J, V539, pL133, DOI 10.1086/312847; SANDERS DB, 1991, ASTROPHYS J, V370, P158, DOI 10.1086/169800; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; TELESCO CM, 1988, ANNU REV ASTRON ASTR, V26, P343; YOUNG JS, 1982, ASTROPHYS J, V258, P467, DOI 10.1086/160099; YOUNG JS, 1991, ANNU REV ASTRON ASTR, V29, P581, DOI 10.1146/annurev.aa.29.090191.003053	23	71	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					58	60		10.1038/35051029	http://dx.doi.org/10.1038/35051029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343109	Green Submitted			2022-12-28	WOS:000166175600035
J	Schwechheimer, C; Serino, G; Callis, J; Crosby, WL; Lyapina, S; Deshaies, RJ; Gray, WM; Estelle, M; Deng, XW				Schwechheimer, C; Serino, G; Callis, J; Crosby, WL; Lyapina, S; Deshaies, RJ; Gray, WM; Estelle, M; Deng, XW			Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIR1 in mediating auxin response	SCIENCE			English	Article							ARABIDOPSIS-THALIANA DEFINE; GENE; COMPLEX; MUTATIONS; PROTEIN; MUTANTS; DEGRADATION; EXPRESSION; REGULATOR; ENCODES	The COP9 signalosome is an evolutionary conserved multiprotein complex of unknown function that acts as a negative regulator of photomorphogenic seedling development in Arabidopsis. Here, we show that plants with reduced COP9 signalosome levels had decreased auxin response similar to loss-of-function mutants of the E3 ubiquitin ligase SCFTIR1. Furthermore, we found that the COP9 signalosome and SCFTIR1 interacted in vivo and that the COP9 signalosome was required for efficient degradation of PSIAA6, a candidate substrate of SCFTIR1. Thus, the COP9 signalosome may play an important role in mediating E3 ubiquitin ligase-mediated responses.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, Sect Mol Cellular & Dev Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Yale University; University of California System; University of California Davis; National Research Council Canada; California Institute of Technology; University of Texas System; University of Texas Austin	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		Gray, William M/F-9402-2010; Deshaies, Raymond/B-8354-2014; Estelle, Mark/ABD-6742-2021; Serino, Giovanna/W-4683-2019; Ding, Cheng-Qiang/B-6287-2011; Deng, Xing Wang/ABF-4107-2020; Schwechheimer, Claus/Q-7907-2016	Gray, William M/0000-0002-1320-290X; Deshaies, Raymond/0000-0002-3671-9354; Serino, Giovanna/0000-0001-8689-6132; Schwechheimer, Claus/0000-0003-0269-2330; Callis, Judy/0000-0002-0622-078X				ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; GIL P, 1994, PLANT PHYSIOL, V104, P777, DOI 10.1104/pp.104.2.777; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gray WM, 2000, TRENDS BIOCHEM SCI, V25, P133, DOI 10.1016/S0968-0004(00)01544-9; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hobbie L, 2000, DEVELOPMENT, V127, P23; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mayer R, 1996, PLANT CELL, V8, P1951, DOI 10.1105/tpc.8.11.1951; Napoli CA, 1999, CURR TOP DEV BIOL, V44, P127; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Schwechheimer C, 2000, SEMIN CELL DEV BIOL, V11, P495, DOI 10.1006/scdb.2000.0203; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Staub JM, 1996, PLANT CELL, V8, P2047, DOI 10.1105/tpc.8.11.2047; TIMPTE CS, 1992, PLANTA, V188, P271, DOI 10.1007/BF00216824; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200	28	379	411	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1379	1382		10.1126/science.1059776	http://dx.doi.org/10.1126/science.1059776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11337587				2022-12-28	WOS:000168862900047
J	Levin, BR; Antia, R				Levin, BR; Antia, R			Why we don't get sick: The within-host population dynamics of bacterial infections	SCIENCE			English	Editorial Material							LYMPHOCYTE MEMORY; IN-VIVO; SELECTION; COMPETITION; HOMEOSTASIS; RESPONSES; MODEL; HIV; REPERTOIRE; EVOLUTION	To pathogenic microparasites (viruses, bacteria, protozoa, or fungi), we and other mammals (Living organisms at large) are Little more than soft, thin-walled flasks of culture media. Almost every time we eat, brush our teeth, scrape our skin, have sex, get bitten by insects, and inhale, we are confronted with populations of microbes that are capable of colonizing the mucosa lining our orifices and alimentary tract and proliferating in fluids and cells within us. Nevertheless, we rarely get sick, much Less succumb to these infections. The massive numbers of bacteria and other micro- and not-mo-micro organisms that abound and replicate in our alimentary tract and cover our skin and the mucosa Lining our orifices normally maintain their communities in seemingly peaceful coexistence with the somatic cells that define us. Why don't these microbes invade and proliferate in the culture media within the soft, thin-walled flask that envelops us? Why don't they cause disease and Lead to our rapid demise?	Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Levin, BR (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040662] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40662] Funding Source: Medline; NIGMS NIH HHS [GM33782, GM 54268] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGUR Z, 1991, P ROY SOC B-BIOL SCI, V245, P147, DOI 10.1098/rspb.1991.0101; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Craig W., 1993, European Journal of Clinical Microbiology and Infectious Diseases, V12, pS6, DOI 10.1007/BF02389870; DeBoer RJ, 1997, INT IMMUNOL, V9, P779, DOI 10.1093/intimm/9.5.779; Detours V, 1999, P NATL ACAD SCI USA, V96, P5153, DOI 10.1073/pnas.96.9.5153; DEVRIES FP, 1996, INFECT IMMUN, V64, P2999; Drusano GL, 1997, J CHEMOTHERAPY, V9, P38; Falk PG, 2000, TRENDS MICROBIOL, V8, P321, DOI 10.1016/S0966-842X(00)01780-7; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FISHMAN MA, 1995, J THEOR BIOL, V173, P241, DOI 10.1016/S0022-5193(95)80003-4; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; GERNE JWS, 1991, INFECT IMMUN, V59, P1325; GRAVENOR MB, 1995, PARASITOLOGY, V110, P115, DOI 10.1017/S0031182000063861; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; KEPLER TB, 1993, J THEOR BIOL, V164, P37, DOI 10.1006/jtbi.1993.1139; Kerksiek KM, 1999, CURR OPIN IMMUNOL, V11, P400, DOI 10.1016/S0952-7915(99)80067-3; Kesmir C, 1999, J IMMUNOL, V163, P2463; Krakauer DC, 1999, P ROY SOC B-BIOL SCI, V266, P1069, DOI 10.1098/rspb.1999.0745; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; McLean AR, 1997, P NATL ACAD SCI USA, V94, P5792, DOI 10.1073/pnas.94.11.5792; MEHR R, 1995, J THEOR BIOL, V175, P103, DOI 10.1006/jtbi.1995.0124; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P396, DOI 10.1099/00221287-16-2-396; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P38, DOI 10.1099/00221287-16-1-38; MOXON ER, 1978, P NATL ACAD SCI USA, V75, P1534, DOI 10.1073/pnas.75.3.1534; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak MA., 2000, VIRUS DYNAMICS MATH; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Oprea M, 1996, J THEOR BIOL, V181, P215, DOI 10.1006/jtbi.1996.0127; PAUL WE, 1989, FUNDAMENTALS IMMUNOL; Segel LA, 1999, J IMMUNOL, V163, P1342; SPITZNAGEL JK, 1993, MECH MICROBIAL DIS, P90; Wick D, 2000, MATH BIOSCI, V165, P115, DOI 10.1016/S0025-5564(00)00013-4; Wodarz D, 2000, PHILOS T R SOC B, V355, P329, DOI 10.1098/rstb.2000.0570; Wodarz D, 1999, IMMUNOL TODAY, V20, P220, DOI 10.1016/S0167-5699(99)01446-2; ZEIGLER HK, 1993, MECH MICROBIAL DIS, P114; 1997, ANTIMICROB AGENTS CH, V41, P365	42	78	83	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1112	1115		10.1126/science.1058879	http://dx.doi.org/10.1126/science.1058879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352067				2022-12-28	WOS:000168609200045
J	Klein, AL; Grimm, RA; Murray, RD; Apperson-Hansen, C; Asinger, RW; Black, IW; Davidoff, R; Erbel, R; Halperin, JL; Orsinelli, DA; Porter, TR; Stoddard, MF				Klein, AL; Grimm, RA; Murray, RD; Apperson-Hansen, C; Asinger, RW; Black, IW; Davidoff, R; Erbel, R; Halperin, JL; Orsinelli, DA; Porter, TR; Stoddard, MF		Assessment Cardioversion Using Tra	Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVITY STATUS INDEX; ELECTIVE CARDIOVERSION; FUNCTIONAL-CAPACITY; ANTICOAGULATION; THROMBUS; MANAGEMENT; ACCURACY	Background: The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion. It has been proposed that if transesophageal echocardiography reveals no atrial thrombus, cardioversion may be performed safely after only a short period of anticoagulant therapy. Methods: In a multicenter, randomized, prospective clinical trial, we enrolled 1222 patients with atrial fibrillation of more than two days' duration and assigned them to either treatment guided by the findings on transesophageal echocardiography or conventional treatment. The composite primary end point was cerebrovascular accident, transient ischemic attack, and peripheral embolism within eight weeks. Secondary end points were functional status, successful restoration and maintenance of sinus rhythm, hemorrhage, and death. Results: There was no significant difference between the two treatment groups in the rate of embolic events (five embolic events among 619 patients in the transesophageal-echocardiography group [0.8 percent]) vs. three among 603 patients in the conventional-treatment group [0.5 percent], P=0.50). However, the rate of hemorrhagic events was significantly lower in the transesophageal-echocardiography group (18 events [2.9 percent] vs. 33 events [5.5 percent], P=0.03). Patients in the transesophageal-echocardiography group also had a shorter time to cardioversion (mean [+/-SD], 3.0+/-5.6 vs. 30.6+/-10.6 days; P<0.001) and a greater rate of successful restoration of sinus rhythm (440 patients [71.1 percent] vs. 393 patients [65.2 percent], P=0.03). At eight weeks, there were no significant differences between the two groups in the rates of death or maintenance of sinus rhythm or in functional status. Conclusions: The use of transesophageal echocardiography to guide the management of atrial fibrillation may be considered a clinically effective alternative strategy to conventional therapy for patients in whom elective cardioversion is planned. (N Engl J Med 2001;344:1411-20.) Copyright (C) 2001 Massachusetts Medical Society.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Manly Hosp, Manly, NSW, Australia; Boston Med Ctr, Boston, MA USA; Univ Klinikum Essen, Essen, Germany; Mt Sinai Sch Med, New York, NY USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Nebraska, Omaha, NE 68182 USA; Univ Louisville, Louisville, KY 40292 USA	Cleveland Clinic Foundation; Hennepin County Medical Center; Boston Medical Center; University of Duisburg Essen; Icahn School of Medicine at Mount Sinai; University System of Ohio; Ohio State University; University of Nebraska System; University of Louisville	Klein, AL (corresponding author), Cleveland Clin Fdn, Dept Cardiol, 9500 Euclid Ave,Desk F15, Cleveland, OH 44195 USA.	kleina@ccf.org	Halperin, Jonathan/AAJ-4721-2020	Halperin, Jonathan/0000-0002-8318-5471; Davidoff, Ravin/0000-0002-3797-5325; Orsinelli, David/0000-0002-6420-856X; Apperson-Hansen, Carolyn/0000-0001-9057-3037				ASCHENBERG W, 1986, J AM COLL CARDIOL, V7, P163, DOI 10.1016/S0735-1097(86)80275-3; BJERKELUND CJ, 1969, AM J CARDIOL, V23, P208, DOI 10.1016/0002-9149(69)90068-X; BLACK IW, 1994, CIRCULATION, V89, P2509, DOI 10.1161/01.CIR.89.6.2509; Blackshear JL, 1996, MAYO CLIN PROC, V71, P150, DOI 10.4065/71.2.150; Carlsson J, 1996, AM J CARDIOL, V78, P1380, DOI 10.1016/S0002-9149(96)00647-9; Corrado G, 1999, CHEST, V115, P140, DOI 10.1378/chest.115.1.140; Fatkin D, 1996, AM J CARDIOL, V77, P321, DOI 10.1016/S0002-9149(97)89406-4; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; GRIMM RA, 1995, AM HEART J, V130, P174, DOI 10.1016/0002-8703(95)90253-8; Grimm RA, 1998, J AM COLL CARDIOL, V31, p353A, DOI 10.1016/S0735-1097(97)85243-6; GRIMM RA, 1994, J AM COLL CARDIOL, V23, P533, DOI 10.1016/0735-1097(94)90443-X; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; KANNEL WB, 1983, AM HEART J, V106, P389, DOI 10.1016/0002-8703(83)90208-9; Klein AL, 1997, ANN INTERN MED, V126, P200, DOI 10.7326/0003-4819-126-3-199702010-00004; Klein AL, 2000, CIRCULATION, V102, P575; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LEVINE MN, 1995, CHEST, V108, pS276, DOI 10.1378/chest.108.4_Supplement.276S; LOWN B, 1967, BRIT HEART J, V29, P469; MANNING WJ, 1995, J AM COLL CARDIOL, V25, P1354, DOI 10.1016/0735-1097(94)00560-D; MANNING WJ, 1995, ANN INTERN MED, V123, P817, DOI 10.7326/0003-4819-123-11-199512010-00001; NELSON CL, 1991, AM J CARDIOL, V68, P973, DOI 10.1016/0002-9149(91)90423-I; ORSINELLI DA, 1993, AM J CARDIOL, V72, P1337, DOI 10.1016/0002-9149(93)90315-4; OSTRANDER LD, 1965, CIRCULATION, V31, P888, DOI 10.1161/01.CIR.31.6.888; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Prystowsky EN, 1997, ANN INTERN MED, V126, P244, DOI 10.7326/0003-4819-126-3-199702010-00012; Schlicht JR, 1996, ARCH INTERN MED, V156, P290, DOI 10.1001/archinte.156.3.290; Seto TB, 1997, J AM COLL CARDIOL, V29, P122, DOI 10.1016/S0735-1097(96)00448-2; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Silverman DI, 1998, CIRCULATION, V98, P479, DOI 10.1161/01.CIR.98.5.479; Stein B, 1990, Cardiovasc Clin, V21, P231; STODDARD MF, 1995, AM HEART J, V129, P1204, DOI 10.1016/0002-8703(95)90405-0; Stoddard MF, 1998, AM J CARDIOL, V81, P877; Weigner MJ, 1998, CIRCULATION, V98, P500; WEINBERG DM, 1989, AM J CARDIOL, V63, P745, DOI 10.1016/0002-9149(89)90264-6; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954	35	561	580	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1411	1420		10.1056/NEJM200105103441901	http://dx.doi.org/10.1056/NEJM200105103441901			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346805	Bronze			2022-12-28	WOS:000168554000001
J	Joffe, BI; Panz, VR; Raal, FJ				Joffe, BI; Panz, VR; Raal, FJ			From lipodystrophy syndromes to diabetes mellitus	LANCET			English	Editorial Material							INSULIN-RESISTANCE; LEPTIN LEVELS; FATTY-ACIDS; GENE; THIAZOLIDINEDIONES; FAMILIES; PATHOGENESIS; RECEPTOR; PATIENT; PPAR		Univ Witwatersrand, Sch Med, Dept Med, Carbohydrate & Lipid Metab Res Grp, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Joffe, BI (corresponding author), Univ Witwatersrand, Sch Med, Dept Med, Carbohydrate & Lipid Metab Res Grp, ZA-2193 Johannesburg, South Africa.	014bar@chiron.wits.ac.za	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938				Arioglu E, 2000, ANN INTERN MED, V133, P263, DOI 10.7326/0003-4819-133-4-200008150-00009; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Collier GR, 2000, DIABETES, V49, P1766, DOI 10.2337/diabetes.49.11.1766; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Joffe B, 1998, ENDOCRINE, V9, P139, DOI 10.1385/ENDO:9:2:139; Kahn CR, 2000, J CLIN INVEST, V106, P1305, DOI 10.1172/JCI11705; MAGRE J, 1988, DIABETES, V37, P421, DOI 10.2337/diabetes.37.4.421; Panz VR, 1997, CLIN ENDOCRINOL, V46, P365, DOI 10.1046/j.1365-2265.1997.970912.x; Panz VR, 1997, S AFR MED J, V87, P1277; Pardini VC, 1998, J CLIN ENDOCR METAB, V83, P503, DOI 10.1210/jc.83.2.503; RANDLE PJ, 1963, LANCET, V1, P785; Reue K, 2000, Curr Atheroscler Rep, V2, P390, DOI 10.1007/s11883-000-0077-1; Schoonjans K, 2000, LANCET, V355, P1008, DOI 10.1016/S0140-6736(00)90002-3; Schoonjans K, 1996, J LIPID RES, V37, P907; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; van der Merwe MT, 1999, INT J OBESITY, V23, P909, DOI 10.1038/sj.ijo.0800969; Vigouroux C, 1997, J CLIN ENDOCR METAB, V82, P3438, DOI 10.1210/jc.82.10.3438	20	28	29	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1379	1381		10.1016/S0140-6736(00)04616-X	http://dx.doi.org/10.1016/S0140-6736(00)04616-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356429				2022-12-28	WOS:000168478200003
J	Gallo, V; Chittajallu, R				Gallo, V; Chittajallu, R			Neuroscience - Unwrapping glial cells from the synapse: What lies inside?	SCIENCE			English	Editorial Material							KAINATE RECEPTORS; GLUTAMATE; CLEARANCE; EFFICACY		NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gallo, V (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.		Chittajallu, Ramesh/AAX-3749-2020	Chittajallu, Ramesh/0000-0002-9794-0052				Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Borges K, 1998, PROG BRAIN RES, V116, P153, DOI 10.1016/S0079-6123(08)60436-7; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; INO M, 2001, SCIENCE, V292, P926; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657	12	24	25	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					872	873		10.1126/science.1060854	http://dx.doi.org/10.1126/science.1060854			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341285				2022-12-28	WOS:000168514900032
J	Oliet, SHR; Piet, R; Poulain, DA				Oliet, SHR; Piet, R; Poulain, DA			Control of glutamate clearance and synaptic efficacy by glial coverage of neurons	SCIENCE			English	Article							HYPOTHALAMIC MAGNOCELLULAR NEURONS; RAT-BRAIN; DIFFERENTIAL EXPRESSION; OXYTOCIN NEURONS; TRANSPORTERS; RECEPTORS; PLASTICITY; SYNAPSES; INHIBITION; INPUTS	Analysis of excitatory synaptic transmission in the rat hypothalamic supraoptic nucleus revealed that glutamate clearance and, as a consequence, glutamate concentration and diffusion in the extracellular space, is associated with the degree of astrocytic coverage of its neurons. Reduction in glutamate clearance, whether induced pharmacologically or associated with a relative decrease of glial coverage in the vicinity of synapses, affected transmitter release through modulation of presynaptic metabotropic glutamate receptors, Astrocytic wrapping of neurons, therefore, contributes to the regulation of synaptic efficacy in the central nervous system.	Univ Bordeaux 2, INSERM, U378, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Oliet, SHR (corresponding author), Univ Bordeaux 2, INSERM, U378, F-33077 Bordeaux, France.		Piet, Richard/H-7958-2019	Piet, Richard/0000-0001-5160-6027; Oliet, Stephane/0000-0003-0595-9029				ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bergles DE, 1998, J NEUROSCI, V18, P7709; Brussaard AB, 1997, NEURON, V19, P1103, DOI 10.1016/S0896-6273(00)80401-8; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Diamond JS, 1997, J NEUROSCI, V17, P4672; El Majdoubi M, 2000, BIOCHEM CELL BIOL, V78, P317; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; Jourdain P, 1998, J NEUROSCI, V18, P6641; Laming PR, 2000, NEUROSCI BIOBEHAV R, V24, P295, DOI 10.1016/S0149-7634(99)00080-9; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Oliet SHR, 1999, J PHYSIOL-LONDON, V520, P815, DOI 10.1111/j.1469-7793.1999.00815.x; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schrader LA, 1997, J NEUROPHYSIOL, V77, P527, DOI 10.1152/jn.1997.77.2.527; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TORP R, 1994, EUR J NEUROSCI, V6, P936, DOI 10.1111/j.1460-9568.1994.tb00587.x	24	458	475	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					923	926		10.1126/science.1059162	http://dx.doi.org/10.1126/science.1059162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340204				2022-12-28	WOS:000168514900042
J	Dragoi, V; Rivadulla, C; Sur, M				Dragoi, V; Rivadulla, C; Sur, M			Foci of orientation plasticity in visual cortex	NATURE			English	Article							CAT AREA 17; OCULAR DOMINANCE; ADAPTATION; SELECTIVITY; CONNECTIONS; INHIBITION; CONTRAST	Cortical areas are generally assumed to be uniform in their capacity for adaptive changes or plasticity(1-4). Here we demonstrate, however, that neurons in the cat striate cortex (V1) show pronounced adaptation-induced short-term plasticity of orientation tuning primarily at specific foci. V1 neurons are clustered according to their orientation preference in iso-orientation domains(5) that converge at singularities or pinwheel centres(6,7). Although neurons in pinwheel centres have similar orientation tuning and responses to those in iso-orientation domains, we rnd that they differ markedly in their capacity for adaptive changes. Adaptation with an oriented drifting grating stimulus alters responses of neurons located at and near pinwheel centres to a broad range of orientations, causing repulsive shifts in orientation preference and changes in response magnitude. In contrast, neurons located in iso-orientation domains show minimal changes in their tuning properties after adaptation. The anisotropy of adaptation-induced orientation plasticity is probably mediated by inhomogeneities in local intracortical interactions that are overlaid on the map of orientation preference in V1.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	vdragoi@ai.mit.edu	RIVADULLA, CASTO/K-8425-2012	RIVADULLA, CASTO/0000-0001-5580-3917				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V., 1999, Society for Neuroscience Abstracts, V25, P1548; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fregnac Y, 1999, J NEUROBIOL, V41, P69; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HAMMOND P, 1989, VISION RES, V29, P1671, DOI 10.1016/0042-6989(89)90149-1; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMERS DC, CEREBRAL CORTEX CAT; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665	30	131	132	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2001	411	6833					80	86		10.1038/35075070	http://dx.doi.org/10.1038/35075070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333981	Green Submitted			2022-12-28	WOS:000168432800047
J	Jeong, H; Mason, SP; Barabasi, AL; Oltvai, ZN				Jeong, H; Mason, SP; Barabasi, AL; Oltvai, ZN			Lethality and centrality in protein networks	NATURE			English	Article							ORGANIZATION; DATABASE; GENOME		Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame	Jeong, H (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	alb@nd.edu; zno008@nwu.edu	Jeong, Hawoong/A-2469-2009; Jeong, Hawoong/AAR-2524-2021; Barabasi, Albert-Laszlo/S-6474-2017; Jeong, Hawoong/C-1587-2011	Jeong, Hawoong/0000-0002-2491-8620; Jeong, Hawoong/0000-0002-2491-8620; Barabasi, Albert/0000-0002-4028-3522				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; FELL DA, ANIMATING CELLULAR M, P79; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289	13	3535	3719	3	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2001	411	6833					41	42		10.1038/35075138	http://dx.doi.org/10.1038/35075138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333967	Green Submitted			2022-12-28	WOS:000168432800033
J	Tuomilehto, J; Lindstrom, J; Eriksson, JG; Valle, TT; Hamalainen, H; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, S; Laakso, M; Louheranta, A; Rastas, M; Salminen, V; Uusitupa, M; Aunola, S; Cepaitis, Z; Moltchanov, V; Hakumaki, M; Mannelin, M; Martikkala, V; Sundvall, J				Tuomilehto, J; Lindstrom, J; Eriksson, JG; Valle, TT; Hamalainen, H; Ilanne-Parikka, P; Keinanen-Kiukaanniemi, S; Laakso, M; Louheranta, A; Rastas, M; Salminen, V; Uusitupa, M; Aunola, S; Cepaitis, Z; Moltchanov, V; Hakumaki, M; Mannelin, M; Martikkala, V; Sundvall, J		Finnish Diabet Prevention Study Gr	Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; EXERCISE; NIDDM; DIET	Background: Type 2 diabetes mellitus is increasingly common, primarily because of increases in the prevalence of a sedentary lifestyle and obesity. Whether type 2 diabetes can be prevented by interventions that affect the lifestyles of subjects at high risk for the disease is not known. Methods: We randomly assigned 522 middle-aged, overweight subjects (172 men and 350 women; mean age, 55 years; mean body-mass index [weight in kilograms divided by the square of the height in meters], 31) with impaired glucose tolerance to either the intervention group or the control group. Each subject in the intervention group received individualized counseling aimed at reducing weight, total intake of fat, and intake of saturated fat and increasing intake of fiber and physical activity. An oral glucose-tolerance test was performed annually; the diagnosis of diabetes was confirmed by a second test. The mean duration of follow-up was 3.2 years. Results: The mean (+/-SD) amount of weight lost between base line and the end of year 1 was 4.2+/-5.1 kg in the intervention group and 0.8+/-3.7 kg in the control group; the net loss by the end of year 2 was 3.5+/-5.5 kg in the intervention group and 0.8+/-4.4 kg in the control group (P<0.001 for both comparisons between the groups). The cumulative incidence of diabetes after four years was 11 percent (95 percent confidence interval, 6 to 15 percent) in the intervention group and 23 percent (95 percent confidence interval, 17 to 29 percent) in the control group. During the trial, the risk of diabetes was reduced by 58 percent (P<0.001) in the intervention group. The reduction in the incidence of diabetes was directly associated with changes in lifestyle. Conclusions: Type 2 diabetes can be prevented by changes in the lifestyles of high-risk subjects. (N Engl J Med 2001;344:1343-50.) Copyright (C) 2001 Massachusetts Medical Society.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Social Insurance Inst, Ctr Res & Dev, Turku, Finland; Finnish Diabet Assoc, Dept Internal Med, Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland; Inst Nursing & Hlth Care, Tampere, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Eastern Finland	Tuomilehto, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Mannerheimintie 166, FIN-00300 Helsinki, Finland.	jaakko.tuomilehto@ktl.fi	Cerviño, Alejandro/L-5853-2014; Samaan, M. Constantine/R-1456-2017; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Cerviño, Alejandro/0000-0001-8014-3279; Samaan, M. Constantine/0000-0002-6403-4715; Lindstrom, Jaana/0000-0001-9255-020X				[Anonymous], 1994, World Health Organ Tech Rep Ser, V844, P1; Borch-Johnsen K, 1999, LANCET, V354, P617; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Haapa E., 1985, ANNOSKUVAKIRJA PICTU; Haffner SM, 2000, CIRCULATION, V101, P975, DOI 10.1161/01.CIR.101.9.975; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; HARRIS MI, 1989, DIABETES CARE, V12, P464, DOI 10.2337/diacare.12.7.464; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; KING H, 1990, DIABETOLOGIA, V33, P3, DOI 10.1007/BF00586454; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; NEEL JV, 1962, AM J HUM GENET, V14, P353; OHLSON LO, 1988, DIABETOLOGIA, V31, P798; Ovaskainen ML, 1996, FOOD CHEM, V57, P133, DOI 10.1016/0308-8146(96)00113-6; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; STERN MP, 1991, DIABETES CARE, V14, P399, DOI 10.2337/diacare.14.5.399; TUOMILEHTO J, 1987, DIABETES CARE, V10, P238, DOI 10.2337/diacare.10.2.238; Tuomilehto J, 1997, INT TXB DIABETES MEL, P1799; UUSITUPA M, 1985, DIABETOLOGIA, V28, P22, DOI 10.1007/BF00276995; World Health Organization, 1985, WHO TECH REP SER, V727, P7; ZIMMET PZ, 1988, DIABETES CARE, V11, P258, DOI 10.2337/diacare.11.3.258	22	5680	5923	17	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1343	1350		10.1056/NEJM200105033441801	http://dx.doi.org/10.1056/NEJM200105033441801			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333990				2022-12-28	WOS:000168413500001
J	Kates, RW; Clark, WC; Corell, R; Hall, JM; Jaeger, CC; Lowe, I; McCarthy, JJ; Schellnhuber, HJ; Bolin, B; Dickson, NM; Faucheux, S; Gallopin, GC; Grubler, A; Huntley, B; Jager, J; Jodha, NS; Kasperson, RE; Mabogunje, A; Matson, P; Mooney, H; Moore, B; O'Riordan, T; Svedin, U				Kates, RW; Clark, WC; Corell, R; Hall, JM; Jaeger, CC; Lowe, I; McCarthy, JJ; Schellnhuber, HJ; Bolin, B; Dickson, NM; Faucheux, S; Gallopin, GC; Grubler, A; Huntley, B; Jager, J; Jodha, NS; Kasperson, RE; Mabogunje, A; Matson, P; Mooney, H; Moore, B; O'Riordan, T; Svedin, U			Environment and development - Sustainability science	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Amer Meteorol Soc, Washington, DC 20005 USA; NOAA, Silver Spring, MD 20910 USA; Potsdam Inst Climate Imapct Res, D-14412 Potsdam, Germany; Griffith Univ, Nathan, Qld 4111, Australia; Stockholm Univ, S-18451 Stockholm, Sweden; Univ Versailles, Ctr Econ & Eth Environm & Dev, F-78047 Guyancourt, France; Comis Econ Amer Latina & Carib, Santiago, Chile; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; Natl Bot Inst, ZA-7735 Cape Town, South Africa; Int Human Dimens Programme Global Environm Change, D-53113 Bonn, Germany; Int Ctr Integrated Mt Dev, Kathmandu, Nepal; Stockholm Environm Inst, S-10314 Stockholm, Sweden; Stanford Univ, Stanford, CA 94305 USA; Univ New Hampshire, Inst Earth Oceans & Space, Durham, NH 03824 USA; Univ E Anglia, Ctr Social & Econ Res Global Environm, Norwich NR4 7TJ, Norfolk, England; Swedish Council Planning & Coordinat Res FRN, S-10387 Stockholm, Sweden; Dev Policy Ctr, Ibadan, Nigeria	Harvard University; National Oceanic Atmospheric Admin (NOAA) - USA; Potsdam Institut fur Klimafolgenforschung; Griffith University; Stockholm University; UDICE-French Research Universities; Universite Paris Saclay; International Institute for Applied Systems Analysis (IIASA); Stockholm Environment Institute; Stanford University; University System Of New Hampshire; University of New Hampshire; University of East Anglia	Clark, WC (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	william_clark@harvard.edu	Schellnhuber, Hans Joachim/O-3873-2019; Schellnhuber, Hans Joachim/B-2607-2012; Lowe, Ian/AAH-7449-2019; Clark, William C/A-4832-2008	Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; O'Riordan, Timothy/0000-0002-0492-8477; Grubler, Arnulf/0000-0002-6225-7712				[Anonymous], 2000, ROLE UN 21 CENTURY; BOLIN B, 2000, UNEP ENCY GLOBAL ENV; BRANDOM R, 1988, MAKING IT EXPLICIT R; Cash DW, 2000, GLOBAL ENVIRON CHANG, V10, P109, DOI 10.1016/S0959-3780(00)00017-0; Dixon J., 1998, PROTECTING OUR PLANE; Faucheux S., 2000, NATURE SCI SOC, V8, P31; Faucheux S., 2000, FUTURIBLES, V251, P29; GALLOPIN G, IN PRESS INT SOC SCI; German Advisory Council on Global Change, 1997, WORLD TRANS RES CHAL; Gibson CC, 2000, ECOL ECON, V32, P217, DOI 10.1016/S0921-8009(99)00092-0; Grubler A, 1999, ANNU REV ENERG ENV, V24, P545, DOI 10.1146/annurev.energy.24.1.545; JAGER J, 1999, EFIEA WORKSH UNC EUR; Jodha N.S., 1998, LINKING SOCIAL ECOLO; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; *NAT RES COUNC BOA, 1999, OUR COMMON JOURNEY T; *NAT RES COUNC COM, 2000, SCI REG GLOB CHANG P; Parson Edward A., 1995, BARRIERS BRIDGES REN, P428; Petschel-Held G., 1999, Environmental Modeling & Assessment, V4, P295, DOI 10.1023/A:1019080704864; Petschel- Held G, 1999, CLIMATIC CHANGE, V41, P303, DOI 10.1023/A:1005487123751; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; Tuinstra W, 1999, ENVIRONMENT, V41, P33, DOI 10.1080/00139159909605536; *U SO CAL, SUST CIT PROGR ENV S; Varis O, 1997, CLIMATIC CHANGE, V37, P539, DOI 10.1023/A:1005358216361; Wilbanks TJ, 1999, CLIMATIC CHANGE, V43, P601, DOI 10.1023/A:1005418924748; 2000, TRANSITION SUSTAINAB	25	1625	1823	39	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					641	642		10.1126/science.1059386	http://dx.doi.org/10.1126/science.1059386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330321				2022-12-28	WOS:000168478300024
J	Wei, MC; Zong, WX; Cheng, EHY; Lindsten, T; Panoutsakopoulou, V; Ross, AJ; Roth, KA; MacCregor, GR; Thompson, CB; Korsmeyer, SJ				Wei, MC; Zong, WX; Cheng, EHY; Lindsten, T; Panoutsakopoulou, V; Ross, AJ; Roth, KA; MacCregor, GR; Thompson, CB; Korsmeyer, SJ			Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death	SCIENCE			English	Article							BCL-2 FAMILY MEMBERS; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; CELL-DEATH; APOPTOTIC PATHWAYS; PROTEIN; ACTIVATION; MEMBRANE; CASPASE-9; SURVIVAL	Multiple death signals influence mitochondria during apoptosis, yet the critical initiating event for mitochondrial dysfunction in vivo has been unclear. tBID, the caspase-activated form of a "BH3-domain-only" BCL-2 family member, triggers the homooligomerization of "multidomain" conserved proapoptotic family members BAK or BAX, resulting in the release of cytochrome c from mitochondria. We find that cells lacking both Bax and Bak, but not cells lacking only one of these components, are completely resistant to tBID-induced cytochrome c release and apoptosis. Moreover, doubly deficient cells are resistant to multiple apoptotic stimuli that act through disruption of mitochondrial function: staurosporine, ultraviolet radiation, growth factor deprivation, etoposide, and the endoplasmic reticulum stress stimuli thapsigargin and tunicamycin. Thus, activation of a "multidomain" proapoptotic member, BAX or BAK, appears to be an essential gateway to mitochondrial dysfunction required for cell death in response to diverse stimuli.	Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Dana Farber Canc Inst, Dept Pathol,Howard Huges Med Inst, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Dana Farber Canc Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Washington University (WUSTL); Emory University; Washington University (WUSTL)	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA.			Roth, Kevin/0000-0002-0643-995X; Panoutsakopoulou, Vily/0000-0002-1569-1508	NCCIH NIH HHS [5T32AT09361] Funding Source: Medline; NCI NIH HHS [R01CA50239, R37CA4802] Funding Source: Medline; NICHD NIH HHS [R01 HD036437-02, R01 HD036437-03, R01 HD036437-04, R01 HD036437-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036437] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA050239] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; WEI M, UNPUB; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	33	3183	3300	4	248	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					727	730		10.1126/science.1059108	http://dx.doi.org/10.1126/science.1059108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326099	Green Accepted			2022-12-28	WOS:000168478300051
J	Wade, J; Wood, BJ				Wade, J; Wood, BJ			The Earth's 'missing' niobium may be in the core	NATURE			English	Article							SILICATE PARTITION-COEFFICIENTS; CONTINENTAL-CRUST; HIGH-PRESSURE; MAGMA OCEAN; TEMPERATURE; MANTLE; DIFFERENTIATION; GEOCHEMISTRY; ELEMENTS	As the Earth's metallic core segregated from the silicate mantle, some of the moderately siderophile ('iron-loving') elements such as vanadium and chromium(1,2) are thought to have entered the metal phase, thus causing the observed depletions of these elements in the silicate part of the Earth. In contrast, refractory 'lithophile' elements such as calcium, scandium and the rare-earth elements are known to be present in the same proportions in the silicate portion of the Earth as in the chondritic meteorites- thought to represent primitive planetary material(1,3). Hence these lithophile elements apparently did not enter the core. Niobium has always been considered to be lithophile and refractory yet it has been observed to be depleted relative to other elements of the same type in the crust and upper mantle(4,5). This observation has been used to infer the existence of hidden niobium-rich reservoirs in the Earth's deep mantle(5). Here we show, however, that niobium and vanadium partition in virtually identical fashion between liquid metal and liquid silicate at high pressure. Thus, if a significant fraction of the Earth's vanadium entered the core (as is thought), then so has a similar fraction of its niobium, and no hidden reservoir need be sought in the Earth's deep mantle.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Wood, BJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.		Wood, Bernard J/E-8173-2010; Wade, Jon/H-7012-2012	Wood, Bernard J/0000-0003-1038-7301; Wade, Jon/0000-0002-6998-236X				ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; DRAKE MJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2101, DOI 10.1016/0016-7037(89)90328-1; GESSMANN CK, IN PRESS EARTH PLANE; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Hofmann AW, 1996, J GEOPHYS RES-SOL EA, V101, P11831, DOI 10.1029/95JB03701; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Kilburn MR, 1997, EARTH PLANET SC LETT, V152, P139, DOI 10.1016/S0012-821X(97)00125-8; KILBURN MR, 1999, THESIS U BRISTOL; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Newsom H. E., 1995, GLOBAL EARTH PHYS HD, V1, P159, DOI DOI 10.1029/RF001P0159; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; Righter K, 1999, EARTH PLANET SC LETT, V171, P383, DOI 10.1016/S0012-821X(99)00156-9; Robie R. A., 1978, US GEOL SURV B, V1452; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Rudnick RL, 2000, SCIENCE, V287, P278, DOI 10.1126/science.287.5451.278; THIBAULT Y, 1995, GEOCHIM COSMOCHIM AC, V59, P991, DOI 10.1016/00167-0379(50)00178-; WASSON JT, 1995, METEORITES THEIR REC; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3	19	135	141	0	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					75	78		10.1038/35051064	http://dx.doi.org/10.1038/35051064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343115				2022-12-28	WOS:000166175600041
J	Hu, JT; Li, LS; Yang, WD; Manna, L; Wang, LW; Alivisatos, AP				Hu, JT; Li, LS; Yang, WD; Manna, L; Wang, LW; Alivisatos, AP			Linearly polarized emission from colloidal semiconductor quantum rods	SCIENCE			English	Article							CDSE NANOCRYSTALS; II-VI; DOTS; SPECTROSCOPY; LUMINESCENCE; COMPOSITES; CLUSTERS; POLYMER; GROWTH	Colloidal quantum rods of cadmium selenide (CdSe) exhibit linearly polarized emission. Empirical pseudopotential calculations predict that slightly elongated CdSe nanocrystals have polarized emission along the long axis, unlike spherical dots, which emit plane-polarized light. Single-molecule luminescence spectroscopy measurements on CdSe quantum rods with an aspect ratio between 1 and 30 confirm a sharp transition from nonpolarized to purely linearly polarized emission at an aspect ratio of 2. Linearly polarized luminescent chromophores are highly desirable in a variety of applications.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Energy Res Sci Comp Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Alivisatos, Paul/N-8863-2015; Manna, Liberato/G-2339-2010	Alivisatos, Paul/0000-0001-6895-9048; Manna, Liberato/0000-0003-4386-7985	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014891] Funding Source: NIH RePORTER; NCRR NIH HHS [1 R01 RR-14891-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALIVISATOS AP, 1989, J CHEM PHYS, V90, P3463, DOI 10.1063/1.455855; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BRUS L, 1991, APPL PHYS A-MATER, V53, P465, DOI 10.1007/BF00331535; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; DABBOUSI BO, 1995, APPL PHYS LETT, V66, P1316, DOI 10.1063/1.113227; DANEK M, 1994, J CRYST GROWTH, V145, P714, DOI 10.1016/0022-0248(94)91132-0; EFROS AL, 1992, PHYS REV B, V46, P7448, DOI 10.1103/PhysRevB.46.7448; Efros AL, 1996, PHYS REV B, V54, P4843, DOI 10.1103/PhysRevB.54.4843; Efros AL, 2000, ANNU REV MATER SCI, V30, P475, DOI 10.1146/annurev.matsci.30.1.475; Empedocles SA, 1999, NATURE, V399, P126, DOI 10.1038/20138; GRUNDMANN M, 1995, PHYS REV LETT, V74, P4043, DOI 10.1103/PhysRevLett.74.4043; Ha T, 1999, J PHYS CHEM B, V103, P6839, DOI 10.1021/jp990948j; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; KLEIN MC, 1990, PHYS REV B, V42, P11123, DOI 10.1103/PhysRevB.42.11123; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; KOVALEV D, 1995, APPL PHYS LETT, V67, P1585, DOI 10.1063/1.114947; LEON R, 1995, SCIENCE, V267, P1966, DOI 10.1126/science.267.5206.1966; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; MIRMAL M, 1996, NATURE, V383, P802; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m; Peng ZA, 2001, J AM CHEM SOC, V123, P1389, DOI 10.1021/ja0027766; Rabani E, 1999, J CHEM PHYS, V110, P5355, DOI 10.1063/1.478431; Shim M, 1999, J CHEM PHYS, V111, P6955, DOI 10.1063/1.479988; Wang LW, 1996, PHYS REV B, V53, P9579, DOI 10.1103/PhysRevB.53.9579; YANG W, UNPUB	32	1101	1145	10	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2060	2063		10.1126/science.1060810	http://dx.doi.org/10.1126/science.1060810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11337589				2022-12-28	WOS:000169284700042
J	Chuang, YD; Gromko, AD; Dessau, DS; Kimura, T; Tokura, Y				Chuang, YD; Gromko, AD; Dessau, DS; Kimura, T; Tokura, Y			Fermi surface nesting and nanoscale fluctuating charge/orbital ordering in colossal magnetoresistive oxides	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; DOUBLE EXCHANGE; MANGANESE OXIDES; RESISTIVITY; PSEUDOGAPS; PHYSICS; SCENARIO; COLLAPSE; STATE	We used high-resolution angle-resolved photoemission spectroscopy to reveal the Fermi surface and key transport parameters of the metallic state of the layered colossal magnetoresistive oxide La1.2Sr1.8Mn2O7. With these parameters, the calculated in-plane conductivity is nearly one order of magnitude larger than the measured direct current conductivity. This discrepancy can be accounted for by including the pseudogap, which removes at least 90% of the spectral weight at the Fermi energy. Key to the pseudogap and to many other properties are the parallel straight Fermi surface sections, which are highly susceptible to nesting instabilities. These nesting instabilities produce nanoscale fluctuating charge/orbital modulations, which cooperate with Jahn-Teller distortions and compete with the electron itinerancy favored by double exchange.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Tokyo, Dept Appl Phys, Tokyo 113, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Joint Res Ctr Atom Technol, Tsukuba, Ibaraki 3050046, Japan	University of Colorado System; University of Colorado Boulder; University of Tokyo; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute of Advanced Industrial Science & Technology (AIST)	Chuang, YD (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.		Tokura, Yoshinori/C-7352-2009; Kimura, Tsuyoshi/F-8090-2018	Tokura, Yoshinori/0000-0002-2732-4983; Chuang, Yi-De/0000-0002-2773-3840				Abrikosov AA, 2000, PHYS REV B, V61, P7770, DOI 10.1103/PhysRevB.61.7770; Alexandrov AS, 1999, PHYS REV LETT, V82, P141, DOI 10.1103/PhysRevLett.82.141; ANDERSON PW, 1955, PHYS REV, V100, P675, DOI 10.1103/PhysRev.100.675; Argyriou DN, 2000, PHYS REV B, V61, P15269, DOI 10.1103/PhysRevB.61.15269; CAMPBELL BM, UNPUB; DEGENNES PG, 1960, PHYS REV, V118, P141, DOI 10.1103/PhysRev.118.141; Dessau DS, 1998, PHYS REV LETT, V81, P192, DOI 10.1103/PhysRevLett.81.192; DESSAU DS, 2000, SCIENCE, V287, pA767; HAMADA N, UNPUB; Hotta T, 2000, PHYS REV LETT, V84, P2477, DOI 10.1103/PhysRevLett.84.2477; Ishida N, 1998, GLYCOBIOLOGY, V8, P1119; Ishikawa T, 2000, PHYS REV B, V62, P12354, DOI 10.1103/PhysRevB.62.12354; Joynt R, 1999, SCIENCE, V284, P777, DOI 10.1126/science.284.5415.777; Kubota M, 2000, J PHYS SOC JPN, V69, P1986, DOI 10.1143/JPSJ.69.1986; Li QA, 2001, PHYS REV B, V63; Ling CD, 2000, PHYS REV B, V62, P15096, DOI 10.1103/PhysRevB.62.15096; MASSIDDA S, 1988, PHYSICA C, V152, P251, DOI 10.1016/0921-4534(88)90136-0; Mayr M, 2001, PHYS REV LETT, V86, P135, DOI 10.1103/PhysRevLett.86.135; MILLIS AJ, 1995, PHYS REV LETT, V74, P5144, DOI 10.1103/PhysRevLett.74.5144; Millis AJ, 1996, PHYS REV B, V54, P5405, DOI 10.1103/PhysRevB.54.5405; Millis AJ, 1996, PHYS REV LETT, V77, P175, DOI 10.1103/PhysRevLett.77.175; Moreo A, 1999, SCIENCE, V283, P2034, DOI 10.1126/science.283.5410.2034; Moreo A, 2000, PHYS REV LETT, V84, P5568, DOI 10.1103/PhysRevLett.84.5568; Mori S, 1998, NATURE, V392, P473, DOI 10.1038/33105; Moritomo Y, 1996, NATURE, V380, P141, DOI 10.1038/380141a0; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Roder H, 1996, PHYS REV LETT, V76, P1356, DOI 10.1103/PhysRevLett.76.1356; Saitoh T, 2000, PHYS REV B, V62, P1039, DOI 10.1103/PhysRevB.62.1039; Schulte K, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165429; SHEN ZX, 1995, PHYS REP, V253, P2; Shimomura S, 1999, PHYS REV LETT, V83, P4389, DOI 10.1103/PhysRevLett.83.4389; Singh DJ, 1998, PHYS REV B, V57, P88, DOI 10.1103/PhysRevB.57.88; Tokura Y., 2000, COLOSSAL MAGNETORESI, V2; Vasiliu-Doloc L, 1999, PHYS REV LETT, V83, P4393, DOI 10.1103/PhysRevLett.83.4393; ZENER C, 1951, PHYS REV, V82, P403, DOI 10.1103/PhysRev.82.403; Zhou XJ, 1999, SCIENCE, V286, P268, DOI 10.1126/science.286.5438.268	36	167	171	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1509	1513		10.1126/science.1059255	http://dx.doi.org/10.1126/science.1059255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11326084	Green Submitted			2022-12-28	WOS:000168963800034
J	Dragert, H; Wang, KL; James, TS				Dragert, H; Wang, KL; James, TS			A silent slip event on the deeper Cascadia subduction interface	SCIENCE			English	Article							SOUTHWEST JAPAN; ZONE; DEFORMATION; EARTHQUAKE; THRUST; FAULT; STRAIN; PLATE	Continuous Global Positioning System sites in southwestern British Columbia, Canada, and northwestern Washington state, USA, have been moving Landward as a result of the locked state of the Cascadia subduction fault offshore. In the summer of 1999, a cluster of seven sites briefly reversed their direction of motion. No seismicity was associated with this event. The sudden displacements are best explained by similar to2 centimeters of aseismic slip over a 50-kilometer-by-300-kilometer area on the subduction interface downdip from the seismogenic zone, a rupture equivalent to an earthquake of moment magnitude 6.7. This provides evidence that slip of the hotter, plastic part of the subduction interface, and hence stress Loading of the megathrust earthquake zone, can occur in discrete pulses.	Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Dragert, H (corresponding author), Geol Survey Canada, Pacific Geosci Ctr, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.		James, Thomas S/D-9301-2013	James, Thomas S/0000-0001-7321-047X				ATWATER BF, 1996, EARTHQ SPECTRA, V11, P1; BEUTLER G, 2000, BERNESE GPS SOFTWARE; DRAGERT H, 1994, J GEOPHYS RES-SOL EA, V99, P653, DOI 10.1029/93JB02516; DRAGERT H, 1995, GEOPHYS RES LETT, V22, P755, DOI 10.1029/95GL00469; Fluck P, 1997, J GEOPHYS RES-SOL EA, V102, P20539, DOI 10.1029/97JB01642; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; HENTON JA, 2000, THESIS U VICTORIA BR; Hirose H, 1999, GEOPHYS RES LETT, V26, P3237, DOI 10.1029/1999GL010999; HYNDMAN RD, 1993, J GEOPHYS RES-SOL EA, V98, P2039, DOI 10.1029/92JB02279; James TS, 2000, QUATERNARY SCI REV, V19, P1527, DOI 10.1016/S0277-3791(00)00076-7; Khazaradze G, 1999, GEOPHYS RES LETT, V26, P3153, DOI 10.1029/1999GL010458; Langbein J, 1995, GEOPHYS RES LETT, V22, P3533, DOI 10.1029/95GL03325; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; LINDE AT, 1989, GEOPHYS RES LETT, V16, P1305, DOI 10.1029/GL016i011p01305; LINDE AT, 1998, EOS, V79, pF600; McCaffrey R, 2000, GEOPHYS RES LETT, V27, P3117, DOI 10.1029/2000GL011768; Miller MM, 2001, TECTONICS, V20, P161, DOI 10.1029/2000TC001224; Murray MH, 2000, GEOPHYS RES LETT, V27, P3631, DOI 10.1029/1999GL011127; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Ozawa S, 2001, J GEOPHYS RES-SOL EA, V106, P787, DOI 10.1029/2000JB900317; RANALLI G, 1989, GEOPH MONOG SERIES, V49, P55; SAGIYA T, 1997, EOS T, V78, pF165; Satake K, 1996, NATURE, V379, P246, DOI 10.1038/379246a0; THATCHER W, 1982, NATURE, V299, P12, DOI 10.1038/299012a0; WANG KL, 1995, J GEOPHYS RES-SOL EA, V100, P12907, DOI 10.1029/95JB00516; Wang KL, 1996, GEOPHYS RES LETT, V23, P2021, DOI 10.1029/96GL02067; WANG KL, 1995, TECTONOPHYSICS, V248, P53, DOI 10.1016/0040-1951(95)00028-L; Wells RE, 1998, GEOLOGY, V26, P759, DOI 10.1130/0091-7613(1998)026<0759:FAMICA>2.3.CO;2	28	686	699	2	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1525	1528		10.1126/science.1060152	http://dx.doi.org/10.1126/science.1060152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11313500				2022-12-28	WOS:000168963800039
J	Allan, L; Hays, H; Jensen, NH; de Waroux, BL; Bolt, M; Donald, R; Kalso, E				Allan, L; Hays, H; Jensen, NH; de Waroux, BL; Bolt, M; Donald, R; Kalso, E			Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain	BRITISH MEDICAL JOURNAL			English	Article							PATIENT-CONTROLLED ANALGESIA; CHRONIC NONMALIGNANT PAIN; CHRONIC NONCANCER PAIN; LONG-TERM TREATMENT; QUALITY-OF-LIFE; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; DOUBLE-BLIND; EFFICACY; MANAGEMENT	Objectives To compare patients' preference for transdermal fentanyl or sustained release oral morphine, their level of pain control, and their quality of life after treatment. Design Randomised, multicentre, international, open label, crossover trial. Setting 35 centres in Belgium, Canada, Denmark, Finland, the United Kingdom, the Netherlands, and South Africa. Participants 256 patients (aged 26-82 years) with chronic non-cancer pain who had been treated with opioids. Main outcome measures Patients' preference for transdermal fentanyl or sustained release oral morphine, pain control, quality of life, and safety assessments. Results Of 212 patients, 138 (65%) preferred transdermal fentanyl, whereas 59 (28%) preferred sustained release oral morphine and 15 (7%) expressed no preference. Better pain relief was the main reason for preference for fentanyl given by 35% of patients. More patients considered pain control as being "good" or "very good'' with fentanyl than with morphine (35% v 23%, P = 0.002). These results were reflected in both patients' and investigators' opinions on the global efficacy of transdermal fentanyl. Patients receiving fentanyl had on average higher quality of life scores than those receiving morphine. The incidence of adverse events was similar in both treatment groups; however, more patients experienced constipation with morphine than with fentanyl (48% v 29%, P< 0.001). Overall, 41% of patients experienced mild or moderate cutaneous problems associated with wearing the transdermal fentanyl patch, and more patients withdrew because of adverse events during treatment with fentanyl than with morphine (10% v 5%). However, within the subgroup of patients naive to both fentanyl and morphine, similar numbers of patients withdrew owing to adverse effects (11% v 10%. respectively). Conclusion Transdermal fentanyl was preferred to sustained release oral morphine by patients with chronic non-cancer pain previously treated with opioids. The main reason for preference was better pain relief, achieved with less constipation and an enhanced quality of life.	Northwick Pk & St Marks NHS Trust, Chron Pain Serv, Harrow HA1 3UJ, Middx, England; Univ Alberta, Dept Family Med, Edmonton, AB T6G 2C8, Canada; Herlev Univ Hosp, Dept Anaesthesiol, Ctr Multidisciplinary Pain, DK-2730 Herlev, Denmark; Clin Univ St Luc, B-1200 Brussels, Belgium; Alg Ziekenhuis Eemland De Lichtenberg, NL-3818 ES Amersfoort, Netherlands; Strand Private Hosp, ZA-7139 Cape Town, South Africa; Univ Helsinki, Cent Hosp, Pain Clin, FIN-00290 Helsinki, Finland	Imperial College London; University of Alberta; University of Copenhagen; Herlev & Gentofte Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Helsinki; Helsinki University Central Hospital	Allan, L (corresponding author), Northwick Pk & St Marks NHS Trust, Chron Pain Serv, Harrow HA1 3UJ, Middx, England.							AHMEDZAI S, 1994, J DRUG DEV, V6, P93; Ahmedzai S, 1997, J PAIN SYMPTOM MANAG, V13, P254, DOI 10.1016/S0885-3924(97)00082-1; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; ARKINSTALL W, 1995, PAIN, V62, P169, DOI 10.1016/0304-3959(94)00262-D; Ashburn MA, 1999, LANCET, V353, P1865, DOI 10.1016/S0140-6736(99)04088-X; Brown R L, 1996, J Am Board Fam Pract, V9, P191; Bruera E, 1996, J CLIN ONCOL, V14, P1713, DOI 10.1200/JCO.1996.14.5.1713; Collett BJ, 1998, BRIT J ANAESTH, V81, P58, DOI 10.1093/bja/81.1.58; CUMMINGSAJEMIAN.I, 1993, CANC PAIN 3; Dellemijn PLI, 1998, J PAIN SYMPTOM MANAG, V16, P220, DOI 10.1016/S0885-3924(98)00070-0; Dellemijn PLI, 1997, LANCET, V349, P753, DOI 10.1016/S0140-6736(96)09024-1; Donner B, 1996, PAIN, V64, P527, DOI 10.1016/0304-3959(95)00180-8; Donner B, 1998, J PAIN SYMPTOM MANAG, V15, P168, DOI 10.1016/S0885-3924(97)00361-8; Goodare H, 1999, BRIT MED J, V319, P724, DOI 10.1136/bmj.319.7212.724; Graziotti PJ, 1997, MED J AUSTRALIA, V167, P30, DOI 10.5694/j.1326-5377.1997.tb138760.x; Grond S, 1997, PAIN, V69, P191, DOI 10.1016/S0304-3959(96)03254-X; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Haddox JD, 1997, PAIN FORUM, V6, P77; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Jeal W, 1997, DRUGS, V53, P109, DOI 10.2165/00003495-199753010-00011; KOCH GG, 1972, BIOMETRICS, V28, P577, DOI 10.2307/2556170; MAX M, 1999, PAIN 1999 UPDATE REV; McQuay H, 1999, LANCET, V353, P2229, DOI 10.1016/S0140-6736(99)03528-X; MCQUAY HJ, 1992, ANAESTHESIA, V47, P757, DOI 10.1111/j.1365-2044.1992.tb03253.x; Megens AAHP, 1998, J PAIN SYMPTOM MANAG, V15, P253, DOI 10.1016/S0885-3924(97)00371-0; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Moulin DE, 1996, LANCET, V347, P143, DOI 10.1016/S0140-6736(96)90339-6; Payne R, 1998, J CLIN ONCOL, V16, P1588, DOI 10.1200/JCO.1998.16.4.1588; Portenoy RK, 1996, J PAIN SYMPTOM MANAG, V11, P203, DOI 10.1016/0885-3924(95)00187-5; Portenoy RK, 1999, PAIN 1999 UPDATED RE, P3; ROWBOTHAM MC, 1991, NEUROLOGY, V41, P1024, DOI 10.1212/WNL.41.7.1024; SCHUG SA, 1991, DRUGS, V42, P228, DOI 10.2165/00003495-199142020-00005; SENN S, 1999, PAIN 1999 UPDATE REV; SOUTHAM MA, 1995, ANTI-CANCER DRUG, V6, P29, DOI 10.1097/00001813-199504003-00005; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Tramer MR, 1998, BMJ-BRIT MED J, V317, P875, DOI 10.1136/bmj.317.7162.875; Uhl GR, 1999, P NATL ACAD SCI USA, V96, P7752, DOI 10.1073/pnas.96.14.7752; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson CPN, 1998, NEUROLOGY, V50, P1837; WATSON H R, 1990, Pharmaceutical Medicine (London), V4, P207; World Health Organization, 1996, CANC PAIN REL; ZECH DFJ, 1992, PAIN, V50, P293, DOI 10.1016/0304-3959(92)90034-9	42	185	200	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1154	1158		10.1136/bmj.322.7295.1154	http://dx.doi.org/10.1136/bmj.322.7295.1154			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348910	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000168748900016
J	Affolter, M; Mann, R				Affolter, M; Mann, R			Development - Legs, eyes, or wings - Selectors and signals make the difference	SCIENCE			English	Editorial Material							TRANSCRIPTION FACTORS; PROTEINS ACT; DROSOPHILA; DPP		Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	University of Basel; Columbia University	Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.			Affolter, Markus/0000-0002-5171-0016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054510] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354	12	22	27	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1080	1081		10.1126/science.1060856	http://dx.doi.org/10.1126/science.1060856			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352058				2022-12-28	WOS:000168609200036
J	Istvan, ES; Deisenhofer, J				Istvan, ES; Deisenhofer, J			Structural mechanism for statin inhibition of HMG-CoA reductase	SCIENCE			English	Article							ELECTRON-DENSITY MAPS; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; CRYSTAL-STRUCTURE; CATALYSIS; INSIGHTS; ML-236B	HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase (HMGR) catalyzes the committed step in cholesterol biosynthesis. Statins are HMGR inhibitors with inhibition constant values in the nanomolar range that effectively lower serum cholesterol levels and are widely prescribed in the treatment of hypercholesterolemia. We have determined structures of the catalytic portion of human HMGR complexed with six different statins. The statins occupy a portion of the binding site of HMG-CoA, thus blocking access of this substrate to the active site. Near the carboxyl terminus of HMGR, several catalytically relevant residues are disordered in the enzyme-statin complexes. If these residues were not flexible, they would sterically hinder statin binding.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	Johann.Deisenhofer@UTSouthwestern.edu						BISCHOFF KM, 1992, BIOCHEM MED METAB B, V48, P149, DOI 10.1016/0885-4505(92)90060-C; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Davignon J, 1999, CURR OPIN LIPIDOL, V10, P543, DOI 10.1097/00041433-199912000-00010; Eisenberg Daniel A., 1998, American Journal of Medicine, V104, p2S, DOI 10.1016/S0002-9343(98)00038-2; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSER L, COMMUNICATION; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; HOLDGATE GA, UNPUB; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LAWRENCE CM, 1995, SCIENCE, V268, P1758, DOI 10.1126/science.7792601; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Tabernero L, 1999, P NATL ACAD SCI USA, V96, P7167, DOI 10.1073/pnas.96.13.7167	20	1062	1112	8	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1160	1164		10.1126/science.1059344	http://dx.doi.org/10.1126/science.1059344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349148				2022-12-28	WOS:000168609200059
J	Righton, D; Metcalfe, J; Connolly, P				Righton, D; Metcalfe, J; Connolly, P			Fisheries - Different behaviour of north and Irish sea cod	NATURE			English	Article							TAGS		Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England; Inst Marine, Marine Fisheries Serv Div, Dublin 15, Ireland	Centre for Environment Fisheries & Aquaculture Science; Marine Institute Ireland	Righton, D (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England.		Righton, David/D-6140-2013	Righton, David/0000-0001-8643-3672				ARNOLD GP, 1994, ICES J MAR SCI, V51, P207, DOI 10.1006/jmsc.1994.1021; BEAMISH FWH, 1966, J FISH RES BOARD CAN, V23, P109, DOI 10.1139/f66-009; *FAO, 1997, YB FISH STAT, V84; Godo OR, 2000, FISH RES, V48, P127, DOI 10.1016/S0165-7836(00)00177-6; *ICES, 1999, REP ICES ADV COMM FI, V236; MAGNUSSON KG, 1995, REV FISH BIOL FISHER, V5, P195; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Wroblewski JS, 2000, FISH RES, V45, P51, DOI 10.1016/S0165-7836(99)00096-X	9	65	66	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					156	156		10.1038/35075667	http://dx.doi.org/10.1038/35075667			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346784	Bronze			2022-12-28	WOS:000168563000039
J	Reynolds, AJ; Temple, JA; Robertson, DL; Mann, EA				Reynolds, AJ; Temple, JA; Robertson, DL; Mann, EA			Long-term effects of an early childhood intervention on educational achievement and juvenile arrest - A 15-year follow-up of low-income children in public schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARENT CENTERS; RISK; DELINQUENCY	Context Most studies of the long-term effects of early childhood educational interventions are of demonstration programs rather than large-scale public programs. Previous studies of one of the oldest federally funded preschool programs have reported positive effects on school performance, but effects on educational attainment and crime are unknown. Objective To determine the long-term effectiveness of a federal center-based preschool and school-based intervention program for urban low-income children. Design, Setting, and Participants Fifteen-year follow-up of a nonrandomized, matched-group cohort of 1539 low-income, mostly black children born in 1980 and enrolled in alternative early childhood programs in 25 sites in Chicago, ill. Interventions The Chicago Child-Parent Center (CPC) Program (n = 989 children) provides comprehensive education, family, and health services and includes half-day preschool at ages 3 to 4 years, haf- or full-day kindergarten, and school-age services in linked elementary schools at ages 6 to 9 years. The comparison group (n=550) consisted of children who participated in alternative early childhood programs (full-day kindergarten): 374 in the preschool comparison group from 5 randomly selected schools plus 2 others that provided full-day kindergarten and additional instructional resources and 176 who attended full-day kindergartens in 6 CPCs without preschool participation. Main Outcome Measures Rates of high school completion and school dropout by age 20 years, juvenile arrests for Violent and nonviolent offenses, and grade retention and special education placement by age 18 years, Results Relative to the preschool comparison group and adjusted for several covariates, children who participated in the preschool intervention for 1 or 2 years had a higher rate of high school completion (49.7% vs 38.5%; P=.01); more years of completed education (10.6 vs 10.2; P=.03); and lower rates of juvenile arrest (16.9% vs 25.1%;P=.003), violent arrests (9.0% vs 15.3%;P=.002), and school dropout (46.7% vs 55.0%; P=.047). Both preschool and school-age participation were significantly associated with lower rates of grade retention and special education services. The effects of preschool participation on educational attainment were greater for boys than girls, especially in reducing school dropout rates (P=.03). Relative to less extensive participation, children with extended program participation from preschool through second or third grade also experienced lower rates of grade retention (21.9% vs 32.3%; P=.001) and special education (13.5% vs 20.7%; P=.004). Conclusions Participation in an established early childhood intervention for low-income children was associated with better educational and social outcomes up to age 20 years. These findings are among the strongest evidence that established programs administered through public schools can promote children's long-term success.	Univ Wisconsin, Waisman Ctr Mental Retardat & Human Dev, Madison, WI 53705 USA; Univ Wisconsin, Sch Social Work, Madison, WI 53706 USA; No Illinois Univ, Dept Econ, De Kalb, IL 60115 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northern Illinois University	Reynolds, AJ (corresponding author), Univ Wisconsin, Waisman Ctr Mental Retardat & Human Dev, 1500 Highland Ave, Madison, WI 53705 USA.				NICHD NIH HHS [R01HD34294] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034294] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barnett WS, 1995, FUTURE CHILD, V5, P25, DOI 10.2307/1602366; BENDERSKY M, 1994, DEV PSYCHOL, V30, P484, DOI 10.1037/0012-1649.30.4.484; Bureau of Justice Statistics, 1997, SOURC CRIM JUST STAT; *CARN TASK FORC, 1994, START POINTS M NEEDS; *CHIC PUBL SCH, 1985, EL SCH CRIT PROM; Cohen MA, 1998, J QUANT CRIMINOL, V14, P5, DOI 10.1023/A:1023092324459; Consortium for Longitudinal Studies, 1983, TWIG IS BENT LAST EF; *COUNC EC ADV, 1997, 1 3 YEARS INV PAY; Currie J, 2000, J HUM RESOUR, V35, P755, DOI 10.2307/146372; GREENE WH, 1995, LIMDEP USERS GUIDE V; HIERONYMUS AN, 1980, IOWA TESTS BASIC SKI; Karoly L. A., 1998, INVESTING OUR CHILDR; Nelson CA, 1997, CHILD DEV, V68, P970, DOI 10.1111/j.1467-8624.1997.tb01974.x; *OFF SPEC ED PROGR, 1994, 16 US DEP ED; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; RAMEY CT, 1992, PEDIATRICS, V89, P454; RAMEY CT, 2000, APPL DEV SCI, V0004; Reynolds A., 2000, SUCCESS EARLY INTERV; Reynolds AJ, 1998, CHILD DEV, V69, P231, DOI 10.2307/1132082; REYNOLDS AJ, 1995, EVALUATION REV, V19, P347, DOI 10.1177/0193841X9501900401; REYNOLDS AJ, 1994, DEV PSYCHOL, V30, P787; Reynolds AJ, 1998, EVALUATION REV, V22, P341, DOI 10.1177/0193841X9802200302; Reynolds AJ, 1999, J SCHOOL PSYCHOL, V37, P345, DOI 10.1016/S0022-4405(99)00025-4; REYNOLDS AJ, 2000, BIENN M SOC RES AD M; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P41, DOI 10.2307/2288332; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Schweinhart L.J., 1993, SIGNIFICANT BENEFITS; SHEA S, 1991, AM J EPIDEMIOL, V134, P567, DOI 10.1093/oxfordjournals.aje.a116130; Temple JA, 2000, URBAN EDUC, V35, P31, DOI 10.1177/0042085900351003; *US GEN ACC OFF, 1999, HEHES0011 GAO; *US NAT SCI TECHN, 1997, INV OUR FUT NAT RES; WILSON WJ, 1996, WHEN WORK DISAPPEARS; Wittner D. S., 1988, ZERO 3, V8, P13; WOLFE BL, 1987, J HEALTH ECON, V6, P239, DOI 10.1016/0167-6296(87)90011-7; WOOD D, 1993, JAMA-J AM MED ASSOC, V270, P1334, DOI 10.1001/jama.270.11.1334; ZIGLER E, 1992, AM PSYCHOL, V47, P997, DOI 10.1037/0003-066X.47.8.997; ZIGLER E, 1993, HEAD START NATL PLAN; [No title captured]	38	461	465	2	82	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2339	2346		10.1001/jama.285.18.2339	http://dx.doi.org/10.1001/jama.285.18.2339			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427NB	11343481	Bronze			2022-12-28	WOS:000168411200025
J	Achermann, JC; Silverman, BL				Achermann, JC; Silverman, BL			Dehydroepiandrosterone replacement for patients with adrenal insufficiency	LANCET			English	Editorial Material							SULFATE; DHEA; CORTISOL; WOMEN		Northwestern Univ, Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Pediat, Div Endocrinol, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Silverman, BL (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.		Achermann, John/N-2906-2019; Achermann, John/C-5476-2008	Achermann, John/0000-0001-8787-6272; Achermann, John/0000-0001-8787-6272				Arlt W, 1998, J CLIN ENDOCR METAB, V83, P1928, DOI 10.1210/jc.83.6.1928; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; HUPPERT FA, 2000, COCHRANE DATABASE SY, V2; Kalmijn S, 1998, J CLIN ENDOCR METAB, V83, P3487, DOI 10.1210/jc.83.10.3487; Kimonides VG, 1999, NEUROSCIENCE, V89, P429, DOI 10.1016/S0306-4522(98)00347-9; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Morales AJ, 1998, CLIN ENDOCRINOL, V49, P421, DOI 10.1046/j.1365-2265.1998.00507.x; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551	12	25	26	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1381	1382		10.1016/S0140-6736(00)04617-1	http://dx.doi.org/10.1016/S0140-6736(00)04617-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356430				2022-12-28	WOS:000168478200004
J	Kilpatrick, ES; Holding, S				Kilpatrick, ES; Holding, S			Use of computer terminals on wards to access emergency test results: a retrospective audit	BRITISH MEDICAL JOURNAL			English	Article								Objective To assess delay in clinicians obtaining emergency biochemistry test results when the telephoning of results by laboratory staff is supplanted by installation of computer ward terminals. Design Retrospective observational study. Setting Accident and emergency department and acute medical admissions ward of a teaching hospital. Sample 3228 emergency requests for biochemistry tests sent from the accident and emergency department and 1836 from the medical admissions ward during August 1999 to January 2000 when there was no recorded telephone contact for results. Main outcome measures Proportion of emergency biochemistry results accessed via a ward terminal within 1 or 3 hours of becoming available and the proportion never seen by this means. Results The results from 1443/3228 (45%) of urgent requests from accident and emergency and 529/1836 (29%) from the admissions ward were never accessed via the ward terminal. Results from 794/3228 (25%) of accident and emergency requests and 413/1836 (22%) of admissions ward requests were seen within 1 hour of becoming available while a further 491/3228 (15%) and 341/1836 (19%) respectively were accessed between 1 and 3 hours. In up to 43/1443 (3%) of the accident and emergency test results that were never looked at the findings might have led to an immediate change in patient management Conclusions When used as the sole substitute for telephoning results, the provision of terminal access to laboratory results on wards can hinder rather than promote the communication of emergency blood results to healthcare staff.	Hull Royal Infirm, Dept Clin Biochem, Hull HU3 2JZ, N Humberside, England; Hull Royal Infirm, Dept Immunol, Hull, N Humberside, England		Kilpatrick, ES (corresponding author), Hull Royal Infirm, Dept Clin Biochem, Hull HU3 2JZ, N Humberside, England.		Holding, Stephen/P-9460-2017	Holding, Stephen/0000-0002-2118-1037				*CLIN BENCHM CO, 1999, PATH BENCHM FEEDB RE; MANORP G, 1999, CLIN LAB SCI, V12, P85; Powsner SM, 1998, LANCET, V352, P1617, DOI 10.1016/S0140-6736(98)08309-3; Winkelman JW, 1997, AM J CLIN PATHOL, V108, P400	4	54	55	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1101	1103		10.1136/bmj.322.7294.1101	http://dx.doi.org/10.1136/bmj.322.7294.1101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337442	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000168628300024
J	Fukami, K; Nakao, K; Inoue, T; Kataoka, Y; Kurokawa, M; Fissore, RA; Nakamura, K; Katsuki, M; Mikoshiba, K; Yoshida, N; Takenawa, T				Fukami, K; Nakao, K; Inoue, T; Kataoka, Y; Kurokawa, M; Fissore, RA; Nakamura, K; Katsuki, M; Mikoshiba, K; Yoshida, N; Takenawa, T			Requirement of phospholipase C delta 4 for the zona pellucida-induced acrosome reaction	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRACELLULAR CA2+; MAMMALIAN SPERM; MOUSE SPERM; C DELTA-4; EXOCYTOSIS; BETA; EGGS; FERTILIZATION; SPERMATOZOA	Several phospholipase C (PLC) isoforms have been found in male and female mammalian gametes, and splicing isoforms of PLC delta4 are predominantly expressed in testis. Here we report that male mice in which the PLC delta4 gene had been disrupted either produced few small litters or were sterile. In vitro fertilization studies showed that insemination with PLC delta4(-/-) sperm resulted in significantly fewer eggs becoming activated and that the calcium transients associated with fertilization were absent or delayed. PLC delta4(-/-) sperm were unable to initiate the acrosome reaction, an exocytotic event required for fertilization and induced by interaction with the egg coat, the zona pellucida. These data demonstrate that PLC delta4 functions in the acrosome reaction that is induced by the zona pellucida during mammalian fertilization.	Univ Tokyo, Inst Med Sci, Dept Biochem, Tokyo 1088039, Japan; Univ Tokyo, Inst Med Sci, Div DNA Biol & Embryo Engn, Ctr Med Expt, Tokyo 1088039, Japan; Univ Tokyo, Inst Med Sci, Dept Neurobiol, Tokyo 1088039, Japan; Univ Tokyo, Inst Med Sci, Div Gene Express & Regulat, Tokyo 1088039, Japan; Univ Massachusetts, Paige Lab, Dept Vet & Anim Sci, Amherst, MA 01003 USA; RIKEN, Brian Sci Inst, Wako, Saitama 3510198, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst; RIKEN	Fukami, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Tokyo 1088039, Japan.		Mikoshiba, Katsuhiko/N-7943-2015; Inoue, Takafumi/AAM-9533-2020	Inoue, Takafumi/0000-0002-2728-0060; Kurokawa, Manabu/0000-0002-4138-5934				CAMILLI PD, 1996, SCIENCE, V271, P1533; Dupont G, 1996, BIOCHEM J, V316, P583, DOI 10.1042/bj3160583; FLORMAN HM, 1994, DEV BIOL, V165, P152, DOI 10.1006/dbio.1994.1242; Jones KT, 2000, BIOCHEM J, V346, P743, DOI 10.1042/0264-6021:3460743; Kaznacheyeva E, 2000, J BIOL CHEM, V275, P4561, DOI 10.1074/jbc.275.7.4561; Lee SB, 1996, J BIOL CHEM, V271, P25, DOI 10.1074/jbc.271.1.25; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Llanos MN, 1998, MOL REPROD DEV, V51, P84, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;84::AID-MRD10&gt;3.0.CO;2-U; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; Nolan JP, 1997, FASEB J, V11, P670, DOI 10.1096/fasebj.11.8.9240968; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; Shirakawa H, 1999, DEV BIOL, V208, P70, DOI 10.1006/dbio.1998.9194; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; WARD CR, 1992, J BIOL CHEM, V267, P14061; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wu H, 1998, DEV BIOL, V203, P369, DOI 10.1006/dbio.1998.9070	19	149	150	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					920	923		10.1126/science.1059042	http://dx.doi.org/10.1126/science.1059042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340203				2022-12-28	WOS:000168514900041
J	Fabrega, C; Farrow, MA; Mukhopadhyay, B; de Crecy-Lagard, V; Ortiz, AR; Schimmel, P				Fabrega, C; Farrow, MA; Mukhopadhyay, B; de Crecy-Lagard, V; Ortiz, AR; Schimmel, P			An aminoacyl tRNA synthetase whose sequence fits into neither of the two known classes	NATURE			English	Article							TRANSFER-RNA-SYNTHETASE; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; METHANOCOCCUS-JANNASCHII; TWILIGHT ZONE; SIMILARITIES; ALIGNMENT; PROTEINS; HOMOLOGY; SEARCH	Aminoacyl transfer RNA synthetases catalyse the first step of protein synthesis and establish the rules of the genetic code through the aminoacylation of tRNAs. There is a distinct synthetase for each of the 20 amino acids and throughout evolution these enzymes have been divided into two classes of ten enzymes each(1,2). These classes are defined by the distinct architectures of their active sites, which are associated with specific and universal sequence motifs(1-5). Because the synthesis of aminoacyl-tRNAs containing each of the twenty amino acids is a universally conserved, essential reaction, the absence of a recognizable gene for cysteinyl tRNA synthetase in the genomes of Archae such as Methanococcus jannaschii and Methanobacterium thermoautotrophicum(6-8) has been difficult to interpret. Here we describe a different cysteinyl-tRNA synthetase from M. jannaschii and Deinococcus radiodurans and its characterization in vitro and in vivo. This protein lacks the characteristic sequence motifs seen in the more than 700 known members of the two canonical classes of tRNA synthetase and may be of ancient origin. The existence of this protein contrasts with proposals that aminoacylation with cysteine in M. jannaschii is an auxiliary function of a canonical prolyl-tRNA synthetase(9,10).	Scripps Res Inst, Skaggs Inst Chem Biol, Beckman Ctr, La Jolla, CA 92037 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, Beckman Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Fabrega, Carme/AAZ-5469-2021; de Crecy-Lagard, Valerie/AAN-8995-2020; Fàbrega, MCarme/K-9847-2014	Fàbrega, MCarme/0000-0003-3816-7634; Mukhopadhyay, Biswarup/0000-0003-0736-0298				Abagyan RA, 1997, J MOL BIOL, V273, P355, DOI 10.1006/jmbi.1997.1287; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BOHMAN K, 1979, MOL GEN GENET, V176, P53, DOI 10.1007/BF00334295; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Bunjun S, 2000, P NATL ACAD SCI USA, V97, P12997, DOI 10.1073/pnas.230444397; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1681, DOI 10.1021/bi00869a033; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Glasfeld E, 1996, BIOCHEMISTRY-US, V35, P4139, DOI 10.1021/bi9527810; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hamann CS, 1999, J BACTERIOL, V181, P5880, DOI 10.1128/JB.181.18.5880-5884.1999; HOUNTONDJI C, 1986, BIOCHIMIE, V68, P1071, DOI 10.1016/S0300-9084(86)80181-X; Johnson RA., 2007, APPL MULTIVARIATE ST; Lipman RSA, 2000, BIOCHEMISTRY-US, V39, P7792, DOI 10.1021/bi0004955; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P5059; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Reeve JN, 1999, J BACTERIOL, V181, P3613, DOI 10.1128/JB.181.12.3613-3617.1999; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sambrook J., 2002, MOL CLONING LAB MANU; SHEPARD A, 1992, P NATL ACAD SCI USA, V89, P9964, DOI 10.1073/pnas.89.20.9964; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392	29	25	28	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					110	114		10.1038/35075121	http://dx.doi.org/10.1038/35075121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333988				2022-12-28	WOS:000168432800054
J	Guillin, O; Diaz, J; Carroll, P; Griffon, N; Schwartz, JC; Sokoloff, P				Guillin, O; Diaz, J; Carroll, P; Griffon, N; Schwartz, JC; Sokoloff, P			BDNF controls dopamine D-3 receptor expression and triggers behavioural sensitization	NATURE			English	Article							COCAINE-SEEKING BEHAVIOR; NEUROTROPHIC FACTOR; ANTEROGRADE TRANSPORT; MESSENGER-RNA; RAT-BRAIN; AXONAL-TRANSPORT; NEURONS; LESIONS; SCHIZOPHRENIA; MECHANISM	Brain-derived neurotrophic factor (BDNF), like other neurotrophins, is a polypeptidic factor initially regarded to be responsible for neuron proliferation, differentiation and survival, through its uptake at nerve terminals and retrograde transport to the cell body(1). A more diverse role for BDNF has emerged progressively from observations showing that it is also transported anterogradely(2,3), is released on neuron depolarization(1), and triggers rapid intracellular signals(4) and action potentials in central neurons(5). Here we report that BDNF elicits long-term neuronal adaptations by controlling the responsiveness of its target neurons to the important neurotransmitter, dopamine. Using lesions and gene-targeted mice lacking BDNF, we show that BDNF from dopamine neurons is responsible for inducing normal expression of the dopamine D-3 receptor in nucleus accumbens(6-8) both during development and in adulthood. BDNF from corticostriatal neurons(3) also induces behavioural sensitization, by triggering overexpression of the D-3 receptor in striatum of hemiparkinsonian rats(9). Our results suggest that BDNF may be an important determinant of pathophysiological conditions such as drug addiction(10), schizophrenia(11) or Parkinson's disease(12), in which D-3 receptor expression is abnormal.	Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, F-75014 Paris, France; Univ Paris 05, Physiol Lab, F-75006 Paris, France; INSERM, U382, IBDM, Unite Dev & Pathol Motoneurone Spinal, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Sokoloff, P (corresponding author), Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, 2Ter Rue Alesia, F-75014 Paris, France.		Carroll, Patrick/AAL-7773-2021	Diaz, Jorge/0000-0001-9894-0444				Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Bordet R, 1997, P NATL ACAD SCI USA, V94, P3363, DOI 10.1073/pnas.94.7.3363; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; COLE DG, 1994, P NATL ACAD SCI USA, V91, P9631, DOI 10.1073/pnas.91.20.9631; Conner JM, 1997, J NEUROSCI, V17, P2295; Diaz J, 1997, J NEUROSCI, V17, P4282; DIAZ J, 1995, NEUROSCIENCE, V65, P731, DOI 10.1016/0306-4522(94)00527-C; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Flores G, 1996, J NEUROSCI, V16, P2020; Gurevich EV, 1997, ARCH GEN PSYCHIAT, V54, P225; Horger BA, 1999, J NEUROSCI, V19, P4110; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEVESQUE D, 1995, P NATL ACAD SCI USA, V92, P1719, DOI 10.1073/pnas.92.5.1719; Numan S, 1997, EUR J NEUROSCI, V9, P489, DOI 10.1111/j.1460-9568.1997.tb01626.x; OBRIEN CP, 1992, RES P ARNMD, V70, P157; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Ryoo HL, 1998, MOVEMENT DISORD, V13, P788, DOI 10.1002/mds.870130506; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Staley JK, 1996, J NEUROSCI, V16, P6100; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996	30	456	472	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					86	89		10.1038/35075076	http://dx.doi.org/10.1038/35075076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333982				2022-12-28	WOS:000168432800048
J	Okabe, M; Imai, T; Kurusu, M; Hiromi, Y; Okano, H				Okabe, M; Imai, T; Kurusu, M; Hiromi, Y; Okano, H			Translational repression determines a neuronal potential in Drosophila asymmetric cell division	NATURE			English	Article							SENSORY ORGAN DEVELOPMENT; FATE DETERMINATION; GLIAL-CELL; STEM-CELL; PROTEIN; TRAMTRACK; BINDING; NOTCH; RNA; LINEAGE	Asymmetric cell division is a fundamental strategy for generating cellular diversity during animal development(1). Daughter cells manifest asymmetry in their differential gene expression. Transcriptional regulation of this process has been the focus of many studies, whereas cell-type-specific 'translational' regulation has been considered to have a more minor role. During sensory organ development in Drosophila, Notch signalling directs the asymmetry between neuronal and non-neuronal lineages(2), and a zinc-finger transcriptional repressor Tramtrack69 (TTK69) acts downstream of Notch as a determinant of non-neuronal identity(3,4). Here we show that repression of TTK69 protein expression in the neuronal lineage occurs translationally rather than transcriptionally. This translational repression is achieved by a direct interaction between cis-acting sequences in the 3' untranslated region of ttk69 messenger RNA and its trans-acting repressor, the RNA-binding protein Musashi (MSI)(5). Although msi can act downstream of Notch, Notch signalling does not affect MSI expression. Thus, Notch signalling is likely to regulate MSI activity rather than its expression. Our results define cell-type-specific translational control of ttk69 by MSI as a downstream event of Notch signalling in asymmetric cell division.	Grad Univ Adv Studies, Div Dev Genet, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; Osaka Univ, Grad Sch Med, Dept Neurosci,Biomed Res Ctr, Div Neuroanat D12, Osaka 5650871, Japan; Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Neurosci Lab, Osaka 5608531, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058572, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Minato Ku, Tokyo 1050011, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Osaka University; Keio University; Osaka University; University of Tsukuba; Japan Science & Technology Agency (JST)	Okabe, M (corresponding author), Grad Univ Adv Studies, Div Dev Genet, Natl Inst Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.		Okano, Hideyuki/I-7584-2019; Imai, Takao/L-1232-2013					BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; GHYSEN A, 1989, DEVELOPMENT, V105, P35; Giesen K, 1997, DEVELOPMENT, V124, P2307; Goto S, 1997, DEV GENES EVOL, V207, P194, DOI 10.1007/s004270050107; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Jin MH, 2000, MOL CELL BIOL, V20, P2098, DOI 10.1128/MCB.20.6.2098-2107.2000; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Ramaekers G, 1997, DEV GENES EVOL, V207, P97, DOI 10.1007/s004270050096; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SPANA EP, 1995, DEVELOPMENT, V121, P3187; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	29	149	161	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					94	98		10.1038/35075094	http://dx.doi.org/10.1038/35075094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333984				2022-12-28	WOS:000168432800050
J	Wessely, S				Wessely, S			Chronic fatigue: Symptom and syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; MULTIPLE-SCLEROSIS; PRIMARY-CARE; FIBROMYALGIA; MEMORY; SCALE	Chronic fatigue is common, is difficult to measure, can be associated with considerable morbidity, and is rarely a subject of controversy. The chronic fatigue syndrome also presents problems in definition and measurement, is associated with even more morbidity than chronic fatigue itself, and is often controversial. Particularly unclear is the way in which chronic fatigue and the chronic fatigue syndrome relate to each other: Is one the severe form of the other, or are they qualitatively and quantitatively different? We know that many things can cause chronic fatigue, and this is probably true for the chronic fatigue syndrome, too. We can anticipate that discrete causes of the chronic fatigue syndrome will be found in the future, even if these causes are unlikely to fall neatly along the physical-psychological divide that some expect. The causes of chronic fatigue are undoubtedly many, both in a population and in any individual person, even when a discrete cause, such as depression or cancer, is identified. Social, behavioral, and psychological variables are important in both chronic fatigue and the chronic fatigue syndrome. Interventions that address these general variables can be successful, and currently they are often more successful than interventions directed at specific causes.	Guys Kings & St Thomass Sch Med, Acad Dept Psychol Med, London SE5 8AF, England; Inst Psychiat, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Wessely, S (corresponding author), Guys Kings & St Thomass Sch Med, Acad Dept Psychol Med, 103 Denmark Hill, London SE5 8AF, England.	s.wessely@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929				Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; BELZA BL, 1995, J RHEUMATOL, V22, P639; CATHEBRAS PJ, 1992, J GEN INTERN MED, V7, P276, DOI 10.1007/BF02598083; Cauch-Dudek K, 1998, GUT, V43, P705, DOI 10.1136/gut.43.5.705; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CHEN MK, 1986, PREV MED, V15, P74, DOI 10.1016/0091-7435(86)90037-X; Dalakas MC, 1998, SEMIN ONCOL, V25, P48; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; DeLuca J, 1997, J PSYCHIAT RES, V31, P83, DOI 10.1016/S0022-3956(96)00052-0; Demitrack MA, 1998, PSYCHIAT CLIN N AM, V21, P671, DOI 10.1016/S0193-953X(05)70031-9; DOHRENWEND BP, 1970, AM J PSYCHIAT, V126, P1611, DOI 10.1176/ajp.126.11.1611; DROSSMAN DA, 1992, ANN INTERN MED, V116, P1009, DOI 10.7326/0003-4819-116-12-1009; Ford H, 1998, J PSYCHOSOM RES, V45, P33, DOI 10.1016/S0022-3999(98)00004-X; Goshorn RK, 1998, SEMIN NEUROL, V18, P237, DOI 10.1055/s-2008-1040876; HICKIE I, 1995, PSYCHOL MED, V25, P925, DOI 10.1017/S0033291700037417; Hickie IB, 1996, MED J AUSTRALIA, V164, P585, DOI 10.5694/j.1326-5377.1996.tb122199.x; JASON L, 1998, UNDERSTANDING CHRONI; Jason L A, 1999, J Health Psychol, V4, P9, DOI 10.1177/135910539900400103; Joyce E, 1996, J NEUROL NEUROSUR PS, V60, P495, DOI 10.1136/jnnp.60.5.495; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LANE TJ, 1990, AM J MED SCI, V299, P313, DOI 10.1097/00000441-199005000-00005; LANGNER TS, 1962, J HEALTH HUM BEHAV, V3, P269; Lawrie SM, 1997, PSYCHOL MED, V27, P995, DOI 10.1017/S0033291797005370; Levine Paul H., 1998, American Journal of Medicine, V105, p100S, DOI 10.1016/S0002-9343(98)00181-8; Machale SM, 2000, BRIT J PSYCHIAT, V176, P550, DOI 10.1192/bjp.176.6.550; Marshall PS, 1997, PSYCHOSOM MED, V59, P58, DOI 10.1097/00006842-199701000-00008; Mawle AC, 1997, J INFECT DIS, V175, P136, DOI 10.1093/infdis/175.1.136; MIKKELSSON M, 1992, ARCH PHYS MED REHAB, V73, P814; Mosso A., 1904, FATIGUE; Muscio B, 1921, B J PSYCHOL-GEN SECT, V12, P31, DOI 10.1111/j.2044-8295.1921.tb00036.x; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Pinard G, 1974, Mod Probl Pharmacopsychiatry, V7, P8; RAY C, 1992, PSYCHOL HEALTH, V7, P27, DOI 10.1080/08870449208404293; Reid S, 2000, BMJ-BRIT MED J, V320, P292, DOI 10.1136/bmj.320.7230.292; ROSE G, 1978, BRIT MED J, V2, P873, DOI 10.1136/bmj.2.6141.873; Shorter E., 1992, PARALYSIS FATIGUE HI; Smets EMA, 1998, J PSYCHOSOM RES, V45, P277, DOI 10.1016/S0022-3999(97)00286-9; Steele Lea, 1998, American Journal of Medicine, V105, p83S, DOI 10.1016/S0002-9343(98)00158-2; Taylor RR, 2000, PSYCHOL MED, V30, P849, DOI 10.1017/S0033291799002500; TIBBLIN G, 1990, Scandinavian Journal of Primary Health Care, V8, P9, DOI 10.3109/02813439008994923; Wang B, 1998, J RHEUMATOL, V25, P892; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1998, CHRONIC FATIGUE ITS; Wright JB, 1998, ARCH DIS CHILD, V79, P368, DOI 10.1136/adc.79.4.368	45	79	81	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			838	843		10.7326/0003-4819-134-9_Part_2-200105011-00007	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00007			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346319				2022-12-28	WOS:000168543100007
J	Lorains, JW; Henry, C; Agbamu, DA; Rossi, M; Bishop, M; Will, RG; Ironside, JW				Lorains, JW; Henry, C; Agbamu, DA; Rossi, M; Bishop, M; Will, RG; Ironside, JW			Variant Creutzfeldt-Jakob disease in an elderly patient	LANCET			English	Article							DIAGNOSIS; UK	We report a case of variant Creutzfeldt-Jakob disease (vCJD) in a 74-year old man in whom diagnosis was made at necropsy, The occurrence of vCJD in an individual in this age group is unlikely to be an isolated event. Doctors need to be aware that vCJD can arise in elderly patients so that appropriate investigations [including magnetic resonance imaging) can be done, and permission for neuropathological necropsy requested, in suspected cases. This case could also have important implications for public health policy decisions and surveillance programmes that target the younger age range of vCJD cases.	Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Walton Ctr, Liverpool, Merseyside, England	University of Edinburgh; Walton Centre	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.			Ironside, James/0000-0001-5869-2108				Andrews NJ, 2000, LANCET, V356, P481, DOI 10.1016/S0140-6736(00)02559-9; Ironside JW, 1996, NEUROPATH APPL NEURO, V22, P388, DOI 10.1111/j.1365-2990.1996.tb00908.x; Ironside JW, 2000, HISTOPATHOLOGY, V37, P1, DOI 10.1046/j.1365-2559.2000.00946.x; Will RG, 2000, ANN NEUROL, V47, P575; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	5	29	29	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1339	1340		10.1016/S0140-6736(00)04504-9	http://dx.doi.org/10.1016/S0140-6736(00)04504-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343744				2022-12-28	WOS:000168411400017
J	Sellman, BR; Mourez, M; Collier, RJ				Sellman, BR; Mourez, M; Collier, RJ			Dominant-negative mutants of a toxin subunit: An approach to therapy of anthrax	SCIENCE			English	Article							PROTECTIVE ANTIGEN; LETHAL FACTOR; MACROPHAGES; TRANSLOCATION; RECEPTOR; EFFICACY; TERMINUS; CHANNEL; SURFACE; CELLS	The protective antigen moiety of anthrax toxin translocates the toxin's enzymic moieties to the cytosol of mammalian cells by a mechanism that depends on its ability to heptamerize and insert into membranes. We identified dominant-negative mutants of protective antigen that co-assemble with the wild-type protein and block its ability to translocate the enzymic moieties across membranes. These mutants strongly inhibited toxin action in cell culture and in an animal intoxication model, suggesting that they could be useful in therapy of anthrax.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.			Collier, R John/0000-0002-2427-4239	NIAID NIH HHS [5T32AI07410, R37-AI22021] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022021, T32AI007410] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; IVINS BE, 1989, APPL ENVIRON MICROB, V55, P2098, DOI 10.1128/AEM.55.8.2098-2100.1989; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOEHLER TM, 1991, MOL MICROBIOL, V5, P1501, DOI 10.1111/j.1365-2958.1991.tb00796.x; Leppla S.H., 1991, SOURCEBOOK BACTERIAL, P277; McBride B, 1998, VACCINE, V16, P810, DOI 10.1016/S0264-410X(97)00268-5; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; RAPUOLI R, 2000, CELLULAR MICROBIOLOG, P193; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; SINGH Y, IN PRESS J BIOL CHEM; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WALKER B, 1992, J BIOL CHEM, V267, P21782; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i	26	165	178	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					695	697		10.1126/science.109563	http://dx.doi.org/10.1126/science.109563			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326092	Green Submitted			2022-12-28	WOS:000168478300042
J	Kenyon, C				Kenyon, C			A conserved regulatory system for aging	CELL			English	Review							EXTENDS LIFE-SPAN; EXTENSION; MECHANISMS; HOMOLOG; KINASE; CHICO; CELL		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu						Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; FABRIZIO P, 2001, SCIENCE         0405; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kenyon C, 1996, CELL, V84, P501, DOI 10.1016/S0092-8674(00)81024-7; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8	18	384	420	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					165	168		10.1016/S0092-8674(01)00306-3	http://dx.doi.org/10.1016/S0092-8674(01)00306-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336665	Bronze			2022-12-28	WOS:000168384300002
J	Min, JR; Landry, J; Sternglanz, R; Xu, RM				Min, JR; Landry, J; Sternglanz, R; Xu, RM			Crystal structure of a SIR2 homolog-NAD complex	CELL			English	Article							SILENCING PROTEIN SIR2; SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; DEACETYLASE ACTIVITY; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; DIFFRACTION DATA; GENE-EXPRESSION; ZINC RIBBON; YEAST	The SIR2 protein family comprises a novel class of nicotinamide-adenine dinucleotide (NAD)-dependent protein deacetylases that function in transcriptional silencing, DNA repair, and life-span extension in Saccharomyces cerevisiae. Two crystal structures of a SIR2 homolog from Archaeoglobus fulgidus complexed with NAD have been determined at 2.1 Angstrom and 2.4 Angstrom resolutions. The structures reveal that the protein consists of a large domain having a Rossmann fold and a small domain containing a three-stranded zinc ribbon motif. NAD is bound in a pocket between the two domains. A distinct mode of NAD binding and an unusual configuration of the zinc ribbon motif are observed. The structures also provide important insights into the catalytic mechanism of NAB-dependent protein deacetylation by this family of enzymes.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Xu, RM (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Min, Jinrong/G-3449-2011; xu, rui/GRX-5734-2022	Min, Jinrong/0000-0001-5210-3130; 	NIGMS NIH HHS [GM55641] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055641] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; ALLSHIRE RC, 1996, EPIGENETIC MECH GENE, P443; APARICIO OM, 1991, CELL, V66, P1; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cockell MM, 2000, GENETICS, V154, P1069; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3; Gottschling DE, 2000, CURR BIOL, V10, pR708, DOI 10.1016/S0960-9822(00)00714-4; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Holm L, 1996, METHOD ENZYMOL, V266, P653; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; RINE J, 1987, GENETICS, V116, P9; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Wang B, 1998, STRUCTURE, V6, P555, DOI 10.1016/S0969-2126(98)00058-6; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	55	260	274	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					269	279		10.1016/S0092-8674(01)00317-8	http://dx.doi.org/10.1016/S0092-8674(01)00317-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336676	Bronze			2022-12-28	WOS:000168384300013
J	Harada, Y; Ohara, O; Takatsuki, A; Itoh, H; Shimamoto, N; Kinosita, K				Harada, Y; Ohara, O; Takatsuki, A; Itoh, H; Shimamoto, N; Kinosita, K			Direct observation of DNA rotation during transcription by Escherichia coli RNA polymerase	NATURE			English	Article							SINGLE MOLECULES; MOTOR	Helical filaments driven by linear molecular motors are anticipated to rotate around their axis, but rotation consistent with the helical pitch has not been observed. 14S dynein(1) and non-claret disjunctional protein (ncd)(2) rotated a microtubule more efficiently than expected for its helical pitch, and myosin rotated an actin filament only poorly(3). For DNA-based motors such as RNA polymerase, transcription-induced supercoiling of DNA(4) supports the general picture of tracking along the DNA helix(5). Here we report direct and real-time optical microscopy measurements of rotation rate that are consistent with high-fidelity tracking. Single RNA polymerase molecules attached to a glass surface rotated DNA for >100 revolutions around the right-handed screw axis of the double helix with a rotary torque of >5 pN nm. This real-time observation of rotation opens the possibility of resolving individual transcription steps.	Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; CREST, Genet Programming, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan; Kazusa DNA Res Inst, Kisarazu 2920812, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	Keio University; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute; Hamamatsu Photonics; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Harada, Y (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Hiyoshi 3-14-1, Yokohama, Kanagawa 2238522, Japan.		Ohara, Osamu/G-5448-2015; Ohara, Osamu/A-9119-2012; Shimamoto, Nobuo/AAJ-4999-2020	Ohara, Osamu/0000-0002-3328-9571; Shimamoto, Nobuo/0000-0001-7579-0084				Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DeRosier DJ, 1998, CELL, V93, P17, DOI 10.1016/S0092-8674(00)81141-1; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Strick T, 1999, PHYSICA A, V263, P392, DOI 10.1016/S0378-4371(98)00540-8; STRYER I, 1995, BIOCHEMISTRY; STUDIER FW, 1975, J MOL BIOL, V94, P283, DOI 10.1016/0022-2836(75)90083-2; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; VALE RD, 1988, CELL, V52, P459, DOI 10.1016/S0092-8674(88)80038-2; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	22	179	188	0	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					113	115		10.1038/35051126	http://dx.doi.org/10.1038/35051126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343125				2022-12-28	WOS:000166175600051
J	Gnatt, AL; Cramer, P; Fu, JH; Bushnell, DA; Kornberg, RD				Gnatt, AL; Cramer, P; Fu, JH; Bushnell, DA; Kornberg, RD			Structural basis of transcription: An RNA polymerase II elongation complex at 3.3 angstrom resolution	SCIENCE			English	Article							CRYSTAL-STRUCTURE; DNA-POLYMERASE; TERNARY COMPLEXES; INITIATION; MECHANISM; PROMOTER; HYBRID; REPLICATION; TRANSITIONS; SUBUNITS	The crystal structure of RNA polymerase II in the act of transcription was determined at 3.3 Angstrom resolution. Duplex DNA is seen entering the main cleft of the enzyme and unwinding before the active site. Nine base pairs of DNA-RNA hybrid extend from the active center at nearly right angles to the entering DNA, with the 3' end of the RNA in the nucleotide addition site. The 3' end is positioned above a pore, through which nucleotides may enter and through which RNA may be extruded during back-tracking. The 5'-most residue of the RNA is close to the point of entry to an exit groove. Changes in protein structure between the transcribing complex and free enzyme include closure of a clamp over the DNA and RNA and ordering of a series of "switches" at the base of the clamp to create a binding site complementary to the DNA-RNA hybrid. Protein-nucleic acid contacts help explain DNA and RNA strand separation, the specificity of RNA synthesis, "abortive cycling" during transcription initiation, and RNA and DNA translocation during transcription elongation.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.				NIGMS NIH HHS [GM49985] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTHOLOME K, 1982, J INHERIT METAB DIS, V5, P7, DOI 10.1007/BF01799747; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Conaway RC, 1997, PROG NUCLEIC ACID RE, V56, P327, DOI 10.1016/S0079-6603(08)61009-0; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; CRAMER P, 2001, SCIENCE, V292, P1882; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; GRZESKOWIAK K, 1993, BIOCHEMISTRY-US, V32, P8923, DOI 10.1021/bi00085a025; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; JIN DJ, 1994, J MOL BIOL, V236, P72, DOI 10.1006/jmbi.1994.1119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KINSELLA L, 1982, BIOCHEMISTRY-US, V21, P2719, DOI 10.1021/bi00540a022; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; NUDLER E, 1997, CELL, V89, P38; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; TINTUT Y, 1995, J BIOL CHEM, V270, P24392, DOI 10.1074/jbc.270.41.24392; Wooddell CI, 2000, BIOCHEMISTRY-US, V39, P13405, DOI 10.1021/bi0014249; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	40	717	746	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1876	1882		10.1126/science.1059495	http://dx.doi.org/10.1126/science.1059495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11313499	Green Published			2022-12-28	WOS:000169200700040
J	Audet, MC; Moreau, M; Koltun, WD; Waldbaum, AS; Shangold, G; Fisher, AC; Creasy, GW				Audet, MC; Moreau, M; Koltun, WD; Waldbaum, AS; Shangold, G; Fisher, AC; Creasy, GW		ORTHO EVRA EVRA 004 Study Grp	Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							1995 NATIONAL-SURVEY; FAMILY GROWTH; PHARMACOKINETICS; DISCONTINUATION; FAILURE; PILL	Context Oral contraceptive (OC) pills are effective, but poor compliance increases rates of pregnancy during treatment. Objective To compare the contraceptive efficacy, cycle control, compliance, and safety of a transdermal contraceptive patch and an OC, Design Randomized, open-label, parallel-group trial conducted October 1997 to June 1999. Setting Forty-five clinics in the United States and Canada. Participants A total of 1417 healthy adult women of child-bearing potential. Interventions Participants were randomly assigned to receive a transdermal contraceptive patch (n=812) vs an OC (n=605) for 6 or 13 cycles. Patch treatment consisted of application of 3 consecutive 7-day patches followed by 1 patch-free week. Main Outcome Measures Overall and method-failure Pearl Indexes (number of pregnancies/100 person-years of use) and life-table estimates of the probability of pregnancy were calculated. Cycle control, compliance, patch adhesion, and adverse events were also assessed. Results Overall and method-failure Pearl Indexes were numerically lower with the patch (1.24 and 0.99, respectively) vs the OC (2.18 and 1.25, respectively); this difference was not statistically significant (P=.57 and .80, respectively), The incidence of breakthrough bleeding and/or spotting was significantly higher only in the first 2 cycles in the patch group, but the incidence of breakthrough bleeding alone was comparable between treatments in all cycles. The mean proportion of participants' cycles with perfect compliance was 88.2% (811 total participants, 5141 total cycles) with the patch and 77.7% (605 total participants, 4134 total cycles) with the OC (P <.001). Only 1.8% (300/16673) of patches completely detached. Both treatments were similarly well tolerated; however, application site reactions, breast discomfort, and dysmenorrhea were significantly more common in the patch group. Conclusion The contraceptive patch is comparable to a combination OC in contraceptive efficacy and cycle control. Compliance was better with the weekly contraceptive patch than with the OC.	RW Johnson Pharmaceut Res Inst, Dept Clin Res, Raritan, NJ 08869 USA; Ctr Med Halles de St Foy, Ste Foy, PQ, Canada; Ctr Hosp Univ Montreal, Dept Obstet Gynecol, Montreal, PQ, Canada; Med Ctr Womens Clin Res, San Diego, CA USA	Johnson & Johnson; Johnson & Johnson USA; Universite de Montreal	Creasy, GW (corresponding author), RW Johnson Pharmaceut Res Inst, Dept Clin Res, 920 Route 202,POB 300, Raritan, NJ 08869 USA.	gcreasy@prius.jnj.com		Creasy, George/0000-0002-6645-4238				Abrams L, 2000, FASEB J, V14, pA1479; Abrams LS, 2000, CLIN PHARMACOL THER, V67, P105; Abrams LS, 2000, CLIN PHARMACOL THER, V67, P106; Bishop Y.M.M., 1975, DISCRETE MULTIVARIAT, P486; *COMM PROPR MED PR, 2000, NOT GUID CLIN INV ST, P3; CREASY G, 2000, FERTIL STERIL, V74, pS185; CREASY G, 1995, OBSTET GYNECOL S, V95, pS60; CROMER BA, 1994, PEDIATRICS, V94, P687; Fu HS, 1999, FAM PLANN PERSPECT, V31, P56, DOI 10.2307/2991640; Hatcher RA, 1998, CONTRACEPTIVE TECHNO, P405; Huezo CM, 1998, INT J GYNECOL OBSTET, V62, pS3; KAUNITZ AM, 1995, MED CLIN N AM, V79, P1377, DOI 10.1016/S0025-7125(16)30007-4; Mosher William D, 1998, FAMILY PLANNING PERS, V30, P46; Piccinino LJ, 1998, FAM PLANN PERSPECT, V30, P4, DOI 10.2307/2991517; Potter L, 1996, FAM PLANN PERSPECT, V28, P154, DOI 10.2307/2136191; Roach J, 2000, FASEB J, V14, pA1341; ROSENBERG MJ, 1995, CONTRACEPTION, V51, P283, DOI 10.1016/0010-7824(95)00074-K; Rosenberg MJ, 1998, FAM PLANN PERSPECT, V30, P89, DOI 10.2307/2991665; Skee D, 2000, CLIN PHARMACOL THER, V67, P159; Skee D, 2000, CLIN PHARMACOL THER, V67, P160; Thorne EG, 2000, FASEB J, V14, pA1341; Trussell J, 1999, FAM PLANN PERSPECT, V31, P64, DOI 10.2307/2991641; TRUSSELL J, 1998, CONTRACEPTIVE TECHNO, P211	23	209	216	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2347	2354		10.1001/jama.285.18.2347	http://dx.doi.org/10.1001/jama.285.18.2347			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343482				2022-12-28	WOS:000168411200026
J	Brown, MG; Dokun, AO; Heusel, JW; Smith, HRC; Beckman, DL; Blattenberger, EA; Dubbelde, CE; Stone, LR; Scalzo, AA; Yokoyama, WM				Brown, MG; Dokun, AO; Heusel, JW; Smith, HRC; Beckman, DL; Blattenberger, EA; Dubbelde, CE; Stone, LR; Scalzo, AA; Yokoyama, WM			Vital involvement of a natural killer cell activation receptor in resistance to viral infection	SCIENCE			English	Article							GENE-COMPLEX; MOUSE CHROMOSOME-6; PHYSICAL MAP; LOCUS CMV1; IN-VIVO; LY49; MOUSE-CHROMOSOME-6; DEPLETION; SUBSETS; CONTIG	Natural killer (NK) cells are lymphocytes that can be distinguished from T and B cells through their involvement in innate immunity and their lack of rearranged antigen receptors. Although NK cells and their receptors were initially characterized in terms of tumor killing in vitro, we have determined that the NK cell activation receptor, Ly-49H, is critically involved in resistance to murine cytomegalovirus in vivo. Ly-49H requires an immunoreceptor tyrosine-based activation motif (ITAM)-containing transmembrane molecule for expression and signal transduction. Thus, NK cells use receptors functionally resembling ITAM-coupled T and B cell antigen receptors to provide vital innate host defense.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA; Mt Sinai Sch Med, Immunobiol Grad Program, New York, NY 10029 USA; Univ Western Australia, Dept Microbiol, Nedlands, WA 6907, Australia	Howard Hughes Medical Institute; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; University of Western Australia	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA.		Heusel, Jon/AAC-8050-2021; Brown, Michael G/AAX-5569-2021	Brown, Michael G/0000-0003-2872-7685				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Bakker ABH, 2000, HUM IMMUNOL, V61, P18, DOI 10.1016/S0198-8859(99)00160-3; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Brown MG, 1999, J IMMUNOL, V163, P1991; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Forbes CA, 1997, GENOMICS, V41, P406, DOI 10.1006/geno.1997.4667; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; McQueen KL, 1999, IMMUNOGENETICS, V49, P685, DOI 10.1007/s002510050665; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Tay CH, 1999, J IMMUNOL, V162, P718; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Yokoyama WM, 2000, NAT IMMUNOL, V1, P95, DOI 10.1038/77878	25	487	495	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					934	937		10.1126/science.1060042	http://dx.doi.org/10.1126/science.1060042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340207				2022-12-28	WOS:000168514900045
J	Tapon, N; Ito, N; Dickson, BJ; Treisman, JE; Hariharan, IK				Tapon, N; Ito, N; Dickson, BJ; Treisman, JE; Hariharan, IK			The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation	CELL			English	Article							EKER RAT MODEL; TSC2 GENE; CYCLIN-E; S-PHASE; PHOSPHOINOSITIDE 3-KINASE; IMAGINAL DISC; PRODUCT; SIZE; HAMARTIN; EYE	The inherited human disease tuberous sclerosis, characterized by hamartomatous tumors, results from mutations in either TSC1 or TSC2. We have characterized mutations in the Drosophila Tsc1 and Tsc2/gigas genes. Inactivating mutations in either gene cause an identical phenotype characterized by enhanced growth and increased cell sire with no change in ploidy. Overall, mutant cells spend less time in G1. Coexpression of both Tsc1 and Tsc2 restricts tissue growth and reduces cell size and cell proliferation. This phenotype is modulated by manipulations in cyclin levels. In postmitotic mutant cells, levels of Cyclin E and Cyclin A are elevated. This correlates with a tendency for these cells to reenter the cell cycle inappropriately as is observed in the human lesions.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Mol Neurogenet Unit, Charlestown, MA 02129 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); New York University; New York University	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.		Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Treisman, Jessica/0000-0002-7453-107X; Tapon, Nicolas/0000-0001-5267-6510	NEI NIH HHS [EY11632] Funding Source: Medline; NIGMS NIH HHS [GM61672] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061672] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avedisov SN, 2000, MOL CELL BIOL, V20, P8220, DOI 10.1128/MCB.20.21.8220-8229.2000; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Edgar BA, 1999, NAT CELL BIOL, V1, pE191, DOI 10.1038/70217; FERRUS A, 1976, NATURE, V260, P425, DOI 10.1038/260425a0; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gomez MR, 1988, TUBEROUS SCLEROSIS; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kobayashi T, 1999, CANCER RES, V59, P1206; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Plank TL, 1998, CANCER RES, V58, P4766; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tsuchiya H, 1996, CANCER RES, V56, P429; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; XU T, 1993, DEVELOPMENT, V117, P1223; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	46	429	440	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2001	105	3					345	355		10.1016/S0092-8674(01)00332-4	http://dx.doi.org/10.1016/S0092-8674(01)00332-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348591	Bronze			2022-12-28	WOS:000168515900004
J	Lee, CT; Yin, QZ; Rudnick, RL; Jacobsen, SB				Lee, CT; Yin, QZ; Rudnick, RL; Jacobsen, SB			Preservation of ancient and fertile lithospheric mantle beneath the southwestern United States	NATURE			English	Article							PERIDOTITE XENOLITHS; COLORADO PLATEAU; SUBCONTINENTAL MANTLE; CONTINENTAL TECTOSPHERE; ISOTOPE SYSTEMATICS; THERMAL STRUCTURE; VOLCANIC FIELD; MOJAVE DESERT; HEAT-FLOW; EVOLUTION	Stable continental regions, free from tectonic activity, are generally found only within ancient cratons-the centres of continents which formed in the Archaean era, 4.0-2.5 Gyr ago. But in the Cordilleran mountain belt of western North America some younger (middle Proterozoic) regions have remained stable(1,2), whereas some older (late Archaean) regions have been tectonically disturbed(1,3), suggesting that age alone does not determine lithospheric strength and crustal stability. Here we report rhenium-osmium isotope and mineral compositions of peridotite xenoliths from two regions of the Cordilleran mountain belt. We found that the younger, undeformed Colorado plateau is underlain by lithospheric mantle that is 'depleted' (deficient in minerals extracted by partial melting of the rock), whereas the older (Archaean), yet deformed, southern Basin and Range province is underlain by 'fertile' lithospheric mantle (not depleted by melt extraction). We suggest that the apparent relationship between composition and lithospheric strength, inferred from different degrees of crustal deformation, occurs because depleted mantle is intrinsically less dense than fertile mantle (due to iron having been lost when melt was extracted from the rock). This allows the depleted mantle to form a thicker thermal boundary layer(4) between the deep convecting mantle and the crust, thus reducing tectonic activity at the surface. The inference that not all Archaean crust developed a strong and thick thermal boundary layer leads to the possibility that such ancient crust may have been overlooked because of its intensive reworking or lost from the geological record owing to preferential recycling.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Lee, CT (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Jacobsen, Stein/ABA-1063-2021; Yin, Qing-Zhu/B-8198-2009; Lee, Cin-Ty/AAV-8155-2021; Jacobsen, Stein/B-1759-2013; Lee, Cin-Ty/A-5469-2008; Rudnick, Roberta Lyn/J-2398-2013	Jacobsen, Stein/0000-0003-2164-0720; Yin, Qing-Zhu/0000-0002-4445-5096; Lee, Cin-Ty/0000-0002-3586-0110; Rudnick, Roberta Lyn/0000-0003-1559-7463				ALIBERT C, 1994, J GEOPHYS RES-SOL EA, V99, P21605, DOI 10.1029/94JB01555; BASS JD, 1995, MINERAL PHYSICS CRYS, P45; BENNETT VC, 1987, GEOL SOC AM BULL, V99, P674, DOI 10.1130/0016-7606(1987)99<674:PCHOTW>2.0.CO;2; BOWRING SA, 1995, SCIENCE, V269, P1535, DOI 10.1126/science.7667634; Boyd F.R., 1987, MAGMATIC PROCESSES P, VVolume 1, P13; Boyd FR, 1997, CONTRIB MINERAL PETR, V128, P228, DOI 10.1007/s004100050305; BREY GP, 1990, J PETROL, V31, P1353, DOI 10.1093/petrology/31.6.1353; BURCHFIEL BC, 1975, AM J SCI, VA275, P363; DICKINSON WR, 1989, ARIZONA GEOL SOC DIG, V0017, P00001, DOI DOI 10.1130/GES00763.1; EHRENBERG SN, 1982, J PETROL, V23, P507, DOI 10.1093/petrology/23.4.507; Handler MR, 1999, GEOCHIM COSMOCHIM AC, V63, P3597, DOI 10.1016/S0016-7037(99)00143-X; HIRTH G, GEOCHEM GEOPHYS GEOS; JORDAN TH, 1978, NATURE, V274, P544, DOI 10.1038/274544a0; Lee C.-T., 1999, P 7 INT KIMB C, P503; Lee CT, 2000, SCIENCE, V289, P1912, DOI 10.1126/science.289.5486.1912; MCDONOUGH WF, 1995, CHEM GEOL, V120, P1535; NYBLADE AA, 1993, J GEOPHYS RES-SOL EA, V98, P12207, DOI 10.1029/93JB00521; POLLACK HN, 1986, EARTH PLANET SC LETT, V80, P175, DOI 10.1016/0012-821X(86)90031-2; Ramo OT, 1998, GEOLOGY, V26, P891; REISBERG L, 1995, NATURE, V376, P159, DOI 10.1038/376159a0; RODEN MF, 1990, J GEOPHYS RES-SOLID, V95, P2811, DOI 10.1029/JB095iB03p02811; Rudnick R.L., 1994, KIMBERLITES RELATED, P336; Rudnick RL, 1998, CHEM GEOL, V145, P395, DOI 10.1016/S0009-2541(97)00151-4; SASS JH, 1994, J GEOPHYS RES-SOL EA, V99, P22093, DOI 10.1029/94JB01891; Shapiro SS, 1999, LITHOS, V48, P135, DOI 10.1016/S0024-4937(99)00027-4; Smith D, 2000, J GEOPHYS RES-SOL EA, V105, P16769, DOI 10.1029/2000JB900103; WALKER RJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1583, DOI 10.1016/0016-7037(89)90240-8; WENDLANDT E, 1993, EARTH PLANET SC LETT, V116, P23, DOI 10.1016/0012-821X(93)90043-9; WERNICKE B, 1988, GEOL SOC AM BULL, V100, P1738, DOI 10.1130/0016-7606(1988)100<1738:BARETA>2.3.CO;2; WILSHIRE HG, 1991, J PETROL, V32, P169, DOI 10.1093/petrology/32.1.169; WINTERBURN PA, 1990, GEOCHIM COSMOCHIM AC, V54, P329, DOI 10.1016/0016-7037(90)90322-C; WOODEN JL, 1990, J GEOPHYS RES-SOLID, V95, P20133, DOI 10.1029/JB095iB12p20133	32	149	161	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					69	73		10.1038/35075048	http://dx.doi.org/10.1038/35075048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333978				2022-12-28	WOS:000168432800044
J	Cosmi, B; Legnani, C; Bernardi, F; Coccheri, S; Palareti, G				Cosmi, B; Legnani, C; Bernardi, F; Coccheri, S; Palareti, G			Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study	BRITISH MEDICAL JOURNAL			English	Article							PROTHROMBIN GENE; THROMBOSIS	Common inherited thrombophilic defects such as factor V Leiden and G20120A mutation of the prothrombin gene inter act synergistically with oral contraceptives to increase the risk of venous thromboembolism.(1 2) The best approach to identify women at higher risk of venous thromboembolism before taking oral contraceptives is controversial. Universal screening is not cost effective because 8000 women need to be screened for factor V Leiden to detect 400 mutations and prevent one episode of venous thromboembolism.(1) Many authors recommend selective screening in women with a personal or family history of venous thromboembolism.(1) However; the effectiveness of this approach has not been proved, The aim of our study was to evaluate the sensitivity and positive predictive value of a family history of venous thromboembolism for identifying common thrombophilic defects in women without thrombosis before taking oral contraceptives.	Univ Hosp S Orsola Malpighi, Unita Ric Clin Trombofilia M Golinelli, Div Angiol, Cardiovasc Dept, I-40138 Bologna, Italy; Univ Ferrara, Dept Biochem & Mol Biol, Ctr Biochim Genoma Umano, I-44100 Ferrara, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Ferrara	Cosmi, B (corresponding author), Univ Hosp S Orsola Malpighi, Unita Ric Clin Trombofilia M Golinelli, Div Angiol, Cardiovasc Dept, I-40138 Bologna, Italy.		bernardi, francesco/F-5443-2013; Cosmi, Benilde/K-9459-2016	Cosmi, Benilde/0000-0003-0606-6038; LEGNANI, CRISTINA/0000-0003-1999-7800				Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; Martinelli I, 1999, ARTERIOSCL THROM VAS, V19, P700, DOI 10.1161/01.ATV.19.3.700; Palareti G, 1999, CONTRACEPTION, V59, P293, DOI 10.1016/S0010-7824(99)00033-5; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127	5	43	44	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1024	1025		10.1136/bmj.322.7293.1024	http://dx.doi.org/10.1136/bmj.322.7293.1024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325765	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168478700019
J	Mani, KS; Rangan, G; Srinivas, HV; Srindharan, VS; Subbakrishna, DK				Mani, KS; Rangan, G; Srinivas, HV; Srindharan, VS; Subbakrishna, DK			Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study	LANCET			English	Article							ANTIEPILEPTIC DRUG-TREATMENT; SODIUM VALPROATE; CARBAMAZEPINE; COMMUNITY; PROGNOSIS; TRIAL	Background Epilepsy is a controllable disorder if detected and treated early. For most families in rural areas of less developed countries. however. treatment can be delayed because of the inaccessibility of specialist neurological assessment facilities. We aimed to find a practical solution to rural epilepsy control by doing a non-randomised trial in south India. Methods 135 patients with partial or generalised tonic-clonic seizures agreed to long-term treatment with phenobarbital (n=68), phenytoin (n=60), or both (n=7). Drugs were given once daily. and at the lowest effective dose, by trained primary-care physicians and health workers. All management was entirely clinical. The main outcome measure was absence of seizures of any type for at least 2 years (terminal remission). Analysis was by intention to treat. Findings The proportion with terminal remission at each of 4 successive years of follow-up ranged from 58% to 66% for patients who were drug compliant and who had a lifetime total of 30 or fewer generalised tonic-clonic seizures. The corresponding range for patients who were not compliant and who had ever had more than 30 such seizures was 6-16%. Multivariate logistic regression analysis confirmed that strict drug compliance and early treatment were important predictors of a 2-year terminal remission. Clinical adverse effects were noted in three (4%) patients on phenobarbital and 67 (43%) of those on phenytoin (mainly in the form of gingival hyperplasia). Interpretation In rural areas of less developed countries. epilepsy control in its early stages can be practical and effective with existing resources. The key to success is a combination of trained primary-care physicians. health workers, inexpensive phenobarbital, drug compliance, health education, and follow-up.	Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore 560029, Karnataka, India; Indian Epilepsy Assoc, Bangalore, Karnataka, India; Karuna Trust, Yelandur, India	National Institute of Mental Health & Neurosciences - India	Subbakrishna, DK (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore 560029, Karnataka, India.	subba@nimhans.kar.nic.in						[Anonymous], 1993, EPILEPSIA, V34, P592; deSilva M, 1996, LANCET, V347, P709, DOI 10.1016/S0140-6736(96)90074-4; DUNCAN JS, 1996, CLIN EPILEPSY, P212; EADIE MJ, 1997, EPILEPSY COMPREHENSI, V2, P1547; ELWES RDC, 1984, NEW ENGL J MED, V311, P944, DOI 10.1056/NEJM198410113111503; FEKSI AT, 1991, LANCET, V337, P406, DOI 10.1016/0140-6736(91)91176-U; HELLER AJ, 1995, J NEUROL NEUROSUR PS, V58, P44, DOI 10.1136/jnnp.58.1.44; Mani KS, 1998, SEIZURE-EUR J EPILEP, V7, P281, DOI 10.1016/S1059-1311(98)80019-8; MANI KS, 1997, EPILEPSY COMPREHENSI, V3, P2835; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Organization WH, 1990, IN SUPP PEOPL EP; Pal DK, 1999, LANCET, V353, P1817, DOI 10.1016/S0140-6736(99)00189-0; Pal DK, 1998, LANCET, V351, P19, DOI 10.1016/S0140-6736(97)06250-8; PLACENCIA M, 1993, EPILEPSY RES, V14, P237, DOI 10.1016/0920-1211(93)90048-C; REYNOLDS EH, 1995, BRIT MED J, V310, P176, DOI 10.1136/bmj.310.6973.176; REYNOLDS EH, 1978, LANCET, V2, P721; REYNOLDS EH, 1987, EPILEPSIA, V28, P97, DOI 10.1111/j.1528-1157.1987.tb03633.x; SMITH DB, 1987, EPILEPSIA, V28, pS50, DOI 10.1111/j.1528-1157.1987.tb05778.x; TRIMBLE MR, 1988, EPILEPSIA, V29, pS15, DOI 10.1111/j.1528-1157.1988.tb05805.x; WATTS AE, 1989, BRIT MED J, V298, P805, DOI 10.1136/bmj.298.6676.805; 1997, LANCET, V349, P1851	22	70	70	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1316	1320		10.1016/S0140-6736(00)04516-5	http://dx.doi.org/10.1016/S0140-6736(00)04516-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343735				2022-12-28	WOS:000168411400009
J	Boolchand, P; Bresser, WJ				Boolchand, P; Bresser, WJ			Mobile silver ions and glass formation in solid electrolytes	NATURE			English	Article							NEUTRON-DIFFRACTION; CONDUCTING GLASSES; ORDER	Solid electrolytes are a class of materials in which the cationic or anionic constituents are not confined to specific lattice sites, but are essentially free to move throughout the structure. The solid electrolytes AgI and Ag2Se (refs 1-7) are of interest for their use as additives in network glasses(8-12), such as chalcogenides and oxides, because the resulting composite glasses can show high electrical conductivities with potential applications for batteries, sensors and displays. Here we show that these composite glasses can exhibit two distinct types of molecular structures-an intrinsic phase-separation that results in a bimodal distribution of glass transition temperatures, and a microscopically homogeneous network displaying a single glass transition temperature. For the first case, the two transition temperatures correspond to the solid-electrolyte glass phase and the main glass phase (the 'base glass'), enabling us to show that the glass transition temperatures for the AgI and Ag2Se phases are respectively 75 and 230 degreesC. Furthermore, we show that the magnitude of the bimodal glass transition temperatures can be quantitatively understood in terms of network connectivity, provided that the Ag+ cations undergo fast-ion motion in the glasses. These results allow us to unambiguously distinguish base glasses in which these additives are homogeneously alloyed from those in which an intrinsic phase separation occurs, and to provide clues to understanding ion-transport behaviour in these superionic conductors.	Univ Cincinnati, Dept Elect & Comp Engn & Comp Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Boolchand, P (corresponding author), Univ Cincinnati, Dept Elect & Comp Engn & Comp Sci, Cincinnati, OH 45221 USA.	punit.boolchand@uc.edu	Boolchand, Punit -/A-3334-2008					ANGELL CA, 1992, ANNU REV PHYS CHEM, V43, P693, DOI 10.1146/annurev.physchem.43.1.693; Barnes AC, 1997, J PHYS-CONDENS MAT, V9, P6159, DOI 10.1088/0953-8984/9/29/002; Boolchand P, 2000, PHILOS MAG B, V80, P1757, DOI 10.1080/13642810008216504; BRADLEY JN, 1967, T FARADAY SOC, V63, P424, DOI 10.1039/tf9676300424; Bunde A, 1998, SOLID STATE IONICS, V105, P1, DOI 10.1016/S0167-2738(97)00444-X; Cramer C, 1998, J PHYS-CONDENS MAT, V10, P6229, DOI 10.1088/0953-8984/10/28/005; Feng XW, 1997, PHYS REV LETT, V78, P4422, DOI 10.1103/PhysRevLett.78.4422; Georgiev DG, 2000, PHYS REV B, V62, pR9228, DOI 10.1103/PhysRevB.62.R9228; Kerner R, 1997, J NON-CRYST SOLIDS, V210, P298, DOI 10.1016/S0022-3093(96)00678-3; Kincs J, 1996, PHYS REV LETT, V76, P70, DOI 10.1103/PhysRevLett.76.70; Micoulaut M, 1998, EUR PHYS J B, V1, P277, DOI 10.1007/s100510050184; MINAMI T, 1980, J NON-CRYST SOLIDS, V42, P469, DOI 10.1016/0022-3093(80)90045-9; Mitkova M, 1999, PHYS REV LETT, V83, P3848, DOI 10.1103/PhysRevLett.83.3848; NIELD VM, 1993, SOLID STATE IONICS, V66, P247, DOI 10.1016/0167-2738(93)90414-X; PHILLIPS JC, 1979, J NON-CRYST SOLIDS, V34, P153, DOI 10.1016/0022-3093(79)90033-4; PHILLIPS JC, 1973, BONDS BANDS SEMICOND, V45; Roling B, 1997, PHYS REV LETT, V78, P2160, DOI 10.1103/PhysRevLett.78.2160; ROUSSELOT C, 1995, SOLID STATE IONICS, V78, P211, DOI 10.1016/0167-2738(95)00103-D; SHASTRY MCR, 1990, P INDIAN AS-CHEM SCI, V102, P541; Slivka V. Yu., 1982, Soviet Physics - Solid State, V24, P392; Swenson J, 1996, PHYS REV LETT, V77, P3569, DOI 10.1103/PhysRevLett.77.3569; Swenson J, 1996, J PHYS-CONDENS MAT, V8, P3545, DOI 10.1088/0953-8984/8/20/003; Thorpe MF, 2000, J NON-CRYST SOLIDS, V266, P859, DOI 10.1016/S0022-3093(99)00856-X; Tubandt C, 1914, Z PHYS CHEM-STOCH VE, V87, P513; ZALLEN R, 1998, PHYSICS AMORPHOUS SO, P190; ZHANG M, 1994, SCIENCE, V266, P1355, DOI 10.1126/science.266.5189.1355	26	151	182	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1070	1073		10.1038/35074049	http://dx.doi.org/10.1038/35074049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323665				2022-12-28	WOS:000168285500041
J	Fischbacher, C; Bhopal, R; Patel, S; White, M; Unwin, N; Alberti, KGMM				Fischbacher, C; Bhopal, R; Patel, S; White, M; Unwin, N; Alberti, KGMM			Anaemia in Chinese, South Asian, and European populations in Newcastle upon Tyne: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS		Univ Newcastle Upon Tyne, Sch Med, Div Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Diabet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Edinburgh, Dept Publ Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	Newcastle University - UK; Newcastle University - UK; University of Edinburgh	Fischbacher, C (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Div Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		White, Martin J. R./G-2410-2010	Fischbacher, Colin/0000-0003-3090-1857; Patel, Sheila/0000-0002-0626-1899; Unwin, Nigel/0000-0002-1368-1648				Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; BRITT RP, 1983, POSTGRAD MED J, V59, P645, DOI 10.1136/pgmj.59.696.645; Harland JO, 1997, J EPIDEMIOL COMMUN H, V51, P636, DOI 10.1136/jech.51.6.636; *HLTH ED AUTH, 2000, BLACK ETHN MIN GROUP; *NHS CTR REV DISS, 1996, ETHN HLTH REV LIT GU	5	12	12	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					958	959		10.1136/bmj.322.7292.958	http://dx.doi.org/10.1136/bmj.322.7292.958			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312228	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168345100018
J	Fricke, C; Lee, JS; Geiger-Rudolph, S; Bonhoeffer, F; Chien, CB				Fricke, C; Lee, JS; Geiger-Rudolph, S; Bonhoeffer, F; Chien, CB			astray, a zebrafish roundabout homolog required for retinal axon guidance	SCIENCE			English	Article							OPTIC CHIASM; C-ELEGANS; RECEPTORS; REPELLENT; MIDLINE; GENES; DISC; SLIT; MAP	As growing retinotectal axons navigate from the eye to the tectum, they sense guidance molecules distributed along the optic pathway. Mutations in the zebrafish astray gene severely disrupt retinal axon guidance, causing anterior-posterior pathfinding defects, excessive midline crossing, and defasciculation of the retinal projection, Eye transplantation experiments show that astray function is required in the eye, We identify astray as zebrafish robo2, a member of the Roundabout family of axon guidance receptors. Retinal ganglion cells express robo2 as they extend axons. Thus, robo2 is required for multiple axon guidance decisions during establishment of the Vertebrate visual projection.	Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; Max Planck Inst Entwicklungsbiol, Abt Phys Biol, D-72076 Tubingen, Germany	Utah System of Higher Education; University of Utah; Max Planck Society; Max Planck Society	Chien, CB (corresponding author), Univ Utah, Med Ctr, Dept Neurobiol & Anat, 401 MREB,50 N Med Dr, Salt Lake City, UT 84132 USA.				NATIONAL EYE INSTITUTE [R01EY012873] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY12873] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; BURRILL JD, 1995, J NEUROSCI, V15, P2935; Chien C. C., UNPUB; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Erskine L, 2000, J NEUROSCI, V20, P4975; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Haffter P, 1996, DEVELOPMENT, V123, P1; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; HUTSON L, UNPUB; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kruger K, 1998, J NEUROSCI, V18, P5692; LEE JS, IN PRESS DEV DYN; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	27	152	155	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					507	510		10.1126/science.1059496	http://dx.doi.org/10.1126/science.1059496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313496				2022-12-28	WOS:000168187300048
J	Lutwick, LI				Lutwick, LI			Brill-Zinsser disease	LANCET			English	Article							EPIDEMIC TYPHUS; TRENCH FEVER; OUTBREAK; LOUSE; BURUNDI		Vet Affairs New York Hlth Care Syst, Brooklyn, NY 11209 USA; SUNY, Downstate Med Sch, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College	Lutwick, LI (corresponding author), Vet Affairs New York Hlth Care Syst, Brooklyn Campus, Brooklyn, NY 11209 USA.	larry.lutwick@med.va.gov						Brill NE, 1910, AM J MED SCI, V139, P484; DUMA RJ, 1981, JAMA-J AM MED ASSOC, V245, P2318, DOI 10.1001/jama.245.22.2318; GREEN CR, 1990, JAMA-J AM MED ASSOC, V264, P1811, DOI 10.1001/jama.1990.03450140031026; Hans Z, 1934, AM J HYG, V20, P513, DOI 10.1093/oxfordjournals.aje.a118091; MURRAY ES, 1951, AM J HYG, V53, P22, DOI 10.1093/oxfordjournals.aje.a119434; PORTNOY J, 1974, CAN MED ASSOC J, V111, P166; PRICE WH, 1958, AM J HYG, V67, P154, DOI 10.1093/oxfordjournals.aje.a119925; PRICE WH, 1954, J BACTERIOL, V69, P106; Raoult D, 1997, EMERG INFECT DIS, V3, P357, DOI 10.3201/eid0303.970313; Raoult D, 1999, CLIN INFECT DIS, V29, P434, DOI 10.1086/520229; Raoult D, 1998, LANCET, V352, P353, DOI 10.1016/S0140-6736(97)12433-3; Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454; REILLY PJ, 1980, WESTERN J MED, V133, P338; SMADEL JE, 1952, AM J HYG, V56, P294, DOI 10.1093/oxfordjournals.aje.a119553; Stein A, 1999, LANCET, V353, P1936, DOI 10.1016/S0140-6736(99)01995-9; Tarasevich I, 1998, LANCET, V352, P1151, DOI 10.1016/S0140-6736(05)79799-3	16	24	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1198	1200		10.1016/S0140-6736(00)04339-7	http://dx.doi.org/10.1016/S0140-6736(00)04339-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323068				2022-12-28	WOS:000168192100035
J	Knill, E; Laflamme, R; Milburn, GJ				Knill, E; Laflamme, R; Milburn, GJ			A scheme for efficient quantum computation with linear optics	NATURE			English	Article							PODOLSKY-ROSEN CHANNELS; EXPERIMENTAL REALIZATION; ERROR-CORRECTION; TELEPORTATION; STATE; ENTANGLEMENT; ALGORITHMS; CODES	Quantum computers promise to increase greatly the efficiency of solving problems such as factoring large integers, combinatorial optimization and quantum physics simulation. One of the greatest challenges now is to implement the basic quantum-computational elements in a physical system and to demonstrate that they can be reliably and scalably controlled. One of the earliest proposals for quantum computation is based on implementing a quantum bit with two optical modes containing one photon. The proposal is appealing because of the ease with which photon interference can be observed. Until now, it suffered from the requirement for non-linear couplings between optical modes containing few photons. Here we show that efficient quantum computation is possible using only beam splitters, phase shifters, single photon sources and photo-detectors. Our methods exploit feedback from photo-detectors and are robust against errors from photon loss and detector inefficiency. The basic elements are accessible to experimental investigation with current technology.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Queensland, Ctr Quantum Comp Technol, St Lucia, Qld, Australia	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Queensland	Knill, E (corresponding author), Los Alamos Natl Lab, MS B265, Los Alamos, NM 87545 USA.	knill@lanl.gov	MIlburn, Gerard J/B-6381-2008	MIlburn, Gerard J/0000-0002-5404-9681				Adleman LM, 1997, SIAM J COMPUT, V26, P1524, DOI 10.1137/S0097539795293639; Aharonov D., 1999, ANN REV COMPUTATIONA, VVI; AHARONOV D, 1996, P 29 ANN ACM S THEOR, P176; Bennett C. H., 1992, Journal of Cryptology, V5, P3, DOI 10.1007/BF00191318; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; Calderbank AR, 1997, PHYS REV LETT, V78, P405, DOI 10.1103/PhysRevLett.78.405; Cerf NJ, 1998, PHYS REV A, V57, pR1477, DOI 10.1103/PhysRevA.57.R1477; CORMEN TH, 1990, INTRO ALGORITHMS, P795; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Dur W, 1999, PHYS REV A, V59, P169, DOI 10.1103/PhysRevA.59.169; Foden CL, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.011803; Gottesman D, 1998, PHYS REV A, V57, P127, DOI 10.1103/PhysRevA.57.127; Gottesman D, 1996, PHYS REV A, V54, P1862, DOI 10.1103/PhysRevA.54.1862; GOTTESMAN D, 2000, QUANTPH0008040; Grassl M, 1997, PHYS REV A, V56, P33, DOI 10.1103/PhysRevA.56.33; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; HONG CK, 1986, PHYS REV LETT, V56, P58, DOI 10.1103/PhysRevLett.56.58; Howell JC, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.052303; Hughes RJ, 2000, J MOD OPTIC, V47, P533, DOI 10.1080/095003400148367; Kim J, 1999, NATURE, V397, P500, DOI 10.1038/17295; KNILL E, 2000, QUANTPH0006120; Kwiat PG, 2000, J MOD OPTIC, V47, P257, DOI 10.1080/095003400148187; Lutkenhaus N, 1999, PHYS REV A, V59, P3295, DOI 10.1103/PhysRevA.59.3295; MILBURN GJ, 1989, PHYS REV LETT, V62, P2124, DOI 10.1103/PhysRevLett.62.2124; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; RECK M, 1994, PHYS REV LETT, V73, P58, DOI 10.1103/PhysRevLett.73.58; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Steane A, 1996, P ROY SOC A-MATH PHY, V452, P2551, DOI 10.1098/rspa.1996.0136; Steane AM, 1999, NATURE, V399, P124, DOI 10.1038/20127; Takeuchi S, 1999, APPL PHYS LETT, V74, P1063, DOI 10.1063/1.123482; Tittel W, 1999, PHYS REV A, V59, P4150, DOI 10.1103/PhysRevA.59.4150; TOWNSEND PD, 1993, ELECTRON LETT, V29, P1291, DOI 10.1049/el:19930862; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Walls D. F., 1994, QUANTUM OPT; Weihs G, 1996, OPT LETT, V21, P302, DOI 10.1364/OL.21.000302; 2000, FORT PHYS, V48, P767	45	4144	4248	28	779	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					46	52		10.1038/35051009	http://dx.doi.org/10.1038/35051009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343107				2022-12-28	WOS:000166175600033
J	Smil, V				Smil, V			Genius loci - The twentieth century was made in Budapest.	NATURE			English	Editorial Material									Univ Manitoba, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Smil, V (corresponding author), Univ Manitoba, Winnipeg, MB R3T 2N2, Canada.								0	8	8	1	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					21	21		10.1038/35051162	http://dx.doi.org/10.1038/35051162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343090				2022-12-28	WOS:000166175600017
J	Liu, HH; Golin, CE; Miller, LG; Hays, RD; Beck, K; Sanandaji, S; Christian, J; Maldonado, T; Duran, D; Kaplan, AH; Wenger, NS				Liu, HH; Golin, CE; Miller, LG; Hays, RD; Beck, K; Sanandaji, S; Christian, J; Maldonado, T; Duran, D; Kaplan, AH; Wenger, NS			A comparison study of multiple measures of adherence to HIV protease inhibitors	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICATION COMPLIANCE; PATIENT COMPLIANCE; THERAPY; INTERVENTIONS; VALIDATION; TRIAL	Background: Poor adherence to HIV protease inhibitors may compromise the effectiveness of treatment. Few studies have compared methods for measuring adherence or have related adherence measures to a clinical outcome. Objective: To examine the relationship among a composite score of adherence, the three primary measures of adherence, and HIV virologic response. Design: Longitudinal cohort study. Setting: Public HIV clinic. Patients: 108 HIV-infected adults receiving protease inhibitors or non-nucleoside reverse transcriptase inhibitors who were monitored for 666 monthly intervals. Measurements: Medication Event Monitoring System (MEMS), pill count, and interview combined into a composite adherence score (CAS), and HIV viral load. Results: Mean antiretroviral adherence differed by adherence measure (MEMS, 0.63; pill count, 0.83; interview, 0.93; and GAS, 0.76). Composite adherence score decreased significantly over time. Composite adherence score, MEMS values, pill values, and interview values were statistically significantly associated with achievement of an undetectable viral load within 6 months of initiating therapy. Composite adherence score showed the strongest predictive relationship (odds ratios for a 10% increase in adherence for GAS, MEMS, pill count and interview, respectively, were 1.26 [95% CI, 1.16 to 1.37], 1.13 [CI, 1.06 to 1.21], 1.10 [CI, 1.02 to 1.19], and 1.35 [CI, 0.93 to 1.94]). Conclusions: Different measures applied to the same patient suggest different levels of adherence. Adherence may be underestimated by MEMS and overestimated by pill count and interview. A summary measure combining several measures is more strongly related to a clinical response, but more practical measurement methods are needed for clinical use.	Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif Los Angeles, Harbor Med Ctr, Sheps Ctr Hlth Serv Res, Los Angeles, CA 90024 USA; Univ N Carolina, Chapel Hill, NC USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Liu, HH (corresponding author), Div Gen Internal Med & Hlth Serv Res, 911 Broxton Plaza,Room 102,Box 951736, Los Angeles, CA 90095 USA.	hhliu@ucla.edu			NIAID NIH HHS [R01 AI 41413] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041413] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*APREX, 1998, MEMS VIEW US GUID VE; BERG JS, 1993, ANN PHARMACOTHER, V27, pS1; Burney KD, 1996, ARCH FAM MED, V5, P297, DOI 10.1001/archfami.5.5.297; CHRISTENSEN DB, 1978, HEALTH SERV RES, V13, P171; CRAMER JA, 1989, JAMA-J AM MED ASSOC, V261, P3273, DOI 10.1001/jama.261.22.3273; CUMMINGS KM, 1984, HEALTH SERV RES, V19, P103; Eldred LJ, 1998, J ACQ IMMUN DEF SYND, V18, P117, DOI 10.1097/00042560-199806010-00003; Farris Karen B., 1994, Journal of Pharmacoepidemiology, V3, P63, DOI 10.1300/J055V03N01_05; Gordis L, 1979, COMPLIANCE HLTH CARE, P23; Grymonpre RE, 1998, ANN PHARMACOTHER, V32, P743, DOI 10.1345/aph.17417; HAYNES RB, 1976, LANCET, V1, P1265; KRUSE W, 1992, J AM GERIATR SOC, V40, P1151, DOI 10.1111/j.1532-5415.1992.tb01806.x; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MASON BJ, 1995, DIABETES EDUCATOR, V21, P52, DOI 10.1177/014572179502100109; MATSUYAMA JR, 1993, ANN PHARMACOTHER, V27, P851, DOI 10.1177/106002809302700705; Mostashari F, 1998, J ACQ IMMUN DEF SYND, V18, P341, DOI 10.1097/00042560-199808010-00005; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pekovic V, 1998, J CLIN EPIDEMIOL, V51, P597, DOI 10.1016/S0895-4356(98)00033-X; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Sorensen JL, 1998, AIDS CARE, V10, P297, DOI 10.1080/713612419; SPILKER B, 1991, PATIENT COMPLIANCE M, P37; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; STROM BL, 1990, EPIDEMIOL REV, V12, P87, DOI 10.1093/oxfordjournals.epirev.a036064; Westfall U E, 1986, Top Clin Nurs, V7, P23	27	581	592	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					968	977		10.7326/0003-4819-134-10-200105150-00011	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	432FX	11352698				2022-12-28	WOS:000168682500005
J	Lawler, A				Lawler, A			US science policy - Former advisers fret over OSTP vacancy	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1041	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352042				2022-12-28	WOS:000168609200011
J	Krause, DS; Theise, ND; Collector, MI; Henegariu, O; Hwang, S; Gardner, R; Neutzel, S; Sharkis, SJ				Krause, DS; Theise, ND; Collector, MI; Henegariu, O; Hwang, S; Gardner, R; Neutzel, S; Sharkis, SJ			Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell	CELL			English	Article							TERM REPOPULATING CELLS; IN-VIVO; HEMATOPOIETIC-CELLS; TRANSCRIPTION FACTOR; CD34(+) CELLS; MICE; BLOOD; HEPATOCYTES; EXPRESSION; DIFFERENTIATION	Purification of rare hematopoietic stem cell(s) (HSC) to homogeneity is required to study their self-renewal, differentiation, phenotype, and homing. Long-term repopulation (LTR) of irradiated hosts and serial transplantation to secondary hosts represent the gold standard for demonstrating self-renewal and differentiation, the defining properties of HSC, We show that rare cells that home to bone marrow can LTR primary and secondary recipients. During the homing, CD34 and SCA-1 expression increases uniquely on cells that home to marrow. These adult bone marrow cells have tremendous differentiative capacity as they can also differentiate into epithelial cells of the liver, lung, GI tract, and skin. This finding may contribute to clinical treatment of genetic disease or tissue repair.	Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21231 USA	Yale University; Yale University; Johns Hopkins University; Johns Hopkins Medicine	Krause, DS (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	diane.krause@yale.edu		Gardner, Rebekah/0000-0001-5823-9178	NCI NIH HHS [P01 CA70970] Funding Source: Medline; NHLBI NIH HHS [R01 HL54330, P01 HL63357] Funding Source: Medline; NIDDK NIH HHS [R01 DK53037, R01 DK53812] Funding Source: Medline; PHS HHS [P30-34989] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054330, P01HL063357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053812, R01DK053037] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Craddock CF, 1997, BLOOD, V90, P4779, DOI 10.1182/blood.V90.12.4779.4779_4779_4788; Donnelly DS, 1999, EXP HEMATOL, V27, P788, DOI 10.1016/S0301-472X(99)00032-6; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; HAWKINS AL, 1992, CANCER GENET CYTOGEN, V64, P145, DOI 10.1016/0165-4608(92)90345-9; Healy L, 1995, P NATL ACAD SCI USA, V92, P12240, DOI 10.1073/pnas.92.26.12240; Ito M, 1997, HUM GENE THER, V8, P57, DOI 10.1089/hum.1997.8.1-57; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; JONES RJ, 1989, BLOOD, V73, P397; KRAUSE DS, 1994, BLOOD, V84, P691; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Magdaleno S M, 1998, Adv Pediatr, V45, P363; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Morel F, 1996, BLOOD, V88, P3774, DOI 10.1182/blood.V88.10.3774.bloodjournal88103774; Nakamura Y, 1999, BLOOD, V94, P4053, DOI 10.1182/blood.V94.12.4053.424k41_4053_4059; NOLTA JA, 1992, EXP HEMATOL, V20, P1065; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; Oosterwijk JC, 1998, CYTOMETRY, V32, P170, DOI 10.1002/(SICI)1097-0320(19980701)32:3<170::AID-CYTO2>3.0.CO;2-O; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pazouki S, 1996, ACTA HISTOCHEM, V98, P29, DOI 10.1016/S0065-1281(96)80047-X; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rosen JM, 1998, BIOCHEM SOC SYMP, P101; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Sun TT, 1984, CANCER CELLS, V1, P169; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; TRAVIS EL, 1985, RADIOTHER ONCOL, V4, P341, DOI 10.1016/S0167-8140(85)80122-5; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zanjani ED, 1998, EXP HEMATOL, V26, P353	42	2101	2390	2	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					369	377		10.1016/S0092-8674(01)00328-2	http://dx.doi.org/10.1016/S0092-8674(01)00328-2			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348593	Bronze			2022-12-28	WOS:000168515900006
J	Ruelle, D				Ruelle, D			Here be no dragons	NATURE			English	Article									Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay	Ruelle, D (corresponding author), Inst Hautes Etud Sci, 35 Route Chartres, F-91440 Bures Sur Yvette, France.							HAO BL, 1990, CHAOS, V2; LASKAR J, 1994, P 11 IOMP M PAR JUL, P75; OVITANOVIC P, 1984, U CHAOS; RUELLE D, 1991, CHANCE CHAOS	5	3	4	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					27	27		10.1038/35075175	http://dx.doi.org/10.1038/35075175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333956	Bronze			2022-12-28	WOS:000168432800024
J	Binder, EF; Williams, DB; Schechtman, KB; Jeffe, DB; Kohrt, WM				Binder, EF; Williams, DB; Schechtman, KB; Jeffe, DB; Kohrt, WM			Effects of hormone replacement therapy on serum lipids in elderly women - A randomized, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; POSTMENOPAUSAL ESTROGEN; CARDIOVASCULAR-DISEASE; FOLLOW-UP; CHOLESTEROL; MORTALITY; OLDER; RISK	Background: Coronary heart disease (CHD) is the leading cause of death among older women. In observational studies, the incidence of CHD has been reduced in postmenopausal women who take hormone replacement therapy (HRT). A low serum level of high-density lipoprotein (HDL) cholesterol is one of the risk factors predictive of death from CHD. Objective: To determine the effects of HRT on serum lipid and lipoprotein levels in elderly women. Design: Randomized, double-blind, placebo-controlled trial. Setting: University research center. Participants: 59 sedentary women 75 years of age or older. Intervention: Participants were assigned to 9 months of oral therapy with placebo or conjugated estrogens, 0.625 mg/d, plus trimonthly medroxyprogesterone acetate, 5 mg/d for 13 days. Measurements: Serum lipid and lipoprotein levels. Results: After 9 months of treatment, women in the HRT group compared with women in the placebo group had decreased low-density lipoprotein cholesterol levels (mean change [+/-SD], -0.47 +/- 0.69 mmol/L [-18.2+/-26.5 mg/dL] vs. -0.06+/-0.32 mmol/L [-2.2 +/-12.2 mg/dL], respectively; between-group difference, 0.41 mmol/L [95% CI, 0.09 to 0.74 mmol/L], 16 mg/dL [95% CI, 3.5 to 28.5 mg/dL]; P = 0.01) and increased HDL cholesterol levels (mean change, 0.21 +/- 0.27 mmol/L [8.1+/-10.5 mg/dL] vs. 0.06+/-0.11 mmol/L [2.4+/-4.3 mg/dL], respectively; between-group difference, 0.15 mmol/L [CI, 0.008 to 0.29 mmol/L], 5.7 mg/dL [CI, 0.8 to 10.6 mg/dL]; P = 0.02). The observed changes were independent of age at menopause onset, baseline lipid values, body weight, waist circumference, percentage body fat, and peak aerobic power. Conclusions: In women 75 years of age or older, HRT improved the lipoprotein profile to the extent observed previously in younger postmenopausal women. Further studies are needed to evaluate whether these effects protect against CHD in this population.	Washington Univ, Sch Med, Div Geriatr & Gerontol, St Louis, MO 63108 USA	Washington University (WUSTL)	Binder, EF (corresponding author), Washington Univ, Sch Med, Div Geriatr & Gerontol, 4488 Forest Pk Blvd,Suite 201, St Louis, MO 63108 USA.	ebinder@imgate.wustl.edu	Jeffe, Donna B./AAI-3732-2020	Jeffe, Donna B./0000-0002-7642-3777	NCRR NIH HHS [5-MO1-RR00036] Funding Source: Medline; NIA NIH HHS [P01-AG13629] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG013629] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrams J, 1995, Curr Probl Cardiol, V20, P533; Binder EF, 1996, J AM GERIATR SOC, V44, P231, DOI 10.1111/j.1532-5415.1996.tb00907.x; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM353, DOI 10.1093/gerona/54.7.M353; Bjorn I, 1999, MATURITAS, V32, P77, DOI 10.1016/S0378-5122(99)00018-3; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CORTI MC, 1995, JAMA-J AM MED ASSOC, V274, P539, DOI 10.1001/jama.274.7.539; ETTINGER B, 1994, OBSTET GYNECOL, V83, P693; Friedman LM., 1981, FUNDAMENTALS CLIN TR; Frost PH, 1996, CIRCULATION, V94, P2381, DOI 10.1161/01.CIR.94.10.2381; Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Holland KR, 1996, NOISE CONTROL ENG, V44, P231, DOI 10.3397/1.2828407; Kannel William B., 1996, Am J Geriatr Cardiol, V5, P9; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; MALENKA DJ, 1988, ARCH INTERN MED, V148, P2247, DOI 10.1001/archinte.148.10.2247; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; *NAT CTR HLTH STAT, 1988, VIT STAT US 1986, V2; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; ZIMETBAUM P, 1992, ARTERIOSCLER THROMB, V12, P416, DOI 10.1161/01.ATV.12.4.416	23	29	34	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					754	760		10.7326/0003-4819-134-9_Part_1-200105010-00012	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329233				2022-12-28	WOS:000168470700005
J	Klapow, JC; Schmidt, SM; Taylor, LA; Roller, P; Li, Q; Calhoun, JW; Wallander, J; Pennebaker, J				Klapow, JC; Schmidt, SM; Taylor, LA; Roller, P; Li, Q; Calhoun, JW; Wallander, J; Pennebaker, J			Symptom management in older primary care patients: Feasibility of an experimental, written self-disclosure protocol	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH; PERCEPTIONS; TRIAL	Background: Distress-driven symptoms are prevalent among older primary care patients and account for a large percentage of office visits and increased medical costs, An experimental written self-disclosure protocol has been shown to reduce symptoms and use of health care services in healthy adults. Written self-disclosure as a method for reducing symptoms has not been evaluated in the primary care setting, Objective: To evaluate the feasibility of adapting an experimental written self-disclosure protocol for the primary care setting. Design: Randomized, single-blind feasibility study. Setting: University-based geriatric and internal medicine primary care clinics. Patients: 45 patients 66 years of age or older without a psychiatric diagnosis, Intervention: Three 20-minute writing sessions focusing on distressing experiences (in the intervention group) or health behaviors (in the control group). Measurements: The feasibility outcomes were patient recruitment, protocol logistics, and patient and provider satisfaction. The clinical outcomes were somatic and distress symptoms, health care utilization, and associated costs. Results: one third of patients screened were recruited; 96% of patients recruited completed the protocol, Clinic contact time was an average of 55 minutes per patient. Patients and providers reported high levels of satisfaction with the protocol. Reductions in symptoms were minimal for both groups. Use of outpatient services and associated costs decreased in both groups, but the reduction was twice as great in the treatment group as in the control group. Conclusions: Findings support the feasibility of implementing the protocol as a primary care intervention.	Univ Alabama Birmingham, Birmingham, AL 35294 USA; Univ Texas, Austin, TX 78712 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Austin	Klapow, JC (corresponding author), Univ Alabama Birmingham, 330 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.	jklapow@uab.edu	Pennebaker, James/GLR-6058-2022; Pennebaker, James W/E-5997-2013	Pennebaker, James W/0000-0001-9091-214X; Schmidt, Steven/0000-0002-0878-735X	NIA NIH HHS [AG00932-01] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CONNELLY JE, 1989, MED CARE, V27, pS99, DOI 10.1097/00005650-198903001-00009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Kroenke K, 1994, Arch Fam Med, V3, P774; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Marple RL, 1997, ARCH INTERN MED, V157, P1482, DOI 10.1001/archinte.157.13.1482; PENNEBAKER JW, 1985, J PERS SOC PSYCHOL, V49, P1427, DOI 10.1037/0022-3514.49.5.1427; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; Pennebaker JW, 1999, J CLIN PSYCHOL, V55, P1243, DOI 10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; SELIGMAN MEP, 1995, AM PSYCHOL, V50, P965, DOI 10.1037/0003-066X.50.12.965; Smyth JM, 1998, J CONSULT CLIN PSYCH, V66, P174, DOI 10.1037/0022-006X.66.1.174; Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; WARE JE, 1988, MED CARE, V26, P393, DOI 10.1097/00005650-198804000-00008; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5	16	31	31	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			905	911		10.7326/0003-4819-134-9_Part_2-200105011-00015	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346327				2022-12-28	WOS:000168543100015
J	Danielson, D				Danielson, D			Scientist's birthright - How a new name embodied ideals of connection and inclusiveness.	NATURE			English	Editorial Material									Univ British Columbia, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Danielson, D (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z1, Canada.								0	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1031	1031		10.1038/35074216	http://dx.doi.org/10.1038/35074216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323647	Bronze			2022-12-28	WOS:000168285500025
J	Singh, H; Chen, Y; Staudt, A; Jacob, D; Blake, D; Heikes, B; Snow, J				Singh, H; Chen, Y; Staudt, A; Jacob, D; Blake, D; Heikes, B; Snow, J			Evidence from the Pacific troposphere for large global sources of oxygenated organic compounds	NATURE			English	Article							IN-SITU MEASUREMENTS; NONMETHANE HYDROCARBONS; CARBONYL-COMPOUNDS; ATMOSPHERE; CHEMISTRY; NITRATE; ACETONE; FATE; AIR; HOX	The presence of oxygenated organic compounds in the troposphere strongly influences key atmospheric processes. Such oxygenated species are, for example, carriers of reactive nitrogen and are easily photolysed, producing free radicals(1-3)-and so influence the oxidizing capacity and the ozone-forming potential of the atmosphere(4-6)-and may also contribute significantly to the organic component of aerosols(7,8). But knowledge of the distribution and sources of oxygenated organic compounds, especially in the Southern Hemisphere, is limited. Here we characterize the tropospheric composition of oxygenated organic species, using data from a recent airborne survey(9) conducted over the tropical Pacific Ocean (30 degrees N to 30 degrees S). Measurements of a dozen oxygenated chemicals (carbonyls, alcohols, organic nitrates, organic pernitrates and peroxides), along with several C-2-C-8 hydrocarbons, reveal that abundances of oxygenated species are extremely high, and collectively, oxygenated species are nearly five times more abundant than non-methane hydrocarbons in the Southern Hemisphere. Current atmospheric models are unable to correctly simulate these findings, suggesting that large, diffuse, and hitherto-unknown sources of oxygenated organic compounds must therefore exist. Although the origin of these sources is still unclear, we suggest that oxygenated species could be formed via the oxidation of hydrocarbons in the atmosphere, the photochemical degradation of organic matter in the oceans, and direct emissions from terrestrial vegetation.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Harvard Univ, Cambridge, MA 02138 USA; Univ Calif Irvine, Irvine, CA 92697 USA; Univ Rhode Isl, Narragansett, RI 02882 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Harvard University; University of California System; University of California Irvine; University of Rhode Island	Singh, H (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.		jianwu, shi/B-2557-2009	Blake, Donald/0000-0002-8283-5014				ARLANDER DW, 1995, J ATMOS CHEM, V22, P243, DOI 10.1007/BF00696636; ATLAS E, 1992, J GEOPHYS RES-ATMOS, V97, P10331, DOI 10.1029/91JD01540; Blake NJ, 1999, J GEOPHYS RES-ATMOS, V104, P16213, DOI 10.1029/1999JD900067; CARLIER P, 1986, ATMOS ENVIRON, V20, P2079, DOI 10.1016/0004-6981(86)90304-5; Crutzen PJ, 2000, ATMOS ENVIRON, V34, P1161, DOI 10.1016/S1352-2310(99)00482-3; Jaegle L, 2001, ATMOS ENVIRON, V35, P469, DOI 10.1016/S1352-2310(00)00376-9; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Lamanna MS, 1999, J GEOPHYS RES-ATMOS, V104, P21247, DOI 10.1029/1999JD900289; LAZRUS AL, 1988, ANAL CHEM, V60, P1074, DOI 10.1021/ac00161a025; LEE M, 1995, J ATMOS OCEAN TECH, V12, P1060, DOI 10.1175/1520-0426(1995)012<1060:MFTCAH>2.0.CO;2; LI P, IN PRESS J GEOPHYS R; LOGAN JA, 1981, J GEOPHYS RES-OCEANS, V86, P7210, DOI 10.1029/JC086iC08p07210; MADRONICH S, 1990, J GEOPHYS RES-ATMOS, V95, P5697, DOI 10.1029/JD095iD05p05697; Muller JF, 1999, J GEOPHYS RES-ATMOS, V104, P1705, DOI 10.1029/1998JD100005; Murphy DM, 1998, SCIENCE, V282, P1664, DOI 10.1126/science.282.5394.1664; NEMECEKMARSHALL M, 1995, APPL ENVIRON MICROB, V61, P44, DOI 10.1128/AEM.61.1.44-47.1995; Prather MJ, 1997, GEOPHYS RES LETT, V24, P3189, DOI 10.1029/97GL03027; RAPER JL, 1999, IN PRESS J GEOPHYS R; Reissell A, 1999, J GEOPHYS RES-ATMOS, V104, P13869, DOI 10.1029/1999JD900198; Riemer D, 1998, J GEOPHYS RES-ATMOS, V103, P28111, DOI 10.1029/98JD02677; Singh H, 2000, J GEOPHYS RES-ATMOS, V105, P3795, DOI 10.1029/1999JD900779; Singh H.B., 1992, ATMOSPHERIC DISTRIBU, P177; SINGH HB, 1981, GEOPHYS RES LETT, V8, P941, DOI 10.1029/GL008i008p00941; SINGH HB, 1995, NATURE, V378, P50, DOI 10.1038/378050a0; STAUDT AC, 2001, UNPUB J GEOPHYS RES; Wennberg PO, 1998, SCIENCE, V279, P49, DOI 10.1126/science.279.5347.49; Zhou XL, 1997, MAR CHEM, V56, P201, DOI 10.1016/S0304-4203(96)00076-X	27	317	323	2	87	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1078	1081		10.1038/35074067	http://dx.doi.org/10.1038/35074067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323667				2022-12-28	WOS:000168285500043
J	Parker, RA; Jenike, MA				Parker, RA; Jenike, MA			A 45-year-old woman with obsessive-compulsive disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAGNETIC-RESONANCE; SEROTONERGIC RESPONSIVITY; SYMPTOM PROVOCATION; DOUBLE-BLIND; ABNORMALITIES; STIMULATION; RISPERIDONE; MECHANISMS		Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; McLean Hosp, OCD Inst, Belmont, MA 02178 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Parker, RA (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY318, Boston, MA 02215 USA.							American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bachofen M, 1999, J CLIN PSYCHIAT, V60, P545, DOI 10.4088/JCP.v60n0807; BAER L, 1990, ARCH GEN PSYCHIAT, V47, P826; BAER L, 2000, GETTING CONTROL; BAKER RW, 1992, J CLIN PSYCHIAT, V53, P439; Basco MR, 2000, B MENNINGER CLIN, V64, pA52; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; CLAUDE H, 1927, ENCEPHALE, V22, P716; Dinn WM, 1999, PSYCHIATRY, V62, P313, DOI 10.1080/00332747.1999.11024877; EALES MJ, 1994, BRIT J PSYCHIAT, V164, P687, DOI 10.1192/bjp.164.5.687; Franklin ME, 2000, J CONSULT CLIN PSYCH, V68, P594, DOI 10.1037//0022-006X.68.4.594; GARBER HJ, 1989, AM J PSYCHIAT, V146, P1001; Geller D, 1998, J AM ACAD CHILD PSY, V37, P420, DOI 10.1097/00004583-199804000-00020; GHAEMI SN, 1995, COMPR PSYCHIAT, V36, P267; Giedd JN, 1996, J AM ACAD CHILD PSY, V35, P913, DOI 10.1097/00004583-199607000-00017; Haddad P, 1998, J PSYCHOPHARMACOL, V12, P305, DOI 10.1177/026988119801200311; Hristova A, 2000, CLIN NEUROPHARMACOL, V23, P208, DOI 10.1097/00002826-200007000-00007; Jenike M. A., 1988, J ANXIETY DISORD, V2, P353, DOI [DOI 10.1016/0887-6185(88)90030-8, 10.1016/0887-6185(88)90030-8]; JENIKE MA, 1986, AM J PSYCHIAT, V143, P530; Jenike MA, 1996, ARCH GEN PSYCHIAT, V53, P625; JENIKE MA, 1993, HARVARD REV PSYCHIAT, V1, P17, DOI 10.3109/10673229309017053; JENIKE MA, 1986, ARCH GEN PSYCHIAT, V43, P296; JENIKE MA, 1993, PSYCHOPHARMACOL BULL, V29, P487; Jenike MA, 1998, OBSESSIVE COMPULSIVE; JENIKE MA, 1998, OBSESSIVE COMPULSIVE, P592; Katayama Y, 2000, Nihon Rinsho, V58, P2078; KELLNER CH, 1991, PSYCHIAT RES, V36, P45, DOI 10.1016/0165-1781(91)90116-7; KEUTHEN NJ, 1994, J CLIN PSYCHOPHARM, V14, P206, DOI 10.1097/00004714-199406000-00010; KOPALA L, 1994, AM J PSYCHIAT, V151, P1714; LUXENBERG JS, 1988, AM J PSYCHIAT, V145, P1089; McDougle CJ, 2000, ARCH GEN PSYCHIAT, V57, P794, DOI 10.1001/archpsyc.57.8.794; MCDOUGLE CJ, 1994, ARCH GEN PSYCHIAT, V51, P302; McDougle CJ, 1996, J AM ACAD CHILD PSY, V35, P837, DOI 10.1097/00004583-199607000-00001; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; Murphy TK, 2000, BIOL PSYCHIAT, V47, P851, DOI 10.1016/S0006-3223(00)00843-X; ORLOFF LM, 1994, AM J PSYCHIAT, V151, P441; PATEL MI, 1993, MED J AUSTRALIA, V159, P836; Pato MT, 1998, OBSESSIVE-COMPULSIVE DISORDER, P327; Perlmutter SJ, 1999, LANCET, V354, P1153, DOI 10.1016/S0140-6736(98)12297-3; RASMUSSEN SA, 1998, OBSESSIVE COMPULSIVE, P34; RAUCH SL, 1993, PSYCHOSOMATICS, V34, P20, DOI 10.1016/S0033-3182(93)71924-6; Rauch SL, 1996, J CLIN PSYCHOPHARM, V16, P81, DOI 10.1097/00004714-199602000-00017; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Rauch SL, 1997, CURRENT REV MOOD ANX, V1, P84; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Salkovskis PM, 1999, BEHAV RES THER, V37, pS29, DOI 10.1016/S0005-7967(99)00049-2; SALZMAN C, 1982, AM J PSYCHIAT, V139, P67; Trifiletti RR, 1999, CHILD ADOL PSYCH CL, V8, P767; WEILBURG JB, 1989, ARCH NEUROL-CHICAGO, V46, P233, DOI 10.1001/archneur.1989.00520380139028; Weiss AP, 2000, J NEUROPSYCH CLIN N, V12, P265, DOI 10.1176/appi.neuropsych.12.2.265; WILLIAMS AC, 1988, J NEUROL NEUROSUR PS, V51, P447, DOI 10.1136/jnnp.51.3.447; Wolff M, 2000, PSYCHIAT CLIN N AM, V23, P535, DOI 10.1016/S0193-953X(05)70179-9; ZOHAR J, 1988, ARCH GEN PSYCHIAT, V45, P167; ZOHAR J, 1987, ARCH GEN PSYCHIAT, V44, P946	55	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2121	2128		10.1001/jama.285.16.2121	http://dx.doi.org/10.1001/jama.285.16.2121			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	422QW	11311102				2022-12-28	WOS:000168131600033
J	Pollock, AM; Player, S; Godden, S				Pollock, AM; Player, S; Godden, S			How private finance is moving primary care into corporate ownership	BRITISH MEDICAL JOURNAL			English	Article							NHS; PFI		UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England	University of London; University College London	Pollock, AM (corresponding author), UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England.	allyson.pollock@ucl.ac.uk		pollock, allyson/0000-0002-7388-3110				BAILEY J, 1997, BETTER BUILDINGS BET; BAWDEN T, 1999, DESIGN WEEK     0319, P8; CARIL M, 1999, HLTH SERVICE J  0729, P14; *DEP HLTH, 2001, NHS WALK IN CTR W MI; *DEP HLTH, 1999, GOV EXP PLANS 1999 2; *DEP HLTH, 2000, STAT B; Gaffney D, 1999, PUBLIC MONEY MANAGE, V19, P55, DOI 10.1111/1467-9302.00153; Gaffney D, 1999, BRIT MED J, V319, P116, DOI 10.1136/bmj.319.7202.116; HUGHES S, 1998, PFI REPORT       OCT, P10; LAING, 1999, COMMUNITY CARE M APR, P1; PERSAUD J, 1997, MEDECONOMICS     DEC, P21; Pollock AM, 1999, BMJ-BRIT MED J, V319, P179, DOI 10.1136/bmj.319.7203.179; POLLOCK AM, 1999, PUBLIC FINANCE  1202, P26; RIVETT G, 1998, CRADLE GRAVE; *SECR STAT HLTH, 1997, CM3807; SLINGSBY C, 2000, MEDECONOMICS     MAY, P78; STEWART T, 2000, PFI REPORT       NOV, P24; WAPLES J, 2000, SUNDAY TIMES    0102; WILD S, 1999, MEDECONOMICS     MAR, P56; 2000, PFI REPORT       SEP, P36; 1999, PFI REPORT       JUL, P2	21	11	11	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					960	963		10.1136/bmj.322.7292.960	http://dx.doi.org/10.1136/bmj.322.7292.960			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312229	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168345100019
J	Abelson, M; Baer, G; Agnon, A				Abelson, M; Baer, G; Agnon, A			Evidence from gabbro of the Troodos ophiolite for lateral magma transport along a slow-spreading mid-ocean ridge	NATURE			English	Article							MAGNETIC-SUSCEPTIBILITY; MIDOCEAN RIDGES; OMAN OPHIOLITE; SEGMENTATION; ANISOTROPY; CYPRUS; FLOW	The lateral flow of magma and ductile deformation of the lower crust along oceanic spreading axes has been thought to play a significant role in suppressing both mid-ocean ridge segmentation(1,2) and variations in crustal thickness(3,4). Direct investigation of such flow patterns is hampered by the kilometres of water that cover the oceanic crust, but such studies can be made on ophiolites(5) (fragments of oceanic crust accreted to a continent). In the Oman ophiolite, small-scale radial patterns of flow have been mapped along what is thought to be the relict of a fast-spreading mid-ocean ridge(5). Here we present evidence for broad-scale along-axis flow that has been frozen into the gabbro of the Troodos ophiolite in Cyprus (thought to be representative of a slow-spreading ridge axis). The gabbro suite of Troodos spans nearly 20 km of a segment of a fossil spreading axis, near a ridge- transform intersection(6,7). We mapped the pattern of magma flow by analysing the rocks' magnetic fabric at 20 sites widely distributed in the gabbro suite, and by examining the petrographic fabric at 9 sites. We infer an along-axis magma flow for much of the gabbro suite, which indicates that redistribution of melt occurred towards the segment edge in a large depth range of the oceanic crust. Our results support the magma plumbing structure that has been inferred indirectly from a seismic tomography experiment on the slow-spreading Mid-Atlantic Ridge(8).	Geol Survey Israel, IL-95501 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Geological Survey Israel; Hebrew University of Jerusalem	Abelson, M (corresponding author), Geol Survey Israel, 30 Malkhey Yisrael St, IL-95501 Jerusalem, Israel.		Agnon, Amotz/AAC-8753-2019					Abelson M, 1997, EARTH PLANET SC LETT, V148, P405, DOI 10.1016/S0012-821X(97)00054-X; BELL RE, 1992, NATURE, V357, P583, DOI 10.1038/357583a0; BENN K, 1989, J PETROL, V30, P925, DOI 10.1093/petrology/30.4.925; ERNST RE, 1992, NATURE, V356, P511, DOI 10.1038/356511a0; *GEOL SURV DEP, 1982, MIN RES MAP CYPR; GEORGE RP, 1978, GEOL SOC AM BULL, V89, P845, DOI 10.1130/0016-7606(1978)89<845:SPOTOU>2.0.CO;2; HARGRAVES RB, 1991, GEOPHYS RES LETT, V18, P2193, DOI 10.1029/91GL01777; HURST SD, 1994, TECTONICS, V13, P139, DOI 10.1029/93TC02066; HURST SD, 1990, P S TROODOS 87 CYPRU, P125; Jelinek V., 1981, TECTONOPHYSICS, V79, P63; LIN J, 1992, GEOPHYS RES LETT, V19, P13, DOI 10.1029/91GL03041; MACLEOD CJ, 1990, NATURE, V348, P717, DOI 10.1038/348717a0; Magde LS, 2000, EARTH PLANET SC LETT, V175, P55, DOI 10.1016/S0012-821X(99)00281-2; MALPAS J, 1998, 3 INT C GEOL E MEDIT; MALPAS J, 1987, GEOLOGICAL ANIMANDOS; Malpas J., 1990, OPHIOLITES OCEANIC C, P65; Muller MR, 1999, GEOLOGY, V27, P867, DOI 10.1130/0091-7613(1999)027<0867:SAMSAT>2.3.CO;2; Naslund H., 1996, LAYERED INTRUSIONS, V15, P1, DOI DOI 10.1016/S0167-2894(96)80003-0; NICOLAS A, 1995, J GEOPHYS RES-SOL EA, V100, P6179, DOI 10.1029/94JB01188; Nicolas A, 1996, J GEOPHYS RES-SOL EA, V101, P17941, DOI 10.1029/96JB00195; PHIPPSMORGAN J, 1995, EARTH PLANET SC LETT, V129, P73; RICHTER C, 1996, P OCEAN DRILL PROGRA, V147, P393; ROCHETTE P, 1992, REV GEOPHYS, V30, P209, DOI 10.1029/92RG00733; SOLOMON SC, 1992, ANNU REV EARTH PL SC, V20, P329; STAUDIGEL H, 1992, GEOLOGY, V20, P841, DOI 10.1130/0091-7613(1992)020<0841:SIDOSD>2.3.CO;2; STAUDIGEL H, 1999, GEOCHEM GEOPHYS GEOS, V1; TAUXE L., 1998, PALEOMAGNETIC PRINCI; Varga RJ, 1999, EARTH PLANET SC LETT, V171, P221, DOI 10.1016/S0012-821X(99)00147-8; WANG XJ, 1995, GEOLOGY, V23, P29, DOI 10.1130/0091-7613(1995)023<0029:AAGGAM>2.3.CO;2; YAOUANCQ G, IN PRESS MAR GEOPHYS	30	43	44	1	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					72	75		10.1038/35051058	http://dx.doi.org/10.1038/35051058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343114				2022-12-28	WOS:000166175600040
J	Sorensen, A; Duan, LM; Cirac, JI; Zoller, P				Sorensen, A; Duan, LM; Cirac, JI; Zoller, P			Many-particle entanglement with Bose-Einstein condensates	NATURE			English	Article							PROJECTION NOISE; DYNAMICS; STATES	The possibility of creating and manipulating entangled states of systems of many particles is of significant interest for quantum information processing; such a capability could lead to new applications that rely on the basic principles of quantum mechanics(1). So far, up to four atoms have been entangled in a controlled way(2,3). A crucial requirement for the production of entangled states is that they can be considered pure at the single-particle level. Bose-Einstein condensates(4-6) fulfil this requirement; hence it is natural to investigate whether they can also be used in some applications of quantum information. Here we propose a method to achieve substantial entanglement of a large number of atoms in a Bose-Einstein condensate. A single resonant laser pulse is applied to all the atoms in the condensate, which is then allowed to evolve freely; in this latter stage, collisional interactions produce entanglement between the atoms. The technique should be realizable with present technology.	Aarhus Univ, Inst Phys & Astron, DK-8000 Aarhus C, Denmark; Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	Aarhus University; University of Innsbruck	Sorensen, A (corresponding author), Aarhus Univ, Inst Phys & Astron, DK-8000 Aarhus C, Denmark.		Sørensen, Anders Søndberg/L-1868-2013; Cirac, J. Ignacio/A-9105-2017; Zoller, Peter/O-1639-2014	Sørensen, Anders Søndberg/0000-0003-1337-9163; Cirac, J. Ignacio/0000-0003-3359-1743; Zoller, Peter/0000-0003-4014-1505				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; Bouyer P, 1997, PHYS REV A, V56, pR1083, DOI 10.1103/PhysRevA.56.R1083; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Miesner HJ, 1999, PHYS REV LETT, V82, P2228, DOI 10.1103/PhysRevLett.82.2228; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; MOLMER K, 1993, J OPT SOC AM B, V10, P524, DOI 10.1364/JOSAB.10.000524; Parkins AS, 1998, PHYS REP, V303, P2; Rauschenbeutel A, 2000, SCIENCE, V288, P2024, DOI 10.1126/science.288.5473.2024; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Santarelli C, 1999, PHYS REV LETT, V82, P4619, DOI 10.1103/PhysRevLett.82.4619; Sinatra A, 2000, EUR PHYS J D, V8, P319, DOI 10.1007/s100530050042; Sorensen A, 1999, PHYS REV LETT, V83, P2274, DOI 10.1103/PhysRevLett.83.2274; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67; 1998, PHYS WORLD, V11, P33	20	744	759	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					63	66		10.1038/35051038	http://dx.doi.org/10.1038/35051038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343111	Green Submitted			2022-12-28	WOS:000166175600037
J	Prinn, RG; Huang, J; Weiss, RF; Cunnold, DM; Fraser, PJ; Simmonds, PG; McCulloch, A; Harth, C; Salameh, P; O'Doherty, S; Wang, RHJ; Porter, L; Miller, BR				Prinn, RG; Huang, J; Weiss, RF; Cunnold, DM; Fraser, PJ; Simmonds, PG; McCulloch, A; Harth, C; Salameh, P; O'Doherty, S; Wang, RHJ; Porter, L; Miller, BR			Evidence for substantial variations of atmospheric hydroxyl radicals in the past two decades	SCIENCE			English	Article							METHYL CHLOROFORM CH3CCL3; TROPOSPHERIC OZONE; MODEL; OH; CHEMISTRY; LIFETIME; PHOTOCHEMISTRY; EMISSIONS; TREND	The hydroxyl radical (OH) is the dominant oxidizing chemical in the atmosphere. It destroys most air pollutants and many gases involved in ozone depletion and the greenhouse effect. Global measurements of 1,1,1-trichloroethane (CH3CCl3, methyl chloroform) provide an accurate method for determining the global and hemispheric behavior of OH. Measurements show that CH3CCl3 Levels rose steadily from 1978 to reach a maximum in 1992 and then decreased rapidly to levels in 2000 that were Lower than the levels when measurements began in 1978. Analysis of these observations shows that global OH Levels were growing between 1978 and 1988, but the growth rate was decreasing at a rate of 0.23 +/- 0.18% year(-2), so that OH Levels began declining after 1988. Overall, the global average OH trend between 1978 and 2000 was -0.64 +/- 0.60% year(-1). These variations imply important and unexpected gaps in current understanding of the capability of the atmosphere to cleanse itself.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Georgia Inst Technol, Dept Earth & Atmospher Sci, Atlanta, GA 30332 USA; CSIRO, Atmospher Res, Aspendale, Vic 3195, Australia; Univ Bristol, Sch Chem, Bristol 8S8 1TH, Avon, England; Bur Meteorol, Cape Grim Baseline Air Pollut Stn, Smithton, Tas 7330, Australia	Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Scripps Institution of Oceanography; University System of Georgia; Georgia Institute of Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Bristol; Bureau of Meteorology - Australia	Prinn, RG (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Fraser, Paul J. B./D-1755-2012	Miller, Benjamin/0000-0003-1647-0122				BUTLER JH, 1991, J GEOPHYS RES-ATMOS, V96, P22347, DOI 10.1029/91JD02126; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; CRUTZEN PJ, 1991, TELLUS A, V43, P136, DOI 10.1034/j.1600-0870.1991.00012.x; CUNNOLD DM, 1991, J GEOPHYS RES-ATMOS, V96, P17391, DOI 10.1029/91JD01495; Demore W.B., 1997, PUBLICATION JET PROP; DOUGLASS AR, 1989, J GEOPHYS RES-ATMOS, V94, P9862, DOI 10.1029/JD094iD07p09862; EHHALT D, IN PRESS CLIMATE CHA; FRASER PJ, UNPUB; GOLOMBEK A, 1993, J ATMOS CHEM, V16, P179, DOI 10.1007/BF00702787; Houweling S, 1998, J GEOPHYS RES-ATMOS, V103, P10673, DOI 10.1029/97JD03582; HUANG J, 1999, THESIS MIT; JACKMAN CH, 1990, J GEOPHYS RES-ATMOS, V95, P7417, DOI 10.1029/JD095iD06p07417; Karlsdottir S, 2000, GEOPHYS RES LETT, V27, P93, DOI 10.1029/1999GL010860; KO MKW, 1991, J GEOPHYS RES-ATMOS, V96, P7547, DOI 10.1029/91JD00273; Krol M, 1998, J GEOPHYS RES-ATMOS, V103, P10697, DOI 10.1029/98JD00459; Kurylo MJ, 1999, SCI ASSESSMENT OZONE, P21; Kutsuna S, 2000, J GEOPHYS RES-ATMOS, V105, P6611, DOI 10.1029/1999JD901072; Lawrence MG, 1999, J GEOPHYS RES-ATMOS, V104, P26245, DOI 10.1029/1999JD900425; Mayer M, 2000, J GEOPHYS RES-ATMOS, V105, P22869, DOI 10.1029/2000JD900307; MCCULLOCH A, IN PRESS ATMOS ENV; MIDGLEY PM, 1995, ATMOS ENVIRON, V29, P1601, DOI 10.1016/1352-2310(95)00078-D; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; PRATHER M, 1996, CLIMATE CHANGE 1995, P86; PRINN R, 1992, J GEOPHYS RES-ATMOS, V97, P2445, DOI 10.1029/91JD02755; PRINN RG, 1995, SCIENCE, V269, P187, DOI 10.1126/science.269.5221.187; Prinn RG, 2000, GEOPH MONOG SERIES, V114, P3; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; PRINN RG, IN PRESS J GEOPHYS R; Rudolph J, 2000, GEOPHYS RES LETT, V27, P1887, DOI 10.1029/1999GL011178; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; THOMPSON AM, 1992, SCIENCE, V256, P1157, DOI 10.1126/science.256.5060.1157; *UN ENV PROGR, 1996, HDB INT TREAT PROT O; Wang C, 1998, J GEOPHYS RES-ATMOS, V103, P3399, DOI 10.1029/97JD03465; Wang YH, 1998, J GEOPHYS RES-ATMOS, V103, P10757, DOI 10.1029/98JD00156; Wang YH, 1998, J GEOPHYS RES-ATMOS, V103, P31123, DOI 10.1029/1998JD100004	35	483	488	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1882	1888		10.1126/science.1058673	http://dx.doi.org/10.1126/science.1058673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11337586				2022-12-28	WOS:000169200700041
J	Khan, AA; Bose, C; Yam, LS; Soloski, MJ; Rupp, F				Khan, AA; Bose, C; Yam, LS; Soloski, MJ; Rupp, F			Physiological regulation of the immunological synapse by agrin	SCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; RECEPTOR; COSTIMULATION; THYMOCYTES; MYOTUBES; ANTIGEN; DOMAINS; BINDING; SYSTEM; CELLS	T cell activation is dependent on both a primary signal delivered through the T cell receptor and a secondary costimulatory signal mediated by coreceptors. Although controversial, costimulation is thought to act through the specific redistribution and clustering of membrane and intracellular kinase-rich Lipid raft microdomains at the contact site between T cells and antigen-presenting cells. This site has been termed the immunological synapse. Endogenous mediators of raft clustering in lymphocytes have not been identified, although they are essential for T cell activation. We now demonstrate that agrin, an aggregating protein crucial for formation of the neuromuscular junction, is also expressed in Lymphocytes and is important in reorganization of membrane Lipid microdomains and setting the threshold for T cell signaling. Our data show that agrin induces the aggregation of signaling proteins and the creation of signaling domains in both immune and nervous systems through a common Lipid raft pathway.	Outer Banks Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Khan, AA (corresponding author), Outer Banks Neurosci, Baltimore, MD 21218 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020922] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI20922] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1994, EMBO J, V13, P2814, DOI 10.1002/j.1460-2075.1994.tb06575.x; KHAN AT, UNPUB; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Luck G, 2000, MOL CELL NEUROSCI, V16, P269, DOI 10.1006/mcne.2000.0873; LUSTIG S, 1983, J CELL PHYSIOL, V115, P87, DOI 10.1002/jcp.1041150113; MALISSEN B, 1993, CURR OPIN IMMUNOL, V5, P324, DOI 10.1016/0952-7915(93)90049-X; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MOSIER DE, 1974, J IMMUNOL, V112, P305; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	23	148	160	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1681	1686		10.1126/science.1056594	http://dx.doi.org/10.1126/science.1056594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11349136				2022-12-28	WOS:000169031800034
J	Garcia, CK; Wilund, K; Arca, M; Zuliani, G; Fellin, R; Maioli, M; Calandra, S; Bertolini, S; Cossu, F; Grishin, N; Barnes, R; Cohen, JC; Hobbs, HH				Garcia, CK; Wilund, K; Arca, M; Zuliani, G; Fellin, R; Maioli, M; Calandra, S; Bertolini, S; Cossu, F; Grishin, N; Barnes, R; Cohen, JC; Hobbs, HH			Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein	SCIENCE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; MOLECULAR CHARACTERIZATION; CYTOSOLIC ADAPTER; SHC; REGION; INTERNALIZATION; DISTINCT; SIGNALS; DOMAIN	Atherogenic low density lipoproteins are cleared from the circulation by hepatic low density lipoprotein receptors (LDLR). Two inherited forms of hypercholesterolemia result from loss of LDLR activity: autosomal dominant familiar hypercholesterolemia (FH), caused by mutations in the LDLR gene, and autosomal recessive hypercholesterolemia (ARH), of unknown etiology. Here we map the ARH Locus to a similar to1-centimorgan interval on chromosome 1p35 and identify six mutations in a gene encoding a putative adaptor protein (ARH). ARH contains a phosphotyrosine binding (PTB) domain, which in other proteins binds NPXY motifs in the cytoplasmic tails of cell-surface receptors, including the LDLR. ARH appears to have a tissue-specific role in LDLR function, as it is required in liver but not in fibroblasts.	Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med & Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Roma La Sapienza, Inst Systemat Med Therapy, I-00161 Rome, Italy; Univ Ferrara, Dept Internal Med, I-44100 Ferrara, Italy; Univ Sassari, Dept Internal Med, Metab Dis Unit, I-07100 Sassari, Italy; Univ Modena & Reggioemilia, Dept Biol Sci, I-41100 Modena, Italy; Univ Genoa, Dept Internal Med, I-16100 Genoa, Italy; Osped Microcitemico Cagliari, Bone Marrow Transplant Unit, I-09121 Cagliari, Italy	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sapienza University Rome; University of Ferrara; University of Sassari; Universita di Modena e Reggio Emilia; University of Genoa	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	helen.hobbs@UTSouthwestern.edu	/V-4899-2019; ARCA, Marcello/AAC-3883-2022	ARCA, Marcello/0000-0003-3786-0883; Cossu, Fausto/0000-0001-5485-2098	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NHLBI NIH HHS [P0I-HL2048, HL07360] Funding Source: Medline; Telethon [E.0565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCA M, UNPUB; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Eden ER, 2001, AM J HUM GENET, V68, P653, DOI 10.1086/318795; GOLDSTEIN JL, UNPUB; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HARADASHIBA M, 1992, ARTERIOSCLER THROMB, V12, P1071, DOI 10.1161/01.ATV.12.9.1071; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; KHACHADURIAN AK, 1973, NUTR METAB, V15, P132; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PATHAK RK, 1990, J CELL BIOL, V111, P347, DOI 10.1083/jcb.111.2.347; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; Schmidt HHJ, 1998, J CLIN ENDOCR METAB, V83, P2167, DOI 10.1210/jc.83.6.2167; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Zhou MM, 1995, PROG BIOPHYS MOL BIO, V64, P221, DOI 10.1016/S0079-6107(96)00005-3; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802; ZULIANI G, 1995, EUR J CLIN INVEST, V25, P322, DOI 10.1111/j.1365-2362.1995.tb01709.x	34	425	448	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1394	1398		10.1126/science.1060458	http://dx.doi.org/10.1126/science.1060458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11326085				2022-12-28	WOS:000168862900051
J	Kang, PJ; Sanson, A; Lee, B; Park, HO				Kang, PJ; Sanson, A; Lee, B; Park, HO			A GDP/GTP exchange factor involved in linking a spatial landmark to cell polarity	SCIENCE			English	Article							BUD-SITE SELECTION; YEAST SACCHAROMYCES-CEREVISIAE; GTPASE-ACTIVATING PROTEIN; GENE-PRODUCT; BUDDING SITE; LOCALIZATION; CYCLE; MORPHOGENESIS; BUD1/RSR1; PATTERN	In both animal and yeast cells, signaling pathways involving small guanosine triphosphatases (GTPases) regulate polarized organization of the actin cytoskeleton. In the budding yeast Saccharomyces cerevisiae, the Ras-like GTPase Bud1/Rsr1 and its guanosine 5'-diphosphate (GDP)/guanosine 5'-triphosphate (GTP) exchange factor Bud5 are involved in the selection of a specific site for growth, thus determining cell polarity. We found that Bud5 is localized at the cell division site and the presumptive bud site. Its localization is dependent on potential cellular landmarks, such as Bud3 and Axl2/Bud10 in haploid cells and Bud8 and Bud9 in diploid cells. Bud5 also physically interacts with Axl2/Bud10, a transmembrane glycoprotein, suggesting that a receptor-like transmembrane protein recruits a GDP/GTP exchange factor to connect an intrinsic spatial signal to oriented cell growth.	Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Ohio State University	Park, HO (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12th Ave, Columbus, OH 43210 USA.			Park, Hay-Oak/0000-0001-5782-2257	NIGMS NIH HHS [R01 GM056997-02, R01 GM056997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; HARKINS HA, IN PRESS MOL BIOL CE; HICKS JB, 1977, GENETICS, V85, P373; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Michelitch M, 1996, CURR BIOL, V6, P446, DOI 10.1016/S0960-9822(02)00512-2; Park HO, 1999, GENE DEV, V13, P1912, DOI 10.1101/gad.13.15.1912; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; POWERS S, 1991, CELL, V65, P1225, DOI 10.1016/0092-8674(91)90017-S; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; ZHENG Y, 1995, J BIOL CHEM, V270, P626, DOI 10.1074/jbc.270.2.626	26	79	83	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1376	1378		10.1126/science.1060360	http://dx.doi.org/10.1126/science.1060360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11313501	Green Accepted			2022-12-28	WOS:000168862900046
J	Ansell, P; Roman, E; Fear, NT; Renfrew, MJ				Ansell, P; Roman, E; Fear, NT; Renfrew, MJ			Vitamin K policies and midwifery practice: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							CHILDHOOD-CANCER; PROPHYLAXIS; LEUKEMIA; NEWBORN	Objectives To investigate policies on neonatal vitamin K and their implementation, Design Two phase postal survey. Setting United Kingdom, Participants A 10% random sample of midwives registered with the United Kingdom Central Council for nursing, midwifery, and health visiting, Of 3191 midwives in the sample, 2515 (79%) responded to phase one and 2294 (72%) completed questionnaires on their current jobs (November 1998 to May 1999), In phase two, 853 (62%) of 1383 eligible midwives gave details on 2179 of their earliest jobs (start dates before 1990). Results All the midwives in clinical practice at the time of the survey (2271, 99%) reported that the) were working in areas with official policies on neonatal vitamin K. Seven distinct policies were described: intramuscular vitamin K for all babies (1159, 51.0%); intramuscular vitamin K for babies at "high risk," oral for others (470, 20.7%); oral vitamin K for all babies (323, 14.2%); parental choice for all (124, 5.5%): parental choice for all except babies at high risk. (119, 5.2%); intramuscular vitamin K for babies at high risk only (33, 1.5%); oral vitamin K for babies at high risk only. (17, 0.7%); and a disparate group of policies including intravenous vitamin K for some babies (26, 1.1%). Previous policies were land some may still be) open to individual interpretation and were not always followed. Conclusions Hospital policy is not necessarily a good guide to individual practice. The primary purpose of clinical records is to document patient care, and recording practices reflect this. There is considerable variation in vitamin K policies and midwifery practice in the United Kingdom, and there is no clear consensus on which babies should receive vitamin K intramuscularly.	Univ Leeds, Inst Epidemiol, Leukaemia Res Fund Ctr, Leeds LS2 9LN, W Yorkshire, England; Univ Leeds, Mother & Infant Res Unit, Leeds LS2 9LN, W Yorkshire, England	University of Leeds; University of Leeds	Ansell, P (corresponding author), Univ Leeds, Inst Epidemiol, Leukaemia Res Fund Ctr, Leeds LS2 9LN, W Yorkshire, England.		Fear, Nicola/A-1917-2012; Renfrew, Mary/A-2440-2010	Fear, Nicola/0000-0002-5792-2925; Renfrew, Mary/0000-0003-2905-403X; Roman, Eve/0000-0001-7603-3704				Ansell P, 1996, BRIT MED J, V313, P204, DOI 10.1136/bmj.313.7051.204; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BARTON JS, 1995, BRIT MED J, V310, P632, DOI 10.1136/bmj.310.6980.632; BARTON JS, 1994, LANCET, V343, P1168, DOI 10.1016/S0140-6736(94)90277-1; *DEP HLTH, 1999, NHS HOSP COMM HLTH S; *DEP HLTH, 1998, VIT K NEWB BAB; EKELUND H, 1993, BRIT MED J, V307, P89, DOI 10.1136/bmj.307.6896.89; GOLDING J, 1992, BRIT MED J, V305, P341, DOI 10.1136/bmj.305.6849.341; HANDEL J, 1991, BRIT MED J, V303, P1109, DOI 10.1136/bmj.303.6810.1109; *ISD SCOTL, 2001, SCOTT HLTH STAT 2000; KLEBANOFF MA, 1993, NEW ENGL J MED, V329, P905, DOI 10.1056/NEJM199309233291301; McKinney PA, 1998, BRIT MED J, V316, P173, DOI 10.1136/bmj.316.7126.173; *NAT CHILDB TRUST, 1994, PAR RIGHTS DEN VIT K; OLSEN JH, 1994, BRIT MED J, V308, P895, DOI 10.1136/bmj.308.6933.895; PARKER L, 1998, BRIT MED J, V316, P184; Passmore SJ, 1998, BRIT MED J, V316, P184, DOI 10.1136/bmj.316.7126.184; Passmore SJ, 1998, BRIT MED J, V316, P178, DOI 10.1136/bmj.316.7126.178; *ROYAL COLL MIDW, 1999, RCM MIDWIVES J, V2, P252; vonKries R, 1996, BRIT MED J, V313, P199, DOI 10.1136/bmj.313.7051.199	19	16	16	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1148	+		10.1136/bmj.322.7295.1148	http://dx.doi.org/10.1136/bmj.322.7295.1148			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348908	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000168748900014
J	Kusky, TM; Li, JH; Tucker, RD				Kusky, TM; Li, JH; Tucker, RD			The Archean Dongwanzi ophiolite complex, North China craton: 2.505-billion-year-old oceanic crust and mantle	SCIENCE			English	Article							PB ZIRCON AGES; SECTION; BELT	We report a thick, Laterally extensive 2505 +/- 2.2-million-year-old (uranium-lead ratio in zircon) Archean ophiolite complex in the North China craton. Basal harzburgite tectonite is overlain by cumulate ultramafic rocks, a mafic-ultramafic transition zone of interlayered gabbro and ultramafic cumulates, compositionally Layered olivine-gabbro and pyroxenite, and isotropic gabbro. A sheeted dike complex is rooted in the gabbro and overlain by a mixed dike-pillow lava section, chert, and banded iron formation. The documentation of a complete Archean ophiolite implies that mechanisms of oceanic crustal accretion similar to those of today were in operation by 2.5 billion years ago at divergent plate margins and that the temperature of the early mantle was not extremely elevated, as compared to the present-day temperature. Plate tectonic processes similar to those of the present must also have emplaced the ophiolite in a convergent margin setting.	St Louis Univ, Dept Earth & Atmospher Sci, St Louis, MO 63103 USA; Peking Univ, Dept Geol, Beijing, Peoples R China; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	Saint Louis University; Peking University; Washington University (WUSTL)	Kusky, TM (corresponding author), St Louis Univ, Dept Earth & Atmospher Sci, St Louis, MO 63103 USA.	kusky@eas.slu.edu	Kusky, Timothy/E-6016-2010	Kusky, Timothy/0000-0002-4553-620X				Anonymous, 1972, GEOTIMES, V17, P24; BICKLE MJ, 1994, J GEOL, V102, P121, DOI 10.1086/629658; Davis G.A., 1996, TECTONIC EVOLUTION A, P253; DEWIT MJ, 1987, J AFR EARTH SCI, V6, P681, DOI 10.1016/0899-5362(87)90007-8; Harper G.D., 1985, OFIOLITI, V10, P297; Harper GD, 1999, J SHOULDER ELB SURG, V8, P53, DOI 10.1016/S1058-2746(99)90056-3; KONTINEN A, 1987, PRECAMBRIAN RES, V35, P313, DOI 10.1016/0301-9268(87)90061-1; KROGH TE, 1973, GEOCHIM COSMOCHIM AC, V37, P485, DOI 10.1016/0016-7037(73)90213-5; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Kusky TM, 1999, TECTONOPHYSICS, V305, P43, DOI 10.1016/S0040-1951(99)00014-1; Li JH, 2000, ACTA PETROL SIN, V16, P1; Li JH, 2000, ACTA GEOL SIN-ENGL, V74, P246; LUDWIG KR, 1980, EARTH PLANET SC LETT, V46, P212, DOI 10.1016/0012-821X(80)90007-2; PARSON LM, 1992, GEOL SOC SPEC PUBL L, V60, P1; SCOTT DJ, 1992, GEOLOGY, V20, P173, DOI 10.1130/0091-7613(1992)020<0173:POCSBN>2.3.CO;2; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Tucker RD, 1998, EARTH PLANET SC LETT, V158, P175, DOI 10.1016/S0012-821X(98)00050-8; Wang QC, 1995, REGIONAL GEOLOGY CHI, P173; ZHANG RY, 1982, SCI SINICA, V25, P37	19	273	316	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1142	1145		10.1126/science.1059426	http://dx.doi.org/10.1126/science.1059426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349144				2022-12-28	WOS:000168609200053
J	Lino, M; Goto, K; Kakegawa, W; Okado, H; Sudo, M; Ishiuchi, S; Miwa, A; Takayasu, Y; Saito, I; Tsuzuki, K; Ozawa, S				Lino, M; Goto, K; Kakegawa, W; Okado, H; Sudo, M; Ishiuchi, S; Miwa, A; Takayasu, Y; Saito, I; Tsuzuki, K; Ozawa, S			Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; CHANNELS; DESENSITIZATION; TRANSPORTERS; PERMEABILITY; SUBUNIT; NEURONS; FIBERS	Glial cells express a variety of neurotransmitter receptors, Notably, Bergmann glial cells in the cerebellum have Ca2+-permeable alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) assembled without the GluR2 subunit, To elucidate the role of these Ca2+-permeable AMPARs, we converted them into Ca2+-impermeable receptors by adenoviral-mediated delivery of the GluR2 gene. This conversion retracted the glial processes ensheathing synapses on Purkinje cell dendritic spines and retarded the removal of synaptically released glutamate, Furthermore, it caused multiple innervation of Purkinje cells by the climbing fibers. Thus, the glial Ca2+-permeable AMPARs are indispensable for proper structural and functional relations between Bergmann glia and glutamatergic synapses.	Gunma Univ, Sch Med, Gunma 3718511, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1080071, Japan; Tokyo Metropolitan Inst Neurosci, Inst Neurosci, Dept Neurobiol, Fuchu, Tokyo 1838526, Japan	Gunma University; Japan Science & Technology Agency (JST); University of Tokyo; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Ozawa, S (corresponding author), Gunma Univ, Sch Med, Gunma 3718511, Japan.		Kakegawa, Wataru/G-5569-2016; Kakegawa, Wataru/L-4900-2013	Ozawa, Seiji/0000-0003-4893-3443				Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Isa T, 1996, J PHYSIOL-LONDON, V491, P719, DOI 10.1113/jphysiol.1996.sp021252; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; OZAWA S, 1991, J NEUROPHYSIOL, V66, P2, DOI 10.1152/jn.1991.66.1.2; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Yamada K, 2000, J COMP NEUROL, V418, P106; YAMADA KA, 1993, J NEUROSCI, V13, P3904	20	304	308	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					926	929		10.1126/science.1058827	http://dx.doi.org/10.1126/science.1058827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340205				2022-12-28	WOS:000168514900043
J	Creed, F; Ratcliffe, J; Fernandez, L; Tomenson, B; Palmer, S; Rigby, C; Guthrie, E; Read, N; Thompson, D				Creed, F; Ratcliffe, J; Fernandez, L; Tomenson, B; Palmer, S; Rigby, C; Guthrie, E; Read, N; Thompson, D			Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; PHYSICAL ABUSE HISTORY; OF-LIFE; MEDICAL OUTCOMES; TREATMENT TRIALS; IMPACT; SYMPTOMS; ILLNESS; MODEL; SF-36	Background: The irritable bowel syndrome (IBS) may lead to considerable impairment of health-related quality of life and high health care costs. It is not clear whether these poor outcomes directly result from severe bower symptoms or reflect a coexisting psychiatric disorder. Objective: To determine whether bowel symptom severity and psychological symptoms directly influence health-related quality of life and health care costs. Design: Cross-sectional survey. Setting: secondary and tertiary gastroenterology clinics. Patients: 257 patients with severe IBS who did not respond to usual treatments and were recruited for a trial of psychological treatment. Measurements: Predictors were abdominal pain, entries in a diary of 10 IBS symptoms, and measures of psychological symptoms. Outcomes were inability to work, health-related quality of life (measured by Medical Outcomes Survey 36-item short-form questionnaire [SF-36] physical component summary scores), and health care and productivity costs. Predictor and outcome measures were compared by using multiple regression and logistic regression analyses. Results: Abdominal pain occurred on average 24 days per month and activities were restricted on 145 days of the previous 12 months. The mean (+/- SD) Hamilton depression score was 11.3 +/-6.1. The SF-36 physical component summary score was low (37.7 +/- 10.6), and the patients had incurred high health care costs ($1743 +/- $2263) over the previous year. Global severity and somatization scores on the Symptom Checklist 90 Revised, abdominal pain, and Hamilton depression scores independently contributed to the physical component score of the SF-36 (adjusted R-2 = 35.2%), but only psychological scores were associated with disability due to ill health. These variables did not accurately predict health care or other costs (adjusted R-2 = 9.3%), History of sexual abuse was not an independent predictor of outcome. Conclusions: Both abdominal and psychological symptoms are independently associated with impaired health-related quality of life in patients with severe IBS, Optimal treatment is likely to require a holistic approach. Since health care and loss of productivity costs are not clearly associated with these symptoms, alleviation of them will not necessarily lead to reduced costs.	Univ Manchester, Sch Psychiat & Behav Sci, Manchester M13 9WL, Lancs, England; Hope Hosp, Manchester, Lancs, England; Belmont Day Hosp, Bolton, England; St Georges Community Hlth, Sheffield, S Yorkshire, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Mental Hlth Serv Salford, Salford, Lancs, England	University of Manchester; Northern General Hospital; University of York - UK	Creed, F (corresponding author), Univ Manchester, Sch Psychiat & Behav Sci, Rawnsley Bldg,Oxford Rd, Manchester M13 9WL, Lancs, England.	francis.creed@man.ac.uk		Guthrie, Elspeth/0000-0002-5834-6616				[Anonymous], 1992, GASTROENTEROL INT; Beecham J, 1992, MEASURING MENTAL HLT; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bergmann JF, 1998, EUR J SURG, V164, P87; *BRIT MED ASS ROYA, 1998, BRIT NATL FORMULARY, V35; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 1998, PSYCHOSOM MED, V60, P258, DOI 10.1097/00006842-199805000-00007; DROSSMAN DA, 1995, DIGEST DIS SCI, V40, P986, DOI 10.1007/BF02064187; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; Hahn BA, 1997, ALIMENT PHARM THERAP, V11, P553, DOI 10.1046/j.1365-2036.1997.00160.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hawkey Christopher J., 1999, American Journal of Medicine, V107, p98S; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Leserman J, 1998, PSYCHOL MED, V28, P417, DOI 10.1017/S0033291797006508; Leserman J, 1996, PSYCHOSOM MED, V58, P4, DOI 10.1097/00006842-199601000-00002; Naliboff BD, 1998, J PSYCHOSOM RES, V45, P485; Naliboff BD, 1998, EUR J SURG, V164, P57; Netten A, 1998, UNIT COSTS HLTH SOCI; Talley NJ, 1996, AM J GASTROENTEROL, V91, P277; van Zanten SJOV, 1999, GUT, V45, P69; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; Ware J.E, 1994, PHYS MENTAL HLTH SUM; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 1999, AM J PSYCHIAT, V156, P5, DOI 10.1176/ajp.156.1.5; Whitehead WE, 1996, DIGEST DIS SCI, V41, P2248, DOI 10.1007/BF02071408	28	171	182	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			860	868		10.7326/0003-4819-134-9_Part_2-200105011-00010	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346322				2022-12-28	WOS:000168543100010
J	Sharp, D				Sharp, D			Resuscitating dead languages	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), Lancet, London WC1X 8RR, England.							Bignall J, 2001, LANCET, V357, P776, DOI 10.1016/S0140-6736(05)71206-X; BROAD WJ, 2001, NY TIMES        0327, pF1; HOGBEN L, 1969, VOCABULARY SCI OUR G; Phaneup B. A., 2001, ARCHAEOLOGY      MAR, P26	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1310	1310		10.1016/S0140-6736(00)04530-X	http://dx.doi.org/10.1016/S0140-6736(00)04530-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343733				2022-12-28	WOS:000168411400007
J	Sijbrands, EJG; Westendorp, RGJ; Defesche, JC; de Meier, PHEM; Smelt, AHM; Kastelein, JJP				Sijbrands, EJG; Westendorp, RGJ; Defesche, JC; de Meier, PHEM; Smelt, AHM; Kastelein, JJP			Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIPOPROTEIN RECEPTOR GENE; CORONARY-ARTERY-DISEASE; ENVIRONMENTAL-FACTORS; HEART-DISEASE; MUTATIONS; MEN	Objective To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease. Design Family tree mortality study S Setting Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century. Subjects All members of pedigree aged over 20 years with 0.5 probability of carrying a mutation for familial hypercholesterolaemia. Main outcome measure All cause mortality. Results A total of 70 deaths took place among 250 people analysed for 6950 person years. Mortality was not increased in carriers of the mutation during the 19th and early 20th century; it rose after 1915, reached its maximum between 1935 and 1964 (standardised mortality ratio 1.78, 95% confidence interval 1.13 to 2.76; P = 0.003), and fell thereafter. Mortality differed significantly between two branches of the pedigree (relative risk 3.20, 95% confidence interval 1.74 to 6.11; P = 0.001). Conclusions Risk of death varies significantly among patients with familial hypercholesterolaemia. This large variability over time and between branches of the pedigree points to a strong interaction with environmental factors. Future research is required to identify patients with familial hypercholesterolaemia who are at extreme risk and need early and vigorous preventive measures.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Gen Internal Med, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sijbrands, EJG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Gen Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	nrexpert@euronet.nl	Sijbrands, Eric/A-1065-2009; Kastelein, John/AAF-7950-2020	Sijbrands, Eric/0000-0001-8857-7389; 				[Anonymous], 1991, BMJ, V303, P893; BEAUMONT V, 1976, ATHEROSCLEROSIS, V24, P441, DOI 10.1016/0021-9150(76)90136-2; COLEMAN MP, 1989, PERSON YEARS PYRS FU; DEFESCHE JC, 1993, HUM GENET, V92, P567, DOI 10.1007/BF00420940; HARLAN WR, 1966, MEDICINE, V45, P77, DOI 10.1097/00005792-196603000-00001; HAZZARD WR, 1973, J CLIN INVEST, V52, P1569, DOI 10.1172/JCI107333; HILL JS, 1991, ARTERIOSCLER THROMB, V11, P290, DOI 10.1161/01.ATV.11.2.290; Hille ETM, 1997, BLOOD, V89, P1963, DOI 10.1182/blood.V89.6.1963; KOTZE MJ, 1993, CLIN GENET, V43, P295; LOMBARDI P, 1995, J LIPID RES, V36, P860; Muller C, 1939, ARCH INTERN MED, V64, P675; Netea MG, 1996, J CLIN INVEST, V97, P1366, DOI 10.1172/JCI118556; NOBILI A, 1994, BRIT HEART J, V71, P468; ROSENDAAL FR, 1991, LANCET, V337, P260, DOI 10.1016/0140-6736(91)90867-O; ROTHENBERG RB, 1994, EPIDEMIOLOGY, V5, P197, DOI 10.1097/00001648-199403000-00010; SEED M, 1990, NEW ENGL J MED, V322, P1494, DOI 10.1056/NEJM199005243222104; Sijbrands EJG, 2000, ATHEROSCLEROSIS, V149, P421, DOI 10.1016/S0021-9150(99)00336-6; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; WILLIAMS RR, 1986, JAMA-J AM MED ASSOC, V255, P219, DOI 10.1001/jama.255.2.219; WILLIAMS RR, 1992, CLIN EXP PHARM P S20, V19, P1	21	161	161	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2001	322	7293					1019	1022		10.1136/bmj.322.7293.1019	http://dx.doi.org/10.1136/bmj.322.7293.1019			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325764	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000168478700017
J	Chen, J				Chen, J			Smithsonian closure plan under fire	NATURE			English	News Item																		2001, NATURE, V410, P727	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1011	1011		10.1038/35074250	http://dx.doi.org/10.1038/35074250			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323623	Bronze			2022-12-28	WOS:000168285500004
J	Johnson, L; Mercer, K; Greenbaum, D; Bronson, RT; Crowley, D; Tuveson, DA; Jacks, T				Johnson, L; Mercer, K; Greenbaum, D; Bronson, RT; Crowley, D; Tuveson, DA; Jacks, T			Somatic activation of the K-ras oncogene causes early onset lung cancer in mice	NATURE			English	Article							TUMOR-DEVELOPMENT; GENE-MUTATIONS; ADENOCARCINOMA; PROGRESSION; MOUSE; TRANSFORMATION; HYPERPLASIA; PREVALENCE; FREQUENT; FOCI	About 30% of human tumours carry ras gene mutations(1,2). Of the three genes in this family (composed of K-ras, N-ras and H-ras), K-ras is the most frequently mutated member in human tumours, including adenocarcinomas of the pancreas (similar to 70-90% incidence), colon (similar to 50%) and lung (similar to 25-50%)(1-6). To constuct mouse tumour models involving K-ras, we used a new gene targeting procedure to create mouse strains carrying oncogenic alleles of K-ras that can be activated only on a spontaneous recombination event in the whole animal. Here we show that mice carrying these mutations were highly predisposed to a range of tumour types, predominantly early onset lung cancer. This model was further characterized by examining the effects of germline mutations in the tumour suppressor gene p53, which is known to be mutated along with K-ras in human tumours. This approach has several advantages over traditional transgenic strategies, including that it more closely recapitulates spontaneous oncogene activation as seen in human cancers.	MIT, Dept Biol, Cambridge, MA 02139 USA; Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Dana Farber Canc Inst, Div Adult Oncol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Dana-Farber Cancer Institute	Jacks, T (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							ADAMS JM, 1991, SCIENCE, V254, P1161, DOI 10.1126/science.1957168; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; HASTY P, 1991, NATURE, V353, P94, DOI 10.1038/353094b0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; Kitamura H, 1999, AM J CLIN PATHOL, V111, P610; Lerner EC, 1997, ANTI-CANCER DRUG DES, V12, P229; Linnoila R I, 1992, J Natl Cancer Inst Monogr, P61; MILLS NE, 1995, CANCER RES, V55, P1444; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; NAKANISHI K, 1990, ARCH PATHOL LAB MED, V114, P363; PELLEGATA NS, 1994, CANCER RES, V54, P1556; PRETLOW TP, 1991, CANCER RES, V51, P1564; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; SEPERACK PK, 1988, P NATL ACAD SCI USA, V85, P189, DOI 10.1073/pnas.85.1.189; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Thrane EV, 1997, EXP LUNG RES, V23, P35, DOI 10.3109/01902149709046046; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YAMASHITA N, 1995, CANCER, V75, P1527, DOI 10.1002/1097-0142(19950315)75:6+<1527::AID-CNCR2820751524>3.0.CO;2-Y; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	31	876	935	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1111	1116		10.1038/35074129	http://dx.doi.org/10.1038/35074129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323676				2022-12-28	WOS:000168285500052
J	Ghalambor, CK; Martin, TE				Ghalambor, CK; Martin, TE			Fecundity-survival trade-offs and parental risk-taking in birds	SCIENCE			English	Article							LIFE-HISTORY EVOLUTION; NEST PREDATION; RATES; POPULATIONS; NORTH	Life history theory predicts that parents should value their own survival over that of their offspring in species with a higher probability of adult survival and fewer offspring. We report that Southern Hemisphere birds have higher adult survival and smaller clutch sizes than Northern Hemisphere birds. We subsequently manipulated predation risk to adults versus offspring in 10 species that were paired between North and South America on the basis of phylogeny and ecology. As predicted, southern parents responded more strongly to reduce mortality risk to themselves oven at a cost to their offspring, whereas northern parents responded more strongly to reduce risk to their offspring even at greater risk to themselves.	Univ Montana, Montana Cooperat Wildlife Res Unit, Avian Studies Program, US Geol Survey,Biol Resources Div, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Ghalambor, CK (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	camerong@citrus.ucr.edu	Ghalambor, Cameron/HGE-0411-2022; Martin, Thomas E/F-6016-2011; Ghalambor, Cameron/V-4486-2019; Bond, Alexander L/A-3786-2010	Martin, Thomas E/0000-0002-4028-4867; Ghalambor, Cameron/0000-0003-2515-4981; 				Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C; Ghalambor CK, 2000, ANIM BEHAV, V60, P263, DOI 10.1006/anbe.2000.1472; GHALAMBOR CK, IN PRESS BEHAV ECOL; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; KARR JR, 1990, AM NAT, V136, P277, DOI 10.1086/285098; KING JR, 1987, CONDOR, V89, P549, DOI 10.2307/1368644; Lack D., 1968, pvii; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; Martin TE, 1995, J APPL STAT, V22, P863, DOI 10.1080/02664769524676; Martin TE, 1996, AM NAT, V147, P1028, DOI 10.1086/285891; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; MOREAU R. E., 1944, IBIS, V86, P286, DOI 10.1111/j.1474-919X.1944.tb04093.x; Ricklefs RE, 1997, ECOL MONOGR, V67, P23, DOI 10.1890/0012-9615(1997)067[0023:CDONWP]2.0.CO;2; RICKLEFS RE, 1977, AM NAT, V111, P453, DOI 10.1086/283179; Roff Derek A., 1992; SAETHER BE, 1988, NATURE, V331, P616, DOI 10.1038/331616a0; Sandercock BK, 2000, ECOLOGY, V81, P1351, DOI 10.2307/177213; Skutch A.F., 1985, ORNITHOLOGICAL MONOG, V36, P575, DOI [10.2307/40168306, DOI 10.2307/40168306]; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	22	395	406	3	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					494	497		10.1126/science.1059379	http://dx.doi.org/10.1126/science.1059379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313493				2022-12-28	WOS:000168187300044
J	Seligsohn, U; Lubetsky, A				Seligsohn, U; Lubetsky, A			Medical progress: Genetic susceptibility to venous thrombosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACTIVATED PROTEIN-C; FACTOR-V-LEIDEN; DEEP-VEIN THROMBOSIS; ANTITHROMBIN-III-DEFICIENCY; ADDITIONAL RISK FACTOR; PROTHROMBIN-GENE; INHERITED THROMBOPHILIA; FAMILIAL THROMBOPHILIA; THROMBOEMBOLIC DISEASE; 3'-UNTRANSLATED REGION		Chaim Sheba Med Ctr, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; Chaim Sheba Med Ctr, Dept Hematol, Natl Hemophilia Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Seligsohn, U (corresponding author), Chaim Sheba Med Ctr, Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel.	zeligson@post.tau.ac.il						Alhenc-Gelas M, 1999, THROMB HAEMOSTASIS, V81, P506; BECK EA, 1965, NATURE, V208, P143, DOI 10.1038/208143a0; BENTAL O, 1989, THROMB HAEMOSTASIS, V61, P50; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; BOYER C, 1986, THROMB HAEMOSTASIS, V56, P18; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brown K, 1997, BRIT J HAEMATOL, V98, P907, DOI 10.1046/j.1365-2141.1997.3093130.x; Bucciarelli P, 1999, ARTERIOSCL THROM VAS, V19, P1026, DOI 10.1161/01.ATV.19.4.1026; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; COMP PC, 1984, NEW ENGL J MED, V311, P1525, DOI 10.1056/NEJM198412133112401; Corral A, 1997, BRIT J HAEMATOL, V99, P304, DOI 10.1046/j.1365-2141.1997.3943208.x; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; De Stefano V, 1999, BRIT J HAEMATOL, V106, P564, DOI 10.1046/j.1365-2141.1999.01613.x; De Stefano V, 1998, SEMIN THROMB HEMOST, V24, P367, DOI 10.1055/s-2007-996025; De Stefano V, 1998, THROMB HAEMOSTASIS, V80, P342; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; de Visser MCH, 1999, BLOOD, V93, P1271, DOI 10.1182/blood.V93.4.1271.404k22_1271_1276; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; DeStefano V, 1996, BLOOD, V87, P3531, DOI 10.1182/blood.V87.9.3531.bloodjournal8793531; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; Ehrenforth S, 1999, ARTERIOSCL THROM VAS, V19, P276, DOI 10.1161/01.ATV.19.2.276; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Emmerich J, 1997, THROMB HAEMOSTASIS, V77, P620; Faioni EM, 1999, BLOOD, V94, P3062, DOI 10.1182/blood.V94.9.3062.421k13_3062_3066; Ferraresi P, 1997, ARTERIOSCL THROM VAS, V17, P2418, DOI 10.1161/01.ATV.17.11.2418; FINAZZI G, 1987, THROMB HAEMOSTASIS, V58, P1094; Fisher M, 1996, STROKE, V27, P1163, DOI 10.1161/01.STR.27.7.1163; Friederich PW, 1996, ANN INTERN MED, V125, P955, DOI 10.7326/0003-4819-125-12-199612150-00003; Friederich PW, 1997, ANN INTERN MED, V127, P1138; Friederich PW, 1997, ANN INTERN MED, V126, P835; Gerhardt A, 2000, NEW ENGL J MED, V342, P374, DOI 10.1056/NEJM200002103420602; Girling J, 1998, CURR OPIN OBSTET GYN, V10, P135, DOI 10.1097/00001703-199804000-00010; GLADSON CL, 1988, THROMB HAEMOSTASIS, V59, P18; Grandone E, 1998, AM J OBSTET GYNECOL, V179, P1324, DOI 10.1016/S0002-9378(98)70155-3; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Hainaut P, 1998, ACTA CLIN BELG, V53, P344, DOI 10.1080/17843286.1998.11754187; HEEB MJ, 1995, BLOOD, V85, P3405, DOI 10.1182/blood.V85.12.3405.bloodjournal85123405; HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202; Hillarp A, 1997, THROMB HAEMOSTASIS, V78, P990; Hirsh J, 1997, ARCH INTERN MED, V157, P2174, DOI 10.1001/archinte.157.19.2174; Holbraaten E, 1999, THROMB HAEMOSTASIS, V82, P1218; HORELLOU MH, 1984, BRIT MED J, V289, P1285, DOI 10.1136/bmj.289.6454.1285; Howard TE, 1998, BLOOD, V91, P1092, DOI 10.1182/blood.V91.3.1092.1092_1092_1093; Kearon C, 1999, NEW ENGL J MED, V341, P298; Koeleman BPC, 1997, SEMIN HEMATOL, V34, P256; KOELEMAN BPC, 1995, THROMB HAEMOSTASIS, V74, P580; KOELEMAN BPC, 1994, BLOOD, V84, P1031; KOSTER T, 1995, BLOOD, V85, P2756, DOI 10.1182/blood.V85.10.2756.bloodjournal85102756; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Kupferminc MJ, 1999, NEW ENGL J MED, V341, P384; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Lensing AWA, 1999, THROMB HAEMOSTASIS, V82, P1564; Leroyer C, 1998, THROMB HAEMOSTASIS, V80, P49; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Lowe G, 2000, THROMB HAEMOSTASIS, V83, P530; Makris M, 1997, THROMB HAEMOSTASIS, V78, P1426; Margaglione M, 1998, ANN INTERN MED, V129, P89, DOI 10.7326/0003-4819-129-2-199807150-00003; Martinelli I, 2000, NEW ENGL J MED, V343, P1015, DOI 10.1056/NEJM200010053431405; Martinelli I, 1998, BLOOD, V92, P2353, DOI 10.1182/blood.V92.7.2353.2353_2353_2358; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; MELISSARI E, 1992, BLOOD COAGUL FIBRIN, V3, P749, DOI 10.1097/00001721-199212000-00008; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; MUDD SH, 1985, AM J HUM GENET, V37, P1; Pabinger I, 1996, ARTERIOSCL THROM VAS, V16, P742, DOI 10.1161/01.ATV.16.6.742; PABINGER I, 1992, BLOOD COAGUL FIBRIN, V3, P547, DOI 10.1097/00001721-199210000-00005; PABINGER I, 1994, THROMB HAEMOSTASIS, V71, P548; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Preston FE, 1996, LANCET, V348, P913, DOI 10.1016/S0140-6736(96)04125-6; Ray JG, 1998, ARCH INTERN MED, V158, P2101, DOI 10.1001/archinte.158.19.2101; Rees DC, 1999, BRIT J HAEMATOL, V105, P564, DOI 10.1046/j.1365-2141.1999.01361.x; Ridker PM, 1998, ANN INTERN MED, V128, P1000, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00007; Ridker PM, 1999, CIRCULATION, V99, P999, DOI 10.1161/01.CIR.99.8.999; Ridker PM, 1997, CIRCULATION, V95, P1777; Rosendaal FR, 1997, THROMB HAEMOSTASIS, V78, P1; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; Salomon O, 1999, ARTERIOSCL THROM VAS, V19, P511, DOI 10.1161/01.ATV.19.3.511; Sanson BJ, 1999, BLOOD, V94, P3702; Sanson BJ, 1996, THROMB HAEMOSTASIS, V75, P387; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Schulman S, 2000, Curr Opin Pulm Med, V6, P321, DOI 10.1097/00063198-200007000-00012; Seligsohn U, 1997, THROMB HAEMOSTASIS, V78, P297; Shen L, 1997, THROMB HAEMOSTASIS, V78, P1030; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; Souto JC, 1998, THROMB HAEMOSTASIS, V80, P366; TABERNERO MD, 1991, AM J HEMATOL, V36, P249, DOI 10.1002/ajh.2830360405; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; TAIT RC, 1994, BRIT J HAEMATOL, V87, P106, DOI 10.1111/j.1365-2141.1994.tb04878.x; Tosetto A, 1999, THROMB HAEMOSTASIS, V82, P1395; van Boven HH, 1999, BLOOD, V94, P2590, DOI 10.1182/blood.V94.8.2590.420k40_2590_2594; vandenBelt AGM, 1997, ARCH INTERN MED, V157, P2227, DOI 10.1001/archinte.157.19.2227; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Vlieg AV, 2000, BLOOD, V95, P3678; Williamson D, 1998, BLOOD, V91, P1140, DOI 10.1182/blood.V91.4.1140; Zivelin A, 1997, BLOOD, V89, P397; Zivelin A, 1998, BLOOD, V92, P1119, DOI 10.1182/blood.V92.4.1119.416k39_1119_1124; Zivelin A, 1999, BLOOD, V94, P895, DOI 10.1182/blood.V94.3.895.415k01_895_901; ZOLLER B, 1995, BLOOD, V85, P3518, DOI 10.1182/blood.V85.12.3518.bloodjournal85123518	105	580	614	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1222	1231		10.1056/NEJM200104193441607	http://dx.doi.org/10.1056/NEJM200104193441607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309638				2022-12-28	WOS:000168127600007
J	Williams, E; Fulop, M				Williams, E; Fulop, M			A puzzling case of hyperkalaemia	LANCET			English	Editorial Material							HYPERKALEMIA		Albert Einstein Coll Med, Dept Med, Bronx, NY 10471 USA	Yeshiva University; Albert Einstein College of Medicine	Fulop, M (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10471 USA.							BORRA S, 1988, MT SINAI J MED, V55, P226; Fan K, 1996, DIABETES CARE, V19, P1457, DOI 10.2337/diacare.19.12.1457; KIEM L, 1970, DOCUMENTA GEIGY SCI, P499; PAICE B, 1983, BRIT MED J, V286, P1189, DOI 10.1136/bmj.286.6372.1189	4	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1176	1176		10.1016/S0140-6736(00)04336-1	http://dx.doi.org/10.1016/S0140-6736(00)04336-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323046				2022-12-28	WOS:000168192100013
J	Thi, WF; Blake, GA; van Dishoeck, EF; van Zadelhoff, GJ; Horn, JMM; Becklin, EE; Mannings, V; Sargent, AI; van den Ancker, ME; Natta, A				Thi, WF; Blake, GA; van Dishoeck, EF; van Zadelhoff, GJ; Horn, JMM; Becklin, EE; Mannings, V; Sargent, AI; van den Ancker, ME; Natta, A			Substantial reservoirs of molecular hydrogen in the debris disks around young stars	NATURE			English	Article							MAIN-SEQUENCE STARS; CIRCUMSTELLAR DISKS; VEGA; DUST; SEARCH; INTERSTELLAR; H-2; AGE	Circumstellar accretion disks transfer matter from molecular clouds to young stars and to the sites of planet formation. The disks observed around pre-main-sequence stars have properties consistent with those expected for the pre-solar nebula from which our own Solar System formed 4.5 Gyr ago(1). But the 'debris' disks that encircle more than 15% of nearby main-sequence stars(2-5) appear to have very small amounts of gas, based on observations of the tracer molecule carbon monoxide(6-8) : these observations have yielded gas/dust ratios much less than 0.1, whereas the interstellar value is about 100 (ref. 9). Here we report observations of the lowest rotational transitions of molecular hydrogen (H-2) that reveal large quantities of gas in the debris disks around the stars beta Pictoris, 49 Ceti and HD135344. The gas masses calculated from the data are several hundreds to a thousand times greater than those estimated from the CO observations, and yield gas/dust ratios of the same order as the interstellar value.	CALTECH 15021, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, SIRTF Sci Ctr, Pasadena, CA 91125 USA; CALTECH 10524, Div Phys Math & Astron, Pasadena, CA 91125 USA; Leiden Observ, NL-2300 RA Leiden, Netherlands; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Osserv Astrofis Arcetri, I-50125 Florence, Italy; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Leiden University; Leiden University - Excl LUMC; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles	Blake, GA (corresponding author), CALTECH 15021, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	gab@gps.caltech.edu	van Zadelhoff, Gerd-Jan/K-6283-2013					Artymowicz P, 1997, ASTROPHYS J, V490, P863, DOI 10.1086/304889; AUMANN HH, 1984, ASTROPHYS J, V278, pL23, DOI 10.1086/184214; Backman D. E., 1993, PROTOSTARS PLANETS, P1253; Beckwith SVW, 1996, NATURE, V383, P139, DOI 10.1038/383139a0; de Muizon MJ, 1999, ASTRON ASTROPHYS, V350, P875; deGraauw T, 1996, ASTRON ASTROPHYS, V315, pL49; DENT WRF, 1995, MON NOT R ASTRON SOC, V277, pL25; Dunkin SK, 1997, MON NOT R ASTRON SOC, V290, P165, DOI 10.1093/mnras/290.1.165; Fajardo-Acosta SB, 1999, ASTROPHYS J, V520, P215, DOI 10.1086/307458; Greaves JS, 2000, MON NOT R ASTRON SOC, V312, pL1, DOI 10.1046/j.1365-8711.2000.03233.x; Habing HJ, 1999, NATURE, V401, P456, DOI 10.1038/46749; Heap SR, 2000, ASTROPHYS J, V539, P435, DOI 10.1086/309188; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; Hollenbach D. J., 2000, Protostars and planets 4, P401; Kamp I, 2000, ASTRON ASTROPHYS, V353, P276; Kessler MF, 1996, ASTRON ASTROPHYS, V315, pL27; KLAHR HH, IN PRESS ASTRON J; Lagrange A.-M., 2000, Protostars and planets 4, P639; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; SANDFORD SA, 1993, ASTROPHYS J, V409, pL65, DOI 10.1086/186861; Siess L, 1999, ASTRON ASTROPHYS, V342, P480; Thi WF, 1999, ASTROPHYS J, V521, pL63, DOI 10.1086/312171; THI WF, UNPUB ASTROPHYS J; Valentijn EA, 2000, EXP ASTRON, V10, P215, DOI 10.1023/A:1008169124088; Walker HJ, 2000, ICARUS, V143, P147, DOI 10.1006/icar.1999.6235; Zuckerman B, 2000, ASTROPHYS J, V535, P959, DOI 10.1086/308897; ZUCKERMAN B, 1995, NATURE, V373, P494, DOI 10.1038/373494a0	29	96	96	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					60	63		10.1038/35051033	http://dx.doi.org/10.1038/35051033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343110				2022-12-28	WOS:000166175600036
J	Beck, JW; Richards, DA; Edwards, RL; Silverman, BW; Smart, PL; Donahue, DJ; Hererra-Osterheld, S; Burr, GS; Calsoyas, L; Jull, AJT; Biddulph, D				Beck, JW; Richards, DA; Edwards, RL; Silverman, BW; Smart, PL; Donahue, DJ; Hererra-Osterheld, S; Burr, GS; Calsoyas, L; Jull, AJT; Biddulph, D			Extremely large variations of atmospheric C-14 concentration during the last glacial period	SCIENCE			English	Article							YOUNGER DRYAS; ICE CORE; RADIOCARBON CALIBRATION; OCEAN CIRCULATION; BERYLLIUM 10; NORDIC SEAS; TH-230 AGES; RECORD; BE-10; KA	A long record of atmospheric C-14 concentration, from 45 to 11 thousand years ago (ka), was obtained from a stalagmite with thermal-ionization mass-spectrometric Th-230 and accelerator mass-spectrometric C-14 measurements. This record reveals highly elevated Delta C-14 between 45 and 33 ka, portions of which may correlate with peaks in cosmogenic Cl-36 and Be-10 isotopes observed in polar ice cores. Superimposed on this broad peak of Delta C-14 are several rapid excursions, the Largest of which occurs between 44.3 and 43.3 ka. Between 26 and 11 ka, atmospheric Delta C-14 decreased from similar to 700 to similar to 100 per mil, modulated by numerous minor excursions. Carbon cycle models suggest that the major features of this record cannot be produced with solar or terrestrial magnetic field modulation alone but also require substantial fluctuations in the carbon cycle.	Univ Arizona, Dept Phys, NSF, Arizona Accelerator Mass Spectrometry Facil, Tucson, AZ 85721 USA; Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA; Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England	National Science Foundation (NSF); University of Arizona; University of Bristol; University of Minnesota System; University of Minnesota Twin Cities; University of Bristol	Beck, JW (corresponding author), Univ Arizona, Dept Phys, NSF, Arizona Accelerator Mass Spectrometry Facil, Tucson, AZ 85721 USA.	wbeck@physics.arizona.edu; David.Richards@bristol.ac.uk	Richards, David A/B-7298-2008; Edwards, R. Lawrence/I-3124-2014; Silverman, Bernard W/K-6417-2012	Richards, David A/0000-0001-8389-8079; Edwards, R. Lawrence/0000-0002-7027-5881; Silverman, Bernard W/0000-0002-4059-2376; Burr, George/0000-0003-0068-7589				Alley RB, 1997, J GEOPHYS RES-OCEANS, V102, P26367, DOI 10.1029/96JC03837; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bard E, 1998, GEOCHIM COSMOCHIM AC, V62, P2025, DOI 10.1016/S0016-7037(98)00130-6; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; BARD E, 1998, RADIOCARBON, V40, P1095; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Baumgartner S, 1998, SCIENCE, V279, P1330, DOI 10.1126/science.279.5355.1330; BEER J, 1991, SUN TIME, P343; Bjorck S, 1996, SCIENCE, V274, P1155, DOI 10.1126/science.274.5290.1155; Broecker W.S., 1982, TRACERS SEA; Burr GS, 1998, RADIOCARBON, V40, P1093, DOI 10.1017/S0033822200019147; BURR GS, 1992, RADIOCARBON, V34, P611, DOI 10.1017/S003382220006389X; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Damon P.E., 1991, SUN TIME, P360; DAMON PE, 1989, RADIOCARBON, V31, P697; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Edwards RL, 1997, SCIENCE, V276, P782, DOI 10.1126/science.276.5313.782; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; Frank M, 1997, EARTH PLANET SC LETT, V149, P121, DOI 10.1016/S0012-821X(97)00070-8; Genty D, 1997, RADIOCARBON, V39, P33, DOI 10.1017/S0033822200040881; Genty D, 1999, RADIOCARBON, V41, P251, DOI 10.1017/S003382220005712X; Goslar T, 2000, NATURE, V403, P877, DOI 10.1038/35002547; Green P.J., 1993, NONPARAMETRIC REGRES, DOI [10.1201/b15710, DOI 10.1201/B15710]; Guyodo Y, 1996, EARTH PLANET SC LETT, V143, P23, DOI 10.1016/0012-821X(96)00121-5; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; HOUTERMANS JC, 1971, THESIS U BERN BERN; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Hughen KA, 1998, NATURE, V391, P65, DOI 10.1038/34150; KAUFMAN A, 1993, GEOCHIM COSMOCHIM AC, V57, P2303, DOI 10.1016/0016-7037(93)90571-D; Kissel C, 1999, EARTH PLANET SC LETT, V171, P489, DOI 10.1016/S0012-821X(99)00162-4; Kitagawa H, 1998, SCIENCE, V279, P1187, DOI 10.1126/science.279.5354.1187; Laj C, 2000, PHILOS T ROY SOC A, V358, P1009, DOI 10.1098/rsta.2000.0571; LAL D, 1988, SOLAR TERRESTRIAL RE, P216; LAL D, 1962, PROGR ELEMENTARY PAR, P1; LUDWIG KR, 1994, GEOCHIM COSMOCHIM AC, V58, P5031, DOI 10.1016/0016-7037(94)90229-1; Masarik J, 1999, J GEOPHYS RES-ATMOS, V104, P12099, DOI 10.1029/1998JD200091; MCHARGUE LR, 1995, GEOPHYS RES LETT, V22, P659, DOI 10.1029/95GL00169; Munhoven G, 1997, THESIS U LIEGE LIEGE; Muscheler R, 2000, NATURE, V408, P567, DOI 10.1038/35046041; O'Brien K., 1991, SUN TIME, P317; Parker EN, 1997, SPACE SCI S, P3; PICKETT DA, 1994, ANAL CHEM, V66, P1044, DOI 10.1021/ac00079a020; RAISBECK GM, 1981, NATURE, V292, P825, DOI 10.1038/292825a0; REEDY R, 1998, SOLAR PARTICLE EVENT, P317; Schramm A, 2000, EARTH PLANET SC LETT, V175, P27, DOI 10.1016/S0012-821X(99)00279-4; SMITH EJ, 1991, SUN TIME, P175; STUIVER M, 1961, J GEOPHYS RES, V66, P273, DOI 10.1029/JZ066i001p00273; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; SUESS HE, 1980, RADIOCARBON, V22, P200, DOI 10.1017/S0033822200009462; SUNDQUIST ET, 1985, GEOPHYSICAL MONOGRAP, V32; Voelker AHL, 1998, RADIOCARBON, V40, P517; Vogel JC, 1997, RADIOCARBON, V39, P27, DOI 10.1017/S003382220004087X; Yiou F, 1997, J GEOPHYS RES-OCEANS, V102, P26783, DOI 10.1029/97JC01265; Yokoyama Y, 2000, RADIOCARBON, V42, P383, DOI 10.1017/S0033822200030320	56	267	276	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2001	292	5526					2453	2458		10.1126/science.1056649	http://dx.doi.org/10.1126/science.1056649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11349137				2022-12-28	WOS:000169658200031
J	Read, AF; Taylor, LH				Read, AF; Taylor, LH			The ecology of genetically diverse infections	SCIENCE			English	Editorial Material							MIXED-GENOTYPE INFECTIONS; PLASMODIUM-FALCIPARUM; RODENT MALARIA; CLINICAL MALARIA; PARASITES; TRANSMISSION; DYNAMICS; STRAINS; COLONIZATION; INTERFERENCE	Microparasite infections often consist of genetically distinct clonal Lineages. Ecological interactions between these Lineages within hosts can influence disease severity, epidemiology, and evolution. Many medical and veterinary interventions have an impact on genetic diversity within infections, but there is Little understanding of the Long-term consequences of such interventions for public and animal health. Indeed, much of the theory in this area is based on assumptions contradicted by the available data.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Read, AF (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	a.read@ed.ac.uk	Taylor, Louise/H-9765-2019	Taylor, Louise/0000-0001-8141-2346				AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Anderson TJC, 2000, GENET RES, V75, P285, DOI 10.1017/S0016672300004481; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Babiker HA, 1998, AM J TROP MED HYG, V59, P582, DOI 10.4269/ajtmh.1998.59.582; Barbujani G., 1999, EVOLUTION HLTH DIS; Barrow PA, 2000, FEMS MICROBIOL LETT, V182, P87, DOI 10.1111/j.1574-6968.2000.tb08879.x; Begon M, 1996, ECOLOGY INDIVIDUALS; BERCHIERI A, 1990, EPIDEMIOL INFECT, V104, P427, DOI 10.1017/S0950268800047440; Buckling A, 1999, PARASITOLOGY, V118, P339, DOI 10.1017/S0031182099003960; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Chao L, 2000, Q REV BIOL, V75, P261, DOI 10.1086/393499; CONWAY DJ, 1991, PARASITOLOGY, V103, P1, DOI 10.1017/S0031182000059217; Daubersies P, 1996, AM J TROP MED HYG, V54, P18, DOI 10.4269/ajtmh.1996.54.18; DIECKMANN U, IN PRESS VIRULENCE M; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; HARGREAVES BJ, 1975, ANN TROP MED PARASIT, V69, P289, DOI 10.1080/00034983.1975.11687013; HART AR, 1990, VIROLOGY, V177, P1, DOI 10.1016/0042-6822(90)90454-Y; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; Kyes S, 1997, AM J TROP MED HYG, V57, P205, DOI 10.4269/ajtmh.1997.57.205; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; MEAD GC, 1990, LETT APPL MICROBIOL, V10, P221, DOI 10.1111/j.1472-765X.1990.tb00113.x; MercereauPuijalon O, 1996, PARASITE IMMUNOL, V18, P173, DOI 10.1046/j.1365-3024.1996.d01-79.x; MORRISON WI, 1982, J PARASITOL, V68, P755, DOI 10.2307/3280980; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Read A, 2000, MOL EPIDEMIOLOGY INF, P59; READ AF, IN PRESS VIRULENCE M; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; SEGENT E, 1935, ARCH I PASTEUR ALGER, V13, P279; Sernicola L, 1999, VIROLOGY, V256, P291, DOI 10.1006/viro.1999.9652; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; SNOUNOU G, 1989, MOL BIOCHEM PARASIT, V37, P37, DOI 10.1016/0166-6851(89)90100-X; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Taylor LH, 1998, EVOLUTION, V52, P583, DOI 10.1111/j.1558-5646.1998.tb01656.x; Taylor LH, 1997, P ROY SOC B-BIOL SCI, V264, P927, DOI 10.1098/rspb.1997.0128; Thompson RCA, 2000, MOL EPIDEMIOLOGY INF; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726	40	458	465	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1099	1102		10.1126/science.1059410	http://dx.doi.org/10.1126/science.1059410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352063				2022-12-28	WOS:000168609200041
J	Martinez-Perez, E; Shaw, P; Moore, G				Martinez-Perez, E; Shaw, P; Moore, G			The Ph1 locus is needed to ensure specific somatic and meiotic centromere association	NATURE			English	Article							DROSOPHILA-MELANOGASTER; CHIASMA FORMATION; WHEAT; ORGANIZATION; CHROMOSOMES; HYBRIDS; COMPLEX; MEIOSIS; NUCLEI	The correct pairing and segregation of chromosomes during meiosis is essential for genetic stability and subsequent fertility. This is more difficult to achieve in polyploid species, such as wheat, because they possess more than one diploid set of similar chromosomes. In wheat, the Ph1 locus ensures correct homologue pairing and recombination(1). Although clustering of telomeres into a bouquet early in meiosis has been suggested to facilitate homologue pairing(2,3), centromeres associate in pairs in polyploid cereals early during floral development(4). We can now extend this observation to root development. Here we show that the Ph1 locus acts both meiotically and somatically by reducing non-homologous centromere associations. This has the effect of promoting true homologous association when centromeres are induced to associate. In fact, non-homologously associated centromeres separate at the beginning of meiosis in the presence, but not the absence, of Ph1. This permits the correction of homologue association during the telomere-bouquet stage in meiosis. We conclude that the Ph1 locus is not responsible for the induction of centromere association, but rather for its specificity.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Moore, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.		shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669				Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Ananiev EV, 1998, P NATL ACAD SCI USA, V95, P13073, DOI 10.1073/pnas.95.22.13073; AragonAlcaide L, 1997, CURR BIOL, V7, P905, DOI 10.1016/S0960-9822(06)00383-6; DHALIWAL HS, 1977, J HERED, V68, P206; Dvorak J, 2000, CHROMOSOMA, V109, P410, DOI 10.1007/s004120000093; DVORAK J, 1977, CAN J GENET CYTOL, V19, P549; FELDMAN M, 1966, P NATL ACAD SCI USA, V55, P1447, DOI 10.1073/pnas.55.6.1447; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; GILLIES CB, 1987, THEOR APPL GENET, V74, P430, DOI 10.1007/BF00289817; Henikoff S, 1997, CURR OPIN CELL BIOL, V9, P388, DOI 10.1016/S0955-0674(97)80012-9; HOLM PB, 1988, CARLSBERG RES COMMUN, V53, P191, DOI 10.1007/BF02907179; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; HOLM PB, 1988, CARLSBERG RES COMMUN, V53, P91, DOI 10.1007/BF02907175; Langdon T, 2000, GENETICS, V156, P313; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; Martinez-Perez E, 2000, J CELL BIOL, V148, P233, DOI 10.1083/jcb.148.2.233; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; RILEY R, 1970, NATURE, V227, P82, DOI 10.1038/227082a0; Roberts MA, 1999, GENETICS, V153, P1909; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; WALL AM, 1971, GENET RES, V18, P329, DOI 10.1017/S0016672300012726; WANG XZ, 1988, CARLSBERG RES COMMUN, V53, P167, DOI 10.1007/BF02907178; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481	25	130	144	1	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					204	207		10.1038/35075597	http://dx.doi.org/10.1038/35075597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346798				2022-12-28	WOS:000168563000053
J	Ostrowsky, BE; Trick, WE; Sohn, AH; Quirk, SB; Holt, S; Carson, LA; Hill, BC; Arduino, MJ; Kuehnert, MJ; Jarvis, WR				Ostrowsky, BE; Trick, WE; Sohn, AH; Quirk, SB; Holt, S; Carson, LA; Hill, BC; Arduino, MJ; Kuehnert, MJ; Jarvis, WR			Control of vancomycin-resistant enterococcus in health care facilities in a region.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONIZATION; EPIDEMIOLOGY; FAECIUM; RISK	Background: In late 1996, vancomycin-resistant enterococci were first detected in the Siouxland region of Iowa, Nebraska, and South Dakota. A task force was created, and in 1997 the assistance of the Centers for Disease Control and Prevention was sought in assessing the prevalence of vancomycin-resistant enterococci in the region's facilities and implementing recommendations for screening, infection control, and education at all 32 health care facilities in the region. Methods: The infection-control intervention was evaluated in October 1998 and October 1999. We performed point-prevalence surveys, conducted a case-control study of gastrointestinal colonization with vancomycin-resistant enterococci, and compared infection-control practices and screening policies for vancomycin-resistant enterococci at the acute care and long-term care facilities in the Siouxland region. Results: Perianal-swab samples were obtained from 1954 of 2196 eligible patients (89 percent) in 1998 and 1820 of 2049 eligible patients (89 percent) in 1999. The overall prevalence of vancomycin-resistant enterococci at 30 facilities that participated in all three years of the study decreased from 2.2 percent in 1997 to 1.4 percent in 1998 and to 0.5 percent in 1999 (P<0.001 by chi-square test for trend). The number of facilities that had had at least one patient with vancomycin-resistant enterococci declined from 15 in 1997 to 10 in 1998 to 5 in 1999. At both acute care and long-term care facilities, the risk factors for colonization with vancomycin-resistant enterococci were prior hospitalization and treatment with antimicrobial agents. Most of the long-term care facilities screened for vancomycin-resistant enterococci (26 of 28 in 1998 [93 percent] and 23 of 25 in 1999 [92 percent]) and had infection-control policies to prevent the transmission of vancomycin-resistant enterococci (22 of 25 [88 percent] in 1999). All four acute care facilities had screening and infection-control policies for vancomycin-resistant enterococci in 1998 and 1999. Conclusions: An active infection-control intervention, which includes the obtaining of surveillance cultures and the isolation of infected patients, can reduce or eliminate the transmission of vancomycin-resistant enterococci in the health care facilities of a region. (N Engl J Med 2001;344:1427-33.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Hosp Infect Program, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Siouxland Dist Hlth Dept, Sioux City, IA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ostrowsky, BE (corresponding author), Virginia Commonwealth Univ, Epidemiol & Infect Control Unit, W Hosp, Med Coll Virginia Campus,1200 E Broad St,E Wing,R, Richmond, VA 23298 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X; Trick, William/0000-0002-3243-5098				[Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597; Bonilla HF, 1997, INFECT CONT HOSP EP, V18, P333, DOI 10.1086/647621; Bonten MJM, 1996, LANCET, V348, P1615, DOI 10.1016/S0140-6736(96)02331-8; EDMOND MB, 1995, CLIN INFECT DIS, V20, P1126, DOI 10.1093/clinids/20.5.1126; Eliopoulos G M, 1996, Curr Clin Top Infect Dis, V16, P21; Eliopoulos GM, 1997, INFECT DIS CLIN N AM, V11, P851, DOI 10.1016/S0891-5520(05)70393-7; Facklam Richard R., 1995, P308; Farr BM, 1998, CRIT CARE MED, V26, P1942, DOI 10.1097/00003246-199812000-00008; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; *HOSP INF CONTR PR, 1995, MMWR-MORBID MORTAL W, V44, P1; LAI E, 1989, BIOTECHNIQUES, V7, P34; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; *NAT COMM CLIN LAB, 1998, M100S8 NCCLS; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; *SIOUXL VRE TASK F, 1998, GUID MAN PAT VANC RE; Trick WE, 1999, J INFECT DIS, V180, P391, DOI 10.1086/314898; Weinstein JT, 1996, INFECT CONT HOSP EP, V17, P36	19	228	232	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1427	1433		10.1056/NEJM200105103441903	http://dx.doi.org/10.1056/NEJM200105103441903			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346807	Green Published			2022-12-28	WOS:000168554000003
J	Tarricone, C; Xiao, B; Justin, N; Walker, PA; Rittinger, K; Gamblin, SJ; Smerdon, SJ				Tarricone, C; Xiao, B; Justin, N; Walker, PA; Rittinger, K; Gamblin, SJ; Smerdon, SJ			The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signalling pathways	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; RAC1-INTERACTING PROTEIN; CRYSTAL-STRUCTURE; BINDING PROTEIN; PHOSPHOLIPASE-D; RHO PROTEINS; COMPLEX; CDC42; ACTIVATION; DOMAIN	Small G proteins are GTP-dependent molecular switches that regulate numerous cellular functions(1). They can be classified into homologous subfamilies that are broadly associated with specific biological processes. Cross-talk between small G-protein families has an important role in signalling, but the mechanism by which it occurs is poorly understood(2). The coordinated action of Arf and Rho family GTPases is required to regulate many cellular processes including lipid signalling(3), cell motility(4) and Golgi function(5). Arfaptin is a ubiquitously expressed protein implicated in mediating cross-talk between Rac (a member of the Rho family) and Arf small GTPases. Here we show that Arfaptin binds specifically to GTP-bound Arf1 and Arf6, but binds to Rac.GTP and Rac.GDP with similar affinities. The X-ray structure of Arfaptin reveals an elongated, crescent-shaped dimer of three-helix coiled-coils. Structures of Arfaptin with Rac bound to either GDP or the slowly hydrolysable analogue GMPPNP show that the switch regions adopt similar conformations in both complexes. Our data highlight fundamental differences between the molecular mechanisms of Rho and Ras family signalling, and suggest a model of Arfaptin-mediated synergy between the Arf and Rho family signalling pathways.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England	MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk	Justin, Neil/E-1774-2011; Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Smerdon, Stephen/0000-0001-5688-8465	MRC [MC_U117565398] Funding Source: UKRI; Medical Research Council [MC_U117565398] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Fensome A, 1998, J BIOL CHEM, V273, P13157, DOI 10.1074/jbc.273.21.13157; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	26	197	210	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					215	219		10.1038/35075620	http://dx.doi.org/10.1038/35075620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346801				2022-12-28	WOS:000168563000056
J	Barry, MJ				Barry, MJ			Prostate-specificy-antigen testing for early diagnosis of prostate cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							4.0 NG/ML; MEN 50; PSA; BIOPSY; EJACULATION; HYPERPLASIA; MORTALITY; TRIAL; OLD		Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Med Practices Evaluat Ctr, 50 Staniford St,9th Fl, Boston, MA 02114 USA.				AHRQ HHS [HS 08397] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008397] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM UR ASS, 2000, ONCOLOGY, V14, P277; *AM UR ASS, 2000, ONCOLOGY HUNTINGT, V14, P280; *AUA, 2000, ONCOLOGY WILLISTON P, V14, P267; Babaian RJ, 2001, J UROLOGY, V165, P757, DOI 10.1016/S0022-5347(05)66519-6; Babaian RJ, 2000, UROLOGY, V55, P453, DOI 10.1016/S0090-4295(00)00469-6; Boer R, 1999, PROSTATE, V40, P130; Carter HB, 2000, UROLOGY, V55, P796, DOI 10.1016/S0090-4295(00)00517-3; Carter HB, 1999, UROLOGY, V54, P780, DOI 10.1016/S0090-4295(99)00271-X; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Chan ECY, 1998, AM J MED, V105, P266, DOI 10.1016/S0002-9343(98)00257-5; Coley CM, 1997, ANN INTERN MED, V126, P480; Djavan B, 2000, J UROLOGY, V163, P1144, DOI 10.1016/S0022-5347(05)67711-7; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Fowler FJ, 1998, AM J MED, V104, P526, DOI 10.1016/S0002-9343(98)00124-7; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Herschman JD, 1997, UROLOGY, V50, P239, DOI 10.1016/S0090-4295(97)00209-4; Klotz LH, 1997, UROLOGY, V50, P831, DOI 10.1016/S0090-4295(97)00490-1; Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B; Lodding P, 1998, J UROLOGY, V159, P899, DOI 10.1016/S0022-5347(01)63766-2; NADLER RB, 1995, J UROLOGY, V154, P407, DOI 10.1016/S0022-5347(01)67064-2; Oliver S, 2000, LANCET, V355, P1788, DOI 10.1016/S0140-6736(00)02269-8; Patel D, 2000, BJU INT, V85, P686, DOI 10.1046/j.1464-410x.2000.00526.x; Polascik TJ, 1999, J UROLOGY, V162, P293, DOI 10.1016/S0022-5347(05)68543-6; PRUTHI R, 2000, PROSTATE J, V2, P111; RICHIE JP, 1993, UROLOGY, V42, P365, DOI 10.1016/0090-4295(93)90359-I; Ries LAG, 2000, NIH PUBLICATION, V00-2789; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; SERSHON PD, 1994, EUR UROL, V25, P281; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5; Terris MK, 2000, UROLOGY, V55, P457, DOI 10.1016/S0090-4295(00)00450-7; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P119; Volk RJ, 2000, J FAM PRACTICE, V49, P425; Walsh PC, 2001, UROLOGY, V57, P491, DOI 10.1016/S0090-4295(00)01067-0	37	281	294	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1373	1377		10.1056/NEJM200105033441806	http://dx.doi.org/10.1056/NEJM200105033441806			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333995				2022-12-28	WOS:000168413500006
J	de Picciotto, R; Stormer, HL; Pfeiffer, LN; Baldwin, KW; West, KW				de Picciotto, R; Stormer, HL; Pfeiffer, LN; Baldwin, KW; West, KW			Four-terminal resistance of a ballistic quantum wire	NATURE			English	Article							QUANTIZED CONDUCTANCE; POINT CONTACTS; TRANSPORT	The electrical resistance of a conductor is intimately related to the relaxation of the momentum of charge carriers. In a simple model, the accelerating force exerted on electrons by an applied electric field is balanced by a frictional force arising from their frequent collisions with obstacles such as impurities, grain boundaries or other deviations from a perfect crystalline order(1). Thus, in the absence of any scattering, the electrical resistance should vanish altogether. Here, we observe such vanishing four-terminal resistance in a single-mode ballistic quantum wire. This result contrasts the value of the standard two-probe resistance measurements of h/2e(2) approximate to 13 k Omega. The measurements are conducted in the highly controlled geometry afforded by epitaxial growth onto the cleaved edge of a high-quality GaAs/AlGaAs heterostructure. Two weakly invasive voltage probes are attached to the central section of a ballistic quantum wire to measure the inherent resistance of this clean one-dimensional conductor.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; NYU, Dept Phys, New York, NY 10003 USA; NYU, Dept Appl Phys, New York, NY 10003 USA	Alcatel-Lucent; Lucent Technologies; AT&T; New York University; New York University	de Picciotto, R (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	rd25@lucent.com						BUTTIKER M, 1986, PHYS REV LETT, V57, P1761, DOI 10.1103/PhysRevLett.57.1761; BUTTIKER M, 1988, IBM J RES DEV, V32, P317, DOI 10.1147/rd.323.0317; BUTTIKER M, 1986, PHYS REV B, V33, P3020, DOI 10.1103/PhysRevB.33.3020; de Picciotto R, 2000, PHYS REV LETT, V85, P1730, DOI 10.1103/PhysRevLett.85.1730; Drude P., 1900, ANN, V308, P369, DOI [10.1002/andp.19003081102, DOI 10.1002/ANDP.19003081102]; ENGQUIST HL, 1981, PHYS REV B, V24, P1151, DOI 10.1103/PhysRevB.24.1151; GLAZMAN LI, 1988, JETP LETT+, V48, P238; Grinstein G, 1986, DIRECTIONS CONDENSED; HEIBLUM M, 1981, SOLID STATE ELECTRON, V24, P343, DOI 10.1016/0038-1101(81)90029-0; Imry Y., 1997, INTRO MESOSCOPIC PHY; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; LANDAUER R, 1970, PHILOS MAG, V21, P863, DOI 10.1080/14786437008238472; Pfeiffer L, 1997, MICROELECTR J, V28, P817, DOI 10.1016/S0026-2692(96)00120-6; ROTHER M, 1998, P ICPS24, V2; TARUCHA S, 1995, SOLID STATE COMMUN, V94, P413, DOI 10.1016/0038-1098(95)00102-6; VANHOUTEN H, 1989, PHYS REV B, V39, P8556, DOI 10.1103/PhysRevB.39.8556; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Yacoby A, 1996, PHYS REV LETT, V77, P4612, DOI 10.1103/PhysRevLett.77.4612	19	145	147	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2001	411	6833					51	54		10.1038/35075009	http://dx.doi.org/10.1038/35075009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333972				2022-12-28	WOS:000168432800038
J	Veen, T; Borge, T; Griffith, SC; Saetre, GP; Bures, S; Gustafsson, L; Sheldon, BC				Veen, T; Borge, T; Griffith, SC; Saetre, GP; Bures, S; Gustafsson, L; Sheldon, BC			Hybridization and adaptive mate choice in flycatchers	NATURE			English	Article							COLLARED FLYCATCHERS; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; PREMATING ISOLATION; FICEDULA-HYPOLEUCA; CONSPECIFIC SPERM; SEASONAL DECLINE; PATERNAL EFFORT; OFFSPRING SEX; HYBRID ZONE	Hybridization in natural populations is strongly selected against when hybrid offspring have reduced fitness. Here we show that, paradoxically, pairing with another species may offer the best fitness return for an individual, despite reduced fitness of hybrid offspring. Two mechanisms reduce the costs to female collared flycatchers of pairing with male pied flycatchers. A large proportion of young are sired by conspecific male collared flycatchers through extra-pair copulations, and there is a bias in favour of male offspring (which, unlike females, are fertile) within hybrid pairs. In combination with temporal variation in breeding success, these cost-reducing mechanisms yield quantitative predictions about when female collared flycatchers should accept a male pied flycatcher as a mate; empirical data agree with these predictions. Apparent hybridization may thus represent adaptive mate choice under some circumstances.	Univ Oxford, Dept Zool, EGI, Oxford OX1 3PS, England; Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Univ Groningen, Dept Biol, NL-9750 Haren, Netherlands; Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; Palacky Univ, Ornithol Lab, Olomouc 77146, Czech Republic	University of Oxford; Uppsala University; University of Groningen; Uppsala University; Palacky University Olomouc	Sheldon, BC (corresponding author), Univ Oxford, Dept Zool, EGI, S Parks Rd, Oxford OX1 3PS, England.		Griffith, Simon/AAH-3706-2021; Griffith, Simon/A-1996-2010; Sheldon, Ben C/A-8056-2010; Gustafsson, Lars/O-8056-2019; Gustafsson, Lars/A-7634-2012	Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999; Sheldon, Ben C/0000-0002-5240-7828; Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863				ALATALO RV, 1990, J EVOLUTION BIOL, V3, P375, DOI 10.1046/j.1420-9101.1990.3050375.x; ARNOLD ML, 1997, NATURAL HYBRIDIZATIO, P7; CRAWLEY MJ, 1993, GLIM ECOLOGISTS, P279; DAAN S, 1990, BEHAVIOUR, V114, P83, DOI 10.1163/156853990X00068; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; GELTER HP, 1992, IBIS, V134, P62, DOI 10.1111/j.1474-919X.1992.tb07231.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 1997, AM NAT, V149, P1, DOI 10.1086/285976; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gustafsson L., 1989, P75; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; LUNDBERG A, 1992, PIED FLYCATCHER, P121; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; Mild Krister, 1994, Birding World, V7, P231; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Saetre GP, 1997, J AVIAN BIOL, V28, P259, DOI 10.2307/3676978; Saetre GP, 2000, HEREDITAS, V132, P171, DOI 10.1111/j.1601-5223.2000.00171.x; Saetre GP, 1999, J ZOOL, V247, P53, DOI 10.1111/j.1469-7998.1999.tb00192.x; Saetre GP, 2001, MOL ECOL, V10, P737, DOI 10.1046/j.1365-294x.2001.01208.x; Saetre GP, 1997, NATURE, V387, P589; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sheldon BC, 1996, P ROY SOC B-BIOL SCI, V263, P1017, DOI 10.1098/rspb.1996.0150; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968; Sheldon BC, 1997, BEHAV ECOL, V8, P421, DOI 10.1093/beheco/8.4.421; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; WIGGINS DA, 1994, OIKOS, V70, P359, DOI 10.2307/3545773	43	223	230	0	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					45	50		10.1038/35075000	http://dx.doi.org/10.1038/35075000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333971				2022-12-28	WOS:000168432800037
J	Yale, JF; Valiquett, TR; Ghazzi, MN; Owens-Grillo, JK; Whitcomb, RW; Foyt, HL				Yale, JF; Valiquett, TR; Ghazzi, MN; Owens-Grillo, JK; Whitcomb, RW; Foyt, HL		Troglitazone Triple Therapy Study	The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin - A multicenter, randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							INSULIN-RESISTANCE; MONOTHERAPY; EFFICACY	Background: The thiazolidinediones are a new class of anti-diabetes medication that enhances the actions of insulin in muscle, liver, and adipose tissue. Data have been lacking on their use in combination with both sulfonylurea and metformin among patients for whom insulin is the usual therapeutic alternative for improved glycemic control. Objective: To determine the effects of troglitazone on hemoglobin A(1c) level in patients treated with maximum tolerated doses of sulfonylurea and metformin who have hemoglobin A(1c) levels of at least 0.085 (8.5%). This trial was completed before troglitazone was taken off the U.S. market. Design: Randomized, double-blind, placebo-controlled trial, followed by an open-label extension during which all patients received troglitazone. Setting: 16 outpatient clinics in Canada. Patients: 200 patients (mean age, 59 years) with type 2 diabetes mellitus and hemoglobin A(1c) levels at least 0.085 (8.5%) (mean hemoglobin A(1c) level, 0.097 [9.7%] and mean fasting plasma glucose level, 12.9 mmol/L [233 mg/dL]) while receiving maximum doses of sulfonylurea and metformin. Measurements: Levels of hemoglobin A(1c), fasting plasma glucose, total insulin, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol, Results: Troglitazone, 400 mg/d, when added to sulfonylurea and metformin, significantly decreased hemoglobin A(1c) level by 0.014+/-0.002 (95% CI, 0.0167 to 0.0109; P<0.001) (1.4%+/-0.2% [CI, 1.67% to 1.09%]) and insulin by 19+/-4 pmol/L (CI, 30 to 10 pmol/L; P< 0.001). At 6 months, 43% of troglitazone-treated patients achieved hemoglobin A(1c) levels of 0.08 (8%) or lower compared with 6% of placebo recipients. Efficacy was maintained at 12 months. Conclusions: The thiazolidinedione troglitazone, at a dosage of 400 mg/d, is effective when used in combination with sulfonylurea and metformin. Thiazolidinediones may therefore offer an effective alternative to insulin for patients treated with sulfonylurea and metformin who do not achieve adequate glycemic control.	McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA	McGill University; Pfizer	Yale, JF (corresponding author), McGill Univ, Ctr Hlth, 687 Pine Ave W,Room H685, Montreal, PQ H3A 1A1, Canada.		Hramiak, Irene/G-3305-2011					*AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS32; Cusi K, 1998, DIABETES REV, V6, P89; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Fonseca VA, 1998, J CLIN ENDOCR METAB, V83, P3169, DOI 10.1210/jc.83.9.3169; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghazzi MN, 1997, DIABETES, V46, P433, DOI 10.2337/diabetes.46.3.433; Granberry MC, 1998, PHARMACOTHERAPY, V18, P973; HARRIS M, 1979, DIABETES, V28, P1039; Horton ES, 1998, DIABETES CARE, V21, P1462, DOI 10.2337/diacare.21.9.1462; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Johnson M, 1998, CLIN THER, V20, P691, DOI 10.1016/S0149-2918(98)80132-X; Lardinois CK, 1998, GERIATRICS, V53, P22; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Schwartz S, 1998, NEW ENGL J MED, V338, P861, DOI 10.1056/NEJM199803263381302; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Sunayama S, 1999, ATHEROSCLEROSIS, V146, P187, DOI 10.1016/S0021-9150(99)00138-0; SUTER SL, 1992, DIABETES CARE, V15, P193, DOI 10.2337/diacare.15.2.193; Tercyak KP, 1998, J DIABETES COMPLICAT, V12, P279, DOI 10.1016/S1056-8727(98)00005-1; Trischitta V, 1998, J ENDOCRINOL INVEST, V21, P744, DOI 10.1007/BF03348039; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; Yu JG, 1999, DIABETES, V48, P2414, DOI 10.2337/diabetes.48.12.2414	23	71	70	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					737	745		10.7326/0003-4819-134-9_Part_1-200105010-00010	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329231				2022-12-28	WOS:000168470700003
J	Lucassen, A; Watson, E; Eccles, D				Lucassen, A; Watson, E; Eccles, D			Evidence based case report - Advice about mammography for a young woman with a family history of breast cancer	BRITISH MEDICAL JOURNAL			English	Review							SCREENING MAMMOGRAPHY; RADIATION RISK; WOMEN; BENEFITS; EFFICACY; AGE		Princess Anne Hosp, Wessex Reg Genet Serv, Southampton SO16 5YA, Hants, England; Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, CRC,Primary Care Educ Res Grp, Oxford OX3 7LG, England	University of Oxford	Lucassen, A (corresponding author), Princess Anne Hosp, Wessex Reg Genet Serv, Southampton SO16 5YA, Hants, England.		Watson, Eila/R-1182-2019; Eccles, Diana/K-6327-2019; Lucassen, Anneke/D-7764-2017	Watson, Eila/0000-0002-3592-1315; Eccles, Diana/0000-0002-9935-3169; Lucassen, Anneke/0000-0003-3324-4338				Beemsterboer PMM, 1998, J MED SCREEN, V5, P81, DOI 10.1136/jms.5.2.81; Brett J, 1998, J PUBLIC HEALTH MED, V20, P396, DOI 10.1093/oxfordjournals.pubmed.a024793; Chart PL, 1997, CAN MED ASSOC J, V157, P1235; Christiansen CL, 2000, JNCI-J NATL CANCER I, V92, P1657, DOI 10.1093/jnci/92.20.1657; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Eccles DM, 2000, J MED GENET, V37, P203, DOI 10.1136/jmg.37.3.203; Feig S A, 1997, J Natl Cancer Inst Monogr, P119; Fletcher S, 1997, BRIT MED J, V314, P764, DOI 10.1136/bmj.314.7083.764; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Kollias J, 1998, EUR J CANCER, V34, P878, DOI 10.1016/S0959-8049(97)00365-1; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; Lalloo F, 1998, EUR J CANCER, V34, P937, DOI 10.1016/S0959-8049(98)00005-7; Law J, 1997, BRIT J RADIOL, V70, P62, DOI 10.1259/bjr.70.829.9059297; Macmillan RD, 2000, EUR J SURG ONCOL, V26, P149, DOI 10.1053/ejso.1999.0759; Mattsson A, 2000, BRIT J CANCER, V82, P220; Mettler FA, 1996, CANCER, V77, P903, DOI 10.1002/(SICI)1097-0142(19960301)77:5<903::AID-CNCR15>3.0.CO;2-7; Moller P, 1999, DIS MARKERS, V15, P179, DOI 10.1155/1999/805420; Tabar L, 1996, INT J CANCER, V68, P693; Tilanus-Linthorst MMA, 2000, EUR J CANCER, V36, P514, DOI 10.1016/S0959-8049(99)00337-8; WATSON E, 1999, FAMILIAL BREAST OVAR	22	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1040	1042		10.1136/bmj.322.7293.1040	http://dx.doi.org/10.1136/bmj.322.7293.1040			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325772	Green Published			2022-12-28	WOS:000168478700026
J	Fishman, MC				Fishman, MC			The genomic cosmos	NATURE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fishman, MC (corresponding author), Harvard Univ, Sch Med, Fruit St, Boston, MA 02114 USA.							Borges J. L., 1962, LABYRINTHS; Eco Umberto, 1998, SERENDIPITIES LANGUA; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fishman MC, 1997, CELL, V91, P153, DOI 10.1016/S0092-8674(00)80397-9; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0	5	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1033	1033		10.1038/35074219	http://dx.doi.org/10.1038/35074219			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323648				2022-12-28	WOS:000168285500026
J	Pollock, AM				Pollock, AM			Will primary care trusts lead to US-style health care?	BRITISH MEDICAL JOURNAL			English	Article							RISK ADJUSTMENT		UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9EZ, England	University of London; University College London	Pollock, AM (corresponding author), UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9EZ, England.	allyson.pollock@ucl.ac.uk		pollock, allyson/0000-0002-7388-3110				*DEP HLTH, 2001, INT CAR; *DEP HLTH, 2000, EXP QUEST 2000 MEM H; Department of Health, 2000, DEP INV STRAT; Department of Health, 1997, NEW NHS; Ellis RP, 1996, HEALTH CARE FINANC R, V17, P101; *HLTH SEL COMM, 2000, PUBL EXP HLTH PERS S; *HOUS COMM, 2000, HLTH SOC CAR BILL; *I PUBL POL RES WO, 2000, PPPS HLTH SUMM REC C; Kronick R, 1996, HEALTH CARE FINANC R, V17, P7; KUTTNER R, 1999, EVERYTHING SALE, P143; Majeed A, 1999, BRIT MED J, V318, P772, DOI 10.1136/bmj.318.7186.772; *NHS EX, 2001, PRIM CAR TRUSTS; PLAYER S, 1999, HLTH SERVICE J  1104, P28; Pollock AM, 2000, BMJ-BRIT MED J, V321, P393, DOI 10.1136/bmj.321.7258.393; POLLOCK AM, 1998, NOV, P6; POLLOCK AM, 1998, HLTH SERVICE J  0409, P28; POLLOCK AM, 2001, BMJ, V322; Secretary of State for Health, 2000, NHS PLAN; *TRAD PARTN UK, 2001, SECT OV	19	13	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					964	967		10.1136/bmj.322.7292.964	http://dx.doi.org/10.1136/bmj.322.7292.964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312230	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168345100020
J	Wareham, NJ; Griffin, SJ				Wareham, NJ; Griffin, SJ			Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMA-GLUCOSE CONCENTRATIONS; NIDDM; MELLITUS; RISK; TESTS		Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England	University of Cambridge	Wareham, NJ (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England.	njw1001@medschl.cam.ac.uk	Griffin, Simon J/K-3106-2013	Griffin, Simon J/0000-0002-2157-4797				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Audit Commission, 2000, TEST TIM REV DIAB SE; Borch-Johnsen K, 1999, LANCET, V354, P617; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; ENGELGAU MM, 1995, DIABETES CARE, V18, P1606, DOI 10.2337/diacare.18.12.1606; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gerstein HC, 2000, LANCET, V355, P253; Gerstein HC, 1996, LANCET, V347, P949, DOI 10.1016/S0140-6736(96)91420-8; Goyder EC, 2000, DIABETIC MED, V17, P469, DOI 10.1046/j.1464-5491.2000.00308.x; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Marks L., 1996, COUNTING COST REAL I; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; *NAT SCREEN COMM, 2001, 1 NAT SCREEN COMM; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; ROSENTHAL M, 1985, J CHRON DIS, V38, P5, DOI 10.1016/0021-9681(85)90003-7; Ruige JB, 1997, DIABETES CARE, V20, P491, DOI 10.2337/diacare.20.4.491; Segal L, 1998, HEALTH PROMOT INT, V13, P197, DOI 10.1093/heapro/13.3.197; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x; WU MS, 1990, DIABETES CARE, V13, P1, DOI 10.2337/diacare.13.1.1	27	103	105	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2001	322	7292					986	988		10.1136/bmj.322.7292.986	http://dx.doi.org/10.1136/bmj.322.7292.986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312236	Green Published			2022-12-28	WOS:000168345100025
J	Goldin, DS; Dahl, CA; Olsen, KL; Ostrach, LH; Klausner, RD				Goldin, DS; Dahl, CA; Olsen, KL; Ostrach, LH; Klausner, RD			Biomedicine - The NASA-NCI collaboration on biomolecular sensors	SCIENCE			English	Editorial Material									NCI, Off Technol & Ind Relat, Bethesda, MD 20892 USA; NASA, Off Biol & Phys Res, Washington, DC 20546 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Aeronautics & Space Administration (NASA)	Dahl, CA (corresponding author), NCI, Off Technol & Ind Relat, Bethesda, MD 20892 USA.							HOCH HC, 1996, INTEGRATING MAT SCI; Lawler A, 2000, SCIENCE, V288, P415; SARIKAYA M, 1995, DESIGN PROCESSING MA	3	8	8	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					443	444		10.1126/science.1059744	http://dx.doi.org/10.1126/science.1059744			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330296				2022-12-28	WOS:000168187300025
J	Inguscio, M				Inguscio, M			Bose-Einstein condensation - A new trick of the trade	SCIENCE			English	Editorial Material									Univ Florence, European Lab Nonlinear Spect, Dept Phys, Florence, Italy	University of Florence	Inguscio, M (corresponding author), Univ Florence, European Lab Nonlinear Spect, Dept Phys, Florence, Italy.							ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; COHENTANNOUDJI C, COMMUNICATION; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Dos Santos FP, 2001, PHYS REV LETT, V86, P3459, DOI 10.1103/PhysRevLett.86.3459; Inguscio M., 1999, P INT SCH PHYS E FER; MARTELLUCCI S, 2000, BOSE EINSTEIN CONDEN; Minardi F, 1999, PHYS REV LETT, V82, P1112, DOI 10.1103/PhysRevLett.82.1112; O'Hara KM, 2001, SCIENCE, V291, P2556, DOI 10.1126/science.1060025; Robert A, 2001, SCIENCE, V292, P461, DOI 10.1126/science.1060622; Roberts JL, 2000, PHYS REV LETT, V85, P728, DOI 10.1103/PhysRevLett.85.728; SHLYAPNIKOV V, 1993, PHYS REV LETT, V73, P3247; Stamper-Kurn DM, 1998, PHYS REV LETT, V81, P500, DOI 10.1103/PhysRevLett.81.500	12	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					452	452		10.1126/science.1061175	http://dx.doi.org/10.1126/science.1061175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330298				2022-12-28	WOS:000168187300031
J	McComb, K; Moss, C; Durant, SM; Baker, L; Sayialel, S				McComb, K; Moss, C; Durant, SM; Baker, L; Sayialel, S			Matriarchs as repositories of social knowledge in African elephants	SCIENCE			English	Article							AGE	Despite widespread interest in the evolution of social intelligence, Little is known about how wild animals acquire and store information about social companions or whether individuals possessing enhanced social knowledge derive biological fitness benefits. Using playback experiments on African elephants (Loxodonta africana), we demonstrated that the possession of enhanced discriminatory abilities by the oldest individual in a group can influence the social knowledge of the group as a whole. These superior abilities for social discrimination may result in higher per capita reproductive success for female groups led by older individuals. Our findings imply that the removal of older, more experienced individuals, which are often targets for hunters because of their large size, could have serious consequences for endangered populations of advanced social mammals such as elephants and whales.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; African Wildlife Fdn, Amboseli Elephant Res Project, Nairobi, Kenya; Zool Soc London, Inst Zool, London NW1 4RY, England	University of Sussex; Zoological Society of London	McComb, K (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.		Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878				Cheney D. L., 1990, MONKEYS SEE WORLD IN; Connor RC, 2000, CETACEAN SOCIETIES, P199; Dobson A, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P193; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Gigerenzer G., 1997, MACHIAVELLIAN INTELL, V2, P264; Humphrey N., 1976, GROWING POINTS ETHOL, P303; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McConway KJ, 1999, STAT MODELLING USING; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Moss Cynthia, 1996, P58; NISHIDA T, 1986, PRIMATE SOC, P165; Payne R. W., 1987, GENSTAT 5 REFERENCE; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Ratcliffe N, 1998, J ANIM ECOL, V67, P853, DOI 10.1046/j.1365-2656.1998.6760853.x; Spinage C.A., 1994, ELEPHANTS; Stevick PT, 1999, MAR MAMMAL SCI, V15, P725, DOI 10.1111/j.1748-7692.1999.tb00839.x	17	393	408	3	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					491	494		10.1126/science.1057895	http://dx.doi.org/10.1126/science.1057895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313492				2022-12-28	WOS:000168187300043
J	Sternberg, PW				Sternberg, PW			Working in the post-genomic C-elegans world	CELL			English	Review							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PROTEINS; RNAI		CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA.	pws@caltech.edu						Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Jakubowski J, 1999, GENETICS, V153, P743; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LYNCH AS, 1995, NAT GENET, V11, P309, DOI 10.1038/ng1195-309; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Sommer RJ, 2000, CURR OPIN GENET DEV, V10, P443, DOI 10.1016/S0959-437X(00)00110-6; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	20	28	30	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					173	176		10.1016/S0092-8674(01)00308-7	http://dx.doi.org/10.1016/S0092-8674(01)00308-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336667	Bronze			2022-12-28	WOS:000168384300004
J	Omacini, M; Chaneton, EJ; Ghersa, CM; Muller, CB				Omacini, M; Chaneton, EJ; Ghersa, CM; Muller, CB			Symbiotic fungal endophytes control insect host-parasite interaction webs	NATURE			English	Article							APPARENT COMPETITION; PRODUCTIVITY; DIVERSITY; HERBIVORES	Symbiotic microorganisms that live intimately associated with terrestrial plants affect both the quantity and quality of resources(1,2), and thus the energy supply to consumer populations at higher levels in the food chain. Empirical evidence on resource limitation of food webs points to primary productivity as a major determinant of consumer abundance and trophic structure(3-6). Prey quality plays a critical role in community regulation(7,8). Plants infected by endophytic fungi are known to be chemically protected against herbivore consumption(9-11). However, the influence of this microbe-plant association on multi-trophic interactions remains largely unexplored. Here we present the effects of fungal endophytes on insect food webs that reflect limited energy transfer to consumers as a result of low plant quality, rather than low productivity. Herbivore-parasite webs on endophyte-free grasses show enhanced insect abundance at alternate trophic levels, higher rates of parasitism, and increased dominance by a few trophic links. These results mirror predicted effects of increased productivity on food-web dynamics(12). Thus 'hidden' microbial symbionts can have community-wide impacts on the pattern and strength of resource-consumer interactions.	Univ Buenos Aires, Fac Agron, IFEVA, Dept Recursos Nat & Ambiente, RA-1417 Buenos Aires, DF, Argentina; Imperial Coll, Dept Biol, Ascot SL5 7PY, Berks, England; Imperial Coll, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Zool Soc London, Inst Zool, London NW1 4RY, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Zoological Society of London	Omacini, M (corresponding author), Univ Buenos Aires, Fac Agron, IFEVA, Dept Recursos Nat & Ambiente, Av San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	omacini@ifeva.edu.ar; christine.mueller@ioz.ac.uk		Omacini, Marina/0000-0003-1460-262X				ABRAMS PA, 1993, AM NAT, V141, P351, DOI 10.1086/285478; ALATALO RV, 1981, OIKOS, V37, P199, DOI 10.2307/3544465; Barker GM, 1996, BIOL CONTROL, V7, P281, DOI 10.1006/bcon.1996.0095; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Bultman TL, 1997, OIKOS, V78, P170, DOI 10.2307/3545812; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; CLAY K, 1990, ANNU REV ECOL SYST, V21, P275, DOI 10.1146/annurev.es.21.110190.001423; Dahlman D.L., 1991, MICROBIAL MEDIATION, P227; DeAngelis D. L., 1992, DYNAMICS NUTR CYCLIN; DOBSON A, 1994, TRENDS ECOL EVOL, V9, P393, DOI 10.1016/0169-5347(94)90062-0; GEHRING CA, 1994, TRENDS ECOL EVOL, V9, P251, DOI 10.1016/0169-5347(94)90290-9; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HOLT RD, 1993, AM NAT, V142, P623, DOI 10.1086/285561; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hulot FD, 2000, NATURE, V405, P340, DOI 10.1038/35012591; HUNTER MD, 1992, ECOLOGY, V73, P724; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; LATCH GCM, 1988, NEW ZEAL J AGR RES, V31, P57, DOI 10.1080/00288233.1988.10421364; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Mikola J, 1998, OIKOS, V82, P158, DOI 10.2307/3546926; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Osenberg Craig W., 1996, P134; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; WOOTTON JT, 1993, P NATL ACAD SCI USA, V90, P1384, DOI 10.1073/pnas.90.4.1384	30	245	272	3	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					78	81		10.1038/35051070	http://dx.doi.org/10.1038/35051070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343116				2022-12-28	WOS:000166175600042
J	Ochman, H; Moran, NA				Ochman, H; Moran, NA			Genes lost and genes found: Evolution of bacterial pathogenesis and symbiosis	SCIENCE			English	Editorial Material							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; PATHOGENICITY ISLANDS; MICROBIAL DIVERSITY; EXCHANGE; HOST; ENDOSYMBIONT; TYPHIMURIUM; INSIGHTS; ORIGIN	Traditionally, evolutionary biologists have viewed mutations within individual genes as the major source of phenotypic variation leading to adaptation through natural selection, and ultimately generating diversity among species. Although such processes must contribute to the initial development of gene functions and their subsequent fine-tuning, changes in genome repertoire, occurring through gene acquisition and deletion, are the major events underlying the emergence and evolution of bacterial pathogens and symbionts. Furthermore, pathogens and symbionts depend on similar mechanisms for interacting with hosts and show parallel trends in genome evolution.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85718 USA	University of Arizona	Ochman, H (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85718 USA.	hochman@email.arizona.edu	Moran, Nancy A/G-1591-2010					Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Bandi C, 1999, PARASITOL TODAY, V15, P428, DOI 10.1016/S0169-4758(99)01543-4; BANDI C, 2000, J EXP MED, V191, P1429; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; CHEETHAM BF, 1995, MOL MICROBIOL, V18, P201, DOI 10.1111/j.1365-2958.1995.mmi_18020201.x; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Cheng LW, 2000, TRENDS MICROBIOL, V8, P214, DOI 10.1016/S0966-842X(99)01665-0; Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; DeLong EF, 1997, TRENDS BIOTECHNOL, V15, P203, DOI 10.1016/S0167-7799(97)01044-5; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; Lee RW, 1999, J EXP BIOL, V202, P289; Maniloff J, 1996, P NATL ACAD SCI USA, V93, P10004, DOI 10.1073/pnas.93.19.10004; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; NAKATA N, 1993, MOL MICROBIOL, V9, P459, DOI 10.1111/j.1365-2958.1993.tb01707.x; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; RANON MR, 1999, TRENDS BIOTECHNOL, V17, P403; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Sullivan JT, 1998, P NATL ACAD SCI USA, V95, P5145, DOI 10.1073/pnas.95.9.5145; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7	52	392	410	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1096	1098		10.1126/science.1058543	http://dx.doi.org/10.1126/science.1058543			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352062	Green Submitted			2022-12-28	WOS:000168609200040
J	Chen, J; Rathore, SS; Radford, MJ; Wang, Y; Krumholz, HM				Chen, J; Rathore, SS; Radford, MJ; Wang, Y; Krumholz, HM			Racial differences in the use of cardiac catheterization after acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-VETERANS-AFFAIRS; HOSPITAL DISCHARGE SURVEY; HEART-DISEASE; UNITED-STATES; RACE; BLACK; MANAGEMENT; MORTALITY; OUTCOMES; CARE	Background: Several studies have reported that black patients are less likely than white patients to undergo cardiac catheterization after acute myocardial infarction. The role of the race of the physician in this pattern is unknown. Methods: We analyzed data from the Cooperative Cardiovascular Project, a study of Medicare beneficiaries hospitalized for acute myocardial infarction in 1994 and 1995, to evaluate whether differences between black patients and white patients in the use of cardiac catheterization within 60 days after acute myocardial infarction varied according to the race of their attending physician. Results: Our study cohort consisted of 35,676 white and 4039 black patients with acute myocardial infarction who were treated by 17,550 white and 588 black physicians. Black patients had lower rates of cardiac catheterization than white patients, regardless of whether their attending physician was white (rate of catheterization, 38.4 percent vs. 45.7 percent; P<0.001) or black (38.2 percent vs. 49.6 percent, P<0.001). We did not find a significant interaction between the race of the patients and the race of the physicians in the use of cardiac catheterization. The adjusted mortality rate among black patients was lower than or similar to that among white patients for up to three years after the infarction. Conclusions: Racial differences in the use of cardiac catheterization are similar among patients treated by white physicians and those treated by black physicians, suggesting that this pattern of care is independent of the race of the physician. (N Engl J Med 2001;344:1443-9.) Copyright (C) 2001 Massachusetts Medical Society.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Chron Dis Epidemiol, New Haven, CT 06510 USA; Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA	Yale University; Yale University; Yale University	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	PHS HHS [500-96-P549] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM HOSP ASS, 1994, ANN SURV HOSP DAT DO; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; *BUR CENS, 1991, STAT METR AR DAT BOO; CASTANER A, 1988, ANN INTERN MED, V109, P33, DOI 10.7326/0003-4819-109-1-33; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; *DEP HLTH HUM SERV, 1999, SOC SEC ADM DEATH MA; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; Ferguson JA, 1997, J AM COLL CARDIOL, V30, P1707, DOI 10.1016/S0735-1097(97)00365-3; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; *HLTH CAR FIN ADM, 1997, ICD9CM HLTH CAR FIN; HOOPER EM, 1982, MED CARE, V20, P630, DOI 10.1097/00005650-198206000-00009; IEZZONI LI, 1994, RISK ADJUSTMENT MEAS, P119; KEIL JE, 1985, AM HEART J, V109, P776, DOI 10.1016/0002-8703(85)90638-6; Kenward K, 1996, AM J PUBLIC HEALTH, V86, P1481, DOI 10.2105/AJPH.86.10.1481; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MIRVIS DM, 1994, J AM COLL CARDIOL, V24, P1297, DOI 10.1016/0735-1097(94)90112-0; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; RACZYNSKI JM, 1994, AM J PUBLIC HEALTH, V84, P951, DOI 10.2105/AJPH.84.6.951; RICE T, 1985, INQUIRY-J HEALTH CAR, V22, P188; ROIG E, 1987, CIRCULATION, V76, P280, DOI 10.1161/01.CIR.76.2.280; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sedlis SP, 1997, J CLIN EPIDEMIOL, V50, P899, DOI 10.1016/S0895-4356(97)00089-9; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Summers RL, 1999, AM J MED SCI, V318, P142, DOI 10.1097/00000441-199909000-00008; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; TOFLER GH, 1987, J AM COLL CARDIOL, V9, P473, DOI 10.1016/S0735-1097(87)80038-4; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; WENNEKER MB, 1989, JAMA-J AM MED ASSOC, V261, P253, DOI 10.1001/jama.261.2.253; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Whittle J, 1997, J GEN INTERN MED, V12, P267, DOI 10.1046/j.1525-1497.1997.012005267.x; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	39	218	219	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1443	1449		10.1056/NEJM200105103441906	http://dx.doi.org/10.1056/NEJM200105103441906			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	430BQ	11346810	Bronze			2022-12-28	WOS:000168554000006
J	Elbert, T; Heim, S				Elbert, T; Heim, S			A light and a dark side	NATURE			English	Editorial Material									Univ Konstanz, Dept Psychol, D-78457 Constance, Germany	University of Konstanz	Elbert, T (corresponding author), Univ Konstanz, Dept Psychol, Box D25, D-78457 Constance, Germany.		Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Elbert T, 2001, HDB DEV COGNITIVE NE; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	5	24	25	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					139	139		10.1038/35075678	http://dx.doi.org/10.1038/35075678			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346769	Bronze, Green Published			2022-12-28	WOS:000168563000026
J	Lack, HW				Lack, HW			Floral tributes - Early science texts carried illustrations that are master-works in their own right.	NATURE			English	Editorial Material									Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; Bot Garden, D-14191 Berlin, Germany; Bot Museum Berlin Dahlem, D-14191 Berlin, Germany	Free University of Berlin	Lack, HW (corresponding author), Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany.							Baumann B, 2001, KRAUTERBUCH HANDSCHR; FUCHS L, 2001, KREUTERBUCH BEITRAGE; MEYER FG, 2001, GREAT HERBAL LEONHAR	3	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					137	137		10.1038/35075675	http://dx.doi.org/10.1038/35075675			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346768	Bronze			2022-12-28	WOS:000168563000025
J	Lake, JA; Quick, WP; Beerling, DJ; Woodward, FI				Lake, JA; Quick, WP; Beerling, DJ; Woodward, FI			Plant development - Signals from mature to new leaves	NATURE			English	Article							STOMATAL RESPONSES; ATMOSPHERIC CO2		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Lake, JA (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.		Woodward, Ian F/B-7762-2008; Woodward, Frank Ian/P-4530-2019; Beerling, David J/C-2840-2009	Beerling, David J/0000-0003-1869-4314				Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; BERRYMAN CA, 1994, J EXP BOT, V45, P539, DOI 10.1093/jxb/45.5.539; Buchmann N, 1996, GLOBAL CHANGE BIOL, V2, P421, DOI 10.1111/j.1365-2486.1996.tb00092.x; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Douville H, 2000, J GEOPHYS RES-ATMOS, V105, P14841, DOI 10.1029/1999JD901086; EAMUS D, 1993, AUST J PLANT PHYSIOL, V20, P741, DOI 10.1071/PP9930741; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; JACKSON D, 1994, DEVELOPMENT, V120, P405; Muraoka H, 2000, PLANT CELL ENVIRON, V23, P235, DOI 10.1046/j.1365-3040.2000.00547.x; TICHA I, 1982, PHOTOSYNTHETICA, V16, P375; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; WOODWARD FI, 1988, J EXP BOT, V39, P1771, DOI 10.1093/jxb/39.12.1771	13	282	317	4	132	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					154	154		10.1038/35075660	http://dx.doi.org/10.1038/35075660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346781	Bronze			2022-12-28	WOS:000168563000036
J	Gavazzi, C; Stacchiotti, S; Cavalletti, R; Lodi, R				Gavazzi, C; Stacchiotti, S; Cavalletti, R; Lodi, R			Confusion after antibiotics	LANCET			English	Editorial Material							D-LACTIC ACIDOSIS; GG		Natl Canc Inst, Nutr Support Unit, I-20133 Milan, Italy; Univ Milan, Dept Food Sci & Technol, I-20122 Milan, Italy; Natl Res Council, Milk Ctr, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Gavazzi, C (corresponding author), Natl Canc Inst, Nutr Support Unit, Via Venezian 1, I-20133 Milan, Italy.		Stacchiotti, Silvia/C-2017-2017; Gavazzi, Cecilia/E-9345-2017	Stacchiotti, Silvia/0000-0002-1742-8666; Gavazzi, Cecilia/0000-0001-5251-0086				Alander M, 1999, APPL ENVIRON MICROB, V65, P351; OH MS, 1979, NEW ENGL J MED, V301, P249, DOI 10.1056/NEJM197908023010505; Uribarri J, 1998, MEDICINE, V77, P73, DOI 10.1097/00005792-199803000-00001; Vanderhoof JA, 1999, J PEDIATR-US, V135, P564, DOI 10.1016/S0022-3476(99)70053-3; Vella A, 1998, MAYO CLIN PROC, V73, P451	5	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1410	1410		10.1016/S0140-6736(00)04565-7	http://dx.doi.org/10.1016/S0140-6736(00)04565-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356440				2022-12-28	WOS:000168478200014
J	Hanley, J; Capewell, A; Hagen, S				Hanley, J; Capewell, A; Hagen, S			Validity study of the severity index, a simple measure of urinary incontinence in women	BRITISH MEDICAL JOURNAL			English	Article									Edenhall Hosp, Lothian Primary Care NHS Trust, Musselburgh EH21 7TZ, Scotland; Royal Victoria Hosp, Edinburgh EH4 2DN, Midlothian, Scotland; Glasgow Caledonian Univ, Fac Hlth, Nursing Res Initiat Scotland, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Hanley, J (corresponding author), Edenhall Hosp, Lothian Primary Care NHS Trust, Musselburgh EH21 7TZ, Scotland.			HAGEN, SUZANNE/0000-0002-9741-9160; Hanley, Janet/0000-0003-1728-0136				ELSER DM, 1995, NEUROUROL URODYNAM, V14, P311, DOI 10.1002/nau.1930140403; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; MAHONEY F I, 1965, Md State Med J, V14, P61; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497	5	99	102	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1096	1097		10.1136/bmj.322.7294.1096	http://dx.doi.org/10.1136/bmj.322.7294.1096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337439	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000168628300021
J	Lanzafame, M; Trevenzoli, M; Vento, S; Parrinello, A				Lanzafame, M; Trevenzoli, M; Vento, S; Parrinello, A			Clinical picture: tuberculous chorioretinitis	LANCET			English	Editorial Material									Osped Civile Legnago, Unita Operat Malattie Infett, Verona, Italy; Osped Civile Maggiore Borgo Trento, Inst Immunol & Malattie Infett, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Lanzafame, M (corresponding author), Osped Civile Legnago, Unita Operat Malattie Infett, Verona, Italy.		Lanzafame, Massimiliano/AAU-5736-2021; Vento, Sandro/I-1662-2017	Vento, Sandro/0000-0003-0084-4062					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1390	1390		10.1016/S0140-6736(00)04622-5	http://dx.doi.org/10.1016/S0140-6736(00)04622-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356435				2022-12-28	WOS:000168478200009
J	Boppana, SB; Rivera, LB; Fowler, KB; Mach, M; Britt, WJ				Boppana, SB; Rivera, LB; Fowler, KB; Mach, M; Britt, WJ			Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNA-POLYMERASE GENE; GLYCOPROTEIN-H; ANTIBODY-RESPONSES; NEWBORN-INFANTS; CELL RESPONSE; INFECTION; MOTHERS; VIRUS; GANCICLOVIR; RESISTANCE	Background: Preconceptional immunity against cytomegalovirus (CMV) provides only partial protection against intrauterine transmission of the virus. Whether congenital CMV infection in the offspring of women who are seropositive for CMV can occur after maternal reinfection with a different strain of CMV is unknown. Methods: Serum specimens from 46 women with preconceptional immunity against CMV that were obtained during the previous pregnancy and the current pregnancy were analyzed for antibodies against the strain-specific epitopes of CMV glycoprotein H. Virus-neutralizing activity in maternal serum samples was measured against the AD169 laboratory strain of CMV and the CMV isolates available from seven infected infants. In addition, the nucleotide sequences of the glycoprotein H gene from the seven CMV isolates were determined. Results: Eleven of the 16 mothers with infected infants (69 percent) had antibodies against the glycoprotein H epitopes present on two laboratory strains of CMV, AD169 and Towne. Ten of the 16 mothers with infected children (62 percent) acquired new antibody specificities against glycoprotein H, as compared with only 4 of the 30 mothers of uninfected infants (13 percent, P<0.001). The samples obtained at the time of the current delivery from four of the seven mothers contained at least twice as many neutralizing antibodies against the CMV isolated from their infants as were present in the samples obtained at the previous delivery. The specificity of the newly acquired maternal antibodies reflected the amino acid sequence of the glycoprotein H epitope of CMV from these four infants. Conclusions: In women who are seropositive for CMV, reinfection with a different strain of CMV can lead to intrauterine transmission and symptomatic congenital infection. (N Engl J Med 2001;344:1366-71.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama, Dept Epidemiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA; Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Erlangen Nuremberg	Boppana, SB (corresponding author), Univ Alabama, Dept Pediat, 1600 7th Ave S,Suite 752, Birmingham, AL 35233 USA.				NCRR NIH HHS [M01 RR000032] Funding Source: Medline; NIAID NIH HHS [P01 AI43681, P01 AI043681] Funding Source: Medline; NIDCD NIH HHS [R01 DC04163, R01 DC004163] Funding Source: Medline; PHS HHS [M01 R00032] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004163] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; ANDREONI M, 1989, J VIROL METHODS, V23, P157, DOI 10.1016/0166-0934(89)90129-8; BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Beninga J, 1996, J INFECT DIS, V173, P1051, DOI 10.1093/infdis/173.5.1051; BENINGA J, 1995, J GEN VIROL, V76, P153, DOI 10.1099/0022-1317-76-1-153; BOPPANA SB, 1995, J INFECT DIS, V171, P1115, DOI 10.1093/infdis/171.5.1115; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; BOPPANA SB, 1993, J INFECT DIS, V167, P72, DOI 10.1093/infdis/167.1.72; BRITT WJ, 1996, FIELDS VIROLOGY, V2, P2493; CHOU SW, 1995, J INFECT DIS, V172, P239, DOI 10.1093/infdis/172.1.239; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; HUANG ES, 1980, NEW ENGL J MED, V303, P958, DOI 10.1056/NEJM198010233031702; Klein M, 1999, J VIROL, V73, P878, DOI 10.1128/JVI.73.2.878-886.1999; LI L, 1995, J VIROL, V69, P6047, DOI 10.1128/JVI.69.10.6047-6053.1995; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; LURAIN NS, 1992, J VIROL, V66, P7146, DOI 10.1128/JVI.66.12.7146-7152.1992; MORRIS DJ, 1994, PEDIATR INFECT DIS J, V13, P61, DOI 10.1097/00006454-199401000-00013; PASS RF, 1982, J INFECT DIS, V146, P1, DOI 10.1093/infdis/146.1.1; PECKHAM CS, 1983, LANCET, V1, P1352; SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536; SIMPSON JA, 1993, J VIROL, V67, P489, DOI 10.1128/JVI.67.1.489-496.1993; SMITH KL, 1993, TRANSFUSION, V33, P497, DOI 10.1046/j.1537-2995.1993.33693296813.x; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STAGNO S, 1982, Clinical Obstetrics and Gynecology, V25, P563, DOI 10.1097/00003081-198209000-00014; Stagno S., 1995, INFECT DIS FETUS NEW, P312; SULLIVAN V, 1993, ANTIMICROB AGENTS CH, V37, P19, DOI 10.1128/AAC.37.1.19; Urban M, 1996, J GEN VIROL, V77, P1537, DOI 10.1099/0022-1317-77-7-1537; URBAN M, 1992, J VIROL, V66, P1303, DOI 10.1128/JVI.66.3.1303-1311.1992; WIRTSCHAFTER D D, 1982, Journal of Medical Systems, V6, P277, DOI 10.1007/BF00992804	31	501	534	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1366	1371		10.1056/NEJM200105033441804	http://dx.doi.org/10.1056/NEJM200105033441804			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333993				2022-12-28	WOS:000168413500004
J	Park, PW; Pier, GB; Hinkes, MT; Bernfield, M				Park, PW; Pier, GB; Hinkes, MT; Bernfield, M			Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ACUTE PULMONARY INFECTION; HOST-DEFENSE; LUNG INFECTIONS; BINDING; ELASTASE; MICE; RECEPTORS; ADHERENCE; MODEL	Cell-surface heparan sulphate proteoglycans (HSPGs) are ubiquitous and abundant receptors/co-receptors of extracellular ligands(1,2), including many microbes(3-10). Their role in microbial infections is poorly defined, however, because no cell-surface HSPG has been clearly connected to the pathogenesis of a particular microbe. We have previously shown that Pseudomonas aeruginosa, through its virulence factor LasA, enhances the in vitro shedding of syndecan-1-the predominant cell-surface HSPG of epithelia(11). Here we show that shedding of syndecan-1 is also activated by P. aeruginosa in vivo, and that the resulting syndecan-1 ectodomains enhance bacterial virulence in newborn mice. Newborn mice deficient in syndecan-1 resist P. aeruginosa lung infection but become susceptible when given purified syndecan-1 ectodomains or heparin, but not when given ectodomain core protein, indicating that the ectodomain's heparan sulphate chains are the effectors. In wild-type newborn mice, inhibition of syndecan-1 shedding or inactivation of the shed ectodomain's heparan sulphate chains prevents lung infection. Our findings uncover a pathogenetic mechanism in which a host response to tissue injury-syndecan-1 shedding-is exploited to enhance microbial virulence apparently by modulating host defences.	Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bernfield, M (corresponding author), Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA.		Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Park, Pyong Woo/0000-0002-7979-4979				Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Bals R, 1999, J CLIN INVEST, V103, P303, DOI 10.1172/JCI6277; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BLACKWOOD LL, 1983, INFECT IMMUN, V39, P198, DOI 10.1128/IAI.39.1.198-201.1983; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; Grassme H, 1997, CELL, V91, P605, DOI 10.1016/S0092-8674(00)80448-1; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; PANCAKE SJ, 1992, J CELL BIOL, V117, P1351, DOI 10.1083/jcb.117.6.1351; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Rostand KS, 1997, INFECT IMMUN, V65, P1; ROSTAND KS, 1993, J BIOL CHEM, V268, P24053; Schmidtchen A, 2001, MOL MICROBIOL, V39, P708, DOI 10.1046/j.1365-2958.2001.02251.x; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982	29	192	196	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					98	102		10.1038/35075100	http://dx.doi.org/10.1038/35075100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333985				2022-12-28	WOS:000168432800051
J	Tramere, A				Tramere, A			Cell biology - Asymmetry in action	NATURE			English	Editorial Material																		Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; WILKIE GS, 2001, NATURE, V105, P209	2	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					33	33		10.1038/35075187	http://dx.doi.org/10.1038/35075187			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333960	Bronze			2022-12-28	WOS:000168432800028
J	Douglas, S; Zauner, S; Fraunholz, M; Beaton, M; Penny, S; Deng, LT; Wu, XN; Reith, M; Cavalier-Smith, T; Maier, UG				Douglas, S; Zauner, S; Fraunholz, M; Beaton, M; Penny, S; Deng, LT; Wu, XN; Reith, M; Cavalier-Smith, T; Maier, UG			The highly reduced genome of an enslaved algal nucleus	NATURE			English	Article							EUKARYOTIC GENOME; PLASTID GENOME; RED ALGAE; NUCLEOMORPH; EVOLUTION; CRYPTOMONADS; CHLOROPLASTS; TRANSPORT; CHIMERAS; PROTEIN	Chromophyte algae differ fundamentally from plants in possessing chloroplasts that contain chlorophyll c and that have a more complex bounding-membrane topology(1). Although chromophytes are known to be evolutionary chimaeras of a red alga and a non-photosynthetic host(1), which gave rise to their exceptional membrane complexity, their cell biology is poorly understood. Cryptomonads are the only chromophytes that still retain the enslaved red algal nucleus as a minute nucleomorph(2-4). Here we report complete sequences for all three nucleomorph chromosomes from the cryptomonad Guillardia theta. This tiny 551-kilobase eukaryotic genome is the most gene-dense known, with only 17 diminutive spliceosomal introns and 44 overlapping genes. Marked evolutionary compaction hundreds of millions of years ago(1,4,5) eliminated nearly all the nucleomorph genes for metabolic functions, but left 30 for chloroplast-located proteins. To allow expression of these proteins, nucleomorphs retain hundreds of genetic-housekeeping genes(5). Nucleomorph DNA replication and periplastid protein synthesis require the import of many nuclear gene products across endoplasmic reticulum and periplastid membranes. The chromosomes have centromeres, but possibly only one loop domain, offering a means for studying eukaryotic chromosome replication, segregation and evolution.	Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Program Evolutionary Biol, Vancouver, BC V6T 1Z4, Canada; Univ Marburg, D-35032 Marburg, Germany; Natl Res Council Canada, Inst Marine Biosci, Halifax, NS B3H 3Z1, Canada; Canadian Inst Adv Res, Program Evolutionary Biol, Halifax, NS B3H 3Z1, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Philipps University Marburg; International Business Machines (IBM); National Research Council Canada; Canadian Institute for Advanced Research (CIFAR)	Cavalier-Smith, T (corresponding author), Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Program Evolutionary Biol, Vancouver, BC V6T 1Z4, Canada.	tom.cavalier-smith@zoo.ox.ac.uk		Fraunholz, Martin/0000-0002-4581-6244				Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cavalier-Smith T, 1999, GENETICA, V106, P3, DOI 10.1023/A:1003701925110; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T., 1986, Progress phycol. Res., V4, P309; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; DOUGLAS SE, 1988, CURR GENET, V14, P591, DOI 10.1007/BF00434085; ESCHBACH S, 1991, NUCLEIC ACIDS RES, V19, P1779, DOI 10.1093/nar/19.8.1779; Gaasterland T, 1996, BIOCHIMIE, V78, P302, DOI 10.1016/0300-9084(96)84761-4; Gilson PR, 1996, P NATL ACAD SCI USA, V93, P7737, DOI 10.1073/pnas.93.15.7737; HEGEMANN JH, 1993, BIOESSAYS, V15, P451, DOI 10.1002/bies.950150704; Kawahara H, 2000, J CELL SCI, V113, P2659; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; LUDWIG M, 1987, ANN NY ACAD SCI, V503, P198, DOI 10.1111/j.1749-6632.1987.tb40609.x; Maier UG, 2000, MOL BIOL EVOL, V17, P576, DOI 10.1093/oxfordjournals.molbev.a026337; Maier UG, 2000, PROTIST, V151, P103, DOI 10.1078/1434-4610-00011; McFadden G.I., 2000, GENOME BIOL, V1; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; MEYER SR, 1987, S AFR J BOT, V53, P129, DOI 10.1016/S0254-6299(16)31447-8; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Paul AL, 1999, PLANT MOL BIOL, V41, P713, DOI 10.1023/A:1006323222693; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Wastl J, 2000, J BIOL CHEM, V275, P23194, DOI 10.1074/jbc.M003125200; WHATLEY JM, 1979, PROC R SOC SER B-BIO, V204, P165, DOI 10.1098/rspb.1979.0020; Zauner S, 2000, P NATL ACAD SCI USA, V97, P200, DOI 10.1073/pnas.97.1.200	30	343	374	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1091	1096		10.1038/35074092	http://dx.doi.org/10.1038/35074092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323671	Bronze			2022-12-28	WOS:000168285500047
J	Pan, JW; Simon, C; Brukner, C; Zeilinger, A				Pan, JW; Simon, C; Brukner, C; Zeilinger, A			Entanglement purification for quantum communication	NATURE			English	Article							CRYPTOGRAPHY; STATE; TELEPORTATION; PHOTONS	The distribution of entangled states between distant locations will be essential for the future large-scale realization of quantum communication schemes such as quantum cryptography(1,2) and quantum teleportation(3). Because of unavoidable noise in the quantum communication channel, the entanglement between two particles is more and more degraded the further they propagate. Entanglement purircation(4-7) is thus essential to distil highly entangled states from less entangled ones. Existing general purification protocols(4-6) are based on the quantum controlled-NOT (CNOT) or similar quantum logic operations, which are very difficult to implement experimentally. Present realizations of CNOT gates are much too imperfect to be useful for long-distance quantum communication(8). Here we present a scheme for the entanglement purification of general mixed entangled states, which achieves 50 per cent of the success probability of schemes based on the CNOT operation, but requires only simple linear optical elements. Because the perfection of such elements is very high, the local operations necessary for purification can be performed with the required precision. Our procedure is within the reach of current technology, and should significantly simplify the implementation of long-distance quantum communication.	Univ Vienna, Inst Expt Phys, A-1090 Vienna, Austria	University of Vienna	Zeilinger, A (corresponding author), Univ Vienna, Inst Expt Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	Zeilinger-office@exp.univie.ac.at	Brukner, Caslav/C-1405-2011; Pan, Jian-Wei/A-2332-2010; Simon, Christoph/F-8163-2010; Zeilinger, Anton/A-1170-2011	Pan, Jian-Wei/0000-0002-6100-5142; Simon, Christoph/0000-0003-0747-8800; 				BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Bose S, 1999, PHYS REV A, V60, P194, DOI 10.1103/PhysRevA.60.194; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.040301; Bouwmeester D, 1999, PHYS REV LETT, V82, P1345, DOI 10.1103/PhysRevLett.82.1345; Bouwmeester D, 2000, J MOD OPTIC, V47, P279, DOI 10.1080/095003400148204; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Cerf NJ, 1998, PHYS REV A, V57, pR1477, DOI 10.1103/PhysRevA.57.R1477; Deutsch D, 1996, PHYS REV LETT, V77, P2818, DOI 10.1103/PhysRevLett.77.2818; Duan LM, 2000, PHYS REV LETT, V84, P4002, DOI 10.1103/PhysRevLett.84.4002; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Jennewein T, 2000, PHYS REV LETT, V84, P4729, DOI 10.1103/PhysRevLett.84.4729; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Mattle K, 1996, PHYS REV LETT, V76, P4656, DOI 10.1103/PhysRevLett.76.4656; Naik DS, 2000, PHYS REV LETT, V84, P4733, DOI 10.1103/PhysRevLett.84.4733; Pan JW, 1998, PHYS REV A, V57, P2208, DOI 10.1103/PhysRevA.57.2208; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Rauschenbeutel A, 1999, PHYS REV LETT, V83, P5166, DOI 10.1103/PhysRevLett.83.5166; SANAKA K, 2000, QUANTPH0012028; Takeuchi S, 1999, APPL PHYS LETT, V74, P1063, DOI 10.1063/1.123482; TANZILLI S, 2000, QUANTPH0012053; Tittel W, 2000, PHYS REV LETT, V84, P4737, DOI 10.1103/PhysRevLett.84.4737; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; YAMAMOTO T, 2001, QUANTPH0101042	30	551	572	5	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1067	1070		10.1038/35074041	http://dx.doi.org/10.1038/35074041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323664	Green Submitted			2022-12-28	WOS:000168285500040
J	Rambaut, A; Robertson, DL; Pybus, OG; Peeters, M; Holmes, EC				Rambaut, A; Robertson, DL; Pybus, OG; Peeters, M; Holmes, EC			Human immunodeficiency virus - Phylogeny and the origin of HIV-1	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; IRD, Retrovirus Lab, F-34032 Montpellier, France	University of Oxford; Institut de Recherche pour le Developpement (IRD)	Rambaut, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Rambaut, Andrew/B-2481-2009; Pybus, Oliver G/B-2640-2012	Rambaut, Andrew/0000-0003-4337-3707; Pybus, Oliver G/0000-0002-8797-2667; Holmes, Edward/0000-0001-9596-3552				Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hooper Edward, 1999, RIVER JOURNEY SOURCE; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Pybus OG, 2000, GENETICS, V155, P1429; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000	6	122	127	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1047	1048		10.1038/35074179	http://dx.doi.org/10.1038/35074179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323659				2022-12-28	WOS:000168285500035
J	Suarez-Lopez, P; Wheatley, K; Robson, F; Onouchi, H; Valverde, F; Coupland, G				Suarez-Lopez, P; Wheatley, K; Robson, F; Onouchi, H; Valverde, F; Coupland, G			CONSTANS mediates between the circadian clock and the control of flowering in Arabidopsis	NATURE			English	Article							CONTROLLED GENE; PROTEIN; RHYTHMS; THALIANA; ENCODES; RNA; EXPRESSION; GIGANTEA; ROLES; TIME	Flowering is often triggered by exposing plants to appropriate day lengths. This response requires an endogenous timer called the circadian clock to measure the duration of the day or night(1). This timer also controls daily rhythms in gene expression and behavioural patterns such as leaf movements. Several Arabidopsis mutations affect both circadian processes and flowering time(2-10); but how the effect of these mutations on the circadian clock is related to their influence on flowering remains unknown. Here we show that expression of CONSTANS (CO), a gene that accelerates flowering in response to long days(11), is modulated by the circadian clock and day length. Expression of a CO target gene, called FLOWERING LOCUS T (FT), is restricted to a similar time of day as expression of CO. Three mutations that affect circadian rhythms and flowering time alter CO and FT expression in ways that are consistent with their effects on flowering. In addition, the late flowering phenotype of such mutants is corrected by overexpressing CO. Thus, CO acts between the circadian clock and the control of flowering, suggesting mechanisms by which day length regulates flowering time.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society	Coupland, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	george.coupland@bbsrc.ac.uk	Suárez-López, Paula/D-4894-2012; Coupland, George/AAP-8609-2020; Valverde, Federico/K-1248-2014	Suárez-López, Paula/0000-0001-5748-9263; Coupland, George/0000-0001-6988-4172; Valverde, Federico/0000-0001-8063-0974				Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Chon ML, 1999, PLANT CELL PHYSIOL, V40, P702, DOI 10.1093/oxfordjournals.pcp.a029596; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; SOMERS DE, 1998, BIOL RHYTHMS PHOTOPE, P81; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Thomas B., 1997, PHOTOPERIODISM PLANT; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	31	1004	1115	10	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1116	1120		10.1038/35074138	http://dx.doi.org/10.1038/35074138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323677				2022-12-28	WOS:000168285500053
J	Gray, RH; Wawer, MJ; Brookmeyer, R; Sewankambo, NK; Serwadda, D; Wabwire-Mangen, F; Lutalo, T; Li, XB; vanCott, T; Quinn, TC				Gray, RH; Wawer, MJ; Brookmeyer, R; Sewankambo, NK; Serwadda, D; Wabwire-Mangen, F; Lutalo, T; Li, XB; vanCott, T; Quinn, TC		Rakal Project Team	Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; TYPE-1; FEMALE; RELIABILITY; BEHAVIORS; PARTNERS; AFRICA; AIDS	Background The probability of HIV-1 transmission per coital act in representative African populations is unknown. We aimed to calculate this probability overall, and to estimate how it is affected by various factors thought to influence infectivity. Methods 174 monogamous couples, in which one partner was HIV-1 positive, were retrospectively identified from a population cohort in Rakai, Uganda. Frequency of intercourse and reliability of reporting within couples was assessed prospectively, HIV-1 seroconversion was determined in the uninfected partners, and HIV-1 viral load was measured in the infected partners. Adjusted rate ratios of transmission per coital act were estimated by Poisson regression. Probabilities of transmission per act were estimated by log-log binomial regression for quartiles of age and HIV-1 viral load, and for symptoms or diagnoses of sexually transmitted diseases (STDs) in the HIV-1-infected partners. Results The mean frequency of intercourse was 8.9 per month, which declined with age and HIV-1 viral load. Members of couples reported similar frequencies of intercourse. The overall unadjusted probability of HIV-1 transmission per coital act was 0.0011 (95% CI 0.0008-0.0015). Transmission probabilities increased from 0.0001 per act at viral loads of less than 1700 copies/mL to 0.0023 per act at 38 500 copies/mL or more (p=0.002), and were 0.0041 with genital ulceration versus 0.0011 without (p=0.02). Transmission probabilities per act did not differ significantly by HIV-1 subtypes A and D, sex, STDs, or symptoms of discharge or dysuria in the HIV-l-positive partner. Interpretation Higher viral load and genital ulceration are the main determinants of HIV-1 transmission per coital act in this Ugandan population.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Med, Baltimore, MD 21205 USA; Columbia Univ, Heilbrun Ctr Populat & Family Hlth, Joseph L Mailman Sch Publ Hlth, New York, NY USA; Makerere Univ, Dept Med, Kampala, Uganda; Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Uganda Virus Res Inst, Rakai Project, Entebbe, Uganda; Walter Reed Army Inst Res, Rockville, MD USA; NIAID, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Columbia University; Makerere University; Makerere University; Makerere University; Uganda Virus Research Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gray, RH (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Populat & Family Hlth Sci, Suite 4030,615 N Wolfe St, Baltimore, MD 21205 USA.		Quinn, Thomas/A-2494-2010	Sewankambo, Nelson/0000-0001-9362-053X	FIC NIH HHS [D43 TW001508, 5D43TW00010] Funding Source: Medline; NIAID NIH HHS [R01 AI3426S, R01 AI34826] Funding Source: Medline; NICHD NIH HHS [5P30HD06826] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000010, D43TW001508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, R01AI034826] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AIDS CONTR PROGR, 1992, HIV TEST POL, P1; BLANC AK, 1991, STUD FAMILY PLANN, V22, P162, DOI 10.2307/1966643; Breslow NE., 1987, STAT METHODS CANC RE, P81; BROOKMEYER R, 1994, AIDS EPIDEMIOLOGY QU, P36; CAMERON DW, 1989, LANCET, V2, P403; Cohen MS, 2000, NEW ENGL J MED, V342, P970, DOI 10.1056/NEJM200003303421311; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DUERR A, 1994, 10 INT C AIDS YOK JA; JEWELL NP, 1990, BIOMETRICS, V46, P1133, DOI 10.2307/2532454; LAGARDE E, 1995, AM J EPIDEMIOL, V141, P1194, DOI 10.1093/oxfordjournals.aje.a117393; Lutalo T, 2000, STUD FAMILY PLANN, V31, P217, DOI 10.1111/j.1728-4465.2000.00217.x; MASTRO TD, 1994, LANCET, V343, P204, DOI 10.1016/S0140-6736(94)90990-3; Mastro TD, 1998, AIDS RES HUM RETROV, V14, pS223; Mayer KH, 1995, INFECT AGENT DIS, V4, P273; MCCUTCHAN F, 2000, 13 INT AIDS C DURB S; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RENZULLO P, 2000, 13 INT AIDS C DURB S; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; SANCHEZMARTINEZ D, 1991, J INFECT DIS, V164, P1196, DOI 10.1093/infdis/164.6.1196; SCHOPPER D, 1993, SOC SCI MED, V37, P401, DOI 10.1016/0277-9536(93)90270-E; Schwartlander B, 2000, SCIENCE, V289, P64, DOI 10.1126/science.289.5476.64; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; UPCHURCH DM, 1991, AM J EPIDEMIOL, V134, P1159, DOI 10.1093/oxfordjournals.aje.a116019; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	28	942	972	1	45	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1149	1153		10.1016/S0140-6736(00)04331-2	http://dx.doi.org/10.1016/S0140-6736(00)04331-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423RX	11323041				2022-12-28	WOS:000168192100008
J	Dong, C; Juedes, AE; Temann, UA; Shresta, S; Allison, JP; Ruddle, NH; Flavell, RA				Dong, C; Juedes, AE; Temann, UA; Shresta, S; Allison, JP; Ruddle, NH; Flavell, RA			ICOS co-stimulatory receptor is essential for T-cell activation and function	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN MONOCYTES; TNF-ALPHA; COSTIMULATION; IL-13; INFLAMMATION; EXPRESSION; PHENOTYPE; CTLA-4; CD28	T-lymphocyte activation and immune function are regulated by co-stimulatory molecules. CD28, a receptor for B7 gene products, has a chief role in initiating T-cell immune responses(1,2). CTLA4, which binds B7 with a higher affinity, is induced after T-cell activation and is involved in downregulating T-cell responses(3,4). The inducible co-stimulatory molecule (ICOS), a third member of the CD28/CTLA4 family, is expressed on activated T cells(5,6). Its ligand B7H/B7RP-1 is expressed on B cells and in non-immune tissues after injection of lipopolysaccharide into animals(6,7). To understand the role of ICOS in T-cell activation and function, we generated and analysed ICOS-deficient mice. Here we show that T-cell activation and proliferation are defective in the absence of ICOS. In addition, ICOS-/- T cells fail to produce interleukin-4 when differentiated in vitro or when primed in vivo. ICOS is required for humoral immune responses after immunization with several antigens. ICOS-/- mice showed greatly enhanced susceptibility to experimental autoimmune encephalomyelitis, indicating that ICOS has a protective role in inflammatory autoimmune diseases.	Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Flavell, RA (corresponding author), Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA.		dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Allison, James/0000-0001-8980-5697				CASH E, 1994, J IMMUNOL, V153, P4258; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; COSENTINO G, 1995, J IMMUNOL, V155, P3145; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Juedes AE, 2000, J IMMUNOL, V164, P419, DOI 10.4049/jimmunol.164.1.419; KIM C, 1995, ARCH SURG-CHICAGO, V130, P1330; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; KUNG TT, 1994, INT ARCH ALLERGY IMM, V105, P83, DOI 10.1159/000236807; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; LIU Y, 1993, EUR J IMMUNOL, V23, P780; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Oliveira-dos-Santos AJ, 1999, J IMMUNOL, V162, P4490; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; VIALE G, 1995, INT ARCH ALLERGY IMM, V107, P176, DOI 10.1159/000236969; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	25	709	775	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					97	101		10.1038/35051100	http://dx.doi.org/10.1038/35051100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343121				2022-12-28	WOS:000166175600047
J	Overbaugh, J; Bangham, CRM				Overbaugh, J; Bangham, CRM			Selection forces and constraints on retroviral sequence variation	SCIENCE			English	Editorial Material							CELL LEUKEMIA-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; I HTLV-I; HIV-1 INFECTION; TYPE-1 EVOLUTION; RECEPTOR; CARRIERS; VARIANTS; ESCAPE	All retroviruses possess a highly error-prone reverse transcriptase, but the extent of the consequent sequence diversity and the rate of evolution differ greatly among retroviruses. Because of the high mutability of retroviruses, it is not the generation of new viral variants that Limits the extent of diversity and the rate of evolution of retroviruses, but rather the selection forces that act on these variants. Here, we suggest that two selection forces-the immune response and the limited availability of appropriate target cells during transmission and persistence-are chiefly responsible for the observed sequence diversity in untreated retroviral infections. We illustrate these aspects of positive selection by reference to specific lentiviruses [human and simian immunodeficiency viruses (HIV and SIV)] and oncoviruses [feline Leukemia virus (FeLV) and human T cell Leukemia virus (HTLV)] that differ in their extent of variation and in disease outcomes.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Imperial Coll Sch Med, London W2 1PG, England	Fred Hutchinson Cancer Center; Imperial College London	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.			Bangham, Charles/0000-0003-2624-3599				Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Bangham CRM, 2000, CURR OPIN IMMUNOL, V12, P397, DOI 10.1016/S0952-7915(00)00107-2; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cavrois M, 1996, ONCOGENE, V12, P2419; COSSET FL, 1995, J VIROL, V69, P6314, DOI 10.1128/JVI.69.10.6314-6322.1995; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; DONAHUE PR, 1988, J VIROL, V62, P722, DOI 10.1128/JVI.62.3.722-731.1988; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoffman T L, 1998, AIDS, V12 Suppl A, pS17; HOOVER EA, 1991, J AM VET MED ASSOC, V199, P1392; INA Y, 1990, J MOL EVOL, V31, P493, DOI 10.1007/BF02102076; JARRETT O, 1978, INT J CANCER, V21, P466, DOI 10.1002/ijc.2910210411; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kimata JT, 1999, NAT MED, V5, P535, DOI 10.1038/8414; KORBER B, IN PRESS CHANGING FA; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; LUKASHOV VV, 1995, J VIROL, V69, P6911, DOI 10.1128/JVI.69.11.6911-6916.1995; Mansky LM, 2000, J VIROL, V74, P9525, DOI 10.1128/JVI.74.20.9525-9531.2000; MCKNIGHT A, 1995, J VIROL, V69, P3167, DOI 10.1128/JVI.69.5.3167-3170.1995; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NEI M, 1986, MOL BIOL EVOL, V3, P418; NIEWIESK S, 1995, J VIROL, V69, P2649, DOI 10.1128/JVI.69.4.2649-2653.1995; NIEWIESK S, 1994, J VIROL, V68, P6778, DOI 10.1128/JVI.68.10.6778-6781.1994; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OVERBAUGH J, 1988, NATURE, V332, P731, DOI 10.1038/332731a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Slattery JP, 1999, GENOME RES, V9, P525; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Taylor GP, 1999, J VIROL, V73, P10289, DOI 10.1128/JVI.73.12.10289-10295.1999; TEMIN HM, 1991, TRENDS GENET, V7, P71, DOI 10.1016/0168-9525(91)90048-U; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Zinkernagel RM, 1997, IMMUNOL TODAY, V18, P258, DOI 10.1016/S0167-5699(97)80017-5; [No title captured]	42	145	148	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1106	+		10.1126/science.1059128	http://dx.doi.org/10.1126/science.1059128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352065				2022-12-28	WOS:000168609200043
J	Power, WJ; Harris, E				Power, WJ; Harris, E			Papilledema associated with intracranial hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Royal Victorian Eye & Ear Hosp, Dublin 2, Ireland; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Power, WJ (corresponding author), Royal Victorian Eye & Ear Hosp, Dublin 2, Ireland.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1442	1442		10.1056/NEJM200105103441905	http://dx.doi.org/10.1056/NEJM200105103441905			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346809				2022-12-28	WOS:000168554000005
J	Rogan, WJ; Dietrich, KN; Ware, JH; Dockery, DW; Salganik, M; Radcliffe, J; Jones, RL; Ragan, NB; Chisolm, JJ; Rhoads, GG				Rogan, WJ; Dietrich, KN; Ware, JH; Dockery, DW; Salganik, M; Radcliffe, J; Jones, RL; Ragan, NB; Chisolm, JJ; Rhoads, GG		Treatment Lead Exposed Children Tr	The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-of-Toxicology	MAR   27, 2001	SAN FRANCISCO, CALIFORNIA	Soc Toxicol			PORT-PIRIE COHORT; COGNITIVE FUNCTION; CINCINNATI LEAD; CLINICAL-TRIAL; INTELLIGENCE; AGE	Background: Thousands of children, especially poor children living in deteriorated urban housing, are exposed to enough lead to produce cognitive impairment. It is not known whether treatment to reduce blood lead levels prevents or reduces such impairment. Methods: We enrolled 780 children with blood lead levels of 20 to 44 mug per deciliter (1.0 to 2.1 mu mol per liter) in a randomized, placebo-controlled, double-blind trial of up to three 26-day courses of treatment with succimer, a lead chelator that is administered orally. The children lived in deteriorating inner-city housing and were 12 to 33 months of age at enrollment; 77 percent were black, and 5 percent were Hispanic. Follow-up included tests of cognitive, motor, behavioral, and neuropsychological function over a period of 36 months. Results: During the first six months of the trial, the mean blood lead level in the children given succimer was 4.5 mug per deciliter (0.2 mu mol per liter) lower than the mean level in the children given placebo (95 percent confidence interval, 3.7 to 5.3 mug per deciliter [0.2 to 0.3 mu mol per liter]). At 36 months of follow-up, the mean IQ score of children given succimer was 1 point lower than that of children given placebo, and the behavior of children given succimer was slightly worse as rated by a parent. However, the children given succimer scored slightly better on the Developmental Neuropsychological Assessment, a battery of tests designed to measure neuropsychological deficits thought to interfere with learning. All these differences were small, and none were statistically significant. Conclusions: Treatment with succimer lowered blood lead levels but did not improve scores on tests of cognition, behavior, or neuropsychological function in children with blood lead levels below 45 mug per deciliter. Since succimer is as effective as any lead chelator currently available, chelation therapy is not indicated for children with these blood lead levels. (N Engl J Med 2001;344:1421-6.) Copyright (C) 2001 Massachusetts Medical Society.	NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Childrens Hosp Philadelphia, Dept Psychol, Philadelphia, PA 19104 USA; Ctr Dis Control & Prevent, Nutr Biochem Branch, Atlanta, GA USA; Kennedy Krieger Inst, Baltimore, MD USA; Univ Med & Dent New Jersey, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Ohio; University of Cincinnati; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Centers for Disease Control & Prevention - USA; Kennedy Krieger Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Rogan, WJ (corresponding author), NIEHS, Epidemiol Branch, A3-05,POB 12233, Res Triangle Pk, NC 27709 USA.		Rogan, Walter/I-6034-2012; Jones, Robert L/E-1170-2011; , dwdockery/AAO-7272-2021	Rogan, Walter/0000-0002-9302-0160; Dockery, Douglas/0000-0002-6052-4880	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES043011, ZIAES043011] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bayley N, 1993, BAYLEY SCALES INFANT; BELLINGER D, 1991, PEDIATRICS, V87, P219; BELLINGER D, 1994, PEDIATRICS, V93, pA28; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Bornschein RL, 2000, PEDIATR RES, V48, P593; Centers for Disease Control, 1991, PREV LEAD POIS YOUNG; Conners C.K., 1997, CONNERS RATING SCALE; DIETRICH KN, 1991, NEUROTOXICOL TERATOL, V13, P203, DOI 10.1016/0892-0362(91)90012-L; DIETRICH KN, 1993, NEUROTOXICOL TERATOL, V15, P37, DOI 10.1016/0892-0362(93)90043-N; GRAZIANO JH, 1988, J PEDIATR-US, V113, P751, DOI 10.1016/S0022-3476(88)80396-2; Jonasson G, 1999, EUR RESPIR J, V14, P150, DOI 10.1034/j.1399-3003.1999.14a25.x; Korkman M., 2007, NEPSY 2, V2nd; MCMICHAEL AJ, 1988, NEW ENGL J MED, V319, P468, DOI 10.1056/NEJM198808253190803; MILLER DT, 1987, ANALYST, V112, P1701, DOI 10.1039/an9871201701; NIGHTINGALE SL, 1991, JAMA-J AM MED ASSOC, V265, P1802, DOI 10.1001/jama.265.14.1802; Pirkle JL, 1998, ENVIRON HEALTH PERSP, V106, P745, DOI 10.2307/3434264; POCOCK SJ, 1994, BRIT MED J, V309, P1189, DOI 10.1136/bmj.309.6963.1189; Rhoads GG, 1996, PEDIATRICS, V98, P162; Rogan WJ, 1999, PHARMACOEPIDEM DR S, V8, P343; Rogan WJ, 1998, PAEDIATR PERINAT EP, V12, P313; RUFF HA, 1993, JAMA-J AM MED ASSOC, V269, P1641, DOI 10.1001/jama.269.13.1641; SILVERSTEIN AB, 1985, J CLIN PSYCHOL, V41, P95, DOI 10.1002/1097-4679(198501)41:1<95::AID-JCLP2270410116>3.0.CO;2-V; SMYTH AR, 1993, ARCH DIS CHILD, V68, P235, DOI 10.1136/adc.68.2.235; Tong S, 1998, JAMA-J AM MED ASSOC, V280, P1915, DOI 10.1001/jama.280.22.1915; Wechsler D., 2014, WECHSLER PRESCHOOL P	25	222	233	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1421	1426		10.1056/NEJM200105103441902	http://dx.doi.org/10.1056/NEJM200105103441902			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346806				2022-12-28	WOS:000168554000002
J	Elul, B; Hajri, S; Nguyen, TNN; Ellertson, C; Ben Slama, C; Pearlman, E; Winikoff, B				Elul, B; Hajri, S; Nguyen, TNN; Ellertson, C; Ben Slama, C; Pearlman, E; Winikoff, B			Can women in less-developed countries use a simplified medical abortion regimen?	LANCET			English	Article							VAGINAL MISOPROSTOL; MIFEPRISTONE; HOME	Background Mifepristpne-misoprostol abortion, consisting of oral pills. is potentially simple and safe enough for use in less-developed countries. But the labour-intensive, costly, clinic-based European protocols are not affordable or feasible in most less-developed countries. Methods We prospectively tested two simplifications to the French mifepristone-misoprostol regimen in Vietnam and Tunisia. Women (n = 315) with amenorrhoea 8 weeks or less since their last menstrual period received 200 mg mifepristone in the clinic and then chose whether to take 400 mug oral misoprostol 2 days later either at home or in the clinic. Findings Despite the two-thirds reduction in mifepristone dose, success rates were high: Vietnam 93%, Tunisia 91%. About 88% of participants chose home administration of misoprostol. Most Vietnamese and Tunisian women were satisfied with their abortions, but efficacy and satisfaction rates were higher among those who used misoprostol at home. Interpretations A simplified medical abortion regimen of 200 mg mifepristone followed by the option of home administration of misoprostol seems feasible.	Populat Council, New York, NY 10021 USA; Tunisian Soc Endocrinol, Tunis, Tunisia; Hung Vuong Hosp, Ho Chi Minh City, Vietnam; Populat Council, Mexico City, DF, Mexico	Population Council	Winikoff, B (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.							Guengant JP, 1999, CONTRACEPTION, V60, P167, DOI 10.1016/S0010-7824(99)00074-8; Schaff E A, 2000, J Am Med Womens Assoc (1972), V55, P137; Schaff EA, 1999, CONTRACEPTION, V59, P1, DOI 10.1016/S0010-7824(98)00150-4; Schaff EA, 1997, J FAM PRACTICE, V44, P353; Schaff EA, 2000, JAMA-J AM MED ASSOC, V284, P1948, DOI 10.1001/jama.284.15.1948; STEIN K, 1998, ABORPTION EXPANDING; VANLOOK PFA, 1993, BRIT MED J, V307, P532; Winikoff B, 1996, CONTRACEPTION, V54, P323, DOI 10.1016/S0010-7824(96)00206-5; World Health Organization, 1994, AB TAB AV DAT FREQ M; Wu YM, 2000, BRIT J OBSTET GYNAEC, V107, P524	10	70	72	2	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1402	1405		10.1016/S0140-6736(00)04563-3	http://dx.doi.org/10.1016/S0140-6736(00)04563-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356438				2022-12-28	WOS:000168478200012
J	Greenspan, D; Canchoia, AJ; MacPhail, LA; Cheikh, B; Greenspan, JS				Greenspan, D; Canchoia, AJ; MacPhail, LA; Cheikh, B; Greenspan, JS			Effect of highly active antiretroviral therapy on frequency of oral warts	LANCET			English	Article							MANIFESTATIONS	To investigate changes in the pattern of oral disease associated with highly active antiretroviral therapy (HAART), we assessed the frequency of these lesions in our clinic over 9 years. We retrospectively studied 1280 patients seen between Jury, 1990, and June, 1999, and related oral findings to medication use, immune function, and viral load. We found significant decreases in oral candidosis, hairy leucoplakia, and Kaposi's sarcoma over time, but no change in the occurrence of aphthous ulcers. There was an increase in salivary-gland disease and a striking Increase in warts: three-fold for patients an antiretroviral therapy and six-fold for those an HAART (p = 0.01). This pattern of oral disease in a referral clinic suggests that an increase in oral warts could be occurring as a complication of HAART.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Oral AIDS Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greenspan, D (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.		Greenspan, John/AAE-9321-2020		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE007946] Funding Source: NIH RePORTER; NIDCR NIH HHS [P0 1 DE 07946] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Greenspan D, 1996, LANCET, V348, P729, DOI 10.1016/S0140-6736(96)02308-2; GREENSPAN JS, 1992, ORAL SURG ORAL MED O, V73, P142, DOI 10.1016/0030-4220(92)90185-S; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Leigh IM, 1999, J ACQ IMMUN DEF SYND, V21, pS49; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8	5	149	158	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1411	1412		10.1016/S0140-6736(00)04578-5	http://dx.doi.org/10.1016/S0140-6736(00)04578-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356441				2022-12-28	WOS:000168478200015
J	Mucklow, JC				Mucklow, JC			Reporting drug safety in clinical trials: getting the emphasis right	LANCET			English	Editorial Material									N Staffordshire Hosp NHS Trust, Dept Clin Pharmacol, Stoke On Trent ST4 6QG, Staffs, England	University Hospital of North Staffordshire NHS Trust	Mucklow, JC (corresponding author), N Staffordshire Hosp NHS Trust, Dept Clin Pharmacol, Stoke On Trent ST4 6QG, Staffs, England.							Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Kaufman DW, 2000, LANCET, V356, P1339, DOI 10.1016/S0140-6736(00)02826-9	2	9	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1384	1384		10.1016/S0140-6736(00)04619-5	http://dx.doi.org/10.1016/S0140-6736(00)04619-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356432				2022-12-28	WOS:000168478200006
J	Huber, AH; Weis, WI				Huber, AH; Weis, WI			The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin	CELL			English	Article							APC TUMOR-SUPPRESSOR; TYROSINE PHOSPHORYLATION; CELL-ADHESION; FUNCTIONAL INTERACTION; ALPHA-CATENIN; BINDING; REGION; LOCALIZATION; PLAKOGLOBIN; ASSOCIATION	As a component of adherens junctions and the Wnt signaling pathway, beta -catenin binds cadherins, Tcf family transcription factors, and the tumor suppressor APC. We have determined the crystal structures of both unphosphorylated and phosphorylated E-cadherin cytoplasmic domain complexed with the arm repeat region of beta -catenin. The interaction spans all 12 arm repeats, and features quasi-independent binding regions that include helices which interact with both ends of the arm repeat domain and an extended stretch of 14 residues which closely resembles a portion of XTcf-3. Phosphorylation of E-cadherin results in interactions with a hydrophobic patch of beta -catenin that mimics the binding of an amphipathic XTcf-3 helix. APC contains sequences homologous to the phosphorylated region of cadherin, and is likely to bind similarly.	Stanford Univ, Sch Med, Dept Struct Biol & Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol & Mol & Cellular Physiol, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	NIGMS NIH HHS [GM56169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chitaev NA, 1998, J CELL SCI, V111, P1941; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Finnemann S, 1997, J BIOL CHEM, V272, P11856, DOI 10.1074/jbc.272.18.11856; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Norvell SM, 1998, J CELL SCI, V111, P1305; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Polakis P, 2000, GENE DEV, V14, P1837; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; Takeda H, 1995, J CELL BIOL, V131, P1839, DOI 10.1083/jcb.131.6.1839; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wahl JK, 2000, J CELL SCI, V113, P1737; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	51	573	593	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					391	402		10.1016/S0092-8674(01)00330-0	http://dx.doi.org/10.1016/S0092-8674(01)00330-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348595	Bronze			2022-12-28	WOS:000168515900008
J	Sanudo-Wilhelmy, SA; Kustka, AB; Gobler, CJ; Hutchins, DA; Yang, M; Lwiza, K; Burns, J; Capone, DG; Raven, JA; Carpenter, EJ				Sanudo-Wilhelmy, SA; Kustka, AB; Gobler, CJ; Hutchins, DA; Yang, M; Lwiza, K; Burns, J; Capone, DG; Raven, JA; Carpenter, EJ			Phosphorus limitation of nitrogen fixation by Trichodesmium in the central Atlantic Ocean	NATURE			English	Article							NORTH PACIFIC-OCEAN; IRON; PHYTOPLANKTON; PHYSIOLOGY; EVOLUTION; TRANSPORT; CADMIUM; COASTAL; CARBON; COPPER	Marine fixation of atmospheric nitrogen is believed to be an important source of biologically useful nitrogen to ocean surface waters(1), stimulating productivity of phytoplankton and so influencing the global carbon cycle(2). The majority of nitrogen fixation in tropical waters is carried out by the marine cyanobacterium Trichodesmium(3), which supplies more than half of the new nitrogen used for primary production(4). Although the factors controlling marine nitrogen fixation remain poorly understood, it has been thought that nitrogen fixation is limited by iron availability in the ocean(2,5). This was inferred from the high iron requirement estimated for growth of nitrogen fixing organisms(6) and the higher apparent densities of Trichodesmium where aeolian iron inputs are plentiful(7). Here we report that nitrogen fixation rates in the central Atlantic appear to be independent of both dissolved iron levels in sea water and iron content in Trichodesmium colonies. Nitrogen fixation was, instead, highly correlated to the phosphorus content of Trichodesmium and was enhanced at higher irradiance. Furthermore, our calculations suggest that the structural iron requirement for the growth of nitrogen-fixing organisms is much lower than previously calculated(6). Although iron deficiency could still potentially limit growth of nitrogen-fixing organisms in regions of low iron availability-for example, in the subtropical North Pacific Ocean-our observations suggest that marine nitrogen fixation is not solely regulated by iron supply.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Long Isl Univ, Southampton Coll, Div Nat Sci, Southampton, NY 11968 USA; Univ Delaware, Coll Marine Studies, Lewes, DE 19958 USA; Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Dundee, Sch Life Sci, Div Environm & Appl Biol, Dundee DD1 4HN, Scotland; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Delaware; University of Southern California; University of Southern California; University of Dundee; California State University System; San Francisco State University	Sanudo-Wilhelmy, SA (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.		Hutchins, David A/D-3301-2013	Hutchins, David A/0000-0002-6637-756X; Lwiza, Kamazima/0000-0003-2790-9284				BRAND LE, 1991, LIMNOL OCEANOGR, V36, P1756, DOI 10.4319/lo.1991.36.8.1756; BRULAND KW, 1979, ANAL CHIM ACTA, V105, P233, DOI 10.1016/S0003-2670(01)83754-5; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1976, SCIENCE, V191, P1278, DOI 10.1126/science.1257749; CARPENTER EJ, 1995, MAR ECOL PROG SER, V118, P267, DOI 10.3354/meps118267; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Flynn KJ, 1999, J PHYCOL, V35, P1171, DOI 10.1046/j.1529-8817.1999.3561171.x; GIESKES JM, 1991, OCEAN DRILLING PROGR, P46; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Johnson KS, 1999, NATURE, V398, P697, DOI 10.1038/19511; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; KARL DM, 1995, NATURE, V373, P230, DOI 10.1038/373230a0; Lagerloef GSE, 1998, J CLIMATE, V11, P2297, DOI 10.1175/1520-0442(1998)011<2297:PWPTRD>2.0.CO;2; LANDING WM, 1987, GEOCHIM COSMOCHIM AC, V51, P29, DOI 10.1016/0016-7037(87)90004-4; MAGUE TH, 1977, MAR BIOL, V41, P213, DOI 10.1007/BF00394908; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Postgate J., 1998, NITROGEN FIXATION, P1; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; RUETER JG, 1992, NATO ADV SCI I C-MAT, V362, P289; Schmidt MA, 1999, DEEP-SEA RES PT II, V46, P2487, DOI 10.1016/S0967-0645(99)00073-9; SPRENT JI, 1985, P ROY SOC EDINB B, V85, P215, DOI 10.1017/S0269727000004036; VanderLoeff MR, 1997, GEOCHIM COSMOCHIM AC, V61, P47, DOI 10.1016/S0016-7037(96)00333-X; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 1997, FEMS MICROBIOL LETT, V153, P303, DOI 10.1111/j.1574-6968.1997.tb12589.x; Zwiers FW, 1998, J CLIMATE, V11, P2200, DOI 10.1175/1520-0442(1998)011<2200:CITEOT>2.0.CO;2	30	472	496	3	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					66	69		10.1038/35075041	http://dx.doi.org/10.1038/35075041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333977				2022-12-28	WOS:000168432800043
J	Maurice-Williams, RS				Maurice-Williams, RS			Bedside treatment of chronic subdural haematoma?	LANCET			English	Editorial Material							HEMATOMA		Royal Free Hosp NHS Trust, Dept Surg, London NW3 2QG, England	University of London; University College London	Maurice-Williams, RS (corresponding author), Royal Free Hosp NHS Trust, Dept Surg, London NW3 2QG, England.							KRUPP WF, 1995, BRIT J NEUROSURG, V9, P619, DOI 10.1080/02688699550040909; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P547, DOI 10.1080/02688699943033; MAURICEWILLIAMS RS, 1975, J NEUROSURG, V43, P623, DOI 10.3171/jns.1975.43.5.0623; MAURICEWILLIAMS RS, 1993, AGE AGEING, V22, P337, DOI 10.1093/ageing/22.5.337; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; Reinges MHT, 2000, J NEUROL NEUROSUR PS, V69, P40, DOI 10.1136/jnnp.69.1.40; VanHavenbergh T, 1996, BRIT J NEUROSURG, V10, P35	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1308	1309		10.1016/S0140-6736(00)04528-1	http://dx.doi.org/10.1016/S0140-6736(00)04528-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343731				2022-12-28	WOS:000168411400005
J	Smith, GP; Wiens, DA; Fischer, KM; Dorman, LM; Webb, SC; Hildebrand, JA				Smith, GP; Wiens, DA; Fischer, KM; Dorman, LM; Webb, SC; Hildebrand, JA			A complex pattern of mantle flow in the Lau backarc	SCIENCE			English	Article							TONGA SUBDUCTION ZONE; SEISMIC ANISOTROPY; SHEAR; BENEATH; DEFORMATION; MELT; PLATE; BASIN; ARC	Shear-wave splitting analysis of Local events recorded on Land and on the ocean floor in the Tonga are acid Lau backarc indicate a complex pattern of azimuthal anisotropy that cannot be explained by mantle flow coupled to the downgoing plate. These observations suggest that the direction of mantle flow rotates from convergence-parallel in the Fiji plateau to north-south beneath the Lau basin and are-parallel beneath the Tonga are. These results correlate with helium isotopes that map mantle flow of the Samoan plume into the Lau basin through an opening tear in the Pacific plate.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Washington University (WUSTL); Brown University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Columbia University	Smith, GP (corresponding author), Washington Univ, Dept Earth & Planetary Sci, 1 Brookings Dr,CB1169, St Louis, MO 63130 USA.		Smith, Gideon/AHB-9839-2022; Smith, Gideon/AAO-7088-2021; Wiens, Douglas A/J-9259-2016	Wiens, Douglas A/0000-0002-5169-4386; Hildebrand, John/0000-0002-5418-9799; Webb, Spahr/0000-0002-7277-174X				ALVAREZ W, 1982, J GEOPHYS RES, V87, P6697, DOI 10.1029/JB087iB08p06697; BEVIS M, 1995, NATURE, V374, P249, DOI 10.1038/374249a0; Bjarnason IT, 1996, GEOPHYS RES LETT, V23, P459, DOI 10.1029/96GL00420; Blackman DK, 1996, GEOPHYS J INT, V127, P415, DOI 10.1111/j.1365-246X.1996.tb04730.x; BOWMAN JR, 1987, GEOPHYS J INT, V88, P25, DOI 10.1111/j.1365-246X.1987.tb01367.x; Buttles J, 1998, EARTH PLANET SC LETT, V164, P245, DOI 10.1016/S0012-821X(98)00211-8; Bystricky M, 2000, SCIENCE, V290, P1564, DOI 10.1126/science.290.5496.1564; CHOPRA PN, 1984, J GEOPHYS RES, V89, P7861, DOI 10.1029/JB089iB09p07861; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V76, P89, DOI 10.1111/j.1365-246X.1984.tb05025.x; FISCHER KH, UNPUB; Fischer KM, 1996, EARTH PLANET SC LETT, V142, P253, DOI 10.1016/0012-821X(96)00084-2; Fischer KM, 1998, PURE APPL GEOPHYS, V151, P463, DOI 10.1007/s000240050123; Flinn E. A., 1965, P IEEE, V53, P1874; Forsyth DW, 1998, SCIENCE, V280, P1235, DOI 10.1126/science.280.5367.1235; Fouch MJ, 1998, GEOPHYS RES LETT, V25, P1221, DOI 10.1029/98GL00650; Fouch MJ, 1996, J GEOPHYS RES-SOL EA, V101, P15987, DOI 10.1029/96JB00881; GILL J, 1989, J GEOPHYS RES-SOLID, V94, P4579, DOI 10.1029/JB094iB04p04579; Gledhill K, 1996, PHYS EARTH PLANET IN, V95, P227, DOI 10.1016/0031-9201(95)03118-9; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1107; Hall CE, 2000, J GEOPHYS RES-SOL EA, V105, P28009, DOI 10.1029/2000JB900297; HESS HH, 1964, NATURE, V203, P629, DOI 10.1038/203629a0; JUNG H, 2000, EOS T AGU, V81, pS53; KENDALL JM, 1994, GEOPHYS RES LETT, V21, P301, DOI 10.1029/93GL02791; MCKENZIE D, 1979, GEOPHYS J ROY ASTR S, V58, P689, DOI 10.1111/j.1365-246X.1979.tb04803.x; Peyton V, 2001, GEOPHYS RES LETT, V28, P379, DOI 10.1029/2000GL012200; POREDA RJ, 1992, EARTH PLANET SC LETT, V113, P487, DOI 10.1016/0012-821X(92)90126-G; RIBE NM, 1989, J GEOPHYS RES-SOLID, V94, P4213, DOI 10.1029/JB094iB04p04213; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Sandvol E, 1997, J GEOPHYS RES-SOL EA, V102, P9911, DOI 10.1029/96JB03489; Savage MK, 1999, REV GEOPHYS, V37, P65, DOI 10.1029/98RG02075; Tommasi A, 1998, EARTH PLANET SC LETT, V160, P1, DOI 10.1016/S0012-821X(98)00081-8; Turner S, 1998, GEOLOGY, V26, P1019, DOI 10.1130/0091-7613(1998)026<1019:UGTMMF>2.3.CO;2; Wendt JI, 1997, GEOLOGY, V25, P611, DOI 10.1130/0091-7613(1997)025<0611:EFACFT>2.3.CO;2; Wolfe CJ, 1998, J GEOPHYS RES-SOL EA, V103, P749, DOI 10.1029/97JB02023; WOLFE CJ, 1996, EOS T AGU S, V77, pF653; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0; Zimmerman ME, 1999, GEOPHYS RES LETT, V26, P1505, DOI 10.1029/1999GL900259	37	236	242	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					713	716		10.1126/science.1058763	http://dx.doi.org/10.1126/science.1058763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326095				2022-12-28	WOS:000168478300047
J	Gillespie, WJ				Gillespie, WJ			Extracts from "Clinical Evidence" - Hip fracture	BRITISH MEDICAL JOURNAL			English	Review							PROXIMAL FEMUR; THROMBOEMBOLISM		Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of Otago	Gillespie, WJ (corresponding author), Univ Otago, Dunedin Sch Med, Dunedin, New Zealand.							Agu O, 1999, BRIT J SURG, V86, P992, DOI 10.1046/j.1365-2168.1999.01195.x; AVENELL A, 2000, COCHRANE DATABASE SY; BOYCE WJ, 1985, LANCET, V1, P150; Calder SJ, 1996, J BONE JOINT SURG BR, V78B, P391, DOI 10.1302/0301-620X.78B3.0780391; CAMERON I, 2000, HLTH TECHNOL ASSESS, P4; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Cornell CN, 1998, CLIN ORTHOP RELAT R, P67; CULLUM N, 2000, COCHRANE LIB; Gillespie WJ, 2000, COCHRANE DATABASE SY; HANDOLL HHG, 2000, COCHRANE DATABASE SY; Hochberg MC, 1998, OSTEOPOROSIS INT, V8, P385, DOI 10.1007/s001980050079; Hoffmann R, 1999, UNFALLCHIRURG, V102, P182, DOI 10.1007/s001130050391; JORGENSEN LN, 1993, BRIT J SURG, V80, P689, DOI 10.1002/bjs.1800800607; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; O'Brien J, 2000, LANCET, V355, P1295; Parker MJ., 1993, HIP FRACTURE MANAGEM; Parker MJ, 2000, COCHRANE DATABASE SY; Schurch MA, 1996, J BONE MINER RES, V11, P1935; Tinetti ME, 1999, ARCH PHYS MED REHAB, V80, P916, DOI 10.1016/S0003-9993(99)90083-7; [No title captured]	21	60	63	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					968	975		10.1136/bmj.322.7292.968	http://dx.doi.org/10.1136/bmj.322.7292.968			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312232	Green Published			2022-12-28	WOS:000168345100021
J	Gilson, RJC; Mindel, A				Gilson, RJC; Mindel, A			Recent advances - Sexually transmitted infections	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHLAMYDIA-TRACHOMATIS INFECTIONS; SIMPLEX-VIRUS TYPE-2; GENITAL HERPES; PUBLIC-HEALTH; UNITED-STATES; WOMEN; SEROPREVALENCE; GONORRHEA; DOXYCYCLINE; PREVALENCE		UCL, Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England; Westmead Hosp, Sexually Transmitted Infect Res Ctr, Westmead, NSW 2145, Australia	University of London; University College London; University of Sydney	Gilson, RJC (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England.	rgilson@gum.ucl.ac.uk	Gilson, Richard J C/C-5123-2009	Mindel, Adrian/0000-0002-8780-9982				[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Austin H, 1999, SEX TRANSM DIS, V26, P329, DOI 10.1097/00007435-199907000-00004; Bachmann LH, 1999, SEX TRANSM DIS, V26, P272, DOI 10.1097/00007435-199905000-00006; Burstein GR, 1998, SEX TRANSM DIS, V25, P395, DOI 10.1097/00007435-199809000-00001; *CHIEF MED OFF, 1998, MAIN REP CHIEF MED O; Clavel C, 1999, BRIT J CANCER, V80, P1306, DOI 10.1038/sj.bjc.6690523; *CLIN EFF GROUP, 1999, SEX TRANSM INFECT S1, V75, pS1; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; Duncan B, 1999, BRIT MED J, V318, P931, DOI 10.1136/bmj.318.7188.931; Eberhart-Phillips J, 1998, SEX TRANSM INFECT, V74, P216, DOI 10.1136/sti.74.3.216; Edwards L, 1998, ARCH DERMATOL, V134, P25, DOI 10.1001/archderm.134.1.25; Fortenberry JD, 1999, SEX TRANSM DIS, V26, P26, DOI 10.1097/00007435-199901000-00005; Fox KK, 1998, SEX TRANSM DIS, V25, P386, DOI 10.1097/00007435-199808000-00011; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; Gunn RA, 1998, SEX TRANSM DIS, V25, P49, DOI 10.1097/00007435-199801000-00010; Hagensee ME, 1999, OBSTET GYNECOL, V94, P653, DOI 10.1016/S0029-7844(99)00454-8; Hillis SD, 1998, SEX TRANSM DIS, V25, P5, DOI 10.1097/00007435-199801000-00002; Lacey CJN, 1999, J INFECT DIS, V179, P612, DOI 10.1086/314616; Lang H, 1999, J PRAK CHEM-CHEM ZTG, V341, P1; Lewis LM, 1999, J NATL MED ASSOC, V91, P210; Low N, 1997, BRIT MED J, V314, P1719, DOI 10.1136/bmj.314.7096.1719; MINDEL A, 1998, SEX TRANSM INFECT S1, V74, pS1; Munday PE, 1998, SEX TRANSM INFECT, V74, P175, DOI 10.1136/sti.74.3.175; Munk C, 1999, SEX TRANSM DIS, V26, P325, DOI 10.1097/00007435-199907000-00003; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Ostergaard L, 1998, BRIT MED J, V317, P26, DOI 10.1136/bmj.317.7150.26; *PHLS DHSS PS SCOT, 2000, TRENDS SEX TRANSM IN; Pimenta J, 2000, BRIT MED J, V321, P629, DOI 10.1136/bmj.321.7261.629; Schachter J, 1999, SEX TRANSM DIS, V26, P279, DOI 10.1097/00007435-199905000-00007; Schachter J, 1999, CURR OPIN INFECT DIS, V12, P41, DOI 10.1097/00001432-199902000-00008; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; SPRUANCE S, 2000, 40 INT C ANT AG CHEM; Tao GY, 2000, SEX TRANSM DIS, V27, P32, DOI 10.1097/00007435-200001000-00007; van Driel WJ, 1999, EUR J CANCER, V35, P946, DOI 10.1016/S0959-8049(99)00048-9; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wideroff L, 1999, J INFECT DIS, V180, P1424, DOI 10.1086/315055; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	40	19	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2001	322	7295					1160	1164		10.1136/bmj.322.7295.1160	http://dx.doi.org/10.1136/bmj.322.7295.1160			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348912	Green Published			2022-12-28	WOS:000168748900018
J	Ward, PD; Haggart, JW; Carter, ES; Wilbur, D; Tipper, HW; Evans, T				Ward, PD; Haggart, JW; Carter, ES; Wilbur, D; Tipper, HW; Evans, T			Sudden productivity collapse associated with the Triassic-Jurassic boundary mass extinction	SCIENCE			English	Article								The end-Triassic mass extinction is one of the five most catastrophic in Phanerozoic Earth history. Here we report carbon isotope evidence of a pronounced productivity collapse at the boundary, coincident with a sudden extinction among marine plankton, from stratigraphic sections on the Queen Charlotte Islands, British Columbia, Canada. This signal is similar to (though smaller than) the carbon isotope excursions associated with the Permian-Triassic and Cretaceous-Tertiary events.	Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Geol Survey Canada, Vancouver, BC V6B 5J3, Canada; Portland State Univ, Dept Geol, Portland, OR 97207 USA; Univ Washington, Dept Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Portland State University; University of Washington; University of Washington Seattle	Ward, PD (corresponding author), Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA.							Carter E. S., 1993, MEMOIRES GEOLOGIE LA, V11, P175; CARTER EA, UNPUB; CARTER ES, 1998, GEOL SURV CAN B, V496, P27; CARTER ES, 1999, INT SUBCOMM JURASSIC, P27; Desrochers A, 1991, 9010 GEOL SURV CAN, P163; DUNNING GR, 1990, GEOLOGY, V18, P795, DOI 10.1130/0091-7613(1990)018<0795:UPZABA>2.3.CO;2; HALLAM A, 1997, MASS EXTINCTIONS THE; Morante R, 1996, GEOLOGY, V24, P391, DOI 10.1130/0091-7613(1996)024<0391:OCIRAT>2.3.CO;2; NEWELL ND, 1967, GEOL SOC AM SPEC PAP, V89, P63; Orchard M.J, 1991, 9010 GEOL SURV CAN, P453, DOI DOI 10.4095/131983; Palfy J, 2000, GEOLOGY, V28, P39, DOI 10.1130/0091-7613(2000)28<39:TTEMEF>2.0.CO;2; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Tipper Howard W., 1994, Geobios Memoire Special (Villeurbanne), V17, P477	13	200	209	6	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1148	1151		10.1126/science.1058574	http://dx.doi.org/10.1126/science.1058574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349146				2022-12-28	WOS:000168609200055
J	Crompvoets, FMH; Bethlem, HL; Jongma, RT; Meijer, G				Crompvoets, FMH; Bethlem, HL; Jongma, RT; Meijer, G			A prototype storage ring for neutral molecules	NATURE			English	Article							AMMONIA; STATE	The ability to cool and manipulate atoms with light has yielded atom interferometry, precision spectroscopy, Bose-Einstein condensates and atom lasers. The extension of controlled manipulation to molecules is expected to be similarly rewarding, but molecules are not as amenable to manipulation by light owing to a far more complex energy-level spectrum. However, time-varying electric and magnetic fields have been successfully used to control the position and velocity of ions, suggesting that these schemes can also be used to manipulate neutral particles having an electric or magnetic dipole moment(1-4). Although the forces exerted on neutral species are many orders of magnitude smaller than those exerted on ions, beams of neutral dipolar molecules have been successfully slowed down in a series of pulsed electric fields(5,6) and subsequently loaded into an electrostatic trap(7). Here we extend the scheme to include a prototype electrostatic storage ring made of a hexapole torus with a circumference of 80 cm. After injection, decelerated bunches of deuterated ammonia molecules, each containing about 10(6) molecules in a single quantum state and with a translational temperature of 10 mK, travel up to six times around the ring. Stochastic cooling(8) might provide a means to increase the phase-space density of the stored molecules in the storage ring, and we expect this to open up new opportunities for molecular spectroscopy and studies of cold molecular collisions(9,10).	FOM, Inst Plasma Phys Rijnhuizen, NL-3430 BE Nieuwegein, Netherlands; Univ Nijmegen, Dept Mol & Laser Phys, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Meijer, G (corresponding author), FOM, Inst Plasma Phys Rijnhuizen, POB 1207, NL-3430 BE Nieuwegein, Netherlands.		Meijer, Gerard/D-2141-2009; Jongma, Rienk/D-4506-2012; Bethlem, Hendrick Lucas/B-2831-2008	Meijer, Gerard/0000-0001-9669-8340; Bethlem, Hendrick Lucas/0000-0003-4575-8512				ASHFOLD MNR, 1988, J CHEM PHYS, V89, P1754, DOI 10.1063/1.455715; Bethlem HL, 2000, PHYS REV LETT, V84, P5744, DOI 10.1103/PhysRevLett.84.5744; Bethlem HL, 2000, NATURE, V406, P491, DOI 10.1038/35020030; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; GANDHI SR, 1987, J CHEM PHYS, V87, P6457, DOI 10.1063/1.453427; Gupta M, 1999, J PHYS CHEM A, V103, P10670, DOI 10.1021/jp993560x; Huffman PR, 2000, NATURE, V403, P62, DOI 10.1038/47444; Katz DP, 1997, J CHEM PHYS, V107, P8491, DOI 10.1063/1.475001; KUGLER KJ, 1978, PHYS LETT B, V72, P422, DOI 10.1016/0370-2693(78)90154-5; LEE SY, 1999, ACCELERATOR PHYSICS; Loesch HJ, 2000, PHYS REV LETT, V85, P2709, DOI 10.1103/PhysRevLett.85.2709; NIEL L, 1989, Z PHYS B CON MAT, V74, P133, DOI 10.1007/BF01307246; van der Meer S, 1972, CERNISRPO7231; Vuletic V, 2000, PHYS REV LETT, V84, P3787, DOI 10.1103/PhysRevLett.84.3787; Weiner J, 1999, REV MOD PHYS, V71, P1, DOI 10.1103/RevModPhys.71.1; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949	16	144	145	1	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					174	176		10.1038/35075537	http://dx.doi.org/10.1038/35075537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346789				2022-12-28	WOS:000168563000044
J	Israelian, G; Santos, NC; Mayor, M; Rebolo, R				Israelian, G; Santos, NC; Mayor, M; Rebolo, R			Evidence for planet engulfment by the star HD82943	NATURE			English	Article							ISOTOPIC LITHIUM ABUNDANCES; EXTRASOLAR PLANETS; EVOLUTION; RATIOS	Current models(1,2) of the evolution of the known extrasolar planetary systems need to incorporate orbital migration and/or gravitational interactions among giant planets to explain the presence of large bodies close to their parent stars. These processes could also lead to planets being ingested by their parent stars, which would alter the relative abundances of elements heavier than helium in the stellar atmospheres. In particular, the abundance of the rare Li-6 isotope, which is normally destroyed in the early evolution of solar-type stars(3) but preserved intact in the atmospheres of giant planets, would be boosted substantially. Li-6 has not hitherto been observed reliably in a metal-rich star(4,5), where metallicity refers to the total abundance of elements heavier than helium. Here we report the discovery of Li-6 in the atmosphere of the metal-rich solar-type star HD82943, which is known to have an orbiting giant planet. The presence of Li-6 can probably be interpreted as evidence for a planet (or planets) having been engulfed by the parent star.	Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; Observ Geneva, CH-1290 Sauverny, Switzerland; CSIC, E-28006 Madrid, Spain	Instituto de Astrofisica de Canarias; University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC)	Israelian, G (corresponding author), Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain.	gil@ll.iac.es	Rebolo, Rafael/S-1563-2019; Santos, Nuno C/E-9957-2011	Santos, Nuno C/0000-0003-4422-2919; Rebolo, Rafael/0000-0003-3767-7085				ALEXANDER JB, 1967, OBSERVATORY, V87, P238; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANDERSEN J, 1984, ASTRON ASTROPHYS, V136, P65; Balachandran S, 1990, ASTROPHYS J, V354, P310, DOI 10.1086/168691; BOESGAARD AM, 1986, ASTROPHYS J, V303, P724, DOI 10.1086/164120; Chaussidon M, 1999, NATURE, V402, P270, DOI 10.1038/46235; DANTONA F, 1994, ASTROPHYS J SUPPL S, V90, P467, DOI 10.1086/191867; Fields BD, 1999, NEW ASTRON, V4, P255, DOI 10.1016/S1384-1076(99)00009-3; FORESTINI M, 1994, ASTRON ASTROPHYS, V285, P473; GLASS BP, 1982, INTRO PLANETARY GEOL; Gonzalez G, 2001, ASTRON J, V121, P432, DOI 10.1086/318048; Hobbs LM, 1999, ASTROPHYS J, V523, P797, DOI 10.1086/307757; Jones RB, 1999, PHYSIOL BEHAV, V67, P117, DOI 10.1016/S0031-9384(99)00039-6; Knauth DC, 2000, NATURE, V405, P656, DOI 10.1038/35015028; KURUCZ RL, 1984, NOAO ATLAS, V1; LAMBERT D, 1989, PUBL ASTRON SOC PAC, V105, P568; Levison HF, 1998, ASTRON J, V116, P1998, DOI 10.1086/300557; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; MULLER EA, 1975, SOL PHYS, V41, P53, DOI 10.1007/BF00152955; NAEF D, IN PRESS ASTRON ASTR; Nissen PE, 1999, ASTRON ASTROPHYS, V348, P211; Perryman MAC, 1997, ASTRON ASTROPHYS, V323, pL49; Ramaty R, 2000, ASTROPHYS J, V534, pL207, DOI 10.1086/312671; REBOLO R, 1986, ASTRON ASTROPHYS, V166, P195; Ryan SG, 2000, MON NOT R ASTRON SOC, V316, pL35, DOI 10.1046/j.1365-8711.2000.03777.x; Santos NC, 2000, ASTRON ASTROPHYS, V363, P228; SCHAERER D, 1993, ASTRON ASTROPHYS SUP, V102, P339; Smith VV, 1998, ASTROPHYS J, V506, P405, DOI 10.1086/306238; Thi WF, 2001, NATURE, V409, P60, DOI 10.1038/35051033; Weidenschilling SJ, 1996, NATURE, V384, P619, DOI 10.1038/384619a0	30	139	139	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					163	166		10.1038/35075512	http://dx.doi.org/10.1038/35075512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346786				2022-12-28	WOS:000168563000041
J	Potter, CJ; Huang, H; Xu, T				Potter, CJ; Huang, H; Xu, T			Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size	CELL			English	Article							TUBEROUS SCLEROSIS; PHOSPHOINOSITIDE 3-KINASE; GENETIC MOSAICS; EYE DEVELOPMENT; PROTEIN-KINASE; HOMOLOG; EXPRESSION; HAMARTIN; ENCODES; IDENTIFICATION	Tuberous sclerosis complex is a dominant disorder that leads to the development of benign tumors in multiple organs. We have isolated a mutation in the Drosophila homolog of TSC1 (Tsc1). Cells mutant for Tsc1 are dramatically increased in size yet differentiate normally. Organ size is also increased in tissues that contain a majority of mutant cells. Clones of Tsc1 mutant cells in the imaginal discs undergo additional divisions but retain normal ploidy. We also show that the Tsc1 protein binds to Drosophila Tsc2 in vitro. Overexpression of Tsc1 or Tsc2 alone in the wing and eye has no effect, but co-overexpression leads to a decrease in cell size, cell number, and organ size. Genetic epistasis data are consistent with a model that Tsc1 and Tsc2 function together in the insulin signaling pathway.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst,Dept Genet, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst,Dept Genet, 295 Congress Ave, New Haven, CT 06536 USA.	tian.xu@yale.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112	NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER; NCI NIH HHS [CA69408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; CANAL I, 1994, EUR J NEUROSCI, V6, P1423, DOI 10.1111/j.1460-9568.1994.tb01004.x; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Halder G, 1998, DEVELOPMENT, V125, P2181; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; JOHNSON WG, 1991, ANN NY ACAD SCI, V615, P211; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; NELLIST M, 1993, CELL, V75, P1305; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Plank TL, 1998, CANCER RES, V58, P4766; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Stowers RS, 1999, GENETICS, V152, P1631; TABATA T, 1995, DEVELOPMENT, V121, P3359; Tang AH, 2001, DEVELOPMENT, V128, P801; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Theodosiou NA, 1998, DEVELOPMENT, V125, P3411; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; van Slegtenhorst M, 1999, J MED GENET, V36, P285; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Wittwer F, 2001, DEVELOPMENT, V128, P791; WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201; Wolff T, 1993, DEV DROSOPHILA MELAN; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	45	415	429	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					357	368		10.1016/S0092-8674(01)00333-6	http://dx.doi.org/10.1016/S0092-8674(01)00333-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348592	Bronze			2022-12-28	WOS:000168515900005
J	Rosenstein, NE; Perkins, BA; Stephens, DS; Popovic, T; Hughes, JM				Rosenstein, NE; Perkins, BA; Stephens, DS; Popovic, T; Hughes, JM			Medical progress: Meningococcal disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NEISSERIA-MENINGITIDIS SEROGROUP; MEMBRANE VESICLE VACCINE; GROUP-A; UNITED-STATES; CONJUGATE VACCINE; HUMAN IMMUNITY; GROUP-Y; CAPSULAR POLYSACCHARIDE; BACTERIAL-MENINGITIS; IMMUNOLOGICAL MEMORY		Ctr Dis Control & Prevent, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Sch Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University	Rosenstein, NE (corresponding author), Ctr Dis Control & Prevent, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop C-09, Atlanta, GA 30333 USA.	nar5@cdc.gov	Stephens, David S/A-8788-2012					Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P11; ALMOG R, 1994, INFECTION, V22, P69, DOI 10.1007/BF01739006; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P13; [Anonymous], 1997, Wkly Epidemiol Rec, V72, P313; [Anonymous], 1976, J INFECT DIS, V134, P201, DOI 10.1093/infdis/134.2.201; [Anonymous], 1805, J MED CHIR PHARM; ARTENSTEIN MS, 1967, J AMER MED ASSOC, V201, P1004; AYCOCK WL, 1950, BACTERIOL REV, V14, P115, DOI 10.1128/MMBR.14.2.115-160.1950; BAND JD, 1983, J INFECT DIS, V148, P754, DOI 10.1093/infdis/148.4.754; BARQUET N, 1990, REV INFECT DIS, V12, P838; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Bruce M, 1999, 39 ANN M INF DIS SOC, P63; Brundage JF, 1987, EVOLUTION MENINGOCOC, P5; Campagne G, 2000, PEDIATR INFECT DIS J, V19, P144, DOI 10.1097/00006454-200002000-00013; CARLONE GM, 1997, MANUAL CLIN LAB IMMU, P458; Casado-Flores J, 1997, CLIN INFECT DIS, V25, P1479, DOI 10.1086/516994; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Connolly M, 1999, EPIDEMIOL INFECT, V122, P41, DOI 10.1017/S0950268898001848; COOPER ER, 1986, J PEDIATR-US, V108, P93, DOI 10.1016/S0022-3476(86)80776-4; DAVIES BI, 1991, EUR J CLIN MICROBIOL, V10, P399, DOI 10.1007/BF01968018; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493; Dunbar SA, 1998, J CLIN MICROBIOL, V36, P1617, DOI 10.1128/JCM.36.6.1617-1620.1998; EDWARDS MS, 1981, J PEDIATR-US, V99, P540, DOI 10.1016/S0022-3476(81)80250-8; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Fijen CAP, 1998, CLIN EXP IMMUNOL, V114, P362; FILICE GA, 1985, J CLIN MICROBIOL, V22, P152, DOI 10.1128/JCM.22.2.152-156.1985; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; Fischer M, 1997, SEMIN PEDIAT INFECT, V8, P50; Flexner S, 1913, J EXP MED, V17, P553, DOI 10.1084/jem.17.5.553; FRANCKE EL, 1981, SURG CLIN N AM, V61, P135; FRASCH CE, 1989, CLIN MICROBIOL REV, V2, pS134, DOI 10.1128/CMR.2.Suppl.S134-S138.1989; GALAID EI, 1980, JAMA-J AM MED ASSOC, V244, P2167, DOI 10.1001/jama.244.19.2167; Galimand M, 1999, NEW ENGL J MED, V340, P824; GIRGIS NI, 1989, PEDIATR INFECT DIS J, V8, P848, DOI 10.1097/00006454-198912000-00004; GOLD R, 1979, J INFECT DIS, V140, P690, DOI 10.1093/infdis/140.5.690; GOLD R, 1987, EVOLUTION MENINGOCOC, V2, P69; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; Granoff DM, 1998, J INFECT DIS, V178, P870, DOI 10.1086/515346; GREENFIELD S, 1971, J INFECT DIS, V123, P67, DOI 10.1093/infdis/123.1.67; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P536, DOI 10.1016/0035-9203(87)90397-X; GREENWOOD BM, 1985, LANCET, V2, P829, DOI 10.1016/S0140-6736(85)90812-8; GRIFFISS JM, 1991, T R SOC TROP MED S1, V85, pS32; Grothaus MC, 2000, VACCINE, V18, P1253, DOI 10.1016/S0264-410X(99)00390-4; Halsey NA, 1997, PEDIATRICS, V99, P289, DOI 10.1542/peds.99.2.289; Haneberg B, 1998, INFECT IMMUN, V66, P1334, DOI 10.1128/IAI.66.4.1334-1341.1998; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; KOPPES GM, 1977, AM J MED, V62, P661, DOI 10.1016/0002-9343(77)90867-1; Leach A, 1997, J INFECT DIS, V175, P200, DOI 10.1093/infdis/175.1.200; Lepow M. L, 1999, VACCINES, P711; LEPOW ML, 1986, J INFECT DIS, V154, P1033, DOI 10.1093/infdis/154.6.1033; MacLennan J, 2001, J INFECT DIS, V183, P97, DOI 10.1086/317667; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; MILLER MA, 1979, JAMA-J AM MED ASSOC, V242, P1656, DOI 10.1001/jama.242.15.1656; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Mosleh IM, 1998, J BIOL CHEM, V273, P35332, DOI 10.1074/jbc.273.52.35332; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; PECOUL B, 1991, LANCET, V338, P862, DOI 10.1016/0140-6736(91)91511-R; PEREZTRALLERO E, 1990, LANCET, V335, P1096, DOI 10.1016/0140-6736(90)92668-8; Perkins BA, 2000, JAMA-J AM MED ASSOC, V283, P2842, DOI 10.1001/jama.283.21.2842; Pettersson A, 1997, ANTON LEEUW INT J G, V71, P129, DOI 10.1023/A:1000179301748; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Popovic T, 2000, EMERG INFECT DIS, V6, P428, DOI 10.3201/eid0604.000423; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; Quagliarello VJ, 1997, NEW ENGL J MED, V336, P708, DOI 10.1056/NEJM199703063361007; Racoosin JA, 1998, JAMA-J AM MED ASSOC, V280, P2094, DOI 10.1001/jama.280.24.2094; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; REINGOLD AL, 1985, LANCET, V2, P114; Rosenstein N, 1998, JAMA-J AM MED ASSOC, V279, P435, DOI 10.1001/jama.279.6.435; Rosenstein NE, 2000, PEDIATR CLIN N AM, V47, P337, DOI 10.1016/S0031-3955(05)70210-8; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Sacchi CT, 2000, J INFECT DIS, V182, P1169, DOI 10.1086/315833; SCHAAD UB, 1980, REV INFECT DIS, V2, P880; SCHEIFELE DW, 1994, CAN MED ASSOC J, V150, P14; SCHWARTZ B, 1989, CLIN MICROBIOL REV, V2, pS118, DOI 10.1128/CMR.2.Suppl.S118-S124.1989; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; SMILACK JD, 1974, ANN INTERN MED, V81, P740, DOI 10.7326/0003-4819-81-6-740; STEPHENS DS, 1983, J INFECT DIS, V148, P369, DOI 10.1093/infdis/148.3.369; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Stephens DS, 1999, LANCET, V353, P941, DOI 10.1016/S0140-6736(98)00279-7; SULLIVAN A, 2000, INT C EM INF DIS ATL, P143; SUTCLIFFE EM, 1988, LANCET, V1, P657; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; TAUNAY A E, 1978, Revista do Instituto Adolfo Lutz, V38, P77; Tondella MLC, 2000, J CLIN MICROBIOL, V38, P3323, DOI 10.1128/JCM.38.9.3323-3328.2000; TURNER PC, 1990, LANCET, V335, P732, DOI 10.1016/0140-6736(90)90852-V; TWUMASI PA, 1995, J INFECT DIS, V171, P632, DOI 10.1093/infdis/171.3.632; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Weichselbaum A, 1887, FORTSCHR MED, V5, P573; *WHO WORK GROUP, 1995, WHO PRAC GUID; WOODS CR, 1994, J INFECT DIS, V170, P453, DOI 10.1093/infdis/170.2.453; WOODS CR, 1998, 38 ANN M INF DIS SOC, P99; Wylie PAL, 1997, BRIT MED J, V315, P774, DOI 10.1136/bmj.315.7111.774; YAGUPSKY P, 1993, LANCET, V341, P1152, DOI 10.1016/0140-6736(93)93171-V; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102; ZANGWILL KM, 1994, J INFECT DIS, V169, P847, DOI 10.1093/infdis/169.4.847; ZOLLINGER W D, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P211; Zollinger WD, 1997, MANUAL CLIN LAB IMMU, P473; 1995, MMWR MORB MORTAL WKL, V44, P121	108	866	944	0	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1378	1388		10.1056/NEJM200105033441807	http://dx.doi.org/10.1056/NEJM200105033441807			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333996				2022-12-28	WOS:000168413500007
J	Biesecker, LG				Biesecker, LG			The multifaceted challenges of Proteus syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY THROMBOEMBOLISM; MOSAICISM	Proteus syndrome is a rare and sporadic disorder that causes postnatal overgrowth of multiple tissues in a mosaic pattern. The overgrowth can involve skin, subcutaneous tissue, connective tissue (including bone), the central nervous system, and viscera, Complications of Proteus syndrome include, among others, progressive skeletal deformities, invasive lipomas, benign and malignant tumors, and deep venous thrombosis with pulmonary embolism. Care of patients with Proteus syndrome presents significant challenges to both physicians and parents because of the various medical as well as psychosocial consequences of the disease, Herein, the case of a 5-year-otd patient who manifested a number of these complications is presented. Current knowledge about the diagnosis, natural history, etiology, and management of the disorder is reviewed.	NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bldg 49,Room 4A80, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Biesecker, Leslie/AAG-2526-2021					Biesecker LG, 1998, AM J MED GENET, V79, P311, DOI 10.1002/(SICI)1096-8628(19981002)79:4<311::AID-AJMG14>3.0.CO;2-U; Biesecker LG, 1999, AM J MED GENET, V84, P389, DOI 10.1002/(SICI)1096-8628(19990611)84:5<389::AID-AJMG1>3.0.CO;2-O; Cohen M.M., 1986, P GREENWOOD GENETIC, V6, P187; COHEN MM, 1989, ADV HUM GENET, V18, P181; COHEN MM, 1993, AM J MED GENET, V47, P645, DOI 10.1002/ajmg.1320470514; COHEN MM, 1979, BIRTH DEFECTS-ORIG, P291; EBERHARD DA, 1994, PEDIATR PATHOL, V14, P771, DOI 10.3109/15513819409037674; GORDON PL, 1995, AM J MED GENET, V57, P74, DOI 10.1002/ajmg.1320570117; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; HOWELL M, 1980, TRUE HIST ELEPHANT M, P211; Peters K F, 2000, J Genet Couns, V9, P161, DOI 10.1023/A:1009416126631; SKOVBY F, 1993, AM J MED GENET, V47, P656, DOI 10.1002/ajmg.1320470516; Slavotinek AM, 2000, CLIN GENET, V58, P386, DOI 10.1034/j.1399-0004.2000.580509.x; Treves F., 1885, T PATHOL SOC LOND, V36, P494; WIEDEMANN HR, 1983, EUR J PEDIATR, V140, P5, DOI 10.1007/BF00661895	15	59	64	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2240	2243		10.1001/jama.285.17.2240	http://dx.doi.org/10.1001/jama.285.17.2240			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325326				2022-12-28	WOS:000168256100027
J	Hogan, CM; Hammer, SM				Hogan, CM; Hammer, SM			Host determinants in HIV infection and disease part 1: Cellular and humoral immune responses	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTE; SEXUALLY-TRANSMITTED-DISEASES; AUTOLOGOUS NEUTRALIZING ANTIBODY; COMBINATION ANTIRETROVIRAL THERAPY; SYNCYTIUM-INDUCING PHENOTYPE; BLOOD MONONUCLEAR-CELLS; LONG-TERM SURVIVORS; DYNAMICS IN-VIVO; DENDRITIC CELLS	The course of HIV infection varies widely among individuals. Long-term nonprogressors or slow progressors may remain asymptomatic and have normal CD4 counts despite more than a decade of untreated HIV infection, In contrast, rapid progressors develop AIDS within 5 years. In addition, some persons remain uninfected despite repeated exposure to HIV, Immunologic and genetic studies of long-term nonprogressors and exposed yet uninfected persons, as well as data from studies of primary HIV infection, have helped to elucidate the mechanisms by which some persons are protected from HIV acquisition or have slow rates of disease progression, This review (the first of two parts) describes what is currently known about host factors in HIV-1 infection. Studies for inclusion were identified by a systematic search of PubMed for English-language literature published from 1988 through June 2000. Abstracts of presentations at major meetings convened in 2000 were also included if appropriate. Growing evidence suggests a crucial role of cytotoxic T cells and T-helper cells in controlling viremia, slowing disease progression, and perhaps preventing establishment of infection. Humoral and mucosal immunity, soluble inhibitory factors, the cytokine milieu, and concomitant infections also affect outcome. Genetic host factors, such as inheritance of mutant chemokine receptors or certain HLA types, affect susceptibility to infection and subsequent clinical course. The role of cellular and humoral immunity, mucosal immunity, and other local factors in determining the course of HIV infection is discussed.	Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA	Columbia University	Hogan, CM (corresponding author), Columbia Univ Coll Phys & Surg, Div Infect Dis, P&S Box 82,630 W 168th St, New York, NY 10032 USA.	ch358@columbia.edu			NIAID NIH HHS [AI48013, AI46386, 5P30AI42848-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI048013, P30AI042848, U01AI046386] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Artenstein AW, 1997, J INFECT DIS, V175, P265, DOI 10.1093/infdis/175.2.265; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Ayehunie S, 1997, BLOOD, V90, P1379, DOI 10.1182/blood.V90.4.1379.1379_1379_1386; BARCELLINI W, 1995, AIDS, V9, P691, DOI 10.1097/00002030-199507000-00004; Barker E, 1998, BLOOD, V92, P3105, DOI 10.1182/blood.V92.9.3105.421k46_3105_3114; Baum LL, 1996, J IMMUNOL, V157, P2168; Beretta A, 1996, IMMUNOL LETT, V51, P39, DOI 10.1016/0165-2478(96)02553-9; Bernard NF, 1999, J INFECT DIS, V179, P538, DOI 10.1086/314621; Bjorndal A, 1997, J VIROL, V71, P7478; Blauvelt A, 1997, J CLIN INVEST, V100, P2043, DOI 10.1172/JCI119737; BOND K, 2000, 7 C RETR OPP INF SAN; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Cameron P, 1996, J LEUKOCYTE BIOL, V59, P158, DOI 10.1002/jlb.59.2.158; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLARK SJ, 1991, NEW ENGL J MED, V324, P954, DOI 10.1056/NEJM199104043241404; CLERICI M, 1994, JAMA-J AM MED ASSOC, V271, P42, DOI 10.1001/jama.271.1.42; CLERICI M, 1992, J INFECT DIS, V165, P1012, DOI 10.1093/infdis/165.6.1012; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Connick E, 1996, AIDS RES HUM RETROV, V12, P1129, DOI 10.1089/aid.1996.12.1129; CONNOR RI, 1994, J VIROL, V68, P4400, DOI 10.1128/JVI.68.7.4400-4408.1994; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; Connors M, 1997, NAT MED, V3, P533, DOI 10.1038/nm0597-533; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; DALGLEISH A, 1990, CLIN EXP IMMUNOL, V81, P5, DOI 10.1111/j.1365-2249.1990.tb05283.x; Dalod M, 1999, J VIROL, V73, P7108, DOI 10.1128/JVI.73.9.7108-7116.1999; Del Amo J, 1998, AIDS, V12, P1203, DOI 10.1097/00002030-199810000-00013; DEMARIA A, 1994, J INFECT DIS, V170, P1296, DOI 10.1093/infdis/170.5.1296; Dybul M, 2000, J IMMUNOL, V165, P1685, DOI 10.4049/jimmunol.165.3.1685; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Essex M, 1999, ADV VIRUS RES, V53, P71, DOI 10.1016/S0065-3527(08)60343-7; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Galai N, 1997, LANCET, V349, P180, DOI 10.1016/S0140-6736(05)60982-8; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Goh WC, 1999, J INFECT DIS, V179, P548, DOI 10.1086/314632; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; Greenough TC, 1999, NEW ENGL J MED, V340, P236, DOI 10.1056/NEJM199901213400314; Greenough TC, 1997, J INFECT DIS, V176, P118, DOI 10.1086/514013; GURTLER LG, 1994, J VIROL, V68, P1581; Haigwood N L, 1998, AIDS, V12 Suppl A, pS121; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Harrer T, 1996, J IMMUNOL, V156, P2616; Hay CM, 1999, J VIROL, V73, P5509, DOI 10.1128/JVI.73.7.5509-5519.1999; Haynes WL, 1996, OPHTHALMIC SURG LAS, V27, P324; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Hildreth JEK, 1999, CLIN IMMUNOL, V90, P203, DOI 10.1006/clim.1998.4624; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hu DJ, 1999, AIDS, V13, P873, DOI 10.1097/00002030-199905280-00002; Hu DJ, 1996, JAMA-J AM MED ASSOC, V275, P210, DOI 10.1001/jama.275.3.210; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; HUSSON RN, 1995, J PEDIATR-US, V126, P865, DOI 10.1016/S0022-3476(95)70198-2; Janssens W, 1997, AIDS, V11, P705, DOI 10.1097/00002030-199706000-00002; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnson R P, 1998, AIDS, V12 Suppl A, pS113; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321; Kimata JT, 1999, NAT MED, V5, P535, DOI 10.1038/8414; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KLIKS SC, 1994, JAMA-J AM MED ASSOC, V272, P467, DOI 10.1001/jama.272.6.467; Knight SC, 1996, AIDS, V10, P807, DOI 10.1097/00002030-199607000-00003; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuhn L, 2001, AIDS, V15, P1, DOI 10.1097/00002030-200101050-00003; Kumar A, 2001, VIROLOGY, V279, P97, DOI 10.1006/viro.2000.0710; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LANGLADEDEMOYEN P, 1994, J CLIN INVEST, V93, P1293, DOI 10.1172/JCI117085; Lathey JL, 1999, J INFECT DIS, V180, P344, DOI 10.1086/314886; Lathey JL, 1997, J INFECT DIS, V175, P231, DOI 10.1093/infdis/175.1.231; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; LEARMONT J, 1992, LANCET, V340, P863, DOI 10.1016/0140-6736(92)93281-Q; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; LIFSON AR, 1991, J INFECT DIS, V163, P959, DOI 10.1093/infdis/163.5.959; Loomis-Price LD, 1998, J INFECT DIS, V178, P1306, DOI 10.1086/314436; LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003; LOUWAGIE J, 1995, J VIROL, V69, P263, DOI 10.1128/JVI.69.1.263-271.1995; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mabondzo A, 1998, J ACQ IMMUN DEF SYND, V17, P92, DOI 10.1097/00042560-199801010-00015; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McCutchan FE, 1996, AIDS, V10, pS13; McKinney DM, 1999, J IMMUNOL, V163, P861; MEHENDALE SM, 1995, J INFECT DIS, V172, P1486, DOI 10.1093/infdis/172.6.1486; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MICHAEL NL, 1995, J VIROL, V69, P4228, DOI 10.1128/JVI.69.7.4228-4236.1995; Miedema F, 1996, SCIENCE, V272, P505, DOI 10.1126/science.272.5261.505; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; Mittler JE, 1999, AIDS, V13, P1415, DOI 10.1097/00002030-199907300-00023; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Moog C, 1997, J VIROL, V71, P3734, DOI 10.1128/JVI.71.5.3734-3741.1997; MUNOZ A, 1995, J ACQ IMMUN DEF SYND, V8, P496, DOI 10.1097/00042560-199504120-00010; Murray MCM, 2000, J INFECT DIS, V181, P746, DOI 10.1086/315252; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Musey L, 1997, J EXP MED, V185, P293, DOI 10.1084/jem.185.2.293; Musey LK, 1999, J INFECT DIS, V180, P278, DOI 10.1086/314868; Nielsen K, 1996, J INFECT DIS, V173, P1001, DOI 10.1093/infdis/173.4.1001; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P9848, DOI 10.1073/pnas.94.18.9848; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; PINTO LA, 1995, J CLIN INVEST, V96, P867, DOI 10.1172/JCI118133; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Plummer FA, 1998, AIDS RES HUM RETROV, V14, pS5; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Reinhart TA, 1997, NAT MED, V3, P218, DOI 10.1038/nm0297-218; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; RINALDO C, 1995, J VIROL, V69, P5838, DOI 10.1128/JVI.69.9.5838-5842.1995; ROOK AH, 1987, J IMMUNOL, V138, P1064; ROOS MTL, 1992, J INFECT DIS, V165, P427, DOI 10.1093/infdis/165.3.427; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1998, AIDS RES HUM RETROV, V14, pS143; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; SCHACKLETT BL, 2000, 7 C RETR OPP INF SAN; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SHEPPARD HW, 1993, AIDS, V7, P1159, DOI 10.1097/00002030-199309000-00002; Shioda T, 1997, J VIROL, V71, P4871, DOI 10.1128/JVI.71.7.4871-4881.1997; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504; SotoRamirez LE, 1996, SCIENCE, V271, P1291, DOI 10.1126/science.271.5253.1291; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Steinman RM, 2000, CELL, V100, P491, DOI 10.1016/S0092-8674(00)80684-4; Stranford SA, 1999, P NATL ACAD SCI USA, V96, P1030, DOI 10.1073/pnas.96.3.1030; Sullivan BL, 1996, J IMMUNOL, V157, P1791; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; TERSMETTE M, 1989, LANCET, V1, P983; VALENTIN A, 1994, J VIROL, V68, P6684, DOI 10.1128/JVI.68.10.6684-6689.1994; Valentine FT, 1998, AIDS RES HUM RETROV, V14, pS161; VANDENHAESEVELDE M, 1994, J VIROL, V68, P1586, DOI 10.1128/JVI.68.3.1586-1596.1994; Vernazza PL, 1997, J ACQ IMMUN DEF SYND, V14, P295; Virelizier J L, 1998, AIDS, V12 Suppl A, pS141; Wang B, 2000, AIDS, V14, P213, DOI 10.1097/00002030-200002180-00002; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yoshino N, 1998, ACTA PAEDIATR JAPON, V40, P503; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zaunders JJ, 1999, J INFECT DIS, V180, P320, DOI 10.1086/314880; Zhang LQ, 1999, J VIROL, V73, P855, DOI 10.1128/JVI.73.1.855-860.1999; Zhang YJ, 1997, J INFECT DIS, V176, P1180, DOI 10.1086/514111; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; Zoeteweij JP, 1998, J BIOMED SCI, V5, P253, DOI 10.1007/BF02255856	188	85	97	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					761	776		10.7326/0003-4819-134-9_Part_1-200105010-00013	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00013			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329234				2022-12-28	WOS:000168470700006
J	Kroenke, K				Kroenke, K			Studying symptoms: Sampling and measurement issues	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC-FATIGUE-SYNDROME; QUALITY-OF-LIFE; PRIMARY-CARE; PSYCHIATRIC-DISORDERS; COMMON SYMPTOMS; HEALTH-STATUS; CLINICAL PREDICTORS; PHYSICAL COMPLAINTS; MEDICAL PATIENTS; PRIME-MD	Physical symptoms account for more than half of all outpatient visits, but the specific causes and treatments of many common symptoms are frequently not well established. Because clinical research has primarily targeted specific diseases, symptoms-based research is still an emerging field of scientific inquiry, and optimal methods are still being developed, This paper considers eight important issues in sampling and measurement. First, recognition of the exceptionally high base rates of many symptoms is an essential primary step in selecting appropriate case-patients and controls. Second, the type of population studied (community, primary care clinic, subspecialty clinic, or symptom clinic) can greatly influence the severity and other characteristics of the symptom being evaluated. Third, symptom detection relies on three types of symptoms: documented, elicited, and volunteered. Fourth, temporal factors include recency of onset, episodicity, and duration. Fifth, severity can be assessed with single- or multiple-item symptom-specific scales as well as evaluation of generic functional status and health-related quality-of-life measures. Sixth, recognition of a symptom's cause can be strengthened by explicit criteria, uniform assessment protocols, and multiple raters. Seventh, comorbidity that should be assessed includes medical disorders, psychiatric disorders, and other symptoms. And eighth, since death and serious illness are uncommon, alternative outcomes that might be measured include symptom alleviation, health-related quality of life, patient and provider satisfaction, and health care costs.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, RG-6,1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org	anand, amit/A-7222-2009	Kroenke, Kurt/0000-0002-0114-4669				[Anonymous], 1991, Arch Intern Med, V151, P1413; BANKS MH, 1975, INT J EPIDEMIOL, V4, P189, DOI 10.1093/ije/4.3.189; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; BARSKY AJ, 1995, JAMA-J AM MED ASSOC, V274, P1931, DOI 10.1001/jama.274.24.1931; BASS C, 1990, SOMATIZATION PHYSICA; BAUM A, 1984, SOCIAL PSYCHOL ASPEC; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bigos S., 1994, ACUTE LOW BACK PROBL; CAHILL GF, 1974, NEW ENGL J MED, V291, P905, DOI 10.1056/NEJM197410242911712; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P202, DOI 10.1136/jnnp.68.2.202; CATHEBRAS PJ, 1992, J GEN INTERN MED, V7, P276, DOI 10.1007/BF02598083; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Ciccone DS, 1996, PAIN, V68, P329, DOI 10.1016/S0304-3959(96)03216-2; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DONOVAN LE, 1995, ARCH INTERN MED, V155, P181, DOI 10.1001/archinte.155.2.181; DROSSMAN DA, 1995, ANN INTERN MED, V123, P688, DOI 10.7326/0003-4819-123-9-199511010-00008; Drossman DA, 1999, AM J GASTROENTEROL, V94, P2803, DOI 10.1111/j.1572-0241.1999.02803.x; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; EISENBERG L, 1980, AM J MED, V69, P277, DOI 10.1016/0002-9343(80)90389-7; ESCOBAR JI, 1989, J NERV MENT DIS, V177, P140, DOI 10.1097/00005053-198903000-00003; FEINSTEIN AR, 1983, ANN INTERN MED, V99, P843, DOI 10.7326/0003-4819-99-6-843; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Frank-Stromborg M., 1997, INSTRUMENTS CLIN HLT; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GUYATT GH, 1989, J GEN INTERN MED, V4, P101, DOI 10.1007/BF02602348; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477; HAMMOND EC, 1964, AM J PUBLIC HEALTH N, V54, P11, DOI 10.2105/AJPH.54.1.11; IMBODEN JB, 1959, ARCH INTERN MED, V103, P406, DOI 10.1001/archinte.1959.00270030037004; Jackson JL, 1999, ARCH INTERN MED, V159, P1069, DOI 10.1001/archinte.159.10.1069; Jackson JL, 2001, ANN INTERN MED, V134, P889, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00013; Jackson JL, 1997, MIL MED, V162, P273, DOI 10.1093/milmed/162.4.273; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; KATON W, 1991, AM J PSYCHIAT, V148, P34; Kellner R, 1991, PSYCHOSOMATIC SYNDRO; Khan AA, 2000, J GEN INTERN MED, V15, P76; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Kravitz RL, 2001, ANN INTERN MED, V134, P881, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00012; Kroenke K, 1998, PSYCHOSOMATICS, V39, P263, DOI 10.1016/S0033-3182(98)71343-X; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; KROENKE K, 1993, J GEN INTERN MED, V8, P530, DOI 10.1007/BF02599633; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; KROENKE K, 1988, JAMA-J AM MED ASSOC, V260, P929, DOI 10.1001/jama.260.7.929; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; KROENKE K, 1992, AM J MED, V92, pS3, DOI 10.1016/0002-9343(92)90129-Y; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; Kroenke K, 2000, SOUTH MED J, V93, P160; KROENKE K, 1994, J GEN INTERN MED, V9, P684, DOI 10.1007/BF02599010; Kroenke K, 1997, J GEN INTERN MED, V12, P509, DOI 10.1046/j.1525-1497.1997.00092.x; Lazarus R., 1986, ILLNESS BEHAV, P303, DOI [10.1007/978-1-4684-5257-0_21, DOI 10.1007/978-1-4684-5257-0_21]; LIN EHB, 1991, J GEN INTERN MED, V6, P241, DOI 10.1007/BF02598969; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Manu P., 1998, FUNCTIONAL SOMATIC S; Marple RL, 1997, ARCH INTERN MED, V157, P1482, DOI 10.1001/archinte.157.13.1482; McDowell I., 1996, MEASURING HLTH GUIDE; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; MECHANIC D, 1980, J HEALTH SOC BEHAV, V21, P146, DOI 10.2307/2136734; MECHANIC D, 1982, SYMPTOMS ILLNESS BEH; MERLIN TL, 1986, HUM PATHOL, V17, P2, DOI 10.1016/S0046-8177(86)80149-6; Mumford E, 1983, MED SOCIOLOGY PATIEN; O'Malley PG, 1998, J PSYCHOSOM RES, V44, P279, DOI 10.1016/S0022-3999(97)00250-X; O'Malley PG, 1998, ARCH INTERN MED, V158, P2357, DOI 10.1001/archinte.158.21.2357; PENNEBAKER JW, 1982, PSYCHOL PHYSICAL SYM; QUILL TE, 1988, J GEN INTERN MED, V3, P267, DOI 10.1007/BF02596343; REIDENBERG MM, 1968, NEW ENGL J MED, V279, P678, DOI 10.1056/NEJM196809262791304; Rochon PA, 1996, MED CARE, V34, P1093, DOI 10.1097/00005650-199611000-00004; SCHATZ RT, 1992, POLIT PSYCHOL, V13, P1, DOI 10.2307/3791421; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Sigal LH, 1996, ARCH INTERN MED, V156, P1493, DOI 10.1001/archinte.156.14.1493; Simon G, 1996, PSYCHOSOM MED, V58, P481, DOI 10.1097/00006842-199609000-00010; SIMON GE, 1991, AM J PSYCHIAT, V148, P1494; Speckens AEM, 1996, PSYCHOL MED, V26, P745, DOI 10.1017/S0033291700037764; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; STEERE AC, 1993, JAMA-J AM MED ASSOC, V269, P1812, DOI 10.1001/jama.269.14.1812; Stewart AL, 1992, MEASURING FUNCTIONIN; SULLIVAN M, 1993, ARCH INTERN MED, V153, P1479, DOI 10.1001/archinte.153.12.1479; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008; VONKORFF M, 1993, SPINE, V18, P855, DOI 10.1097/00007632-199306000-00008; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; ZOLA IK, 1966, AM SOCIOL REV, V31, P615, DOI 10.2307/2091854; [No title captured]	93	135	140	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			844	853		10.7326/0003-4819-134-9_Part_2-200105011-00008	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346320				2022-12-28	WOS:000168543100008
J	Marteau, TM; Lerman, CY				Marteau, TM; Lerman, CY			Genetic risk and behavioural change	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; TRANSPORTER GENE; FAMILY-HISTORY; HEART-DISEASE; SMOKING; SUSCEPTIBILITY; ASSOCIATION; IMPACT; WOMEN; SURVEILLANCE		Kings Coll London, GKT Med Sch, Psychol & Genet Res Grp, London SE1 9RT, England; Georgetown Univ, Med Ctr, Washington, DC 20007 USA	University of London; King's College London; Georgetown University	Marteau, TM (corresponding author), Kings Coll London, GKT Med Sch, Psychol & Genet Res Grp, Thomas Guy House, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk		Marteau, Theresa/0000-0003-3025-1129	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMOS CI, 1992, CANCER EPIDEM BIOMAR, V1, P505; ARMITAGE CJ, IN PRESS BR J SOC PS; Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; BECKER DM, 1987, AM J PREV MED, V3, P45; Bratt O, 2000, EUR J CANCER, V36, P235, DOI 10.1016/S0959-8049(99)00272-5; Clavel-Chapelon F, 1999, PREV MED, V28, P174, DOI 10.1006/pmed.1998.0397; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; CROYLE RT, 1995, PSYCHOSOCIAL EFFECTS; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; HOLLON SD, 1994, HDB PSYCHOTHERAPY BE; Hu S, 2000, MOL PSYCHIATR, V5, P181, DOI 10.1038/sj.mp.4000690; Hunt K, 2000, HEALTH EDUC RES, V15, P131, DOI 10.1093/her/15.2.131; HUNT K, IN PRESS UNDERSTANDI; Jepson R, 2000, 3 MRC SOC PUBL HLTH; Jepson R, 2000, HLTH TECHNOL ASSESS, V4; Jorm AF, 2000, AM J MED GENET, V96, P331, DOI 10.1002/1096-8628(20000612)96:3<331::AID-AJMG19>3.0.CO;2-0; Kastelein JJP, 2000, BMJ-BRIT MED J, V321, P1483, DOI 10.1136/bmj.321.7275.1483; Kinney AY, 2000, AM J PREV MED, V18, P249, DOI 10.1016/S0749-3797(99)00162-2; KJOURNY MJ, 2000, GENETICS PUBLIC HLTH; Kok G, 1997, PATIENT EDUC COUNS, V30, P19, DOI 10.1016/S0738-3991(96)00953-6; Lerman C, 1997, HEALTH PSYCHOL, V16, P87, DOI 10.1037/0278-6133.16.1.87; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; Leventhal H, 1997, PERCEPTIONS HLTH ILL; Levitt M, 1999, BRIT MED J, V319, P1283, DOI 10.1136/bmj.319.7220.1283; Marteau TM, 1998, BMJ-BRIT MED J, V316, P693, DOI 10.1136/bmj.316.7132.693; MARTEAU TM, 2001, 99PRT6; McKinney EF, 2000, PHARMACOGENETICS, V10, P483, DOI 10.1097/00008571-200008000-00001; Meiser B, 2000, BREAST CANCER RES TR, V59, P101, DOI 10.1023/A:1006330631832; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Orbell S, 1998, BRIT J SOC PSYCHOL, V37, P151, DOI 10.1111/j.2044-8309.1998.tb01162.x; OSCARSON M, 1999, LANCET, V353, P898; Pianezza ML, 1998, NATURE, V393, P750, DOI 10.1038/31623; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Schwartz MD, 1999, AM J PUBLIC HEALTH, V89, P924, DOI 10.2105/AJPH.89.6.924; Senior V, 1999, PSYCHOL HEALTH, V14, P1077, DOI 10.1080/08870440008407368; Senior V, 1999, SOC SCI MED, V48, P1857, DOI 10.1016/S0277-9536(99)00099-4; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; Sutton S, 1998, J APPL SOC PSYCHOL, V28, P1317, DOI 10.1111/j.1559-1816.1998.tb01679.x; Tilanus-Linthorst MMA, 2000, EUR J CANCER, V36, P514, DOI 10.1016/S0959-8049(99)00337-8; Vasen HFA, 1998, CANCER, V82, P1632, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1632::AID-CNCR6>3.3.CO;2-X; Waterworth DM, 2000, ARTERIOSCL THROM VAS, V20, P2663, DOI 10.1161/01.ATV.20.12.2663	44	238	240	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2001	322	7293					1056	1059		10.1136/bmj.322.7293.1056	http://dx.doi.org/10.1136/bmj.322.7293.1056			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	428UA	11325776	Green Published			2022-12-28	WOS:000168478700031
J	Zachos, J; Pagani, M; Sloan, L; Thomas, E; Billups, K				Zachos, J; Pagani, M; Sloan, L; Thomas, E; Billups, K			Trends, rhythms, and aberrations in global climate 65 Ma to present	SCIENCE			English	Review							PALEOCENE THERMAL MAXIMUM; ANTARCTIC ICE-SHEET; ATMOSPHERIC CARBON-DIOXIDE; STABLE-ISOTOPE; SOUTHERN-OCEAN; SEDIMENTOLOGICAL EVIDENCE; ASTRONOMICAL CALIBRATION; MASSIVE DISSOCIATION; EOCENE TRANSITION; MIOCENE OXYGEN	Since 65 million years ago (Ma), Earth's climate has undergone a significant and complex evolution, the finer details of which are now coming to light through investigations of deep-sea sediment cores. This evolution includes gradual trends of warming and cooling driven by tectonic processes on time scales of 10(5) to 10(7) years, rhythmic or periodic cycles driven by orbital processes with 10(4)- to 10(6)-year cyclicity, and rare rapid aberrant shifts and extreme climate transients with durations of 10(3) to 10(5) years. Here, recent progress in defining the evolution of global climate over the Cenozoic Era is reviewed. We focus primarily on the periodic and anomalous components of variability over the early portion of this era, as constrained by the latest generation of deep-sea isotope records. We also consider how this improved perspective has led to the recognition of previously unforeseen mechanisms for altering climate.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; Yale Univ, Ctr Study Global Change, New Haven, CT 06520 USA; Univ Delaware, Coll Marine Studies, Lewes, DE 19958 USA	University of California System; University of California Santa Cruz; Wesleyan University; Yale University; University of Delaware	Zachos, J (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA.	jzachos@es.ucsc.edu	Zachos, James C/A-7674-2008; Pagani, Mark/B-3233-2008; Thomas, Ellen/E-5573-2011	Zachos, James C/0000-0001-8439-1886; Thomas, Ellen/0000-0002-7141-9904				Alroy J, 2000, PALEOBIOLOGY, V26, P259, DOI 10.1666/0094-8373(2000)26[259:GCCANA]2.0.CO;2; Bains S, 2000, NATURE, V407, P171, DOI 10.1038/35025035; Bains S, 1999, SCIENCE, V285, P724, DOI 10.1126/science.285.5428.724; Baldauf JG., 1992, EOCENE OLIGOCENE CLI, P310; Barker PF, 1999, PALAEOGEOGR PALAEOCL, V150, P247, DOI 10.1016/S0031-0182(98)00224-7; BARRERA E, 1991, P OC DRILL PROGR KER, V119, P736; BARRETT PJ, 1992, NATURE, V359, P816, DOI 10.1038/359816a0; BARRON EJ, 1991, PALAEOGEOGR PALAEOCL, V83, P1, DOI 10.1016/0031-0182(91)90073-Z; Bartek LR, 1996, MAR GEOL, V130, P79, DOI 10.1016/0025-3227(95)00121-2; Beard KC, 1999, B SOC GEOL FR, V170, P697; Beerling DJ, 1998, J GEOL SOC LONDON, V155, P591, DOI 10.1144/gsjgs.155.4.0591; Beerling DJ, 2000, PALAEOGEOGR PALAEOCL, V161, P395, DOI 10.1016/S0031-0182(00)00095-X; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Billups K, 1998, PALEOCEANOGRAPHY, V13, P459, DOI 10.1029/98PA02262; Bralower TJ, 1997, GEOLOGY, V25, P963, DOI 10.1130/0091-7613(1997)025<0963:HRROTL>2.3.CO;2; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Clemens SC, 1997, NATURE, V385, P801, DOI 10.1038/385801a0; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; CORFIELD RM, 1994, EARTH-SCI REV, V37, P225, DOI 10.1016/0012-8252(94)90030-2; CRAMER B, IN PRESS EARTH PLANE; Crouch EM, 2001, GEOLOGY, V29, P315, DOI 10.1130/0091-7613(2001)029<0315:GDEAWT>2.0.CO;2; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; CROWLEY TJ, 1992, SCIENCE, V255, P705, DOI 10.1126/science.255.5045.705; CROWLEY TJ, 1998, TECTONIC BOUNDARY CO, V39; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickens GR, 2000, B SOC GEOL FR, V171, P37; DiesterHaass L, 1996, GEOLOGY, V24, P163, DOI 10.1130/0091-7613(1996)024<0163:EOTITS>2.3.CO;2; Dingle RV, 1998, J S AM EARTH SCI, V11, P571, DOI 10.1016/S0895-9811(98)00035-2; DITCHFIELD PW, 1994, PALAEOGEOGR PALAEOCL, V107, P79, DOI 10.1016/0031-0182(94)90166-X; Driscoll NW, 1998, SCIENCE, V282, P436, DOI 10.1126/science.282.5388.436; EDINGER EN, 1994, PALAIOS, V9, P576, DOI 10.2307/3515129; Ehrmann W, 1998, PALAEOGEOGR PALAEOCL, V139, P213, DOI 10.1016/S0031-0182(97)00138-7; EHRMANN WU, 1992, PALAEOGEOGR PALAEOCL, V93, P85, DOI 10.1016/0031-0182(92)90185-8; EMILIANI C, 1953, NATURE, V171, P887, DOI 10.1038/171887c0; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; FLOWER BP, 1995, PALEOCEANOGRAPHY, V10, P1095, DOI 10.1029/95PA02022; Fordyce R. Ewan, 2000, American Paleontologist, V8, P2; FRANCIS JE, 1988, ARCTIC, V41, P314, DOI 10.14430/arctic1738; Gibson TG, 2000, SEDIMENT GEOL, V134, P65, DOI 10.1016/S0037-0738(00)00014-2; HAMBREY MJ, 1991, P OCEAN DRILLING PRO, V0119; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Herbert TD, 1997, P NATL ACAD SCI USA, V94, P8362, DOI 10.1073/pnas.94.16.8362; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Kaiho K, 1996, PALEOCEANOGRAPHY, V11, P447, DOI 10.1029/96PA01021; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Kelly DC, 1996, GEOLOGY, V24, P423; Kennett J.P., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P937; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1995, PALAEOGEOGR PALAEOCL, V115, P61, DOI 10.1016/0031-0182(94)00107-J; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Kump L. R., 1997, TECTONIC UPLIFT CLIM, P399, DOI [DOI 10.1007/978-1-4615-5935-1, DOI 10.1007/978-1-4615-5935-1_18]; KUTZBACH JE, 1993, J GEOL, V101, P177, DOI 10.1086/648215; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; LAWVER LA, 1998, TECTONIC BOUNDARY CO, V39, P212; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Lourens LJ, 1997, QUATERN INT, V40, P43, DOI 10.1016/S1040-6182(96)00060-2; Lu GY, 1998, ECLOGAE GEOL HELV, V91, P293; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; MATTHEWS RK, 1981, AAPG BULL, V65, P954; Mikolajewicz U, 1997, PALEOCEANOGRAPHY, V12, P429, DOI 10.1029/96PA03542; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; MILLER KG, 1987, MICROPALEONTOLOGY, V33, P97, DOI 10.2307/1485489; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P371, DOI 10.2973/odp.proc.sr.138.120.1995; Mudelsee M, 1997, GEOL RUNDSCH, V86, P499, DOI 10.1007/s005310050157; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pisias NG, 1990, PALEOCEANOGRAPHY, V5, P147, DOI 10.1029/PA005i002p00147; Poore RZ, 1996, MAR MICROPALEONTOL, V27, P1, DOI 10.1016/0377-8398(96)80628-1; PROTHERO DR, 1992, LATE EOCENEOLIGOCENE; RAYMO M, 1992, EARTH PLANET SC LETT, V97, P353; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; ROBERT C, 1992, MAR GEOL, V103, P99, DOI 10.1016/0025-3227(92)90010-F; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Ruddiman W. F., 1997, TECTONIC UPLIFT CLIM; RUDDIMAN WF, 1981, SCIENCE, V212, P617, DOI 10.1126/science.212.4495.617; RUDDIMAN WF, 1986, EARTH PLANET SC LETT, V80, P117, DOI 10.1016/0012-821X(86)90024-5; Ruddiman WF, 1997, TECTONIC UPLIFT CLIM, P20; Salamy KA, 1999, PALAEOGEOGR PALAEOCL, V145, P61, DOI 10.1016/S0031-0182(98)00093-5; SAVIN SM, 1975, GEOL SOC AM BULL, V86, P1499, DOI 10.1130/0016-7606(1975)86<1499:TMP>2.0.CO;2; Schmitz B, 1997, PALAEOGEOGR PALAEOCL, V133, P49, DOI 10.1016/S0031-0182(97)00024-2; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton N.J., 1987, MARINE PETROLEUM SOU, V26, P423, DOI [DOI 10.1144/GSL.SP.1987.026.01.27, 10.1144/GSL.SP.1987.026.01.27]; Shackleton N.J., 1975, INITIAL REPORTS DEEP, V29, P743, DOI [DOI 10.2973/DSDP.PROC.29.117.1975, 10.2973/DSDP.PROC.29.117.1975]; Shackleton NJ, 1999, PHILOS T R SOC A, V357, P1907, DOI 10.1098/rsta.1999.0407; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; SHACKLETON NJ, 1988, PHILOS T ROY SOC B, V318, P679, DOI 10.1098/rstb.1988.0030; SHACKLETON NJ, 1997, P OCEAN DRILL PROGRA, V154, P367, DOI DOI 10.2973/0DP.PR0C.SR.154.119.1997; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; SLOAN LC, 1992, NATURE, V357, P320, DOI 10.1038/357320a0; Stott L.D., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P849, DOI 10.2973/odp.proc.sr.113.187.1990; THIEDE J, 1994, MAR GEOL, V119, P179, DOI 10.1016/0025-3227(94)90180-5; Thomas DJ, 1999, PALEOCEANOGRAPHY, V14, P561, DOI 10.1029/1999PA900031; Thomas E, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P214; THOMAS E, 1996, CORRELATION EARLY PA, V247, P481; Thomas Ellen, 2000, P132; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; VINCENT E, 1985, GEOL SOC AM MEM, V163, P103; WING SL, 1995, PALAEOGEOGR PALAEOCL, V115, P117, DOI 10.1016/0031-0182(94)00109-L; Wise Sherwood W., 1991, CONTROVERSIES MODERN; WOLFE JA, 1994, CENOZOIC CLIMATE PAL; Wright JD, 1992, PALEOCEANOGRAPHY, V7, P357, DOI 10.1029/92PA00760; WRIGHT JD, 1993, ANTAR RES S, V60, P1; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2; Zachos JC, 2000, GFF, V122, P188, DOI 10.1080/11035890001221188; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1997, NATURE, V388, P567, DOI 10.1038/41528; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	120	7051	7588	149	3445	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					686	693		10.1126/science.1059412	http://dx.doi.org/10.1126/science.1059412			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326091	Green Submitted			2022-12-28	WOS:000168478300041
J	Obsil, T; Ghirlando, R; Klein, DC; Ganguly, S; Dyda, F				Obsil, T; Ghirlando, R; Klein, DC; Ganguly, S; Dyda, F			Crystal structure of the 14-3-35 zeta : serotonin N-acetyltransferase complex: A role for scaffolding in enzyme regulation	CELL			English	Article							MULTIPLE SIGNALING PATHWAYS; 14-3-3 PROTEIN; SERINE PHOSPHORYLATION; MELATONIN PRODUCTION; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; CELL-SURVIVAL; BRAIN 14-3-3; PINEAL-GLAND; ZETA-ISOFORM	Serotonin N-acetyltransferase (AANAT) controls the daily rhythm in melatonin synthesis. When isolated from tissue, AANAT copurifies with isoforms epsilon and zeta of 14-3-3. We have determined the structure of AANAT bound to 14-3-3 zeta, an association that is phosphorylation dependent. AANAT is bound in the central channel of the 14-3-3 zeta dimer, and is held in place by extensive interactions both with the amphipathic phosphopeptide binding groove of 14-3-3 zeta and with other parts of the central channel. Thermodynamic and activity measurements, together with crystallographic analysis, indicate that binding of AANAT by 14-3-3 zeta modulates AANAT's activity and affinity for its substrates by stabilizing a region of AANAT involved in substrate binding.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dyda, F (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	dyda@ulti.niddk.nih.gov	Ghirlando, Rodolfo/A-8880-2009; Obsil, Tomas/B-7142-2012	Obsil, Tomas/0000-0003-4602-1272; Ganguly, Surajit/0000-0002-1876-9147; Klein, David/0000-0002-1792-5806	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000095, Z01HD000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036122] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Arendt J., 1995, MELATONIN MAMMALIAN; Banik U, 1997, J BIOL CHEM, V272, P26219, DOI 10.1074/jbc.272.42.26219; BIJMA K, 1994, LANGMUIR, V10, P2578, DOI 10.1021/la00020a015; BOSTON PF, 1982, J NEUROCHEM, V38, P1466, DOI 10.1111/j.1471-4159.1982.tb07927.x; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; HINZ HJ, 1983, ANNU REV BIOPHYS BIO, V12, P285, DOI 10.1146/annurev.bb.12.060183.001441; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 1998, HDB BEHAV STATE CONT, P45; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; MacNicol MC, 2000, J BIOL CHEM, V275, P3803, DOI 10.1074/jbc.275.6.3803; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NAMBOODIRI MAA, 1985, COMP BIOCHEM PHYS B, V80, P731, DOI 10.1016/0305-0491(85)90453-5; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1994, DNA CELL BIOL, V13, P629, DOI 10.1089/dna.1994.13.629; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P8567, DOI 10.1021/bi970484k; TANJI M, 1994, J NEUROCHEM, V63, P1908; THIBAULT C, 1993, J NEUROCHEM, V61, P332, DOI 10.1111/j.1471-4159.1993.tb03572.x; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tronrud DE, 1996, J APPL CRYSTALLOGR, V29, P100, DOI 10.1107/S002188989501421X; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; [No title captured]	53	317	326	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					257	267		10.1016/S0092-8674(01)00316-6	http://dx.doi.org/10.1016/S0092-8674(01)00316-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336675	Bronze			2022-12-28	WOS:000168384300012
J	Shamah, SM; Lin, MZ; Goldberg, JL; Estrach, S; Sahin, M; Hu, L; Bazalakova, M; Neve, RL; Corfas, G; Debant, A; Greenberg, ME				Shamah, SM; Lin, MZ; Goldberg, JL; Estrach, S; Sahin, M; Hu, L; Bazalakova, M; Neve, RL; Corfas, G; Debant, A; Greenberg, ME			EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin	CELL			English	Article							TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; EMBRYONIC-DEVELOPMENT; FOCAL COMPLEXES; CELL-ADHESION; RHO; PROTEINS; FAMILY; RAC; ACTIVATION	Eph receptors transduce short-range repulsive signals for axon guidance by modulating actin dynamics within growth cones. We report the cloning and characterization of ephexin, a novel Eph receptor-interacting protein that is a member of the Dbl family of guanine nucleotide exchange factors (GEFs) for Rho GTPases. Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes. In addition, expression of a mutant form of ephexin in primary neurons interferes with ephrin-A-induced growth cone collapse. The association of ephexin with Eph receptors constitutes a molecular link between Eph receptors and the actin cytoskeleton and provides a novel mechanism for achieving highly localized regulation of growth cone motility.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Stanford Univ, Dept Neurol, SUMC, Stanford, CA 94305 USA; Ctr Rech Biochim Macromol, CNRS, UPR 1086, F-34293 Montpellier 5, France; McLean Hosp, Belmont, MA 02478 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Harvard University; McLean Hospital	Greenberg, ME (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	greenberg@a1.tch.harvard.edu	SAHIN, MUSTAFA/I-8653-2019; Estrach, Soline/D-4226-2017; Estrach, Soline/GYA-4499-2022; Corfas, Gabriel/AAH-2378-2020	SAHIN, MUSTAFA/0000-0001-7044-2953; Corfas, Gabriel/0000-0001-5412-9473; estrach, soline/0000-0003-2088-5988; Lin, Michael/0000-0002-0492-1961; Bazalakova, Mihaela/0000-0002-1718-3320; Goldberg, Jeffrey/0000-0002-1390-7360	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884, R01NS045500] Funding Source: NIH RePORTER; NCI NIH HHS [CA43855] Funding Source: Medline; NEI NIH HHS [R01 EY11310] Funding Source: Medline; NICHD NIH HHS [1K08HD01384, HD18655] Funding Source: Medline; NINDS NIH HHS [NS10070-02, R01 NS045500, R01 NS35884] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BECKER N, 1995, FEBS LETT, V368, P353, DOI 10.1016/0014-5793(95)00652-P; Blangy A, 2000, J CELL SCI, V113, P729; CHAN AML, 1994, ONCOGENE, V9, P1057; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FINLEY RL, 1996, DNA CLONING EXPRESSI, P169; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MORI T, 1995, MOL BRAIN RES, V29, P325, DOI 10.1016/0169-328X(94)00263-E; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rodrigues NR, 2000, GENOMICS, V65, P53, DOI 10.1006/geno.2000.6138; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SHU HKG, 1994, MOL CELL BIOL, V14, P6868, DOI 10.1128/MCB.14.10.6868; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Wyszynski M, 1999, Methods Enzymol, V294, P371; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936	36	428	448	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					233	244		10.1016/S0092-8674(01)00314-2	http://dx.doi.org/10.1016/S0092-8674(01)00314-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336673	Bronze			2022-12-28	WOS:000168384300010
J	Weinberger, DR				Weinberger, DR			Anxiety at the frontier of molecular medicine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECEPTOR		NIMH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Weinberger, DR (corresponding author), NIMH, Bethesda, MD 20892 USA.							Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Whalen PJ, 1998, J NEUROSCI, V18, P411	6	52	54	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1247	1249		10.1056/NEJM200104193441612	http://dx.doi.org/10.1056/NEJM200104193441612			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309643				2022-12-28	WOS:000168127600012
J	Kubo, S; Nishiguchi, S; Hirohashi, K; Tanaka, H; Shuto, T; Yamazaki, O; Shiomi, S; Tamori, A; Oka, H; Igawa, S; Kuroki, T; Kinoshita, H				Kubo, S; Nishiguchi, S; Hirohashi, K; Tanaka, H; Shuto, T; Yamazaki, O; Shiomi, S; Tamori, A; Oka, H; Igawa, S; Kuroki, T; Kinoshita, H			Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; CIRRHOTIC-PATIENTS; CARCINOGENESIS	Background: Interferon therapy decreases the incidence of hepatocellular carcinoma in patients with chronic hepatitis C. Objective: To evaluate effects of interferon-alpha on recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. Design: Randomized. controlled trial. Setting: University hospital, medical center, and affiliated hospital in Osaka, Japan. Patients: 30 men were randomly allocated after resection to the interferon-alpha group (n = 15) or the control group (n = 15). Intervention: Patients in the interferon-alpha group received interferon-alpha, 6 MIU intramuscularly daily for 2 weeks, then three times weekly for 14 weeks, and finally twice weekly for 88 weeks. Measurements: Recurrence rates after resection. Results: Recurrent tumors were detected in 5 patients in the interferon-alpha group and in 12 control patients. The recurrence rate was significantly lower in the interferon-alpha group than in the control group (P = 0.037). Conclusion: Postoperative interferon-alpha therapy appears to decrease recurrence after resection of hepatitis C virus-related hepatocellular carcinoma.	Osaka City Univ, Osaka City Gen Hosp, Sch Med, Osaka 558, Japan; Joto Cent Hosp, Osaka, Japan	Osaka City General Hospital; Osaka Metropolitan University	Nishiguchi, S (corresponding author), Osaka City Univ, Sch Med, Dept Internal Med 3, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	snishiguch@med.osaka-cu.ac.jp						Brunetto MR, 1998, LANCET, V351, P1535; Chen MF, 1998, SURGERY, V123, P554, DOI 10.1067/msy.1998.87237; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Ko S, 1996, ANN SURG, V224, P591, DOI 10.1097/00000658-199611000-00001; Kubo S, 1999, JPN J CANCER RES, V90, P162, DOI 10.1111/j.1349-7006.1999.tb00729.x; Kubo S, 1999, HEPATO-GASTROENTEROL, V46, P3212; Kubo S, 2000, WORLD J SURG, V24, P1559, DOI 10.1007/s002680010277; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; SHERLOCK S, 1994, GUT, V35, P828, DOI 10.1136/gut.35.6.828; Shirabe K, 1996, CANCER, V77, P1050, DOI 10.1002/(SICI)1097-0142(19960315)77:6<1050::AID-CNCR7>3.0.CO;2-L; Shiratori Y, 1999, HEPATOLOGY, V29, P1573, DOI 10.1002/hep.510290529; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; TAKENAKA K, 1995, HEPATOLOGY, V22, P20, DOI 10.1002/hep.1840220104; Tarao K, 1997, CANCER, V79, P688, DOI 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	20	226	233	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					963	967		10.7326/0003-4819-134-10-200105150-00010	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352697				2022-12-28	WOS:000168682500004
J	Dargie, HJ; Colucci, Y; Ford, I; Sendon, JLL; Remme, W; Sharpe, N; Blank, A; Holcslaw, TL				Dargie, HJ; Colucci, Y; Ford, I; Sendon, JLL; Remme, W; Sharpe, N; Blank, A; Holcslaw, TL			Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial	LANCET			English	Article							HEART-FAILURE; BETA-BLOCKADE; MORTALITY; MORBIDITY; BLOCKERS; SURVIVAL	Background The beneficial effects of beta -blockers on longterm outcome after acute myocardial infarction were shown before the introduction of thrombolysis and angiotensin-converting-enzyme (ACE) inhibitors. Generally, the patients recruited to these trials were at low risk: few had heart failure, and none had measurements of left-ventricular function taken. We investigated the long-term efficacy of carvedilol on morbidity and mortality in patients with left-ventricular dysfunction after acute myocardial infarction treated according to current evidence-based practice. Methods In a multicentre, randomised, placebo-controlled trial, 1959 patients with a proven acute myocardial infarction and a left-ventricular ejection fraction of less than or equal to 40% were randomly assigned 6.25 mg carvedilol (n = 975) or placebo (n = 984). Study medication was progressively increased to a maximum of 25 mg twice daily during the next 4-6 weeks, and patients were followed up until the requisite number of primary endpoints had occurred. The primary endpoint was all-cause mortality or hospital admission for cardiovascular problems. Analysis was by intention to treat. Findings Although there was no difference between the carvedilol and placebo groups in the number of patients with the primary endpoint (340 [35%] vs 367 [37%], hazard ratio 0.92 [95% CI 0.80-1.07]), all-cause mortality alone was lower in the carvedilol group than in the placebo group (116 [12%] vs 151 [15%], 0.77 [0.60-0.98], p = 0.03). Cardiovascular mortality, non-fatal myocardial infarctions, and all-cause mortality or non-fatal myocardial infarction were also lower on carvedilol than on placebo. Interpretation In patients treated long-term after an acute myocardial infarction complicated by left-ventricular systolic dysfunction, carvedilol reduced the frequency of all-cause and cardiovascular mortality, and recurrent, non-fatal myocardial infarctions. These beneficial effects are additional to those of evidence-based treatments for acute myocardial infarction including ACE inhibitors.	Western Infirm, Dept Cardiol, Glasgow G11 2NT, Lanark, Scotland		Dargie, HJ (corresponding author), Western Infirm, Dept Cardiol, Glasgow G11 2NT, Lanark, Scotland.		Ford, Ian/ABE-6145-2020					BALL SG, 1993, LANCET, V342, P821; Dargie HJ, 2000, EUR J HEART FAIL, V2, P325, DOI 10.1016/S1388-9842(00)00098-2; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Hjalmarson A, 1999, LANCET, V353, P2001; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lechat P, 1999, LANCET, V353, P9; MacMahon S, 1997, LANCET, V349, P375; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Spargias KS, 1999, HEART, V81, P25, DOI 10.1136/hrt.81.1.25; Vantrimpont P, 1997, J AM COLL CARDIOL, V29, P229, DOI 10.1016/S0735-1097(96)00489-5; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	17	1155	1217	0	25	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1385	1390		10.1016/s0140-6736(00)04560-8	http://dx.doi.org/10.1016/s0140-6736(00)04560-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356434				2022-12-28	WOS:000168478200008
J	Mulrow, CD; Pignone, M				Mulrow, CD; Pignone, M			Evidence based management of hypertension - What are the elements of good treatment for hypertension?	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELEVATED BLOOD-PRESSURE; RANDOMIZED-TRIAL; DOUBLE-BLIND; ANTIHYPERTENSIVE THERAPIES; CARDIOVASCULAR MORBIDITY; 1ST-LINE DRUG; BETA-BLOCKERS; MORTALITY; METAANALYSIS; ENALAPRIL		Univ N Carolina, Chapel Hill, NC 27599 USA; Univ Texas, Div Gen Internal Med, San Antonio, TX 78249 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System	Pignone, M (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	pignone@med.unc.edu		Pignone, Michael/0000-0002-6657-7342				BETO JA, 1992, AM J HYPERTENS, V5, P125, DOI 10.1093/ajh/5.3.125; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; Cutler JA, 1998, NEW ENGL J MED, V338, P679, DOI 10.1056/NEJM199803053381009; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Grossman E, 1999, AM J CARDIOL, V83, P1090; Gueyffier F, 1996, J HUM HYPERTENS, V10, P1; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; MATERSON BJ, 1994, NEW ENGL J MED, V330, P1689, DOI 10.1056/NEJM199406093302316; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; MULROW C, 2001, EVIDENCE BASED HYPER, P81; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; Philipp T, 1997, BMJ-BRIT MED J, V315, P154, DOI 10.1136/bmj.315.7101.154; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Quan A, 1999, J GEN INTERN MED, V14, P718, DOI 10.1046/j.1525-1497.1999.12198.x; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BRIT MED J, V317, P713; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Wright JM, 1999, CAN MED ASSOC J, V161, P25; Wright JM, 2000, CAN MED ASSOC J, V163, P188; Wright JM, 2000, CAN MED ASSOC J, V163, P57; Yusuf S, 2000, NEW ENGL J MED, V342, P145	27	17	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2001	322	7294					1107	1109		10.1136/bmj.322.7294.1107	http://dx.doi.org/10.1136/bmj.322.7294.1107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337444	Green Published			2022-12-28	WOS:000168628300027
J	Porter, K; Pillay, D; Cane, P; Dean, G; Churchill, D; Baily, G; Drake, S; Fisher, M				Porter, K; Pillay, D; Cane, P; Dean, G; Churchill, D; Baily, G; Drake, S; Fisher, M		UK Collaborative Grp Monitoring Tr	Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article								Objectives To identify changes since 1994 in the prevalence of resistance to anti-HIV drugs in primary HIV-1 infections in the United Kingdom. Design Retrospective and prospective assessment of viruses obtained from people recently infected with HIV. Setting Multiple centres (patients enrolled in the UK register of seroconverters) and a single large HIV clinic (active case ascertainment). Participants 69 patients infected with HN between June 1994 and August 2000. Main outcome measures Prevalence of key mutations associated with drug resistance in the reverse transcriptase and protease genes of HIV-1, by year of infection. Results Between June 1994 and August 2000, 10 (14%) of 69 newly infected patients had one or more key HIV-1 mutations associated with drug resistance. The risk of being infected with drug resistant virus increased over time (adjusted relative risk per year 1.74 (95% confidence interval 0.93 to 3.27), P = 0.06). The estimated prevalence of drug resistance in those infected in 2000 was 27% (12% to 48%). Conclusions Transmission of drug resistant HIV-1 in the United Kingdom seems to be increasing. New approaches to encourage safer sexual behaviour in all sectors of the population are urgently needed.	Univ Birmingham, Sch Med, Div Immun & Infect, PHLS Antiviral Susceptibil Reference Unit, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Pillay, D (corresponding author), Univ Birmingham, Sch Med, Div Immun & Infect, PHLS Antiviral Susceptibil Reference Unit, Birmingham B15 2TT, W Midlands, England.		Churchill, Duncan/AAT-5441-2020	Porter, Kholoud/0000-0002-9226-6206				Beral V, 1998, AIDS, V12, P659; de Ronde A, 2001, J VIROL, V75, P595, DOI 10.1128/JVI.75.2.595-602.2001; Dodds JP, 2000, BRIT MED J, V320, P1510, DOI 10.1136/bmj.320.7248.1510; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pillay D, 2000, AIDS, V14, P906, DOI 10.1097/00002030-200005050-00025; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; 2000, COMMUNICABLE DIS REP, V10, P37	8	138	141	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1087	1088						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337435	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000168628300016
J	Scatena, LF; Brown, MG; Richmond, GL				Scatena, LF; Brown, MG; Richmond, GL			Water at hydrophobic surfaces: Weak hydrogen bonding and strong orientation effects	SCIENCE			English	Article							LIQUID-LIQUID INTERFACE; ISOTOPIC DILUTION; SIMULATION; DYNAMICS; SPECTRA; SPECTROSCOPY; HYDRATION; MOLECULES; SOLVENTS; RANGE	Vibrational studies that selectively probe molecular structure at CCl4/H2O and hydrocarbon/H2O interfaces show that the hydrogen bonding between adjacent water molecules at these interfaces is weak, in contrast to generally accepted models of water next to fluid hydrophobic surfaces that suggest strong hydrogen bonding. However, interactions between these water molecules and the organic phase result in substantial orientation of these weakly hydrogen-bonded water molecules in the interfacial region. The results have important implications for understanding water adjacent to hydrophobic surfaces and the penetration of water into hydrophobic phases.	Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon	Richmond, GL (corresponding author), Univ Oregon, Dept Chem, Eugene, OR 97403 USA.							BENJAMIN I, 1992, J CHEM PHYS, V97, P1432, DOI 10.1063/1.463219; Brown MG, 2000, J PHYS CHEM A, V104, P10220, DOI 10.1021/jp0010942; Chang TM, 1996, J CHEM PHYS, V104, P6772, DOI 10.1063/1.471344; COKER DF, 1985, J CHEM PHYS, V82, P3554, DOI 10.1063/1.448935; CONRAD MP, 1987, J PHYS CHEM-US, V91, P1668, DOI 10.1021/j100290a075; DEVLIN JP, 1989, J CHEM PHYS, V90, P1322, DOI 10.1063/1.456127; DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Garde S, 1996, PHYS REV LETT, V77, P4966, DOI 10.1103/PhysRevLett.77.4966; Gragson DE, 1998, J PHYS CHEM B, V102, P569, DOI 10.1021/jp972444w; Gragson DE, 1998, J AM CHEM SOC, V120, P366, DOI 10.1021/ja972570d; GREEN JL, 1986, CHEM PHYS LETT, V130, P67, DOI 10.1016/0009-2614(86)80427-4; HIROSE C, 1992, APPL SPECTROSC, V46, P1051, DOI 10.1366/0003702924124385; Hummer G, 1998, J PHYS CHEM B, V102, P10469, DOI 10.1021/jp982873+; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; LEE SH, 1994, J CHEM PHYS, V100, P3334, DOI 10.1063/1.466425; LINSE P, 1987, J CHEM PHYS, V86, P4177, DOI 10.1063/1.451877; Lobau J, 1997, J OPT SOC AM B, V14, P2505, DOI 10.1364/JOSAB.14.002505; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Scherer J R, 1978, VIBRATIONAL SPECTROS; WALL TT, 1965, J CHEM PHYS, V43, P2079, DOI 10.1063/1.1697078; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; ZOIDIS E, 1995, J MOL LIQ, V64, P197, DOI 10.1016/0167-7322(95)00816-S	24	793	794	14	375	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					908	912		10.1126/science.1059514	http://dx.doi.org/10.1126/science.1059514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340199				2022-12-28	WOS:000168514900037
J	Stewart, FH; Harper, CC; Ellertson, CE; Grimes, DA; Sawaya, GF; Trussell, J				Stewart, FH; Harper, CC; Ellertson, CE; Grimes, DA; Sawaya, GF; Trussell, J			Clinical breast and pelvic examination requirements for hormonal contraception - Current practice vs evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL-CONTRACEPTIVES; RISK-FACTORS; ADOLESCENTS; CANCER	Clinical breast and pelvic examinations are commonly accepted practices prior to provision of hormonal contraception. Such examinations, however, may reduce access to highly effective contraceptive methods, and may therefore increase women's overall health risks, These unnecessary requirements also involve ethical considerations and unwittingly reinforce the widely held but incorrect perception that hormonal contraceptive methods are dangerous. This article reviews and summarizes the relevant medical literature and policy statements from major organizations active in the field of contraception. Consensus developed during the last decade supports a change in practice: hormonal contraception can safely be provided based on careful review of medical history and blood pressure measurement. For most women, no further evaluation is necessary. Pelvic and breast examinations and screening for cervical neoplasia and sexually transmitted infection, while important in their own right, do not provide information necessary for identifying women who should avoid hormonal contraceptives or who need further evaluation before making a decision about their use.	Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Hlth Res & Policy, San Francisco, CA 94143 USA; Populat Council, Mexico City, DF, Mexico; Family Hlth Int, Res Triangle Pk, NC 27709 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Off Populat Res, Princeton, NJ 08544 USA	University of California System; University of California San Francisco; Princeton University	Stewart, FH (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Hlth Res & Policy, 3333 Calif St,Suite 335, San Francisco, CA 94143 USA.	FStear@itsa.ucsf.edu						Abma J C, 1997, Vital Health Stat 23, P1; *AM COLL OBST GYN, 1996, GUID WOM HLTH CAR; *AM COLL OBST GYN, 1994, TECHN B HORM CONTR, V198; American College of Obstetricians and Gynecologists, 1999, OR CONTR AD BEN SAF; [Anonymous], ICRU REP S; ARMSTRONG KA, 1994, J ADOLESCENT HEALTH, V15, P389, DOI 10.1016/1054-139X(94)90262-3; Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Bombard AT, 1996, CLIN OBSTET GYNECOL, V39, P860, DOI 10.1097/00003081-199612000-00013; BRINTON LA, 1991, CONTRACEPTION, V43, P581, DOI 10.1016/0010-7824(91)90005-Z; BRINTON LA, 1990, INT J EPIDEMIOL, V19, P4, DOI 10.1093/ije/19.1.4; Brown S.S., 1995, BEST INTENTIONS UNIN; Chiaffarino F, 1999, BRIT J OBSTET GYNAEC, V106, P857, DOI 10.1111/j.1471-0528.1999.tb08409.x; Chiaffarino F, 1998, CONTRACEPTION, V57, P11, DOI 10.1016/S0010-7824(97)00201-1; Darney PD, 1999, AM J OBSTET GYNECOL, V180, P929, DOI 10.1016/S0002-9378(99)70664-2; *FAC FAM PLANN REP, 2000, BR J FAM PLANN, V26, P27; *FDA, 1994, LAB GUID TEXT COMB O; *FDA, 2001, LAB GUID TEXT PROG O; Finer LB, 1998, FAM PLANN PERSPECT, V30, P30, DOI 10.2307/2991523; FRYE CA, 1994, WOMEN HEALTH, V21, P33, DOI 10.1300/J013v21n01_03; GROVER SR, 1995, MED J AUSTRALIA, V162, P408, DOI 10.5694/j.1326-5377.1995.tb139967.x; Hannaford PC, 1996, CONTRACEPTION, V54, P125, DOI 10.1016/S0010-7824(96)00167-9; Harper C, 2001, FAM PLANN PERSPECT, V33, P13, DOI 10.2307/2673737; HATCHER RA, 1998, CONTRACEPTIVE TECHNO; HILDESHEIM A, 1990, INT J CANCER, V45, P860, DOI 10.1002/ijc.2910450513; *INT MED ADV PAN, 1995, IPPF MED B, V29, P1; JONES CJ, 1990, CANCER RES, V50, P3657; Kaunitz AM, 1999, CONTRACEPTION, V59, p29S, DOI 10.1016/S0010-7824(98)00135-8; KJAER SK, 1993, CANCER CAUSE CONTROL, V4, P513, DOI 10.1007/BF00052426; LARSEN SB, 1995, ACTA OBSTET GYN SCAN, V74, P137, DOI 10.3109/00016349509008923; *MED EC CO INC, 1999, PHYS DESK REF; MILLSTEIN SG, 1984, J ADOLESCENT HEALTH, V5, P105, DOI 10.1016/S0197-0070(84)80008-X; NEGRINI BP, 1990, CANCER RES, V50, P4670; *NEW YORK PLANN PA, 1999, MAN MED STAND GUID H; PERKINS C, 1996, CANC INCIDENCE MORTA; RIES LAG, 1997, SEER CANC STAT REV 1; SAWAYA G, IN PRESS CONTRACEPTI; Schachter J, 1996, NEW ENGL J MED, V335, P1847, DOI 10.1056/NEJM199612123352417; Shafer MAB, 1998, J ADOLESCENT HEALTH, V23, P68, DOI 10.1016/S1054-139X(98)00066-4; *SOC OBST GYN CAN, 2001, CAN CONS C CONTR TOR; Thompson S D, 1998, Lippincotts Prim Care Pract, V2, P244; Trussell J, 1997, FAM PLANN PERSPECT, V29, P248, DOI 10.2307/2953412; URSIN G, 1994, LANCET, V344, P1390, DOI 10.1016/S0140-6736(94)90567-3; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; *WHO, 2000, MED EL CRIT IN CONT; *WHO US AG INT DEV, 1994, REC UPD SEL PRACT CO, V1; World Health Organization, 1996, IMPR ACC QUAL CAR FA; Zabin LS, 1996, JAMA-J AM MED ASSOC, V275, P113, DOI 10.1001/jama.275.2.113; 1993, CONTRACEPT REP, V4, P4	48	127	127	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2232	2239		10.1001/jama.285.17.2232	http://dx.doi.org/10.1001/jama.285.17.2232			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325325				2022-12-28	WOS:000168256100026
J	Yung, RC; Orens, JB				Yung, RC; Orens, JB			Radicalism in therapy of lung cancer	LANCET			English	Editorial Material							BRONCHOGENIC-CARCINOMA; CT; MANAGEMENT		Johns Hopkins Univ, Dept Med & Oncol, Baltimore, MD 21208 USA; Johns Hopkins Univ, Dept Pulm & Crit Care Med, Baltimore, MD 21208 USA	Johns Hopkins University; Johns Hopkins University	Orens, JB (corresponding author), Johns Hopkins Univ, Dept Med & Oncol, Baltimore, MD 21208 USA.							*AM CANC SOC, 1998, CANC FACTS FIG, P1; COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; Dietlein M, 2000, EUR J NUCL MED, V27, P1598, DOI 10.1007/s002590000376; Fountain SW, 2001, THORAX, V56, P89; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Jett James, 1997, American Journal of Respiratory and Critical Care Medicine, V156, P320; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; Lowe VJ, 1998, ANN THORAC SURG, V65, P1821, DOI 10.1016/S0003-4975(98)00106-4; MCLOUD TC, 1992, RADIOLOGY, V182, P319, DOI 10.1148/radiology.182.2.1732943; MOUNTAIN CF, 1997, CHEST, V111, P1701; *NAT COMPR CANC NE, 2000, COMPL LIB NCCN ONC P, V1; Ost D, 2000, AM J RESP CRIT CARE, V162, P782, DOI 10.1164/ajrccm.162.3.9812152; Pisters KMW, 2000, J THORAC CARDIOV SUR, V119, P429, DOI 10.1016/S0022-5223(00)70120-6; TOCKMAN MS, 1985, LUNG CANC; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P135; WANG KP, 1983, AM REV RESPIR DIS, V127, P344	16	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1306	1307		10.1016/S0140-6736(00)04526-8	http://dx.doi.org/10.1016/S0140-6736(00)04526-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343729				2022-12-28	WOS:000168411400003
J	Remskar, M; Mrzel, A; Skraba, Z; Jesih, A; Ceh, M; Demsar, J; Stadelmann, P; Levy, F; Mihailovic, D				Remskar, M; Mrzel, A; Skraba, Z; Jesih, A; Ceh, M; Demsar, J; Stadelmann, P; Levy, F; Mihailovic, D			Self-assembly of subnanometer-diameter single-wall MoS2 nanotubes	SCIENCE			English	Article							NANOPARTICLES; WS2	We report on the synthesis, structure, and self-assembly of single-wall subnanometer-diameter molybdenum disulfide tubes, The nanotubes are up to hundreds of micrometers Long and display diverse self-assembly properties on different Length scales, ranging from twisted bundles to regularly shaped "furry" forms. The bundles, which contain interstitial iodine, can be readily disassembled into individual 'molybdenum disulfide nanotubes. The synthesis was performed using a novel type of catalyzed transport reaction including C-60 as a growth promoter.	Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia; Ecole Polytech Fed Lausanne, Ctr Electron Microscopy, CIME, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Inst Appl Phys, CH-1015 Lausanne, Switzerland	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Remskar, M (corresponding author), Jozef Stefan Inst, Jamova 39, SI-1000 Ljubljana, Slovenia.	maja.remskar@ijs.si	Demsar, Jure/F-7243-2016; Mihailovic, Dragan/H-6753-2014; Jesih, Adolf/A-1831-2008; Demsar, Jure/B-5578-2008	Mihailovic, Dragan/0000-0003-2074-2899; Demsar, Jure/0000-0003-4551-7444; Remskar, Maja/0000-0002-8919-1768				BACHTOLD A, 1999, NATURE, V389, P582; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Chhowalla M, 2000, NATURE, V407, P164, DOI 10.1038/35025020; CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966; Cote M, 1998, PHYS REV B, V58, pR4277, DOI 10.1103/PhysRevB.58.R4277; DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Golan Y, 1999, ADV MATER, V11, P934, DOI 10.1002/(SICI)1521-4095(199908)11:11<934::AID-ADMA934>3.0.CO;2-L; Hacohen YR, 1998, NATURE, V395, P336, DOI 10.1038/26380; Hu WB, 2000, APPL PHYS A-MATER, V70, P231, DOI 10.1007/s003390050039; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; MARGULIS L, 1993, NATURE, V365, P113, DOI 10.1038/365113b0; Remskar M, 1999, APPL PHYS LETT, V74, P3633, DOI 10.1063/1.123205; Remskar M, 1996, APPL PHYS LETT, V69, P351, DOI 10.1063/1.118057; Remskar M, 1998, ADV MATER, V10, P246, DOI 10.1002/(SICI)1521-4095(199802)10:3<246::AID-ADMA246>3.0.CO;2-6; Seifert G, 2000, PHYS REV LETT, V85, P146, DOI 10.1103/PhysRevLett.85.146; Seifert G, 2000, SOLID STATE COMMUN, V115, P635, DOI 10.1016/S0038-1098(00)00264-7; TENNE R, 1992, NATURE, V360, P444, DOI 10.1038/360444a0; Tenne R, 1998, CHEM MATER, V10, P3225, DOI 10.1021/cm9802189; Terrones M, 1996, CHEM PHYS LETT, V259, P568, DOI 10.1016/0009-2614(96)00773-7; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Zak A, 2000, J AM CHEM SOC, V122, P11108, DOI 10.1021/ja002181a	23	484	514	6	541	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					479	481		10.1126/science.1059011	http://dx.doi.org/10.1126/science.1059011			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313488				2022-12-28	WOS:000168187300039
J	Veverka, J; Thomas, PC; Robinson, M; Murchie, S; Chapman, C; Bell, M; Harch, A; Merline, WJ; Bell, JF; Bussey, B; Carcich, B; Cheng, A; Clark, B; Domingue, D; Dunham, D; Farquhar, R; Gaffey, MJ; Hawkins, E; Izenberg, N; Joseph, J; Kirk, R; Li, H; Lucey, P; Malin, M; McFadden, L; Miller, JK; Owen, WM; Peterson, C; Prockter, L; Warren, J; Wellnitz, D; Williams, BG; Yeomans, DK				Veverka, J; Thomas, PC; Robinson, M; Murchie, S; Chapman, C; Bell, M; Harch, A; Merline, WJ; Bell, JF; Bussey, B; Carcich, B; Cheng, A; Clark, B; Domingue, D; Dunham, D; Farquhar, R; Gaffey, MJ; Hawkins, E; Izenberg, N; Joseph, J; Kirk, R; Li, H; Lucey, P; Malin, M; McFadden, L; Miller, JK; Owen, WM; Peterson, C; Prockter, L; Warren, J; Wellnitz, D; Williams, BG; Yeomans, DK			Imaging of small-scale features on 433 Eros from NEAR: Evidence for a complex regolith	SCIENCE			English	Article							MULTISPECTRAL IMAGER; EJECTA BLOCKS; GROOVES	On 25 October 2000, the Near Earth Asteroid Rendevous (NEAR)-Shoemaker spacecraft executed a low-altitude flyover of asteroid 433 Eros, making it possible to image the surface at a resolution of about 1 meter per pixel. The Images reveal an evolved surface distinguished by an abundance of ejecta blocks, a dearth of small craters, and smooth material infilling some topographic lows. The subdued appearance of craters of different diameters and the variety of blocks and different degrees of their burial suggest that ejecta from several impact events blanketed the region imaged at closest approach and led to the building up of a substantial and complex regolith consisting of fine materials and abundant meter-sized blocks.	Cornell Univ, Ithaca, NY 14853 USA; Northwestern Univ, Dept Geol Sci, Evanston, IL 60208 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; SW Res Inst, Boulder, CO 80302 USA; Rensselaer Polytech Inst, Ctr Sci, Dept Earth & Environm Sci, Troy, NY 12180 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Cornell University; Northwestern University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Rensselaer Polytechnic Institute; United States Department of the Interior; United States Geological Survey; University of Hawaii System; University System of Maryland; University of Maryland College Park; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Veverka, J (corresponding author), Cornell Univ, Space Sci Bldg, Ithaca, NY 14853 USA.		Izenberg, Noam R/F-3952-2015; McFadden, Lucy-Ann/I-4902-2013; Wellnitz, Dennis/B-4080-2012; Murchie, Scott L/E-8030-2015; Dunham, David W/A-5214-2014	Izenberg, Noam R/0000-0003-1629-6478; McFadden, Lucy-Ann/0000-0002-0537-9975; Murchie, Scott L/0000-0002-1616-8751; Dunham, David W/0000-0001-7527-4207				CHENG AF, IN PRESS ICARUS; GOLD T, 1955, MON NOT R ASTRON SOC, V115, P585, DOI 10.1093/mnras/115.6.585; Hawkins SE, 1997, SPACE SCI REV, V82, P31, DOI 10.1023/A:1005099211710; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; Lee P, 1996, ICARUS, V120, P87, DOI 10.1006/icar.1996.0039; LINDSAY JF, 1976, LUNAR STRATIGRAPHY S; Michel P, 1998, ASTRON J, V116, P2023, DOI 10.1086/300562; Murchie S, 1999, ICARUS, V140, P66, DOI 10.1006/icar.1999.6118; MURCHIE S, IN PRESS ICARUS; NEUKUM G, 1975, MOON PLANETS, V12, P201, DOI 10.1007/BF00577878; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; QUAIDE WL, 1968, J GEOPHYS RES, V73, P5247, DOI 10.1029/JB073i016p05247; Schultz P. H., 1976, MOON MORPHOLOGY; SCHULTZ PH, 1975, P LUN SCI C, V6, P2862; Sullivan R, 1996, ICARUS, V120, P119, DOI 10.1006/icar.1996.0041; THOMAS P, 1980, ICARUS, V42, P234, DOI 10.1016/0019-1035(80)90073-1; THOMAS P, 1979, ICARUS, V40, P394, DOI 10.1016/0019-1035(79)90032-0; Thomas PC, 2000, J GEOPHYS RES-PLANET, V105, P15091, DOI 10.1029/1999JE001204; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; VEVERKA J, 1994, ICARUS, V107, P72, DOI 10.1006/icar.1994.1007; Veverka J, 1997, J GEOPHYS RES-PLANET, V102, P23709, DOI 10.1029/97JE01742; Veverka J, 1999, SCIENCE, V285, P562, DOI 10.1126/science.285.5427.562; Zuber MT, 2000, SCIENCE, V289, P2097, DOI 10.1126/science.289.5487.2097	23	132	133	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					484	488		10.1126/science.1058651	http://dx.doi.org/10.1126/science.1058651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313490				2022-12-28	WOS:000168187300041
J	Abbott, A				Abbott, A			Human Proteome Index launched	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					3	3		10.1038/35051220	http://dx.doi.org/10.1038/35051220			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343075	Bronze			2022-12-28	WOS:000166175600003
J	McAdam, AJ; Greenwald, RJ; Levin, MA; Chernova, T; Malenkovich, N; Ling, V; Freeman, GJ; Sharpe, AH				McAdam, AJ; Greenwald, RJ; Levin, MA; Chernova, T; Malenkovich, N; Ling, V; Freeman, GJ; Sharpe, AH			ICOS is critical for CD40-mediated antibody class switching	NATURE			English	Article							CO-STIMULATION; MOLECULE ICOS; DIFFERENTIATION; COSTIMULATION; EXPRESSION; IDENTIFICATION; ACTIVATION; IMMUNITY; PROTEIN; CD4(+)	The inducible co-stimulatory molecule (ICOS) is a CD28 homologue implicated in regulating T-cell differentiation(1-5). Because co-stimulatory signals are critical for regulating T-cell activation, an understanding of co-stimulatory signals may enable the design of rational therapies for immune-mediated diseases(6). According to the two-signal model for T-cell activation, T cells require an antigen-specific signal and a second, co-stimulatory, signal for optimal T-cell activation(6). The co-stimulatory signal promotes T-cell proliferation, lymphokine secretion and effector function. The B7-CD28 pathway provides essential signals for T-cell activation, but does not account for all co-stimulation. We have generated mice lacking ICOS (ICOS-/-) to determine the essential functions of ICOS. Here we report that ICOS-/- mice exhibit profound deficits in immunoglobulin isotype class switching, accompanied by impaired germinal centre formation. Class switching was restored in ICOS-/- mice by CD40 stimulation, showing that ICOS promotes T-cell/B-cell collaboration through the CD40/CD40L pathway.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Genet Inst Inc, Dept Immunol, Cambridge, MA 02081 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Sharpe, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, 221 Longwood Ave, Boston, MA 02115 USA.	asharpe@rics.bwh.harvard.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Sharpe, Arlene/0000-0002-9736-2109				Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Greenwald RJ, 1997, J IMMUNOL, V158, P4088; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2000, J VIROL, V74, P203, DOI 10.1128/JVI.74.1.203-208.2000; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tarlinton D, 1998, CURR OPIN IMMUNOL, V10, P245, DOI 10.1016/S0952-7915(98)80161-1; Wang SD, 2000, BLOOD, V96, P2808; Yip HC, 1999, J IMMUNOL, V162, P3942; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	22	516	571	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					102	105		10.1038/35051107	http://dx.doi.org/10.1038/35051107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343122				2022-12-28	WOS:000166175600048
J	Zhang, D; Penttila, TL; Morris, PL; Teichmann, M; Roeder, RG				Zhang, D; Penttila, TL; Morris, PL; Teichmann, M; Roeder, RG			Spermiogenesis deficiency in mice lacking the Trf2 gene	SCIENCE			English	Article							TBP-LIKE FACTOR; POLYMERASE-II TRANSCRIPTION; TATA-BINDING PROTEIN; SPERMATOGENIC CELLS; C-ELEGANS; MOUSE; EXPRESSION; CREM; IDENTIFICATION; ACTIVATION	The discovery of TATA-binding protein-related factors (TRFs) has suggested alternative mechanisms for gene-specific transcriptional regulation and raised interest in their biological functions. In contrast to recent observations of an embryonic Lethal phenotype for TRF2 inactivation in Caenorhabditis elegans and Xenopus laevis, we found that Trf2-deficient mice are viable. However, Trf2(-/-) mice are sterile because of a severe defect in spermiogenesis. Postmeiotic round spermatids advance at most to step 7 of differentiation but fail to progress to the elongated form, and gene-specific transcription deficiencies were identified. We speculate that mammals may have evolved more specialized TRF2 functions in the testis that involve transcriptional regulation of genes essential for spermiogenesis.	Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA; Populat Council, New York, NY 10021 USA	Rockefeller University; Population Council	Roeder, RG (corresponding author), Biochem & Mol Biol Lab, New York, NY 10021 USA.		Teichmann, Martin/M-7407-2014	Teichmann, Martin/0000-0002-5257-0510				Behr R, 2000, BIOL REPROD, V62, P1344, DOI 10.1095/biolreprod62.5.1344; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; Diemer T, 1999, HUM REPROD UPDATE, V5, P120, DOI 10.1093/humupd/5.2.120; Drabent B, 1996, HISTOCHEM CELL BIOL, V106, P247; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; FULCHER KD, 1995, BIOL REPROD, V52, P41, DOI 10.1095/biolreprod52.1.41; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; KLEENE KC, 1990, DEV BIOL, V137, P395, DOI 10.1016/0012-1606(90)90263-I; MATSUMOTO M, 1990, BIOCHEM BIOPH RES CO, V166, P43, DOI 10.1016/0006-291X(90)91909-C; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; ZAKERI ZF, 1988, MOL CELL BIOL, V8, P2925, DOI 10.1128/MCB.8.7.2925; ZHANG D, UNPUB	28	153	158	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1153	1155		10.1126/science.1059188	http://dx.doi.org/10.1126/science.1059188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352070				2022-12-28	WOS:000168609200057
J	Clark, DA; Mitra, PP; Wang, SSH				Clark, DA; Mitra, PP; Wang, SSH			Scalable architecture in mammalian brains	NATURE			English	Article							EVOLUTION; INSECTIVORES; VOLUMES	Comparison of mammalian brain parts has often focused on differences in absolute size(1-3), revealing only a general tendency for all parts to grow together(2). Attempts to find size-independent effects using body weight as a reference variable(1) obscure size relationships owing to independent variation of body size(4) and give phylogenies of questionable significance(5). Here we use the brain itself as a size reference to define the cerebrotype, a species-by-species measure of brain composition. With this measure, across many mammalian taxa the cerebellum occupies a constant fraction of the total brain volume (0.13 +/- 0.02), arguing against the hypothesis that the cerebellum acts as a computational engine principally serving the neocortex(3). Mammalian taxa can be well separated by cerebrotype, thus allowing the use of quantitative neuroanatomical data to test evolutionary relationships. Primate cerebrotypes have progressively shifted and neocortical volume fractions have become successively larger in lemurs and lorises, New World monkeys, Old World monkeys, and hominoids, lending support to the idea that primate brain architecture has been driven by directed selection pressure(4). At the same time, absolute brain size can vary over 100-fold within a taxon, while maintaining a relatively uniform cerebrotype. Brains therefore constitute a scalable architecture.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Princeton University; Princeton University; Alcatel-Lucent; Lucent Technologies; AT&T	Wang, SSH (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Clark, Damon/0000-0001-8487-700X; Mitra, Partha/0000-0001-8818-6804				AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Airapetyants ES, 1973, ECHOLOCATION ANIMALS; Baron G, 1996, COMP NEUROBIOLOGY CH; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Butler A.B., 2005, COMP VERTEBRATE NEUR, DOI DOI 10.1017/CBO9780511525636.010; DOUGLAS RJ, 1975, BRAIN BEHAV EVOLUT, V11, P179, DOI 10.1159/000123632; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FOX JH, 1986, BRAIN BEHAV EVOLUT, V28, P157, DOI 10.1159/000118700; Frahm HD, 1997, J BRAIN RES, V38, P209; Gura T, 2000, NATURE, V406, P230, DOI 10.1038/35018729; Harvey P.H., 1991, COMP METHOD EVOLUTIO; JANSEN J, 1969, BIOL MARINE MAMMALS; JANSEN JAN, 1952, NORWEGIAN WHALING GAZ, V9, P480; Jerison, 1991, BRAIN SIZE EVOLUTION; Kinzey WG., 1997, NEW WORLD PRIMATES E; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KRUSKA D, 1974, Z ANAT ENTWICKLUNGS, V144, P61, DOI 10.1007/BF00518633; MEYER J, 1981, BRAIN BEHAV EVOLUT, V18, P60, DOI 10.1159/000121776; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; Pilleri G., 1964, ACTA ZOOL-STOCKHOLM, V46, P245, DOI [10.1111/j.1463-6395.1964.tb00721.x, DOI 10.1111/J.1463-6395.1964.TB00721.X]; PIRLOT P, 1983, J HIRNFORSCH, V24, P677; PIRLOT P, 1985, Z ZOOL SYST EVOL, V23, P147; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; REEP RL, 1990, BRAIN BEHAV EVOLUT, V35, P185, DOI 10.1159/000115866; RIDGWAY SH, 1989, BOTTLENOSED DOLPHIN, P69; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Zilles K., 1988, P157	30	196	201	1	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					189	193		10.1038/35075564	http://dx.doi.org/10.1038/35075564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346794				2022-12-28	WOS:000168563000049
J	Patek, SN				Patek, SN			Spiny lobsters stick and slip to make sound - These crustaceans can scare off predators even when their usual armour turns soft.	NATURE			English	Article									Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Patek, SN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.			Patek, S. N./0000-0001-9738-882X				Aiken D.E., 1980, P91; Benade A. H., 1990, FUNDAMENTALS MUSICAL; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; LINDBERG ROBERT G., 1955, UNIV CALIFORNIA PUBL ZOOL, V59, P157; MASTERS WM, 1979, BEHAV ECOL SOCIOBIOL, V5, P187; MEYERROCHOW VB, 1976, J EXP MAR BIOL ECOL, V23, P191, DOI 10.1016/0022-0981(76)90141-6; MOULTON JM, 1957, BIOL BULL, V113, P286, DOI 10.2307/1539086; MULLIGAN BE, 1977, CRUSTACEANA, V32, P185, DOI 10.1163/156854077X00575; PATERSON N F, 1968, Annals of the South African Museum, V51, P1; Phillips B.F., 1980, P1	11	73	78	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					153	154		10.1038/35075656	http://dx.doi.org/10.1038/35075656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346780				2022-12-28	WOS:000168563000035
J	Dahlberg, AE				Dahlberg, AE			Ribosome structure - The ribosome in action	SCIENCE			English	Editorial Material							ANGSTROM RESOLUTION; SUBUNIT; RNA		Brown Univ, Div Biol & Med, Providence, RI 02912 USA	Brown University	Dahlberg, AE (corresponding author), Brown Univ, Div Biol & Med, Providence, RI 02912 USA.	albert_dahlberg.@brown.edu						Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; CRICK FHC, 1960, NUCLEIC ACIDS, V3, P401; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	12	10	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					868	869		10.1126/science.1061513	http://dx.doi.org/10.1126/science.1061513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341282				2022-12-28	WOS:000168514900029
J	Kroenke, K; Harris, L				Kroenke, K; Harris, L			Symptoms research: A fertile field	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Indiana Univ, Sch Med, Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Kroenke, K (corresponding author), Indiana Univ, Sch Med, Regenstrief Inst Hlth Care, RG-6,1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org	anand, amit/A-7222-2009	Kroenke, Kurt/0000-0002-0114-4669				DIDION J, 1979, WHITE ALBUM, P171; HAUBRICH WS, 1997, MED MEANINGS GLOSSAR	2	37	37	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			801	802		10.7326/0003-4819-134-9_Part_2-200105011-00001	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00001			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346313				2022-12-28	WOS:000168543100001
J	Evans, JP; Skrzynia, C; Burke, W				Evans, JP; Skrzynia, C; Burke, W			The complexities of predictive genetic testing	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP CARE; BREAST-CANCER; INHERITED PREDISPOSITION; COLORECTAL-CANCER; ALZHEIMER-DISEASE; RISK; POPULATION; TAMOXIFEN; BRCA2; RECOMMENDATIONS		Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Evans, JP (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu						Beutler E, 2000, ANN INTERN MED, V133, P329, DOI 10.7326/0003-4819-133-5-200009050-00008; Burke W, 2000, JAMA-J AM MED ASSOC, V284, P1837, DOI 10.1001/jama.284.14.1837; Burke W, 1998, JAMA-J AM MED ASSOC, V280, P172, DOI 10.1001/jama.280.2.172; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; BURKE W, 1992, GENETIC BASIS COMMON; Burt RW, 1996, PREVENTION EARLY DET, P171; Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z; COHEN MM, 1994, AM J HUM GENET, V55, pR1; Evans DA, 1997, JAMA-J AM MED ASSOC, V277, P822, DOI 10.1001/jama.277.10.822; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisk JD, 1998, CAN J NEUROL SCI, V25, P242, DOI 10.1017/S0317167100034089; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Hoff AO, 2000, ANNU REV PHYSIOL, V62, P377, DOI 10.1146/annurev.physiol.62.1.377; Jarvik GP, 1996, AM J HUM GENET, V58, P191; Jarvik GP, 1996, AM J HUM GENET, V58, P648; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; JONES M, 2000, NY TIMES        0611, P80; Khoury MJ, 2000, GENET MED, V2, P198, DOI 10.1097/00125817-200005000-00007; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; McKinnon WC, 1997, JAMA-J AM MED ASSOC, V278, P1217, DOI 10.1001/jama.278.15.1217; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; Powles T, 1998, LANCET, V352, P98; Stratakis CA, 2000, J PEDIATR ENDOCR MET, V13, P457; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Veronesi U, 1998, LANCET, V352, P93; Weber BL, 2000, AM J HUM GENET, V67, P59; Wells SA, 1998, EXP CLIN ENDOCR DIAB, V106, P29, DOI 10.1055/s-0029-1211946; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2	34	137	139	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2001	322	7293					1052	1056		10.1136/bmj.322.7293.1052	http://dx.doi.org/10.1136/bmj.322.7293.1052			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325775	Green Submitted, Green Published			2022-12-28	WOS:000168478700030
J	Mathew, C				Mathew, C			Science medicine and the future - Postgenomic technologies: hunting the genes for common disorders	BRITISH MEDICAL JOURNAL			English	Review							SUSCEPTIBILITY LOCUS; ALZHEIMER-DISEASE; HUMAN-GENOME; ALLELE		Kings Coll London, Guys Hosp, Guys Kings & St Thomass Sch Med, Div Med & Mol Genet, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Mathew, C (corresponding author), Kings Coll London, Guys Hosp, Guys Kings & St Thomass Sch Med, Div Med & Mol Genet, London SE1 9RT, England.	christopher.mathew@kcl.ac.uk	Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; HAINES JL, 1998, APPROACHES GENE MAPP; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Jackson PE, 2000, MOL MED TODAY, V6, P271, DOI 10.1016/S1357-4310(00)01698-1; JOSEFEN D, NEW GENE IMPLICATED; Kwiatkowski D, 2000, BMJ-BRIT MED J, V321, P1061, DOI 10.1136/bmj.321.7268.1061; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mathew CG, 1999, BRIT MED BULL, V55, P325, DOI 10.1258/0007142991902402; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; POSTE G, 1999, BR MED B, V55; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Searls DB, 2000, ANNU REV GENOM HUM G, V1, P251, DOI 10.1146/annurev.genom.1.1.251; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weatherall DJ, 2000, BMJ-BRIT MED J, V321, P1117, DOI 10.1136/bmj.321.7269.1117; 2001, NATURE, V409, P813	21	31	35	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1031	1034		10.1136/bmj.322.7293.1031	http://dx.doi.org/10.1136/bmj.322.7293.1031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325769	Green Published			2022-12-28	WOS:000168478700023
J	Pagon, RA; Pinsky, L; Beahler, CC				Pagon, RA; Pinsky, L; Beahler, CC			Online medical genetics resources: a US perspective	BRITISH MEDICAL JOURNAL			English	Review							INTERPRETING FAMILY HISTORIES; COMPUTER SUPPORT; OVARIAN-CANCER; PRIMARY-CARE; BREAST; OMIM		Univ Washington, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Pagon, RA (corresponding author), GeneClin, Seattle, WA 98115 USA.							*AM MED ASS, 1998, GEN TEST STUD CONS A; Antonarakis SE, 2000, NAT GENET, V25, P11, DOI 10.1038/75497; Bennett RL, 1999, PRACTICAL GUIDE GENE; DEBOCK, 2001, BMJ, V322, P26; Emery J, 2000, BMJ-BRIT MED J, V321, P28, DOI 10.1136/bmj.321.7252.28; Emery J, 1999, BRIT MED J, V319, P32, DOI 10.1136/bmj.319.7201.32; FEARS, 2000, BMJ, V320, P933; Guttmacher AE, 2000, GENET MED, V2, P296, DOI 10.1097/00125817-200009000-00005; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; HARPER PS, 1998, PRACTICAL GENETIC CO; Hayflick S J, 1998, Community Genet, V1, P18, DOI 10.1159/000016131; Jadad AR, 1999, BMJ-BRIT MED J, V319, P761, DOI 10.1136/bmj.319.7212.761; Khoury M. J., 2000, GENETICS PUBLIC HLTH; *MITR SYST HLTH SU, 2001, CRIT ASS QUAL HLTH I	14	12	12	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1035	1037		10.1136/bmj.322.7293.1035	http://dx.doi.org/10.1136/bmj.322.7293.1035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325770	Green Published			2022-12-28	WOS:000168478700024
J	Liphardt, J; Onoa, B; Smith, SB; Tinoco, I; Bustamante, C				Liphardt, J; Onoa, B; Smith, SB; Tinoco, I; Bustamante, C			Reversible unfolding of single RNA molecules by mechanical force	SCIENCE			English	Article							RIBOZYME DOMAIN; DNA; COOPERATIVITY; SEPARATION; STABILITY; FOLDS	Here we use mechanical force to induce the unfolding and refolding of single RNA molecules: a simple RNA hairpin, a molecule containing a three-helix junction, and the P5abc domain of the Tetrahymena thermophila ribozyme. All three molecules (P5abc only in the absence of Mg2+) can be mechanically unfolded at equilibrium, and when kept at constant force within a critical force range. are bi-stable and hop between folded and-unfolded states. We determine the force-dependent equilibrium constants for folding/unfolding these single RNA molecules and the positions of their transition states along the reaction coordinate.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.		Liphardt, Jan/A-5906-2012	Liphardt, Jan/0000-0003-2835-5025; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032543, R01GM010840, R37GM010840, R01GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM010840-42, R01 GM010840-43, GM-10840, GM-32543, R01 GM010840] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bockelmann U, 1998, PHYS REV E, V58, P2386, DOI 10.1103/PhysRevE.58.2386; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Ferre-d'Amare AR, 1999, ANNU REV BIOPH BIOM, V28, P57, DOI 10.1146/annurev.biophys.28.1.57; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; MA CL, 1995, BIOPOLYMERS, V35, P211, DOI 10.1002/bip.360350209; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; Pan J, 1999, P NATL ACAD SCI USA, V96, P6149, DOI 10.1073/pnas.96.11.6149; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; Ralston CY, 2000, NAT STRUCT BIOL, V7, P371; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Wu M, 1998, P NATL ACAD SCI USA, V95, P11555, DOI 10.1073/pnas.95.20.11555; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	17	722	742	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					733	737		10.1126/science.1058498	http://dx.doi.org/10.1126/science.1058498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326101				2022-12-28	WOS:000168478300053
J	Wakayama, T; Tabar, V; Rodriguez, I; Perry, ACF; Studer, L; Mombaerts, P				Wakayama, T; Tabar, V; Rodriguez, I; Perry, ACF; Studer, L; Mombaerts, P			Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer	SCIENCE			English	Article							MICE; PRECURSORS; CLONING	Embryonic stem (ES) cells are fully pluripotent in that they can differentiate into all cell types, including gametes. We have derived 35 ES cell lines via nuclear transfer (ntES cell lines) from adult mouse somatic cells of inbred, hybrid, and mutant strains. ntES cells contributed to an extensive variety of cell types, including dopaminergic and serotonergic neurons in vitro and germ cells in vivo. Cloning by transfer of ntES cell nuclei could result in normal development of fertile adults. These studies demonstrate the full pluripotency of ntES cells.	Rockefeller Univ, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Lab Stem Cell & Tumor Biol, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Wakayama, T (corresponding author), Adv Cell Technol, 1 Innovat Dr, Worcester, MA 01605 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; rodriguez, ivan/0000-0002-6468-0565; Perry, Tony/0000-0003-3136-5355				Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; DIETRICH W, 1992, GENETICS, V131, P423; Gurdon JB, 1999, NATURE, V402, P743, DOI 10.1038/45429; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.3.CO;2-K; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MATISE MP, 1993, GENE TARGETING PRACT, P129; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; METZGER JM, 1994, J CELL BIOL, V126, P701, DOI 10.1083/jcb.126.3.701; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WAKAYAMA T, UNPUB	19	423	485	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					740	743		10.1126/science.1059399	http://dx.doi.org/10.1126/science.1059399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326103				2022-12-28	WOS:000168478300055
J	Ji, Q; Norell, MA; Gao, KQ; Ji, SA; Ren, D				Ji, Q; Norell, MA; Gao, KQ; Ji, SA; Ren, D			The distribution of integumentary structures in a feathered dinosaur	NATURE			English	Article							YIXIAN FORMATION; THEROPOD; EVOLUTION	Non-avian theropod dinosaurs with preserved integumentary coverings are becoming more common(1-6); but apart from the multiple specimens of Caudipteryx, which have true feathers(2,7), animals that are reasonably complete and entirely articulated that show these structures in relation to the body have not been reported. Here we report on an enigmatic small theropod dinosaur that is covered with filamentous feather-like structures over its entire body.	Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Geol Sci, Beijing 100037, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Geological Sciences	Norell, MA (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org						Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Gao Ke-Qin, 1999, Vertebrata Palasiatica, V37, P1; Gao KQ, 2000, J VERTEBR PALEONTOL, V20, P417, DOI 10.1671/0272-4634(2000)020[0417:EFMOAS]2.0.CO;2; Gauthier J.A., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou LH, 1999, CHINESE SCI BULL, V44, P2113, DOI 10.1007/BF03182691; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q, 1999, NATURE, V398, P326; Ji Q., 1996, CHINESE GEOL, V233, P30; Ji Qiang, 1999, Professional Papers of Stratigraphy and Palaeontology, V27, P74; LO CH, 1999, JEHOL BIOTA, P328; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Ostrom J.H., 1990, P269; Prum RO, 1999, J EXP ZOOL, V285, P291; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SIMMONS LM, 2000, NAT GEOGR MAG    OCT, P128; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Varricchio D. J, 1997, ENCY DINOSAURS, P749; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	29	119	135	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1084	1088		10.1038/35074079	http://dx.doi.org/10.1038/35074079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323669				2022-12-28	WOS:000168285500045
J	Dammai, V; Subramani, S				Dammai, V; Subramani, S			The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol	CELL			English	Article							PROTEIN IMPORT; PTS1 RECEPTOR; 3-KETOACYL-COA THIOLASE; DOCKING SITE; RAT-LIVER; MEMBRANE; COMPLEX; BIOGENESIS; INTERACTS; DISORDERS	Peroxisomal targeting signals (PTSs) are recognized by predominantly cytosolic receptors, Pex5p and Pex7p. The fate of these PTS receptors following their interactions on the peroxisomal membrane with components of docking and putative translocation complexes is unknown. Using both novel and multiple experimental approaches, we show that human Pex5p does not just bind cargo and deliver it to the peroxisome membrane, but participates in multiple rounds of entry into the peroxisome matrix and export to the cytosol independent of the PTS2 import pathway. This unusual shuttling mechanism for the PTS1 receptor distinguishes protein import into peroxisomes from that into most other organelles, with the exception of the nucleus.	Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Div Biol, Mol Biol Sect, Room 3230 Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041737, R56DK041737, R01DK041737] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41737] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Chen K, 2000, BIOCHEM SOC T, V28, P485, DOI 10.1042/0300-5127:0280485; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; JOHNSON MA, 2001, IN PRESS YEAST; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Potter MD, 2000, J BIOL CHEM, V275, P33828, DOI 10.1074/jbc.M005294200; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; SZILARD RK, 1995, J CELL BIOL, V131, P1453, DOI 10.1083/jcb.131.6.1453; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; WILCKE M, 1995, J BIOL CHEM, V270, P6949, DOI 10.1074/jbc.270.12.6949; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	25	189	192	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					187	196		10.1016/S0092-8674(01)00310-5	http://dx.doi.org/10.1016/S0092-8674(01)00310-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336669	Bronze, Green Submitted			2022-12-28	WOS:000168384300006
J	Luo, ZX; Cifelli, RL; Kielan-Jaworowska, Z				Luo, ZX; Cifelli, RL; Kielan-Jaworowska, Z			Dual origin of tribosphenic mammals	NATURE			English	Article							SOUTH-AMERICA; EVOLUTION; DISCOVERY; AUSTRALIA; PLATYPUS; ENGLAND; CHINA	Marsupials, placentals and their close therian relatives possess complex (tribosphenic) molars that are capable of versatile occlusal functions. This functional complex is widely thought to be a key to the early diversification and evolutionary success of extant therians and their close relatives (tribosphenidans). Long thought to have arisen on northern continents, tribosphenic mammals have recently been reported from southern landmasses. The great age and advanced morphology of these new mammals has led to the alternative suggestion of a Gondwanan origin for the group. Implicit in both biogeographic hypotheses is the assumption that tribosphenic molars evolved only once in mammalian evolutionary history. Phylogenetic and morphometric analyses including these newly discovered taxa suggest a different interpretation: that mammals with tribosphenic molars are not monophyletic. Tribosphenic molars evolved independently in two ancient (holotherian) mammalian groups with different geographic distributions during the Jurassic/Early Cretaceous: an australosphenidan clade endemic to Gondwanan landmasses, survived by extant monotremes; and a boreosphenidan clade of Laurasian continents, including extant marsupials, placentals and their relatives.	Oklahoma Museum Nat Hist, Norman, OK 73072 USA; Carnegiw Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Cifelli, RL (corresponding author), Oklahoma Museum Nat Hist, 2401 Chautauqua, Norman, OK 73072 USA.	rlc@uo.edu	Luo, Zhe-XI/AAU-2263-2021; Self, Casey J/B-6871-2011					ARCHER M, 1985, NATURE, V318, P363, DOI 10.1038/318363a0; ARCHER M, 1993, MAMMAL PHYLOGENY; Archer Michael, 1999, Australian Mammalogy, V21, P1; BONAPARTE JF, 1990, NATL GEOGR RES, V6, P63; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P329; BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; CHOW M, 1982, Australian Mammalogy, V5, P127; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; CLEMENS W A, 1971, Bulletin of the British Museum (Natural History) Geology, V20, P89; Crompton A., 1971, EARLY MAMMALS, P65; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Griffiths M., 1978, BIOL MONOTREMES; HOPSON JA, 1994, MAJOR FEATURES VERTE, P190; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JACOBS LL, 1989, P NATL ACAD SCI USA, V86, P4992, DOI 10.1073/pnas.86.13.4992; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z, 1998, LETHAIA, V31, P267; KIELANJAWOROWSKA Z, 1987, NATURE, V326, P871, DOI 10.1038/326871a0; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Lillegraven J.A., 1974, Annual Rev Ecol Syst, V5, P263, DOI 10.1146/annurev.es.05.110174.001403; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; McKenna MC, 1997, CLASSIFICATION MAMMA; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; PASCUAL R, 1992, NATURE, V356, P704, DOI 10.1038/356704a0; Pascual Rosendo, 2000, Geodiversitas, V22, P395; PATTERSON BRUAN, 1956, FIELDIANA GEOL, V13, P1; Penny D, 1997, NATURE, V387, P549, DOI 10.1038/42352; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Sigogneau-Russell D, 1998, CR ACAD SCI II A, V327, P571, DOI 10.1016/S1251-8050(99)80040-8; SIGOGNEAURUSSELL D, 1994, CR ACAD SCI II, V319, P833; SIGOGNEAURUSSELL D, 1991, CR ACAD SCI II, V313, P1635; Wang YQ, 1998, J VERTEBR PALEONTOL, V18, P777, DOI 10.1080/02724634.1998.10011106; Wible John R., 1995, American Museum Novitates, V3149, P1; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1	44	185	202	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					53	57		10.1038/35051023	http://dx.doi.org/10.1038/35051023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343108				2022-12-28	WOS:000166175600034
J	Baumann, P; Cech, TR				Baumann, P; Cech, TR			Pot1, the putative telomere end-binding protein in fission yeast and humans	SCIENCE			English	Article							CATALYTIC SUBUNIT GENE; HUMAN-CHROMOSOMES; DNA-BINDING; OXYTRICHA; HOMOLOGS; PROTECTION; MODULATION; SEQUENCE; SUGGEST; CLONING	Telomere proteins from ciliated protozoa bind to the single-stranded C-rich DNA extensions at the ends of macronuclear chromosomes. We have now identified homologous proteins in fission yeast and in humans. These Pot1 (protection of telomeres) proteins each bind the G-rich strand of their own telomeric repeat sequence, consistent with a direct role in protecting chromosome ends. Deletion of the fission yeast pot1(+) gene has an immediate effect on chromosome stability, causing rapid loss of telomeric DNA and chromosome circularization. It now appears that the protein that caps the ends of chromosomes is widely dispersed throughout the eukaryotic kingdom.	Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Baumann, Peter/0000-0003-4892-1485				Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Eversole A, 2000, MOL CELL BIOL, V20, P5425, DOI 10.1128/MCB.20.15.5425-5432.2000; FAN JB, 1989, NUCLEIC ACIDS RES, V17, P2801, DOI 10.1093/nar/17.7.2801; FANG GW, 1991, NUCLEIC ACIDS RES, V19, P5515, DOI 10.1093/nar/19.20.5515; FANG GW, 1993, P NATL ACAD SCI USA, V90, P6056, DOI 10.1073/pnas.90.13.6056; FANG GW, 1993, GENE DEV, V7, P870, DOI 10.1101/gad.7.5.870; Froelich-Ammon SJ, 1998, GENE DEV, V12, P1504, DOI 10.1101/gad.12.10.1504; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KLOBUTCHER LA, 1981, P NATL ACAD SCI-BIOL, V78, P3015, DOI 10.1073/pnas.78.5.3015; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P6461, DOI 10.1093/nar/20.24.6461; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Prescott JD, 1998, CHROMOSOMA, V107, P293, DOI 10.1007/s004120050311; WANG WL, 1992, NUCLEIC ACIDS RES, V20, P6621, DOI 10.1093/nar/20.24.6621; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801	31	773	820	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1171	1175		10.1126/science.1060036	http://dx.doi.org/10.1126/science.1060036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349150	Green Published			2022-12-28	WOS:000168609200062
J	Spechler, SJ; Lee, E; Ahnen, D; Goyal, RK; Hirano, I; Ramirez, F; Raufman, JP; Sampliner, R; Schnell, T; Sontag, S; Vlahcevic, ZR; Young, R; Williford, W				Spechler, SJ; Lee, E; Ahnen, D; Goyal, RK; Hirano, I; Ramirez, F; Raufman, JP; Sampliner, R; Schnell, T; Sontag, S; Vlahcevic, ZR; Young, R; Williford, W			Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease - Follow-up of a randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVENTIONAL NISSEN FUNDOPLICATION; LAPAROSCOPIC ANTIREFLUX SURGERY; BARRETTS-ESOPHAGUS; CLINICAL-TRIAL; ENDOSCOPIC SURVEILLANCE; SYMPTOM CONTROL; CANCER RISK; ADENOCARCINOMA; MANAGEMENT; OMEPRAZOLE	Context Severe gastroesophageal reflux disease (GERD) is a lifelong problem that can be complicated by peptic esophageal stricture and adenocarcinoma of the esophagus, Objective To determine the long-term outcome of medical and surgical therapies for GERD. Design and Setting Follow-up study conducted from October 1997 through October 1999 of a prospective randomized trial of medical and surgical antireflux treatments in patients with complicated GERD, Mean (median) duration of follow-up was 10.6 years (7.3 years) for medical patients and 9.1 years(6.3 years) for surgical patients. Participants Two hundred thirty-nine (97%) of the original 247 study patients were found (79 were confirmed dead). Among the 160 survivors (157 men and 3 women; mean [SD] age, 67 [12] years), 129 (91 in the medical treatment group and 38 in the surgical treatment group) participated in the follow-up. Main Outcome Measures Use of antireflux medication, Gastroesophageal Reflux Disease Activity Index (GRACI) scores, grade of esophagitis, frequency of treatment of esophageal stricture, frequency of subsequent antireflux operations, 36-item Short Form health survey (SF-36) scores, satisfaction with antireflux therapy, survival, and incidence of esophageal adenocarcinoma, compared between the medical antireflux therapy group and the fundoplication surgery group. Information on cause of death was obtained from autopsy results, hospital records, and death certificates. Results Eighty-three (92%) of 90 medical patients and 23 (62%) of 37 surgical patients reported that they used antireflux medications regularly (P<.001). During a 1-week period after discontinuation of medication, mean (SD) GRACI symptom scores were significantly lower in the surgical treatment group (82.6 [17.5] vs 96.7 [21.4] in the medical treatment group; P=.003). However, no significant differences between the groups were found in grade of esophagitis, frequency of treatment of esophageal stricture and subsequent antireflux operations, SF-36 standardized physical and mental component scale scores, and overall satisfaction with antireflux therapy. Survival during a period of 140 months was decreased significantly in the surgical vs the medical treatment group (relative risk of death in the medical group, 1.57; 95% confidence interval, 1.01-2.46; P=.047), largely because of excess deaths from heart disease, Patients with Barrett esophagus at baseline developed esophageal adenocarcinomas at an annual rate of 0.4%, whereas these cancers developed in patients without Barrett esophagus at an annual rate of only 0.07%, There was no significant difference between groups in incidence of esophageal cancer. Conclusion This study suggests that antireflux surgery should not be advised with the expectation that patients with GERD will no longer need to take antisecretory medications or that the procedure will prevent esophageal cancer among those with GERD and Barrett esophagus.	Dept Vet Affairs Med Ctr, Div Gastroenterol, Dallas, TX 75216 USA; Dept Vet Affairs Med Ctr, Denver, CO USA; Dept Vet Affairs Med Ctr, W Roxbury, MA USA; Dept Vet Affairs Med Ctr, Phoenix, AZ USA; Dept Vet Affairs Med Ctr, Little Rock, AR USA; Dept Vet Affairs Med Ctr, Tucson, AZ USA; Dept Vet Affairs Med Ctr, Hines, IL USA; Dept Vet Affairs Med Ctr, Richmond, VA USA; Dept Vet Affairs Med Ctr, Omaha, NE USA; Dept Vet Affairs Med Ctr, Perry Point, MD USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Spechler, SJ (corresponding author), Dept Vet Affairs Med Ctr, Div Gastroenterol, 111B1,4500 S Lancaster Rd, Dallas, TX 75216 USA.	sjspechler@aol.com						ATTWOOD SEA, 1992, BRIT J SURG, V79, P1050, DOI 10.1002/bjs.1800791021; Bais JE, 2000, LANCET, V355, P170, DOI 10.1016/S0140-6736(99)03097-4; BEHAR J, 1975, NEW ENGL J MED, V293, P263, DOI 10.1056/NEJM197508072930602; BONELLI L, 1993, ENDOSCOPY, V25, P652, DOI 10.1055/s-2007-1010425; BRAND DL, 1979, GASTROENTEROLOGY, V76, P1393; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; COLLARD JM, 1994, ANN SURG, V220, P146, DOI 10.1097/00000658-199408000-00005; DeMeester SR, 2000, ANN SURG, V231, P303, DOI 10.1097/00000658-200003000-00003; DEMEESTER TR, 1986, ANN SURG, V204, P9, DOI 10.1097/00000658-198607000-00002; DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; Falk GW, 1998, ENDOSCOPY, V30, P61, DOI 10.1055/s-2007-1001232; Fuchs KH, 1997, ENDOSCOPY, V29, P298, DOI 10.1055/s-2007-1004194; GARROW DC, 2000, CANCER CAUSE CONTROL, V11, P231; GRANDE L, 1994, BRIT J SURG, V81, P548, DOI 10.1002/bjs.1800810421; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; Hinder RA, 1999, GASTROENTEROL CLIN N, V28, P987, DOI 10.1016/S0889-8553(05)70101-1; HOWDEN CW, 1995, ARCH INTERN MED, V155, P1465, DOI 10.1001/archinte.155.14.1465; JAMIESON GG, 1994, ANN SURG, V220, P137, DOI 10.1097/00000658-199408000-00004; JAROFF L, 1995, TIME            1106; Kahrilas PJ, 1996, JAMA-J AM MED ASSOC, V276, P983, DOI 10.1001/jama.276.12.983; Katz D, 1998, AM J GASTROENTEROL, V93, P536; KAUER WKH, 1995, ANN SURG, V222, P525; Klinkenberg-Knol EC, 2000, GASTROENTEROLOGY, V118, P661, DOI 10.1016/S0016-5085(00)70135-1; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laine S, 1997, SURG ENDOSC-ULTRAS, V11, P441, DOI 10.1007/s004649900386; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell L, 2000, EUR J GASTROEN HEPAT, V12, P879, DOI 10.1097/00042737-200012080-00007; MCCALLUM RW, 1991, GASTROENTEROLOGY, V100, P121; NEBEL OT, 1976, AM J DIG DIS, V21, P953, DOI 10.1007/BF01071906; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; ORLANDO RC, 1995, SCAND J GASTROENTERO, V30, P36, DOI 10.3109/00365529509090267; Ortiz A, 1996, BRIT J SURG, V83, P274; Peters JH, 1997, GASTROENTEROL CLIN N, V26, P647, DOI 10.1016/S0889-8553(05)70320-4; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; RATTNER DW, 1995, ARCH SURG-CHICAGO, V130, P289; ROBERTSON CS, 1988, BRIT J SURG, V75, P760, DOI 10.1002/bjs.1800750813; Sampliner RE, 1998, AM J GASTROENTEROL, V93, P1028; SAMPLINER RE, 1999, AM J GASTROENTEROL, V94, P1434; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; SPECHLER SJ, 1992, NEW ENGL J MED, V326, P786, DOI 10.1056/NEJM199203193261202; Spechlex SJ, 2000, WHO CLASSIFICATION T, P32; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Wetscher GJ, 1999, DIGEST DIS SCI, V44, P1132, DOI 10.1023/A:1026615905170; WILLIFORD WO, 1994, CONTROL CLIN TRIALS, V15, P335, DOI 10.1016/0197-2456(94)90031-0	46	637	652	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2331	2338		10.1001/jama.285.18.2331	http://dx.doi.org/10.1001/jama.285.18.2331			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343480	Bronze			2022-12-28	WOS:000168411200024
J	Waterstone, M; Bewley, S; Wolfe, C				Waterstone, M; Bewley, S; Wolfe, C			Incidence and predictors of severe obstetric morbidity: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE UNIT; MATERNAL MORTALITY; PREGNANCY OUTCOMES; ORGAN FAILURE; SMOKING; DELIVERY; SEPSIS; MISS	Objective To estimate the incidence and predictors of severe obstetric morbidity. Design Development of definitions of severe obstetric morbidity by literature review Case-control study from a defined delivery population with four randomly selected pregnant women as controls for every case. Setting All 19 maternity units within the South East Thames region and six neighbouring hospitals caring for pregnant women from the region between 1 March 1997 and 28 February 1998. Participants 48 865 women who delivered during the time frame. Results There were 588 cases of severe obstetric morbidity giving an incidence of 12.0/1000 deliveries (95% confidence interval 11.2 to 13.2). During the study there were five maternal deaths attributed to conditions studied. Disease specific morbidities per 1000 deliveries were 6.7 (6.0 to 7.5) for severe haemorrhage, 3.9 (3.3 to 4.5) for severe pre-eclampsia, 0.2 (0.1 to 0.4) for eclampsia, 0.5 (0.3 to 0.8) for HELLP (Haemolysis, Elevated Liver enzymes, and Low Platelets) syndrome, 0.4 (0.2 to 0.6) for severe sepsis, and 0.2 (0.1 to 0.4) for uterine rupture. Age over 34 years, non-white ethnic group, past or current hypertension, previous postpartum haemorrhage, delivery by emergency caesarean section, antenatal admission to hospital, multiple pregnancy, social exclusion, and taking iron or anti-depressants at antenatal booking were all independently associated with morbidity after adjustment. Conclusion Severe obstetric morbidity and its relation to mortality may be more sensitive measures of pregnancy outcome than mortality alone. Most events are related to obstetric haemorrhage and severe pre-eclampsia. Caesarean section quadruples the risk of morbidity. Development and evaluation of ways of predicting and reducing risk are required with particular emphasis paid on the management of haemorrhage and pre-eclampsia.	Guys Kings Coll, Dept Publ Hlth Med, London SE1 3QD, England; St Thomas Hosp, Sch Med, London SE1 3QD, England; St Thomas Hosp, Sch Dent, London SE1 3QD, England; Guys & St Thomass NHS Trust, Womens Hlth Directorate, London SE1 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Wolfe, C (corresponding author), Guys Kings Coll, Dept Publ Hlth Med, Capital House, London SE1 3QD, England.	charles.wolfe@kcl.ac.uk		bewley, susan/0000-0001-8064-652X				Benedetti J., 1991, CRITICAL CARE OBSTET, P573; Bewley Susan, 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P26; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BouvierColle MH, 1996, EUR J OBSTET GYN R B, V65, P121, DOI 10.1016/0028-2243(95)02317-L; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; COLLOP NA, 1993, CHEST, V103, P1548, DOI 10.1378/chest.103.5.1548; Department of Health, 1998, WHY MOTH DIE REP CON; FITZPATRICK C, 1992, IRISH MED J, V85, P37; Johanson R., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P174, DOI 10.3109/01443619509015490; JONAS O, 1992, AUST NZ J OBSTET GYN, V32, P1, DOI 10.1111/j.1479-828X.1992.tb01885.x; JONAS O, 1991, MED J AUSTRALIA, V154, P246, DOI 10.5694/j.1326-5377.1991.tb121082.x; KILPATRICK SJ, 1992, CHEST, V101, P1407, DOI 10.1378/chest.101.5.1407; KLONOFFCOHEN H, 1993, OBSTET GYNECOL, V81, P541; Lapinsky SE, 1997, CAN J ANAESTH, V44, P325, DOI 10.1007/BF03015374; LEHMANN DK, 1987, AM J OBSTET GYNECOL, V157, P738, DOI 10.1016/S0002-9378(87)80041-8; MABIE WC, 1990, AM J OBSTET GYNECOL, V162, P1; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; MONACO TJ, 1993, SOUTHERN MED J, V86, P414, DOI 10.1097/00007611-199304000-00008; Ng T I, 1992, Ann Acad Med Singap, V21, P804; NISELL H, 1995, BRIT J OBSTET GYNAEC, V102, P876, DOI 10.1111/j.1471-0528.1995.tb10874.x; Office of Population Censuses and Surveys, 1990, CLASS OCC; PEACOCK JL, 1995, BRIT MED J, V311, P531, DOI 10.1136/bmj.311.7004.531; PEIPERT JF, 1993, OBSTET GYNECOL, V81, P200; Platteau P, 1997, TROP DOCT, V27, P202, DOI 10.1177/004947559702700406; ROBERTS CL, 1994, MED J AUSTRALIA, V160, P539, DOI 10.5694/j.1326-5377.1994.tb138342.x; SIBAI BM, 1990, AM J OBSTET GYNECOL, V163, P1049, DOI 10.1016/0002-9378(90)91123-T; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I; Stones W, 1991, Health Trends, V23, P13; Tan K. T., 1994, Singapore Medical Journal, V35, P495; TUCK SM, 1988, BRIT J OBSTET GYNAEC, V95, P230, DOI 10.1111/j.1471-0528.1988.tb06862.x; Umo-Etuk J, 1996, Int J Obstet Anesth, V5, P79, DOI 10.1016/S0959-289X(96)80001-X	32	473	499	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2001	322	7294					1089	1093		10.1136/bmj.322.7294.1089	http://dx.doi.org/10.1136/bmj.322.7294.1089			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337436	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000168628300017
J	Salieres, P; Carre, B; Le Deroff, L; Grasbon, F; Paulus, GG; Walther, H; Kopold, R; Becker, W; Milosevic, DB; Sanpera, A; Lewenstein, M				Salieres, P; Carre, B; Le Deroff, L; Grasbon, F; Paulus, GG; Walther, H; Kopold, R; Becker, W; Milosevic, DB; Sanpera, A; Lewenstein, M			Feynman's path-integral approach for intense-laser-atom interactions	SCIENCE			English	Article							ABOVE-THRESHOLD IONIZATION; HIGH-ORDER HARMONICS; SOFT X-RAYS; GENERATION; FIELD; PULSES; RESCATTERING; RADIATION; COHERENCE; EMISSION	Atoms interacting with intense laser fields can emit electrons and photons of very high energies. An intuitive and quantitative explanation of these highly nonlinear processes can be found in terms of a generalization of classical Newtonian particle trajectories, the so-called quantum orbits. Very few quantum orbits are necessary to reproduce the experimental results. These orbits are clearly identified, thus opening the way for an efficient control as well as previously unknown applications of these processes.	Leibniz Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany; Ctr Etud Saclay, CEA, DRECAM, SPAM, F-91191 Gif Sur Yvette, France; Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Max Born Inst, D-12489 Berlin, Germany; Univ Sarajevo, Fac Sci, Sarajevo 71000, Bosnia & Herceg	Leibniz University Hannover; CEA; UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy; University of Sarajevo	Lewenstein, M (corresponding author), Leibniz Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany.	lewen@itp.uni-hannover.de	Lewenstein, Maciej/I-1337-2014; SALIERES, Pascal/L-7776-2014; Milosevic, Dejan B/AAH-5972-2019; Sanpera, Anna/L-3174-2014; Paulus, Gerhard G/A-7617-2010; Becker, Wilhelm/B-8581-2014	Lewenstein, Maciej/0000-0002-0210-7800; SALIERES, Pascal/0000-0001-5899-8246; Milosevic, Dejan B/0000-0001-5060-3318; Sanpera, Anna/0000-0002-8970-6127; Paulus, Gerhard G/0000-0002-8343-8811; Becker, Wilhelm/0000-0001-8939-0372				Altucci C, 1998, PHYS REV A, V58, P3934, DOI 10.1103/PhysRevA.58.3934; Bellini M, 1998, PHYS REV LETT, V81, P297, DOI 10.1103/PhysRevLett.81.297; BRYANT HC, 1987, PHYS REV LETT, V58, P2412, DOI 10.1103/PhysRevLett.58.2412; BUDIL KS, 1993, PHYS REV A, V48, pR3437, DOI 10.1103/PhysRevA.48.R3437; Chang Z, 1998, PHYS REV A, V58, pR30, DOI 10.1103/PhysRevA.58.R30; Chang ZH, 1997, PHYS REV LETT, V79, P2967, DOI 10.1103/PhysRevLett.79.2967; COHENTANNOUDJI C, 1977, QANTUM MECH; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Drescher M, 2001, SCIENCE, V291, P1923, DOI 10.1126/science.1058561; Feynman R.P., 1965, QUANTUM MECH PATH IN; Gaarde MB, 1999, PHYS REV A, V59, P1367, DOI 10.1103/PhysRevA.59.1367; Glover TE, 1996, PHYS REV LETT, V76, P2468, DOI 10.1103/PhysRevLett.76.2468; HASEGAWA H, 1989, PROG THEOR PHYS SUPP, P198, DOI 10.1143/PTPS.98.198; Kopold R, 2000, PHYS REV LETT, V85, P3781, DOI 10.1103/PhysRevLett.85.3781; Kopold R, 2000, PHYS REV LETT, V84, P3831, DOI 10.1103/PhysRevLett.84.3831; Kulander K. C., 1996, ATOMIC MOL OPTICAL P, P828; KULANDER KC, 1993, NATO ADV SCI INST SE, V316, P95, DOI 10.1007/978-1-4615-7963-2_10; LEWENSTEINM, 1994, PHYS REV A, V49, P4998; Milosevic DB, 1999, PHYS REV LETT, V82, P2653, DOI 10.1103/PhysRevLett.82.2653; Moshammer R, 2000, PHYS REV LETT, V84, P447, DOI 10.1103/PhysRevLett.84.447; Paulus GG, 2000, PHYS REV LETT, V84, P3791, DOI 10.1103/PhysRevLett.84.3791; PAULUS GG, 1994, PHYS REV LETT, V72, P2851, DOI 10.1103/PhysRevLett.72.2851; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; SALIERES P, 1995, PHYS REV LETT, V74, P3776, DOI 10.1103/PhysRevLett.74.3776; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; WAHLSTROM CG, 1993, PHYS REV A, V48, P4709, DOI 10.1103/PhysRevA.48.4709; Walker B, 1996, PHYS REV LETT, V77, P5031, DOI 10.1103/PhysRevLett.77.5031; Weber T, 2000, NATURE, V405, P658, DOI 10.1038/35015033	29	569	571	6	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					902	905		10.1126/science.108836	http://dx.doi.org/10.1126/science.108836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340197				2022-12-28	WOS:000168514900035
J	Sekinger, EA; Gross, DS				Sekinger, EA; Gross, DS			Silenced chromatin is permissive to activator binding and PIC recruitment	CELL			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK FACTOR; RESOLUTION STRUCTURAL-ANALYSIS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; TRANSCRIPTION FACTORS; TELOMERIC HETEROCHROMATIN; PREINITIATION COMPLEX; HISTONE ACETYLATION; NUCLEOSOMAL DNA	Chromatin is thought to repress transcription by limiting access of the DNA to transcription factors. Using a yeast heat shock gene flanked by mating-type silencers as a model system, we find that repressive, SIR-generated heterochromatin is permissive to the constitutive binding of an activator, HSF, and two components of the preinitiation complex (PIC), TBP and Pol II. These factors cohabitate the promoter with Sir silencing proteins and deacetylated nucleosomal histones. The heterochromatic HMRa1 promoter is also occupied by TBP and pol II, suggesting that SIR regulates gene expression not by restricting factor access to DNA but rather by blocking a step downstream of PIC recruitment. Interestingly, activation of silent promoter chromatin occurs in the absence of histone displacement and without change in histone acetylation state.	Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045842] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45842] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blair WS, 1996, EMBO J, V15, P1658, DOI 10.1002/j.1460-2075.1996.tb00511.x; Blau J, 1996, MOL CELL BIOL, V16, P2044; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; DAHMUS ME, 1994, PROG NUCLEIC ACID RE, V48, P143, DOI 10.1016/S0079-6603(08)60855-7; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; Erkine AM, 1996, MOL CELL BIOL, V16, P7004; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GROSS DS, 1993, EMBO J, V12, P3931, DOI 10.1002/j.1460-2075.1993.tb06071.x; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MCDANIEL D, 1989, MOL CELL BIOL, V9, P4789, DOI 10.1128/MCB.9.11.4789; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Zou S, 1996, GENE DEV, V10, P634, DOI 10.1101/gad.10.5.634	58	122	125	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2001	105	3					403	414		10.1016/S0092-8674(01)00329-4	http://dx.doi.org/10.1016/S0092-8674(01)00329-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348596	Bronze			2022-12-28	WOS:000168515900009
J	Katon, W; Sullivan, M; Walker, E				Katon, W; Sullivan, M; Walker, E			Medical symptoms without identified pathology: Relationship to psychiatric disorders, childhood and adult trauma, and personality traits	ANNALS OF INTERNAL MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL DISABILITY; CHRONIC-FATIGUE; PRIMARY-CARE; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; UNEXPLAINED SYMPTOMS; PSYCHOSOCIAL FACTORS; HIGH UTILIZERS; HEALTH	Community studies have shown that stressful life events, psychological distress, and depressive and anxiety disorders are associated with 1) a range of medical symptoms without identified pathology, 2) increased health care utilization, and 3) increased costs. In both primary care and medical specialty samples, patients who have syndromes with ill-defined pathologic mechanisms (such as the irritable bowel syndrome and fibromyalgia) have been shown to have significantly higher rates of anxiety and depressive disorders than do patients with comparable, well-defined medical diseases and similar symptoms. Other studies show that after adjustment for severity of medical illness, patients with depression or anxiety and comorbid medical disease have significantly more medical symptoms without identified pathology than do patients with a similar medical disease alone. Both childhood maltreatment and psychological trauma in adulthood have been associated with increased vulnerability to psychiatric illness and more medical symptoms. The substantial functional impairment, distress, and costs associated with medical symptoms without identified pathology suggest that research studies promoting a better understanding of the biopsychosocial cause of these symptoms may yield pragmatic, cost-effective approaches to treatment in medical settings.	Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Katon, W (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Bos 356560,1959 NE Pacific St, Seattle, WA 98195 USA.	wkaton@u.washington.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001643] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-01643] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; BRIDGES KW, 1985, J PSYCHOSOM RES, V29, P563, DOI 10.1016/0022-3999(85)90064-9; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; CLARK MR, 1995, AM J MED, V98, P187, DOI 10.1016/S0002-9343(99)80403-3; DEMERS RY, 1980, J FAM PRACTICE, V11, P1085; Dickinson LM, 1999, ARCH FAM MED, V8, P35, DOI 10.1001/archfami.8.1.35; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; Dwight MM, 2000, J PSYCHOSOM RES, V49, P311, DOI 10.1016/S0022-3999(00)00155-0; Engel C. C., 1999, STRATEGIES PROTECT H, P173; ESCOBAR JI, 1992, AM J PSYCHIAT, V149, P965; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FOGARTY J, 1994, ARCH FAM MED, V3, P55; Gureje O, 1997, AM J PSYCHIAT, V154, P989; Hotopf M, 1999, AM J PSYCHIAT, V156, P1796; KATON W, 1988, AM J MED, V84, P1, DOI 10.1016/0002-9343(88)90001-0; KATON W, 1990, GEN HOSP PSYCHIAT, V12, P355, DOI 10.1016/0163-8343(90)90002-T; KATON W, 1992, ARCH INTERN MED, V152, P1604, DOI 10.1001/archinte.152.8.1604; KATON W, 1991, AM J PSYCHIAT, V148, P34; Katon W J, 1991, Psychiatr Med, V9, P577; KATON WJ, 1991, J GEN INTERN MED, V6, P277, DOI 10.1007/BF02597420; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; LUSTMAN PJ, 1988, INT J PSYCHIAT MED, V18, P295; MAGNUS K, 1993, J PERS SOC PSYCHOL, V65, P1046, DOI 10.1037/0022-3514.65.5.1046; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; MCFARLANE AC, 1994, J PSYCHOSOM RES, V38, P715, DOI 10.1016/0022-3999(94)90024-8; MECHANIC D, 1978, J HUM STRESS, V4, P26, DOI 10.1080/0097840X.1978.10545983; O'Malley PG, 1999, J FAM PRACTICE, V48, P980; ORMEL J, 1991, J PERS SOC PSYCHOL, V60, P744, DOI 10.1037/0022-3514.60.5.744; Pearson SD, 1999, J GEN INTERN MED, V14, P461, DOI 10.1046/j.1525-1497.1999.06278.x; PENNEBAKER JW, 1982, PSYCHOL PHYSICAL SYM; ROBBINS PR, 1974, J PERS ASSESS, V38, P578, DOI 10.1080/00223891.1974.10120020; RUSSO J, 1994, PSYCHOSOMATICS, V35, P546, DOI 10.1016/S0033-3182(94)71723-0; Schappert S M, 1992, Vital Health Stat 13, P1; SHARPE M, 1992, International Review of Psychiatry, V4, P81, DOI 10.3109/09540269209066305; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; SIMON GE, 1991, AM J PSYCHIAT, V148, P1494; SIMPSON RJ, 1994, BRIT J GEN PRACT, V44, P352; SOLOMON Z, 1988, BEHAV MED, V14, P179, DOI 10.1080/08964289.1988.9935143; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; STEWART WF, 1992, AM J MED, V92, pS35, DOI 10.1016/0002-9343(92)90135-X; SULLIVAN M, 1993, ARCH INTERN MED, V153, P1479, DOI 10.1001/archinte.153.12.1479; Sullivan MD, 2000, AM J CARDIOL, V86, P1135, DOI 10.1016/S0002-9149(00)01174-7; SULLIVAN MD, 1988, GEN HOSP PSYCHIAT, V10, P285, DOI 10.1016/0163-8343(88)90037-0; SVENSSON TH, 1987, PSYCHOPHARMACOLOGY, V92, P1, DOI 10.1007/BF00215471; TRULL TJ, 1992, J ABNORM PSYCHOL, V101, P553, DOI 10.1037/0021-843X.101.3.553; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Van Os J, 1999, PSYCHOL MED, V29, P1055, DOI 10.1017/S0033291799001026; VANHEMERT AM, 1993, PSYCHOL MED, V23, P167, DOI 10.1017/S0033291700038952; VONKORFF M, 1987, ARCH GEN PSYCHIAT, V44, P152; Walker EA, 1999, AM J MED, V107, P332, DOI 10.1016/S0002-9343(99)00235-1; WALKER EA, 1995, PSYCHOSOMATICS, V36, P531, DOI 10.1016/S0033-3182(95)71608-5; Walker EA, 1996, J PSYCHOSOM OBST GYN, V17, P39, DOI 10.3109/01674829609025662; WALKER EA, 1995, PSYCHOL MED, V25, P1259, DOI 10.1017/S0033291700033225; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; WALKER EA, 1993, J GEN INTERN MED, V8, P436, DOI 10.1007/BF02599621; Walker EA, 1999, ARCH GEN PSYCHIAT, V56, P609, DOI 10.1001/archpsyc.56.7.609; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; Walker EA, 1996, GEN HOSP PSYCHIAT, V18, P220, DOI 10.1016/0163-8343(96)00036-9; Walker EA, 1996, PSYCHOSOM MED, V58, P16, DOI 10.1097/00006842-199601000-00003; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805	68	272	281	0	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			917	925		10.7326/0003-4819-134-9_Part_2-200105011-00017	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346329				2022-12-28	WOS:000168543100017
J	Enne, VI; Livermore, DM; Stephens, P; Hall, LMC				Enne, VI; Livermore, DM; Stephens, P; Hall, LMC			Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction	LANCET			English	Article							GRAM-NEGATIVE BACTERIA; ANTIBIOTIC-RESISTANCE; CONSUMPTION; EVOLUTION; FINLAND	Background There is a clear association between heavy antimicrobial consumption within a population and the frequent recovery of resistant bacteria, but whether a reduction in antimicrobial use can reverse this process is less clear. We investigated the effect of a national restriction of sulphonamide prescribing in the UK on the prevalence of sulphonamide resistance in Escherichia coli. Methods Consecutive clinical isolates of E coli were collected at the Royal London Hospital in 1991 and 1999. These collections, each of more than 350 isolates, were compared. Minimum inhibitory concentrations of sulphamethoxazole and eight other antimicrobials were determined. The presence and locations of sulphonamide-resistance genes were examined by PCR, plasmid extraction, Southern hybridisation, and transconjugation. Findings Despite a huge decrease in sulphonamide prescriptions (from 320 000 prescriptions per year in 1991 to 7 000 in 1999), the frequency of resistance remained high in 1999 (165/359 [46.0%] vs 143/360 [39.7%] in 1991; difference 6.2% [95% CI -0.9 to 13.3]). Integron- borne sulI was present in 16.4% of isolates in 1991 and 17.5% in 1999, The prevalence of sulII increased from 26.7% in 1991 to 36.5% in 1999 (difference 9.8% [3.1 to 16.5] p=0.0046). SulII was located on large plasmids, at least some of which were conjugative multiresistance determinants. Interpretation These results show that a huge decrease in antibiotic prescribing does not necessarily reduce resistance within a useful time. The main reason seems to be the genetic linkage of the index resistance to other resistance determinants.	St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London E1 2AD, England; Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England; IMS Hlth, Pinner, Middx, England	University of London; Queen Mary University London; Public Health England	Hall, LMC (corresponding author), St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London E1 2AD, England.		Enne, Virve/AAP-2357-2021					[Anonymous], 1995, DRUG THER B, V33, P92; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; *BRIT SOC ANT CHEM, 1998, BSAC STAND DISK SENS, P19; Hall RM, 1997, CIBA F SYMP, V207, P192; Huovinen P, 1997, CIBA F SYMP, V207, P36; LAWRENSON RA, 1998, J INFORM PRIMARY MAY; LIU PYF, 1992, J ANTIMICROB CHEMOTH, V30, P429, DOI 10.1093/jac/30.4.429; LIVERMORE DM, 1996, ANTIBIOTICS LAB MED, P561; *NCCLS, 1999, PERF STAND ANT SUSC, V19, P32; RADSTROM P, 1991, ANTIMICROB AGENTS CH, V35, P1840, DOI 10.1128/AAC.35.9.1840; Sambrook J., 2002, MOL CLONING LAB MANU; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; *VET MED DIR, 2001, SAL ANT PROD US VET	14	340	354	1	79	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1325	1328		10.1016/S0140-6736(00)04519-0	http://dx.doi.org/10.1016/S0140-6736(00)04519-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343738				2022-12-28	WOS:000168411400011
J	Hayward, CS; Webb, CM; Collins, P				Hayward, CS; Webb, CM; Collins, P			Effect of sex hormones on cardiac mass	LANCET			English	Article							LEFT-VENTRICULAR MASS; GENDER-RELATED DIFFERENCES; ESSENTIAL-HYPERTENSION; REPLACEMENT THERAPY; ANDROGEN RECEPTORS; PRESSURE-OVERLOAD; BLOOD-PRESSURE; HEART; HYPERTROPHY; RAT	Increased left-ventricular mass is an important cardiovascular risk factor for morbidity and mortality. Apart from obvious differences in cardiac size, the changes in left-ventricular mass in response to age and hypertrophic stimuli are very different in men and women. Whereas left-ventricular mass increases with age in apparently healthy women, it remains constant in men. Under increased cardiac loading conditions, such as hypertension or aortic stenosis, this disparity between sexes is even more striking. Findings are especially pronounced in people aged 50 years or older, In whom reproductive hormone concentrations have fallen, Whether the differences in left-ventricular mass changes are related to endogenous sex-hormone concentrations has never been shown. Androgens have anabolic effects on cardiac cells, and oestrogens have antiproliferative properties, we therefore postulate that the normal decline in endogenous sex hormones with age has contrary effects on ventricular mass in men and women in normal and pathological states.	Natl Heart & Lung Inst, Imperial Coll Sch Med, Dept Cardiac Med, London SW3 6LY, England; St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia	Imperial College London; St Vincents Hospital Sydney	Collins, P (corresponding author), Natl Heart & Lung Inst, Imperial Coll Sch Med, Dept Cardiac Med, Dovehouse St, London SW3 6LY, England.			Webb, Carolyn/0000-0002-2538-6953				AURIGEMMA GP, 1994, AM J CARDIOL, V74, P794, DOI 10.1016/0002-9149(94)90437-5; CABRAL AM, 1988, HYPERTENSION, V11, P93; Chen CH, 1998, CIRCULATION, V98, P422, DOI 10.1161/01.CIR.98.5.422; Chen SJ, 1996, CIRCULATION, V93, P577, DOI 10.1161/01.CIR.93.3.577; DANIELS SR, 1995, CIRCULATION, V92, P3249, DOI 10.1161/01.CIR.92.11.3249; DANNENBERG AL, 1989, AM J CARDIOL, V64, P1066, DOI 10.1016/0002-9149(89)90816-3; Devereux RB, 1997, CIRCULATION, V96, P1416, DOI 10.1161/01.CIR.96.5.1416; Douglas PS, 1998, J AM COLL CARDIOL, V32, P1118, DOI 10.1016/S0735-1097(98)00347-7; Dubey RK, 1998, HYPERTENSION, V31, P522, DOI 10.1161/01.HYP.31.1.522; FUJIMOTO R, 1994, J STEROID BIOCHEM, V50, P169, DOI 10.1016/0960-0760(94)90025-6; GARAVAGLIA GE, 1989, EUR HEART J, V10, P1110, DOI 10.1093/oxfordjournals.eurheartj.a059434; GUYTON AC, 1994, TXB MED PHYSL; Hayward CS, 1997, J AM COLL CARDIOL, V30, P1863, DOI 10.1016/S0735-1097(97)00378-1; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Lim WK, 1999, AM J CARDIOL, V83, P1132, DOI 10.1016/S0002-9149(99)00029-6; LORELL BH, 1997, CIRCULATION, V96, P630; MALHOTRA A, 1990, AM J PHYSIOL, V259, pH866, DOI 10.1152/ajpheart.1990.259.3.H866; MARCUS R, 1994, CIRCULATION, V90, P928, DOI 10.1161/01.CIR.90.2.928; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; Meyer R, 1998, EXP PHYSIOL, V83, P305, DOI 10.1113/expphysiol.1998.sp004115; Modena MG, 1999, HYPERTENSION, V34, P1041, DOI 10.1161/01.HYP.34.5.1041; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; PEARSON AC, 1988, J AM COLL CARDIOL, V12, P989, DOI 10.1016/0735-1097(88)90466-4; RADDINO R, 1989, PHARMACOLOGY, V38, P185, DOI 10.1159/000138536; SCHEUER J, 1987, CIRC RES, V61, P12, DOI 10.1161/01.RES.61.1.12; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Somjen D, 1998, HYPERTENSION, V32, P39, DOI 10.1161/01.HYP.32.1.39; Sullivan ML, 1998, PROG CARDIOVASC DIS, V41, P1, DOI 10.1016/S0033-0620(98)80019-4; Tamura T, 1999, HYPERTENSION, V33, P676, DOI 10.1161/01.HYP.33.2.676; Webb CM, 1999, AM J CARDIOL, V83, P437, DOI 10.1016/S0002-9149(98)00880-7; Webb CM, 1999, CIRCULATION, V100, P1690, DOI 10.1161/01.CIR.100.16.1690; Weinberg EO, 1999, J AM COLL CARDIOL, V34, P264, DOI 10.1016/S0735-1097(99)00165-5	33	82	85	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1354	1356		10.1016/S0140-6736(00)04523-2	http://dx.doi.org/10.1016/S0140-6736(00)04523-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343761				2022-12-28	WOS:000168411400036
J	Pinkney, JH; Sjostrom, CD; Gale, EAM				Pinkney, JH; Sjostrom, CD; Gale, EAM			Should surgeons treat diabetes in severely obese people?	LANCET			English	Editorial Material							INTENTIONAL WEIGHT-LOSS; DOUBLE-BLIND; REDUCTION; HYPERTENSION; INTERVENTION; OPERATION; MELLITUS		Univ Liverpool, Ctr Clin Sci, Dept Med, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England; Univ Gothenburg, Sahlgrens Univ Hosp, Dept Anaesthesia & Intens Care, Gothenburg, Sweden	University of Liverpool; Sahlgrenska University Hospital; University of Gothenburg	Pinkney, JH (corresponding author), Univ Liverpool, Ctr Clin Sci, Dept Med, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England.	jpinkney@liverpool.ac.uk						Brown SA, 1996, DIABETES CARE, V19, P613, DOI 10.2337/diacare.19.6.613; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Finer N, 2000, DIABETES OBES METAB, V2, P105, DOI 10.1046/j.1463-1326.2000.00071.x; FLEGAL KM, 2000, INT J OBES RELAT MET, V22, P39; GLEYSTEEN JJ, 1990, AM J CLIN NUTR, V51, P774, DOI 10.1093/ajcn/51.5.774; HERBST CA, 1984, SURGERY, V95, P209; HODGE AM, 1994, BAILLIERE CLIN ENDOC, V8, P577, DOI 10.1016/S0950-351X(05)80287-3; Hollander PA, 1998, DIABETES CARE, V21, P1288, DOI 10.2337/diacare.21.8.1288; Jung RT, 1997, BRIT MED BULL, V53, P307, DOI 10.1093/oxfordjournals.bmb.a011615; LONG SD, 1994, DIABETES CARE, V17, P372, DOI 10.2337/diacare.17.5.372; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Mason EE, 1999, OBES SURG, V9, P223, DOI 10.1381/096089299765553070; *NIH, 1992, AM J CLIN NUTR, V55, pS487; Pories W J, 1993, Curr Opin Gen Surg, P195; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; PRESCOTTCLARK P, 1996, HLTH SURVEY ENGLAND; Scheen AJ, 1998, DIABETES METAB, V24, P116; Sjostrom CD, 2000, HYPERTENSION, V36, P20, DOI 10.1161/01.HYP.36.1.20; Sjostrom CD, 1999, OBES RES, V7, P477; Sjostrom L, 2000, ENDOCRINE, V13, P213, DOI 10.1385/ENDO:13:2:213; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; WADDEN TA, 1993, ANN INTERN MED, V119, P688, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00012; WING RR, 1995, J AM DIET ASSOC, V95, P569, DOI 10.1016/S0002-8223(95)00155-7	23	44	45	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1357	1359		10.1016/S0140-6736(00)04524-4	http://dx.doi.org/10.1016/S0140-6736(00)04524-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343762				2022-12-28	WOS:000168411400037
J	Dresselhaus, MS				Dresselhaus, MS			Nanotubes - Burn and interrogate	SCIENCE			English	Editorial Material							CARBON NANOTUBES; ELECTRONIC-STRUCTURE		MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dresselhaus, MS (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	millie@mgm.mit.edu						Cao JX, 2001, J PHYS-CONDENS MAT, V13, pL271, DOI 10.1088/0953-8984/13/13/101; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118; Louie SG, 2001, TOP APPL PHYS, V80, P113; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Ouyang M, 2001, SCIENCE, V292, P702, DOI 10.1126/science.1058853; SAITO R, 1992, PHYS REV B, V46, P1804, DOI 10.1103/PhysRevB.46.1804; Saito R, 2000, PHYS REV B, V61, P2981, DOI 10.1103/PhysRevB.61.2981; Saito R., 1998, PHYS PROPERTIES CARB; SCHLITTLER RR, 2001, SCIENCE         0405; Tombler TW, 2000, NATURE, V405, P769, DOI 10.1038/35015519; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139	13	31	31	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					650	651		10.1126/science.1060379	http://dx.doi.org/10.1126/science.1060379			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330324				2022-12-28	WOS:000168478300031
J	Blancou, P; Vartanian, JP; Christopherson, C; Chenciner, N; Basilico, C; Kwok, S; Wain-Hobson, S				Blancou, P; Vartanian, JP; Christopherson, C; Chenciner, N; Basilico, C; Kwok, S; Wain-Hobson, S			Polio vaccine samples not linked to AIDS - A search through the archives clears early vaccines of starting the AIDS pandemic.	NATURE			English	Article							POLIOMYELITIS VIRUS		Inst Pasteur, Unite Retrovirol Mol, F-75724 Paris 15, France; Roche Mol Syst, Dept Infect Dis, Alameda, CA 94501 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Roche Holding; New York University	Blancou, P (corresponding author), Inst Pasteur, Unite Retrovirol Mol, 28 Rue Dr Roux, F-75724 Paris 15, France.	simon@pasteur.fr	Blancou, Philippe/M-4149-2018	Blancou, Philippe/0000-0003-0305-8622; Vartanian, Jean-Pierre/0000-0001-8079-8814				Curtis Tom, 1992, ROLLING STONE, P108; Hooper Edward, 1999, RIVER JOURNEY SOURCE; HULL RN, 1962, J EXP MED, V115, P903, DOI 10.1084/jem.115.5.903; KOPROWSKI H, 1961, JAMA-J AM MED ASSOC, V178, P1151, DOI 10.1001/jama.1961.73040510005008; Plotkin SA, 1999, SCIENCE, V286, P2450; PLOTKIN SA, 1961, B WORLD HEALTH ORGAN, V24, P785; PLOTKIN SA, 1961, P 6 INT C MICR STAND, P48; POLTKIN SA, 1966, AM J DIS CHILD, V111, P27, DOI 10.1001/archpedi.1966.02090040063004; SAITOU N, 1994, MOL BIOL EVOL, V11, P504; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	11	18	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1045	1046		10.1038/35074171	http://dx.doi.org/10.1038/35074171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323657				2022-12-28	WOS:000168285500033
J	Hunt, D; Young, P; Simes, J; Hague, W; Mann, S; Owensby, D; Lane, G; Tonkin, A				Hunt, D; Young, P; Simes, J; Hague, W; Mann, S; Owensby, D; Lane, G; Tonkin, A		LIPID Investigators	Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; CHOLESTEROL LEVELS; RISK; BURDEN; SOCIETY; DESIGN; MEN	Background: The effect of cholesterol-lowering therapy on death from coronary heart disease in older patients with previous coronary heart disease and average cholesterol levels is uncertain. Objective: To compare the relative and absolute effects of pravastatin on cardiovascular disease outcomes in patients with coronary heart disease who are 65 years of age or older with those in patients 31 to 64 years of age. Design: Subgroup analysis of a randomized, placebo-controlled trial. Setting: 87 centers in Australia and New Zealand. Patients: 3514 patients 65 to 75 years of age, chosen from among 9014 patients with previous myocardial infarction or unstable angina and a baseline plasma cholesterol level of 4.0 to 7.0 mmol/L (155 to 271 mg/dl). Intervention: Pravastatin, 40 mg/d, or placebo. Measurements: Major cardiovascular disease events over 6 years. Results: older patients were at greater risk than younger patients (31 to 64 years of age) for death (20.6% vs. 9.8%), myocardial infarction (11.4% vs. 9.5%), unstable angina (26.7% vs. 23.2%), and stroke (6.7% vs. 3.1%) (all P < 0.001). Pravastatin reduced the risk for all cardiovascular disease events, and similar relative effects were observed in older and younger patients. In patients 65 to 75 years of age, pravastatin therapy reduced mortality by 21% (CI, 7% to 32%), death from coronary heart disease by 24% (CI, 7% to 38%), coronary heart disease death or nonfatal myocardial infarction by 22% (CI, 9% to 34%), myocardial infarction by 26% (CI, 9% to 40%), and stroke by 12% (CI, -15% to 32%). For every 1000 older patients treated over 6 years, pravastatin prevented 45 deaths, 33 myocardial infarctions, 32 unstable angina events, 34 coronary revascularization procedures, 13 strokes, or 133 major cardiovascular events, compared with 22 deaths and 107 major cardiovascular events per 1000 younger patients. Among older patients, the numbers needed to treat were 22 (CI, 17 to 36) to prevent one death from any cause, 35 (CI, 24 to 67) to prevent one death from coronary heart disease, and 21 (CI, 17 to 31) to prevent one coronary heart disease death or nonfatal myocardial infarction. Conclusions: In older patients with coronary heart disease and average or moderately elevated cholesterol levels, pravastatin therapy reduced the risk for all major cardiovascular events and all-cause mortality. Since older patients are at greater risk than younger patients for these events, the absolute benefit of treatment is significantly greater in older patients.	Royal Melbourne Hosp, Sydney, NSW, Australia; Wollongong Hosp, Wollongong, NSW, Australia; Fremantle Hosp, Perth, WA, Australia; Hutt Hosp, Lower Hutt, New Zealand	Royal Melbourne Hospital; Wollongong Hospital	Simes, J (corresponding author), Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Locked Bag 77, Camperdown, NSW 1450, Australia.	enquiry@ctc.usyd.edu.au	Simes, Robert John/P-1497-2014					CASTELLI WP, 1989, AM J CARDIOL, V63, pH12; Collett D, 1994, MODELLING SURVIVAL D; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; FURBERG C, 1995, AM J CARDIOL, V76, P899; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hennekens CH, 1998, CIRCULATION, V97, P1095, DOI 10.1161/01.CIR.97.11.1095; Kelly DT, 1997, CIRCULATION, V95, P2459, DOI 10.1161/01.CIR.95.11.2459; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Lee E, 2013, STAT METHODS SURVIVA; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; MELLIES MJ, 1993, ATHEROSCLEROSIS, V101, P97, DOI 10.1016/0021-9150(93)90105-4; Miettinen TA, 1997, CIRCULATION, V96, P4211; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; PAN HY, 1993, ANN PHARMACOTHER, V27, P1029, DOI 10.1177/106002809302700902; PEDERSEN TR, 1994, LANCET, V344, P1383; RUBIN SM, 1990, ANN INTERN MED, V113, P916, DOI 10.7326/0003-4819-113-12-916; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sans S, 1997, EUR HEART J, V18, P1231; SANTORO M, 1994, ONCOGENE, V9, P509; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; TONKIN A, 1995, AM J CARDIOL, V76, P474; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; UEMURA K, 1988, EUR HEART J, V9, P1; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	25	181	189	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					931	940		10.7326/0003-4819-134-10-200105150-00007	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352694				2022-12-28	WOS:000168682500001
J	Pignone, M; Mulrow, CD				Pignone, M; Mulrow, CD			Evidence based management of hypertension - Using cardiovascular risk profiles to individualise hypertensive treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ N Carolina, Div Gen Internal Med, Chapel Hill, NC 27599 USA; Univ Texas, Div Gen Internal Med, San Antonio, TX 78249 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System	Pignone, M (corresponding author), Univ N Carolina, Div Gen Internal Med, Chapel Hill, NC 27599 USA.	pignone@med.unc.edu		Pignone, Michael/0000-0002-6657-7342				Mulrow CD, 2001, BMJ-BRIT MED J, V322, P1107, DOI 10.1136/bmj.322.7294.1107; Padwal R, 2001, BMJ-BRIT MED J, V322, P977, DOI 10.1136/bmj.322.7292.977; PIGNONE M, 2001, EVIDENCE BASED HYPER, P117	3	21	22	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2001	322	7295					1164	1166		10.1136/bmj.322.7295.1164	http://dx.doi.org/10.1136/bmj.322.7295.1164			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348913	Green Published, Green Submitted			2022-12-28	WOS:000168748900019
J	Woolhouse, MEJ; Taylor, LH; Haydon, DT				Woolhouse, MEJ; Taylor, LH; Haydon, DT			Population biology of multihost pathogens	SCIENCE			English	Editorial Material							HOST SPECIALIZATION; ANTIGENIC VARIATION; ESCHERICHIA-COLI; SANTA-ROSALIA; RABIES VIRUS; TRADE-OFFS; RED QUEEN; EVOLUTION; DYNAMICS; TRANSMISSION	The majority of pathogens, including many of medical and veterinary importance, can infect more than one species of host. Population biology has yet to explain why perceived evolutionary advantages of pathogen specialization are, in practice, outweighed by those of generalization. Factors that predispose pathogens to generalism include high Levels of genetic diversity and abundant opportunities for cross-species transmission, and the taxonomic distributions of generalists and specialists appear to reflect these factors. Generalism also has consequences for the evolution of virulence and for pathogen epidemiology, making both much Less predictable. The evolutionary advantages and disadvantages of generalism are so finely balanced that even closely related pathogens can have very different host range sizes.	Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland	University of Edinburgh	Woolhouse, MEJ (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	Taylor, Louise/H-9765-2019	Taylor, Louise/0000-0001-8141-2346; Haydon, Daniel/0000-0002-1240-1886				Alexander DJ, 2000, REV SCI TECH OIE, V19, P197, DOI 10.20506/rst.19.1.1220; ANDERSON R M, 1991; Ashford RW, 1997, BELG J ZOOL, V127, P85; Barbujani G., 1999, EVOLUTION HLTH DIS; BINZ T, 1994, VIRUS RES, V34, P281, DOI 10.1016/0168-1702(94)90128-7; Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Blancou J, 1997, B ACAD NAT MED PARIS, V181, P301; BLEWETT DA, 1993, WATER SCI TECHNOL, V27, P61, DOI 10.2166/wst.1993.0322; CAFRUNY WA, 1988, J VIROL METHODS, V20, P265, DOI 10.1016/0166-0934(88)90129-2; Cane P A, 1993, Trends Microbiol, V1, P156, DOI 10.1016/0966-842X(93)90132-B; CLEAVELAND S, IN PRESS PHILOS T B; Combes C, 2000, INT J PARASITOL, V30, P299, DOI 10.1016/S0020-7519(00)00012-6; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hartland EL, 2000, INFECT IMMUN, V68, P4637, DOI 10.1128/IAI.68.8.4637-4646.2000; Haydon DT, 1998, J THEOR BIOL, V193, P601, DOI 10.1006/jtbi.1998.0726; Hide G, 1996, PARASITOL TODAY, V12, P50, DOI 10.1016/0169-4758(96)80654-5; Horst JP, 1999, TRENDS MICROBIOL, V7, P29, DOI 10.1016/S0966-842X(98)01424-3; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Kellogg VL, 1913, AM NAT, V47, P129, DOI 10.1086/279337; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kettle DS, 1995, MED VET ENTOMOL, P248; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Morand S, 1996, P ROY SOC B-BIOL SCI, V263, P119, DOI 10.1098/rspb.1996.0019; Morimoto K, 1998, P NATL ACAD SCI USA, V95, P3152, DOI 10.1073/pnas.95.6.3152; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0; Rudenko G, 1999, CURR OPIN MICROBIOL, V2, P651, DOI 10.1016/S1369-5274(99)00039-9; SEALE J, 1989, J ROY SOC MED, V82, P519, DOI 10.1177/014107688908200904; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Smirnov YA, 2000, ACTA VIROL, V44, P1; Sutmoller P, 1997, REV SCI TECH OIE, V16, P30, DOI 10.20506/rst.16.1.996; TAYLOR LH, IN PRESS T R SOC L B; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Timms R, 1999, TRENDS ECOL EVOL, V14, P333, DOI 10.1016/S0169-5347(99)01697-3; WainHobson S, 1996, TRENDS MICROBIOL, V4, P135, DOI 10.1016/0966-842X(96)10023-8; WARD RL, 1984, CRIT REV ENV CONTR, V14, P297, DOI 10.1080/10643388409381721; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	49	519	537	1	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1109	1112		10.1126/science.1059026	http://dx.doi.org/10.1126/science.1059026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352066				2022-12-28	WOS:000168609200044
J	Srinivasan, M				Srinivasan, M			Today's learning point.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Indiana Univ, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Srinivasan, M (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN 46202 USA.			Srinivasan, Malathi/0000-0001-9951-0016					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1474	1474		10.1056/NEJM200105103441912	http://dx.doi.org/10.1056/NEJM200105103441912			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346816				2022-12-28	WOS:000168554000012
J	Hiraoka, K; Sato, T; Takayama, T				Hiraoka, K; Sato, T; Takayama, T			Interstellar chemistry - Tunneling reactions in interstellar ices	SCIENCE			English	Editorial Material							TEMPERATURES; ATOMS		Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan	University of Yamanashi	Hiraoka, K (corresponding author), Univ Yamanashi, Clean Energy Res Ctr, Takeda 4, Kofu, Yamanashi 4008511, Japan.							Crovisier J, 1998, FARADAY DISCUSS, V109, P437, DOI 10.1039/a800079d; EHRENFREUND P, 2000, IAU S, V197, P135; GALLOWAY ET, 1989, ASTRON ASTROPHYS, V211, P413; GREENBERG JM, 1991, CHEM SPACE; HASEGAWA TI, 1992, ASTROPHYS J SUPPL S, V82, P167, DOI 10.1086/191713; Heller EJ, 1996, PHYS REV LETT, V77, P4122, DOI 10.1103/PhysRevLett.77.4122; Hiraoka K, 2000, ASTROPHYS J, V532, P1029, DOI 10.1086/308612; HIRAOKA K, 2001, RADIAT PHYS CHEM, V60, P1; Mumma MJ, 1996, SCIENCE, V272, P1310, DOI 10.1126/science.272.5266.1310; Pirronello V, 1997, ASTROPHYS J, V483, pL131, DOI 10.1086/310746; TAKAYANAGI T, 1990, J CHEM PHYS, V92, P2862, DOI 10.1063/1.457932; TIELENS AGGM, 1982, ASTRON ASTROPHYS, V114, P245; WILLIAMS DA, 1993, DUST CHEM ASTRONOMY; WOOD DE, 1996, J CHEM PHYS, V105, P9921; YANG K, 1994, J CHEM PHYS, V101, P8205, DOI 10.1063/1.468205	15	18	18	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					869	870		10.1126/science.1060837	http://dx.doi.org/10.1126/science.1060837			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341283				2022-12-28	WOS:000168514900030
J	Tsujishita, Y; Guo, SL; Stolz, LE; York, JD; Hurley, JH				Tsujishita, Y; Guo, SL; Stolz, LE; York, JD; Hurley, JH			Specificity determinants in phosphoinositide dephosphorylation: Crystal structure of an archetypal inositol polyphosphate 5-phosphatase	CELL			English	Article							MULTIPLE ISOMORPHOUS REPLACEMENT; DNA-REPAIR; LOWE-SYNDROME; SYSTEM; FAMILY; IDENTIFICATION; MECHANISM; PROTEINS; SUGGESTS; PRODUCTS	Inositol polyphosphate 5-phosphatases are central to intracellular processes ranging from membrane trafficking to Ca2+ signaling, and defects in this activity result in the human disease Lowe syndrome. The 1.8 Angstrom resolution structure of the inositol polyphosphate 5-phosphatase domain of SPsynaptojanin bound to Ca2+ and inositol (1,4)-bisphosphate reveals a fold and an active site His and Asp pair resembling those of several Mg2+-dependent nucleases. Additional loops mediate specific inositol polyphosphate contacts. The 4-phosphate of inositol (1,4)-bisphosphate is misoriented by 4.6 Angstrom compared to the reactive geometry observed in the apurinic/apyrimidinic endonuclease 1, explaining the dephosphorylation site selectivity of the 5-phosphatases. Based on the structure, a series of mutants are described that exhibit altered substrate specificity providing general determinants for substrate recognition.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Howard Hughes Med Inst, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Duke University; Howard Hughes Medical Institute	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	jh8e@nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hurley JH, 2000, CURR OPIN STRUC BIOL, V10, P737; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Srinivasan S, 1997, EUR J CELL BIOL, V74, P350; Stolz LE, 1998, GENETICS, V148, P1715; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Whisstock JC, 2000, J BIOL CHEM, V275, P37055, DOI 10.1074/jbc.M006244200; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	53	103	105	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					379	389		10.1016/S0092-8674(01)00326-9	http://dx.doi.org/10.1016/S0092-8674(01)00326-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348594	Bronze			2022-12-28	WOS:000168515900007
J	Barsky, AJ				Barsky, AJ			Palpitations, arrhythmias, and awareness of cardiac activity	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL OUTPATIENTS; HEARTBEAT DETECTION; DISORDER; SYMPTOMS; STIMULI	Somatic and visceral symptoms have a surprisingly weak relationship to objective measures of tissue pathology. This is exemplified by the poor correlation found between palpitations and cardiac arrhythmias. Many factors other than extent of disease influence symptomatic distress, and since symptoms are such a crucial feature of illness and of medical practice, much more investigation of these nonbiomedical influences is needed. Although experimental laboratory paradigms facilitate such investigation, there are problems involved in generalizing from laboratory findings to the reporting of the symptoms of disease in daily life. In studying the awareness of cardiac arrhythmias and of resting heartbeat, we have found that the palpitations of patients who somatize more and have more health-related anxiety and more psychiatric distress are significantly less likely to be related to demonstrable cardiac arrhythmias than are the palpitations of other patients. The accurate awareness of arrhythmias, however, is not associated with the accurate awareness of resting heartbeat. Even more surprising, a relatively large proportion of heart transplant recipients are accurately aware of their resting heartbeat. This work poses more questions than it answers. In so doing, it underscores some of the technical difficulties of conducting research in this area and shows how little is known about symptom perception, processing, and reporting.	Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Barsky, AJ (corresponding author), Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA.				NHLBI NIH HHS [HL 43216] Funding Source: Medline; NIMH NIH HHS [MH 40487] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040487] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adelman G., 1987, ENCY NEUROSCIENCE; Barsky AJ, 1998, PSYCHOSOM MED, V60, P557, DOI 10.1097/00006842-199809000-00007; BARSKY AJ, 1995, ARCH INTERN MED, V155, P1782, DOI 10.1001/archinte.155.16.1782; Barsky AJ, 1996, ARCH INTERN MED, V156, P1102, DOI 10.1001/archinte.156.10.1102; BARSKY AJ, 1992, AM J MED, V92, pS31, DOI 10.1016/0002-9343(92)90134-W; Barsky AJ, 1998, PSYCHOSOM MED, V60, P604, DOI 10.1097/00006842-199809000-00016; Barsky AJ, 1996, J FAM PRACTICE, V42, P465; BARSKY AJ, 1993, CARDIOLOGY, V83, P304, DOI 10.1159/000175986; BARSKY AJ, 1994, AM J MED, V97, P214, DOI 10.1016/0002-9343(94)90003-5; BRENER J, 1988, PSYCHOPHYSIOLOGY, V25, P554, DOI 10.1111/j.1469-8986.1988.tb01891.x; BRENER J, 1993, PSYCHOPHYSIOLOGY, V30, P657, DOI 10.1111/j.1469-8986.1993.tb02091.x; CLARK PI, 1980, CHEST, V77, P722, DOI 10.1378/chest.77.6.722; CLARK WC, 1980, SCIENCE, V209, P410, DOI 10.1126/science.7384815; GRODMAN RS, 1979, AM HEART J, V98, P459, DOI 10.1016/0002-8703(79)90251-5; LIPSKI J, 1976, AM J CARDIOL, V37, P102, DOI 10.1016/0002-9149(76)90507-5; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; ROELANDT J, 1982, LONG TERN AMBULATORY; STONE A, 2000, SCI SELFREPORT IMPLI; ZELDIS SM, 1980, CHEST, V78, P456, DOI 10.1378/chest.78.3.456	19	34	37	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			832	837		10.7326/0003-4819-134-9_Part_2-200105011-00006	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346318				2022-12-28	WOS:000168543100006
J	Beevers, G; Lip, GYH; O'Brien, E				Beevers, G; Lip, GYH; O'Brien, E			ABC of hypertension - Blood pressure measurement Part II - Conventional sphygmomanometry: technique of auscultatory blood pressure measurement	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OBSERVERS											*BRIT HYP SOC, 1998, BLOOD PRESS MEAS; BURKE MJ, 1982, BRIT MED J, V285, P469, DOI 10.1136/bmj.285.6340.469; *EUR COMM STAND, 1995, 10602 EN EUR COMM ST; Keary L, 1998, J HUM HYPERTENS, V12, P787; O'Brien E, 2000, BRIT MED J, V320, P815, DOI 10.1136/bmj.320.7238.815; O'Brien E, 2000, HBK HYPERT, V20, P130; O'Brien E., 1997, BLOOD PRESSURE MEASU; O'Brien Eoin, 1991, V14, P1; OBRIEN E, 1991, J HUM HYPERTENS, V5, P7; OBrien E, 1996, LANCET, V348, P1569, DOI 10.1016/S0140-6736(96)10033-7; OBrien E, 1995, J HUM HYPERTENS, V9, P933; OBRIEN E, 1996, PRACTICAL MANAGEMENT, P13; ROSE G, 1965, LANCET, V1, P673	13	151	159	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2001	322	7293					1043	1047		10.1136/bmj.322.7293.1043	http://dx.doi.org/10.1136/bmj.322.7293.1043			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325773	Green Published			2022-12-28	WOS:000168478700027
J	Weiss, SC; Emanuel, LL; Fairclough, DL; Emanuel, EJ				Weiss, SC; Emanuel, LL; Fairclough, DL; Emanuel, EJ			Understanding the experience of pain in terminally ill patients	LANCET			English	Article							COOPERATIVE-ONCOLOGY-GROUP; CANCER PAIN; OPIOID ANALGESICS; FAMILY MEMBERS; HOSPICE; CAREGIVERS; CARE	Background Terminally ill patients commonly experience substantial pain. Unresolved pain has been cited as evidence that end-of-life care is of poor quality. However, the data on which that conclusion is based are limited. We aimed to provide additional data on the experience of pain in such patients. Methods We interviewed 988 terminally ill patients from six randomly selected US sites. We asked them who had treated their pain in the previous 4 weeks (primary-care physician, pain specialist, or both), and whether they wanted more pain medication than they were receiving, or why they did not want more. Findings 496 (50%) terminally ill patients reported moderate or severe pain. 514 (52%) individuals had seen a primary-care physician for treatment of pain in the previous 4 weeks and 198 (20%) saw a pain specialist. Of those who had been treated by their primary-care physician, 287 (29%) wanted more therapy, 613 (62%) wanted their pain therapy to remain the same, and 89 (9%) wanted to reduce or stop their pain therapy. Several reasons for not wanting additional therapy were offered-fear of addiction, dislike of mental or physical side-effects, and not wanting to take more pills or injections. We saw no association between disease and amount of pain between disease and the desire for more treatment. Black patients were more likely to seek additional pain therapy, see a pain specialist, and refuse additional medication because of fear of addiction than other populations. Interpretation Although half of terminally ill patients experienced moderate to severe pain, only 30% of them wanted additional pain treatment from their primary-care physician. The number of patients experiencing pain remains too high. However, the number is not as large as perceived. Additionally, most are willing to tolerate pain. Furthermore, the experience of pain is constant across major terminal diseases.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Northwestern Univ, Sch Med, Chicago, IL USA; AMC Canc Res Ctr, Ctr Res Methodol & Biometr, Denver, CO USA	National Institutes of Health (NIH) - USA; Northwestern University; AMC Cancer Research Center	Weiss, SC (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.							Arnst C, 1999, BUS WEEK, P190; Bonica J. J., 1980, PAIN, P335; BRESCIA FJ, 1992, J CLIN ONCOL, V10, P149, DOI 10.1200/JCO.1992.10.1.149; Cleeland CS, 1997, ANN INTERN MED, V127, P813, DOI 10.7326/0003-4819-127-9-199711010-00006; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; DAUT RL, 1982, CANCER-AM CANCER SOC, V50, P1913, DOI 10.1002/1097-0142(19821101)50:9<1913::AID-CNCR2820500944>3.0.CO;2-R; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; EMANMUEL LL, IN PRESS J PALLIATIV; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Field MJ, 1997, APPROACHING DEATH IM; Foley KM, 1998, OXFORD TXB PALLIATIV, P310; Jacox A, 1994, AHCPR PUBLICATION; Joranson DE, 2000, JAMA-J AM MED ASSOC, V283, P1710, DOI 10.1001/jama.283.13.1710; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; MCKEGNEY FP, 1981, GEN HOSP PSYCHIAT, V3, P95, DOI 10.1016/0163-8343(81)90050-5; MORRIS JN, 1986, J CHRON DIS, V39, P27, DOI 10.1016/0021-9681(86)90104-9; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; OSTER MW, 1978, ARCH INTERN MED, V138, P1801, DOI 10.1001/archinte.138.12.1801; Paice JA, 1998, J PAIN SYMPTOM MANAG, V16, P1, DOI 10.1016/S0885-3924(98)00025-6; Parker RA, 1999, JAMA-J AM MED ASSOC, V281, P1937, DOI 10.1001/jama.281.20.1937; Petrosino B M, 1985, Hosp J, V1, P3; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; PORTENOY RK, 1992, CANCER, V70, P616; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; STEIN WM, 1993, J PAIN SYMPTOM MANAG, V8, P474, DOI 10.1016/0885-3924(93)90190-7; Tay W. K. J., 1994, Annals Academy of Medicine Singapore, V23, P191; TWYCROSS RG, 1982, PAIN, V14, P303, DOI 10.1016/0304-3959(82)90137-3; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; Ward SE, 1996, RES NURS HEALTH, V19, P205, DOI 10.1002/(SICI)1098-240X(199606)19:3<205::AID-NUR4>3.0.CO;2-O	31	149	152	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1311	1315		10.1016/S0140-6736(00)04515-3	http://dx.doi.org/10.1016/S0140-6736(00)04515-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343734				2022-12-28	WOS:000168411400008
J	Collins, PC; Arnold, MS; Avouris, P				Collins, PC; Arnold, MS; Avouris, P			Engineering carbon nanotubes and nanotube circuits using electrical breakdown	SCIENCE			English	Article							SINGLE-WALL; ELECTRONIC-STRUCTURE; GRAPHENE TUBULES; TRANSPORT; ROPES	Carbon nanotubes display either metallic or semiconducting properties. Both Large, multiwalled nanotubes (MWNTs), with many concentric carbon shells, and bundles or "ropes" of aligned single-walled nanotubes (SWNTs), are complex composite conductors that incorporate many weakly coupled nanotubes that each have a different electronic structure. Here we demonstrate a simple and reliable method for selectively removing single carbon shells from MWNTs and SWNT ropes to tailor the properties of these composite nanotubes. We can remove shells of MWNTs stepwise and individually characterize the different shells. By choosing among the shells, we can convert a MWNT into either a metallic or a semiconducting conductor, as well as directly address the issue of multiple-shell transport. With SWNT ropes, similar selectivity allows us to generate entire arrays of nanoscale field-effect transistors based solely on the fraction of semiconducting SWNTs.	IBM Corp, Thomas J Watson Res Ctr, Yorktown Heights, NY 10598 USA	International Business Machines (IBM)	Avouris, P (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Heights, NY 10598 USA.		Arnold, Michael/L-9112-2015	Avouris, Phaedon/0000-0001-9902-8000				Bachtold A, 1999, NATURE, V397, P673, DOI 10.1038/17755; Chico L, 1996, PHYS REV LETT, V76, P971, DOI 10.1103/PhysRevLett.76.971; Collins PG, 2001, PHYS REV LETT, V86, P3128, DOI 10.1103/PhysRevLett.86.3128; Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523; Fischer JE, 1997, PHYS REV B, V55, pR4921, DOI 10.1103/PhysRevB.55.R4921; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kiang CH, 1998, PHYS REV LETT, V81, P1869, DOI 10.1103/PhysRevLett.81.1869; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; SAITO R, 1993, J APPL PHYS, V73, P494, DOI 10.1063/1.353358; Saito R, 1996, PHYS REV B, V53, P2044, DOI 10.1103/PhysRevB.53.2044; SAITO R, 1992, PHYS REV B, V46, P1804, DOI 10.1103/PhysRevB.46.1804; Schonenberger C, 1999, APPL PHYS A-MATER, V69, P283, DOI 10.1007/s003390051003; Stahl H, 2000, PHYS REV LETT, V85, P5186, DOI 10.1103/PhysRevLett.85.5186; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941	17	1480	1662	14	496	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					706	709		10.1126/science.1058782	http://dx.doi.org/10.1126/science.1058782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326094	Green Submitted			2022-12-28	WOS:000168478300045
J	Olsnes, S; Wesche, J				Olsnes, S; Wesche, J			Microbiology - Fighting anthrax with a mutant toxin	SCIENCE			English	Editorial Material							MEMBRANE		Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway	University of Oslo	Olsnes, S (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, N-0310 Oslo, Norway.			Wesche, Jorgen/0000-0002-9200-9162				Alouf J. E, 1999, COMPREHENSIVE SOURCE, V2nd; Leppla SH, 2000, HANDB EXP PHARM, V145, P445; Olsnes S, 2000, J GEN PHYSIOL, V115, P417, DOI 10.1085/jgp.115.4.417; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; VANDERGOTT G, 2001, CURRENT TOPICS MICRO, V257; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i	8	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					647	648		10.1126/science.1060857	http://dx.doi.org/10.1126/science.1060857			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330322				2022-12-28	WOS:000168478300029
J	Harnad, S				Harnad, S			The self-archiving initiative - Freeing the refereed research literature online.	NATURE			English	Editorial Material									Univ Southampton, Dept Elect & Comp Sci, Intelligence Agents Multimedia Grp, Southampton SO17 1BJ, Hants, England	University of Southampton	Harnad, S (corresponding author), Univ Southampton, Dept Elect & Comp Sci, Intelligence Agents Multimedia Grp, Southampton SO17 1BJ, Hants, England.		Harnad, Stevan R/A-1010-2008	Harnad, Stevan/0000-0001-6153-1129					0	84	87	1	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1024	+		10.1038/35074210	http://dx.doi.org/10.1038/35074210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323640				2022-12-28	WOS:000168285500019
J	Troy, CS; MacHugh, DE; Bailey, JF; Magee, DA; Loftus, RT; Cunningham, P; Chamberlain, AT; Sykes, BC; Bradley, DG				Troy, CS; MacHugh, DE; Bailey, JF; Magee, DA; Loftus, RT; Cunningham, P; Chamberlain, AT; Sykes, BC; Bradley, DG			Genetic evidence for Near-Eastern origins of European cattle	NATURE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; AFRICAN; SEQUENCE; SUGGESTS	The limited ranges of the wild progenitors of many of the primary European domestic species point to their origins further east in Anatolia or the fertile crescent(1,2). The wild ox (Bos primigenius), however, ranged widely(3) and it is unknown whether it was domesticated within Europe as one feature of a local contribution to the farming economy(1,2,4). Here we examine mitochondrial DNA control-region sequence variation from 392 extant animals sampled from Europe, Africa and the Near East, and compare this with data from four extinct British wild oxen. The ancient sequences cluster tightly in a phylogenetic analysis and are clearly distinct from modern cattle. Network analysis of modern Bos taurus identifies four star-like clusters of haplotypes, with intracluster diversities that approximate to that expected from the time depth of domestic history. Notably, one of these clusters predominates in Europe and is one of three encountered at substantial frequency in the Near East. In contrast, African diversity is almost exclusively composed of a separate haplogroup, which is encountered only rarely elsewhere. These data provide strong support for a derived Near-Eastern origin for European cattle.	Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland; Univ Coll Dublin, Fac Agr, Dept Anim Sci & Prod, Dublin 4, Ireland; Univ Sheffield, Dept Archaeol & Prehist, Sheffield S1 4ET, S Yorkshire, England; Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England	Trinity College Dublin; University College Dublin; University of Sheffield; University of Oxford	Bradley, DG (corresponding author), Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland.		Bradley, Daniel G/A-3240-2012; Chamberlain, Andrew T/F-2118-2018	Bradley, Daniel G/0000-0001-7335-7092; MacHugh, David/0000-0002-8112-4704				ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Bailey JF, 1996, P ROY SOC B-BIOL SCI, V263, P1467, DOI 10.1098/rspb.1996.0214; BANDELT HJ, 1995, GENETICS, V141, P743; Bokonyi S., 1974, HIST DOMESTIC ANIMAL; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Epstein H., 1971, ORIGIN DOMESTIC ANIM; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fu YX, 1997, GENETICS, V147, P915; Harris DR, 1996, ORIGINS SPREAD AGR P; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Macaulay V.A., 1998, CRED CREDIBLE REGION; MacHugh DE, 1999, PHILOS T ROY SOC B, V354, P99, DOI 10.1098/rstb.1999.0363; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SCHNEIDER SD, 1999, ARLEQUIN VER 2 0 SOF; Smith B.D., 1995, EMERGENCE AGR; TROY CS, 1998, THESIS U DUBLIN; Wendorf F, 1998, J ANTHROPOL ARCHAEOL, V17, P97, DOI 10.1006/jaar.1998.0319; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	22	416	447	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1088	1091		10.1038/35074088	http://dx.doi.org/10.1038/35074088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323670	Green Published			2022-12-28	WOS:000168285500046
J	Padwal, R; Straus, SE; McAlister, FA				Padwal, R; Straus, SE; McAlister, FA			Evidence based management of hypertension - Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; URIC-ACID; MORTALITY; MEN; STROKE; TRIGLYCERIDES; HOMOCYSTEINE		Univ Alberta, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada; Mt Sinai Hosp, Div Gen Internal Med, Toronto, ON M5G 1XS, Canada	University of Alberta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	McAlister, FA (corresponding author), Univ Alberta, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada.	Finlay.McAlister@ualberta.ca	McAlister, Finlay/C-4151-2013; Padwal, Raj/G-6903-2016	McAlister, Finlay/0000-0001-7435-3341; Padwal, Raj/0000-0003-3541-2817				Alderman MH, 1997, AM J HYPERTENS, V10, P1, DOI 10.1016/S0895-7061(96)00301-9; ASSMANN G, 1993, LIPID METABOLISM DIS; Avins AL, 2000, ARCH INTERN MED, V160, P1937, DOI 10.1001/archinte.160.13.1937; Behar S, 1999, Blood Coagul Fibrinolysis, V10 Suppl 1, pS41; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004; DANESH J, LOW GRADE INFLAMMATI; DUNN FG, 1990, J HYPERTENS, V8, P775, DOI 10.1097/00004872-199008000-00012; ERNST E, 1993, ANN INTERN MED, V118, P956, DOI 10.7326/0003-4819-118-12-199306150-00008; FOLSOM AR, 1990, STROKE, V21, P701, DOI 10.1161/01.STR.21.5.701; Grover SA, 1998, ARCH INTERN MED, V158, P655, DOI 10.1001/archinte.158.6.655; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Harjai KJ, 1999, ANN INTERN MED, V131, P376, DOI 10.7326/0003-4819-131-5-199909070-00009; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; LEVY D, 1994, CIRCULATION, V90, P1786, DOI 10.1161/01.CIR.90.4.1786; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Luft FC, 1999, J CARDIOVASC PHARM, V33, pS11, DOI 10.1097/00005344-199900001-00003; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Marang-van de Mheen PJ, 1998, AM J PUBLIC HEALTH, V88, P618, DOI 10.2105/AJPH.88.4.618; MULROW PJ, 1999, HYPERTENSION PRIMER, P271; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; PADWAL R, 2001, EVIDENCE BASED HYPER, P33; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rubins HB, 2000, ARCH INTERN MED, V160, P1903, DOI 10.1001/archinte.160.13.1903; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SHAPER AG, 1986, BRIT MED J, V293, P474, DOI 10.1136/bmj.293.6545.474; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; TUNSTALLPEDOE H, 1974, BRIT MED J, V303, P744; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Ward HJ, 1998, LANCET, V352, P670, DOI 10.1016/S0140-6736(05)60816-1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	40	107	117	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2001	322	7292					977	980		10.1136/bmj.322.7292.977	http://dx.doi.org/10.1136/bmj.322.7292.977			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312234	Green Published			2022-12-28	WOS:000168345100023
J	Meldrum, DR				Meldrum, DR			Sequencing genomes and beyond	SCIENCE			English	Article							DNA; AUTOMATION; DEVICE; ARRAY		Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Meldrum, DR (corresponding author), Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.	deedee@kant.ee.washington.edu						BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BOGUSLAVSKY J, 2001, DRUG DISCOVERY D JAN, P71; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; CANTOR CR, 1999, GENOMICS; Deamer DW, 2000, TRENDS BIOTECHNOL, V18, P147, DOI 10.1016/S0167-7799(00)01426-8; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Koutny L, 2000, ANAL CHEM, V72, P3388, DOI 10.1021/ac9913614; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; MARZIALI A, IN PRESS ANN REV BIO; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Meldrum D, 2000, GENOME RES, V10, P1288, DOI 10.1101/gr.157400; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Olson MV, 2001, NATURE, V409, P816, DOI 10.1038/35057271; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shi YN, 1999, ANAL CHEM, V71, P5354, DOI 10.1021/ac990518p; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WEBSTER JR, 1998, MICRO TOTAL ANAL SYS, P249	22	15	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					515	+		10.1126/science.292.5516.515	http://dx.doi.org/10.1126/science.292.5516.515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330300				2022-12-28	WOS:000168187300050
J	Lucia, MA; Ely, EW				Lucia, MA; Ely, EW			Superficial thrombophlebitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Nevada, Sch Med, Reno, NV 89520 USA; Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Vanderbilt University	Lucia, MA (corresponding author), Univ Nevada, Sch Med, Reno, NV 89520 USA.		Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1214	1214		10.1056/NEJM200104193441605	http://dx.doi.org/10.1056/NEJM200104193441605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309636				2022-12-28	WOS:000168127600005
J	Kane, B				Kane, B			Should we treat acute HIV infection?	ANNALS OF INTERNAL MEDICINE			English	News Item																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					1011	1013		10.7326/0003-4819-134-10-200105150-00022	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352709				2022-12-28	WOS:000168682500014
J	Goel, V				Goel, V		Crossroads 99 Grp	Appraising organised screening programmes for testing for genetic susceptibility to cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLORECTAL-CANCER; ABC		Dept Hlth Adm, Toronto, ON M5S 1A8, Canada		Goel, V (corresponding author), Dept Hlth Adm, McMurrich Bldg, Toronto, ON M5S 1A8, Canada.	vivek.goel@utoronto.ca	Bottorff, Joan L./A-6420-2018	Bottorff, Joan L./0000-0001-9724-5351; Goel, Vivek/0000-0002-1389-2007				Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; CADMAN D, 1991, AM J PREV MED, V7, P117; CLARKE A, 1995, BMJ-BRIT MED J, V311, P35, DOI 10.1136/bmj.311.6996.35; Cole TRP, 2000, BRIT MED J, V321, P943, DOI 10.1136/bmj.321.7266.943; *COUNC EUR, 2001, 164 ETS COUNC EUR; Haddow JE, 1999, BRIT MED J, V319, P531, DOI 10.1136/bmj.319.7209.531; Hardy RG, 2000, BRIT MED J, V321, P886, DOI 10.1136/bmj.321.7265.886; Holtzman NA, 1998, BMJ-BRIT MED J, V316, P852, DOI 10.1136/bmj.316.7134.852; KIZER KW, 1991, AM J PREV MED, V7, P117, DOI 10.1016/S0749-3797(18)30948-6; Scholefield JH, 2000, BRIT MED J, V321, P1004, DOI 10.1136/bmj.321.7267.1004; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wilson JMG, 1968, PRINCIPLES PRACTICE	13	31	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2001	322	7295					1174	1178		10.1136/bmj.322.7295.1174	http://dx.doi.org/10.1136/bmj.322.7295.1174			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348918	Green Published			2022-12-28	WOS:000168748900023
J	Israelachvili, J; Gourdon, D				Israelachvili, J; Gourdon, D			Liquids - Putting liquids under molecular-scale confinement	SCIENCE			English	Editorial Material							FORCES; SURFACES		Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Israelachvili, J (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.							BUSHAN B, 1995, NATURE, V374, P607; CHRISTENSON HK, 1982, J COLLOID INTERF SCI, V88, P79, DOI 10.1016/0021-9797(82)90156-4; Heuberger M, 2001, SCIENCE, V292, P905, DOI 10.1126/science.1058573; HORN RG, 1981, J CHEM PHYS, V75, P1400, DOI 10.1063/1.442146; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; VANMEGEN W, 1979, J CHEM SOC FARAD T 2, V75, P1095, DOI 10.1039/f29797501095	6	31	31	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					867	868		10.1126/science.1061206	http://dx.doi.org/10.1126/science.1061206			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341281				2022-12-28	WOS:000168514900028
J	Ogle, JM; Brodersen, DE; Clemons, WM; Tarry, MJ; Carter, AP; Ramakrishnan, V				Ogle, JM; Brodersen, DE; Clemons, WM; Tarry, MJ; Carter, AP; Ramakrishnan, V			Recognition of cognate transfer RNA by the 30S ribosomal subunit	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNA; PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI RIBOSOME; ELONGATION-FACTOR TU; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; A-SITE; DNA-REPLICATION; 70S RIBOSOME; P-SITE	Crystal structures of the 30S ribosomal subunit in complex with messenger RNA and cognate transfer RNA in the A site, both in the presence and absence of the antibiotic paromomycin, have been solved at between 3.1 and 3.3 angstroms resolution. Cognate transfer RNA (tRNA) binding induces global domain movements of the 30S subunit and changes in the conformation of the universally conserved and essential bases A1492, A1493, and G530 of 16S RNA. These bases interact intimately with the minor groove of the first two base pairs between the codon and anticodon, thus sensing Watson-Crick base-pairing geometry and discriminating against near-cognate tRNA, The third, or "wobble," position of the codon is free to accommodate certain noncanonical base pairs. By partially inducing these structural changes, paromomycin facilitates binding of near-cognate tRNAs.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Brodersen, Ditlev E./AAQ-5241-2020; Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Ramakrishnan, V/0000-0002-4699-2194; Brodersen, Ditlev/0000-0002-5413-4667; Carter, Andrew/0000-0001-7292-5430	NIGMS NIH HHS [GM 44973, F31 GM019384] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM019384, R01GM044973] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EIGEN M, 1966, NATURWISSENSCHAFTEN, V53, P50, DOI 10.1007/BF00594747; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Gate JH, 1996, SCIENCE, V273, P1696, DOI 10.1126/science.273.5282.1696; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KURLAND CG, 1996, CELLULAR MOL BIOL, V1, P979; MCCARTHY BJ, 1965, P NATL ACAD SCI USA, V54, P880, DOI 10.1073/pnas.54.3.880; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NISSEN P, 2001, P NATL ACAD SCI US 1; OConnor M, 1995, BIOCHEM CELL BIOL, V73, P859, DOI 10.1139/o95-093; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; POTAPOV AP, 1995, J BIOL CHEM, V270, P17680, DOI 10.1074/jbc.270.30.17680; POTAPOV AP, 1982, FEBS LETT, V146, P5, DOI 10.1016/0014-5793(82)80693-5; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; VanLoock MS, 1999, J MOL BIOL, V285, P2069, DOI 10.1006/jmbi.1998.2442; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yokoyama Shigeyuki, 1995, P207; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	50	933	992	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					897	902		10.1126/science.1060612	http://dx.doi.org/10.1126/science.1060612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340196				2022-12-28	WOS:000168514900034
J	Richard, GV; Nakamoto, DM; Lockwood, JH				Richard, GV; Nakamoto, DM; Lockwood, JH			Medical career choices: Traditional and new possibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Richard, GV (corresponding author), Assoc Amer Med Coll, Washington, DC 20037 USA.							AMBROSE P, 1996, NEW PHYSICIAN, V45, P44; Eggener S, 1998, JAMA, V279, P1400, DOI 10.1001/jama.279.17.1400; Fraker S, 1998, JAMA, V279, P1399, DOI 10.1001/jama.279.17.1399; LINNEY B, 1996, HOPE FUTURE CAREER D; Timpane J, 1998, JAMA, V279, P1401, DOI 10.1001/jama.279.17.1401	5	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2249	2250		10.1001/jama.285.17.2249	http://dx.doi.org/10.1001/jama.285.17.2249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325331	hybrid			2022-12-28	WOS:000168256100031
J	Schwetz, BA				Schwetz, BA			Two ophthalmic solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2186	2186		10.1001/jama.285.17.2186	http://dx.doi.org/10.1001/jama.285.17.2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325309				2022-12-28	WOS:000168256100008
J	Ginsburg, J				Ginsburg, J		Amer Coll Phys Amer Soc Internal	Physicians and joint negotiations	ANNALS OF INTERNAL MEDICINE			English	Article								This position paper of the American College of Physicians-American Society of Internal Medicine addresses public policy issues related to physicians' joining to negotiate issues affecting patient care and the working environment in which patient services are provided. It seeks to identify an appropriate way for physicians to negotiate jointly with health care plans while maintaining professionalism and keeping the interests of patients paramount. It proposes that physicians in nonintegrated private practices should be able to meet and communicate among themselves for the purpose of negotiating primarily with health care plans about specific issues that affect quality and access, However, the College opposes strikes or any joint action by physicians that would deny or limit services to patients or result in price-fixing or other anticompetitive behavior. The College states that employed physicians should continue to have negotiating rights. It maintains, despite a recent decision by the National Labor Relations Board, that collective bargaining is not appropriate for resident physicians. Physicians in residency training are protected by accreditation requirements for programs of graduate medical education, and educational content should not be subject to negotiations. The College also calls for determination of negotiating units for physicians but recommends that nonphysician providers not be included in the same units as physicians. Membership in an organization that negotiates for physicians should be voluntary, and conflict-resolution mechanisms must be available for resolving impasses.	Amer Coll Physicians, Amer Soc Internal Med, Washington, DC 20006 USA; Amer Coll Physicians, Amer Soc Internal Med, Customer Serv, Philadelphia, PA 19106 USA	American College of Physicians; American College of Physicians	Ginsburg, J (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, 2011 Penn Ave NW, Washington, DC 20006 USA.							ADELSON A, 1997, NY TIMES        0405, P1; ADELSON A, 1997, NY TIMES        0405, P28; *AM COLL PHYS, 1998, ETH MAN; *AM MED ASS, 1997, HOUS DEL P 50 INT M, P87; *AM MED ASS COUNC, 1998, HOUS DEL P 147 ANN M; COHEN JJ, 1997, COMMUNICATION   0724; FOUBISTER V, 1998, AM MED NEWS     0720; GRINFELD MJ, 1998, MED BEHAV        DEC; GUADAGNINO C, 1997, PHYSICIANS NEWS  DEC; HOWLAND DR, 1998, ACP ASIM OBSERVER, V18, P1; MYERSON M, BRIEF CIR HIST; Snyder L, 1998, J AM GERIATR SOC, V46, P378, DOI 10.1111/j.1532-5415.1998.tb01058.x	12	16	16	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					787	792		10.7326/0003-4819-136-9-200205070-00023	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00023			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329239				2022-12-28	WOS:000168470700010
J	McNamee, D				McNamee, D			Cancer paper retracted	LANCET			English	News Item																		BEZWODA WR, 1995, J CLIN ONCOL, V13, P2483, DOI 10.1200/JCO.1995.13.10.2483	1	0	0	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1343	1343		10.1016/S0140-6736(00)04535-9	http://dx.doi.org/10.1016/S0140-6736(00)04535-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343749				2022-12-28	WOS:000168411400022
J	Amelino-Camelia, G				Amelino-Camelia, G			A phenomenological description of space-time noise in quantum gravity	NATURE			English	Article							INTERFEROMETER; CPT	Space-time 'foam' is a geometric picture of the smallest size scales in the Universe, which is characterized mainly by the presence of quantum uncertainties in the measurement of distances. All quantum-gravity theories should predict some kind of foam(1,2), but the description of the properties of this foam varies according to the theory, thereby providing a possible means of distinguishing between such theories. I previously showed(3) that foam-induced distance fluctuations would introduce a new source of noise to the measurements of gravity-wave interferometers, but the theories are insufficiently developed(4) to permit detailed predictions that would be of use to experimentalists. Here I propose a phenomenological approach that directly describes space-time foam, and which leads naturally to a picture of distance fluctuations that is independent of the details of the interferometer. The only unknown in the model is the length scale that sets the overall magnitude of the effect, but recent data(5) already rule out the possibility that this length scale could be identified with the 'string length' (10(-34) m < L-s < 10(-33) m). Length scales even smaller than the 'Planck length' (L-P approximate to 10(-35) m) will soon be probed experimentally.	Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	Sapienza University Rome	Amelino-Camelia, G (corresponding author), Univ Roma La Sapienza, Dipartimento Fis, Ple Moro 2, I-00185 Rome, Italy.	amelino@roma1.infn.it						Abramovici A, 1996, PHYS LETT A, V218, P157, DOI 10.1016/0375-9601(96)00377-5; ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; Adler R, 1995, PHYS LETT B, V364, P239, DOI 10.1016/0370-2693(95)01416-0; Ahluwalia DV, 1999, NATURE, V398, P199, DOI 10.1038/18325; Amelino-Camelia G, 1999, NATURE, V398, P216, DOI 10.1038/18377; Amelino-Camelia G, 1998, NATURE, V393, P763, DOI 10.1038/31647; Amelino-Camelia G, 2000, LECT NOTES PHYS, V541, P1; AMELINOCAMELIA, 2000, PHYS REV D; AMELINOCAMELIA G, 2001, GRQC0104005; ASHTEKAR A, 1999, GRQC9901023; Astone P, 1996, PHYS LETT B, V385, P421, DOI 10.1016/0370-2693(96)00965-3; Caron B, 1997, CLASSICAL QUANT GRAV, V14, P1461, DOI 10.1088/0264-9381/14/6/011; Danzmann K, 1996, CLASSICAL QUANT GRAV, V13, pA247, DOI 10.1088/0264-9381/13/11A/033; ELLIS J, 1984, NUCL PHYS B, V241, P381, DOI 10.1016/0550-3213(84)90053-1; Garay LJ, 1998, PHYS REV LETT, V80, P2508, DOI 10.1103/PhysRevLett.80.2508; Green M.B., 1988, SUPERSTRING THEORY, V1; HAWKING SW, 1978, NUCL PHYS B, V144, P349, DOI 10.1016/0550-3213(78)90375-9; HUET P, 1995, NUCL PHYS B, V434, P3, DOI 10.1016/0550-3213(94)00390-Z; KOSTELECKY VA, 1995, PHYS REV D, V51, P3923, DOI 10.1103/PhysRevD.51.3923; Maggiore M, 2000, PHYS REP, V331, P284; Ng YJ, 2000, FOUND PHYS, V30, P795, DOI 10.1023/A:1003745212871; Polchinski J., 1998, STRING THEORY, DOI [10.1017/CBO9780511618123, DOI 10.1017/CBO9780511618123]; RADEKA V, 1988, ANNU REV NUCL PART S, V38, P217, DOI 10.1146/annurev.ns.38.120188.001245; Rovelli C, 2000, LECT NOTES PHYS, V541, P277; Smolin L, 1999, PHYS WORLD, V12, P79; 't Hooft G, 1999, CLASSICAL QUANT GRAV, V16, P3263, DOI 10.1088/0264-9381/16/10/316; Wheeler J. A., 1974, Revista Mexicana de Fisica, V23, P1	28	62	62	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1065	1067		10.1038/35074035	http://dx.doi.org/10.1038/35074035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323663	Green Submitted			2022-12-28	WOS:000168285500039
J	Lin, FYC; Ho, VA; Khiem, HB; Trach, DD; Bay, PV; Thanh, TC; Kossaczka, Z; Bryla, DA; Shiloach, J; Robbins, JB; Schneerson, R; Szu, SC; Lanh, MN; Hunt, S; Trinh, L; Kaufman, JB				Lin, FYC; Ho, VA; Khiem, HB; Trach, DD; Bay, PV; Thanh, TC; Kossaczka, Z; Bryla, DA; Shiloach, J; Robbins, JB; Schneerson, R; Szu, SC; Lanh, MN; Hunt, S; Trinh, L; Kaufman, JB			The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZAE TYPE-B; CAPSULAR POLYSACCHARIDE; IMMUNOLOGICAL PROPERTIES; PUBLIC-HEALTH; FEVER; IMMUNOGENICITY; PREVENTION; IMMUNIZATION; TAJIKISTAN; RESISTANCE	Background: Typhoid fever is common in developing countries. The licensed typhoid vaccines confer only about 70 percent immunity, do not protect young children, and are not used for routine vaccination. A newly devised conjugate of the capsular polysaccharide of Salmonella typhi, Vi, bound to nontoxic recombinant Pseudomonas aeruginosa exotoxin A (rEPA), has enhanced immunogenicity in adults and in children 5 to 14 years old and has elicited a booster response in children 2 to 4 years old. Methods: In a double-blind, randomized trial, we evaluated the safety, immunogenicity, and efficacy of the Vi-rEPA vaccine in children two to five years old in 16 communes in Dong Thap Province, Vietnam. Each of the 11,091 children received two injections six weeks apart of either Vi-rEPA or a saline placebo. Cases of typhoid, diagnosed by the isolation of S. typhi from blood cultures after 3 or more days of fever (a temperature of 37.5 degreesC or higher), were identified by active surveillance over a period of 27 months. We estimated efficacy by comparing the attack rate of typhoid in the vaccine group with that in the placebo group. Results: S. typhi was isolated from 4 of the 5525 children who were fully vaccinated with Vi-rEPA and from 47 of the 5566 children who received both injections of placebo (efficacy, 91.5 percent; 95 percent confidence interval, 77.1 to 96.6 percent; P<0.001). Among the 771 children who received only one injection, there was 1 case of typhoid in the vaccine group and 8 cases in the placebo group. Cases were distributed evenly among all age groups and throughout the study period. No serious adverse reactions were observed. In all 36 children studied four weeks after the second injection of the vaccine, levels of serum IgG Vi antibodies had increased by a factor of 10 or more. Conclusions: The Vi-rEPA conjugate typhoid vaccine is safe and immunogenic and has more than 90 percent efficacy in children two to five years old. The antibody responses and the efficacy suggest that this vaccine should be at least as protective in persons who are more than five years old. (N Engl J Med 2001;344:1263-9.) Copyright (C) 2001 Massachusetts Medical Society.	NICHHD, Bethesda, MD 20892 USA; NIDDKD, NIH, Bethesda, MD 20892 USA; Dong Thap Prov Hosp, Cao Lanh, Vietnam; Inst Pasteur, Ho Chi Minh City, Vietnam; Natl Inst Hyg & Epidemiol, Hanoi, Vietnam	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Hygiene & Epidemiology (NIHE)	Lin, FYC (corresponding author), NICHHD, Rm 7B03,6100 Execut Blvd, Bethesda, MD 20892 USA.	link@exchange.nih.gov		Hunt, Steven/0000-0003-3533-0627	NICHD NIH HHS [N01-HD-3269] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001308] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK015500, Z01DK015500] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; *ADV COMM IMM PRAC, 1994, MMWR-MORBID MORTAL W, V14, P1; BHUTTA ZA, 1991, REV INFECT DIS, V13, P832; BYSTRICKY S, 1994, BIOPHYS CHEM, V51, P1, DOI 10.1016/0301-4622(94)00002-6; ESCAMILLA J, 1983, J CLIN MICROBIOL, V18, P380, DOI 10.1128/JCM.18.2.380-383.1983; FAROOQUI BJ, 1991, J CLIN PATHOL, V44, P258, DOI 10.1136/jcp.44.3.258; Felix A, 1934, LANCET, V2, P186; GALLOWAY H, 1966, ARCH DIS CHILD, V41, P63, DOI 10.1136/adc.41.215.63; GILMAN RH, 1975, LANCET, V1, P1211; IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957; KEITEL WA, 1994, VACCINE, V12, P195, DOI 10.1016/0264-410X(94)90194-5; KLUGMAN KP, 1987, LANCET, V2, P1165; Kossaczka Z, 1997, INFECT IMMUN, V65, P2088, DOI 10.1128/IAI.65.6.2088-2093.1997; Kossaczka Z, 1999, INFECT IMMUN, V67, P5806, DOI 10.1128/IAI.67.11.5806-5810.1999; LANDY M, 1954, AM J HYG, V60, P52, DOI 10.1093/oxfordjournals.aje.a119703; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Mermin JH, 1998, ARCH INTERN MED, V158, P633, DOI 10.1001/archinte.158.6.633; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; NOLAN CM, 1980, J MED MICROBIOL, V13, P373, DOI 10.1099/00222615-13-2-373; RAO P T, 1959, Indian J Pediatr, V26, P258; Robbins JB, 1996, JAMA-J AM MED ASSOC, V276, P1181, DOI 10.1001/jama.276.14.1181; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361; SCRAGG J, 1969, ARCH DIS CHILD, V44, P18, DOI 10.1136/adc.44.233.18; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; SZU SC, 1991, INFECT IMMUN, V59, P4555, DOI 10.1128/IAI.59.12.4555-4561.1991; SZU SC, 1989, INFECT IMMUN, V57, P3823, DOI 10.1128/IAI.57.12.3823-3827.1989; SZU SC, 1994, INFECT IMMUN, V62, P4440, DOI 10.1128/IAI.62.10.4440-4444.1994; SZU SC, 1987, J EXP MED, V166, P1510, DOI 10.1084/jem.166.5.1510; Tarr PE, 1999, AM J TROP MED HYG, V61, P163, DOI 10.4269/ajtmh.1999.61.163; THISYAKORN U, 1987, AM J DIS CHILD, V141, P862, DOI 10.1001/archpedi.1987.04460080048025; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; *WHO, 1994, WHO TECH REP SER, V840, P15	37	322	336	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1263	1269		10.1056/NEJM200104263441701	http://dx.doi.org/10.1056/NEJM200104263441701			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320385				2022-12-28	WOS:000168252400001
J	Dutnall, RN; Pillus, L				Dutnall, RN; Pillus, L			Deciphering NAD-dependent deacetylases	CELL			English	Review							SILENCING PROTEIN SIR2; YEAST; FAMILY		Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dutnall, RN (corresponding author), Univ Calif San Diego, Div Biol, Pacific Hall 0347,9500 Gilman Dr, La Jolla, CA 92093 USA.							Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Gottschling DE, 2000, CURR BIOL, V10, pR708, DOI 10.1016/S0960-9822(00)00714-4; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	20	33	40	2	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					161	164		10.1016/S0092-8674(01)00305-1	http://dx.doi.org/10.1016/S0092-8674(01)00305-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336664	Bronze			2022-12-28	WOS:000168384300001
J	Wijdicks, EFM				Wijdicks, EFM			Current concepts: The diagnosis of brain death.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSCRANIAL DOPPLER; MOVEMENTS		Mayo Clin, Dept Neurol, Neurol & Neurosurg Intens Care Unit, Rochester, MN 55905 USA	Mayo Clinic	Wijdicks, EFM (corresponding author), Mayo Clin, Dept Neurol, Neurol & Neurosurg Intens Care Unit, 200 1st St SW, Rochester, MN 55905 USA.	wijde@mayo.edu						*AM EL SOC, 1994, J CLIN NEUROPHYSIOL, V11, P10; AMES A, 1968, AM J PATHOL, V52, P437; [Anonymous], 1976, BMJ-BRIT MED J, V2, P1187; [Anonymous], 1968, JAMA, V205, P337; [Anonymous], 1990, NEUROLOGY, V40, P680; [Anonymous], 1987, PEDIATRICS, V80, P298; Ashwal S, 1997, CLIN PERINATOL, V24, P859, DOI 10.1016/S0095-5108(18)30154-4; ASHWAL S, 1987, PEDIATR NEUROL, V3, P5, DOI 10.1016/0887-8994(87)90046-4; ASHWAL S, 1987, PEDIATR NEUROL, V3, P69, DOI 10.1016/0887-8994(87)90030-0; BONETTI MG, 1995, NEURORADIOLOGY, V37, P365; BRADAC GB, 1974, NEURORADIOLOGY, V7, P25, DOI 10.1007/BF00344671; Brock DW, 1999, DEFINITION OF DEATH, P293; Christie JM, 1996, J CLIN ANESTH, V8, P141, DOI 10.1016/0952-8180(95)00200-6; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Goldfrank LR, 1998, GOLDFRANKS TOXICOLOG; Goudreau JL, 2000, NEUROLOGY, V55, P1045, DOI 10.1212/WNL.55.7.1045; GRATTANSMITH PJ, 1993, ARCH DIS CHILD, V69, P151, DOI 10.1136/adc.69.1.151; HANNA JP, 1995, NEUROLOGY, V45, P985, DOI 10.1212/WNL.45.5.985; Haupt WF, 1999, J NEUROL, V246, P432, DOI 10.1007/s004150050378; HUNG TP, 1995, J NEUROL NEUROSUR PS, V58, P75, DOI 10.1136/jnnp.58.1.75; KOTSORIS H, 1984, ANN NEUROL, V16, P150; MARKS SJ, 1990, ARCH NEUROL-CHICAGO, V47, P1066, DOI 10.1001/archneur.1990.00530100028009; Marti-Fabregas J, 2000, NEUROLOGY, V54, P224, DOI 10.1212/WNL.54.1.224; MCNAIR NL, 1992, MOVEMENT DISORD, V7, P345, DOI 10.1002/mds.870070408; MOHANDAS A, 1971, J NEUROSURG, V35, P211, DOI 10.3171/jns.1971.35.2.0211; MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; President's Commission for the Study of Ethical Problems in Medicine, 1981, DEF DEATH REP MED LE; ROPPER AH, 1981, J NEUROSURG, V55, P942, DOI 10.3171/jns.1981.55.6.0942; ROPPER AH, 1984, NEUROLOGY, V34, P1089, DOI 10.1212/WNL.34.8.1089; ROPPER AH, 1987, NEUROLOGY, V37, P1733, DOI 10.1212/WNL.37.11.1733; ROSENBERG JH, 1995, NEUROLOGY, V45, P1012; Saposnik G, 2000, NEUROLOGY, V54, P221, DOI 10.1212/WNL.54.1.221; SILVERMAN D, 1969, J AMER MED ASSOC, V209, P1505, DOI 10.1001/jama.209.10.1505; Van Norman GA, 1999, ANESTHESIOLOGY, V91, P275, DOI 10.1097/00000542-199907000-00036; Wijdicks Eelco F. M., 2001, BRAIN DEATH; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; Wijdicks EFM, 2001, J NEUROL NEUROSUR PS, V70, P127, DOI 10.1136/jnnp.70.1.127; Willatts SM, 2000, ANAESTHESIA, V55, P676, DOI 10.1046/j.1365-2044.2000.01421.x; YANG KL, 1991, CHEST, V99, P1037, DOI 10.1378/chest.99.4.1037	42	381	418	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2001	344	16					1215	1221		10.1056/NEJM200104193441606	http://dx.doi.org/10.1056/NEJM200104193441606			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422PM	11309637				2022-12-28	WOS:000168127600006
J	Hunt, K; Emslie, C; Watt, G				Hunt, K; Emslie, C; Watt, G			Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter?	LANCET			English	Article							QUALITATIVE-RESEARCH; LIFE-STYLE; HEALTH; RISK; PERCEPTIONS; ADVICE; CARE	Background Family history is recognised as a risk factor for coronary heart disease (CHD) by epidemiologists, health professionals, and the public, and could act either as a spur or barrier to changing health behaviour. However, there has been no systematic investigation of which factors affect whether people regard themselves as having a family history of CHD or not. Methods We used purposive sampling to select 61 men and women who were middle class or working class from a large cross-sectional survey. Half the respondents had indicated in this previous survey that they had heart disease in their family. The range of understanding of the meaning of having a family history was explored in detailed qualitative ssmistructured interviews. Findings Perception of a family history of heart disease depended on knowledge of the health of family members, the number and closeness of relatives with heart conditions, the age of affected relatives, and the respondent's sex and social class. Men, particularly working-class men, required a greater number of close relatives to be affected to perceive that they had a family history. Even when respondents judged that heart disease ran in their family, they did not always perceive themselves as at increased risk because they felt different in crucial ways from affected relatives. Interpretation The factors that people and epidemiologists judge as relevant to establish presence of a family history can differ. We suggest that these differences could lead to misunderstandings between doctor and patient, which could undermine advice on CHD risks and associated behavioural changes.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Glasgow	Hunt, K (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		G, G/A-3459-2012	Emslie, Carol/0000-0003-2170-2039				BACKETT KC, 1995, SOC SCI MED, V40, P629, DOI 10.1016/0277-9536(94)E0120-H; Britten N, 2000, BMJ-BRIT MED J, V320, P484, DOI 10.1136/bmj.320.7233.484; BRITTEN N, 1995, FAM PRACT, V311, P42; Brorsson A, 1995, FAM PRACT, V12, P433, DOI 10.1093/fampra/12.4.433; Butler CC, 1998, BMJ-BRIT MED J, V316, P1878; DAVISON C, 1989, Health Education Research, V4, P329, DOI 10.1093/her/4.3.329; *DEP HLTH, 1998, OUR HLTH NAT CONTR H; Emslie C, 2001, SOCIOL HEALTH ILL, V23, P203, DOI 10.1111/1467-9566.00248; Hunt K, 2000, HEALTH EDUC RES, V15, P131, DOI 10.1093/her/15.2.131; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; KREUTER MW, 1995, HEALTH PSYCHOL, V14, P56, DOI 10.1037/0278-6133.14.1.56; MARTEAU TM, 1995, BRIT J GEN PRACT, V45, P5; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Mostyn B., 1985, RES INTERVIEW, P115; Ponder M, 1996, J MED GENET, V33, P485, DOI 10.1136/jmg.33.6.485; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Richards M, 1996, TROUBLED HELIX SOCIA, P249, DOI DOI 10.1017/CBO9780511570049.014; Silberberg J, 1999, GENET EPIDEMIOL, V16, P344, DOI 10.1002/(SICI)1098-2272(1999)16:4<344::AID-GEPI2>3.0.CO;2-Q; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Stott NCH, 1995, FAM PRACT, V12, P413, DOI 10.1093/fampra/12.4.413; The Scottish Office, 1999, HLTH SCOTL WHIT PAP; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; Watt G, 2000, J EPIDEMIOL COMMUN H, V54, P859, DOI 10.1136/jech.54.11.859; [No title captured]	26	75	75	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1168	1171		10.1016/S0140-6736(00)04334-8	http://dx.doi.org/10.1016/S0140-6736(00)04334-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323044				2022-12-28	WOS:000168192100011
J	Essex, C				Essex, C			Delivering bad news - Receiving bad news will always be unpleasant	BRITISH MEDICAL JOURNAL			English	Letter									Gulson Hosp, Child Dev Univ, Coventry CV1 2HR, W Midlands, England		Essex, C (corresponding author), Gulson Hosp, Child Dev Univ, Coventry CV1 2HR, W Midlands, England.							HOSKING EJ, 2000, BRIT MED J, V321, P2; 2000, BMJ, V321, P1233	2	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					864	865						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11321015				2022-12-28	WOS:000168063000054
J	Cane, MA; Molnar, P				Cane, MA; Molnar, P			Closing of the Indonesian seaway as a precursor to east African aridircation around 3-4 million years ago	NATURE			English	Article							INDIAN-OCEAN; RAINFALL ANOMALIES; PACIFIC; HALMAHERA; BOUNDARY; CLIMATE; REFLECTION; AUSTRALIA; EVOLUTION; MODEL	Global climate change around 3-4 Myr ago is thought to have influenced the evolution of hominids, via the aridification of Africa, and may have been the precursor to Pleistocene glaciation about 2.75 Myr ago. Most explanations of these climatic events involve changes in circulation of the North Atlantic Ocean due to the closing of the Isthmus of Panama. Here we suggest, instead, that closure of the Indonesian seaway 3-4 Myr ago could be responsible for these climate changes, in particular the aridification of Africa. We use simple theory and results from an ocean circulation model to show that the northward displacement of New Guinea, about 5 Myr ago, may have switched the source of flow through Indonesia-from warm South Pacific to relatively cold North Pacific waters. This would have decreased sea surface temperatures in the Indian Ocean, leading to reduced rainfall over eastern Africa. We further suggest that the changes in the equatorial Pacific may have reduced atmospheric heat transport from the tropics to higher latitudes, stimulating global cooling and the eventual growth of ice sheets.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Dept Geol Sci, Boulder, CO 80309 USA	Columbia University; Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Boulder	Cane, MA (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA.	mcane@ldeo.columbia.edu	Cane, Mark/I-8086-2012	Cane, Mark/0000-0001-5408-2388				ABBOTT M.J., 1981, SPEC PUBL GEOL RES D, V2, P253; AUDLEYCHARLES MG, 1981, THRUST NAPPE TECTONI, P407; BESSE J, 1991, J GEOPHYS RES-SOLID, V96, P4029, DOI 10.1029/90JB01916; BONNEFILLE R, 1983, NATURE, V303, P487, DOI 10.1038/303487a0; BONNEFILLE R, 1987, PALAEOGEOGR PALAEOCL, V60, P249, DOI 10.1016/0031-0182(87)90035-6; Bonnefille R, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P299; Bonnefille R., 1984, EVOLUTION E ASIAN EN, VII, P579; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; CANE MA, 1977, J MAR RES, V35, P395; CANE MA, 1982, J MAR RES, V40, P937; Chaisson WP, 2000, PALEOCEANOGRAPHY, V15, P497, DOI 10.1029/1999PA000442; CHAPPELL J, 1978, GEOL SOC AM BULL, V89, P356, DOI 10.1130/0016-7606(1978)89<356:LQTMAS>2.0.CO;2; CHARLTON TR, 1986, NATURE, V319, P394, DOI 10.1038/319394a0; CLARKE AJ, 1991, J GEOPHYS RES-OCEANS, V96, P3289, DOI 10.1029/90JC00985; DALY MC, 1991, MAR PETROL GEOL, V8, P2, DOI 10.1016/0264-8172(91)90041-X; de Heinzelin J, 1999, SCIENCE, V284, P625; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DOW DB, 1977, GEOL GEOPHYS B, V201; DUPENHOAT Y, 1991, J GEOPHYS RES-OCEANS, V96, P3307, DOI 10.1029/90JC01798; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Goddard L, 1999, J GEOPHYS RES-ATMOS, V104, P19099, DOI 10.1029/1999JD900326; Gordon AL, 1999, GEOPHYS RES LETT, V26, P3325, DOI 10.1029/1999GL002340; GORDON AL, 1986, J GEOPHYS RES-OCEANS, V91, P5037, DOI 10.1029/JC091iC04p05037; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; HALL R, 1988, J GEOL SOC LONDON, V145, P577, DOI 10.1144/gsjgs.145.4.0577; Hall R., 1996, TECTONIC EVOLUTION S, V106, P153; HASTENRATH S, 1993, J GEOPHYS RES-OCEANS, V98, P20219, DOI 10.1029/93JC02330; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; Hill A, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P178; Indeje M, 2000, INT J CLIMATOL, V20, P19, DOI [10.1002/(SICI)1097-0088(200001)20:1<19::AID-JOC449>3.0.CO;2-0, 10.1002/(SICI)1097-0088(200001)20:1&lt;19::AID-JOC449&gt;3.0.CO;2-0]; Johnson GC, 1999, J PHYS OCEANOGR, V29, P3073, DOI 10.1175/1520-0485(1999)029<3073:IPFFTS>2.0.CO;2; Latif M, 1999, J CLIMATE, V12, P3497, DOI 10.1175/1520-0442(1999)012<3497:TROIOS>2.0.CO;2; Leakey MG, 1996, J VERTEBR PALEONTOL, V16, P556, DOI 10.1080/02724634.1996.10011339; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Moore D. W., 1977, The sea. Ideas and observations on progress in the study of the seas. Vol.6. Marine modeling, P319; Morey SL, 1999, J GEOPHYS RES-OCEANS, V104, P23281, DOI 10.1029/1999JC900195; NICHOLS GJ, 1991, MAR PETROL GEOL, V8, P50, DOI 10.1016/0264-8172(91)90044-2; Packham G., 1996, GEOL SOC LOND SPEC P, V106, P123; PUNTODEWO SSO, 1994, TECTONOPHYSICS, V237, P141, DOI 10.1016/0040-1951(94)90251-8; RANGIN C, 1990, B SOC GEOL FR, V6, P889; Rangin C, 1999, GEOPHYS J INT, V139, P296, DOI 10.1046/j.1365-246x.1999.00969.x; REVERDIN G, 1986, Q J ROY METEOR SOC, V112, P43, DOI 10.1002/qj.49711247104; Rodgers KB, 2000, GEOPHYS RES LETT, V27, P2941, DOI 10.1029/1999GL002372; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; SILVER EA, 1978, J GEOPHYS RES, V83, P1681, DOI 10.1029/JB083iB04p01681; SMITH IE, 1976, GEOL GEOPHYS B, V165; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; VEEVERS JJ, 1978, TECTONOPHYSICS, V45, P217, DOI 10.1016/0040-1951(78)90008-2; Wesselman HB, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P356; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	54	378	414	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					157	162		10.1038/35075500	http://dx.doi.org/10.1038/35075500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346785				2022-12-28	WOS:000168563000040
J	Freed, AM; Lin, J				Freed, AM; Lin, J			Delayed triggering of the 1999 Hector Mine earthquake by viscoelastic stress transfer	NATURE			English	Article							LANDERS EARTHQUAKE; LOWER CRUST; FAILURE STRESS; CALIFORNIA; DEFORMATION; SEQUENCE; AFTERSHOCKS; NORTHRIDGE; FAULT; SEISMICITY	Stress changes in the crust due to an earthquake can hasten the failure of neighbouring faults and induce earthquake sequences in some cases(1-5). The 1999 Hector Mine earthquake in southern California (magnitude 7.1) occurred only 20 km from, and 7 years after, the 1992 Landers earthquake (magnitude 7.3). This suggests that the Hector Mine earthquake was triggered in some fashion by the earlier event. But uncertainties in the slip distribution and rock friction properties associated with the Landers earthquake have led to widely varying estimates of both the magnitude and sign of the resulting stress change that would be induced at the location of the Hector Mine hypocentre-with estimates varying from -1.4 bar (ref. 6) to +0.5 bar (ref. 7). More importantly, coseismic stress changes alone cannot satisfactorily explain the delay of 7 years between the two events. Here we present the results of a three-dimensional viscoelastic model that simulates stress transfer from the ductile lower crust and upper mantle to the brittle upper crust in the 7 years following the Landers earthquake. Using viscoelastic parameters that can reproduce the observed horizontal surface deformation following the Landers earthquake, our calculations suggest that lower-crustal or upper-mantle flow can lead to postseismic stress increases of up to 1-2 bar at the location of the Hector Mine hypocentre during this time period, contributing to the eventual occurrence of the 1999 Hector Mine earthquake. These results attest to the importance of considering viscoelastic processes in the assessment of seismic hazard(8-11).	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Carnegie Institution for Science; Woods Hole Oceanographic Institution	Freed, AM (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	freed@dtm.ciw.edu		Lin, Jian/0000-0002-6831-2014				Behr J., 2000, SEISMOL RES LETT, V71, P11; Bock Y, 1997, J GEOPHYS RES-SOL EA, V102, P18013, DOI 10.1029/97JB01379; Deng JS, 1996, GEOPHYS RES LETT, V23, P1155, DOI 10.1029/96GL00738; Deng JS, 1999, GEOPHYS RES LETT, V26, P3209, DOI 10.1029/1999GL010496; Deng JS, 1998, SCIENCE, V282, P1689, DOI 10.1126/science.282.5394.1689; Dreger D, 2000, GEOPHYS RES LETT, V27, P1941, DOI 10.1029/1999GL011245; Freed AM, 1998, J GEOPHYS RES-SOL EA, V103, P24393, DOI 10.1029/98JB01764; HARRIS RA, 1995, NATURE, V375, P221, DOI 10.1038/375221a0; HAUKSSON E, 1993, J GEOPHYS RES-SOL EA, V98, P19835, DOI 10.1029/93JB02384; Ivins ER, 1996, J GEOPHYS RES-SOL EA, V101, P28005, DOI 10.1029/96JB02846; Jackson DD, 1997, SCIENCE, V277, P1621, DOI 10.1126/science.277.5332.1621; Jaume SC, 1996, J GEOPHYS RES-SOL EA, V101, P765, DOI 10.1029/95JB02393; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; KIRBY SH, 1987, REV GEOPHYS, V25, P1219, DOI 10.1029/RG025i006p01219; Massonnet D, 1996, NATURE, V382, P612, DOI 10.1038/382612a0; OPPENHEIMER DH, 1988, J GEOPHYS RES-SOLID, V93, P9007, DOI 10.1029/JB093iB08p09007; Parsons T, 2000, GEOPHYS RES LETT, V27, P1949, DOI 10.1029/1999GL011272; Peltzer G, 1998, J GEOPHYS RES-SOL EA, V103, P30131, DOI 10.1029/98JB02302; Pollitz FF, 1997, B SEISMOL SOC AM, V87, P1; Pollitz FF, 2000, J GEOPHYS RES-SOL EA, V105, P8035, DOI 10.1029/1999JB900380; POLLITZ FF, 1995, B SEISMOL SOC AM, V85, P796; REASENBERG PA, 1992, SCIENCE, V255, P1687, DOI 10.1126/science.255.5052.1687; Savage JC, 1997, J GEOPHYS RES-SOL EA, V102, P7565, DOI 10.1029/97JB00210; SHEN ZK, 1994, B SEISMOL SOC AM, V84, P780; STEIN RS, 1983, J GEOPHYS RES, V88, P6477, DOI 10.1029/JB088iB08p06477; STEIN RS, 1992, SCIENCE, V258, P1328, DOI 10.1126/science.258.5086.1328; STEIN RS, 1994, SCIENCE, V265, P1432, DOI 10.1126/science.265.5177.1432; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Toda S, 1998, J GEOPHYS RES-SOL EA, V103, P24543, DOI 10.1029/98JB00765; WALD DJ, 1994, B SEISMOL SOC AM, V84, P668	30	246	282	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					180	183		10.1038/35075548	http://dx.doi.org/10.1038/35075548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346791				2022-12-28	WOS:000168563000046
J	Hazen, RM; Roedder, E				Hazen, RM; Roedder, E			Biogeology - How old are bacteria from the Permian age?	NATURE			English	Article							PALO-DURO BASIN; FLUID INCLUSIONS; SALT; TEXAS		Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; Carnegie Inst Washington, NASA, Astrobiol Inst, Washington, DC 20015 USA	Carnegie Institution for Science; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA)	Hazen, RM (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.							BEIN A, 1991, J SEDIMENT PETROL, V61, P1; ONEIL JR, 1986, APPL GEOCHEM, V1, P265, DOI DOI 10.1016/0883-2927(86)90011-9; ROEDDER E, 1984, AM MINERAL, V69, P413; ROEDDER E, 1987, CHEM GEOL, V61, P79, DOI 10.1016/0009-2541(87)90029-5; Shlichta P.J., 1968, GEOL SOC AM SPEC PAP, V88, P597; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060	6	34	37	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					155	155		10.1038/35075663	http://dx.doi.org/10.1038/35075663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346782	Bronze			2022-12-28	WOS:000168563000037
J	Neer, RM; Arnaud, CD; Zanchetta, JR; Prince, R; Gaich, GA; Reginster, JY; Hodsman, AB; Eriksen, EF; Ish-Shalom, S; Genant, HK; Wang, OH; Mitlak, BH				Neer, RM; Arnaud, CD; Zanchetta, JR; Prince, R; Gaich, GA; Reginster, JY; Hodsman, AB; Eriksen, EF; Ish-Shalom, S; Genant, HK; Wang, OH; Mitlak, BH			Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; VITAMIN-D SUPPLEMENTATION; VERTEBRAL FRACTURES; SALMON-CALCITONIN; CALCIUM; INTERMITTENT; ALENDRONATE; RISK; HYPERPARATHYROIDISM; CALCITRIOL	Background: Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown. Methods: We randomly assigned 1637 postmenopausal women with prior vertebral fractures to receive 20 or 40 mug of parathyroid hormone (1-34) or placebo, administered subcutaneously by the women daily. We obtained vertebral radiographs at base line and at the end of the study (median duration of observation, 21 months) and performed serial measurements of bone mass by dual-energy x-ray absorptiometry. Results: New vertebral fractures occurred in 14 percent of the women in the placebo group and in 5 percent and 4 percent, respectively, of the women in the 20-mug and 40-mug parathyroid hormone groups; the respective relative risks of fracture in the 20-mug and 40-mug groups, as compared with the placebo group, were 0.35 and 0.31 (95 percent confidence intervals, 0.22 to 0.55 and 0.19 to 0.50). New nonvertebral fragility fractures occurred in 6 percent of the women in the placebo group and in 3 percent of those in each parathyroid hormone group (relative risk, 0.47 and 0.46, respectively [95 percent confidence intervals, 0.25 to 0.88 and 0.25 to 0.86]). As compared with placebo, the 20-mug and 40-mug doses of parathyroid hormone increased bone mineral density by 9 and 13 more percentage points in the lumbar spine and by 3 and 6 more percentage points in the femoral neck; the 40-mug dose decreased bone mineral density at the shaft of the radius by 2 more percentage points. Both doses increased total-body bone mineral by 2 to 4 more percentage points than did placebo. Parathyroid hormone had only minor side effects (occasional nausea and headache). Conclusions: Treatment of postmenopausal osteoporosis with parathyroid hormone (1-34) decreases the risk of vertebral and nonvertebral fractures; increases vertebral, femoral, and total-body bone mineral density; and is well tolerated. The 40-mug dose increased bone mineral density more than the 20-mug dose but had similar effects on the risk of fracture and was more likely to have side effects. (N Engl J Med 2001;344:1434-41.) Copyright (C) 2001 Massachusetts Medical Society.	Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Fdn Invest Metab, Buenos Aires, DF, Argentina; Univ Western Australia, Perth, WA 6009, Australia; Sir Charles Gairdner Hosp, Perth, WA, Australia; Policlin Univ L Brull, Liege, Belgium; St Josephs Hlth Ctr, London, ON, Canada; Aarhus Kommune Hosp, Aarhus, Denmark; Rambam Med Ctr, Haifa, Israel	Eli Lilly; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Western Australia; University of Western Australia; Western University (University of Western Ontario); Aarhus University; Rambam Health Care Campus; Technion Israel Institute of Technology	Mitlak, BH (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.		Eriksen, Erik Fink/AAF-5056-2020; Hodsman, Anthony/G-3303-2011	Marcinowska-Suchowierska, Ewa/0000-0002-9047-8731				Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; DEMPSTER DW, 1994, ENDOCR REV, V15, P261; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HEIKINHEIMO RJ, 1992, CALCIFIED TISSUE INT, V51, P105, DOI 10.1007/BF00298497; HOCK JM, 1992, J BONE MINER RES, V7, P65, DOI 10.1002/jbmr.5650070110; HODSMAN AB, 1991, BONE MINER, V14, P67, DOI 10.1016/0169-6009(91)90103-7; Horwitz M, 2000, J CLIN ENDOCR METAB, V85, P2127, DOI 10.1210/jc.85.6.2127; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; LINDSAY R, 1980, LANCET, V2, P1151; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lu Y, 1996, J BONE MINER RES, V11, P626; Lu Y, 1997, STAT MED, V16, P1889, DOI 10.1002/(SICI)1097-0258(19970830)16:16<1889::AID-SIM607>3.0.CO;2-V; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; NEER R, 1990, OSTEOPOROSIS 1990, P1314; OTT SM, 1989, ANN INTERN MED, V110, P267, DOI 10.7326/0003-4819-110-4-267; PALMER M, 1988, AM J EPIDEMIOL, V127, P1031, DOI 10.1093/oxfordjournals.aje.a114879; PODBESEK R, 1983, ENDOCRINOLOGY, V112, P1000, DOI 10.1210/endo-112-3-1000; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; STORM T, 1990, NEW ENGL J MED, V322, P1265, DOI 10.1056/NEJM199005033221803; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601; Turner CH, 1999, J BONE MINER RES, V14, pS414; WATTS NB, 1990, NEW ENGL J MED, V323, P73, DOI 10.1056/NEJM199007123230201; Wermers RA, 1998, AM J MED, V104, P115, DOI 10.1016/S0002-9343(97)00270-2	31	3171	3404	4	296	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1434	1441		10.1056/NEJM200105103441904	http://dx.doi.org/10.1056/NEJM200105103441904			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346808				2022-12-28	WOS:000168554000004
J	Tong, F; Engel, SA				Tong, F; Engel, SA			Interocular rivalry revealed in the human cortical blind-spot representation	NATURE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; PERCEPTION	To understand conscious vision, scientists must elucidate how the brain selects specific visual signals for awareness. When different monocular patterns are presented to the two eyes, they rival for conscious expression such that only one monocular image is perceived at a time(1,2). Controversy surrounds whether this binocular rivalry reflects neural competition among pattern representations or monocular channels(3,4). Here we show that rivalry arises from interocular competition, using functional magnetic resonance imaging of activity in a monocular region of primary visual cortex corresponding to the blind spot. This cortical region greatly prefers stimulation of the ipsilateral eye to that of the blind-spot eye. Subjects reported their dominant percept while viewing rivalrous orthogonal gratings in the visual location corresponding to the blind spot and its surround. As predicted by interocular rivalry, the monocular blind-spot representation was activated when the ipsilateral grating became perceptually dominant and suppressed when the blind-spot grating became dominant. These responses were as large as those observed during actual alternations between the gratings, indicating that rivalry may be fully resolved in monocular visual cortex. Our findings provide the first physiological evidence, to our knowledge, that interocular competition mediates binocular rivalry, and indicate that V1 may be important in the selection and expression of conscious visual information.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	Princeton University; University of California System; University of California Los Angeles	Tong, F (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	ftong@princeton.edu						Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; COBB WA, 1967, NATURE, V216, P1123, DOI 10.1038/2161123b0; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; LANSING RW, 1964, SCIENCE, V146, P1325, DOI 10.1126/science.146.3649.1325; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Levelt WJM, 1965, BINOCULAR RIVALRY; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; STENSAAS SS, 1974, J NEUROSURG, V40, P747, DOI 10.3171/jns.1974.40.6.0747; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; von Helmholtz H., 1924, HELMHOLTZS TREATISE; WADE NJ, 1975, PERCEPTION, V4, P85, DOI 10.1068/p040085; WALLS G L, 1954, Am J Optom Arch Am Acad Optom, V31, P329	24	336	342	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					195	199		10.1038/35075583	http://dx.doi.org/10.1038/35075583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346796				2022-12-28	WOS:000168563000051
J	Knight, J				Knight, J			Study says authors are averse to declaring conflicts of interest	NATURE			English	News Item																		Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7	2	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					3	4		10.1038/35075210	http://dx.doi.org/10.1038/35075210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333934	Bronze			2022-12-28	WOS:000168432800003
J	Ziauddin, J; Sabatini, DM				Ziauddin, J; Sabatini, DM			Microarrays of cells expressing defined cDNAs	NATURE			English	Article							PEPTIDYL-PROLYL ISOMERASE; IMMUNOSUPPRESSANT FK506; GENE-EXPRESSION; RECEPTOR; PROTEIN; IDENTIFICATION	Genome and expressed sequence tag projects are rapidly cataloguing and cloning the genes of higher organisms, including humans. An emerging challenge is to rapidly uncover the functions of genes and to identify gene products with desired properties. We have developed a microarray-driven gene expression system for the functional analysis of many gene products in parallel. Mammalian cells are cultured on a glass slide printed in defined locations with different DNAs. Cells growing on the printed areas take up the DNA, creating spots of localized transfection within a lawn of non-transfected cells. By printing sets of complementary DNAs cloned in expression vectors, we make microarrays whose features are clusters of live cells that express a defined cDNA at each location. Here we demonstrate two uses for our approach: as an alternative to protein microarrays for the identification of drug targets, and as an expression cloning system for the discovery of gene products that alter cellular physiology. By screening transfected cell microarrays expressing 192 different cDNAs, we identified proteins involved in tyrosine kinase signalling, apoptosis and cell adhesion, and with distinct subcellular distributions.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			/0000-0002-1446-7256				de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; MacBeath G, 2000, SCIENCE, V289, P1760; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIMONSEN H, 1994, TRENDS PHARMACOL SCI, V15, P437, DOI 10.1016/0165-6147(94)90052-3; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Yudate HT, 2001, NUCLEIC ACIDS RES, V29, P185, DOI 10.1093/nar/29.1.185	21	767	884	1	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					107	110		10.1038/35075114	http://dx.doi.org/10.1038/35075114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333987				2022-12-28	WOS:000168432800053
J	Dember, LM; Sanchorawala, V; Seldin, DC; Wright, DG; LaValley, M; Berk, JL; Falk, RH; Skinner, M				Dember, LM; Sanchorawala, V; Seldin, DC; Wright, DG; LaValley, M; Berk, JL; Falk, RH; Skinner, M			Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; LABORATORY FEATURES; SUPPORT; PREDNISONE; COLCHICINE; SURVIVAL; TRIAL	Background: Dose-intensive intravenous melphalan with autologous blood stem-cell transplantation induces remission of the plasma cell dyscrasia in a substantial proportion of patients with AL amyloidosis. The impact of this treatment on associated renal disease is not known. Objective: To determine the effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease. Design: Prospective cohort study. Setting: Academic medical center. Patients: 65 patients with AL amyloidosis and urinary protein excretion greater than 1 g/24 h who received dose-intensive intravenous melphalan and autologous blood stem-cell transplantation between 1 July 1994 and 30 June 1998, Measurements: 24-hour urinary protein excretion, serum cholesterol level, serum albumin level, creatinine clearance, urine and serum immunoelectrophoresis, and bone marrow biopsy. Renal response was defined as a greater than 50% reduction in urinary protein excretion in the absence of a 25% or greater reduction in creatinine clearance. Complete hematologic response was defined as absence of detectable monoclonal protein in serum and urine and a bone marrow specimen containing less than 5% plasma cells without clonal dominance of kappa or lambda isotype. Results: Among the 50 patients who survived for at least 12 months, proteinuria, hypoalbuminemia, and hypercholesterolemia improved during follow-up; 36% met criteria for a renal response. Median 24-hour urinary protein excretion decreased from a baseline value of 9.6 g/24 h to 1.6 g/24 h at 12 months among patients with complete hematologic response, and 71% met criteria for a renal response. Twenty-hour urinary protein excretion did not decrease during follow-up among patients with persistent plasma cell disease, and only 11% had a renal response at 12 months (P < 0.001 for hematologic responders vs, nonresponders). Conclusion: Dose-intensive intravenous melphalan with autologous blood stem-cell transplantation improves the nephrotic syndrome In patients with AL amyloidosis-associated renal disease. The benefit is largely limited to patients achieving eradication of the underlying plasma cell dyscrasia.	Boston Univ, Med Ctr, Sch Med, EBRC 504,Renal Sect, Boston, MA 02118 USA	Boston University	Dember, LM (corresponding author), Boston Univ, Med Ctr, Sch Med, EBRC 504,Renal Sect, 650 Albany St, Boston, MA 02118 USA.	ldember@bu.edu	LaValley, Michael/AAA-2030-2020	Seldin, David C/0000-0003-0168-2333; Berk, John/0000-0002-1768-2373; LaValley, Michael/0000-0002-8488-5170; Sanchorawala, Vaishali/0000-0002-6307-2445				Comenzo RL, 1999, BRIT J HAEMATOL, V104, P553, DOI 10.1046/j.1365-2141.1999.01216.x; Comenzo RL, 1996, BLOOD, V88, P2801, DOI 10.1182/blood.V88.7.2801.bloodjournal8872801; Comenzo RL, 1998, BLOOD, V91, P3662; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; GERTZ MA, 1992, ARCH INTERN MED, V152, P2245, DOI 10.1001/archinte.152.11.2245; GERTZ MA, 1991, BLOOD, V77, P257; Hahn G., 1991, STAT INTERVALS GUIDE; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; KYLE RA, 1982, ARCH INTERN MED, V142, P1445, DOI 10.1001/archinte.142.8.1445; OGG CS, 1981, CLIN NEPHROL, V15, P9; Perna A, 1996, AM J KIDNEY DIS, V27, P34, DOI 10.1016/S0272-6386(96)90028-1; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; Ruggenenti P, 1997, CURR OPIN NEPHROL HY, V6, P489, DOI 10.1097/00041552-199709000-00014; Skinner M, 1996, AM J MED, V100, P290, DOI 10.1016/S0002-9343(97)89487-9	19	86	87	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					746	753		10.7326/0003-4819-134-9_Part_1-200105010-00011	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329232				2022-12-28	WOS:000168470700004
J	Jackson, JL; Kroenke, K				Jackson, JL; Kroenke, K			The effect of unmet expectations among adults presenting with physical symptoms	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT REQUESTS; PRIMARY-CARE; RESPIRATORY-INFECTIONS; MENTAL-DISORDERS; PATIENTS WANT; MEDICAL-CARE; FOLLOW-UP; SATISFACTION; PSYCHOPATHOLOGY; QUESTIONNAIRE	Background: Unmet patient expectations are common and have been associated with decreased patient satisfaction. Objective: To assess the prevalence and effect of unmet expectations in patients presenting with physical symptoms. Design: Prospective cohort study. Setting: Primary care walk-in clinic. Most patients were seeing a particular provider for the first time. Patients: 750 adults whose principal reason for the clinic visit was a physical symptom. Measurements: Patients completed previsit questionnaires that assessed symptom characteristics, the patient's expectations of the visit, functional status (Medical Outcomes Study Short Form-6), and mental disorders (Primary Care Evaluation of Mental Disorders [PRIME-MD]). Patient questionnaires given immediately after the visit and 2 weeks after the visit assessed patient satisfaction with the visit and unmet expectations; the 2-week questionnaire also assessed symptom outcome and functional status. Postvisit physician questionnaires measured encounter difficulty (Difficult Doctor Patient Relationship Questionnaire) and what the physician did in response to the patient's symptom. Results: Nearly all patients (98%) had at least one previsit expectation, including a diagnosis (81%), an estimate of how long the symptom was likely to last (63%), a prescription (60%), a diagnostic test (54%), and a subspecialty referral (45%). Immediately after the visit, the most common unmet expectations were for prognostic information (51%) or diagnostic information (33%). Only 11% of patients had an unmet expectation of a diagnostic test, subspecialty referral, prescription, or sick slip. Unmet patient expectations were more common after encounters experienced as difficult by the clinician and in patients with underlying mental disorders. Patients with no unmet expectations had less worry about serious illness (54% vs. 27%; P < 0.001) and greater satisfaction (59% vs. 19%; P < 0.001), and patients who reported receiving diagnostic or prognostic information were more likely to have symptom alleviation (relative risk, 1.2 [95% Cl, 1.02 to 1.3]) and functional improvement (functional status score, 25 vs. 23; P = 0.01) at 2 weeks. Conclusions: Patients who seek care for physical symptoms and do not leave the encounter with an unmet expectation are more likely to be satisfied with their care and to have less worry about serious illness. Diagnostic and prognostic information are particularly valued by patients and may be associated with greater improvement in symptoms and functional status 2 weeks after the visit.	Uniformed Serv Univ Hlth Sci, Dept Med EDP, Bethesda, MD 20814 USA; Indiana Univ, Sch Med, Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	Uniformed Services University of the Health Sciences - USA; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Jackson, JL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med EDP, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	jejackson@usuhs.mil	anand, amit/A-7222-2009; Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834; Kroenke, Kurt/0000-0002-0114-4669				BARSKY AJ, 1995, JAMA-J AM MED ASSOC, V274, P1931, DOI 10.1001/jama.274.24.1931; BARSKY AJ, 1981, ANN INTERN MED, V94, P492, DOI 10.7326/0003-4819-94-4-492; BRODY DS, 1989, MED CARE, V27, P1027, DOI 10.1097/00005650-198911000-00004; BRODY DS, 1990, ARCH INTERN MED, V150, P993, DOI 10.1001/archinte.150.5.993; BRODY DS, 1986, MED CARE, V24, P742, DOI 10.1097/00005650-198608000-00009; BURGOYNE RW, 1979, ARCH GEN PSYCHIAT, V36, P400; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; EISENTHAL S, 1979, ARCH GEN PSYCHIAT, V36, P393; EISENTHAL S, 1976, J NERV MENT DIS, V162, P169, DOI 10.1097/00005053-197603000-00003; FRANCIS V, 1969, NEW ENGL J MED, V280, P535, DOI 10.1056/NEJM196903062801004; Froehlich GW, 1996, J GEN INTERN MED, V11, P470, DOI 10.1007/BF02599041; Gillette R D, 1986, Fam Med, V18, P68; GOOD MJD, 1983, J BEHAV MED, V6, P151; Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477; HAHN SR, 1994, J CLIN EPIDEMIOL, V47, P647, DOI 10.1016/0895-4356(94)90212-7; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Hornberger J, 1997, J GEN INTERN MED, V12, P597, DOI 10.1046/j.1525-1497.1997.07119.x; Jackson JL, 1999, ARCH FAM MED, V8, P135, DOI 10.1001/archfami.8.2.135; Jackson JL, 1999, MIL MED, V164, P194, DOI 10.1093/milmed/164.3.194; Jackson JL, 1999, MIL MED, V164, P112, DOI 10.1093/milmed/164.2.112; Jackson JL, 1997, MIL MED, V162, P273, DOI 10.1093/milmed/162.4.273; Joos SK, 1996, J GEN INTERN MED, V11, P147, DOI 10.1007/BF02600266; JOOS SK, 1993, PUBLIC HEALTH REP, V108, P751; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; KORSCH BM, 1968, PEDIATRICS, V42, P855; KRAVITZ RL, 1994, J GEN INTERN MED, V9, P75, DOI 10.1007/BF02600205; Kravitz RL, 1996, ANN INTERN MED, V125, P730, DOI 10.7326/0003-4819-125-9-199611010-00004; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; Kroenke K, 1997, J GEN INTERN MED, V12, P509, DOI 10.1046/j.1525-1497.1997.00092.x; Laine C, 1996, ANN INTERN MED, V125, P640, DOI 10.7326/0003-4819-125-8-199610150-00003; LINN MW, 1982, MED CARE, V20, P606, DOI 10.1097/00005650-198206000-00006; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Marple RL, 1997, ARCH INTERN MED, V157, P1482, DOI 10.1001/archinte.157.13.1482; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; Salmon P, 1968, Hospitals, V42, P103; SANCHEZMENEGAY C, 1994, J GEN INTERN MED, V9, P404, DOI 10.1007/BF02629524; SANCHEZMENEGAY C, 1992, J GEN INTERN MED, V7, P432, DOI 10.1007/BF02599162; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; STARFIELD B, 1979, JAMA-J AM MED ASSOC, V242, P344, DOI 10.1001/jama.242.4.344; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; UHLMANN RF, 1984, AM J PUBLIC HEALTH, V74, P257, DOI 10.2105/AJPH.74.3.257; UHLMANN RF, 1984, MED CARE, V22, P681, DOI 10.1097/00005650-198407000-00011; UHLMANN RF, 1988, J GEN INTERN MED, V3, P458, DOI 10.1007/BF02595922; Valori R, 1996, J PSYCHOSOM RES, V40, P87, DOI 10.1016/0022-3999(95)00548-X; VANDULMEN AM, 1994, J PSYCHOSOM RES, V38, P581, DOI 10.1016/0022-3999(94)90055-8; WARE JE, 1992, MEASURING FUNCTIONIN, P291	47	148	149	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			889	897		10.7326/0003-4819-134-9_Part_2-200105011-00013	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346325				2022-12-28	WOS:000168543100013
J	Sloane, PD; Coeytaux, RR; Beck, RS; Dallara, J				Sloane, PD; Coeytaux, RR; Beck, RS; Dallara, J			Dizziness: State of the science	ANNALS OF INTERNAL MEDICINE			English	Article							PERSISTENT DIZZINESS; DIZZY; PREVALENCE; COMMUNITY; SYMPTOMS; QUALITY; VERTIGO; CARE; THERAPY; SYNCOPE	Dizziness is prevalent in all adult populations, causing considerable morbidity and utilization of health services. In the community, the prevalence of dizziness ranges from 1.8% in young adults to more than 30% in the elderly. In the primary care setting, dizziness increases in frequency as a presenting complaint; as many as 7% of elderly patients present with this symptom. Classification of dizziness by subtype (vertigo, presyncope, disequilibrium, and other) assists in the differential diagnosis. Various disease entities may cause dizziness, and the reported frequency of specific diagnoses varies widely, depending on setting, patient age, and investigator bias. Life-threatening illnesses are rare in patients with dizziness, but many have serious functional impairment. Dizziness can be difficult to diagnose, particularly in elderly persons, in whom it often represents dysfunction in more than one body system. Given the relatively underdeveloped state of the empirical literature on dizziness, investigators would benefit from use of consistent criteria to describe dizziness symptoms and establish diagnoses. Investigation of the effects of testing and treatment should focus on diagnoses that are life threatening or lead to significant morbidity. In the elderly, a function-oriented approach should be studied and compared with current diagnosis-focused strategies. Alternative therapies for chronic and recurrent dizziness also merit investigation.	Univ N Carolina, Dept Family Med, Chapel Hill, NC 27599 USA; Duke Univ, Durham, NC 27706 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University	Sloane, PD (corresponding author), Univ N Carolina, Dept Family Med, CB 7595, Chapel Hill, NC 27599 USA.	psloane@med.unc.edu			NIA NIH HHS [K08-AG00341] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG000341] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aoki M, 1999, AM J OTOL, V20, P741; Bailey K E, 1993, Arch Fam Med, V2, P847, DOI 10.1001/archfami.2.8.847; Baloh R.W., 1990, CLIN NEUROPHYSIOL; BALOH RW, 1992, J AM GERIATR SOC, V40, P713, DOI 10.1111/j.1532-5415.1992.tb01966.x; BELAL A, 1986, J LARYNGOL OTOL, V100, P1037, DOI 10.1017/S0022215100100520; BERGSNEIDER M, 1995, OTOLARYNG HEAD NECK, V112, P118, DOI 10.1016/S0194-5998(95)70310-1; Bigos S., 1994, ACUTE LOW BACK PROBL; Bohmer A, 1999, ACTA OTO-LARYNGOL, V119, P126, DOI 10.1080/00016489950181495; BOULT C, 1991, J AM GERIATR SOC, V39, P858, DOI 10.1111/j.1532-5415.1991.tb04451.x; Cheng B, 1996, J Tradit Chin Med, V16, P35; COLLEDGE NR, 1994, AGE AGEING, V23, P117, DOI 10.1093/ageing/23.2.117; Colledge NR, 1996, BMJ-BRIT MED J, V313, P788; DALLARA J, 1994, AM J EMERG MED, V12, P421, DOI 10.1016/0735-6757(94)90052-3; DORLAND WA, 1994, DORLAND ILLUSTRATED; Drachman DA, 2000, ANN INTERN MED, V132, P403, DOI 10.7326/0003-4819-132-5-200003070-00010; Drachman DA, 1998, JAMA-J AM MED ASSOC, V280, P2111, DOI 10.1001/jama.280.24.2111; DRACHMAN DA, 1972, NEUROLOGY, V22, P323, DOI 10.1212/WNL.22.4.323; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; FROEHLING DA, 1994, JAMA-J AM MED ASSOC, V271, P385, DOI 10.1001/jama.271.5.385; GRONTVED A, 1986, ORL J OTO-RHINO-LARY, V48, P282, DOI 10.1159/000275883; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; HANLON JT, 1990, ARCH INTERN MED, V150, P2309, DOI 10.1001/archinte.150.11.2309; HERR RD, 1989, ANN EMERG MED, V18, P664, DOI 10.1016/S0196-0644(89)80524-4; Hewson MG, 1996, J GEN INTERN MED, V11, P481, DOI 10.1007/BF02599044; Honrubia V, 1996, AM J OTOL, V17, P595; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JANNETTA PJ, 1984, NEW ENGL J MED, V310, P1700, DOI 10.1056/NEJM198406283102604; Joseph DL, 1987, PATIENT CARE, V21, P99; KATSARKAS A, 1994, OTOLARYNG HEAD NECK, V110, P296, DOI 10.1016/S0194-5998(94)70772-3; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; Kroenke K, 2000, SOUTH MED J, V93, P160; Lawson J, 1999, J AM GERIATR SOC, V47, P12, DOI 10.1111/j.1532-5415.1999.tb01895.x; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; MANOLIS AS, 1990, ANN INTERN MED, V112, P850, DOI 10.7326/0003-4819-112-11-850; Martinez M T, 1994, J La State Med Soc, V146, P43; MEYERHOFF WL, 1994, OTOLARYNG CLIN N AM, V27, P411; Moller MB, 1997, STEREOT FUNCT NEUROS, V68, P270, DOI 10.1159/000099938; NEDZELSKI JM, 1986, J OTOLARYNGOL, V15, P101; Palmer RH, 1997, ANN INTERN MED, V127, P733, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00059; Prieto L, 1999, QUAL LIFE RES, V8, P131, DOI 10.1023/A:1026433113262; Radtke A, 1999, NEUROLOGY, V53, P1358, DOI 10.1212/WNL.53.6.1358; Roberts B L, 1983, J Gerontol Nurs, V9, P151; RUTKA JA, 1986, J OTOLARYNGOL, V15, P105; SACKETT D, 2000, EVIDENCE BASES MED; Simon N M, 1998, Ann Clin Psychiatry, V10, P75, DOI 10.3109/10401239809147746; SKIENDZIELEWSKI JJ, 1980, ANN EMERG MED, V9, P353, DOI 10.1016/S0196-0644(80)80111-9; SLOANE P, 1989, J AM GERIATR SOC, V37, P101, DOI 10.1111/j.1532-5415.1989.tb05867.x; SLOANE P, 1998, ESSENTIALS FAMILY ME; Sloane P D, 1994, J Am Board Fam Pract, V7, P1; SLOANE PD, 1994, J AM GERIATR SOC, V42, P847, DOI 10.1111/j.1532-5415.1994.tb06556.x; SLOANE PD, 1989, J AM GERIATR SOC, V37, P1031, DOI 10.1111/j.1532-5415.1989.tb06916.x; Sloane PD, 1999, J AM GERIATR SOC, V47, P113, DOI 10.1111/j.1532-5415.1999.tb01912.x; SLOANE PD, 1989, J FAM PRACTICE, V29, P33; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Tesio L, 1999, AM J PHYS MED REHAB, V78, P233, DOI 10.1097/00002060-199905000-00009; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002; VARTIAINEN E, 1991, J LARYNGOL OTOL, V105, P270, DOI 10.1017/S0022215100115580; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131; Yardley L, 1998, BRIT J GEN PRACT, V48, P1136; ZIEVE PD, 1995, HDB AMBULATORY MED; 2000, DRUG INFORMATION HLT; 2001, CLIN PHARM	65	148	158	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			823	832		10.7326/0003-4819-134-9_Part_2-200105011-00005	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346317				2022-12-28	WOS:000168543100005
J	Donnai, D; Elles, R				Donnai, D; Elles, R			Integrated regional genetic services: current and future provision	BRITISH MEDICAL JOURNAL			English	Article									Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; St Marys Hosp, Reg Genet Serv, Cent Manchester Healthcare Trust, Manchester M13 0JH, Lancs, England	University of Manchester; University of Manchester	Donnai, D (corresponding author), Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England.							CLARKE A, 1994, J MED GENET, V31, P785, DOI 10.1136/jmg.31.10.785; Eccles DM, 2000, J MED GENET, V37, P203, DOI 10.1136/jmg.37.3.203; Harris R, 1997, EUR J HUM GENET, V5, P1; *ROYAL COLL PHYS L, 1996, CLIN GEN SERV 21 CEN; Skirton H, 1998, J MED GENET, V35, P410, DOI 10.1136/jmg.35.5.410; WENT L, 1994, J MED GENET, V31, P555; 2001, DIS SPECIFIC GENETIC	7	31	31	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1048	1051		10.1136/bmj.322.7293.1048	http://dx.doi.org/10.1136/bmj.322.7293.1048			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325774	Green Published			2022-12-28	WOS:000168478700028
J	McCarthy, A				McCarthy, A			Pharmacogenetics - Industry and academic researchers must collaborate to deliver its benefits	BRITISH MEDICAL JOURNAL			English	Editorial Material									GlaxoSmithKline, Drug Dev Genet, Greenford UB6 0HE, Middx, England	GlaxoSmithKline	McCarthy, A (corresponding author), GlaxoSmithKline, Drug Dev Genet, Greenford UB6 0HE, Middx, England.							Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Mathew C, 2001, BRIT MED J, V322, P1031, DOI 10.1136/bmj.322.7293.1031; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728	3	1	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1007	1008		10.1136/bmj.322.7293.1007	http://dx.doi.org/10.1136/bmj.322.7293.1007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325750	Green Published			2022-12-28	WOS:000168478700003
J	Nijman, RJM				Nijman, RJM			Vesicoureteric reflux: to operate or not?	LANCET			English	Editorial Material									Sophia Childrens Hosp, Dept Paediat Nephrol, NL-3015 GJ Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Nijman, RJM (corresponding author), Sophia Childrens Hosp, Dept Paediat Nephrol, NL-3015 GJ Rotterdam, Netherlands.							Avni EF, 1996, BRIT J UROL, V78, P454, DOI 10.1046/j.1464-410X.1996.00106.x; Bailey R R, 1973, Clin Nephrol, V1, P132; Farhat W, 2000, J UROLOGY, V164, P1057, DOI 10.1016/S0022-5347(05)67249-7; SCHOLTMEIJER RJ, 1994, UROLOGY, V43, P714, DOI 10.1016/0090-4295(94)90194-5; Sillen U, 1999, BJU INT, V83, P83, DOI 10.1046/j.1464-410X.1999.00914.x; Willemsen J, 2000, UROLOGY, V55, P939, DOI 10.1016/S0090-4295(00)00549-5	6	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1309	1310		10.1016/S0140-6736(00)04529-3	http://dx.doi.org/10.1016/S0140-6736(00)04529-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343732				2022-12-28	WOS:000168411400006
J	Stewart, A; Haites, N; Rose, P				Stewart, A; Haites, N; Rose, P			Online medical genetics resources: a UK perspective	BRITISH MEDICAL JOURNAL			English	Review							QUALITY		Strangeways Lab, Publ Hlth Genet Unit, Cambridge CB1 8RN, England; Univ Aberdeen, Dept Med Genet, Aberdeen AB25 2ZD, Scotland; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Aberdeen; University of Oxford	Stewart, A (corresponding author), Strangeways Lab, Publ Hlth Genet Unit, Cambridge CB1 8RN, England.							DELAMOTHE, 2000, BMJ, V321, P843; Kim P, 1999, BMJ-BRIT MED J, V318, P647, DOI 10.1136/bmj.318.7184.647; Shepperd S, 1999, BMJ-BRIT MED J, V319, P764, DOI 10.1136/bmj.319.7212.764	3	7	7	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1037	1039		10.1136/bmj.322.7293.1037	http://dx.doi.org/10.1136/bmj.322.7293.1037			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325771	Green Published			2022-12-28	WOS:000168478700025
J	Adam, D				Adam, D			Reef gets off the starting blocks	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1012	1012		10.1038/35074255	http://dx.doi.org/10.1038/35074255			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323625	Bronze			2022-12-28	WOS:000168285500006
J	Berry, N; Davis, C; Jenkins, A; Wood, D; Minor, P; Schild, G; Bottiger, M; Holmes, H; Almond, N				Berry, N; Davis, C; Jenkins, A; Wood, D; Minor, P; Schild, G; Bottiger, M; Holmes, H; Almond, N			Vaccine safety - Analysis of oral polio vaccine CHAT stocks	NATURE			English	Article							ORIGIN; AIDS		Natl Inst Biol Stand & Controls, Div Retrovirol, Potters Bar EN6 3QG, Herts, England; Natl Inst Biol Stand & Controls, Div Virol, Potters Bar EN6 3QG, Herts, England; Karolinska Inst, S-17177 Stockholm, Sweden	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; Karolinska Institutet	Berry, N (corresponding author), Natl Inst Biol Stand & Controls, Div Retrovirol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.			Almond, Neil/0000-0001-6105-0616				Berry N, 1998, J Hum Virol, V1, P457; Dickson D, 2000, NATURE, V407, P117, DOI 10.1038/35025249; GARRETT AJ, 1993, LANCET, V342, P932, DOI 10.1016/0140-6736(93)91982-R; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hooper Edward, 1999, RIVER JOURNEY SOURCE; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	7	20	21	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1046	1047		10.1038/35074176	http://dx.doi.org/10.1038/35074176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323658	Bronze			2022-12-28	WOS:000168285500034
J	Shankaran, V; Ikeda, H; Bruce, AT; White, JM; Swanson, PE; Old, LJ; Schreiber, RD				Shankaran, V; Ikeda, H; Bruce, AT; White, JM; Swanson, PE; Old, LJ; Schreiber, RD			IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity	NATURE			English	Article							TARGETED DISRUPTION; IN-VIVO; MICE; SURVEILLANCE; CELLS; SPECIFICITY; RECEPTOR	Lymphocytes were originally thought to form the basis of a 'cancer immunosurveillance' process that protects immunocompetent hosts against primary tumour development(1,2), but this idea was largely abandoned when no differences in primary tumour development were found between athymic nude mice and syngeneic wild-type mice(3-5). However, subsequent observations that nude mice do not completely lack functional T cells(6,7) and that two components of the immune system-IFN gamma (8,9) and perforin(10-12)-help to prevent tumour formation in mice have led to renewed interest in a tumour-suppressor role for the immune response. Here we show that lymphocytes and IFN gamma collaborate to protect against development of carcinogen-induced sarcomas and spontaneous epithelial carcinomas and also to select for tumour cells with reduced immunogenicity. The immune response thus functions as an effective extrinsic tumour-suppressor system. However, this process also leads to the immunoselection of tumour cells that are more capable of surviving in an immunocompetent host, which explains the apparent paradox of tumour formation in immunologically intact individuals.	Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA; Mem Sloan Kettering Canc Ctr, New York Branch, Ludwig Inst Canc Res, New York, NY 10021 USA	Washington University (WUSTL); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341; White, James Michael/0000-0001-5110-6567				Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUNIG T, 1983, IMMUNOL TODAY, V4, P84, DOI 10.1016/0167-5699(83)90125-1; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; MALECKAR JR, 1987, J IMMUNOL, V138, P3873; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Marusina K, 1997, J IMMUNOL, V158, P5251; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; OLD LJ, 1977, ANNU REV GENET, V11, P127, DOI 10.1146/annurev.ge.11.120177.001015; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; STUTMAN O, 1979, EXP CELL BIOL, V47, P129; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; STUTMAN O, 1979, J NATL CANCER I, V2, P353; Thomas L, 1959, CELLULAR HUMORAL ASP, P529; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781	21	1934	2034	6	171	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1107	1111		10.1038/35074122	http://dx.doi.org/10.1038/35074122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323675				2022-12-28	WOS:000168285500051
J	Audet, AM; Hartman, EE				Audet, AM; Hartman, EE			A 33-year-old woman with morbid obesity, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																		Atkinson RL, 2000, JAMA-J AM MED ASSOC, V283, P3236, DOI 10.1001/jama.283.24.3236	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2128	2128		10.1001/jama.285.16.2128	http://dx.doi.org/10.1001/jama.285.16.2128			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311103				2022-12-28	WOS:000168131600034
J	Viner, RM				Viner, RM			National survey of use of hospital beds by adolescents aged 12 to 19 in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article									UCL, Dept Med, London W1T 3AA, England	University of London; University College London	Viner, RM (corresponding author), UCL, Dept Med, London W1T 3AA, England.	R.Viner@ich.ucl.ac.uk	Viner, Russell M/A-1441-2009	Viner, Russell M/0000-0003-3047-2247				*BRIT PAED ASS, 1985, REP WORK PART NEEDS; HENDERSON J, 1993, ARCH DIS CHILD, V169, P559; *HOUS COMM SEL COM, 1997, SPEC HLTH NEEDS CHIL, pR40; Viner R, 1999, ARCH DIS CHILD, V81, P271, DOI 10.1136/adc.81.3.271; 1999, HLTH PERS SOC SERV S	5	28	28	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					957	958		10.1136/bmj.322.7292.957	http://dx.doi.org/10.1136/bmj.322.7292.957			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312227	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000168345100017
J	Renault, L; Kuhlmann, J; Henkel, A; Wittinghofer, A				Renault, L; Kuhlmann, J; Henkel, A; Wittinghofer, A			Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1)	CELL			English	Article							NUCLEAR EXPORT SIGNAL; GTP-BINDING PROTEINS; XENOPUS EGG EXTRACTS; GDP-BOUND FORM; EF-TS COMPLEX; CRYSTAL-STRUCTURE; MOLECULAR MECHANISM; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; RAN/TC4 GTPASE	RCC1 (regulator of chromosome condensation), a beta propeller chromatin-bound protein, is the guanine nucleotide exchange factor (GEF) for the nuclear GTP binding protein Ran. We report here the 1.8 Angstrom crystal structure of a Ran . RCC1 complex in the absence of nucleotide, an intermediate in the multistep GEF reaction. In contrast to previous structures, the phosphate binding region of the nucleotide binding site is perturbed only marginally, possibly due to the presence of a polyvalent anion in the P loop. Biochemical experiments show that a sulfate ion stabilizes the Ran . RCC1 complex and inhibits dissociation by guanine nucleotides. Based on the available structural and biochemical evidence, we present a unified scenario for the GEF mechanism where interaction of the P loop lysine with an acidic residue is a crucial element for the overall reaction.	Max Planck Inst Mol Physiol, D-44202 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Postfach 50 02 47, D-44202 Dortmund, Germany.	alfred.wittinghofer@mpl-dortmund.mpg.de		RENAULT, Louis/0000-0003-1722-074X				Azuma Y, 1999, J MOL BIOL, V289, P1119, DOI 10.1006/jmbi.1999.2820; Azuma Y, 1996, J BIOCHEM-TOKYO, V120, P82; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; DREUSICKE D, 1986, FEBS LETT, V208, P301, DOI 10.1016/0014-5793(86)81037-7; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; HALL A, 1986, J BIOL CHEM, V261, P963; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHN J, 1988, J BIOL CHEM, V263, P11792; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; Muegge I, 1996, STRUCTURE, V4, P475, DOI 10.1016/S0969-2126(96)00052-4; Mueller L, 1998, FEBS LETT, V427, P330, DOI 10.1016/S0014-5793(98)00459-1; Murphy GA, 1997, MOL BIOL CELL, V8, P2591, DOI 10.1091/mbc.8.12.2591; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Noguchi E, 1997, MOL CELL BIOL, V17, P2235, DOI 10.1128/MCB.17.4.2235; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Pasquinelli AE, 1997, P NATL ACAD SCI USA, V94, P14394, DOI 10.1073/pnas.94.26.14394; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; RENSLAND H, 1995, BIOCHEMISTRY-US, V34, P593, DOI 10.1021/bi00002a026; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; SCHEFFZEK K, 1994, ACTA CRYSTALLOGR D, V50, P521, DOI 10.1107/S0907444994001253; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seki T, 1996, J BIOCHEM, V120, P207; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittinghofer F, 1998, NATURE, V394, P317, DOI 10.1038/28492; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamada M, 1998, CURR BIOL, V8, P1339, DOI 10.1016/S0960-9822(07)00566-0; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zolotukhin AS, 1997, J BIOL CHEM, V272, P11356, DOI 10.1074/jbc.272.17.11356	71	189	196	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					245	255		10.1016/S0092-8674(01)00315-4	http://dx.doi.org/10.1016/S0092-8674(01)00315-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336674	Bronze			2022-12-28	WOS:000168384300011
J	Rodaway, A; Patient, R				Rodaway, A; Patient, R			Mesendoderm: An ancient germ layer?	CELL			English	Review							ENDODERM; XENOPUS; SPECIFICATION; INDUCTION; ZEBRAFISH; MESODERM; VERTEBRATES; DROSOPHILA; CATENIN; EMBRYOS		Kings Coll London, Randall Ctr, London SE1 1UL, England; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of London; King's College London; University of Nottingham	Rodaway, A (corresponding author), Kings Coll London, Randall Ctr, New Hunts House,Guys Campus, London SE1 1UL, England.	rager.patient@nottingham.ac.uk						Angerer LM, 2000, DEV BIOL, V218, P1, DOI 10.1006/dbio.1999.9553; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Imai K, 2000, DEVELOPMENT, V127, P3009; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kumano G, 2000, DEV BIOL, V228, P304, DOI 10.1006/dbio.2000.9937; Lemaire P, 1998, DEVELOPMENT, V125, P2371; LOGAN M, 1993, DEVELOPMENT, V118, P865; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Nieuwkoop PD, 1997, CELL MOL LIFE SCI, V53, P305, DOI 10.1007/PL00000608; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Reiter JF, 2001, DEVELOPMENT, V128, P125; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Warga RM, 1999, DEVELOPMENT, V126, P827; Weber H, 2000, DEVELOPMENT, V127, P4345; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	18	122	143	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					169	172		10.1016/S0092-8674(01)00307-5	http://dx.doi.org/10.1016/S0092-8674(01)00307-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336666	Bronze			2022-12-28	WOS:000168384300003
J	Gradden, C; Lawrence, D; Doyle, PM; Welch, CR				Gradden, C; Lawrence, D; Doyle, PM; Welch, CR			Uses of error: Addison's disease in pregnancy	LANCET			English	Article									Royal Liverpool Hosp, Renal Unit, Liverpool L7 8XP, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Gradden, C (corresponding author), Royal Liverpool Hosp, Renal Unit, Prescot St, Liverpool L7 8XP, Merseyside, England.								0	17	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1197	1197		10.1016/S0140-6736(05)71786-4	http://dx.doi.org/10.1016/S0140-6736(05)71786-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11330268				2022-12-28	WOS:000168192100034
J	Clement, S; Krause, U; Desmedt, F; Tanti, JF; Behrends, J; Pesesse, X; Sasaki, T; Penninger, J; Doherty, M; Malaisse, W; Dumont, JE; Le Marchand-Brustel, Y; Erneux, C; Hue, L; Schurmans, S				Clement, S; Krause, U; Desmedt, F; Tanti, JF; Behrends, J; Pesesse, X; Sasaki, T; Penninger, J; Doherty, M; Malaisse, W; Dumont, JE; Le Marchand-Brustel, Y; Erneux, C; Hue, L; Schurmans, S			The lipid phosphatase SHIP2 controls insulin sensitivity	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE 3-KINASE; 5-PHOSPHATASE SHIP2; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; PROTEIN; METABOLISM; CELLS; GENE	Insulin is the primary hormone involved in glucose homeostasis, and impairment of insulin action and/or secretion has a critical role in the pathogenesis of diabetes mellitus. Type-II SH2-domain-containing inositol 5-phosphatase, or 'SHIP2', is a member of the inositol polyphosphate 5-phosphatase family(1). In vitro studies have shown that SHIP2, in response to stimulation by numerous growth factors and insulin, is closely linked to signalling events mediated by both phosphoinositide-3-OH kinase and Ras/mitogen-activated protein kinase(2-5). Here we report the generation of mice lacking the SHIP2 gene. Loss of SHIP2 leads to increased sensitivity to insulin, which is characterized by severe neonatal hypoglycaemia, deregulated expression of the genes involved in gluconeogenesis, and perinatal death. Adult mice that are heterozygous for the SHIP2 mutation have increased glucose tolerance and insulin sensitivity associated with an increased recruitment of the GLUT4 glucose transporter and increased glycogen synthesis in skeletal muscles. Our results show that SHIP2 is a potent negative regulator of insulin signalling and insulin sensitivity in vivo.	IBMM, IRIBHN, B-6041 Gosselies, Belgium; ICP, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; IRIBHN, B-1070 Brussels, Belgium; Fac Med Nice, INSERM, E9911, F-06107 Nice 02, France; Univ Toronto, Ontario Canc Inst, Amgen Inst, Dept Med Biophys & Immunol, Toronto, ON M5G 2C1, Canada; Free Univ Brussels, Expt Med Lab, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Schurmans, S (corresponding author), IBMM, IRIBHN, Rue Professeurs Jeener & Brachet 12, B-6041 Gosselies, Belgium.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748; Tanti, Jean-Francois/0000-0003-1782-1318				BENVENISTY N, 1984, LESSONS ANIMAL DIABE, P717; Bruyns C, 1999, BIOL CHEM, V380, P969, DOI 10.1515/BC.1999.120; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Girard J, 1998, BIOCHEM SOC T, V26, P69, DOI 10.1042/bst0260069; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1973, ENZYME, V15, P272; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; HANSON RW, 1973, ENZYME, V15, P97, DOI 10.1159/000481055; Higaki Y, 1999, J BIOL CHEM, V274, P20791, DOI 10.1074/jbc.274.30.20791; Ishihara H, 1999, BIOCHEM BIOPH RES CO, V260, P265, DOI 10.1006/bbrc.1999.0888; JONES CT, 1982, DEV METABOLISM FETAL; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Lteif AN, 1999, ENDOCRIN METAB CLIN, V28, P619, DOI 10.1016/S0889-8529(05)70091-8; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Pesesse X, 1998, FEBS LETT, V437, P301, DOI 10.1016/S0014-5793(98)01255-1; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; Schurmans S, 1999, GENOMICS, V62, P260, DOI 10.1006/geno.1999.5995; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stenbit AE, 1996, J CLIN INVEST, V98, P629, DOI 10.1172/JCI118833; WARRAM JH, 1995, JOSLINS DIABETES MEL, P201; Wisniewski D, 1999, BLOOD, V93, P2707, DOI 10.1182/blood.V93.8.2707.408k17_2707_2720; YEUNG D, 1968, BIOCHEM J, V108, P325, DOI 10.1042/bj1080325	25	280	290	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					92	97		10.1038/35051094	http://dx.doi.org/10.1038/35051094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343120				2022-12-28	WOS:000166175600046
J	Duan, XF; Huang, Y; Cui, Y; Wang, JF; Lieber, CM				Duan, XF; Huang, Y; Cui, Y; Wang, JF; Lieber, CM			Indium phosphide nanowires as building blocks for nanoscale electronic and optoelectronic devices	NATURE			English	Article							CARBON NANOTUBES; QUANTUM WIRES; SINGLE-WALL; DOTS	Nanowires and nanotubes carry charge and excitons efficiently, and are therefore potentially ideal building blocks for nanoscale electronics and optoelectronics(1,2). Carbon nanotubes have already been exploited in devices such as field-effect(3,4) and single-electron (5,6) transistors, but the practical utility of nanotube components for building electronic circuits is limited, as it is not yet possible to selectively grow semiconducting or metallic nanotubes(7,8). Here we report the assembly of functional nanoscale devices from indium phosphide nanowires, the electrical properties of which are controlled by selective doping. Gate-voltage-dependent transport measurements demonstrate that the nanowires can be predictably synthesized as either n- or p-type. These doped nanowires function as nanoscale field-effect transistors, and can be assembled into crossed-wire p-n junctions that exhibit rectifying behaviour. Significantly, the p-n junctions emit light strongly and are perhaps the smallest light-emitting diodes that have yet been made. Finally, we show that electric-field-directed assembly can be used to create highly integrated device arrays from nanowire building blocks.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.		Cui, Yi/L-5804-2013; Duan, Xiangfeng/AAQ-9674-2020; Duan, Xiangfeng/E-7522-2011; Wang, Jianfang/O-1810-2013; Huang, Yu/AAZ-9747-2020	Cui, Yi/0000-0002-6103-6352; Duan, Xiangfeng/0000-0002-4321-6288; Duan, Xiangfeng/0000-0002-4321-6288; Wang, Jianfang/0000-0002-2467-8751; Huang, Yu/0000-0003-1793-0741				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bessolov VN, 1998, SEMICONDUCTORS+, V32, P1141, DOI 10.1134/1.1187580; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; BOLM GM, 1970, APPL PHYS LETT, V17, P373; Cui Y, 2000, J PHYS CHEM B, V104, P5213, DOI 10.1021/jp0009305; Dekker C, 1999, PHYS TODAY, V52, P22, DOI 10.1063/1.882658; Duan XF, 2000, APPL PHYS LETT, V76, P1116, DOI 10.1063/1.125956; Duan XF, 2000, J AM CHEM SOC, V122, P188, DOI 10.1021/ja993713u; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Hu JT, 1999, ACCOUNTS CHEM RES, V32, P435, DOI 10.1021/ar9700365; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Micic OI, 1996, APPL PHYS LETT, V68, P3150, DOI 10.1063/1.115807; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Odom TW, 1998, NATURE, V391, P62, DOI 10.1038/34145; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; SZE SM, 1981, PHYSICS SEMICONDUCTO; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q	20	3242	3380	22	1293	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					66	69		10.1038/35051047	http://dx.doi.org/10.1038/35051047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343112				2022-12-28	WOS:000166175600038
J	Tafuri, A; Shahinian, A; Bladt, F; Yoshinaga, SK; Jordana, M; Wakeham, A; Boucher, LM; Bouchard, D; Chan, VSF; Duncan, G; Odermatt, B; Ho, A; Itie, A; Horan, T; Whoriskey, JS; Pawson, T; Penninger, JM; Ohashi, PS; Mak, TW				Tafuri, A; Shahinian, A; Bladt, F; Yoshinaga, SK; Jordana, M; Wakeham, A; Boucher, LM; Bouchard, D; Chan, VSF; Duncan, G; Odermatt, B; Ho, A; Itie, A; Horan, T; Whoriskey, JS; Pawson, T; Penninger, JM; Ohashi, PS; Mak, TW			ICOS is essential for effective T-helper-cell responses	NATURE			English	Article							DEFICIENT MICE; CD40 LIGAND; IMMUNE-RESPONSES; CO-STIMULATION; CD28; INTERLEUKIN-4	The outcome of T-cell responses after T-cell encounter with specific antigens is modulated by co-stimulatory signals, which are required for both lymphocyte activation and development of adaptive immunity(1-3). ICOS4,5, an inducible co-stimulator with homology to CD28, is expressed on activated, but not resting T cells, and shows T-cell co-stimulatory function in vitro. ICOS binds specifically to its counter-receptor B7RP-1 (refs 5-7), but not to B7-1 or B7-2. Here we provide in vivo genetic evidence that ICOS delivers a co-stimulatory signal that is essential both for efficient interaction between T and B cells and for normal antibody responses to T-cell-dependent antigens. To determine the physiological function of ICOS, we generated and characterized gene-targeted ICOS-deficient mice. In vivo, a lack of ICOS results in severely deficient T-cell-dependent B-cell responses. Germinal centre formation is impaired and immunoglobulin class switching, including production of allergy-mediating IgE, is defective. ICOS-deficient T cells primed in in vivo and restimulated in vitro with specific antigen produce only low levels of interleukin-4, but remain fully competent to produce interferon-gamma.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Amgen Inc, Thousand Oaks, CA 91320 USA; McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Amgen; McMaster University; University of Zurich; University Zurich Hospital	Mak, TW (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Tafuri, Agostino/AAC-2186-2019; Pawson, Tony J/E-4578-2013; Penninger, Josef M/I-6860-2013; /B-3419-2011	Tafuri, Agostino/0000-0001-7911-9263; Penninger, Josef M/0000-0002-8194-3777; Ohashi, Pamela S./0000-0003-2915-9317; /0000-0001-6985-6227; Boucher, Louis-Martin/0000-0003-2802-2124				Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; BUNCHER CR, 1994, STAT METHODS PHARM I, P517; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Ferguson SE, 1996, J IMMUNOL, V156, P4576; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Grewal IS, 1997, IMMUNOL RES, V16, P59, DOI 10.1007/BF02786323; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; Stampfli MR, 1999, AM J RESP CELL MOL, V21, P317; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	29	542	591	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					105	109		10.1038/35051113	http://dx.doi.org/10.1038/35051113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343123				2022-12-28	WOS:000166175600049
J	Zhang, PH; Crespi, VH; Chang, E; Louie, SG; Cohen, ML				Zhang, PH; Crespi, VH; Chang, E; Louie, SG; Cohen, ML			Computational design of direct-bandgap semiconductors that lattice-match silicon	NATURE			English	Article							ALLOYS; GROWTH; HETEROSTRUCTURES; GAPS	Crystalline silicon is an indirect-bandgap semiconductor, making it an inefficient emitter of light. The successful integration of silicon-based electronics with optical components will therefore require optically active (for example, direct-bandgap) materials that can be grown on silicon with high-quality interfaces. For well ordered materials, this effectively translates into the requirement that such materials lattice-match silicon: lattice mismatch generally causes cracks and poor interface properties once the mismatched overlayer exceeds a very thin critical thickness. But no direct-bandgap semiconductor has yet been produced that can lattice-match silicon, and previously suggested structures(1) pose formidable challenges for synthesis. Much recent work has therefore focused on introducing compliant transition layers between the mismatched components(2-4). Here we propose a more direct solution to integrating silicon electronics with optical components. We have computationally designed two hypothetical direct-bandgap semiconductor alloys, the synthesis of which should be possible through the deposition of specific group-IV precursor molecules(5,6) and which lattice-match silicon to 0.5-1% along lattice planes with low Miller indices. The calculated bandgaps (and hence the frequency of emitted light) lie in the window of minimal absorption in current optical fibres.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Crespi, VH (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.		Zhang, Peihong/D-2787-2012	Zhang, Peihong/0000-0002-0836-316X; Crespi, Vincent/0000-0003-3846-3193				Cohen M. L., 1988, ELECT STRUCTURE OPTI; CORKILL JL, 1993, PHYS REV B, V47, P10304, DOI 10.1103/PhysRevB.47.10304; Ejeckam FE, 1997, APPL PHYS LETT, V70, P1685, DOI 10.1063/1.118669; He G, 1997, PHYS REV LETT, V79, P1937, DOI 10.1103/PhysRevLett.79.1937; Herman M. A., 1989, MOL BEAM EPITAXY FUN; HYBERTSEN MS, 1986, PHYS REV B, V34, P5390, DOI 10.1103/PhysRevB.34.5390; IHM J, 1979, J PHYS C SOLID STATE, V12, P4409, DOI 10.1088/0022-3719/12/21/009; JENKINS DW, 1987, PHYS REV B, V36, P7994, DOI 10.1103/PhysRevB.36.7994; KLINKHAMMER KW, 1995, J ORGANOMET CHEM, V496, P241, DOI 10.1016/0022-328X(95)05505-J; Kouvetakis J, 1998, APPL PHYS LETT, V72, P930, DOI 10.1063/1.120876; Kouvetakis J, 1998, CHEM MATER, V10, P2935, DOI 10.1021/cm980294b; Kouvetakis J, 1998, J AM CHEM SOC, V120, P6738, DOI 10.1021/ja9810033; LO YH, 1991, APPL PHYS LETT, V59, P2311, DOI 10.1063/1.106053; MADER KA, 1989, SOLID STATE COMMUN, V69, P1123, DOI 10.1016/0038-1098(89)91046-6; Min KS, 1998, APPL PHYS LETT, V72, P1884, DOI 10.1063/1.121215; POWELL AR, 1994, APPL PHYS LETT, V64, P1856, DOI 10.1063/1.111778; RUCHER H, 1994, PHYS REV LETT, V72, P3578; SCHMIDBAUR H, 1992, EUR J SOL STATE INOR, V29, P5; Wang T, 1999, PHYS REV LETT, V82, P3304, DOI 10.1103/PhysRevLett.82.3304	19	68	72	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					69	71		10.1038/35051054	http://dx.doi.org/10.1038/35051054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343113				2022-12-28	WOS:000166175600039
J	Lindroth, AM; Cao, XF; Jackson, JP; Zilberman, D; McCallum, CM; Henikoff, S; Jacobsen, SE				Lindroth, AM; Cao, XF; Jackson, JP; Zilberman, D; McCallum, CM; Henikoff, S; Jacobsen, SE			Requirement of CHROMOMETHYLASE3 for maintenance of CpXpG methylation	SCIENCE			English	Article							DNA METHYLATION; EPIGENETIC ALLELES; PLANT DNA; ARABIDOPSIS; METHYLTRANSFERASES; HYPERMETHYLATION; RETROTRANSPOSONS; SEQUENCES; MUTANTS; DOMAIN	Epigenetic silenced alleles of the Arabidopsis SUPERMAN locus (the clark kent alleles) are associated with dense hypermethylation at noncanonical cytosines (CpXpG and asymmetric sites, where X = A, T, C, or G). A genetic screen for suppressors of a hypermethylated clark kent mutant identified nine loss-of-function alleles of CHROMOMETHYLASE3 (CMT3), a novel cytosine methyltransferase homolog. These cmt3 mutants display a wild-type morphology but exhibit decreased CpXpG methylation of the SUP gene and of other sequences throughout the genome. They also show reactivated expression of endogenous retrotransposon sequences. These results show that a non-CpG DNA methyltransferase is responsible for maintaining epigenetic gene silencing.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.		Lindroth, Anders M/C-7744-2015	Lindroth, Anders M/0000-0002-8291-2745; Zilberman, Daniel/0000-0002-0123-8649; Henikoff, Steven/0000-0002-7621-8685	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398, T32GM007185, R01GM029009] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM60398, GM07104, GM29009, GM07185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Henikoff S, 1998, GENETICS, V149, P307; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; KISHIMOTO N, IN PRESS PLANT MOL B; KONIECZNY A, 1991, GENETICS, V127, P801; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; PAPA CM, UNPUB; Pelissier T, 1996, GENETICA, V97, P141, DOI 10.1007/BF00054621; PRADHAN S, 1995, PLANT J, V7, P471, DOI 10.1046/j.1365-313X.1995.7030471.x; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	22	641	697	4	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2077	2080		10.1126/science.1059745	http://dx.doi.org/10.1126/science.1059745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11349138				2022-12-28	WOS:000169284700048
J	Vorel, SR; Liu, XH; Hayes, RJ; Spector, JA; Gardner, EL				Vorel, SR; Liu, XH; Hayes, RJ; Spector, JA; Gardner, EL			Relapse to cocaine-seeking after hippocampal theta burst stimulation	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; SELF-ADMINISTRATION BEHAVIOR; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; EXTRACELLULAR DOPAMINE; PREFRONTAL CORTEX; RAT-BRAIN; IN-VIVO; AMYGDALA; REWARD	Treatment efforts for cocaine addiction are hampered by high relapse rates. To map brain areas underlying relapse, we used electrical brain stimulation and intracranial injection of pharmacological compounds after extinction of cocaine self-administration behavior in rats. Electrical stimulation of the hippocampus containing glutamatergic fibers, but not the medial forebrain bundle containing dopaminergic fibers, elicited cocaine-seeking behavior dependent on glutamate in the ventral tegmental area. This suggests a role for glutamatergic neurotransmission in relapse to cocaine abuse. The medial forebrain bundle electrodes supported intense electrical self-stimulation. These findings suggest a dissociation of neural systems subserving positive reinforcement (self-stimulation) and incentive motivation (relapse).	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10461 USA; NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Vorel, SR (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	robvorel@hotmail.com						Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; BALL GG, 1974, PHYSIOL BEHAV, V13, P123, DOI 10.1016/0031-9384(74)90313-8; BEAN AJ, 1991, J NEUROSCI, V11, P2694; Benoit-Marand M, 2000, EUR J NEUROSCI, V12, P2985, DOI 10.1046/j.1460-9568.2000.00155.x; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; Blaha CD, 1997, EUR J NEUROSCI, V9, P902, DOI 10.1111/j.1460-9568.1997.tb01441.x; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brudzynski SM, 1997, BRAIN RES BULL, V42, P303, DOI 10.1016/S0361-9230(96)00290-0; Childress A R, 1993, NIDA Res Monogr, V137, P73; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; CORBETT D, 1982, BEHAV BRAIN RES, V6, P167, DOI 10.1016/0166-4328(82)90012-2; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Estes WK, 1943, J EXP PSYCHOL, V32, P150, DOI 10.1037/h0058316; GALLISTEL CR, 1969, J COMP PHYSIOL PSYCH, V69, P713, DOI 10.1037/h0028232; GARRIS PA, 1994, J NEUROSCI, V14, P442; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Grimm JW, 2000, NEUROPSYCHOPHARMACOL, V22, P473, DOI 10.1016/S0893-133X(99)00157-8; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; JONES SR, 1995, J NEUROCHEM, V64, P2581; Karreman M, 1996, J NEUROCHEM, V67, P601; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Legault M, 1999, SYNAPSE, V31, P241, DOI 10.1002/(SICI)1098-2396(19990315)31:4<241::AID-SYN1>3.0.CO;2-#; Legault M, 2000, J NEUROSCI, V20, P1635; Lepore M, 1996, LIFE SCI, V58, pPL365, DOI 10.1016/0024-3205(96)00237-8; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; MARKOU A, 1993, PSYCHOPHARMACOLOGY, V112, P163, DOI 10.1007/BF02244907; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; NG JP, 1991, J NEUROCHEM, V56, P1485, DOI 10.1111/j.1471-4159.1991.tb02042.x; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; ROUTTENB.A, 1969, J COMP PHYSIOL PSYCH, V68, P22, DOI 10.1037/h0027655; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Self DW, 1998, ANN MED, V30, P379, DOI 10.3109/07853899809029938; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shalev Z, 2000, PSYCHOPHARMACOLOGY, V150, P337, DOI 10.1007/s002130000441; Simpson DD, 1999, ARCH GEN PSYCHIAT, V56, P507, DOI 10.1001/archpsyc.56.6.507; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; STEWART J, 1988, BRAIN RES, V457, P287, DOI 10.1016/0006-8993(88)90698-1; STEWART J, 1984, PHARMACOL BIOCHEM BE, V20, P917, DOI 10.1016/0091-3057(84)90017-0; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sweet KL, 1999, ANN NY ACAD SCI, V877, P828, DOI 10.1111/j.1749-6632.1999.tb09332.x; Todd CL, 1999, ANN NY ACAD SCI, V877, P688, DOI 10.1111/j.1749-6632.1999.tb09302.x; URSIN R, 1966, J COMP PHYSIOL PSYCH, V61, P353, DOI 10.1037/h0023253; VANDERKOOY D, 1977, BRAIN RES, V136, P119, DOI 10.1016/0006-8993(77)90136-6; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; WALAAS I, 1980, NEUROSCIENCE, V5, P1691, DOI 10.1016/0306-4522(80)90088-3; Walker KC, 1942, J EXP PSYCHOL, V31, P312, DOI 10.1037/h0062929; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Westerink BHC, 1996, J NEUROSCI, V16, P2605; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; ZACZEK R, 1979, EXP NEUROL, V65, P145, DOI 10.1016/0014-4886(79)90255-3	63	379	392	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1175	1178		10.1126/science.1058043	http://dx.doi.org/10.1126/science.1058043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349151				2022-12-28	WOS:000168609200063
J	Paterson, ICM				Paterson, ICM			Consent to cancer registration - an unnecessary burden	BRITISH MEDICAL JOURNAL			English	Editorial Material									Velindre Hosp, Cardiff, S Glam, Wales	Velindre Hospital	Paterson, ICM (corresponding author), Velindre Hosp, Cardiff, S Glam, Wales.			Paterson, Ian/0000-0001-9156-401X					0	8	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1130	1130		10.1136/bmj.322.7294.1130	http://dx.doi.org/10.1136/bmj.322.7294.1130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337454	Green Published			2022-12-28	WOS:000168628300056
J	Wong, TY				Wong, TY			Regular review - Effect of increasing age on cataract surgery outcomes in very elderly patients	BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; MACULAR DEGENERATION; LOCAL-ANESTHESIA; VISUAL OUTCOMES; EXTRACTION		Natl Univ Singapore, Dept Ophthalmol, Singapore 119260, Singapore	National University of Singapore	Wong, TY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264				Armbrecht AM, 2000, BRIT J OPHTHALMOL, V84, P1343, DOI 10.1136/bjo.84.12.1343; BERNTHPETERSEN P, 1983, ACTA OPHTHALMOL, V61, P392; Desai P, 1999, BRIT J OPHTHALMOL, V83, P1336, DOI 10.1136/bjo.83.12.1336; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; DUNCALF D, 1970, AM J OPHTHALMOL, V69, P610, DOI 10.1016/0002-9394(70)91629-6; ELAM JT, 1988, J GERONTOL, V43, pM122, DOI 10.1093/geronj/43.5.M122; Glantz L, 2000, ANESTH ANALG, V91, P1415, DOI 10.1097/00000539-200012000-00021; Gray CS, 1999, BRIT MED J, V318, P1367, DOI 10.1136/bmj.318.7195.1367; HAMPL KF, 1993, OPHTHALMIC SURG LAS, V24, P422; Lundstrom M, 2000, J CATARACT REFR SURG, V26, P408, DOI 10.1016/S0886-3350(99)00418-6; McKibbin M, 1996, EYE, V10, P138, DOI 10.1038/eye.1996.25; Minassian DC, 2000, BRIT J OPHTHALMOL, V84, P4, DOI 10.1136/bjo.84.1.4; Mittra RA, 2000, ARCH OPHTHALMOL-CHIC, V118, P912; Norregaard JC, 1998, ARCH OPHTHALMOL-CHIC, V116, P1095, DOI 10.1001/archopht.116.8.1095; Norregaard JC, 1997, BRIT J OPHTHALMOL, V81, P102, DOI 10.1136/bjo.81.2.102; PETRUSCAK J, 1973, ARCH OPHTHALMOL-CHIC, V89, P106; POWE NR, 1994, ARCH OPHTHALMOL-CHIC, V112, P239, DOI 10.1001/archopht.1994.01090140115033; QUIGLEY HA, 1974, AM J OPHTHALMOL, V77, P517, DOI 10.1016/0002-9394(74)90465-6; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; SCHEIN OD, 1995, OPHTHALMOLOGY, V102, P817, DOI 10.1016/S0161-6420(95)30952-9; Spalton D, 2000, BRIT MED J, V321, P1304, DOI 10.1136/bmj.321.7272.1304; Taylor HR, 2000, BRIT J OPHTHALMOL, V84, P1, DOI 10.1136/bjo.84.1.1; TUFAIL A, 1995, BRIT J OPHTHALMOL, V79, P646, DOI 10.1136/bjo.79.7.646; Westcott MC, 2000, BRIT J OPHTHALMOL, V84, P1380, DOI 10.1136/bjo.84.12.1380; Wong TY, 2000, BRIT J OPHTHALMOL, V84, P1337, DOI 10.1136/bjo.84.12.1337	25	30	30	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1104	1106		10.1136/bmj.322.7294.1104	http://dx.doi.org/10.1136/bmj.322.7294.1104			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337443	Green Published			2022-12-28	WOS:000168628300026
J	Hunot, S; Flavell, RA				Hunot, S; Flavell, RA			Apoptosis - Death of a monopoly?	SCIENCE			English	Editorial Material							CELL-DEATH; CASPASE		Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Hunot, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.		Hunot, Stephane/ABE-4204-2021	Hunot, Stephane/0000-0002-8266-5211				Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Exley GE, 1999, BIOL REPROD, V61, P231, DOI 10.1095/biolreprod61.1.231; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; LIK, 2000, CELL, V101, P389; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	15	58	66	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					865	866		10.1126/science.1060885	http://dx.doi.org/10.1126/science.1060885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341280				2022-12-28	WOS:000168514900027
J	Bytzer, P; Talley, NJ				Bytzer, P; Talley, NJ			Dyspepsia	ANNALS OF INTERNAL MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; HELICOBACTER-PYLORI; FUNCTIONAL DYSPEPSIA; NONULCER DYSPEPSIA; GASTROINTESTINAL SYMPTOMS; ABDOMINAL SYMPTOMS; GLASGOW DYSPEPSIA; SINGLE SUBJECTS; SEVERITY SCORE	Dyspepsia refers to pain or discomfort centered in the upper abdomen. This symptom is remarkably common, with 1-year prevalence rates averaging 25% in the community. Symptoms suggestive of the irritable bowel syndrome and reflux disease frequently overlap but do not form part of the definition of dyspepsia. Electrical and other stimuli can cause similar or different symptoms in various patients, and even the site to which symptoms are referred varies considerably. Dyspeptic symptoms are therefore a relatively poor guide to the origin or nature of any "disturbances" in the gut, identification of patients who require further investigation to rule out serious structural disease, such as peptic ulcer disease or cancer, is a key issue because unaided clinical diagnosis is unreliable. The use of an age threshold (typically 45 years) and the identification of alarm features, including weight loss, repeated vomiting, acid signs of bleeding, seem to be valid on the basis of the limited evidence available. Dyspeptic symptoms fall into distinct subgroups resembling the perceived clinical entities of ulcer-like and dysmotility-like dyspepsia. Unfortunately, because of overlap with reflux symptoms and between the subgroups, the clinical significance of these groups remains highly questionable. A focus on symptom predominance may be more rewarding. Lack of validated outcome measures has hampered clinical studies and has led to the development of complex outcome measures that integrate and weigh different symptoms or other indirect indicators of outcome into a general score. Further testing and validation are in progress.	Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia; Univ Sydney, Sydney, NSW 2006, Australia	Nepean Hospital; University of Sydney; University of Sydney	Talley, NJ (corresponding author), Nepean Hosp, Dept Med, Box 63,Clin Sci Bldg, Penrith, NSW 2751, Australia.	ntalley@blackburn.med.usyd.edu.au	Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092				ADANG RP, 1994, EUR J GASTROEN HEPAT, V6, P329; AGREUS L, 1995, GASTROENTEROLOGY, V109, P671, DOI 10.1016/0016-5085(95)90373-9; AGREUS L, 1994, SCAND J GASTROENTERO, V29, P102, DOI 10.3109/00365529409090447; ALMY TP, 1983, FUNCTIONAL DISORDERS, P7; BATES S, 1989, GASTROENTEROLOGY, V97, P376, DOI 10.1016/0016-5085(89)90073-5; BERNERSEN B, 1990, GUT, V31, P989, DOI 10.1136/gut.31.9.989; Blum AL, 1998, NEW ENGL J MED, V339, P1875, DOI 10.1056/NEJM199812243392602; Breslin NP, 2000, GUT, V46, P93, DOI 10.1136/gut.46.1.93; Brignoli R, 1997, EUR J GASTROEN HEPAT, V9, P337, DOI 10.1097/00042737-199704000-00005; Bytzer P, 1996, GASTROENTEROLOGY, V110, P302, DOI 10.1053/gast.1996.v110.agast960302; BYTZER P, 1994, LANCET, V343, P811, DOI 10.1016/S0140-6736(94)92023-0; Bytzer P, 2000, ALIMENT PHARM THER, V14, P1485; Bytzer P, 1996, EUR J GASTROEN HEPAT, V8, P359, DOI 10.1097/00042737-199604000-00014; CARVALHINHOS A, 1995, EUR J GASTROEN HEPAT, V7, P411; Christie J, 1997, GUT, V41, P513, DOI 10.1136/gut.41.4.513; COLINJONES DG, 1988, LANCET, V1, P576; DAPOIGNY M, 1995, DIGEST DIS SCI, V40, P2244, DOI 10.1007/BF02209014; Drewes AM, 1997, GUT, V41, P753, DOI 10.1136/gut.41.6.753; ElOmar EM, 1996, EUR J GASTROEN HEPAT, V8, P967, DOI 10.1097/00042737-199610000-00006; Farup PG, 1999, SCAND J GASTROENTERO, V34, P575; GEORGE AA, 1991, GASTROENTEROLOGY, V101, P3, DOI 10.1016/0016-5085(91)90453-R; Gillen D, 1999, AM J GASTROENTEROL, V94, P75; GOTTHARD R, 1988, SCAND J GASTROENTERO, V23, P7, DOI 10.3109/00365528809093840; GUYATT GH, 1985, J CHRON DIS, V38, P1003, DOI 10.1016/0021-9681(85)90098-0; Hallas J, 1998, EUR J GASTROEN HEPAT, V10, P27, DOI 10.1097/00042737-199801000-00006; Hammer J, 1999, GASTROENTEROLOGY, V116, pA63; Hansen JM, 1998, AM J GASTROENTEROL, V93, P368, DOI 10.1016/S0002-9270(97)00107-X; Heading RC, 1997, EUR J GASTROEN HEPAT, V9, P779, DOI 10.1097/00042737-199708000-00008; HEADING RC, 1991, SCAND J GASTROENTERO, V26, P1, DOI 10.3109/00365529109109529; HEATLEY RV, 1987, LANCET, V2, P779; HORROCKS JC, 1975, AM J DIG DIS, V20, P397, DOI 10.1007/BF01070783; JOHANNESSEN T, 1992, SCAND J GASTROENTERO, V27, P189, DOI 10.3109/00365529208999947; JOHANNESSEN T, 1991, BMJ-BRIT MED J, V303, P173, DOI 10.1136/bmj.303.6795.173; JONES R, 1989, BRIT MED J, V298, P30, DOI 10.1136/bmj.298.6665.30; JORGENSEN T, 1989, HEPATOLOGY, V9, P856, DOI 10.1002/hep.1840090611; Kay L, 1996, SCAND J GASTROENTERO, V31, P469, DOI 10.3109/00365529609006767; KNILLJONES RP, 1985, CLIN GASTROENTEROL, V14, P517; KRAAG N, 1995, SCAND J GASTROENTERO, V30, P411, DOI 10.3109/00365529509093300; Kuykendall DH, 1998, J CLIN EPIDEMIOL, V51, P99, DOI 10.1016/S0895-4356(97)00245-X; LEWIS JA, 1991, BRIT MED J, V303, P175, DOI 10.1136/bmj.303.6795.175; Lin ZY, 1999, AM J GASTROENTEROL, V94, P2384; LOOF L, 1985, SCAND J GASTROENTERO, V20, P35, DOI 10.3109/00365528509103933; MACKENZIE CR, 1986, BRIT MED J, V292, P40, DOI 10.1136/bmj.292.6512.40; Madsen LG, 2000, CAN J GASTROENTEROL, V14, P713, DOI 10.1155/2000/783950; Malagelada JR, 1998, GASTROENTEROLOGY, V115, P1586, DOI 10.1016/S0016-5085(98)70041-1; McColl KEL, 1998, BAILLIERE CLIN GASTR, V12, P489, DOI 10.1016/S0950-3528(98)90020-3; McColl KEL, 1997, EUR J GASTROEN HEPAT, V9, P413, DOI 10.1097/00042737-199704000-00019; Meineche-Schmidt V, 1998, SCAND J GASTROENTERO, V33, P1262; MEINECHESCHMIDT V, 1996, GASTROENTEROLOGY, V110, pA29; MISRA SP, 1990, J CLIN GASTROENTEROL, V12, P624, DOI 10.1097/00004836-199012000-00005; Moayyedi P, 1998, ALIMENT PHARM THER, V12, P1257; Moayyedi P, 1998, GUT, V42, pA75; NYREN O, 1987, J CLIN GASTROENTEROL, V9, P408, DOI 10.1097/00004836-198708000-00010; NYREN O, 1987, J CLIN GASTROENTEROL, V9, P303, DOI 10.1097/00004836-198706000-00012; Penston JG, 1996, ALIMENT PHARM THERAP, V10, P83; Samsom M, 1999, GASTROENTEROLOGY, V116, P515, DOI 10.1016/S0016-5085(99)70171-X; Sheu BS, 1996, AM J GASTROENTEROL, V91, P441; Stanghellini V, 1996, GASTROENTEROLOGY, V110, P1036, DOI 10.1053/gast.1996.v110.pm8612991; Stanghellini V, 1998, BAILLIERE CLIN GASTR, V12, P533; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Tack J, 2000, GUT, V46, P468, DOI 10.1136/gut.46.4.468; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Talley N, 1993, GASTROENTEROL INT, V6, P189; Talley N, 1991, GASTROENTEROL INT, V4, P145; Talley NI, 1999, ALIMENT PHARM THERAP, V13, P225; Talley NJ, 1998, GUT, V42, P690, DOI 10.1136/gut.42.5.690; TALLEY NJ, 1994, GASTROENTEROLOGY, V106, P1174, DOI 10.1016/0016-5085(94)90007-8; TALLEY NJ, 1993, GASTROENTEROLOGY, V105, P1378, DOI 10.1016/0016-5085(93)90142-Y; Talley NJ, 1999, GUT, V45, P37; Talley NJ, 1998, ALIMENT PHARM THER, V12, P1055; Talley NJ, 1999, BMJ-BRIT MED J, V318, P833, DOI 10.1136/bmj.318.7187.833; TALLEY NJ, 1989, ANN INTERN MED, V111, P671, DOI 10.7326/0003-4819-111-8-671; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; TALLEY NJ, 1995, J CLIN GASTROENTEROL, V20, P182, DOI 10.1097/00004836-199504000-00002; THOMPSON WG, 1984, CAN MED ASSOC J, V130, P565; Undeland KA, 1998, EUR J GASTROEN HEPAT, V10, P677; van Zanten SJOV, 1999, GUT, V45, P69; van Zanten SJOV, 1999, AM J GASTROENTEROL, V94, P9; VANZANTEN SJOV, 1993, J CLIN EPIDEMIOL, V46, P273, DOI 10.1016/0895-4356(93)90075-C; vanZanten SJOV, 1996, AM J GASTROENTEROL, V91, P660; VANZANTEN SJV, 2000, ROME, V2, P577; WARNDORFF DK, 1989, J ROY COLL GEN PRACT, V39, P499; WHITE LJ, 1985, ANN INTERN MED, V102, P266, DOI 10.7326/0003-4819-102-2-266; 1996, BRIT SOC GASTROENTER, V1, P1	84	52	56	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			815	822		10.7326/0003-4819-134-9_Part_2-200105011-00004	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346316				2022-12-28	WOS:000168543100004
J	Hahn, SR				Hahn, SR			Physical symptoms and physician-experienced difficulty in the physician-patient relationship	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL PREDICTORS; CARE; PSYCHOPATHOLOGY; PREVALENCE; COMPLAINTS; DISORDERS; THERAPY	Background: The practice of medicine has many expected and accepted challenges, but all physicians experience some patients as difficult to a degree that transcends these expectations. Physician-experienced difficulty is associated with a syndrome of three characteristics: patient psychopathology, abrasive interpersonal styles, and multiple physical symptoms. Objective: To assess the roles played by the number of physical symptoms and by specific symptoms in determining whether physician-experienced difficulty occurs. Design: New analyses of epidemiologic survey data from the Primary Care Evaluation of Mental Disorders (PRIME-MD) 1000 Study. Setting: Four primary care clinics. Participants: 627 ambulatory patients seen by 27 physicians. Measurements: Physician-experienced difficulty was measured by using the 10-item Difficult Doctor Patient Relationship Questionnaire (DDPRQ-10); patient-reported physical symptoms and physician-assessed psychopathology and somatoform symptoms were evaluated by using the PRIME-MD; and physical illnesses were measured by using a physician questionnaire. Results: The number of physical symptoms and the number of somatoform symptoms correlated with difficulty (r = 0.39 and r = 0.37, respectively; P < 0.001), and the correlations remained significant after adjustment for physical and mental disorders (r = 0.20 for both correlations; P < 0.001). Difficult patients were more likely to have each of 16 physical symptoms; the odds of being difficult were greater for patients with 1 of 5 particular symptoms (stomach pain, fainting, loose stools/diarrhea, palpitations, and sleep problems), even after adjustment for physical and mental disorders. All 10 items on the DDPRQ-10 were influenced by physical symptoms, particularly those items that asked about physician frustration and whether patients were manipulative and time consuming. Conclusions: The association between physical symptoms and difficulty is due in part to the association between physical symptoms and mental disorders, but symptoms also contribute independently to difficulty, The independent component of symptom-associated difficulty may be due to 1) differences between patient and physician in expectations about treatment and 2) the part that symptoms play in conferring the "sick role" on a patient.	Jacobi Med Ctr, Adult Primary Care Serv, Bronx, NY 10461 USA	Jacobi Medical Center	Hahn, SR (corresponding author), Jacobi Med Ctr, Adult Primary Care Serv, Ambulatory Care Pavil 316E, Bronx, NY 10461 USA.	shahn@aecom.yu.edu						American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; DROSSMAN DA, 1978, ANN INTERN MED, V88, P366, DOI 10.7326/0003-4819-88-3-366; GOODWIN JM, 1979, JAMA-J AM MED ASSOC, V241, P1117, DOI 10.1001/jama.241.11.1117; Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477; HAHN SR, 1994, J CLIN EPIDEMIOL, V47, P647, DOI 10.1016/0895-4356(94)90212-7; HAHN SR, 1997, BEHAV MED PRIMARY CA; ISSELBACHER KJ, 1994, HARRISONS PRINCIPLES, pR31; Jackson JL, 1999, ARCH INTERN MED, V159, P1069, DOI 10.1001/archinte.159.10.1069; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; LIN EHB, 1991, J GEN INTERN MED, V6, P241, DOI 10.1007/BF02598969; MCGAGHIE WC, 1982, J NERV MENT DIS, V170, P598, DOI 10.1097/00005053-198210000-00003; MERRILL JM, 1987, SOUTHERN MED J, V80, P1211, DOI 10.1097/00007611-198710000-00003; Nimnuan C, 2000, QJM-INT J MED, V93, P21, DOI 10.1093/qjmed/93.1.21; NOVACK DH, 1985, PSYCHOSOMATICS, V26, P853, DOI 10.1016/S0033-3182(85)72776-4; ODOWD TC, 1988, BRIT MED J, V297, P528, DOI 10.1136/bmj.297.6647.528; Parsons T, 1958, PATIENTS PHYSICIANS, P165; SCHWENK TL, 1989, J FAM PRACTICE, V28, P59; SHARPE M, 1994, Q J MED, V87, P187; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Walker EA, 1997, GEN HOSP PSYCHIAT, V19, P315, DOI 10.1016/S0163-8343(97)00042-X; WIEFFERINK CH, 1998, TIJDSCHRIFT GEZONDHE, V76, P298; 1983, WEBSTERS 9 NEW COLL; [No title captured]	27	158	160	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			897	904		10.7326/0003-4819-134-9_Part_2-200105011-00014	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00014			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346326				2022-12-28	WOS:000168543100014
J	Von Korff, M; Moore, JC				Von Korff, M; Moore, JC			Stepped care for back pain: Activating approaches for primary care	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; CHRONIC ILLNESS; BED REST; MANAGEMENT; DISABILITY; OUTCOMES; INTERVENTION; INFORMATION; ADVICE; FEAR	Interventions that encourage return to normal function and reduce fear of physical activity have been shown to improve outcomes for patients with back pain, but routine medical care for back pain often does not provide such interventions. This paper proposes a stepped-care approach that addresses the functional outcomes of back pain. Step 1, which is relevant to most patients, addresses the common fears of patients with back pain and encourages patients to resume normal activities. Step 2, which targets the substantial minority of patients who require more than simple advice to resume activities, provides brief, structured interventions that support physical exercise and return to normal activities. Step 3 targets patients who require more intensive interventions, including treatment of psychological illness when present, before they can return to normal activities in work and family life. Patient needs relevant to these three levels of care are delineated. This stepped-care approach provides a framework for sequencing progressively more intensive interventions and coordinating the efforts of primary care physicians, allied health professionals, behavioral health clinicians, and patients to improve functional outcomes in patients with back pain.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	Group Health Cooperative	Von Korff, M (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	vonkorff.m@ghc.org		VonKorff, Michael/0000-0001-5386-8477	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008773] Funding Source: NIH RePORTER; NIDCR NIH HHS [P01 DE08773] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Davison GC, 2000, J CONSULT CLIN PSYCH, V68, P580, DOI 10.1037/0022-006X.68.4.580; Haaga DAF, 2000, J CONSULT CLIN PSYCH, V68, P547, DOI 10.1037/0022-006X.68.4.547; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; KOES BW, 1994, J CLIN EPIDEMIOL, V47, P851, DOI 10.1016/0895-4356(94)90188-0; Linton SJ, 2000, SPINE, V25, P2825, DOI 10.1097/00007632-200011010-00017; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; Moffett JK, 1999, BRIT MED J, V319, P279, DOI 10.1136/bmj.319.7205.279; Moore JE, 2000, PAIN, V88, P145, DOI 10.1016/S0304-3959(00)00314-6; Ritvo P G, 1997, Cancer Prev Control, V1, P289; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rossignol M, 2000, SPINE, V25, P251, DOI 10.1097/00007632-200001150-00018; Turk DC, 1983, PAIN BEHAV MED; Turner JA, 1998, SPINE, V23, P463, DOI 10.1097/00007632-199802150-00011; Turner JA, 1996, SPINE, V21, P2851, DOI 10.1097/00007632-199612150-00010; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Von Korff M, 1998, SPINE, V23, P2608, DOI 10.1097/00007632-199812010-00016; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Von Korff M, 2000, WESTERN J MED, V172, P133, DOI 10.1136/ewjm.172.2.133; VONKORFF M, 1993, SPINE, V18, P855, DOI 10.1097/00007632-199306000-00008; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; VONKORFF M, 1999, PSYCHOSOCIAL FACTORS, P360; Waddell G, 1997, BRIT J GEN PRACT, V47, P647; Waddell G., 1998, BACK PAIN REVOLUTION; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391	27	89	90	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			911	917		10.7326/0003-4819-134-9_Part_2-200105011-00016	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00016			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346328				2022-12-28	WOS:000168543100016
J	Meurice, T; Bauters, C; Hermant, X; Codron, V; VanBelle, E; Mc Fadden, EP; Lablanche, JM; Bertrand, ME; Amouyel, P				Meurice, T; Bauters, C; Hermant, X; Codron, V; VanBelle, E; Mc Fadden, EP; Lablanche, JM; Bertrand, ME; Amouyel, P			Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							I-CONVERTING-ENZYME; SERIAL INTRAVASCULAR ULTRASOUND; MAJOR RISK FACTOR; INSERTION/DELETION POLYMORPHISM; ANGIOTENSIN; PLACEMENT; PROLIFERATION; INTERVENTION; ANGIOPLASTY; DISEASE	Background The DD genotype for the angiotensin-1 converting enzyme (ACE I) deletion allele (D) polymorphism is a possible genetic risk factor for restenosis after coronary stent implantation. We aimed to establish whether or not blockade of ACE with high doses of ACE inhibitors could reduce this risk of angiographic restenosis. Methods We characterised the ACE I/D polymorphism in 345 consecutive patients who were undergoing coronary stenting. 115 had the DD genotype. We assigned 91 of these 115 patients to quinapril 40 mg daily (n=46) or placebo (n=45). Treatment was started within 48 h after stent implantation and continued for 6 months. 79 patients complied with the protocol and underwent follow-up angiography after 6 months. Findings Our primary endpoint of late loss in minimum lumen diameter (a quantitative index of restenosis) was significantly higher in the quinapril group than in the controls (mean 1.11 mm [SD 0.70] vs 0.76 mm [0.60]: p=0.018). Secondary endpoints also showed consistent trends towards increased angiographic restenosis in the treatment group. Interpretation Contrary to our expectations, ACE inhibitor treatment did not reduce restenosis after coronary stent implantation in patients with DD genotype, but was associated with an exaggerated restenotic process when compared with administration of placebo.	CHU Lille, F-59037 Lille, France; Inst Pasteur, INSERM, U508, F-59019 Lille, France; Hop Cardiovasc, F-69394 Lyon, France	Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lyon	Amouyel, P (corresponding author), CHU Lille, F-59037 Lille, France.			Amouyel, Philippe/0000-0001-9088-234X; Bauters, christophe/0000-0001-8268-8467				Amant C, 1997, CIRCULATION, V96, P56; Anderson TJ, 2000, J AM COLL CARDIOL, V35, P60, DOI 10.1016/S0735-1097(99)00537-9; BALCON R, 1992, CIRCULATION, V86, P100; Bauters C, 1998, CIRCULATION, V97, P318; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; FARHY RD, 1993, CIRC RES, V72, P1202, DOI 10.1161/01.RES.72.6.1202; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; HALL JM, 1992, PHARMACOL THERAPEUT, V56, P131, DOI 10.1016/0163-7258(92)90016-S; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Koch W, 2000, CIRCULATION, V102, P197, DOI 10.1161/01.CIR.102.2.197; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; *MERCATOR STUD GRO, 1995, J AM COLL CARDIOL, V2, P362; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; TEXTER M, 1993, CARDIOVASC DRUG THER, V7, P273, DOI 10.1007/BF00878518; Yusuf S, 2000, NEW ENGL J MED, V342, P145	19	77	81	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1321	1324		10.1016/S0140-6736(00)04518-9	http://dx.doi.org/10.1016/S0140-6736(00)04518-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343737				2022-12-28	WOS:000168411400010
J	Eriksson, JG; Forsen, T; Tuomilehto, J; Osmond, C; Barker, DJP				Eriksson, JG; Forsen, T; Tuomilehto, J; Osmond, C; Barker, DJP			Early growth and coronary heart disease in later life: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							REDUCED FETAL GROWTH; ADULT LIFE; IN-UTERO; CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; FACTOR-VII; FOLLOW-UP; DEATH; WOMEN; CHOLESTEROL	Objective To determine how growth during infancy and childhood modifies the increased risk of coronary heart disease associated with small body size at birth. Design Longitudinal study. Setting Helsinki, Finland. Subjects 4630 men who were born in the Helsinki University Hospital during 1934-44 and who attended child welfare clinics in the city. Each man had on average 18.0 (SD 9.5) measurements of height and weight between birth and age 12 years. Main outcome measures Hospital admission or death from coronary heart disease. Results Low birth weight and low ponderal index (birth weight/length(3)) were associated with increased risk of coronary heart disease. Low height, weight, and body mass index (weight/height(2)) at age 1 year also increased the risk. Hazard ratios fell progressively from 1.83 (95% confidence interval 1.28 to 2.60) in men whose body mass index at age 1 year was below 16 kg/m(2) to 1.00 in those whose body mass index was > 19 (P for trend = 0.0004). After age 1 year, rapid gain in weight and body mass index increased the risk of coronary heart disease. This effect was confined, however, to men with a ponderal index < 26 at birth. In these men the hazard ratio associated with a one unit increase in standard deviation score for body mass index between ages 1 and 12 years was 1.27 (1.10 to 1.47; P = 0.001). Conclusion Irrespective of size at birth, low weight gain during infancy is associated with increased risk of coronary heart disease. After age 1 year, rapid weight gain is associated with further increase in risk, but only among boys who were thin at birth. In these boys the adverse effects of rapid weight gain on later coronary heart disease are already apparent at age 3 years. Improvements in fetal, infant, and child growth could lead to substantial reductions in the incidence of coronary heart disease.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	Finland National Institute for Health & Welfare; University of Southampton	Eriksson, JG (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Mannerheimintie 166, FIN-00300 Helsinki, Finland.			Osmond, Clive/0000-0002-9054-4655				BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; BARKER DJP, 1995, BRIT MED J, V310, P703, DOI 10.1136/bmj.310.6981.703; BARKER DJP, 1989, LANCET, V2, P557; BATESON P, 1999, DESIGN LIFE BEHAV DE; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; COX DR, 1972, J R STAT SOC B, V34, P187; DESAI M, 1995, BIOCHEM SOC T, V23, P331, DOI 10.1042/bst0230331; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; HOOPER L, BMJ, V322, P737; Kind KL, 1999, AM J PHYSIOL-REG I, V277, pR1675, DOI 10.1152/ajpregu.1999.277.6.R1675; Kuh D, 1997, LIFE COURSE APPROACH; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MARMOT MG, 1984, LANCET, V1, P1003; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; MARTYN CN, 1995, BRIT J HAEMATOL, V89, P142, DOI 10.1111/j.1365-2141.1995.tb08920.x; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Tanner JM, 1989, FOETUS INTO MAN; WIDDOWSON EM, 1972, ARCH DIS CHILD, V47, P652, DOI 10.1136/adc.47.254.652	30	710	738	0	31	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					949	953		10.1136/bmj.322.7292.949	http://dx.doi.org/10.1136/bmj.322.7292.949			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312225	Green Published, Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000168345100015
J	Doring, V; Mootz, HD; Nangle, LA; Hendrickson, TL; de Crecy-Lagard, V; Schimmel, P; Marliere, P				Doring, V; Mootz, HD; Nangle, LA; Hendrickson, TL; de Crecy-Lagard, V; Schimmel, P; Marliere, P			Enlarging the amino acid set of Escherichia coli by infiltration of the valine coding pathway	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASES; THYMIDYLATE SYNTHASE; GENETIC-CODE; BIOSYNTHESIS; EVOLUTION; CYSTEINE; ERRORS	Aminoacyl transfer RNA (tRNA) synthetases establish the rules of the genetic code by catalyzing the aminoacylation of tRNAs. For some synthetases, accuracy depends critically on an editing function at a site distinct from the aminoacylation site. Mutants of Escherichia coli that incorrectly charge tRNA(Val) with cysteine were selected after random mutagenesis of the whole chromosome. All mutations obtained were located in the editing site of valyl-tRNA synthetase. More than 20% of the valine in cellular proteins from such an editing mutant organism could be replaced with the noncanonical aminobutyrate, sterically similar to cysteine, Thus, the editing function may have played a central role in restricting the genetic code to 20 amino acids. Disabling this editing function offers a powerful approach for diversifying the chemical composition of proteins and for emulating evolutionary stages of ambiguous translation.	Scripps Res Inst, Res Inst, La Jolla, CA 92037 USA; Evolog SA, F-91000 Evry, France; Genoscope, UMR8030, F-91057 Evry, France; Univ Marburg, Biochem Fachbereich Chem, D-35032 Marburg, Germany	Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Philipps University Marburg	Schimmel, P (corresponding author), Scripps Res Inst, Res Inst, BCC-379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		de Crecy-Lagard, Valerie/AAN-8995-2020		NIGMS NIH HHS [GM23562] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; BELFORT M, 1983, P NATL ACAD SCI-BIOL, V80, P4914, DOI 10.1073/pnas.80.16.4914; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; DEFELICE M, 1977, J MOL BIOL, V156, P1; DEV IK, 1988, P NATL ACAD SCI USA, V85, P1472, DOI 10.1073/pnas.85.5.1472; Doring V, 1998, GENETICS, V150, P543; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; FERSHT A, 1999, STRUCTURE MECH PROTE, P347; Fotheringham IG, 1999, BIOORGAN MED CHEM, V7, P2209, DOI 10.1016/S0968-0896(99)00153-4; Gevaert K, 2000, ELECTROPHORESIS, V21, P1145, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1145::AID-ELPS1145>3.0.CO;2-Z; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hendrickson TL, 2000, BIOCHEMISTRY-US, V39, P8180, DOI 10.1021/bi0004798; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Kowal AK, 2001, P NATL ACAD SCI USA, V98, P2268, DOI 10.1073/pnas.031488298; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; LEMEIGNAN B, 1995, THESIS U PARIS 6; Lin L, 1996, BIOCHEMISTRY-US, V35, P5596, DOI 10.1021/bi960011y; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; MUSLERFORSYTH K, 2000, NAT STRUCT BIOL, V7, P435; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; PINE MJ, 1978, ANTIMICROB AGENTS CH, V13, P676, DOI 10.1128/AAC.13.4.676; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SUSSMAN AJ, 1971, ANNU REV BIOCHEM, V40, P397, DOI 10.1146/annurev.bi.40.070171.002145; WEBER AL, 1981, J MOL EVOL, V17, P273, DOI 10.1007/BF01795749	30	157	203	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					501	504		10.1126/science.1057718	http://dx.doi.org/10.1126/science.1057718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313495				2022-12-28	WOS:000168187300046
J	Nesbitt, AD; Cooper, PJ; Kohl, P				Nesbitt, AD; Cooper, PJ; Kohl, P			Rediscovering commotio cordis	LANCET			English	Article							CHEST-WALL IMPACT; SUDDEN-DEATH; CARDIAC CONCUSSION; SPORTS		Univ Oxford, Physiol Lab, Cardiac Mechanoelect Feedback Grp, Oxford OX1 3PT, England; Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Kohl, P (corresponding author), Univ Oxford, Physiol Lab, Cardiac Mechanoelect Feedback Grp, Parks Rd, Oxford OX1 3PT, England.			Kohl, Peter/0000-0003-0416-6270				Albers A, 1966, Lebensversicher Med, V18, P9; BERNSTEIN R, 1896, Z KLIN MED, V29, P519; BRUNNER W, 1939, ZB CHIRURG, V39, P2145; Casper Johann Ludwig, 1857, PRACTISCHES HDB GERI; COOPER GJ, 1982, J TRAUMA, V22, P994, DOI 10.1097/00005373-198212000-00004; DEUTSCH F, 1930, WIEN ARCH INTERN MED, V20, P279; Dickman Gerald L, 1978, Phys Sportsmed, V6, P85, DOI 10.1080/00913847.1978.11948393; EDLICH R F JR, 1987, Journal of Emergency Medicine, V5, P181, DOI 10.1016/0736-4679(87)90176-4; FRAZER M, 1984, AM J FOREN MED PATH, V5, P249, DOI 10.1097/00000433-198409000-00015; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GLATZEL H, 1936, DEUT MED WOCHENSCHR, V10, P377; GOGLER E, 1962, UNFALLOPFER STRASSEN, P51; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; GREINER H, 1953, Monatsschr Unfallheilkd Versicherungsmed, V56, P90; HADOM W, 1940, SCHWEIZ Z UNFALLHEIL, V1, P156; HADOM W, 1940, SCHWEIZ Z UNFALLHEIL, V1, P227; ISFORT A, 1969, MON UNFALL VERISCH-V, V72, P409; JACOBI, 1937, ARCH ORTHOPAD UNFALL, V42, P418; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; Kohl P, 2001, CARDIOVASC RES, V50, P280, DOI 10.1016/S0008-6363(01)00194-8; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Kohl P, 1999, HEART, V82, P397, DOI 10.1136/hrt.82.3.397; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Link MS, 1999, HEART, V81, P109, DOI 10.1136/hrt.81.2.109; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; Meola F, 1879, GIORNALE INT SCI MED, V1, P923; Michalodimitrakis EN, 1997, AM J FOREN MED PATH, V18, P282, DOI 10.1097/00000433-199709000-00010; NELATON A, 1876, ELEMENTS PATHOLOGIE; NORDMANN M, 1942, Z KREISLAUFFORSCH, V11, P361; RIEDINGER F, 1903, HDB PRAKTISCHEN CHIR, P373; RIEDINGER F, 1882, BRUSTERSCHUTTERUNG F, P221; Schlomka G., 1934, ERG INN MED KINDERHK, V47, P1, DOI 10.1007/ 978-3-642-90672-5_1.; SELVIN P, 1998, WASHINGTON POST 0530; SPUHLER O, 1937, SCHWEIZ MED WOCHENSC, V26, P571; Walther G, 1968, Lebensversicher Med, V20, P136; Wirth E, 1973, Beitr Gerichtl Med, V30, P458	38	59	62	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1195	1197		10.1016/S0140-6736(00)04338-5	http://dx.doi.org/10.1016/S0140-6736(00)04338-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323067				2022-12-28	WOS:000168192100033
J	Borgani, S; Guzzo, L				Borgani, S; Guzzo, L			X-ray clusters of galaxies as tracers of structure in the Universe	NATURE			English	Review							CAMPANAS REDSHIFT SURVEY; SPATIAL CORRELATION-FUNCTION; ALL-SKY SURVEY; RICH CLUSTERS; COSMOLOGICAL CONSTRAINTS; ABELL CLUSTERS; POWER SPECTRUM; SAMPLE; MASS; CATALOG	Clusters of galaxies are visible tracers of the network of matter in the Universe, marking the high-density regions where filaments of dark matter join together. When observed at X-ray wavelengths these clusters shine like cosmic lighthouses, as a consequence of the hot gas trapped within their gravitational potential wells. The X-ray emission is linked directly to the total mass of a cluster, and so can be used to investigate the mass distribution for a sizeable fraction of the Universe. The picture that has emerged from recent studies is remarkably consistent with the predictions for a low-density Universe dominated by cold dark matter.	Univ Trieste, Dipartimento Astron, Ist Nazl Fis Nucl, Sez Trieste, I-34131 Trieste, Italy; Univ Perugia, Dipartimento Fis, Ist Nazl Fis Nucl, Sez Perugia, Perugia, Italy; Osserv Astron Brera, I-23807 Merate, Italy	Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Istituto Nazionale Astrofisica (INAF)	Borgani, S (corresponding author), Univ Trieste, Dipartimento Astron, Ist Nazl Fis Nucl, Sez Trieste, Via Tiepolo 11, I-34131 Trieste, Italy.	borgani@ts.astro.it; guzzo@merate.mi.astro.it	Guzzo, Luigi/R-4939-2017	Guzzo, Luigi/0000-0001-8264-5192; Borgani, Stefano/0000-0001-6151-6439				Abadi MG, 1998, ASTROPHYS J, V507, P526, DOI 10.1086/306342; Abell G. O., 1958, ASTROPHYS J        S, V3, P211, DOI DOI 10.1086/190036; ABELL GO, 1989, ASTROPHYS J SUPPL S, V70, P1, DOI 10.1086/191333; Arnaud M, 1999, MON NOT R ASTRON SOC, V305, P631, DOI 10.1046/j.1365-8711.1999.02442.x; BAHCALL NA, 1983, ASTROPHYS J, V270, P20, DOI 10.1086/161094; Bahcall NA, 1999, SCIENCE, V284, P1481, DOI 10.1126/science.284.5419.1481; Balbi A, 2000, ASTROPHYS J, V545, pL1, DOI 10.1086/317323; BARTLETT JG, IN PRESS ASTRON ASTR; BARTLETT JG, 2000, ASTROPH0001267; Benson AJ, 2000, MON NOT R ASTRON SOC, V311, P793, DOI 10.1046/j.1365-8711.2000.03101.x; Bohringer H, 2000, ASTROPHYS J SUPPL S, V129, P435, DOI 10.1086/313427; BOHRINGER H, UNPUB ASTRON ASTROPH; BOHRINGER H, 2000, ASTROPH001226; Borgani S, 1999, ASTROPHYS J, V517, P40, DOI 10.1086/307158; Borgani S, 1999, MON NOT R ASTRON SOC, V305, P866, DOI 10.1046/j.1365-8711.1999.02468.x; BORGANI S, 1995, PHYS REP, V251, P2; BORGANI S, UNPUB ASTROPHYS J; BOWER RG, UNPUB MON NOT R ASTR; BOWER RG, 2000, ASTROPH0006109; Bryan GL, 1998, ASTROPHYS J, V495, P80, DOI 10.1086/305262; Burles S, 1998, ASTROPHYS J, V499, P699, DOI 10.1086/305667; BURROWS CJ, 1992, ASTROPHYS J, V392, P760, DOI 10.1086/171479; Carlstrom JE, 2000, PHYS SCRIPTA, VT85, P148, DOI 10.1238/Physica.Topical.085a00148; CAVALIER.AG, 1971, NATURE, V231, P437, DOI 10.1038/231437a0; Colberg JM, 2000, MON NOT R ASTRON SOC, V319, P209, DOI 10.1046/j.1365-8711.2000.03832.x; Collins CA, 2000, MON NOT R ASTRON SOC, V319, P939, DOI 10.1046/j.1365-8711.2000.03918.x; de Bernardis P, 2000, NATURE, V404, P955, DOI 10.1038/35010035; De Grandi S, 1999, ASTROPHYS J, V514, P148, DOI 10.1086/306939; Della Ceca R, 2000, ASTRON ASTROPHYS, V353, P498; Ebeling H, 1998, MON NOT R ASTRON SOC, V301, P881, DOI 10.1046/j.1365-8711.1998.01949.x; Ebeling H, 1996, MON NOT R ASTRON SOC, V281, P799, DOI 10.1093/mnras/281.3.799; Eisenstein DJ, 1998, ASTROPHYS J, V496, P605, DOI 10.1086/305424; Eke VR, 1996, MON NOT R ASTRON SOC, V282, P263, DOI 10.1093/mnras/282.1.263; Eke VR, 1996, MON NOT R ASTRON SOC, V281, P703, DOI 10.1093/mnras/281.2.703; Evrard AE, 1996, ASTROPHYS J, V469, P494, DOI 10.1086/177798; Evrard AE, 1997, MON NOT R ASTRON SOC, V292, P289, DOI 10.1093/mnras/292.2.289; Folkes S, 1999, MON NOT R ASTRON SOC, V308, P459, DOI 10.1046/j.1365-8711.1999.02721.x; GIACCONI R, 1974, ASTROPHYS J SUPPL S, V27, P37, DOI 10.1086/190288; GIOIA I, IN PRESS P IAP2000 C; GIOIA I, 2000, ASTROPH0010059; Girardi M, 1998, ASTROPHYS J, V505, P74, DOI 10.1086/306157; Girardi M, 1998, ASTROPHYS J, V506, P45, DOI 10.1086/306252; Gorski KM, 1996, ASTROPHYS J, V464, pL11, DOI 10.1086/310077; Governato F, 1999, MON NOT R ASTRON SOC, V307, P949, DOI 10.1046/j.1365-8711.1999.02706.x; GURSKY H, 1971, ASTROPHYS J, V167, pL81, DOI 10.1086/180765; Guzzo L, 1997, NEW ASTRON, V2, P517, DOI 10.1016/S1384-1076(97)00037-7; GUZZO L, 2000, NUCL PHYS B, V80, P241; Guzzo L., 1999, MESSENGER, V95, P27; GUZZO L, 1999, ASTROPH9911115; Hasinger G, 1998, ASTRON ASTROPHYS, V329, P482; Henry JP, 2000, ASTROPHYS J, V534, P565, DOI 10.1086/308783; Hoyle F, 1999, MON NOT R ASTRON SOC, V309, P659, DOI 10.1046/j.1365-8711.1999.02904.x; KAISER N, 1984, ASTROPHYS J, V284, pL9, DOI 10.1086/184341; KELLOGG E, 1971, ASTROPHYS J, V165, pL49, DOI 10.1086/180714; KLYPIN AA, 1983, SOV ASTRON LETT+, V9, P41; LAHAV O, 1989, MON NOT R ASTRON SOC, V238, P881, DOI 10.1093/mnras/238.3.881; Lin H, 1996, ASTROPHYS J, V471, P617, DOI 10.1086/177993; Lucchin F., 1995, COSMOLOGY ORIGIN EVO; LUMSDEN SL, 1992, MON NOT R ASTRON SOC, V258, P1; Margon B, 1999, PHILOS T R SOC A, V357, P93, DOI 10.1098/rsta.1999.0316; MARGON B, 1998, ASTROPH9805314; Mellier Y, 1999, ANNU REV ASTRON ASTR, V37, P127, DOI 10.1146/annurev.astro.37.1.127; MILLER CJ, UNPUB ASTROPHYS J; Mo HJ, 1996, MON NOT R ASTRON SOC, V282, P347, DOI 10.1093/mnras/282.2.347; Moscardini I, 2000, MON NOT R ASTRON SOC, V314, P647, DOI 10.1046/j.1365-8711.2000.03372.x; Moscardini L, 2000, MON NOT R ASTRON SOC, V316, P283, DOI 10.1046/j.1365-8711.2000.03494.x; MUSHOTZKY RF, 1997, APJ, V482, P13; NICHOL RC, 1994, MON NOT R ASTRON SOC, V267, P771, DOI 10.1093/mnras/267.3.771; PEACOCK JA, 1999, COSMOLOGICAL PHYSICS; PEEBLES PJE, 1993, PRINCIPLES PHYSICAL; POSTMAN M, 1999, EVOLUTION LARGE SCAL, P270; Reiprich TH, 1999, ASTRON NACHR, V320, P296, DOI 10.1002/1521-3994(199908)320:4/5<296::AID-ASNA296>3.0.CO;2-8; Retzlaff J, 1998, NEW ASTRON, V3, P631, DOI 10.1016/S1384-1076(98)00034-7; ROMER AK, 1994, NATURE, V372, P75, DOI 10.1038/372075a0; ROOD HJ, 1988, ANNU REV ASTRON ASTR, V26, P245; Rosati P, 1999, ASTRON J, V118, P76, DOI 10.1086/300934; ROSATI P, 2000, LARGE SCALE STRUCTUR, P13; Sarazin C. L., 1988, XRAY EMISSION CLUSTE; SCHUECKER P, 2000, ASTROPH0012105; SCHUECKER P, IN PRESS MON NOT R A; Shectman SA, 1996, ASTROPHYS J, V470, P172, DOI 10.1086/177858; SHETH RK, 1999, ASTROPH9907024; SHETH RK, UNPUB MON NOT R ASTR; Smith S, 1936, ASTROPHYS J, V83, P23, DOI 10.1086/143697; Suto Y, 2000, ASTROPHYS J, V534, P551, DOI 10.1086/308778; TOZZI P, IN PRESS ASTROPHYS J; TOZZI P, 2000, ASTROPH0003289; Tucker DL, 1997, MON NOT R ASTRON SOC, V285, pL5, DOI 10.1093/mnras/285.1.L5; Viana PTP, 1999, MON NOT R ASTRON SOC, V303, P535, DOI 10.1046/j.1365-8711.1999.02229.x; Voges W., 1996, Rontgenstrahlung from the Universe. International Conference on X-Ray Astronomy and Astrophysics. Conference Proceedings (MPE Report 263), P637; White DA, 1997, MON NOT R ASTRON SOC, V292, P419, DOI 10.1093/mnras/292.2.419; Wu KKS, 1999, NATURE, V397, P225, DOI 10.1038/16637; Zwicky F., 1933, HELV PHYS ACTA, V6, P110, DOI [DOI 10.1007/S10714-008-0707-4, 10.1007/s10714-008-0707-4]; Zwicky F., 1961, CATALOGUE GALAXIES C	95	113	113	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					39	45		10.1038/35051000	http://dx.doi.org/10.1038/35051000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343106	Green Submitted			2022-12-28	WOS:000166175600032
J	Lumelsky, N; Blondel, O; Laeng, P; Velasco, I; Ravin, R; McKay, R				Lumelsky, N; Blondel, O; Laeng, P; Velasco, I; Ravin, R; McKay, R			Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets	SCIENCE			English	Article							IN-VITRO; HUMAN BLASTOCYSTS; MICE; NEURONS; EXPRESSION; LINES; TRANSCRIPTION; CULTURE; PDX-1; GENE	Although the source of embryonic stem (ES) cells presents ethical concerns, their use may lead to many clinical benefits if differentiated cell types can be derived from them and used to assemble functional organs. in pancreas, insulin is produced and secreted by specialized structures, islets of Langerhans. Diabetes, which affects 16 million people in the United States, results from abnormal function of pancreatic islets. We have generated cells expressing insulin and other pancreatic endocrine hormones from mouse ES cells. The cells self-assemble to form three-dimensional clusters similar in topology to normal pancreatic islets where pancreatic cell types are in close association with neurons. Glucose triggers insulin release from these cell clusters by mechanisms similar to those employed in vivo. When injected into diabetic mice, the insulin-producing cells undergo rapid vascularization and maintain a clustered, islet-like organization.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIMH, Lab Syst Neurosci, NIH, Bethesda, MD 20892 USA; Human Genome Sci, Rockville, MD 20850 USA; Psychiat Genom, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); GlaxoSmithKline; Human Genome Sciences Inc	McKay, R (corresponding author), NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	mckay@codon.nih.gov	Velasco, Ivan/AAE-4249-2019; Velasco, Iván/D-3593-2014	Velasco, Ivan/0000-0002-8953-6578; Velasco, Iván/0000-0002-8953-6578				AHREN B, 1990, PROG BRAIN RES, V84, P209; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Csernus VJ, 1998, CELL MOL LIFE SCI, V54, P733, DOI 10.1007/s000180050201; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim SK, 1997, DEVELOPMENT, V124, P4243; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li H, 1999, NAT GENET, V23, P67; McClenaghan NH, 1999, J MOL MED, V77, P235, DOI 10.1007/s001090050344; MONTAGUE W, 1971, BIOCHEM J, V122, P115, DOI 10.1042/bj1220115; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Offield MF, 1996, DEVELOPMENT, V122, P983; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; ORKIN SH, 2000, NAT MED, V16, P1212; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Ramiya VK, 2000, NAT MED, V6, P278; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; ROJAS E, 1990, FEBS LETT, V261, P265, DOI 10.1016/0014-5793(90)80568-4; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; SHAPIRO AM, 2000, NEW ENGL J MED, V27, P2308; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Vinik A, 1997, HORM METAB RES, V29, P278, DOI 10.1055/s-2007-979037; WOLLHEIM CB, 1990, METHOD ENZYMOL, V192, P188; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	39	1093	1379	1	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1389	1394		10.1126/science.1058866	http://dx.doi.org/10.1126/science.1058866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11326082				2022-12-28	WOS:000168862900050
J	Sethi, AA; Tybjaerg-Hansen, A; Gronholdt, MLM; Steffensen, R; Schnohr, P; Nordestgaard, BG				Sethi, AA; Tybjaerg-Hansen, A; Gronholdt, MLM; Steffensen, R; Schnohr, P; Nordestgaard, BG			Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease - Six case-control studies from the Copenhagen City Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACE GENE POLYMORPHISM; ESSENTIAL-HYPERTENSION; CARDIOVASCULAR-DISEASE; LIPOPROTEIN-LIPASE; CONVERTING ENZYME; BLOOD-PRESSURE; T235 VARIANT; ASSOCIATION; POPULATION; M235T	Background: The M235T and T174M angiotensinogen mutations have been linked to increased risk for ischemic heart and cerebrovascular disease. Objective: To determine whether angiotensinogen mutations are associated with ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Design: Six case-control studies from the Copenhagen City Heart Study. Setting: Copenhagen, Denmark. Participants: Participants in the Copenhagen City Heart Study and patients from the same hospital with ischemic heart disease (n = 866 and n = 943, respectively), myocardial infarction (n = 519 and n = 493, respectively), or ischemic cerebrovascular disease (n = 489 and n = 434, respectively) and 7975 controls without these conditions. Measurements: Genotypes for the M235T and T174M angiotensinogen mutations were compared between controls and Copenhagen City Heart Study participants with ischemic heart disease, myocardial infarction, and cerebrovascular disease (studies 1a, 1b, and 1c) and patients from Copenhagen University Hospital with the same conditions (studies 2a, 2b, and 2c). Results: Relative allele frequencies of 235T and 174M in the general population were 0.41 and 0.12, respectively. Genotype was not associated with increased risk for ischemic heart or ischemic cerebrovascular disease in studies of either mutation alone or combined in women or men. Among compound heterozygotes (235MT/174TM), women in case-control study 2a had decreased risk for ischemic heart disease in age-adjusted analysis; however, this decreased risk was not seen in multifactorial-adjusted or matched analyses, in men, or in case-control study 1a. Among double homozygotes (235TT/174MM), women in case-control study 2b had increased risk for myocardial infarction in matched analysis; however, this increased risk was not seen in age- or multifactorial-adjusted analyses, in men, or in case-control study 1b. Among single homozygotes (235TT/174TT), men in case-control study 2b had increased risk for myocardial infarction in multifactorial-adjusted and matched analyses. This risk was not present in age-adjusted analysis, in women, or in case-control study 1b. In addition, male single homozygotes had decreased risk for ischemic cerebrovascular disease in case-control study 2c in age- and multifactorial-adjusted analyses, but this finding was not seen in matched analysis, in women, or in case-control study 1c. Conclusions: In six large case-control studies, the M235T and T174M angiotensinogen mutations were not consistently associated with increased (or decreased) risk for ischemic heart disease, myocardial infarction, or ischemic cerebrovascular disease. Statistically significant associations may represent chance findings rather than real phenomena.	Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Copenhagen Univ Hosp, Copenhagen, Denmark; Herlev Univ Hosp, Copenhagen, Denmark; Bispebjerg Hosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital	Nordestgaard, BG (corresponding author), Herlev Univ Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@herlevhosp.kbhamt.dk	Nordestgaard, Borge Gronne/ABF-1310-2020					Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002; AgerholmLarsen B, 1997, CIRCULATION, V95, P2358, DOI 10.1161/01.CIR.95.10.2358; BARLEY R, 1995, J HUM HYPERTENS, V9, P681; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fauci AS, 2015, HARRISONS PRINCIPLES; FORNAGE M, 1995, HUM GENET, V96, P295; FUKAMIZU A, 1990, J BIOL CHEM, V265, P7576; Gardemann A, 1999, ATHEROSCLEROSIS, V145, P309, DOI 10.1016/S0021-9150(99)00082-9; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Julian DG, 1997, EUR HEART J, V18, P394; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Ludwig EH, 1997, ANN EPIDEMIOL, V7, P3, DOI 10.1016/S1047-2797(96)00105-6; Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)00315-4; *NOR MJ SPSS INC, 1998, SPSS WIND BAS SYST U; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; Schunkert H, 1997, HYPERTENSION, V29, P628, DOI 10.1161/01.HYP.29.2.628; Sethi AA, 2001, HYPERTENSION, V37, P875, DOI 10.1161/01.HYP.37.3.875; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; TIRET L, 1995, J HYPERTENS, V13, P311; Tiret L, 1998, J HYPERTENS, V16, P37, DOI 10.1097/00004872-199816010-00007; Tybjaerg-Hansen A, 1998, NEW ENGL J MED, V338, P1577, DOI 10.1056/NEJM199805283382203; Winkelmann BR, 1999, AM HEART J, V137, P698, DOI 10.1016/S0002-8703(99)70226-7; Wittrup HH, 1997, J CLIN INVEST, V99, P1606, DOI 10.1172/JCI119323; YAMAKAWAKOBAYASHI K, 1995, LANCET, V346, P515, DOI 10.1016/S0140-6736(95)91369-6	28	54	59	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					941	954		10.7326/0003-4819-134-10-200105150-00008	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00008			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352695				2022-12-28	WOS:000168682500002
J	Robinson, DP; Henry, C; Das, S; Woodhouse, JH				Robinson, DP; Henry, C; Das, S; Woodhouse, JH			Simultaneous rupture along two conjugate planes of the Wharton Basin earthquake	SCIENCE			English	Article							MACQUARIE RIDGE EARTHQUAKE; PLATE; INVERSION; HISTORY	Analysis of broadband teleseismic data shows that the 18 June 2000 Wharton Basin earthquake, a moment magnitude 7.8 intraplate event in the region of diffuse deformation separating the Indian and Australian plates, consisted of two subevents that simultaneously ruptured two near-conjugate planes. This mode of rupture accommodates shortening by a mechanism different from that previously known elsewhere in the region. The larger subevent occurred on a fossil fracture zone, with a relatively high stress drop of about 20 megapascals, showing that large stresses can accumulate in regions of distributed deformation.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England	University of Oxford	Das, S (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.							Aki K., 1980, QUANTITATIVE SEISMOL; DAS S, 1993, GEOPHYS J INT, V115, P778, DOI 10.1111/j.1365-246X.1993.tb01492.x; DAS S, 1990, J GEOPHYS RES-SOLID, V95, P6899, DOI 10.1029/JB095iB05p06899; DAS S, 1994, PHYS EARTH PLANET IN, V85, P293, DOI 10.1016/0031-9201(94)90119-8; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Deplus C, 1998, GEOLOGY, V26, P131, DOI 10.1130/0091-7613(1998)026<0131:DEOADI>2.3.CO;2; Dziewonski A. M., 1983, Proceedings of the International School of Physics `Enrico Fermi'. Course LXXXV. Earthquakes: Observation, Theory and Interpretation, P45; DZIEWONSKI AM, 1983, PHYS EARTH PLANET IN, V33; Gutenberg B., 1954, SEISMICITY EARTH ASS; Henry C, 2000, J GEOPHYS RES-SOL EA, V105, P16097, DOI 10.1029/2000JB900077; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; Pegler G, 1996, TECTONOPHYSICS, V257, P111, DOI 10.1016/0040-1951(95)00112-3; Royer JY, 1997, SCIENCE, V277, P1268, DOI 10.1126/science.277.5330.1268; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956	15	62	64	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1145	1148		10.1126/science.1059395	http://dx.doi.org/10.1126/science.1059395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349145				2022-12-28	WOS:000168609200054
J	Eccles, M; Steen, N; Grimshaw, J; Thomas, L; McNamee, P; Soutter, J; Wilsdon, J; Matowe, L; Needham, G; Gilbert, F; Bond, S				Eccles, M; Steen, N; Grimshaw, J; Thomas, L; McNamee, P; Soutter, J; Wilsdon, J; Matowe, L; Needham, G; Gilbert, F; Bond, S			Effect of audit and feedback, and reminder messages on primary-care radiology referrals: a randomised trial	LANCET			English	Article							GENERAL-PRACTITIONERS; CLINICAL GUIDELINES; ROYAL-COLLEGE; RADIOGRAPHS; MANAGEMENT	Background Radiological tests are often used by general practitioners (GPs). These tests can be overused and contribute little to clinical management. We aimed to assess two methods of reducing GP requests for radiological tests in accordance with the UK Royal College of Radiologists' guidelines on lumbar spine and knee radiographs, practitioners (GPs), These tests can be overused contribute little to clinical management. Methods We assessed audit and feedback, and educational reminder messages in six radiology departments and 244 general practices that they served. The study was a before and-after, pragmatic, cluster randomised controlled trial with a 2 x 2 factorial design. A random subset of GP patients' records were examined for concordance with the guidelines. The main outcome measure was number of radiograph requests per 1000 patients per year. Analysis was by intention to treat. Findings The effect of educational reminder messages (ie, the change in request rate after intervention) was an absolute change of -1.53 (95% CI -2.5 to -0.57) for lumbar spine and of -1.61 (-2.6 to -0.62) for knee radiographs, both relative reductions of about 28%. The effect of audit and feedback was an absolute change of -0.07 (-1.3 to 0.9) for lumbar spine of 0.04 (-0.95 to 1.03) for knee radiograph requests, both relative reductions of about 1%. Concordance between groups did not differ significantly. Interpretation 6-monthy feedback of audit data is ineffective but the routine attachment of educational reminder messages to radiographs is effective and does not affect quality of referrals, Any department of radiology that handles referrals from primary care could deliver this intervention to good effect.	Newcastle Univ, Sch Hlth Sci, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Newcastle Univ, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Newcastle Gen Hosp, Dept Radiol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; Aberdeen Royal Infirm, Dept Radiol, Aberdeen, Scotland	Newcastle University - UK; Newcastle University - UK; Newcastle General Hospital; University of Aberdeen; University of Aberdeen	Eccles, M (corresponding author), Newcastle Univ, Sch Hlth Sci, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	martin.eccles@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020; Grimshaw, Jeremy/D-8726-2013	Grimshaw, Jeremy/0000-0001-8015-8243; McNamee, Paul/0000-0002-4540-8718; Gilbert, Fiona/0000-0002-0124-9962				BEARCROFT PWP, 1994, CLIN RADIOL, V49, P56, DOI 10.1016/S0009-9260(05)82916-2; BOURDILLON P, 1993, BRIT MED J, V306, P110; BUTT WP, 1989, CLIN RADIOL, V40, P6, DOI 10.1016/S0009-9260(89)80004-2; Campbell MK, 2000, FAM PRACT, V17, P192, DOI 10.1093/fampra/17.2.192; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; EMSLIE C, 1993, BRIT MED J, V306, P1728, DOI 10.1136/bmj.306.6894.1728; Espeland A, 1999, ACTA RADIOL, V40, P52; FOWKES FGR, 1984, LANCET, V2, P795; FOWKES FGR, 1986, LANCET, V1, P367; GOLDSTEIN G, 1998, USERS GUIDE MLWIN MU; Grimshaw J, 2000, FAM PRACT, V17, pS11, DOI 10.1093/fampra/17.suppl_1.S11; Grimshaw J M, 1994, Qual Health Care, V3, P45, DOI 10.1136/qshc.3.1.45; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Grol R, 1992, Qual Health Care, V1, P184, DOI 10.1136/qshc.1.3.184; Kerry S, 2000, FAM PRACT, V17, P46, DOI 10.1093/fampra/17.1.46; Lomas J., 1994, DISSEMINATING RES CH, P1; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MEIRING PDV, 1990, CLIN RADIOL, V42, P327; Morgan B, 1997, BRIT J RADIOL, V70, P256, DOI 10.1259/bjr.70.831.9166050; NHS Centre for Reviews and Dissemination, 1994, EFFECTIVE HLTH CARE, V8, P1; OAKESHOTT P, 1994, BRIT J GEN PRACT, V44, P197; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Rosner B., 2010, FUNDAMENTALS BIOSTAT; The Royal College of Radiologists, 1998, MAK BEST US DEP CLIN, V4th; THOMSONOBRIEN MA, 1998, COCHRANE LIB; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; van Tulder MW, 1998, FAM PRACT, V15, P126, DOI 10.1093/fampra/15.2.126; Waddell G, 1996, CLIN GUIDELINES MANA; WINKENS RAG, 1995, BRIT J GEN PRACT, V45, P289	29	158	160	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1406	1409		10.1016/S0140-6736(00)04564-5	http://dx.doi.org/10.1016/S0140-6736(00)04564-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356439				2022-12-28	WOS:000168478200013
J	Bulavin, DV; Higashimoto, Y; Popoff, IJ; Gaarde, WA; Basrur, V; Potapova, O; Appella, E; Fornace, AJ				Bulavin, DV; Higashimoto, Y; Popoff, IJ; Gaarde, WA; Basrur, V; Potapova, O; Appella, E; Fornace, AJ			Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase	NATURE			English	Article							DNA-DAMAGE CHECKPOINT; CELL-CYCLE; CDC25 PHOSPHATASE; PROTEIN-KINASE; PHOSPHORYLATION; CHK1; MITOSIS; P53	Response to genotoxic stress can be considered as a multistage process involving initiation of cell-cycle arrest and maintenance of arrest during DNA repair(1). Although maintenance of G2/M checkpoints is known to involve Chk1, Chk2/Rad53 and upstream components, the mechanisms involved in its initiation are less well defined(1-4). Here we report that p38 kinase has a critical role in the initiation of a G2 delay after ultraviolet radiation. Inhibition of p38 blocks the rapid initiation of this checkpoint in both human and murine cells after ultraviolet radiation. In vitro, p38 binds and phosphorylates Cdc25B at serines 309 and 361, and Cdc25C at serine 216; phosphorylation of these residues is required for binding to 14-3-3 proteins. In vivo, inhibition of p38 prevents both phosphorylation of Cdc25B at serine 309 and 14-3-3 binding after ultraviolet radiation, and mutation of this site is sufficient to inhibit the checkpoint initiation. In contrast, in vivo Cdc25C binding to 14-3-3 is not affected by p38 inhibition after ultraviolet radiation. We propose that regulation of Cdc25B phosphorylation by p38 is a critical event for initiating the G2/M checkpoint after ultraviolet radiation.	NCI, Div Basic Sci, NIH, Bethesda, MD 20892 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA; NIA, Biol Chem Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Isis Pharmaceuticals Inc; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fornace, AJ (corresponding author), NCI, Div Basic Sci, NIH, Bethesda, MD 20892 USA.		Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Higashimoto, Yuichiro/0000-0003-1382-8598	DIVISION OF BASIC SCIENCES - NCI [Z01BC007184] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Lammer C, 1998, J CELL SCI, V111, P2445; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu QH, 2000, GENE DEV, V14, P1448; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lopez JB, 1999, INT J BIOL MARKER, V14, P172, DOI 10.1177/172460089901400309; Morris MC, 2000, J BIOL CHEM, V275, P28849, DOI 10.1074/jbc.M002942200; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	23	446	476	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					102	107		10.1038/35075107	http://dx.doi.org/10.1038/35075107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333986				2022-12-28	WOS:000168432800052
J	Chaudhari, P; Lacey, J; Doyle, J; Galligan, E; Lien, SCA; Callegari, A; Hougham, G; Lang, ND; Andry, PS; John, R; Yang, KH; Lu, MH; Cai, C; Speidell, J; Purushothaman, S; Ritsko, J; Samant, M; Stohr, J; Nakagawa, Y; Katoh, Y; Saitoh, Y; Sakai, K; Satoh, H; Odahara, S; Nakano, H; Nakagaki, J; Shiota, Y				Chaudhari, P; Lacey, J; Doyle, J; Galligan, E; Lien, SCA; Callegari, A; Hougham, G; Lang, ND; Andry, PS; John, R; Yang, KH; Lu, MH; Cai, C; Speidell, J; Purushothaman, S; Ritsko, J; Samant, M; Stohr, J; Nakagawa, Y; Katoh, Y; Saitoh, Y; Sakai, K; Satoh, H; Odahara, S; Nakano, H; Nakagaki, J; Shiota, Y			Atomic-beam alignment of inorganic materials for liquid-crystal displays	NATURE			English	Article								The technique used to align liquid crystals-rubbing the surface of a substrate on which a liquid crystal is subsequently deposited(1-3)-has been perfected by the multibillion-dollar liquid-crystal display industry. However, it is widely recognized that a non-contact alignment technique would be highly desirable for future generations of large, high-resolution liquid-crystal displays. A number of alternative alignment techniques have been reported(4-7), but none of these have so far been implemented in large-scale manufacturing. Here, we report a non-contact alignment process, which uses low-energy ion beams impinging at a glancing angle on amorphous inorganic films, such as diamondlike carbon. Using this approach, we have produced both laptop and desktop displays in pilot-line manufacturing, and found that displays of higher quality and reliability could be made at a lower cost than the rubbing technique. The mechanism of alignment is explained by adopting a random network model of atomic arrangement in the inorganic films. Order is induced by exposure to an ion beam because unfavourably oriented rings of atoms are selectively destroyed. The planes of the remaining rings are predominantly parallel to the direction of the ion beam.	IBM Corp, Thomas J Watson Res Ctr, Yorktown Heights, NY 10598 USA; IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA; IBM Japan Ltd, Display Business Unit, Yamato, Kenagawa, Japan; IBM Japan Ltd, Adv Mfg Engn, Yasu, Shiga, Japan	International Business Machines (IBM); International Business Machines (IBM); International Business Machines (IBM); International Business Machines (IBM)	Chaudhari, P (corresponding author), IBM Corp, Thomas J Watson Res Ctr, POB 218, Yorktown Heights, NY 10598 USA.		Hougham, Gavin/D-4565-2013; Hougham, Gavin Wade/F-4554-2012	Hougham, Gavin Wade/0000-0001-7006-1835				AOYAMA H, 1981, MOL CRYST LIQ CRYST, V72, P127, DOI 10.1080/01406568108084048; BERREMAN DW, 1972, J OPT SOC AM, V62, P502, DOI 10.1364/JOSA.62.000502; CHAUDHARI P, 1975, PHILOS MAG, V31, P727, DOI 10.1080/14786437508226552; Chaudhari P, 1998, JPN J APPL PHYS 2, V37, pL55, DOI 10.1143/JJAP.37.L55; DEGENNES PG, 1993, PHYSICS LIQUID CRYST, P161; IKENO Y, 1998, JPN J APPL PHYS, V27, pL475; JANNING JL, 1972, APPL PHYS LETT, V21, P173, DOI 10.1063/1.1654331; Schadt M, 1996, NATURE, V381, P212, DOI 10.1038/381212a0; Stohr J, 1999, J ELECTRON SPECTROSC, V98, P189, DOI 10.1016/S0368-2048(98)00286-2; Stohr J, 1998, MACROMOLECULES, V31, P1942, DOI 10.1021/ma9711708	10	397	405	1	66	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					56	59		10.1038/35075021	http://dx.doi.org/10.1038/35075021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333974				2022-12-28	WOS:000168432800040
J	Smellie, JM; Barratt, TM; Chantler, C; Gordon, I; Prescod, NP; Ransley, PG; Woolf, AS				Smellie, JM; Barratt, TM; Chantler, C; Gordon, I; Prescod, NP; Ransley, PG; Woolf, AS			Medical versus surgical treatment in children with severe bilateral vesicoureteric reflux and bilateral nephropathy: a randomised trial	LANCET			English	Article							WEIGHT HEIGHT VELOCITY; INTERNATIONAL REFLUX; RENAL SCARS; 5-YEAR; STANDARDS; MATURITY; BIRTH	Background Nephropathy associated with vesicoureteric reflux (VUR) and urinary tract infection can result in end-stage renal failure, hypertension, or both. Whether long-term VUR contributes to these outcomes is unknown. We compared, in a randomised trial. medical with surgical management of children with bilateral severe VUR and bilateral nephropathy. Methods We stratified by age and glomerular filtration rate (GFR) 25 boys and 27 girls aged 1-12 years and randomly assigned them to medical or surgical management. At enrolment and 4 years' follow-up we estimated GFR from the plasma clearance of Cr-51-labelled edetic acid (EDTA), and did intravenous urography. We also did a metastable Tc-99m-labelled dimercaptosuccinic acid (DMSA) assay and contrast cystography. The change in GFR at 4 years, expressed as a percentage change between enrolment and 4 years, was available for 26 of 27 patients in the medical and 24 of 25 in the surgical group. We assessed GFR in 48 patients 10 years after enrolment. Findings Mean GFR at enrolment was 72.4 mL/min per 1.73 m(2) (SD 24.1) in the medical and 71.7 mL/min per 1.73 m(2) (22.6) in the surgical group. The mean percentage change in Gm at 4 years was -2.4% (SE 4.5) versus 4.7% (5.0) in the medical and surgical groups, respectively. The difference in change in GFR at 4 years between the two groups was not significant(7.1%, 95% CI -6.4% to 20.6%). Interpretation Our data do not lend support to the view that the outcome for renal function is improved by surgical correction of VUR in children with bilateral disease.	UCL, Great Ormond St Hosp Children NHS Trust, London WC1N 1EH, England; UCL, Inst Child Hlth, London WC1N 1EH, England; Kings Coll London, Guys Hosp, Sch Dent, London WC2R 2LS, England; Kings Coll London, Guys Hosp, Sch Med, London WC2R 2LS, England; Kings Coll London, St Thomas Hosp, Sch Med, London WC2R 2LS, England; Kings Coll London, St Thomas Hosp, Sch Dent, London WC2R 2LS, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Barratt, TM (corresponding author), UCL, Great Ormond St Hosp Children NHS Trust, London WC1N 1EH, England.	M.Barratt@ich.ucl.ac.uk	Woolf, Adrian S./AAZ-1075-2020	Woolf, Adrian S./0000-0001-5541-1358				[Anonymous], 1987, PEDIATRICS, V79, P1; APERIA A, 1975, ACTA PAEDIATR SCAND, V64, P393, DOI 10.1111/j.1651-2227.1975.tb03853.x; ASTLEY R, 1983, British Medical Journal, V287, P171; ASTLEY R, 1987, BRIT MED J, V295, P237; BERGSTROM J, 1986, CLIN NEPHROL, V25, P1; CHANTLER C, 1972, ARCH DIS CHILD, V47, P613, DOI 10.1136/adc.47.254.613; COHEN SJ, 1997, PEDIAT UROLOGY, P466; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; FOGO A, 1999, PEDIAT NEPHROLOGY, P1183; HINCHLIFFE SA, 1992, PEDIATR NEPHROL, V6, P439, DOI 10.1007/BF00874007; HODSON CJ, 1979, REFLUX NEPHROPATHY, P29; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; LEWIS M, 1999, 2 REN ASS UK REN REG, P175; OLBING H, 1992, J UROLOGY, V148, P1653, DOI 10.1016/S0022-5347(17)36995-1; Olbing H, 2000, RADIOLOGY, V216, P731, DOI 10.1148/radiology.216.3.r00au35731; Piepsz A, 1998, EUR J PEDIATR, V157, P753, DOI 10.1007/s004310050929; POLITANO VA, 1958, J UROLOGY, V79, P932, DOI 10.1016/S0022-5347(17)66369-9; RANSLEY PG, 1978, BRIT J RADIOL      S, V14, P1; RISDON RA, 1993, CLIN NEPHROL, V40, P308; Smellie J, 1975, Kidney Int Suppl, V4, pS65; SMELLIE JM, 1994, BRIT MED J, V308, P1193, DOI 10.1136/bmj.308.6938.1193; SMELLIE JM, 1985, BRIT MED J, V290, P1957, DOI 10.1136/bmj.290.6486.1957; SMELLIE JM, 1995, ARCH DIS CHILD, V72, P251, DOI 10.1136/adc.72.3.251; Smellie JM, 1998, PEDIATR NEPHROL, V12, P727, DOI 10.1007/s004670050535; SMELLIE JM, 1992, PEDIATR NEPHROL, V6, P223, DOI 10.1007/BF00878353; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Wennerstrom M, 2000, J PEDIATR-US, V136, P30, DOI 10.1016/S0022-3476(00)90045-3	28	160	171	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1329	1333		10.1016/S0140-6736(00)04520-7	http://dx.doi.org/10.1016/S0140-6736(00)04520-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343739				2022-12-28	WOS:000168411400012
J	Eisenberg, MS; Mengert, TJ				Eisenberg, MS; Mengert, TJ			Primary care: Cardiac resuscitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							AMERICAN-HEART-ASSOCIATION; AUTOMATED EXTERNAL DEFIBRILLATORS; INTERPOSED ABDOMINAL COMPRESSION; TO-MOUTH VENTILATION; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; LIFE-SUPPORT; MYOCARDIAL-INFARCTION; HEALTH-PROFESSIONALS; IMPROVING SURVIVAL		Univ Washington, Med Ctr, Emergency Med Serv, Dept Med,Div Emergency Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eisenberg, MS (corresponding author), Univ Washington, Med Ctr, Emergency Med Serv, Dept Med,Div Emergency Med, Box 356123, Seattle, WA 98195 USA.							*AM HEART ASS, 1998, 1999 HEART STROK STA; BABBS CF, 1994, AM HEART J, V127, P412, DOI 10.1016/0002-8703(94)90132-5; Ballew KA, 1995, RESUSCITATION, V30, P203, DOI 10.1016/0300-9572(95)00894-2; Bardy GH, 1996, CIRCULATION, V94, P2507, DOI 10.1161/01.CIR.94.10.2507; Baubin M, 1999, RESUSCITATION, V41, P33, DOI 10.1016/S0300-9572(99)00033-7; Becker L, 1996, CARDIAC ARREST SCI P, P28; Becker LB, 1997, CIRCULATION, V96, P2102, DOI 10.1161/01.CIR.96.6.2102; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; BERGNER L, 1985, AM J PUBLIC HEALTH, V75, P1321, DOI 10.2105/AJPH.75.11.1321; BONNIN MJ, 1993, JAMA-J AM MED ASSOC, V270, P1457, DOI 10.1001/jama.270.12.1457; Brown J, 2000, JAMA-J AM MED ASSOC, V284, P1438, DOI 10.1001/jama.284.11.1438; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1984, LANCET, V2, P318; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1988, J AM COLL CARDIOL, V11, P597, DOI 10.1016/0735-1097(88)91537-9; Cummins RO, 1997, CIRCULATION, V95, P2172, DOI 10.1161/01.CIR.95.8.2172; CUMMINS RO, 1985, JAMA-J AM MED ASSOC, V253, P2408, DOI 10.1001/jama.253.16.2408; Domanski MJ, 1997, CIRCULATION, V95, P2694, DOI 10.1161/01.CIR.95.12.2694; Eisenberg M., 1997, LIFE BALANCE EMERGEN, P251; Eisenberg MS, 2000, JAMA-J AM MED ASSOC, V284, P1435, DOI 10.1001/jama.284.11.1435; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EISENBERG MS, 1979, JAMA-J AM MED ASSOC, V241, P1905, DOI 10.1001/jama.241.18.1905; EISENBERG MS, 1997, LIFE BALANCE EMERGEN, P188; EISENBERG MS, 1984, SUDDEN CARDIAC DEATH; GILLUM RF, 1994, J AM COLL CARDIOL, V23, P1273, DOI 10.1016/0735-1097(94)90367-0; Gliner BE, 1999, RESUSCITATION, V41, P133, DOI 10.1016/S0300-9572(99)00040-4; Gliner Bradford E., 1998, Biomedical Instrumentation and Technology, V32, P631; Gregoratos G, 1998, J AM COLL CARDIOL, V31, P1175; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; HALPERIN HR, 1996, CARDIAC ARREST SCI P, P252; Hossack KF, 1982, J CARDIAC REHABIL, V2, P402; Iserson KV, 1999, GRAVE WORDS NOTIFYIN; Kataoka K, 1998, NEUROSCI RES, V32, P103, DOI 10.1016/S0168-0102(98)00076-5; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1433, DOI 10.1001/jama.270.12.1433; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Levine RL, 1997, NEW ENGL J MED, V337, P301, DOI 10.1056/NEJM199707313370503; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; MYERBURG RJ, 1997, HEART DIS TXB CARDIO, V1, P742; ORNATO JP, 1998, TXB CARDIOVASCULAR M, P1779; OSBORN LA, 1996, CARDIAC ARREST SCI P, P243; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Plaisance P, 1999, NEW ENGL J MED, V341, P569, DOI 10.1056/NEJM199908193410804; Poole JE, 1997, J CARDIOVASC ELECTR, V8, P1373, DOI 10.1111/j.1540-8167.1997.tb01034.x; REICHENBACH DD, 1977, AM J CARDIOL, V39, P865, DOI 10.1016/S0002-9149(77)80041-6; RIEGEL B, 1997, SUDDEN CARDIAC DEATH, P275; Rubertsson S, 2000, TXB CRITICAL CARE, P9; Rumball C J, 1997, Prehosp Emerg Care, V1, P1, DOI 10.1080/10903129708958776; SACK JB, 1992, CIRCULATION, V86, P1692, DOI 10.1161/01.CIR.86.6.1692; SAFAR P, 1994, CRIT CARE MED, V22, P1703; SAFAR P, 1958, JAMA-J AM MED ASSOC, V167, P335, DOI 10.1001/jama.1958.72990200026008c; Smith SC, 1998, CIRCULATION, V97, P1321, DOI 10.1161/01.CIR.97.13.1321; SWANSON RW, 1993, ANN EMERG MED, V22, P350, DOI 10.1016/S0196-0644(05)80464-0; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Valenzuela TD, 1997, CIRCULATION, V96, P3308; van Walraven C, 1999, ARCH INTERN MED, V159, P129, DOI 10.1001/archinte.159.2.129; WEAVER WD, 1986, ANN EMERG MED, V15, P1181; 2000, CIRCULATION S1, V102, P1; 1999, HLTH DEVICES, V28, P186	61	337	368	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1304	1313		10.1056/NEJM200104263441707	http://dx.doi.org/10.1056/NEJM200104263441707			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320390				2022-12-28	WOS:000168252400007
J	Bode, F; Sachs, F; Franz, MR				Bode, F; Sachs, F; Franz, MR			Tarantula peptide inhibits atrial fibrillation - A peptide from spider venom can prevent the heartbeat from losing its rhythm.	NATURE			English	Article							ACTIVATED ION CHANNELS; STRETCH; MYOCYTES		Georgetown Univ, Dept Pharmacol, Washington, DC 20007 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bode, F (corresponding author), Univ Klinikum Luebeck, Med Klin 2, Ratzeburger Allee 160, D-23538 Lubeck, Germany.		Bode, Frank/A-6395-2015					Bode F, 2000, CIRCULATION, V101, P2200, DOI 10.1161/01.CIR.101.18.2200; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; HAGIWARA N, 1992, J PHYSIOL-LONDON, V456, P285, DOI 10.1113/jphysiol.1992.sp019337; KIM D, 1992, J GEN PHYSIOL, V100, P1021, DOI 10.1085/jgp.100.6.1021; NAZIR SA, 1996, J PHYSL P, V494, P111; Ravelli F, 1997, CIRCULATION, V96, P1686, DOI 10.1161/01.CIR.96.5.1686; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; SACHS F, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P308; Sato R, 1998, J MEMBRANE BIOL, V163, P67, DOI 10.1007/s002329900371; SMALL DL, 1995, BRIT J PHARMACOL, V114, P180, DOI 10.1111/j.1476-5381.1995.tb14923.x; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2	12	237	247	1	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					35	36		10.1038/35051165	http://dx.doi.org/10.1038/35051165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343101				2022-12-28	WOS:000166175600027
J	Russell, JB; Rychlik, JL				Russell, JB; Rychlik, JL			Factors that alter rumen microbial ecology	SCIENCE			English	Editorial Material							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; RUMINAL CELLULOLYTIC BACTERIA; FEEDLOT CATTLE; PREVOTELLA-RUMINICOLA; FERMENTATION; FIBER; EPIDEMIOLOGY; ANTAGONISM; SEQUENCES; DIVERSITY	Ruminant animals and ruminal microorganisms have a symbiotic relationship that facilitates fiber digestion, but domestic ruminants in developed countries are often fed an abundance of grain and Little fiber. When ruminants are fed fiber-deficient rations, physiological mechanisms of homeostasis are disrupted, ruminal pH declines, microbial ecology is altered, and the animal becomes more susceptible to metabolic disorders and, in some cases, infectious disease. Some disorders can be counteracted by feed additives (for example, antibiotics and buffers), but these additives can alter the composition of the ruminal ecosystem even further.	Cornell Univ, USDA, ARS, Ithaca, NY 14853 USA; Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University	Russell, JB (corresponding author), Cornell Univ, USDA, ARS, Ithaca, NY 14853 USA.							Allen MS, 1997, J DAIRY SCI, V80, P1447, DOI 10.3168/jds.S0022-0302(97)76074-0; Armstrong GL, 1996, EPIDEMIOL REV, V18, P29, DOI 10.1093/oxfordjournals.epirev.a017914; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; Bates J, 1997, J HOSP INFECT, V37, P89, DOI 10.1016/S0195-6701(97)90179-1; BAUCHOP T, 1979, ANN RECH VET, V10, P246; BIRD SH, 1978, BRIT J NUTR, V40, P163, DOI 10.1079/BJN19780108; BRYANT MP, 1953, J DAIRY SCI, V36, P205, DOI 10.3168/jds.S0022-0302(53)91482-9; Cheng KJ, 1998, J ANIM SCI, V76, P299; Conlan JW, 1999, CAN J MICROBIOL, V45, P723, DOI 10.1139/cjm-45-9-723; COSTERTON JW, 1974, J BACTERIOL, V118, P1132, DOI 10.1128/JB.118.3.1132-1143.1974; Dehority BA, 2000, APPL ENVIRON MICROB, V66, P2921, DOI 10.1128/AEM.66.7.2921-2927.2000; Diez-Gonzalez F, 1998, SCIENCE, V281, P1666, DOI 10.1126/science.281.5383.1666; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Gardner RG, 1997, CURR MICROBIOL, V35, P274, DOI 10.1007/s002849900253; Glock RD, 1998, J ANIM SCI, V76, P315; Hancock DD, 1997, J FOOD PROTECT, V60, P462, DOI 10.4315/0362-028X-60.5.462; Hoyle B, 2000, ASM NEWS, V66, P331; HUNGATE RE, 1966, RUMEN ITS MICROBES; KEEN JE, 1999, 80 C RES WORK AN DIS; Krause DO, 1996, J DAIRY SCI, V79, P1467, DOI 10.3168/jds.S0022-0302(96)76506-2; Krause DO, 1996, APPL ENVIRON MICROB, V62, P815, DOI 10.1128/AEM.62.3.815-821.1996; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Mantovani HC, 2001, APPL ENVIRON MICROB, V67, P808, DOI 10.1128/AEM.67.2.808-813.2001; Nagaraja TG, 1998, J ANIM SCI, V76, P287; NOCEK JE, 1988, J DAIRY SCI, V71, P2070, DOI 10.3168/jds.S0022-0302(88)79782-9; Oetzel G.R., 2000, P 33 ANN M AM ASS BO, P46, DOI 10.21423/aabppro20005359; ORPIN CG, 1997, RUMEN MICROBIAL ECOS, pCH4; Owens FN, 1998, J ANIM SCI, V76, P275; Piwonka EJ, 1996, J DAIRY SCI, V79, P2196, DOI 10.3168/jds.S0022-0302(96)76596-7; ROWE JB, 1999, ADV ANIMAL NUTR AUST, P81; Russell J. B., 1991, PHYSL ASPECTS DIGEST; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P3383, DOI 10.1128/AEM.57.11.3383-3384.1991; RUSSELL JB, 1993, J DAIRY SCI, V76, P826, DOI 10.3168/jds.S0022-0302(93)77407-X; Russell JB, 1996, J DAIRY SCI, V79, P1503, DOI 10.3168/jds.S0022-0302(96)76510-4; RUSSELL JB, 1989, APPL ENVIRON MICROB, V55, P1; RUSSELL JB, 2000, ENCY MICROBIOLOGY, V4, P186; RUSSELL JB, 1997, RUMEN MICROBIAL ECOS, pCH6; Rychlik JL, 2000, FEMS MICROBIOL ECOL, V32, P121, DOI 10.1111/j.1574-6941.2000.tb00706.x; SALYERS AA, 1995, ANTIBIOTIC TRANSFER; SCOTT T, 2000, NEBRASKA BEEF REP, P39; Smith RA, 1998, J ANIM SCI, V76, P272; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Tajima K, 2000, ANAEROBE, V6, P273, DOI 10.1006/anae.2000.0353; Teather RM, 1998, CAN J ANIM SCI, V78, P57; TEATHER RM, 1997, RUMEN MICROBIAL ECOS, pCH10; VANBELLE M, 1990, ARCH ANIM NUTR, V7, P543; Weimer PJ, 1998, J ANIM SCI, V76, P3114; Weimer PJ, 1999, J DAIRY SCI, V82, P122, DOI 10.3168/jds.S0022-0302(99)75216-1; Wells JE, 1997, FEMS MICROBIOL ECOL, V22, P237, DOI 10.1111/j.1574-6941.1997.tb00376.x; Williams A.G., 1992, RUMEN PROTOZOA; WILLIAMS AG, 1997, RUMAN MICROBIAL ECOS, pCH3; Wolin M.J., 1975, DIGESTION METABOLISM, P134; Wright ADG, 1997, J EUKARYOT MICROBIOL, V44, P61, DOI 10.1111/j.1550-7408.1997.tb05693.x	54	480	518	7	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1119	1122		10.1126/science.1058830	http://dx.doi.org/10.1126/science.1058830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352069				2022-12-28	WOS:000168609200047
J	Chapman, LE; Bloom, ET				Chapman, LE; Bloom, ET			Clinical xenotransplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PORCINE ENDOGENOUS RETROVIRUS; NO EVIDENCE; INFECTION; CELLS; TRANSPLANTATION		CDC, HIV AIDS & Retrovirol Branch, Div HIV STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; US FDA, Ctr Biol Evaluat & Res, Div Cellular & Gene Therapy, Lab Immunol & Virol, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Chapman, LE (corresponding author), CDC, HIV AIDS & Retrovirol Branch, Div HIV STD & TB Lab Res, Natl Ctr Infect Dis, Mailstop G-19,1600 Clifton Rd, Atlanta, GA 30333 USA.	lec3@cdc.gov						Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Allan JS, 1998, AIDS RES HUM RETROV, V14, P821, DOI 10.1089/aid.1998.14.821; Allan JS, 1998, ANN NY ACAD SCI, V862, P87, DOI 10.1111/j.1749-6632.1998.tb09120.x; Bach FH, 1998, NAT MED, V4, P141, DOI 10.1038/nm0298-141; CHAPMAN LE, 1995, NEW ENGL J MED, V333, P1498, DOI 10.1056/NEJM199511303332211; CHARI RS, 1994, NEW ENGL J MED, V331, P234, DOI 10.1056/NEJM199407283310404; Dapolito Gail, 2000, Xenotransplantation, V7, P75; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; Heneine W, 1998, LANCET, V352, P695, DOI 10.1016/S0140-6736(98)07145-1; Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949, DOI 10.1038/79432; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; McDaniel HB, 1999, CLIN TRANSPLANT, V13, P187, DOI 10.1034/j.1399-0012.1999.130206.x; Michaels MG, 2001, J VIROL, V75, P2825, DOI 10.1128/JVI.75.6.2825-2828.2001; Nelson J. Lee, 1998, Current Opinion in Rheumatology, V10, P564, DOI 10.1097/00002281-199811000-00010; Nyberg SL, 1999, TRANSPLANTATION, V67, P1251, DOI 10.1097/00007890-199905150-00009; OLDMIXON B, 2000, 12 INT WORKSH RETR P; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Pitkin Z, 1999, ARTIF ORGANS, V23, P829, DOI 10.1046/j.1525-1594.1999.06444.x; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Public Health Service, 2001, PHS GUIDELINE INFECT; Qari SH, 2001, J VIROL, V75, P1048, DOI 10.1128/JVI.75.2.1048-1053.2001; Schumacher JM, 2000, NEUROLOGY, V54, P1042, DOI 10.1212/WNL.54.5.1042; Soin B, 2000, BRIT J SURG, V87, P138, DOI 10.1046/j.1365-2168.2000.01351.x; *US DHHS, 1997, 1997 REP OPTN WAIT L; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Zhang Z, 2000, EXPERT OPIN INV DRUG, V9, P2051, DOI 10.1517/13543784.9.9.2051	31	15	16	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2304	2306		10.1001/jama.285.18.2304	http://dx.doi.org/10.1001/jama.285.18.2304			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343460				2022-12-28	WOS:000168411200002
J	Guillebaud, J				Guillebaud, J			Medical-eligibility criteria for contraceptive use	LANCET			English	Editorial Material									UCL, Dept Family Planning & Reprod Hlth, London W1T 4PL, England; Margaret Pyke Family Planning Ctr, London W1T 4PL, England	University of London; University College London	Guillebaud, J (corresponding author), UCL, Dept Family Planning & Reprod Hlth, London W1T 4PL, England.	j.guillebaud@lineone.net						GRAHAMSMITH F, 1994, POPULATION COMPLEX R; GUILLEBAUD J, 1995, BRIT MED J, V311, P1111, DOI 10.1136/bmj.311.7013.1111; GUILLEBAUD J, 1999, CONTRACEPTION YOUR Q, P195; Hinrichsen D., 2000, POPULATION REPORTS M, V15; Kubba A, 2000, LANCET, V356, P1913, DOI 10.1016/S0140-6736(00)03269-4; Potts M, 1999, BRIT MED J, V319, P933, DOI 10.1136/bmj.319.7215.933; ROBEY B, 2000, POPULATION REPORTS J, V43; *WHO, 2001, IMPR ACC QUAL CAR FA	8	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1378	1379		10.1016/S0140-6736(00)04615-8	http://dx.doi.org/10.1016/S0140-6736(00)04615-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356428				2022-12-28	WOS:000168478200002
J	Ding, ZL; Fong, RB; Long, CJ; Stayton, PS; Hoffman, AS				Ding, ZL; Fong, RB; Long, CJ; Stayton, PS; Hoffman, AS			Size-dependent control of the binding of biotinylated proteins to streptavidin using a polymer shield	NATURE			English	Article								Many medical and biotechnological processes rely on controlling and manipulating the molecular-recognition capabilities of proteins(1-4). This can be achieved using small molecules capable of competing for protein binding or by changing environmental parameters that affect protein structure and hence binding. An alternative is provided by stimuli-responsive polymers that change reversibly from a water-soluble expanded coil to a water-insoluble collapsed globule upon small changes in temperature, pH or light intensity: when attached to proteins in the vicinity of their binding sites, they reversibly block and release small ligands(1,5-7). Here we show how this approach can be extended to achieve size-selective binding of large, macromolecular ligands. We use the thermally responsive polymer poly(N,N-diethylacrylamide) (PDEAAm), and attach it to the protein streptavidin approximately 20 Angstrom from the binding site for biotinylated proteins. Below the lower critical solution temperature of PDEAAm, the polymer is in its extended state and acts as a 'shield' to block the binding of large biotinylated proteins; above this temperature, it collapses and exposes the binding site, thereby allowing binding. We rnd that the degree of shielding depends on both the size of the biotinylated protein and the size of PDEAAm, suggesting that 'smart' polymer shields could be tailored to achieve a wide range of size-dependent ligand discrimination for use in affinity separations, biosensors and diagnostics technologies.	Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hoffman, AS (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.		Stayton, Patrick/C-1975-2018	Stayton, Patrick/0000-0001-6939-6371				BLOCH B, 1993, J HISTOCHEM CYTOCHEM, V41, P1751, DOI 10.1177/41.12.8245422; Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043; Ding ZL, 1999, BIOCONJUGATE CHEM, V10, P395, DOI 10.1021/bc980108s; Fong RB, 1999, BIOCONJUGATE CHEM, V10, P720, DOI 10.1021/bc980151f; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Schlosser M, 1997, J IMMUNOASSAY, V18, P289, DOI 10.1080/01971529708005823; SOGAH DY, 1987, MACROMOLECULES, V20, P1473, DOI 10.1021/ma00173a006; STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0; Wilchek M, 1990, AVIDIN BIOTIN TECHNO; Wu C, 1998, PHYS REV LETT, V80, P4092, DOI 10.1103/PhysRevLett.80.4092	10	213	222	0	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					59	62		10.1038/35075028	http://dx.doi.org/10.1038/35075028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333975				2022-12-28	WOS:000168432800041
J	Hogan, CM; Hammer, SM				Hogan, CM; Hammer, SM			Host determinants in HIV infection and disease - Part 2: Genetic factors and implications for antiretroviral therapeutics	ANNALS OF INTERNAL MEDICINE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; CHEMOKINE RECEPTOR CXCR4; TUMOR-NECROSIS-FACTOR; HLA CLASS-I; STRUCTURED TREATMENT INTERRUPTIONS; NEUTRALIZING ANTIBODY-RESPONSE; ENVELOPE SUBUNIT VACCINE; SMALL-MOLECULE INHIBITOR; BLOOD MONONUCLEAR-CELLS	The course of HIV infection varies widely among individuals. Immunologic and genetic studies of long-term nonprogressors and exposed yet uninfected persons have helped to elucidate the mechanisms by which some persons are protected from HIV acquisition or have slow rates of disease progression. This two-part review describes what is currently known about host factors in HIV-1 infection. Studies for inclusion were identified by a systematic search of PubMed for English-language literature published from 1988 through lune 2000. Abstracts of presentations at major meetings convened in 2000 were also included if appropriate. The first part of the review discussed cellular and humoral immunity to HIV infection. This second part describes genetic host factors-namely, inheritance of mutant chemokine receptors or ligands, such as CCR5-Delta 32, CCR2-V64I, stromal cell-derived factor-1 3'alpha, and CCR5 promoter polymorphisms, as well as HLA type-that affect susceptibility to infection and subsequent clinical course. Soluble inhibitory factors, the cytokine milieu, and concomitant infections also affect outcome. Knowledge of host responses is increasingly being applied to new therapeutic strategies, including early treatment, immune modulation, structured treatment interruptions, therapeutic vaccination, and new chemotherapeutic agents, as well as to vaccine development.	Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA	Columbia University	Hogan, CM (corresponding author), Columbia Univ Coll Phys & Surg, Div Infect Dis, 630 W 168th St,P&S Box 82, New York, NY 10032 USA.	ch358@columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046386, U01AI048013, P30AI042848] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46386, AI48013, 5P30AI42848-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal B.B., 1995, HUMAN CYTOKINES THEI; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; BALER M, 1995, NATURE, V378, P563; Balotta C, 1999, J INFECT DIS, V180, P285, DOI 10.1086/314864; Balotta C, 1997, AIDS, V11, pF67, DOI 10.1097/00002030-199710000-00001; Barker E, 1998, BLOOD, V92, P3105, DOI 10.1182/blood.V92.9.3105.421k46_3105_3114; Barker TD, 1996, J IMMUNOL, V156, P4476; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Baroudy B. M., 2000, 7 C RETR OPP INF SAN; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Binley JM, 2000, J INFECT DIS, V181, P1249, DOI 10.1086/315379; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brambilla A, 2000, J INFECT DIS, V182, P311, DOI 10.1086/315650; Bratt G, 1999, INT J STD AIDS, V10, P514, DOI 10.1258/0956462991914591; Cairns JS, 1998, NAT MED, V4, P563, DOI 10.1038/nm0598-563; Cammack N, 1999, ANTIVIR CHEM CHEMOTH, V10, P53, DOI 10.1177/095632029901000201; Canque B, 1996, BLOOD, V87, P2011; Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Churdboonchart V, 1998, AIDS, V12, P1521, DOI 10.1097/00002030-199812000-00015; CLAYDON EJ, 1991, AIDS, V5, P113, DOI 10.1097/00002030-199101000-00022; Clements-Mann ML, 1998, J INFECT DIS, V177, P1230, DOI 10.1086/515288; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen J, 1998, SCIENCE, V279, P1854, DOI 10.1126/science.279.5358.1854; Corey L, 1998, J INFECT DIS, V177, P301, DOI 10.1086/514202; CORNELISSEN M, 1995, J VIROL, V69, P1810, DOI 10.1128/JVI.69.3.1810-1818.1995; Dalod M, 1999, J VIROL, V73, P7108, DOI 10.1128/JVI.73.9.7108-7116.1999; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001; DOLIN R, 1995, J INFECT DIS, V172, P1175, DOI 10.1093/infdis/172.5.1175; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P667, DOI 10.1016/0959-440X(93)90047-O; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; DYBUL M, 2000, SOCIAL SCI RIGHTS PO; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Endres MJ, 1997, SCIENCE, V278, P1462, DOI 10.1126/science.278.5342.1462; Eugen-Olsen J, 1998, J ACQ IMMUN DEF SYND, V18, P110, DOI 10.1097/00042560-199806010-00002; Evans TG, 1999, J INFECT DIS, V180, P290, DOI 10.1086/314895; FAGARD C, 2000, 7 C RETR OPP INF SAN; Falk Lydia A., 2000, AIDS Research and Human Retroviruses, V16, P91, DOI 10.1089/088922200309421; FAN Z, 2000, 7 C RETR OPP INF SAN; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Fomsgaard A, 1999, IMMUNOL LETT, V65, P127, DOI 10.1016/S0165-2478(98)00135-7; Francis DP, 1998, AIDS RES HUM RETROV, V14, pS325; Fraser C, 2000, AIDS, V14, P659, DOI 10.1097/00002030-200004140-00005; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; FURCI L, 2000, 7 C RETR OPP INF SAN; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; GARCIA F, 2000, 7 C RETR OPP INF SAN; Garred P, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)22001-0; GOLDFELD AE, 2000, 7 C RETR OPP INF SAN; Goletti D, 1996, J IMMUNOL, V157, P1271; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; Gordon CJ, 1999, J VIROL, V73, P684, DOI 10.1128/JVI.73.1.684-694.1999; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Guerin S, 2000, AIDS, V14, P2788, DOI 10.1097/00002030-200012010-00020; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hel Z, 2000, NAT MED, V6, P1140, DOI 10.1038/80481; Hendel H, 1999, J IMMUNOL, V162, P6942; Hendel H, 1998, J ACQ IMMUN DEF SYND, V19, P381, DOI 10.1097/00042560-199812010-00009; Hill AVS, 1996, NAT MED, V2, P395, DOI 10.1038/nm0496-395; HO DD, 1992, LANCET, V339, P1549, DOI 10.1016/0140-6736(92)91321-X; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Ho DD, 1998, SCIENCE, V280, P1866, DOI 10.1126/science.280.5371.1866; Hoff R, 1999, LANCET, V353, P1723, DOI 10.1016/S0140-6736(99)90025-9; Hoffman T L, 1998, AIDS, V12 Suppl A, pS17; Hoffman TL, 1997, J INFECT DIS, V176, P1093, DOI 10.1086/516519; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; Ioannidis JPA, 1998, NAT MED, V4, P536, DOI 10.1038/nm0598-536; ITESCU S, 1994, P NATL ACAD SCI USA, V91, P11472, DOI 10.1073/pnas.91.24.11472; ITSCU S, 1992, J ACQ IMMUN DEF SYND, V5, P37; Janoff EN, 1999, AIDS RES HUM RETROV, V15, P837, DOI 10.1089/088922299310746; Janssens W, 1997, AIDS, V11, P705, DOI 10.1097/00002030-199706000-00002; JEANNET M, 1989, J ACQ IMMUN DEF SYND, V2, P28; JIN X, 2000, 7 C RETR OPP INF SAN; Kahn JO, 2000, JAMA-J AM MED ASSOC, V284, P2193, DOI 10.1001/jama.284.17.2193; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Keefer MC, 1997, AIDS RES HUM RETROV, V13, P1163, DOI 10.1089/aid.1997.13.1163; Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kinter A, 1998, P NATL ACAD SCI USA, V95, P11880, DOI 10.1073/pnas.95.20.11880; Kinter AL, 1996, P NATL ACAD SCI USA, V93, P14076, DOI 10.1073/pnas.93.24.14076; KINTER AL, 1995, J IMMUNOL, V154, P2448; Klein MR, 1998, J GEN VIROL, V79, P2191, DOI 10.1099/0022-1317-79-9-2191; Kootstra NA, 1997, AIDS RES HUM RETROV, V13, P685, DOI 10.1089/aid.1997.13.685; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; KRONER BL, 1995, AIDS, V9, P275, DOI 10.1097/00002030-199509030-00009; Kroon FP, 1999, AIDS, V13, P135; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LANDAY AL, 1993, CLIN IMMUNOL IMMUNOP, V69, P106, DOI 10.1006/clin.1993.1157; LATHEY J, 2000, 7 C RETR OPP INF SAN; Lathey JL, 1997, J INFECT DIS, V175, P231, DOI 10.1093/infdis/175.1.231; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; LEE B, 1998, SCIENCE, V281, P487; Lehner T, 1999, J INFECT DIS, V179, pS489, DOI 10.1086/314809; Lehner T, 1996, NAT MED, V2, P767, DOI 10.1038/nm0796-767; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; LI Q, 2000, 7 C RETR OPP INF SAN; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lori F, 2000, SCIENCE, V290, P1591, DOI 10.1126/science.290.5496.1591; Lori F, 2000, LANCET, V355, P287, DOI 10.1016/S0140-6736(99)03515-1; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MACKEWICZ CE, 1994, LANCET, V344, P1671, DOI 10.1016/S0140-6736(94)90459-6; MACKEWICZ CE, 1991, J CLIN INVEST, V87, P1462, DOI 10.1172/JCI115153; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McDermott DH, 2000, AIDS, V14, P2671, DOI 10.1097/00002030-200012010-00006; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; McKenzie SW, 1996, AIDS, V10, pF29, DOI 10.1097/00002030-199610090-00001; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Mebatsion T, 1997, CELL, V90, P841, DOI 10.1016/S0092-8674(00)80349-9; MESTECKY J, 1994, J CLIN IMMUNOL, V14, P259, DOI 10.1007/BF01540979; Meyer L, 1999, AIDS, V13, P624, DOI 10.1097/00002030-199904010-00015; Michael NL, 1997, NAT MED, V3, P1160, DOI 10.1038/nm1097-1160; Michael NL, 1999, NAT MED, V5, P740, DOI 10.1038/10462; Michael NL, 1998, J VIROL, V72, P6040, DOI 10.1128/JVI.72.7.6040-6047.1998; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miller V, 2000, AIDS, V14, P2857, DOI 10.1097/00002030-200012220-00007; Montefiori David C., 1999, AIDS Research and Human Retroviruses, V15, P689, DOI 10.1089/088922299310773; Moriuchi H, 1996, P NATL ACAD SCI USA, V93, P15341, DOI 10.1073/pnas.93.26.15341; Mosier DE, 1999, J VIROL, V73, P3544, DOI 10.1128/JVI.73.5.3544-3550.1999; Moss RB, 1999, J INFECT DIS, V180, P641, DOI 10.1086/314924; Moss RB, 1998, AIDS RES HUM RETROV, V14, pS167; Mummidi S, 1997, J BIOL CHEM, V272, P30662, DOI 10.1074/jbc.272.49.30662; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Musey LK, 1999, J INFECT DIS, V180, P278, DOI 10.1086/314868; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; ORTIZ GM, 1909, J CLIN INVEST, V104; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Ourmanov I, 2000, J VIROL, V74, P2960, DOI 10.1128/JVI.74.6.2960-2965.2000; Pal R, 1997, SCIENCE, V278, P695, DOI 10.1126/science.278.5338.695; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Papasavvas E, 2000, J INFECT DIS, V182, P766, DOI 10.1086/315748; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; PERRIENS JH, 1991, AIDS, V5, pS127; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; POLI G, 1991, J EXP MED, V173, P589, DOI 10.1084/jem.173.3.589; Pontesilli O, 1998, AIDS, V12, P473, DOI 10.1097/00002030-199805000-00008; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 1999, BIOCHEM PHARMACOL, V57, P451; Quillent C, 1998, LANCET, V351, P14, DOI 10.1016/S0140-6736(97)09185-X; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Ratto-Kim S, 1999, J INFECT DIS, V179, P337, DOI 10.1086/314587; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Rida W, 1997, J ACQ IMMUN DEF SYND, V16, P195, DOI 10.1097/00042560-199711010-00009; Rizzardi GP, 1998, NAT MED, V4, P252, DOI 10.1038/nm0398-252; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROOS MTL, 1992, J INFECT DIS, V165, P427, DOI 10.1093/infdis/165.3.427; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1998, AIDS RES HUM RETROV, V14, pS143; Rosok B, 1997, AIDS RES HUM RETROV, V13, P79, DOI 10.1089/aid.1997.13.79; Rousseau MC, 1999, VACCINE, V18, P825, DOI 10.1016/S0264-410X(99)00321-7; Rowland-Jones S, 1999, SEX TRANSM INFECT, V75, P148, DOI 10.1136/sti.75.3.148; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Ruiz L, 2000, AIDS, V14, P397, DOI 10.1097/00002030-200003100-00013; Rusconi S, 2000, J VIROL, V74, P9328, DOI 10.1128/JVI.74.19.9328-9332.2000; Rusconi S, 2000, ANTIVIR THER, V5, P199; Saag MS, 1999, NAT MED, V5, P609, DOI 10.1038/9452; Salmon-Ceron D, 1999, AIDS RES HUM RETROV, V15, P633, DOI 10.1089/088922299310935; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Sandstrom E, 1999, LANCET, V353, P1735, DOI 10.1016/S0140-6736(98)06493-9; Schinkel J, 1999, J INFECT DIS, V179, P825, DOI 10.1086/314658; Schmidtmayerova H, 1996, NATURE, V382, P767, DOI 10.1038/382767a0; Schmidtmayerova H, 1996, P NATL ACAD SCI USA, V93, P700, DOI 10.1073/pnas.93.2.700; Schnell MJ, 2000, P NATL ACAD SCI USA, V97, P3544, DOI 10.1073/pnas.050589197; Schnell MJ, 1997, CELL, V90, P849, DOI 10.1016/S0092-8674(00)80350-5; Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Schonning K, 1998, J ACQ IMMUN DEF SYND, V18, P195, DOI 10.1097/00042560-199807010-00001; Seth A, 2000, J VIROL, V74, P2502, DOI 10.1128/JVI.74.6.2502-2509.2000; Shearer GM, 1996, IMMUNOL TODAY, V17, P21, DOI 10.1016/0167-5699(96)80564-0; Simmons G, 1996, J VIROL, V70, P8355, DOI 10.1128/JVI.70.12.8355-8360.1996; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sodroski JG, 1999, CELL, V99, P243, DOI 10.1016/S0092-8674(00)81655-4; Stanley SK, 1996, NEW ENGL J MED, V334, P1222, DOI 10.1056/NEJM199605093341903; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; STELLBRINK HJ, 2000, 7 C RETR OPP INF SAN; Stranford SA, 1999, P NATL ACAD SCI USA, V96, P1030, DOI 10.1073/pnas.96.3.1030; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tang JM, 1999, AIDS RES HUM RETROV, V15, P317, DOI 10.1089/088922299311277; Theodorou I, 1997, LANCET, V349, P1219; Tomiyama H, 1997, J IMMUNOL, V158, P5026; TRAUGER RJ, 1995, J ACQ IMMUN DEF SYND, V10, pS74; Tremblay CL, 2000, J ACQ IMMUN DEF SYND, V25, P99, DOI 10.1097/00126334-200010010-00001; Trkola A, 2001, J VIROL, V75, P579, DOI 10.1128/JVI.75.2.579-588.2001; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; Tsoukas CM, 1998, AIDS RES HUM RETROV, V14, P483, DOI 10.1089/aid.1998.14.483; Ullum H, 1998, J INFECT DIS, V177, P331, DOI 10.1086/514192; Valentin A, 1998, P NATL ACAD SCI USA, V95, P8886, DOI 10.1073/pnas.95.15.8886; van Rij RP, 1998, AIDS, V12, pF85, DOI 10.1097/00002030-199809000-00001; Vicenzi E, 1997, J LEUKOCYTE BIOL, V62, P34, DOI 10.1002/jlb.62.1.34; Wagner R, 1999, VACCINE, V17, P1706, DOI 10.1016/S0264-410X(98)00431-9; Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WALKER CM, 1991, J VIROL, V65, P5921, DOI 10.1128/JVI.65.11.5921-5927.1991; WEISSMAN D, 1995, J ACQ IMMUN DEF SYND, V9, P442; WEISSMAN D, 1994, AIDS RES HUM RETROV, V10, P1199, DOI 10.1089/aid.1994.10.1199; Wilson CC, 1999, J IMMUNOL, V162, P3070; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; WOLDAY D, 2000, 7 C RETR OPP INF SAN; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; WORKMAN C, 2000, 7 C RETR OPP INF SAN; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Ylisastigui L, 1998, AIDS, V12, P977, DOI 10.1097/00002030-199809000-00003; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665; ZollaPazner S, 1997, J INFECT DIS, V175, P764, DOI 10.1086/513969; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	255	100	109	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					978	996		10.7326/0003-4819-134-10-200105150-00012	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00012			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352699				2022-12-28	WOS:000168682500006
J	Kamermans, M; Fahrenfort, I; Schultz, K; Janssen-Bienhold, U; Sjoerdsma, T; Weiler, R				Kamermans, M; Fahrenfort, I; Schultz, K; Janssen-Bienhold, U; Sjoerdsma, T; Weiler, R			Hemichannel-mediated inhibition in the outer retina	SCIENCE			English	Article							GAP-JUNCTION CHANNELS; HORIZONTAL CELLS; GOLDFISH RETINA; FEEDBACK; NEUROTRANSMITTER; SYNAPSE; CONES	An essential feature of the first synapse in the retina is a negative feedback pathway from horizontal cells to cones. Here we show that at this synapse, connexin26 forms hemichannels on horizontal cell dendrites near the glutamate release site of the cones. Blocking these hemichannels hyperpolarizes horizontal cells, modulates the Ca2+ channels of the cones, and abolishes all feedback-mediated responses. We propose a feedback mechanism in which the activity of the Ca2+ channels and the subsequent glutamate release of the cones are modulated by a current through these hemichannels. Because the current through the hemichannels depends on the polarization of the horizontal cells, their activity modulates the output of the cones.	Netherlands Ophthalm Res Inst, Res Unit Retinal Signal Proc, NL-1105 BA Amsterdam, Netherlands; Univ Oldenburg, Dept Biol, D-26111 Oldenburg, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Carl von Ossietzky Universitat Oldenburg	Kamermans, M (corresponding author), Netherlands Ophthalm Res Inst, Res Unit Retinal Signal Proc, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.							BYZOV AL, 1986, VISION RES, V26, P33, DOI 10.1016/0042-6989(86)90069-6; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Fahrenfort I, 1999, J GEN PHYSIOL, V114, P511, DOI 10.1085/jgp.114.4.511; Janssen-Bienhold U, 2001, VISUAL NEUROSCI, V18, P169, DOI 10.1017/S0952523801182015; Janssen-Bienhold U, 1998, J COMP NEUROL, V396, P310, DOI 10.1002/(SICI)1096-9861(19980706)396:3<310::AID-CNE3>3.0.CO;2-5; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Klooster J, 2001, INVEST OPHTH VIS SCI, V42, pS727; Kraaij DA, 2000, J NEUROPHYSIOL, V84, P1256, DOI 10.1152/jn.2000.84.3.1256; Lu CB, 1996, VISUAL NEUROSCI, V13, P1049, DOI 10.1017/S0952523800007707; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Osborne PB, 1996, J NEUROPHYSIOL, V76, P1559, DOI 10.1152/jn.1996.76.3.1559; SCHULTZ K, IN PRESS J COMP NEUR; Suchyna TM, 1999, BIOPHYS J, V77, P2968, DOI 10.1016/S0006-3495(99)77129-8; TOYODA JI, 1982, S POTENTIAL, P151; Vandenbranden CAV, 1996, VISION RES, V36, P3859, DOI 10.1016/S0042-6989(96)00134-4; Vaney DI, 1998, J NEUROSCI, V18, P10594; WEILER R, 1984, BRAIN RES, V298, P1, DOI 10.1016/0006-8993(84)91141-7; WITKOVSKY P, 1995, P NATL ACAD SCI USA, V92, P3556, DOI 10.1073/pnas.92.8.3556; WU SM, 1994, ANNU REV PHYSIOL, V56, P141	20	302	306	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1178	1180		10.1126/science.1060101	http://dx.doi.org/10.1126/science.1060101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349152				2022-12-28	WOS:000168609200064
J	del Campo, ML; Miles, CI; Schroeder, FC; Mueller, C; Booker, R; Renwick, JA				del Campo, ML; Miles, CI; Schroeder, FC; Mueller, C; Booker, R; Renwick, JA			Host recognition by the tobacco hornworm is mediated by a host plant compound	NATURE			English	Article							MANDUCA-SEXTA; FOOD DISCRIMINATION; CHEMOSENSORY ORGANS; CHEMORECEPTORS; SPECIFICITY; SENSITIVITY; LEPIDOPTERA; SPHINGIDAE; INSECT; SYSTEM	It is generally believed that animals make decisions about the selection of mates, kin or food on the basis of pre-constructed recognition templates. These templates can be innate or acquired through experience(1). An example of an acquired template is the feeding preference exhibited by larvae of the moth, Manduca sexta. Naive hatchlings will feed and grow successfully on many different plants or artificial diets, but once they have fed on a natural host they become specialist feeders(2-6). Here we show that the induced feeding preference of M. sexta involves the formation of a template to a steroidal glycoside, indioside D, that is present in solanaceous foliage. This compound is both necessary and sufficient to maintain the induced feeding preference. The induction of host plant specificity is at least partly due to a tuning of taste receptors to indioside D. The taste receptors of larvae fed on host plants show an enhanced response to indioside D as compared with other plant compounds tested.	Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Cornell University; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research	del Campo, ML (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	moliva@binghamton.edu	Schroeder, Frank/H-5026-2012; Muller, Caroline/G-5073-2011	Muller, Caroline/0000-0002-8447-534X; Schroeder, Frank/0000-0002-4420-0237				ABISGOLD JD, 1988, J EXP BIOL, V135, P215; Bell RA., 1981, USDA TECH B, P599; Bernays EA, 1996, ENTOMOL EXP APPL, V80, P125, DOI 10.1007/BF00194741; CROASMUM WA, 1994, 2 DIMENSIONAL NMR SP; DEBOER G, 1993, J INSECT PHYSIOL, V39, P17, DOI 10.1016/0022-1910(93)90013-H; DEBOER G, 1991, ENTOMOL EXP APPL, V61, P159, DOI 10.1007/BF00191746; DEBOER G, 1991, J INSECT PHYSIOL, V37, P763, DOI 10.1016/0022-1910(91)90111-C; DETHIER VG, 1982, J GEN PHYSIOL, V79, P549, DOI 10.1085/jgp.79.4.549; FLOWERS RW, 1992, FLA ENTOMOL, V75, P89, DOI 10.2307/3495484; Glendinning JI, 1999, J EXP BIOL, V202, P2091; GOTHILF S, 1994, ENTOMOL EXP APPL, V72, P305, DOI 10.1007/BF02383819; JERMY T, 1968, ENTOMOL EXP APPL, V11, P211, DOI 10.1007/BF00305230; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; ROTHSCHILD M, 1979, NATURE, V280, P487, DOI 10.1038/280487a0; Schoonhoven L. M., 1966, ARCH NEERL ZOOL, V16, P497, DOI DOI 10.1163/036551666X00057; SCHOONHOVEN LM, 1969, P K NED AKAD C BIOL, V72, P491; SCHOONHOVEN LM, 1967, ENTOMOL EXP APPL, V10, P270, DOI 10.1007/BF00302248; Sherman Paul W., 1997, P69; Stadler E., 1976, Symposia Biologica Hungarica, V16, P267; WALDBAUER G. P., 1961, ANN ENT SOC AMER, V54, P477, DOI 10.1093/aesa/54.4.477; YAJARA S, 1996, PHYTOCHEMISTRY, V43, P1319; YAMAMOTO ROBERT T., 1960, ANN ENT SOC AMER, V53, P503, DOI 10.1093/aesa/53.4.503; YAMAMOTO RT, 1974, J INSECT PHYSIOL, V20, P641, DOI 10.1016/0022-1910(74)90185-1	23	78	83	1	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					186	189		10.1038/35075559	http://dx.doi.org/10.1038/35075559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346793				2022-12-28	WOS:000168563000048
J	O'Brien, E; Beevers, G; Lip, GYH				O'Brien, E; Beevers, G; Lip, GYH			ABC of hypertension - Blood pressure measurement - Part III - Automated sphygmomanometry: ambulatory blood pressure measurement	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREGNANCY; POPULATION; PREDICTOR; SOCIETY											*ASS ADV MED INSTR, 1993, SP101987 ANSIAAMI, P40; Atkins N, 1998, J HYPERTENS, V16, pS198; Bellomo G, 1999, JAMA-J AM MED ASSOC, V282, P1447, DOI 10.1001/jama.282.15.1447; British Hypertension Society, 1998, BLOOD PRESS MEAS CD; Churchill D, 1997, LANCET, V349, P7, DOI 10.1016/S0140-6736(96)06297-6; Fagard, 1997, Blood Press Monit, V2, P315; HALLIGAN A, 1993, J HYPERTENS, V11, P869, DOI 10.1097/00004872-199308000-00014; Halligan AWF, 1997, BRIT J OBSTET GYNAEC, V104, P559, DOI 10.1111/j.1471-0528.1997.tb11532.x; Higgins JR, 1997, BRIT J OBSTET GYNAEC, V104, P356, DOI 10.1111/j.1471-0528.1997.tb11468.x; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 1993, J HYPERTENS S2, V11, pS43; O'Brien Eoin, 1995, Blood Pressure, V4, P266; OBRIEN E, 1988, LANCET, V2, P397; Owens P, 1999, HEART, V82, P477, DOI 10.1136/hrt.82.4.477; Owens P, 1999, HYPERTENSION, V34, P267, DOI 10.1161/01.HYP.34.2.267; Owens P, 1998, J HYPERTENS, V16, P1735, DOI 10.1097/00004872-199816120-00005; OWENS PE, 1996, BLOOD PRESS MONIT, V2, P3; Penny JA, 1998, AM J OBSTET GYNECOL, V178, P521, DOI 10.1016/S0002-9378(98)70432-6; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; STAESSEN J, 1999, J HYPERTENS       S3, V17, pS16; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528	22	61	65	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2001	322	7294					1110	1114		10.1136/bmj.322.7294.1110	http://dx.doi.org/10.1136/bmj.322.7294.1110			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337446	Green Published			2022-12-28	WOS:000168628300028
J	Smith, R				Smith, R			For and against - Should Nottingham University give back its tobacco money?	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England; Univ Nottingham, Nottingham NG7 2RD, England	University of Nottingham	Smith, R (corresponding author), BMJ, BMA House, London WC1H 9JR, England.							Chapman S, 2001, TOB CONTROL, V10, P1, DOI 10.1136/tc.10.1.1	1	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1118	1118		10.1136/bmj.322.7294.1118	http://dx.doi.org/10.1136/bmj.322.7294.1118			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337449	Green Published			2022-12-28	WOS:000168628300030
J	Calvert, PD; Govardovskii, VI; Krasnoperova, N; Anderson, RE; Lem, J; Makino, CL				Calvert, PD; Govardovskii, VI; Krasnoperova, N; Anderson, RE; Lem, J; Makino, CL			Membrane protein diffusion sets the speed of rod phototransduction	NATURE			English	Article							PHOTORECEPTOR LIGHT ADAPTATION; LATERAL DIFFUSION; OUTER SEGMENT; LIPID BILAYERS; RETINAL RODS; IN-VIVO; RHODOPSIN; TRANSDUCIN; PHOTORESPONSE; ACTIVATION	Retinal rods signal the activation of a single receptor molecule by a photon(1). To ensure efficient photon capture, rods maintain about 10(9) copies of rhodopsin densely packed into membranous disks(2). But a high packing density of rhodopsin may impede other steps in phototransduction that take place on the disk membrane(3), by restricting the lateral movement of, and hence the rate of encounters between, the molecules involved(4-6). Although it has been suggested that lateral diffusion of proteins on the membrane sets the rate of onset of the photoresponse(7), it was later argued that the subsequent processing of the complexes was the main determinant of this rate(8,9). The effects of protein density on response shut-off have not been reported. Here we show that a roughly 50% reduction in protein crowding achieved by the hemizygous knockout of rhodopsin in transgenic mice accelerates the rising phases and recoveries of flash responses by about 1.7-fold in vivo. Thus, in rods the rates of both response onset and recovery are set by the diffusional encounter frequency between proteins on the disk membrane.	Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; New England Med Ctr, Dept Ophthalmol, Mol Cardiol Res Inst, Boston, MA 02111 USA; New England Med Ctr, Dept Genet, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Tufts Medical Center; Tufts Medical Center; Tufts University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Calvert, PD (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.		Makino, Clint Lawrence/H-8428-2019; Govardovskii, Victor I/K-2655-2018	Makino, Clint Lawrence/0000-0002-6005-9069; 				BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BRUCKERT F, 1992, BIOPHYS J, V63, P616, DOI 10.1016/S0006-3495(92)81650-8; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; DODD RL, 1995, INVEST OPHTH VIS SCI, V36, pS641; HECK M, 1993, BIOCHEMISTRY-US, V32, P8220, DOI 10.1021/bi00083a024; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; NAQVI KR, 1974, CHEM PHYS LETT, V28, P280; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; PINK DA, 1985, BIOCHIM BIOPHYS ACTA, V818, P200, DOI 10.1016/0005-2736(85)90562-0; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; SAXTON MJ, 1989, BIOCHIM BIOPHYS ACTA, V979, P27, DOI 10.1016/0005-2736(89)90519-1; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SMITH HG, 1975, EXP EYE RES, V20, P211, DOI 10.1016/0014-4835(75)90134-7; SUNG CH, 1994, J NEUROSCI, V14, P5818; TANK DW, 1982, BIOPHYS J, V40, P129, DOI 10.1016/S0006-3495(82)84467-6; TILTON RD, 1990, BIOPHYS J, V58, P1321, DOI 10.1016/S0006-3495(90)82473-5; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; Yuan C, 1998, COMP BIOCHEM PHYS B, V120, P785, DOI 10.1016/S0305-0491(98)10079-2	30	143	145	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					90	94		10.1038/35075083	http://dx.doi.org/10.1038/35075083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333983				2022-12-28	WOS:000168432800049
J	Montgomery, SL				Montgomery, SL			Newton in Japan	NATURE			English	Article																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					25	25		10.1038/35075172	http://dx.doi.org/10.1038/35075172			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333955	Bronze			2022-12-28	WOS:000168432800023
J	Guillausseau, PJ; Massin, P; Dubois-LaForgue, D; Timsit, J; Virally, M; Gin, H; Bertin, E; Blickle, JF; Bouhanick, B; Cahen, J; Caillat-Zucman, S; Charpentier, G; Chedin, P; Derrien, C; Ducluzeau, PH; Grimaldi, A; Guerci, B; Kaloustian, E; Murat, A; Olivier, F; Paques, M; Paquis-Flucklinger, V; Porokhov, B; Samuel-Lajeunesse, J; Vialettes, B				Guillausseau, PJ; Massin, P; Dubois-LaForgue, D; Timsit, J; Virally, M; Gin, H; Bertin, E; Blickle, JF; Bouhanick, B; Cahen, J; Caillat-Zucman, S; Charpentier, G; Chedin, P; Derrien, C; Ducluzeau, PH; Grimaldi, A; Guerci, B; Kaloustian, E; Murat, A; Olivier, F; Paques, M; Paquis-Flucklinger, V; Porokhov, B; Samuel-Lajeunesse, J; Vialettes, B			Maternally inherited diabetes and deafness: A multicenter study	ANNALS OF INTERNAL MEDICINE			English	Article							MITOCHONDRIAL TRNA(LEU(UUR)) MUTATION; MACULAR PATTERN DYSTROPHY; POINT MUTATION; INSULIN SENSITIVITY; RETINAL DYSTROPHY; GENE MUTATION; MELLITUS; PREVALENCE; DNA; RETINOPATHY	Background: Maternally inherited diabetes and deafness (MIDD), which is seen in 0.5% to 2.8% of patients with type 2 diabetes mellitus, is related to a point mutation at position 3243 of mitochondrial (mt) DNA. Its clinical description is incomplete. Objective: To study the clinical presentation and complications of diabetes in patients with MIDD and to identify clinical characteristics that may help select diabetic patients for mtDNA mutation screening. Design: Multicenter prospective descriptive study. Setting: 16 French departments of internal medicine, diabetes and metabolic diseases, or both, Patients: 54 patients with type 2 diabetes mellitus and the mtDNA 3243 mutation. Measurements: Characteristics of diabetes, metabolic control (glycosylated hemoglobin level), complications of diabetes, and Involvement of other organs. Results: On average, patients with MIDD were young at diabetes onset and presented with a normal or low body mass index. None were obese. Seventy-three percent of probands had a maternal family history of diabetes. Diabetes was non-insulin-dependent at onset in 87% of patients; however, 46% of patients had noninsulin-dependent disease at onset but progressed to insulin therapy after a mean duration of approximately 10 years. Neurosensory hearing loss was present in almost all patients. Eighty-six percent of patients who received an ophthalmologic examination had macular pattern dystrophy (a specific retinal lesion), Forty-three percent of patients had myopathy, 15% had cardiomyopathy, and 18% (9 of 51) had neuropsychiatric symptoms. Although the prevalence of diabetic retinopathy was 8% among patients who received an ophthalmologic examination, lower than expected after a mean 12-year duration of diabetes, prevalence of kidney disease was 28%. This suggests that a specific renal involvement was the result of mitochondrial disease. Conclusions: Maternally inherited diabetes and deafness has a specific clinical profile that may help identify diabetic patients for mtDNA testing.	Hop Lariboisiere, 2 Rue Ambroise Pare, F-75010 Paris, France; Hop Necker Enfants Malad, Paris, France; Hop La Pitie Salpetriere, Paris, France; Univ Hosp, Pessac, France; Hop Robert Debre, Reims, France; Univ Hosp, Strasbourg, France; Univ Hosp, Angers, France; Victor Dupouy Hosp, Argenteuil, France; Gilles de Corbeil Hosp, Corbeil Essonnes, France; Univ Hosp, Rennes, France; Hop Edouard Herriot, Lyon, France; Jeanne dArc Hosp, Dommartin Les Toul, France; Hosp Compiegne, Compiegne, France; Hop Hotel Dieu, Nantes, France; Hosp Cahors, Cahors, France; CNRS, UMR 6549, F-06034 Nice, France; Hop St Marguerite, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; CHU de Reims; CHU Strasbourg; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Rennes; CHU Lyon; CHU de Nancy; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Guillausseau, PJ (corresponding author), Hop Lariboisiere, 2 Rue Ambroise Pare, F-75010 Paris, France.	pierre-jean.guillausseau@lrb.ap-hop-paris.fr	ducluzeau, pierre-henri/ABE-1092-2021; Bertin, Eric/F-8912-2015	Dubois-Laforgue, Daniele/0000-0003-3287-6309; Paques, Michel/0000-0002-9102-9196; Bertin, Eric/0000-0002-8357-985X; Caillat-Zucman, Sophie/0000-0002-4535-3550				ALCOLADO JC, 1994, DIABETOLOGIA, V37, P372, DOI 10.1007/s001250050119; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Bonte C, 1996, Bull Soc Belge Ophtalmol, V261, P9; CHANG TS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1254, DOI 10.1001/archopht.1993.01090090106028; Doleris LM, 2000, KIDNEY INT, V58, P1851, DOI 10.1111/j.1523-1755.2000.00356.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guillausseau PJ, 1998, DIABETIC MED, V15, P151, DOI 10.1002/(SICI)1096-9136(199802)15:2<151::AID-DIA527>3.3.CO;2-9; HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7; Harrison TJ, 1997, AM J OPHTHALMOL, V124, P217, DOI 10.1016/S0002-9394(14)70787-1; IWANISHI M, 1995, DIABETES RES CLIN PR, V29, P75, DOI 10.1016/0168-8227(95)01108-0; JAIN IS, 1967, ARCH OPHTHALMOL-CHIC, V77, P59; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KATAGIRI H, 1994, DIABETOLOGIA, V37, P504, DOI 10.1007/s001250050139; KISHIMOTO M, 1995, DIABETOLOGIA, V38, P193, DOI 10.1007/s001250050270; KITAOKA H, 1995, DIABETES RES CLIN PR, V28, P207, DOI 10.1016/0168-8227(95)01100-R; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281; MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654; MASSIN P, 1995, AM J OPHTHALMOL, V120, P247, DOI 10.1016/S0002-9394(14)72615-7; Massin P, 1999, OPHTHALMOLOGY, V106, P1821, DOI 10.1016/S0161-6420(99)90356-1; Nakamura S, 1999, DIABETES RES CLIN PR, V44, P183, DOI 10.1016/S0168-8227(99)00051-0; Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.0.CO;2-W; Oka Y, 1996, DIABETIC MED, V13, pS98; OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757; Saker PJ, 1997, DIABETIC MED, V14, P42, DOI 10.1002/(SICI)1096-9136(199701)14:1<42::AID-DIA295>3.0.CO;2-T; Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Suzuki Y, 1997, METABOLISM, V46, P1019, DOI 10.1016/S0026-0495(97)90272-9; SUZUKI Y, 1995, DIABETES RES CLIN PR, V29, P69, DOI 10.1016/0168-8227(95)01121-S; Tamagawa Y, 1997, ANN OTO RHINOL LARYN, V106, P338; THART LM, 1994, DIABETOLOGIA, V37, P1169; THOMAS F, 1994, DIABETES, V43, P63, DOI 10.2337/diabetes.43.1.63; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; VIONNET N, 1993, LANCET, V342, P1429, DOI 10.1016/0140-6736(93)92792-R; WALKER M, 1995, DIABETES CARE, V18, P273, DOI 10.2337/diacare.18.2.273; WEITER JJ, 1980, OPHTHALMOLOGY, V87, P1133; *WHO DIV NONC DIS, 1998, OB PRES MAN GLOB EP	46	202	222	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					721	728		10.7326/0003-4819-134-9_Part_1-200105010-00008	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329229				2022-12-28	WOS:000168470700001
J	Jones, PD; Osborn, TJ; Briffa, KR				Jones, PD; Osborn, TJ; Briffa, KR			The evolution of climate over the last millennium	SCIENCE			English	Review							NORTH-ATLANTIC OSCILLATION; TEMPERATURE; RECONSTRUCTION; EXTENSION; VARIABILITY; DENSITY; PROXY; WARM; NAO	Knowledge of past climate variability is crucial for understanding and modeling current and future climate trends. This article reviews present knowledge of changes in temperatures and two major circulation features-El Nino-Southern Oscillation (ENSO) and the North Atlantic Oscillation (NAO)-over much of the Last 1000 years, mainly on the basis of high-resolution paleoclimate records. Average temperatures during the Last three decades were Likely the warmest of the Last millennium, about 0.2 degreesC warmer than during warm periods in the 11th and 12th centuries. The 20th century experienced the strongest warming trend of the millennium (about 0.6 degreesC per century). Some recent changes in ENSO may have been unique since 1800, whereas the recent trend to more positive NAO values may have occurred several times since 1500. Uncertainties will only be reduced through more extensive spatial sampling of diverse proxy climatic records.	Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Jones, PD (corresponding author), Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England.	p.jones@uea.ac.uk	Osborn, Timothy/AAK-9279-2020; Briffa, Keith/C-8834-2009; Jones, Philip Douglas/C-8718-2009; Osborn, Timothy/E-9740-2011	Osborn, Timothy/0000-0001-8425-6799; Jones, Philip Douglas/0000-0001-5032-5493; Osborn, Timothy/0000-0001-8425-6799; Briffa, Keith/0000-0003-3323-3639				Allan R.J., 1996, NINO SO OSCILLATION; Appenzeller C, 1998, SCIENCE, V282, P446, DOI 10.1126/science.282.5388.446; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Barnett TP, 1999, B AM METEOROL SOC, V80, P2631, DOI 10.1175/1520-0477(1999)080<2631:DAAORC>2.0.CO;2; BELL WT, 1978, CLIMATIC CHANGE, V1, P331, DOI 10.1007/BF00135154; Bradley R, 2000, SCIENCE, V288, P1353, DOI 10.1126/science.288.5470.1353; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Bradley RS., 1993, HOLOCENE, V3, P367, DOI [10.1177/095968369300300409, DOI 10.1177/095968369300300409]; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Briffa KR, 1999, SCIENCE, V284, P926, DOI 10.1126/science.284.5416.926; Briffa KR, 1993, HOLOCENE, V3, P77, DOI DOI 10.1177/095968369300300109; Cook ER, 1998, HOLOCENE, V8, P9, DOI 10.1191/095968398677793725; COOK ER, 1995, CLIM DYNAM, V11, P211, DOI 10.1007/BF00215008; COOK ER, UNPUB N ATLANTIC OSC; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Crowley TJ, 2000, AMBIO, V29, P51, DOI 10.1579/0044-7447-29.1.51; Cullen HM, 2001, PALEOCEANOGRAPHY, V16, P27, DOI 10.1029/1999PA000434; Diaz H.F., 2000, NINO SO OSCILLATION, DOI 10.1017/CBO9780511573125; Grove JM, 1988, LITTLE ICE AGE; HUGHES MK, 1994, CLIMATIC CHANGE, V26, P109, DOI 10.1007/BF01092410; Hurrell JW, 1996, GEOPHYS RES LETT, V23, P665, DOI 10.1029/96GL00459; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ingram M. J., 1981, CLIMATE HIST STUDIES, P180; JONES PD, 1990, J CLIMATE, V3, P1193, DOI 10.1175/1520-0442(1990)003<1193:ATOTPC>2.0.CO;2; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Jones PD, 1997, J CLIMATE, V10, P2548, DOI 10.1175/1520-0442(1997)010<2548:ESEILS>2.0.CO;2; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; JONES PD, 1996, CLIMATIC VARIATIONS, P625; LAMB Hubert H., 1977, CLIMATE PRESENT FUTU, V2; Lough JM, 1997, J EXP MAR BIOL ECOL, V211, P29, DOI 10.1016/S0022-0981(96)02710-4; Luterbacher J, 1999, GEOPHYS RES LETT, V26, P2745, DOI 10.1029/1999GL900576; LUTERBACHER J, UNPUB ATMOS SCI LETT; MANLEY G, 1974, Q J ROY METEOR SOC, V100, P389, DOI 10.1002/qj.49710042511; Mann M. E., 2000, NINO SO OSCILLATION, P357; Mann M. E., 2000, EARTH INTERACT, V4, P1, DOI DOI 10.1175/1087-3562(2000)004<0001:GTPIPC>2.3.C0;2; Mann ME, 2000, SCIENCE, V289, P253, DOI 10.1126/science.289.5477.253; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2001, WEATHER, V56, P91; Morgan V, 1997, HOLOCENE, V7, P351, DOI 10.1177/095968369700700312; Ogilvie AEJ, 2001, CLIMATIC CHANGE, V48, P9, DOI 10.1023/A:1005625729889; Ortlieb L., 2000, EL NINO SO OSCILLATI, P207; Osborn TJ, 1999, CLIM DYNAM, V15, P685, DOI 10.1007/s003820050310; Pfister C., 1992, CLIMATE AD, V1500, P118; Quinn WH, 1992, CLIMATE AD 1500, V1500, P623, DOI DOI 10.1002/JOC.3370130411; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P2161, DOI 10.1175/1520-0493(1987)115<2161:AEOTTS>2.0.CO;2; Schmutz C, 2000, GEOPHYS RES LETT, V27, P1135, DOI 10.1029/1999GL011045; Stahle DW, 1998, B AM METEOROL SOC, V79, P2137, DOI 10.1175/1520-0477(1998)079<2137:EDROTS>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; THOMPSON LG, 1984, SCIENCE, V234, P631; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597	53	436	484	8	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					662	667		10.1126/science.1059126	http://dx.doi.org/10.1126/science.1059126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326088				2022-12-28	WOS:000168478300037
J	Moshous, D; Callebaut, I; de Chasseval, R; Corneo, B; Cavazzana-Calvo, M; Le Deist, F; Tezcan, I; Sanal, O; Bertrand, Y; Philippe, N; Fischer, A; de Villartay, JP				Moshous, D; Callebaut, I; de Chasseval, R; Corneo, B; Cavazzana-Calvo, M; Le Deist, F; Tezcan, I; Sanal, O; Bertrand, Y; Philippe, N; Fischer, A; de Villartay, JP			Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency	CELL			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; V(D)J RECOMBINATION; SCID MUTATION; LIGASE-IV; SACCHAROMYCES-CEREVISIAE; INCREASED SENSITIVITY; CATALYTIC SUBUNIT; CHROMOSOME 10P; GENOMIC DNA; GENE	The V(D)J recombination process insures the somatic diversification of immunoglobulin and antigen T cell receptor encoding genes. This reaction is initiated by a DNA double-strand break (dsb), which is resolved by the ubiquitously expressed DNA repair machinery. Human T-B-severe combined immunodeficiency associated with increased cellular radiosensitivity (RS-SCID) is characterized by a defect in the V(D)J recombination leading to an early arrest of both B and T cell maturation. We previously mapped the disease-related locus to the short arm of chromosome 10. We herein describe the cloning of the gene encoding a novel protein involved in V(D)J recombination/DNA repair, Artemis, whose mutations cause human RS-SCID. Protein sequence analysis strongly suggests that Artemis belongs to the metallo-beta -lactamase superfamily.	Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Paris 06, LMCP, CNRS, UMR C7590, F-75005 Paris, France; Univ Paris 07, F-75005 Paris, France; Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Div Immunol, Ankara, Turkey; Hop Debrousse, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; CHU Lyon	Moshous, D (corresponding author), Hop Necker Enfants Malad, INSERM, U429, 149 Rue Sevres, F-75015 Paris, France.		Moshous, Despina/B-7507-2017; de Villartay, jean pierre/H-9353-2017	Moshous, Despina/0000-0001-6719-3693; de Villartay, jean pierre/0000-0001-5987-0463; Cavazzana, Marina/0000-0002-0264-0891; Corneo, Barbara/0000-0001-5189-6749				ARAVIND L, 1997, SILICO BIOL, V1, P5; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; CAVAZZANACALVO M, 1993, J CLIN INVEST, V91, P1214, DOI 10.1172/JCI116282; Corneo B, 2000, J BIOL CHEM, V275, P12672, DOI 10.1074/jbc.275.17.12672; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; GOTTLIEB TM, 1993, CELL, V72, P132; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; HENRIQUES JAP, 1980, GENETICS, V95, P273; HU DC, 1988, PEDIATR RES, V24, P239; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; Li LY, 1998, AM J HUM GENET, V62, P136, DOI 10.1086/301688; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moshous D, 2000, HUM MOL GENET, V9, P583, DOI 10.1093/hmg/9.4.583; Nicolas N, 1996, EUR J IMMUNOL, V26, P1118, DOI 10.1002/eji.1830260524; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Shin EK, 1997, J IMMUNOL, V158, P3565; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	45	666	688	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					177	186		10.1016/S0092-8674(01)00309-9	http://dx.doi.org/10.1016/S0092-8674(01)00309-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336668	Bronze			2022-12-28	WOS:000168384300005
J	Simmonds, AJ; dosSantos, G; Livne-Bar, I; Krause, HM				Simmonds, AJ; dosSantos, G; Livne-Bar, I; Krause, HM			Apical localization of wingless transcripts is required for wingless signaling	CELL			English	Article							SEGMENT-POLARITY GENE; DEPENDENT LOCALIZATION; UBIQUITOUS EXPRESSION; PATTERN-FORMATION; RNA LOCALIZATION; MESSENGER-RNAS; WNT GENE; DROSOPHILA; PROTEIN; ENCODES	Many developing and adult tissues are comprised of polarized epithelia. Proteins that are asymmetrically distributed in these cells are thought to be localized by protein trafficking. Here we show that the distribution and function of the signaling protein Wingless is predetermined by the subcellular localization of its mRNA. High-resolution in situ hybridization reveals apical transcript localization in the majority of tissues examined. This localization is mediated by two independently acting elements in the 3' UTR. Replacement of these elements with non- or basolaterally localizing elements yields proteins with altered intracellular and extracellular distributions and reduced signaling activities. This novel aspect of the wingless signaling pathway is conserved and may prove to be a mechanism used commonly for establishing epithelial cell polarity.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Program Dev Biol, Toronto, ON, Canada	University of Toronto; University of Toronto	Krause, HM (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Room 312,112 Coll St, Toronto, ON M5G 1L6, Canada.	h.krause@utoronto.ca	Simmonds, Andrew J/D-3675-2009	Simmonds, Andrew/0000-0001-7165-9302; Krause, Henry/0000-0002-6182-7074				Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; BAKER NE, 1988, DEVELOPMENT, V102, P489; BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; GULLBERG D, 1994, DEV DYNAM, V199, P116, DOI 10.1002/aja.1001990205; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hays R, 1997, DEVELOPMENT, V124, P3727; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Hughes SC, 1996, BIOTECHNIQUES, V20, P748; Hughes SC, 1999, METH MOL B, V122, P93; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; KU M, 1993, DEVELOPMENT, V119, P1161; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Manoukian AS, 1995, DEVELOPMENT, V121, P4037; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; MOON RT, 1993, DEVELOPMENT, V119, P97; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; MURRAY MA, 1995, DEV BIOL, V168, P150, DOI 10.1006/dbio.1995.1068; NEUMANSILBERBERG FS, 1994, DEVELOPMENT, V120, P2457; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; PARK WJ, 1994, MECH DEVELOP, V45, P127, DOI 10.1016/0925-4773(94)90026-4; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Raj L, 2000, CURR BIOL, V10, P1265, DOI 10.1016/S0960-9822(00)00745-4; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sasakura Y, 1998, INT J DEV BIOL, V42, P573; Saulier-Le Drean B, 1998, DEVELOPMENT, V125, P4851; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOODS DF, 1993, J CELL SCI, P171; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243; Yu X, 1999, MECH DEVELOP, V84, P69, DOI 10.1016/S0925-4773(99)00072-6; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	72	97	97	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					197	207		10.1016/S0092-8674(01)00311-7	http://dx.doi.org/10.1016/S0092-8674(01)00311-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336670	Bronze			2022-12-28	WOS:000168384300007
J	Devlin, N; Maynard, A; Mays, N				Devlin, N; Maynard, A; Mays, N			New Zealand's new health sector reforms: back to the future?	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Dept Econ, Dunedin, New Zealand; Univ York, Dept Hlth Studies, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England; Social Policy Branch Treasury, Hlth & Educ Directorate, Wellington, New Zealand	University of Otago; University of York - UK	Devlin, N (corresponding author), Univ Otago, Dept Econ, POB 56, Dunedin, New Zealand.							ADAM B, 2000, HLTH REFORMS; Alford RR, 1975, HLTH CARE POLITICS; Ashton T, 1997, HEALTH ECON, V6, P43, DOI 10.1002/(SICI)1099-1050(199701)6:1<43::AID-HEC241>3.0.CO;2-I; Ashton T., 1999, REDESIGNING WELFARE, P134; BOLGER JBH, 1999, COALITION AGREEMENT; CUMMING J, 1997, MARKETS HLTH CARE CO, P122; Devlin N, 1999, NEW ZEAL MED J, V112, P369; DEVLIN N, 1998, STRUCTURE DYNAMICS N, P287; Hornblow A, 2000, NEW ZEAL MED J, V113, P133; Hornblow A, 1997, BRIT MED J, V314, P1892, DOI 10.1136/bmj.314.7098.1892; HOSPITAL RELATED SERVICES TASKFORCE, 1988, UNSH HOSP; KING HA, 2000, FUTURE SHAPE PRIMARY; *LAB PART, 1999, FOC PAT LAB HLTH; Mays N, 2000, J Health Serv Res Policy, V5, P122; STENT R, 1998, CANTERBURY HLTH LTD; Upton S., 1991, YOUR HLTH PUBLIC HLT; Vaithianathan R, 1999, AGENDA, V6, P325; 2000, EVENING POST WE 0207	18	21	21	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1171	1174		10.1136/bmj.322.7295.1171	http://dx.doi.org/10.1136/bmj.322.7295.1171			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348917	Green Accepted, Green Published			2022-12-28	WOS:000168748900022
J	Qureshi, AI; Tuhrim, S; Broderick, JP; Batjer, HH; Hondo, H; Hanley, DF				Qureshi, AI; Tuhrim, S; Broderick, JP; Batjer, HH; Hondo, H; Hanley, DF			Medical progress: Spontaneous intracerebral hemorrhage.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CEREBRAL-BLOOD-FLOW; BRAIN-BARRIER PERMEABILITY; MEAN ARTERIAL-PRESSURE; INTRACRANIAL-PRESSURE; RISK-FACTOR; EDEMA DEVELOPMENT; PROGNOSTIC VALUE; NATURAL-HISTORY; STROKE; MORTALITY		Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA; Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; Northwestern Univ, Sch Med, Dept Neurol Surg, Chicago, IL USA; Tokushima Prefectural Cent Hosp, Dept Neurol Surg, Tokushima, Japan	Johns Hopkins University; Johns Hopkins Medicine; Icahn School of Medicine at Mount Sinai; University System of Ohio; University of Cincinnati; Northwestern University	Qureshi, AI (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurosurg, Millard Fillmore Hosp, 3 Gates Cir, Buffalo, NY 14209 USA.	aiqureshi@hotmail.com	Mehdorn, Maximilian/D-2495-2010	Hanley, Daniel/0000-0002-9536-4258; Qureshi, Adnan/0000-0003-4962-540X	FOOD AND DRUG ADMINISTRATION [R01FD001693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024282] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS24282-08] Funding Source: Medline; FDA HHS [FD R-001693-01-1] Funding Source: Medline	FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); FDA HHS		Adams RE, 1998, NEUROLOGY, V50, P519, DOI 10.1212/WNL.50.2.519; Alberts MJ, 1997, ANN NEUROL, V41, P683, DOI 10.1002/ana.410410519; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1982, JAMA-J AM MED ASSOC, V247, P633; Arakawa S, 1998, STROKE, V29, P1806, DOI 10.1161/01.STR.29.9.1806; AUER LM, 1989, J NEUROSURG, V70, P530, DOI 10.3171/jns.1989.70.4.0530; BERGER AR, 1988, NEUROLOGY, V38, P1363, DOI 10.1212/WNL.38.9.1363; BRODERICK JP, 1992, NEW ENGL J MED, V326, P733, DOI 10.1056/NEJM199203123261103; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1990, J NEUROSURG, V72, P195, DOI 10.3171/jns.1990.72.2.0195; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BROTT T, 1986, STROKE, V17, P1078, DOI 10.1161/01.STR.17.6.1078; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; BULLOCK R, 1988, SURG NEUROL, V29, P101, DOI 10.1016/0090-3019(88)90065-1; CAPLAN LR, 1987, STROKE, V18, P686; CARLBERG B, 1993, STROKE, V24, P1372, DOI 10.1161/01.STR.24.9.1372; Catto AJ, 1998, STROKE, V29, P813, DOI 10.1161/01.STR.29.4.813; CERVONI L, 1994, NEUROSURG REV, V17, P185, DOI 10.1007/BF00418427; COLE FM, 1967, J NEUROL NEUROSUR PS, V30, P61, DOI 10.1136/jnnp.30.1.61; Da Pian R, 1984, Neurol Res, V6, P145; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Diringer MN, 1998, NEUROLOGY, V50, pA338; Duong DH, 1999, NEW ENGL J MED, V340, P1812; FISHER CM, 1971, J NEUROPATH EXP NEUR, V30, P536, DOI 10.1097/00005072-197107000-00015; Fogelholm R, 1997, STROKE, V28, P1396, DOI 10.1161/01.STR.28.7.1396; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; FURLAN AJ, 1979, ANN NEUROL, V5, P367, DOI 10.1002/ana.410050410; GIROUD M, 1991, J NEUROL NEUROSUR PS, V54, P595, DOI 10.1136/jnnp.54.7.595; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hankey GJ, 1997, STROKE, V28, P2126, DOI 10.1161/01.STR.28.11.2126; HATAZAWA J, 1995, STROKE, V26, P2267, DOI 10.1161/01.STR.26.12.2267; Hickenbottom SL, 1999, STROKE, V30, P2472, DOI 10.1161/01.STR.30.11.2472; HUSTON J, 1994, AM J NEURORADIOL, V15, P1607; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; JANE JA, 1985, J NEUROSURG, V62, P321, DOI 10.3171/jns.1985.62.3.0321; JANNY P, 1982, ACTA NEUROCHIR, V61, P181, DOI 10.1007/BF01740083; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; KANDEL EI, 1985, J NEUROSURG, V62, P206, DOI 10.3171/jns.1985.62.2.0206; KANE PJ, 1992, J NEUROL NEUROSUR PS, V55, P781, DOI 10.1136/jnnp.55.9.781; KANNO T, 1993, STROKE, V24, pI96; KAUFMAN HH, 1993, STROKE, V24, pI101; Kazui S, 1997, STROKE, V28, P2370, DOI 10.1161/01.STR.28.12.2370; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; KIM JS, 1994, STROKE, V25, P2098; KLATSKY AL, 1989, STROKE, V20, P741, DOI 10.1161/01.STR.20.6.741; KOBAYASHI S, 1994, NEUROSURGERY, V34, P246, DOI 10.1227/00006123-199402000-00006; KONDZIOLKA D, 1995, J NEUROSURG, V83, P820, DOI 10.3171/jns.1995.83.5.0820; Kuwata N, 1995, NEUROSURG REV, V18, P237, DOI 10.1007/BF00383874; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; LISK DR, 1994, NEUROLOGY, V44, P133, DOI 10.1212/WNL.44.1.133; MAYER SA, 1994, NEUROLOGY, V44, P1379, DOI 10.1212/WNL.44.8.1379; MAYER SA, 1995, ANN NEUROL, V38, P288; Mayer SA, 1996, STROKE, V27, P1788, DOI 10.1161/01.STR.27.10.1788; Melo TP, 1996, NEUROLOGY, V47, P494, DOI 10.1212/WNL.47.2.494; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Montes JM, 2000, STROKE, V31, P834, DOI 10.1161/01.STR.31.4.834; MORRIS JH, 1999, PATHOLOGIC BASIS DIS, P1385; MULBRYCE S, 1993, AM J PHYSIOL, V265, pR697; MUTLU N, 1963, ARCH NEUROL-CHICAGO, V8, P644, DOI 10.1001/archneur.1963.00460060074008; Naff NJ, 2000, STROKE, V31, P841, DOI 10.1161/01.STR.31.4.841; Naff NJ, 1998, NEUROLOGY, V50, P1709, DOI 10.1212/WNL.50.6.1709; NATH FP, 1986, J NEUROSURG, V65, P697, DOI 10.3171/jns.1986.65.5.0697; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; OLSON JD, 1993, STROKE, V24, pI109; OTT KH, 1974, ARCH NEUROL-CHICAGO, V31, P160, DOI 10.1001/archneur.1974.00490390042003; PAPO I, 1979, NEUROSURGERY, V4, P504, DOI 10.1227/00006123-197906000-00002; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Powers WJ, 1999, STROKE, V30, P242; Preter M, 1996, STROKE, V27, P243, DOI 10.1161/01.STR.27.2.243; Qureshi AI, 1999, CRIT CARE MED, V27, P965, DOI 10.1097/00003246-199905000-00036; Qureshi AI, 1999, CRIT CARE MED, V27, P480, DOI 10.1097/00003246-199903000-00021; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; QURESHI AI, 1995, STROKE, V26, P1764, DOI 10.1161/01.STR.26.10.1764; Qureshi AI, 1997, STROKE, V28, P961, DOI 10.1161/01.STR.28.5.961; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Qureshi AI, 1999, NEUROLOGY, V52, P1617, DOI 10.1212/WNL.52.8.1617; ROPPER AH, 1991, CEREBROVASC DIS, V1, P38, DOI 10.1159/000108814; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Sacco RL, 1994, INTRACEREBRAL HEMORR, P3; SUZUKI K, 1987, STROKE, V18, P402, DOI 10.1161/01.STR.18.2.402; TAKEBAYASHI S, 1983, STROKE, V14, P28, DOI 10.1161/01.STR.14.1.28; Tanaka A, 1996, J NEUROL SCI, V144, P191, DOI 10.1016/S0022-510X(96)00226-2; TANAKA H, 1982, STROKE, V13, P62, DOI 10.1161/01.STR.13.1.62; Taylor TN, 1998, STROKE, V29, P322; Tellez H, 1973, STROKE, V4, P541, DOI 10.1161/01.STR.4.4.541; Thrift AG, 1998, HYPERTENSION, V31, P1223, DOI 10.1161/01.HYP.31.6.1223; Tuhrim S, 1999, CRIT CARE MED, V27, P617, DOI 10.1097/00003246-199903000-00045; TUHRIM S, 1995, CRIT CARE MED, V23, P950, DOI 10.1097/00003246-199505000-00026; Wagner KR, 1998, J NEUROSURG, V88, P1058, DOI 10.3171/jns.1998.88.6.1058; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; WOODCOCK J, 1982, STROKE, V13, P785, DOI 10.1161/01.STR.13.6.785; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zhu XL, 1997, STROKE, V28, P1406, DOI 10.1161/01.STR.28.7.1406; Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833	100	1156	1253	2	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1450	1460		10.1056/NEJM200105103441907	http://dx.doi.org/10.1056/NEJM200105103441907			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346811				2022-12-28	WOS:000168554000007
J	Scott, RS; McMahon, EJ; Pop, SM; Reap, EA; Caricchio, R; Cohen, PL; Earp, HS; Matsushima, GK				Scott, RS; McMahon, EJ; Pop, SM; Reap, EA; Caricchio, R; Cohen, PL; Earp, HS; Matsushima, GK			Phagocytosis and clearance of apoptotic cells is mediated by MER	NATURE			English	Article							RECEPTOR TYROSINE KINASE; ARREST-SPECIFIC GENE-6; VITRONECTIN RECEPTOR; IN-VITRO; RCS RAT; RECOGNITION; AXL; PHOSPHATIDYLSERINE; ADHESION; MACROPHAGES	Apoptosis is fundamental to the development and maintenance of animal tissues and the immune system(1). Rapid clearance of apoptotic cells by macrophages is important to inhibit inflammation and autoimmune responses against intracellular antigens(2-4). Here we report a new function for Mer, a member of the Axl/Mer/ Tyro3 receptor tyrosine kinase family. mer(kd) mice with a cytoplasmic truncation of Mer had macrophages deficient in the clearance of apoptotic thymocytes. This was corrected in chimaeric mice reconstituted with bone marrow from wild-type animals. Primary macrophages isolated from mer(kd) mice showed that the phagocytic deficiency was restricted to apoptotic cells and was independent of Fc receptor-mediated phagocytosis or ingestion of other particles. The inability to clear apoptotic cells adequately may be linked to an increased number of nuclear autoantibodies in mer(kd) mice. Thus, the Mer receptor tyrosine kinase seems to be critical for the engulfment and efficient clearance of apoptotic cells. This has implications for inflammation and autoimmune diseases such as systemic lupus erythematosus.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Oral Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Comprehens Ctr Inflammatory Disorders, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; Alphavax Human Vaccines, Durham, NC 27701 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania	Matsushima, GK (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.		Ariel, Pablo/AGJ-4118-2022					AGUILAR LK, 1994, J IMMUNOL, V152, P2645; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Casiano CA, 1996, INT ARCH ALLERGY IMM, V111, P308, DOI 10.1159/000237385; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; EISENBERG RA, 1982, J IMMUNOL, V129, P2146; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; GRAHAM DK, 1995, ONCOGENE, V10, P2349; HSU SM, 1983, J HISTOCHEM CYTOCHEM, V31, P538, DOI 10.1177/31.4.6827084; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; LAI C, 1994, ONCOGENE, V9, P2567; Licht R, 1999, J IMMUNOL METHODS, V223, P237, DOI 10.1016/S0022-1759(98)00212-9; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; McCloskey P, 1997, J BIOL CHEM, V272, P23285, DOI 10.1074/jbc.272.37.23285; MERVORACH D, 1998, J EXP MED, V188, P387; MERYHEW NL, 1991, J LAB CLIN MED, V117, P181; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Stern M, 1996, AM J PATHOL, V149, P911; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359	30	872	904	1	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					207	211		10.1038/35075603	http://dx.doi.org/10.1038/35075603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346799				2022-12-28	WOS:000168563000054
J	Mao, HK; Xu, J; Struzhkin, VV; Shu, J; Hemley, RJ; Sturhahn, W; Hu, MY; Alp, EE; Vocadlo, L; Alfe, D; Price, GD; Gillan, MJ; Schwoerer-Bohning, M; Hausermann, D; Eng, P; Shen, G; Giefers, H; Lubbers, R; Wortmann, G				Mao, HK; Xu, J; Struzhkin, VV; Shu, J; Hemley, RJ; Sturhahn, W; Hu, MY; Alp, EE; Vocadlo, L; Alfe, D; Price, GD; Gillan, MJ; Schwoerer-Bohning, M; Hausermann, D; Eng, P; Shen, G; Giefers, H; Lubbers, R; Wortmann, G			Phonon density of states of iron up to 153 gigapascals	SCIENCE			English	Article							EARTHS INNER-CORE; NUCLEAR RESONANT SCATTERING; HIGH-PRESSURE; ELASTIC-CONSTANTS; LIQUID-IRON; ALPHA-IRON; TEMPERATURES; ROTATION; MODEL	We report phonon densities of states (DOS) of iron measured by nuclear resonant inelastic x-ray scattering to 153 gigapascals and calculated from ab initio theory. Qualitatively, they are in agreement, but the theory predicts density at higher energies. From the DOS, we derive elastic and thermodynamic parameters of iron, including shear modulus, compressional and shear velocities, heat capacity, entropy, kinetic energy, zero-point energy, and Debye temperature. In comparison to the compressional and shear velocities from the preliminary reference Earth model (PREM) seismic model, our results suggest that Earth's inner core has a mean atomic number equal to or higher than pure iron, which is consistent with an iron-nickel alloy.	Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; Carnegie Inst Washington, Ctr High Pressure Res, Washington, DC 20015 USA; Adv Photon Source, Argonne, IL 60439 USA; UCL, London WC1E 6BT, England; Univ Chicago, Consortium Adv Radiat Sources, Chicago, IL 60637 USA; Univ Paderborn, Fachbereich Phys, D-33095 Paderborn, Germany; High Pressure Collaborat Access Team, Adv Photon Source, Argonne, IL 60439 USA	Carnegie Institution for Science; Carnegie Institution for Science; United States Department of Energy (DOE); Argonne National Laboratory; University of London; University College London; University of Chicago; University of Paderborn; United States Department of Energy (DOE); Argonne National Laboratory	Mao, HK (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.		Hu, Michael Y./C-7571-2013; Shen, Guoyin/D-6527-2011; Vocadlo, Lidunka/C-4197-2008; Alfe`, Dario/C-1521-2008; Price, Geoffrey D/C-1545-2008; Gillan, Michael J/C-2130-2008; Struzhkin, Viktor V/J-9847-2013; Eng, Peter/ABA-8842-2021	Hu, Michael Y./0000-0002-3718-7169; Shen, Guoyin/0000-0001-5146-1147; Alfe`, Dario/0000-0002-9741-8678; Price, Geoffrey D/0000-0001-8232-6853; Struzhkin, Viktor V/0000-0002-3468-0548; Eng, Peter/0000-0002-8072-3203; Vocadlo, Lidunka/0000-0002-2577-0277				ANDERSON OL, 1995, REV GEOPHYS, V33, P429, DOI 10.1029/95RG00877; BLOCHL PE, 1994, PHYS REV B, V50, P17, DOI DOI 10.1103/PHYSREVB.50.17953); BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; CHEN GQ, 1995, GEOPHYS RES LETT, V22, P21, DOI 10.1029/94GL02892; de Wijs GA, 1998, NATURE, V392, P805, DOI 10.1038/33905; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Glatzmaier GA, 1996, SCIENCE, V274, P1887, DOI 10.1126/science.274.5294.1887; GLAZKOV VP, 1988, JETP LETT, V47, P561; GUINAN MW, 1968, J PHYS CHEM SOLIDS, V29, P541, DOI 10.1016/0022-3697(68)90131-5; Hemley RJ, 1997, SCIENCE, V276, P1242, DOI 10.1126/science.276.5316.1242; Hu MY, 1999, NUCL INSTRUM METH A, V428, P551, DOI 10.1016/S0168-9002(99)00134-5; JEPHCOAT A, 1987, NATURE, V325, P332, DOI 10.1038/325332a0; JEPHCOAT AP, 1986, J GEOPHYS RES-SOLID, V91, P4677, DOI 10.1029/JB091iB05p04677; Kresse G., 1996, PHYS REV B, V54, P11169; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Ladbury R, 1996, PHYS TODAY, V49, P17; Lubbers R, 2000, SCIENCE, V287, P1250, DOI 10.1126/science.287.5456.1250; LUBBERS R, UNPUB; Mao HK, 1998, NATURE, V396, P741, DOI 10.1038/25506; MAO HK, 1978, J APPL PHYS, V49, P3276, DOI 10.1063/1.325277; MAO HK, 1990, J GEOPHYS RES, V95, P21; Merkel S, 2000, SCIENCE, V288, P1626, DOI 10.1126/science.288.5471.1626; POIRIER JP, 2000, INTRO PHYSICS EARTH; SETO M, 1995, PHYS REV LETT, V74, P3828, DOI 10.1103/PhysRevLett.74.3828; Simmons G., 1971, SINGLE CRYSTAL ELAST; Song XD, 1998, SCIENCE, V282, P924, DOI 10.1126/science.282.5390.924; Steinle-Neumann G, 1999, PHYS REV B, V60, P791, DOI 10.1103/PhysRevB.60.791; STIXRUDE L, 1995, SCIENCE, V267, P1972, DOI 10.1126/science.267.5206.1972; Stixrude L., 1997, J GEOPHYS RES, V102, P24; STURHAHN W, 1995, PHYS REV LETT, V74, P3832, DOI 10.1103/PhysRevLett.74.3832; Su WJ, 1996, SCIENCE, V274, P1883, DOI 10.1126/science.274.5294.1883; Vocadlo L, 2000, PHYS EARTH PLANET IN, V117, P123, DOI 10.1016/S0031-9201(99)00092-8; Vocadlo L, 1999, GEOPHYS RES LETT, V26, P1231, DOI 10.1029/1999GL900214; Wasserman E, 1996, PHYS REV B, V53, P8296, DOI 10.1103/PhysRevB.53.8296; Wenk HR, 2000, NATURE, V405, P1044, DOI 10.1038/35016558; YOO CS, 1993, PHYS REV LETT, V70, P3931, DOI 10.1103/PhysRevLett.70.3931	36	239	245	8	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					914	916		10.1126/science.1057670	http://dx.doi.org/10.1126/science.1057670			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340201				2022-12-28	WOS:000168514900039
J	Exner, DV; Dries, DL; Domanski, MJ; Cohn, JN				Exner, DV; Dries, DL; Domanski, MJ; Cohn, JN			Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDIVIDUAL-RESPONSES; RACIAL-DIFFERENCES; MORTALITY; MORBIDITY; BLOCKER	Background: Black patients with heart failure have a poorer prognosis than white patients, a difference that has not been adequately explained. Whether racial differences in the response to drug treatment contribute to differences in outcome is unclear. To address this issue, we pooled and analyzed data from the Studies of Left Ventricular Dysfunction (SOLVD) prevention and treatment trials, two large, randomized trials comparing enalapril with placebo in patients with left ventricular dysfunction. Methods: We used a matched-cohort design in which up to four white patients were matched with each black patient according to trial, treatment assignment, sex, left ventricular ejection fraction, and age. A total of 1196 white patients (580 from the prevention trial and 616 from the treatment trial) were matched with 800 black patients (404 from the prevention trial and 396 from the treatment trial). The average duration of follow-up was 35 months in the prevention trial and 33 months in the treatment trial. Results: The black patients and the matched white patients had similar demographic and clinical characteristics, but the black patients had higher rates of death from any cause (12.2 vs. 9.7 per 100 person-years) and of hospitalization for heart failure (13.2 vs. 7.7 per 100 person-years). Despite similar doses of drug in the two groups, enalapril therapy, as compared with placebo, was associated with a 44 percent reduction (95 percent confidence interval, 27 to 57 percent) in the risk of hospitalization for heart failure among the white patients (P<0.001) but with no significant reduction among black patients (P=0.74). At one year, enalapril therapy was associated with significant reductions from base line in systolic blood pressure (by a mean [+/-SD] of 5.0+/-17.1 mm Hg) and diastolic blood pressure (3.6+/-10.6 mm Hg) among the white patients, but not among the black patients. No significant change in the risk of death was observed in association with enalapril therapy in either group. Conclusions: Enalapril therapy is associated with a significant reduction in the risk of hospitalization for heart failure among white patients with left ventricular dysfunction, but not among similar black patients. This finding underscores the need for additional research on the efficacy of therapies for heart failure in black patients. (N Engl J Med 2001;344:1351-7.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calgary, Cardiovasc Res Grp, Calgary, AB T2N 4N1, Canada; Univ Texas, SW Med Sch, CArdiovasc Res Grp, Dallas, TX USA; NHLBI, Clin Trials Res Grp, Bethesda, MD 20892 USA; Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA	University of Calgary; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities	Exner, DV (corresponding author), Univ Calgary, Cardiovasc Res Grp, 3330 Hosp Dr NW,Rm G208, Calgary, AB T2N 4N1, Canada.	exner@ucalgary.ca	E, D/AAH-1638-2020					Adams KF, 1999, J CARD FAIL, V5, P357; Baruch L, 1999, CIRCULATION, V99, P2658, DOI 10.1161/01.CIR.99.20.2658; BASSETT DR, 1992, AM J HYPERTENS, V5, P781, DOI 10.1093/ajh/5.11.781; BIDIVILLE J, 1988, HYPERTENSION, V11, P166, DOI 10.1161/01.HYP.11.2.166; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; CASE DB, 1977, NEW ENGL J MED, V296, P641, DOI 10.1056/NEJM197703242961201; CODY RJ, 1983, HYPERTENSION, V5, P36; Cohen M, 2000, CIRCULATION, V102, P854; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COX DR, 1972, J R STAT SOC B, V34, P187; DONNELLY R, 1990, HYPERTENSION, V15, P301, DOI 10.1161/01.HYP.15.3.301; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1999, NEW ENGL J MED, V341, P298; GAVRAS H, 1981, LANCET, V2, P543; Hjalmarson A, 1999, LANCET, V353, P2001; LANG CC, 1995, NEW ENGL J MED, V333, P155, DOI 10.1056/NEJM199507203330304; LASKY T, 1994, EPIDEMIOL REV, V16, P6, DOI 10.1093/oxfordjournals.epirev.a036145; Lechat P, 1999, LANCET, V353, P9; LEVINE TB, 1982, AM HEART J, V104, P1159, DOI 10.1016/0002-8703(82)90045-X; MCDONALD KM, 1995, CIRCULATION, V91, P2043, DOI 10.1161/01.CIR.91.7.2043; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Packer M, 1999, AM J CARDIOL, V83, p1A; Preston RA, 1998, JAMA-J AM MED ASSOC, V280, P1168, DOI 10.1001/jama.280.13.1168; SAUNDERS E, 1990, ARCH INTERN MED, V150, P1707, DOI 10.1001/archinte.150.8.1707; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]	30	379	395	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1351	1357		10.1056/NEJM200105033441802	http://dx.doi.org/10.1056/NEJM200105033441802			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333991	Bronze			2022-12-28	WOS:000168413500002
J	Ennen, MP				Ennen, MP			The war for talent: Physicians in management consulting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Ennen, MP (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Beedham T, 1996, BRIT J HOSP MED, V55, P699; Donelan K, 1997, HEALTH AFFAIR, V16, P139, DOI 10.1377/hlthaff.16.5.139; LEONHARDT D, 2000, NY TIMES        1001; PROCTOR J, 2001, MED SCH DEBT MAK SEN; 2001, FROGS WHEELBARROW	5	0	0	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2252	2252		10.1001/jama.285.17.2252	http://dx.doi.org/10.1001/jama.285.17.2252			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325333	Bronze			2022-12-28	WOS:000168256100033
J	Irwin, RS; Madison, JM				Irwin, RS; Madison, JM			Symptom research on chronic cough: A historical perspective	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC PERSISTENT COUGH; SOLE PRESENTING MANIFESTATION; EOSINOPHILIC BRONCHITIS; DIAGNOSTIC EVALUATION; KEY COMPONENTS; FREQUENCY; SPECTRUM; DYSPNEA; DISEASE	This review provides a perspective on how research on the management of cough has evolved, looks at key methodologic lessons that have been learned from this research and how they may relate to the management of other symptoms, identifies important methodologic challenges that remain to be solved, and lists important questions that still need to be answered. Three important methodologic lessons have been learned. First, cough must be evaluated systematically and according to a neuroanatomic framework. Second, the response to specific therapy must be noted to determine the cause or causes of cough and to characterize the strengths and limitations of diagnostic testing. Third, multiple conditions can simultaneously cause cough. Among the three methodologic challenges that still need to be solved are 1) definitively determining the diagnostic accuracy and reliability of 24- hour esophageal pH monitoring and how best to interpret pH test results, 2) definitively determining the role of nonacid reflux in cough due to gastroesophageal reflux disease, and 3) developing reliable and reproducible subjective and objective methods with which to assess the efficacy of cough therapy. Numerous important clinical questions are still unanswered: What role do empirical therapeutic trials play in diagnosing the cause of chronic cough? What is the most cost-effective approach to the diagnosis and treatment of chronic cough: empirical therapeutic trials or laboratory testing-directed therapeutic trials? How often is environmental air pollution, unrelated to allergies or smoking, responsible for chronic cough?	Univ Massachusetts, Sch Med, Div Pulm Allergy & Crit Care Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Irwin, RS (corresponding author), Univ Massachusetts, Sch Med, Div Pulm Allergy & Crit Care Med, 55 Lake Ave N, Worcester, MA 01655 USA.	irwinr@ummhc.org						Brightling CE, 1999, AM J RESP CRIT CARE, V160, P406, DOI 10.1164/ajrccm.160.2.9810100; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; GIBSON PG, 1989, LANCET, V1, P1346; GLAUSER FL, 1972, ANN ALLERGY, V30, P457; HOFFSTEIN V, 1994, CAN RESPIR J, V1, P40; ING AJ, 1994, AM J RESP CRIT CARE, V149, P160, DOI 10.1164/ajrccm.149.1.8111576; Irwin Richard S., 2000, American Journal of Medicine, V108, p126S; Irwin RS, 1999, AM J GASTROENTEROL, V94, P3095, DOI 10.1111/j.1572-0241.1999.03095.x; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; IRWIN RS, 1977, ARCH INTERN MED, V137, P1186, DOI 10.1001/archinte.137.9.1186; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; IRWIN RS, 1997, DIAGNOSIS TREATMENT, P1; LOUDEN RK, 1967, PROGRAMMING IBM 1130, P41; Marchesani F, 1998, Monaldi Arch Chest Dis, V53, P510; MCFADDEN ER, 1975, NEW ENGL J MED, V292, P555, DOI 10.1056/NEJM197503132921103; Mello CJ, 1996, ARCH INTERN MED, V156, P997, DOI 10.1001/archinte.156.9.997; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; POE RH, 1989, CHEST, V95, P723, DOI 10.1378/chest.95.4.723; POE RH, 1982, AM REV RESPIR DIS, V126, P160; POWER JT, 1984, AM REV RESPIR DIS, V130, P999; PRATTER MR, 1993, ANN INTERN MED, V119, P977, DOI 10.7326/0003-4819-119-10-199311150-00003; PRATTER MR, 1989, ARCH INTERN MED, V149, P2277, DOI 10.1001/archinte.149.10.2277; SCHAPPERT SM, 1993, ADV DATA, P1; SMYRNIOS NA, 1995, CHEST, V108, P991, DOI 10.1378/chest.108.4.991; Smyrnios NA, 1998, ARCH INTERN MED, V158, P1222, DOI 10.1001/archinte.158.11.1222; Stansell JD, 1997, AM J RESP CRIT CARE, V155, P60, DOI 10.1164/ajrccm.155.1.9001290; Wang HD, 1998, CHEST, V114, P1496, DOI 10.1378/chest.114.5.1496-a	31	14	15	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			809	814		10.7326/0003-4819-134-9_Part_2-200105011-00003	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346315				2022-12-28	WOS:000168543100003
J	Conway, JF; Wikoff, WR; Cheng, N; Duda, RL; Hendrix, RW; Johnson, JE; Steven, AC				Conway, JF; Wikoff, WR; Cheng, N; Duda, RL; Hendrix, RW; Johnson, JE; Steven, AC			Virus maturation involving large subunit rotations and local refolding	SCIENCE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; DOUBLE-STRANDED-RNA; STRUCTURAL TRANSITIONS; CAPSID PROTEIN; DENSITY MAPS; BACTERIOPHAGE-T4; BINDING; STATES; VISUALIZATION; RESOLUTION	Large-scale conformational changes transform viral precursors into infectious virions. The structure of bacteriophage HK97 capsid, Head-II, was recently solved by crystallography, revealing a catenated cross-linked topology. We have visualized its precursor, Prohead-II, by cryoelectron microscopy and modeled the conformational change by appropriately adapting Head-II. Rigid-body rotations (similar to 40 degrees) cause switching to an entirely different set of interactions; in addition, two motifs undergo refolding. These changes stabilize the capsid by increasing the surface area buried at interfaces and bringing the cross-link-forming residues, initially similar to 40 angstroms apart, close together. The inner surface of Prohead-II is negatively charged, suggesting that the transition is triggered electrostatically by DNA packaging.	NIAMSD, Struct Biol Res Lab, Bethesda, MD 20892 USA; Inst Biol Struct JP Ebel, F-38027 Grenoble, France; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Steven, AC (corresponding author), NIH, Bldg 6,Room B2-34,6 Ctr Dr MSC 2717, Bethesda, MD 20892 USA.		Conway, James F/A-2296-2010	Conway, James F/0000-0002-6581-4748; Duda, Robert/0000-0002-9517-2731	NIAID NIH HHS [R01 AI040101, AI40101] Funding Source: Medline; NIGMS NIH HHS [R01 GM47795, R01 GM047795] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047795] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Canady MA, 2000, J MOL BIOL, V299, P573, DOI 10.1006/jmbi.2000.3723; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; FRICKS CE, 1990, J VIROL, V64, P1934, DOI 10.1128/JVI.64.5.1934-1945.1990; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Hendrix RW, 1998, ADV VIRUS RES, V50, P235, DOI 10.1016/S0065-3527(08)60810-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; KING J, 1997, STRUCTURAL BIOL VIRU, P288; KISTLER J, 1978, J MOL BIOL, V126, P571, DOI 10.1016/0022-2836(78)90059-1; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ROSS PD, 1985, J MOL BIOL, V183, P353, DOI 10.1016/0022-2836(85)90006-3; ROSSMANN MG, 1985, VIRUS STRUCTURE ASSE, P29; Schumacher MA, 2000, J MOL BIOL, V298, P875, DOI 10.1006/jmbi.2000.3753; SIMON LD, 1972, P NATL ACAD SCI USA, V69, P907, DOI 10.1073/pnas.69.4.907; STEVEN AC, 1991, J STRUCT BIOL, V106, P221, DOI 10.1016/1047-8477(91)90072-5; STEVEN AC, 1990, BIOCHEMISTRY-US, V29, P5556, DOI 10.1021/bi00475a020; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; Tuma R, 1996, BIOCHEMISTRY-US, V35, P4619, DOI 10.1021/bi952793l; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang ZX, 2000, J MOL BIOL, V297, P615, DOI 10.1006/jmbi.2000.3601	33	167	172	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					744	748		10.1126/science.1058069	http://dx.doi.org/10.1126/science.1058069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326105				2022-12-28	WOS:000168478300057
J	Hurley, SM; Castleman, AW				Hurley, SM; Castleman, AW			Laser chemistry - Keeping reactions under quantum control	SCIENCE			English	Editorial Material							COHERENT CONTROL; DYNAMICS		Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hurley, SM (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	awc@psu.edu						Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Gordon RJ, 1999, ACCOUNTS CHEM RES, V32, P1007, DOI 10.1021/ar970119l; Hornung T, 2000, APPL PHYS B-LASERS O, V71, P277, DOI 10.1007/s003400000346; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Larsen JJ, 1999, PHYS REV LETT, V83, P1123, DOI 10.1103/PhysRevLett.83.1123; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; PURNELL J, 1994, CHEM PHYS LETT, V229, P333, DOI 10.1016/0009-2614(94)01145-1; Rabitz H, 2000, ACCOUNTS CHEM RES, V33, P572, DOI 10.1021/ar990054h; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Shah SP, 2000, J CHEM PHYS, V113, P6536, DOI 10.1063/1.1311615; Shapiro M, 2000, ADV ATOM MOL OPT PHY, V42, P287, DOI 10.1016/S1049-250X(08)60189-5; SHI SH, 1992, J CHEM PHYS, V97, P276, DOI 10.1063/1.463626; Uberna R, 1999, FARADAY DISCUSS, V113, P385, DOI 10.1039/a901679a; Zewail AH, 2000, ANGEW CHEM INT EDIT, V39, P2587	16	10	10	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					648	649		10.1126/science.1060883	http://dx.doi.org/10.1126/science.1060883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330323				2022-12-28	WOS:000168478300030
J	Ryerson, TB; Trainer, M; Holloway, JS; Parrish, DD; Huey, LG; Sueper, DT; Frost, GJ; Donnelly, SG; Schauffler, S; Atlas, EL; Kuster, WC; Goldan, PD; Hubler, G; Meagher, JF; Fehsenfeld, FC				Ryerson, TB; Trainer, M; Holloway, JS; Parrish, DD; Huey, LG; Sueper, DT; Frost, GJ; Donnelly, SG; Schauffler, S; Atlas, EL; Kuster, WC; Goldan, PD; Hubler, G; Meagher, JF; Fehsenfeld, FC			Observations of ozone formation in power plant plumes and implications for ozone control strategies	SCIENCE			English	Article							UNITED-STATES; EMISSIONS; HYDROCARBONS; TROPOSPHERE; NO2; POLLUTION; CHEMISTRY; ATLANTA; MODELS; O-3	Data taken in aircraft transects of emissions plumes from rural U.S. coal-fired power plants were used to confirm and quantify the nonlinear dependence of tropospheric ozone formation on plume NOx (NO plus NO2) concentration, which is determined by plant NOx emission rate and atmospheric dispersion. The ambient availability of reactive volatile organic compounds, principally biogenic isoprene, was also found to modulate ozone production rate and yield in these rural plumes. Differences of a factor of 2 or greater in plume ozone formation rates and yields as a function of NOx and volatile organic compound concentrations were consistently observed. These large differences suggest that consideration of power plant NOx emission rates and geographic locations in current and future U.S. ozone control strategies could substantially enhance the efficacy of NOx reductions from these sources.	NOAA, Aeron Lab, Boulder, CO 80303 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Natl Ctr Atmospher Res, Div Atmospher Chem, Boulder, CO 80307 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University System of Georgia; Georgia Institute of Technology; National Center Atmospheric Research (NCAR) - USA	Ryerson, TB (corresponding author), NOAA, Aeron Lab, 325 Broadway, Boulder, CO 80303 USA.		Ryerson, Thomas/C-9611-2009; Fehsenfeld, Frederick C/I-4876-2013; Frost, Gregory J/I-1958-2013; Atlas, Elliot/AAE-4605-2021; Trainer, Michael/H-5168-2013; Parrish, David/E-8957-2010; Hübler, Gerhard/E-9780-2010; Kuster, William C/E-7421-2010; Atlas, Elliot/J-8171-2015; Ryerson, Tom/AAA-8399-2021; Holloway, John S/F-9911-2012	Ryerson, Thomas/0000-0003-2800-7581; Trainer, Michael/0000-0002-1668-2961; Parrish, David/0000-0001-6312-2724; Kuster, William C/0000-0002-8788-8588; Holloway, John S/0000-0002-4585-9594; Atlas, Elliot/0000-0003-3847-5346				Chameides WL, 1997, SCIENCE, V276, P916, DOI 10.1126/science.276.5314.916; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; CRUTZEN PJ, 1979, ANNU REV EARTH PL SC, V7, P443, DOI 10.1146/annurev.ea.07.050179.002303; FAHEY DW, 1986, J GEOPHYS RES-ATMOS, V91, P9781, DOI 10.1029/JD091iD09p09781; Fiore AM, 1998, J GEOPHYS RES-ATMOS, V103, P1471, DOI 10.1029/97JD03036; GERON CD, 1994, J GEOPHYS RES-ATMOS, V99, P12773, DOI 10.1029/94JD00246; Gillani NV, 1996, ATMOS ENVIRON, V30, P2043, DOI 10.1016/1352-2310(95)00201-4; Goldan PD, 2000, J GEOPHYS RES-ATMOS, V105, P9091, DOI 10.1029/1999JD900429; HAAGENSMIT AJ, 1952, IND ENG CHEM, V44, P1342, DOI 10.1021/ie50510a045; Jacob DJ, 1996, J GEOPHYS RES-ATMOS, V101, P24235, DOI 10.1029/96JD00336; LIU SC, 1987, J GEOPHYS RES-ATMOS, V92, P4191, DOI 10.1029/JD092iD04p04191; MILLER DF, 1978, SCIENCE, V202, P1186, DOI 10.1126/science.202.4373.1186; National Academy of Sciences, 1991, RETH OZ PROBL URB RE; PARRISH DD, 1993, J GEOPHYS RES-ATMOS, V98, P2927, DOI 10.1029/92JD02384; PARRISH DD, 1993, SCIENCE, V259, P1436, DOI 10.1126/science.259.5100.1436; PLEIM JE, 1991, J GEOPHYS RES-ATMOS, V96, P3065, DOI 10.1029/90JD02026; Ryerson TB, 2000, J GEOPHYS RES-ATMOS, V105, P26447, DOI 10.1029/2000JD900389; Ryerson TB, 1998, J GEOPHYS RES-ATMOS, V103, P22569, DOI 10.1029/98JD01620; St John JC, 2000, J GEOPHYS RES-ATMOS, V105, P9203, DOI 10.1029/1999JD901020; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; TRAINER M, 1995, J GEOPHYS RES-ATMOS, V100, P18823, DOI 10.1029/95JD01641; *US EPA, 2000, 454R00003 EPA; WHITE WH, 1976, SCIENCE, V194, P187, DOI 10.1126/science.959846; WOFSY SC, 1994, J GEOPHYS RES-ATMOS, V99, P1887, DOI 10.1029/93JD02256	24	214	228	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					719	723		10.1126/science.1058113	http://dx.doi.org/10.1126/science.1058113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326097				2022-12-28	WOS:000168478300049
J	Schumacher, MA; Rivard, AF; Bachinger, HP; Adelman, JP				Schumacher, MA; Rivard, AF; Bachinger, HP; Adelman, JP			Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; PEPTIDE COMPLEX; CALMODULIN; RECOGNITION; SOFTWARE; PROGRAM; PORE; NMR	Small-conductance Ca2+-activated K+ channels (SK channels)(1,2) are independent of voltage and gated solely by intracellular Ca2+. These membrane channels are heteromeric complexes that comprise pore-forming a-subunits and the Ca2+-binding protein calmodulin (CaM). CaM binds to the SK channel through the CaM-binding domain (CaMBD), which is located in an intracellular region of the a-subunit immediately carboxy-terminal to the pore(3,4). Channel opening is triggered when Ca2+ binds the EF hands in the N-lobe of CaM4. Here we report the 1.60 Angstrom crystal structure of the SK channel CaMBD/Ca2+/CaM complex. The CaMBD forms an elongated dimer with a CaM molecule bound at each end; each CaM wraps around three alpha -helices, two from one CaMBD subunit and one from the other. As only the CaM N-lobe has bound Ca2+, the structure provides a view of both calcium-dependent and -independent CaM/protein interactions. Together with biochemical data, the structure suggests a possible gating mechanism for the SK channel.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Shriners Hosp Children, Res Unit, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Schumacher, MA (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.							BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELHORST B, 1999, BIOCHEMISTRY-US, V38, P12320; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; FRAGIONI JV, 1993, ANAL BIOCHEM, V210, P179; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IKURA M, 1992, CELL CALCIUM, V13, P391, DOI 10.1016/0143-4160(92)90052-T; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OSAVA M, 1999, NAT STRUCT BIOL, V6, P819; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	30	476	488	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1120	1124		10.1038/35074145	http://dx.doi.org/10.1038/35074145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323678				2022-12-28	WOS:000168285500054
J	Walkup, JT; Labellarte, MJ; Riddle, MA; Pine, DS; Greenhill, L; Klein, R; Davies, M; Sweeney, M; Abikoff, H; Hack, S; Klee, B; McCracken, J; Bergman, L; Piacentini, J; March, J; Compton, S; Robinson, J; O'Hara, T; Baker, S; Vitiello, B; Ritz, LA; Roper, M				Walkup, JT; Labellarte, MJ; Riddle, MA; Pine, DS; Greenhill, L; Klein, R; Davies, M; Sweeney, M; Abikoff, H; Hack, S; Klee, B; McCracken, J; Bergman, L; Piacentini, J; March, J; Compton, S; Robinson, J; O'Hara, T; Baker, S; Vitiello, B; Ritz, LA; Roper, M		Res Unit Pediat Psychopharmacology	Fluvoxamine for the treatment of anxiety disorders in children and adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; MEDICAL LITERATURE; USERS GUIDES; FLUOXETINE; SCALE; RELIABILITY; PREVENTION; DEPRESSION; SERTRALINE; SCHEDULE	Background: Drugs that selectively inhibit serotonin reuptake are effective treatments for adults with mood and anxiety disorders, but limited data are available on the safety and efficacy of serotonin-reuptake inhibitors in children with anxiety disorders. Methods: We studied 128 children who were 6 to 17 years of age; who met the criteria for social phobia, separation anxiety disorder, or generalized anxiety disorder; and who had received psychological treatment for three weeks without improvement. The children were randomly assigned to receive fluvoxamine (at a maximum of 300 mg per day) or placebo for eight weeks and were evaluated with rating scales designed to assess the degree of anxiety and impairment. Results: Children in the fluvoxamine group had a mean (+/-SD) decrease of 9.7+/-6.9 points in symptoms of anxiety on the Pediatric Anxiety Rating Scale (range of possible scores, 0 to 25, with higher scores indicating greater anxiety), as compared with a decrease of 3.1+/-4.8 points among children in the placebo group (P<0.001). On the Clinical Global Impressions-Improvement scale, 48 of 63 children in the fluvoxamine group (76 percent) had a response to the treatment, as indicated by a score of less than 4, as compared with 19 of 65 children in the placebo group (29 percent, P<0.001). Five children in the fluvoxamine group (8 percent) discontinued treatment because of adverse events, as compared with one child in the placebo group (2 percent). Conclusions: Fluvoxamine is an effective treatment for children and adolescents with social phobia, separation anxiety disorder, or generalized anxiety disorder. (N Engl J Med 2001;344:1279-85.) Copyright (C) 2001 Massachusetts Medical Society.	NIMH, Intramural Res Program, Program Mood & Anxiety Disorders, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; Columbia Univ, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; NYU, New York, NY USA; Univ Calif Los Angeles, Los Angeles, CA USA; Duke Univ, Durham, NC 27706 USA; Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Columbia University; New York State Psychiatry Institute; New York University; University of California System; University of California Los Angeles; Duke University; Nathan Kline Institute for Psychiatric Research	Pine, DS (corresponding author), NIMH, Intramural Res Program, Program Mood & Anxiety Disorders, Bldg 10,Rm 4N-222,MSC-1381, Bethesda, MD 20892 USA.	daniel.pine@nih.gov	Piacentini, John/C-4645-2011; Compton, Scott/A-6656-2011; Pine, Daniel/Z-1601-2019; Vitiello, Benedetto/AAC-1758-2022		NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH070010, N01MH060005, N01MH060016] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABIKOFF H, 1985, ARCH GEN PSYCHIAT, V42, P953; Azmitia EC, 1999, NEUROPSYCHOPHARMACOL, V21, pS33; BIRMAHER B, 1994, J AM ACAD CHILD PSY, V33, P993, DOI 10.1097/00004583-199409000-00009; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coplan JD, 1998, ARCH GEN PSYCHIAT, V55, P473, DOI 10.1001/archpsyc.55.5.473; Costello EJ, 1999, J AM ACAD CHILD PSY, V38, P121, DOI 10.1097/00004583-199902000-00010; COSTELLO EJ, 1990, ACTA PSYCHIAT SCAND, V81, P523, DOI 10.1111/j.1600-0447.1990.tb05492.x; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Emslie GJ, 1999, J AM ACAD CHILD PSY, V38, P517, DOI 10.1097/00004583-199905000-00013; Fairbanks JM, 1997, J CHILD ADOL PSYCHOP, V7, P17, DOI 10.1089/cap.1997.7.17; Francis DD, 1999, BIOL PSYCHIAT, V46, P1153, DOI 10.1016/S0006-3223(99)00237-1; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; GRAAE F, 1994, J AM ACAD CHILD PSY, V33, P372, DOI 10.1097/00004583-199403000-00011; Greenhill LL, 1998, PSYCHOPHARMACOL BULL, V34, P155; GREIST JH, 1995, ARCH GEN PSYCHIAT, V52, P53; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hansen C, 1998, J CLIN CHILD PSYCHOL, V27, P246, DOI 10.1207/s15374424jccp2703_2; IALONGO N, 1995, J CHILD PSYCHOL PSYC, V36, P427, DOI 10.1111/j.1469-7610.1995.tb01300.x; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; JOLLY JB, 1994, J AM ACAD CHILD PSY, V33, P1284, DOI 10.1097/00004583-199411000-00009; KAUFMAN AS, 1987, KAUFMAN BRIEF INTELL; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kendall PC, 1998, J CONSULT CLIN PSYCH, V66, P3, DOI 10.1037/0022-006X.66.1.3; KLEIN RG, 1992, J AM ACAD CHILD PSY, V31, P21, DOI 10.1097/00004583-199201000-00005; KLEIN RG, IN PRESS CHILD AEOLE; Labellarte MJ, 1999, BIOL PSYCHIAT, V46, P1567, DOI 10.1016/S0006-3223(99)00248-6; Ladd CO, 2000, PROG BRAIN RES, V122, P81; Last CG, 1998, J AM ACAD CHILD PSY, V37, P404, DOI 10.1097/00004583-199804000-00018; Liebowitz MR, 1999, J CLIN PSYCHIAT, V60, P22; March JS, 1997, J AM ACAD CHILD PSY, V36, P554, DOI 10.1097/00004583-199704000-00019; March JS, 2000, JAMA-J AM MED ASSOC, V283, P1293; March JS, 1998, JAMA-J AM MED ASSOC, V280, P1752, DOI 10.1001/jama.280.20.1752; Meredith LS, 1997, ARCH FAM MED, V6, P231, DOI 10.1001/archfami.6.3.231; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Norrholm SD, 2000, BRAIN RES, V883, P205, DOI 10.1016/S0006-8993(00)02909-7; Pine Daniel S., 1997, Current Opinion in Pediatrics, V9, P329, DOI 10.1097/00008480-199708000-00006; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shaffer D, 1996, J AM ACAD CHILD PSY, V35, P865, DOI 10.1097/00004583-199607000-00012; Stein M B, 1998, Depress Anxiety, V7, P134, DOI 10.1002/(SICI)1520-6394(1998)7:3<134::AID-DA7>3.0.CO;2-B; WAGNER KD, 1998, SCI P 45 ANN M AM AC; WALKUP J, 1999, SCI P 46 ANN M AM AC; Wegerer V, 1999, J CHILD ADOL PSYCHOP, V9, P13, DOI 10.1089/cap.1999.9.13	47	399	405	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1279	1285		10.1056/NEJM200104263441703	http://dx.doi.org/10.1056/NEJM200104263441703			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	424UM	11323729				2022-12-28	WOS:000168252400003
J	Alamowitch, S; Eliasziw, M; Algra, A; Meldrum, H; Barnett, HJM				Alamowitch, S; Eliasziw, M; Algra, A; Meldrum, H; Barnett, HJM		N Amer Symptomatic Carotid Endarte	Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis	LANCET			English	Article							RECURRENT STROKE; CEREBRAL INFARCTION; COPENHAGEN-STROKE; ISCHEMIC STROKE; ENDARTERECTOMY; PREDICTORS; COMMUNITY; AGE; POPULATION; MORTALITY	Background Carotid endarterectomy benefits patients with symptomatic stenosis of 70-99% in the internal carotid artery, with smaller benefit for 50-69% stenosis. The benefit of carotid endarterectomy in patients of 75 years and older remains unclear. Methods American Symptomatic Carotid Endarterectomy Trial were compared with those aged 65-74 years and less than 65 years for baseline characteristics and risk of ipsilateral ischaemic stroke at 2 years by degree of stenosis and treatment group. Patients aged 75 years pr older from the North Symptomatic Carotid Endarterectomy Trial: were Findings Among patients with 70-99% stenosis, the absolute risk reduction of ipsilateral ischaemic stroke with carotid endarterectomy was 28.9% (95% CI 12.9-44.9) for patients aged 75 years or older (n=71), 15.1% (7.2-23.0) for those aged 65-74 years (n=285), and 9.7% (1.5-17.9) for the youngest group (n=303). Among patients with 50-69% stenosis, the absolute risk reduction was significant only in those of 75 years and older (n=145; 17.3% [6.6-28.0]). The perioperative risk of stroke and death at any degree of stenosis was 5.2% for the oldest group, 5.5% for 65-74 years, and 7.9% for less than 65 years. The number of patients aged 75 years or older needed to treat to prevent one ipsilateral stroke within 2 years was three with 70-99% stenosis and six with 50-69% stenosis. Interpretation In the prevention of ipsilateral ischaemic stroke, elderly patients with 50-99% symptomatic carotid stenosis benefited more from carotid endarterectomy than younger patients did. To achieve this treatment benefit, surgeons must be skilled and patients with other life-threatening illnesses must be excluded.	John P Robarts Res Inst, London, ON N6A 5K8, Canada; Tenon Hosp, Dept Neurol, Paris, France; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Univ Utrecht, Med Ctr, Dept Neurol, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Julius Ctr Gen Practice & Patient Oriented Res, Utrecht, Netherlands	Western University (University of Western Ontario); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Western University (University of Western Ontario); Utrecht University; Utrecht University	Barnett, HJM (corresponding author), John P Robarts Res Inst, 100 Perth Dr,POB 5015, London, ON N6A 5K8, Canada.				NINDS NIH HHS [R01-NS-24456] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024456] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTER M, 1987, NEUROLOGY, V37, P503, DOI 10.1212/WNL.37.3.503; Barnett HJM, 2000, JAMA-J AM MED ASSOC, V283, P1429, DOI 10.1001/jama.283.11.1429; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Di Carlo A, 2000, NEUROLOGY, V54, pS28; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Ferguson GG, 1999, STROKE, V30, P1751, DOI 10.1161/01.STR.30.9.1751; FISHER CM, 1979, ARCH NEUROL-CHICAGO, V36, P65, DOI 10.1001/archneur.1979.00500380035003; FISHER ES, 1989, AM J PUBLIC HEALTH, V79, P1617, DOI 10.2105/AJPH.79.12.1617; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; HIER DB, 1991, STROKE, V22, P155, DOI 10.1161/01.STR.22.2.155; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Inzitari D, 2000, NEUROLOGY, V54, P660, DOI 10.1212/WNL.54.3.660; Jorgensen HS, 1997, NEUROLOGY, V48, P891; KOUDSTAAL PJ, 1993, STROKE, V24, P527; Launer LJ, 2000, NEUROLOGY, V54, pS1; Maxwell JG, 2000, ANN SURG, V231, P781, DOI 10.1097/00000658-200006000-00001; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Petty GW, 1998, NEUROLOGY, V50, P208, DOI 10.1212/WNL.50.1.208; PLECHA FR, 1985, J VASC SURG, V2, P769, DOI 10.1067/mva.1985.avs0020769; Pohjasvaara T, 1997, STROKE, V28, P729, DOI 10.1161/01.STR.28.4.729; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; Schmidt R, 2000, NEUROLOGY, V54, pS34; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; VIITANEN M, 1988, EUR NEUROL, V28, P227, DOI 10.1159/000116272; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	35	148	152	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1154	1160		10.1016/S0140-6736(00)04332-4	http://dx.doi.org/10.1016/S0140-6736(00)04332-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323042				2022-12-28	WOS:000168192100009
J	McConnell, J				McConnell, J			New hope for genital herpes treatment	LANCET			English	News Item														McConnell, John/0000-0002-9928-6568					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1185	1185		10.1016/S0140-6736(00)04392-0	http://dx.doi.org/10.1016/S0140-6736(00)04392-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323056				2022-12-28	WOS:000168192100023
J	Heilbron, JL; Bynum, WF				Heilbron, JL; Bynum, WF			1901 and all that - The last will and testament of Alfred Nobel provides rich pickings.	NATURE			English	Editorial Material									Univ Oxford Worcester Coll, Oxford OX1 2HB, England; UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of Oxford; University of London; University College London	Heilbron, JL (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.								0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					13	16		10.1038/35051137	http://dx.doi.org/10.1038/35051137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343084				2022-12-28	WOS:000166175600011
J	Kenyon, G				Kenyon, G			Major UK cancer research charities to consider merger	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					4	4		10.1038/35051225	http://dx.doi.org/10.1038/35051225			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343077	Bronze			2022-12-28	WOS:000166175600005
J	O'Brien, E; Beevers, G; Lip, GEH				O'Brien, E; Beevers, G; Lip, GEH			ABC of hypertension - Blood pressure measurement - Part IV - Automated sphygmomanometry: self blood pressure measurement	BMJ-BRITISH MEDICAL JOURNAL			English	Review																		*AM NAT STAND EL A, 1987, SP101987 ANSIAAMI, P25; Asmar R, 2000, J HYPERTENS, V18, P493, DOI 10.1097/00004872-200018050-00001; Asmar R, 2000, BLOOD PRESS MONIT, V5, P91; British Hypertension Society, 1998, BLOOD PRESS MEAS CD; Denolle T, 2000, BLOOD PRESS MONIT, V5, P145; *EUR COMM STAND, 1997, EN10603 EUR COMM STA; *EUR COMM STAND, 1996, EN10601 EUR COMM STA; Herpin D, 2000, BLOOD PRESS MONIT, V5, P131; Imai Y, 2000, BLOOD PRESS MONIT, V5, P137; LAHER MS, 1981, IRISH MED J, V74, P113; Mengden T, 2000, BLOOD PRESS MONIT, V5, P111; O'Brien E, 2000, HBK HYPERT, V20, P130; O'Brien E, 2000, BLOOD PRESS MONIT, V5, P93; O'Brien E, 1993, J HYPERTENS S2, V11, pS43; OBRIEN E, 1994, J HUM HYPERTENS, V8, P73; Staessen JA, 2000, BLOOD PRESS MONIT, V5, P101	16	52	54	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2001	322	7295					1167	1170		10.1136/bmj.322.7295.1167	http://dx.doi.org/10.1136/bmj.322.7295.1167			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348915	Green Published			2022-12-28	WOS:000168748900021
J	Pickin, M; Sampson, F; Munro, J; Nicholl, J				Pickin, M; Sampson, F; Munro, J; Nicholl, J			General practitioners' reasons for removing patients from their lists: postal survey in England and Wales	BRITISH MEDICAL JOURNAL			English	Article									Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Pickin, M (corresponding author), Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England.		Nicholl, Jon/B-8257-2008	Sampson, Fiona/0000-0003-2321-0302				Cummings R, 2000, Health Serv J, V110, P26; *HOUS COMM SEL COM, 1999, 2 HOUS COMM SEL COMM; MCDONALD J, 1995, SCOTTISH MED, V15, P10; PERRY J, 1995, REMOVED CARE REPORT; Yamey G, 1999, BRIT MED J, V319, P791, DOI 10.1136/bmj.319.7212.791	5	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1158	1159		10.1136/bmj.322.7295.1158	http://dx.doi.org/10.1136/bmj.322.7295.1158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348911	Green Published, Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000168748900017
J	Barbraud, C; Weimerskirch, H				Barbraud, C; Weimerskirch, H			Emperor penguins and climate change	NATURE			English	Article							SEA-ICE EXTENT; SOUTHERN-OCEAN; APTENODYTES-FORSTERI; MARKED ANIMALS; ANTARCTICA; SURVIVAL; POPULATIONS; TEMPERATURE; TRENDS; WINTER	Variations in ocean-atmosphere coupling over time in the Southern Ocean(1-3) have dominant effects on sea-ice extent and ecosystem structure(4-6), but the ultimate consequences of such environmental changes for large marine predators cannot be accurately predicted because of the absence of long-term data series on key demographic parameters(7,8). Here, we use the longest time series available on demographic parameters of an Antarctic large predator breeding on fast ice(9,10) and relying on food resources from the Southern Ocean(11). We show that over the past 50 years, the population of emperor penguins (Aptenodytes forsteri) in Terre Adelie has declined by 50% because of a decrease in adult survival during the late 1970s. At this time there was a prolonged abnormally warm period with reduced sea-ice extent. Mortality rates increased when warm sea-surface temperatures occurred in the foraging area and when annual sea-ice extent was reduced, and were higher for males than for females. In contrast with survival, emperor penguins hatched fewer eggs when winter sea-ice was extended. These results indicate strong and contrasting effects of large-scale oceanographic processes and sea-ice extent on the demography of emperor penguins, and their potential high susceptibility to climate change.	CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Barbraud, C (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.		Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Barbraud, Christophe/A-5870-2012	Weimerskirch, Henri/0000-0002-0457-586X; Barbraud, Christophe/0000-0003-0146-212X				AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; ANCEL A, 1992, NATURE, V360, P336, DOI 10.1038/360336a0; Cherel Y, 1998, MAR BIOL, V130, P335, DOI 10.1007/s002270050253; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; *ECMWF WCRP, 1993, GLOB ATM DAT ARCH; Furness R. W., 1993, BIRDS MONITORS ENV C; Isenmann P., 1971, Oiseau, V41, P9; JOUVENTIN P, 1974, BIOL PENGUINS, P435; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Kooyman GL, 2000, MAR ECOL PROG SER, V204, P269, DOI 10.3354/meps204269; KUKLA G, 1981, SCIENCE, V214, P497, DOI 10.1126/science.214.4520.497; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEBRETON JD, 1991, BIRD POPULATION STUD, P103; LEMAHO Y, 1977, AM SCI, V65, P680; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; OFFREDO C, 1986, IBIS, V128, P409, DOI 10.1111/j.1474-919X.1986.tb02690.x; Pakhomov EA, 1996, POLAR BIOL, V16, P271, DOI 10.1007/s003000050054; PARKINSON CL, 1994, J GEOPHYS RES-OCEANS, V99, P16327, DOI 10.1029/94JC01146; PREVOST J, 1965, ECOLOGIE MANCHOT EMP; REYNOLDS RW, 1993, J CLIMATE, V6, P114, DOI 10.1175/1520-0442(1993)006<0114:AIRTGS>2.0.CO;2; Siriwardena GM, 1999, IBIS, V141, P621, DOI 10.1111/j.1474-919X.1999.tb07370.x; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Williams T.D., 1995, PENGUINS	29	280	292	14	361	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					183	186		10.1038/35075554	http://dx.doi.org/10.1038/35075554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346792				2022-12-28	WOS:000168563000047
J	Laine, C; Hauck, WW; Gourevitch, MN; Rothman, J; Cohen, A; Turner, BJ				Laine, C; Hauck, WW; Gourevitch, MN; Rothman, J; Cohen, A; Turner, BJ			Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS; METHADONE-MAINTENANCE; SUBSTANCE-ABUSE; COMPLICATIONS; PREDICTORS; PROGRESSION; RETENTION; OUTCOMES; ALCOHOL; DISEASE	Context Patients and the public could benefit from identification of factors that prevent drug users' heavy reliance on inpatient care; however, optimal health care delivery models for illicit drug users remain ill-defined. Objective To evaluate associations of outpatient medical and drug abuse care with drug users' subsequent hospitalization rates. Design and Setting Retrospective cohort study of data from longitudinally linked claims for all ambulatory physician/clinic services and drug abuse services covered by the New York State Medicaid program. Subjects A total of 11 556 human immunodeficiency virus (HIV)-positive and 46687 HIV-negative drug users. Main Outcome Measures Hospitalization in federal fiscal year (FFY) 1997 compared by 4 patterns of care in FFY 1996. regular drug abuse care (greater than or equal to6 months in 1 program), regular medical care (>35% of care from 1 clinic, group practice, or individual physician), both, or neither. Results Hospitalization occurred in 55.6% of HIV-positive and 37.5% of HIV-negative drug users, with a mean of 27.5 and 24.5 inpatient days, respectively. In HIV-positive drug users, the adjusted odds ratio (AOR) for hospitalization was lowest among those with both regular medical and drug abuse care (AOR, 0.76; 95% confidence interval [CI], 0.67-0.85) followed by those with regular medical care alone (AOR, 0.82; 95% CI, 0.74-0.91) and regular drug abuse care alone (AOR, 0.85; 95% CI, 0.76-0.96) vs those with neither. In HIV-negative drug users, the AOR of hospitalization was lower for those with regular medical and drug abuse care (AOR, 0.73; 95% CI, 0.68-0.79), regular drug abuse care alone (AOR, 0.71; 95% CI, 0.66-0.76), and regular medical care (AOR, 0.91; 95% CI, 0.86-0.95) vs those with neither. Both types of care showed favorable effects for all but drug abuse-related hospitalizations. Conclusion Our data indicate that regular drug abuse care with regular medical care for drug users is associated with less subsequent hospitalization.	Univ Penn, Div Gen Internal Med, Sch Med, Philadelphia, PA 19104 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Internal Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Clin Pharmacol, Philadelphia, PA 19107 USA; New York State Dept Hlth, AIDS Inst, Albany, NY USA; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Div Subst Abuse, Bronx, NY 10467 USA	University of Pennsylvania; Jefferson University; Jefferson University; Jefferson University; State University of New York (SUNY) System; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Turner, BJ (corresponding author), Univ Penn, Div Gen Internal Med, Sch Med, 1122 Blockley Hall 6021,423 Guardian Dr, Philadelphia, PA 19104 USA.	bturner@mail.med.upenn.edu	Cohen, Abigail/K-9180-2013	Cohen, Abigail/0000-0002-7425-7218; Gourevitch, Marc/0000-0001-6865-2126	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011606] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA11606] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aszalos R, 1999, J SUBST ABUSE TREAT, V17, P149, DOI 10.1016/S0740-5472(98)00075-0; Ball J.C., 2012, EFFECTIVENESS METHAD; Barnett PG, 1999, ADDICTION, V94, P479, DOI 10.1046/j.1360-0443.1999.9444793.x; BATKI SL, 1996, 11 INT C AIDS JUL 7; Brettle RP, 1996, INT J STD AIDS, V7, P151, DOI 10.1258/0956462961917483; CHERUBIN CE, 1993, ANN INTERN MED, V119, P1017, DOI 10.7326/0003-4819-119-10-199311150-00009; Chou CP, 1998, SUBST USE MISUSE, V33, P2281, DOI 10.3109/10826089809056258; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Etheridge RM, 1999, DRUG ALCOHOL DEPEN, V57, P99, DOI 10.1016/S0376-8716(99)00087-3; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Fanning TR, 1995, AIDS PUBLIC POLICY J, V10, P39; FLEISHMAN JA, 1994, HEALTH SERV RES, V29, P527; FOX K, 1995, AM J PUBLIC HEALTH, V85, P48, DOI 10.2105/AJPH.85.1.48; French MT, 2000, SOC SCI MED, V50, P1703, DOI 10.1016/S0277-9536(99)00411-6; Gourevitch MN, 1998, INT J TUBERC LUNG D, V2, P531; Hendryx MS, 1998, ADM POLICY MENT HLTH, V25, P437, DOI 10.1023/A:1022248725615; KEYES M, 1991, J ACQ IMMUN DEF SYND, V4, P1015; KOPSTEIN A, 1992, BR J ADDICT, V87, P281; LANGE WR, 1992, POSTGRAD MED, V92, P205; LANGE WR, 1992, POSTGRAD MED, V2, P211; Magura S, 1998, ADDICTION, V93, P51, DOI 10.1046/j.1360-0443.1998.931516.x; MAKOWER RM, 1992, ARCH EMERG MED, V9, P32; MARKSON LE, 1994, HLTH CARE FINANC REV, V15, P1; MOOS RH, 1994, J STUD ALCOHOL, V55, P561, DOI 10.15288/jsa.1994.55.561; NEIMCRYK SJ, 1998, J COMMUNITY HLTH, V23, P137; Newschaffer CJ, 1998, J URBAN HEALTH, V75, P153, DOI 10.1007/BF02344936; Pettinati H M, 1993, Psychiatr Q, V64, P173, DOI 10.1007/BF01065868; RAWLINGS MK, 1998, INTERSCI C ANTIMICRO, V31, P38; RAWSON RA, 1995, J SUBST ABUSE TREAT, V12, P117, DOI 10.1016/0740-5472(94)00080-B; ROSS HE, 1988, ARCH GEN PSYCHIAT, V45, P1023; Samet J. H., 1996, SUBSTANCE ABUSE, V17, P181; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; Single E, 1999, AM J PUBLIC HEALTH, V89, P385, DOI 10.2105/AJPH.89.3.385; Stein M D, 1993, J Subst Abuse, V5, P187, DOI 10.1016/0899-3289(93)90062-G; STEIN MD, 1994, J ACQ IMMUN DEF SYND, V7, P469; TURNER BJ, 1994, MED CARE, V32, P902, DOI 10.1097/00005650-199409000-00002; Turner BJ, 2000, MED CARE, V38, P911, DOI 10.1097/00005650-200009000-00005; Turner BJ, 1996, J ACQ IMMUN DEF SYND, V12, P259, DOI 10.1097/00042560-199607000-00005; Webber MP, 1998, EPIDEMIOLOGY, V9, P613, DOI 10.1097/00001648-199811000-00008; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	41	121	121	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2355	2362		10.1001/jama.285.18.2355	http://dx.doi.org/10.1001/jama.285.18.2355			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427NB	11343483				2022-12-28	WOS:000168411200027
J	Stiell, IG; Wells, GA; Vandemheen, K; Clement, C; Lesiuk, H; Laupacis, A; McKnight, RD; Verbeek, R; Brison, R; Cass, D; Eisenhauer, MA; Greenberg, GH; Worthington, J				Stiell, IG; Wells, GA; Vandemheen, K; Clement, C; Lesiuk, H; Laupacis, A; McKnight, RD; Verbeek, R; Brison, R; Cass, D; Eisenhauer, MA; Greenberg, GH; Worthington, J		CCC Study Grp	The Canadian CT head rule for patients with minor head injury	LANCET			English	Article							TRAUMATIC INTRACRANIAL HEMATOMA; CLINICAL-PREDICTION RULES; OTTAWA ANKLE RULES; COMPUTED-TOMOGRAPHY; METHODOLOGICAL STANDARDS; DECISION RULES; RADIOGRAPHY; MANAGEMENT; IMPLEMENTATION; VALIDATION	Background There is much controversy about the use of computed tomography (CT) for patients with minor head injury. We aimed to develop a highly sensitive clinical decision rule for use of CT in patients with minor head injuries. Methods We carried out this prospective cohort study in the emergency departments of ten large Canadian hospitals and included consecutive adults who presented with a Glasgow Coma Scale (GCS) score of 13-15 after head injury. We did standardised clinical assessments before the CT scan. The main outcome measures were need for neurological intervention and clinically important brain injury on CT. Findings The 3121 patients had the following characteristics: mean age 38.7 years); GCS scores of 13 (3.5%), 14 (16.7%), 15 (79.8%); 8% had clinically important brain injury; and 1% required neurological intervention. We derived a CT head rule which consists of five high-risk factors (failure to reach GCS of 15 within 2 h, suspected open skull fracture, any sign of basal skull fracture, vomiting greater than or equal to2 episodes, or age greater than or equal to 65 years) and two additional medium-risk factors (amnesia before impact greater than or equal to 30 min and dangerous mechanism of injury). The high-risk factors were 100% sensitive (95% CI 92-100%) for predicting need for neurological intervention, and would require only 32% of patients to undergo CT. The medium-risk factors were 98.4% sensitive (95% CI 96-99%) and 49.6% specific for predicting clinically important brain injury, and would require only 54% of patients to undergo CT. Interpretation We have developed the Canadian CT Head Rule, a highly sensitive decision rule for use of CT. This rule has the potential to significantly standardise and improve the emergency management of patients with minor head injury.	Univ Ottawa, Div Emergency Med, Ottawa, ON, Canada; Univ Ottawa, Dept Epidemiol, Ottawa, ON, Canada; Univ Ottawa, Dept Community Med, Ottawa, ON, Canada; Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Clin Epidemiol Unit, Ottawa, ON, Canada; Queens Univ, Dept Emergency Med, Kingston, ON, Canada; Univ Toronto, Div Emergency Med, Toronto, ON, Canada; Univ Western Ontario, Div Emergency Med, London, ON, Canada; Univ British Columbia, Div Emergency Med, Vancouver, BC V5Z 1M9, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Queens University - Canada; University of Toronto; Western University (University of Western Ontario); University of British Columbia	Stiell, IG (corresponding author), Ottawa Civic Hosp, Loeb Hlth Res Inst, Clin Epidemiol Unit, F6, Ottawa, ON K1Y 4E9, Canada.			Stiell, Ian/0000-0002-2583-6408				[Anonymous], 1993, ADV TRAUMA LIFE SUPP; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; CHARLSON ME, 1987, ARCH INTERN MED, V147, P2155, DOI 10.1001/archinte.147.12.2155; DASCEY RG, 1986, J NEUROSURG, V65, P302; DUUS BR, 1994, ANN EMERG MED, V23, P1279, DOI 10.1016/S0196-0644(94)70352-3; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEVITT MA, 1994, ANN EMERG MED, V23, P1143; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; McCaig L F, 1994, Adv Data, P1; *NAT CTR HLTH STAT, 1994, NAT HOSP AMB MED CAR; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SNOEY ER, 1994, ANN EMERG MED, V23, P127; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; Stiell I.G., 2000, ACAD EMERG MED, V7, P572; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 1997, JAMA-J AM MED ASSOC, V278, P2075, DOI 10.1001/jama.278.23.2075; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; STIELL IG, 2000, ACAD EMERG MED, V7, P533; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P28; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306	32	939	953	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1391	1396		10.1016/S0140-6736(00)04561-X	http://dx.doi.org/10.1016/S0140-6736(00)04561-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356436				2022-12-28	WOS:000168478200010
J	An, ZS; Kutzbach, JE; Prell, WL; Porter, SC				An, ZS; Kutzbach, JE; Prell, WL; Porter, SC			Evolution of Asian monsoons and phased uplift of the Himalayan Tibetan plateau since Late Miocene times	NATURE			English	Article							CHINESE LOESS PLATEAU; NORTHERN-HEMISPHERE; MAGNETOSTRATIGRAPHY; SEQUENCES; DEFORMATION; SENSITIVITY; GLACIATION; ATLANTIC; CLIMATE; ZONE	The climates of Asia are affected significantly by the extent and height of the Himalayan mountains and the Tibetan plateau(1-4). Uplift of this region began about 50 Myr ago, and further significant increases in altitude of the Tibetan plateau are thought to have occurred about 10-8 Myr ago(4,5), or more recently. However, the climatic consequences of this uplift remain unclear. Here we use records of aeolian sediments from China(6,7) and marine sediments from the Indian(8-10) and North Pacific oceans(11) to identify three stages of evolution of Asian climates: first, enhanced aridity in the Asian interior and onset of the Indian and east Asian monsoons, about 9-8 Myr ago; next, continued intensification of the east Asian summer and winter monsoons, together with increased dust transport to the North Pacirc Ocean(11), about 3.6-2.6 Myr ago; and last, increased variability and possible weakening of the Indian and east Asian summer monsoons and continued strengthening of the east Asian winter monsoon since about 2.6 Myr ago. The results of a numerical climate-model experiment, using idealized stepwise increases of mountain-plateau elevation, support the argument that the stages in evolution of Asian monsoons are linked to phases of Himalaya-Tibetan plateau uplift and to Northern Hemisphere glaciation.	Univ Wisconsin, Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA; Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710054, Peoples R China; Brown Univ, Providence, RI 02912 USA; Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Brown University; University of Washington; University of Washington Seattle	Kutzbach, JE (corresponding author), Univ Wisconsin, Inst Environm Studies, Ctr Climat Res, 1225 W Dayton St, Madison, WI 53706 USA.	jek@facstaff.wisc.edu		an, zhi sheng/0000-0002-9538-9826				An ZS, 1999, SCI CHINA SER D, V42, P258, DOI 10.1007/BF02878963; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; BURCHFIEL BC, 1991, TECTONICS, V10, P1091, DOI 10.1029/90TC02685; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen J, 1999, QUATERNARY RES, V51, P215, DOI 10.1006/qres.1999.2038; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; ENGLAND P, 1986, J GEOPHYS RES-SOLID, V91, P3664, DOI 10.1029/JB091iB03p03664; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; KUKLA G, 1989, PALAEOGEOGR PALAEOCL, V72, P203, DOI 10.1016/0031-0182(89)90143-0; Kutzbach J.E., 1997, TECTONIC UPLIFT CLIM, P149; KUTZBACH JE, 1993, J GEOL, V101, P177, DOI 10.1086/648215; Li JJ, 1997, GEOL MIJNBOUW, V76, P121, DOI 10.1023/A:1003153717799; Ma Y, 1998, CHINESE SCI BULL, V43, P301, DOI [10.1360/csb1998-43-3-301, DOI 10.1006/JHGE.2002.0453]; MAHER BA, 1986, PHYS EARTH PLANET IN, V42, P76, DOI 10.1016/S0031-9201(86)80010-3; Metivier F, 1998, TECTONICS, V17, P823, DOI 10.1029/98TC02764; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Prell W L, 1997, TECTONIC UPLIFT CLIM, P172; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; PRELL WL, 1992, SYNTHESIS RESULTS SC, P447; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Ramsey M, 1997, J SOC HIST, V30, P788, DOI 10.1353/jsh/30.3.788; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Royden LH, 1997, SCIENCE, V276, P788, DOI 10.1126/science.276.5313.788; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Sun DG, 1998, GEOPHYS J INT, V134, P207, DOI 10.1046/j.1365-246x.1998.00553.x; Sun DH, 1997, SCI CHINA SER D, V40, P337, DOI 10.1007/BF02877564; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2	31	1961	2455	68	924	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					62	66		10.1038/35075035	http://dx.doi.org/10.1038/35075035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333976				2022-12-28	WOS:000168432800042
J	Kramer, SG; Kidd, T; Simpson, JH; Goodman, CS				Kramer, SG; Kidd, T; Simpson, JH; Goodman, CS			Switching repulsion to attraction: Changing responses to slit during transition in mesoderm migration	SCIENCE			English	Article							AXON GUIDANCE; DROSOPHILA; CELLS; MIDLINE; CHEMOATTRACTANT; RECEPTORS; SELECTION; MUSCLES; PROTEIN	Slit is secreted by cells at the midline of the central nervous system, where it binds to Roundabout (Robo) receptors and functions as a potent repellent. We found that migrating mesodermal cells in vivo respond to Slit as both an attractant and a repellent and that Robe receptors are required for both functions. Mesoderm cells expressing Robe receptors initially migrate away from Slit at the midline. A few hours after migration, these same cells change their behavior and require Robe to extend toward Slit-expressing muscle attachment sites. Thus, Slit functions as a chemoattractant to provide specificity for muscle patterning.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 519 Life Sci Addit, Berkeley, CA 94720 USA.		Kidd, Thomas/AAT-9993-2020	Simpson, Julie/0000-0002-6793-7100; Kramer, Sunita/0000-0001-8372-5928; Kidd, Thomas/0000-0001-7190-4208	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagnard D, 1998, DEVELOPMENT, V125, P5043; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Becker S, 1997, DEVELOPMENT, V124, P2615; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Callahan CA, 1996, DEVELOPMENT, V122, P2761; HO RK, 1983, NATURE, V301, P66, DOI 10.1038/301066a0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KRAMER SC, UNPUB; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Su MW, 2000, DEVELOPMENT, V127, P585; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wong JTW, 1997, DEVELOPMENT, V124, P3597	26	190	198	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					737	740		10.1126/science.1058766	http://dx.doi.org/10.1126/science.1058766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326102				2022-12-28	WOS:000168478300054
J	Sudbo, J; Kildal, W; Risberg, B; Koppang, HS; Danielsen, HE; Reith, A				Sudbo, J; Kildal, W; Risberg, B; Koppang, HS; Danielsen, HE; Reith, A			RETRACTED: DNA content as a prognostic marker in patients with oral leukoplakia (Retracted article. See vol 355, pg 1927, 2006)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Retracted Publication							SQUAMOUS-CELL CARCINOMA; COMMON CLONAL ORIGIN; NECK-CANCER; MUTAGEN SENSITIVITY; GENETIC SUSCEPTIBILITY; PREMALIGNANT LESIONS; FIELD CANCERIZATION; SPINDLE CHECKPOINT; HEAD; TONGUE	Background: Oral leukoplakia may develop into squamous-cell carcinoma, which has a poor prognosis. Risk factors for oral carcinoma have been identified, but there are no reliable predictors of the outcome in individual patients with oral leukoplakia. Methods: We identified 150 patients with oral leukoplakia that was classified as epithelial dysplasia and measured the nuclear DNA content (ploidy) of the lesions to determine whether DNA ploidy could be used to predict the clinical outcome. Biopsy specimens obtained at annual follow-up visits were graded histologically and classified with respect to DNA content in a blinded fashion. Disease-free survival was assessed in relation to DNA ploidy and the histologic grade. The mean duration of follow-up was 103 months (range, 4 to 165). Results: Among 150 patients with verified epithelial dysplasia, a carcinoma developed in 36 (24 percent). Of the 150 patients, 105 (70 percent) had diploid (normal) lesions, 20 (13 percent) had tetraploid (intermediate) lesions, and 25 (17 percent) had aneuploid (abnormal) lesions at the time of the initial diagnosis. A carcinoma developed in 3 of the 105 patients with diploid lesions (3 percent), as compared with 21 of the 25 patients with aneuploid lesions (84 percent), yielding a negative predictive value of 97 percent with respect to the diploid lesions and a positive predictive value of 84 percent with respect to the aneuploid lesions. Carcinoma developed in 12 of 20 patients with tetraploid lesions (60 percent). The mean time from the initial assessment of the DNA content to the development of a carcinoma was 35 months (range, 4 to 57) in the group with aneuploid lesions and 49 months (range, 8 to 78) in the group with tetraploid lesions (P=0.02). The cumulative disease-free survival rate was 97 percent among the group with diploid lesions, 40 percent among the group with tetraploid lesions, and 16 percent among the group with aneuploid lesions (P<0.001). Conclusions: The DNA content in cells of oral leukoplakia can be used to predict the risk of oral carcinoma. (N Engl J Med 2001;344:1270-8.) Copyright (C) 2001 Massachusetts Medical Society.	Norwegian Radium Hosp, Dept Pathol, Div Digital Pathol, N-0310 Oslo, Norway; Univ Oslo, Inst Clin Dent, Dept Pathol & Forens Odontol, N-0316 Oslo, Norway	University of Oslo; University of Oslo	Sudbo, J (corresponding author), Norwegian Radium Hosp, Dept Pathol, Div Digital Pathol, Montebello, N-0310 Oslo, Norway.	jon.sudbo@rh.uio.no	Danielsen, Havard/AAK-8489-2020					ABDELSALAM M, 1990, ORAL SURG ORAL MED O, V69, P345, DOI 10.1016/0030-4220(90)90297-6; Bedi GC, 1996, CANCER RES, V56, P2484; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOUQUOT JE, 1986, ORAL SURG ORAL MED O, V61, P373, DOI 10.1016/0030-4220(86)90422-6; Brunin F, 1999, HEAD NECK-J SCI SPEC, V21, P751, DOI 10.1002/(SICI)1097-0347(199912)21:8<751::AID-HED11>3.3.CO;2-W; BRYNE M, 1991, J ORAL PATHOL MED, V20, P120, DOI 10.1111/j.1600-0714.1991.tb00904.x; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Califano J, 1996, CANCER RES, V56, P2488; Califano J, 2000, CLIN CANCER RES, V6, P347; Cloos J, 1996, JNCI-J NATL CANCER I, V88, P530, DOI 10.1093/jnci/88.8.530; COOPER JS, 1989, INT J RADIAT ONCOL, V17, P449, DOI 10.1016/0360-3016(89)90094-1; COTE RA, 1979, SYSTEMATIZED NOMENCL, V1, P61; Emilion G, 1996, BRIT J CANCER, V73, P809, DOI 10.1038/bjc.1996.142; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Friedlander PL, 1998, HEAD NECK-J SCI SPEC, V20, P363, DOI 10.1002/(SICI)1097-0347(199808)20:5<363::AID-HED1>3.3.CO;2-X; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; GRANT WE, 1993, LANCET, V342, P147, DOI 10.1016/0140-6736(93)91347-O; Haroske G, 1998, ANAL CELL PATHOL, V17, P189, DOI 10.1155/1998/390837; Harrison LB, 1998, HEAD NECK-J SCI SPEC, V20, P668, DOI 10.1002/(SICI)1097-0347(199812)20:8<668::AID-HED2>3.0.CO;2-9; HAYS GL, 1995, J AM DENT ASSOC, V126, P47, DOI 10.14219/jada.archive.1995.0023; HEDLEY DW, 1994, METHOD CELL BIOL, V41, P231; Hogmo A, 1996, HEAD NECK-J SCI SPEC, V18, P433, DOI 10.1002/(SICI)1097-0347(199609/10)18:5<433::AID-HED6>3.0.CO;2-6; HONG WK, 1986, NEW ENGL J MED, V315, P1501, DOI 10.1056/NEJM198612113152401; JONES AS, 1994, ORAL ONCOL, V30B, P8; KARABULUT A, 1995, J ORAL PATHOL MED, V24, P198, DOI 10.1111/j.1600-0714.1995.tb01166.x; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LICCIARDELLO JTW, 1989, INT J RADIAT ONCOL, V17, P467, DOI 10.1016/0360-3016(89)90096-5; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LOTAN R, 1995, NEW ENGL J MED, V332, P1405, DOI 10.1056/NEJM199505253322103; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Nisi KW, 1998, INT J RADIAT ONCOL, V41, P371, DOI 10.1016/S0360-3016(98)00059-5; Ogden GR, 1998, BRIT J ORAL MAX SURG, V36, P247, DOI 10.1016/S0266-4356(98)90707-0; Pindborg JJ, 1997, HISTOLOGICAL TYPING, P21; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; SCHANTZ SP, 1990, J NATL CANCER I, V82, P1773, DOI 10.1093/jnci/82.22.1773; Schantz SP, 1997, LARYNGOSCOPE, V107, P765, DOI 10.1097/00005537-199706000-00011; Schantz SP, 2000, CARCINOGENESIS, V21, P1239, DOI 10.1093/carcin/21.6.1239; Schantz SP, 1997, P SOC EXP BIOL MED, V216, P275; Scholes AGM, 1998, CANCER RES, V58, P2003; Sen S, 2000, CURR OPIN ONCOL, V12, P82, DOI 10.1097/00001622-200001000-00014; Seoane J, 1998, CLIN OTOLARYNGOL, V23, P136; SHAFER WG, 1975, CANCER-AM CANCER SOC, V36, P1021, DOI 10.1002/1097-0142(197509)36:3<1021::AID-CNCR2820360327>3.0.CO;2-W; SHEMEN LJ, 1984, JAMA-J AM MED ASSOC, V252, P1857, DOI 10.1001/jama.252.14.1857; SILVERMAN S, 1984, CANCER, V53, P563; SILVERMAN S, 1990, J AM DENT ASSOC, V120, P495, DOI 10.14219/jada.archive.1990.0082; Suarez P, 1998, Adv Anat Pathol, V5, P137, DOI 10.1097/00125480-199805000-00001; WALDRON CA, 1975, CANCER-AM CANCER SOC, V36, P1386, DOI 10.1002/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7; WARNAKULASURIYA KAAS, 1992, J ORAL PATHOL MED, V21, P404, DOI 10.1111/j.1600-0714.1992.tb01028.x; Warnakulasuriya S, 2000, J PATHOL, V190, P407, DOI 10.1002/(SICI)1096-9896(200003)190:4<407::AID-PATH546>3.0.CO;2-D; Weber RG, 1998, AM J PATHOL, V153, P295, DOI 10.1016/S0002-9440(10)65571-X; Xie X, 1997, CANCER, V79, P2200, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2200::AID-CNCR19>3.0.CO;2-#; Yamasaki H, 2000, TOXICOL LETT, V112, P251, DOI 10.1016/S0378-4274(99)00278-7	54	215	222	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1270	1278		10.1056/NEJM200104263441702	http://dx.doi.org/10.1056/NEJM200104263441702			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320386				2022-12-28	WOS:000168252400002
J	de Bruin, D; Zaman, Z; Liberatore, RA; Ptashne, M				de Bruin, D; Zaman, Z; Liberatore, RA; Ptashne, M			Telomere looping permits gene activation by a downstream UAS in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; DROSOPHILA; HETEROCHROMATIN; TRANSCRIPTION; ACETYLATION; EXPRESSION; NUCLEOSOME; PROTEIN; DNA	In yeast (Saccharomyces cerevisiae), transcriptional activators, such as Gal4 and Gal4-VP16, work ordinarily from sites located in the upstream activating sequence (UAS) positioned about 250 base pairs upstream of the transcription start site(1). In contrast to their behaviour in mammalian cells, however, such activators fail to work when positioned at distances greater than similar to 600-700 base pairs upstream(2), or anywhere downstream(3,4) of the gene. Here we show that, in yeast, a gene bearing an enhancer positioned 1-2 kilobases downstream of the gene is activated if the reporter is linked to a telomere, but not if it is positioned at an internal chromosomal locus. These observations are explained by the finding that yeast telomeres form back-folding, or looped, structures. Because yeast telomeric regions resemble the heterochromatin found in higher eukaryotes, these findings might also explain why transcription of some higher eukaryotic genes depends on their location in heterochromatin.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Program Mol Biol, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	de Bruin, D (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.							Alexandre Cyrille, 1993, Methods (Orlando), V5, P147, DOI 10.1006/meth.1993.1019; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boivin A, 1998, GENETICS, V150, P1539; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; DEVLIN RH, 1990, GENETICS, V125, P129; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GUARENTE L, 1984, P NATL ACAD SCI-BIOL, V81, P7860, DOI 10.1073/pnas.81.24.7860; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; STRUHL K, 1984, P NATL ACAD SCI-BIOL, V81, P7865, DOI 10.1073/pnas.81.24.7865; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	24	118	118	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					109	113		10.1038/35051119	http://dx.doi.org/10.1038/35051119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343124				2022-12-28	WOS:000166175600050
J	Karson, JA				Karson, JA			Geophysics - Oceanic crust when Earth was young	SCIENCE			English	Editorial Material							ARCHEAN PLATE-TECTONICS; LITHOSPHERE; THICKNESS; ORIGIN		Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University	Karson, JA (corresponding author), Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA.	jkarson@duke.edu						ABBOTT DH, 1984, TECTONICS, V3, P429, DOI 10.1029/TC003i004p00429; Anonymous, 1972, GEOTIMES, V17, P24; BICKLE MJ, 1986, EARTH PLANET SC LETT, V80, P314, DOI 10.1016/0012-821X(86)90113-5; BICKLE MJ, 1994, J GEOL, V102, P121, DOI 10.1086/629658; BURKE K, 1978, NATURE, V272, P240, DOI 10.1038/272240a0; Karson JA, 1998, GEOPH MONOG SERIES, V106, P177; Kusky TM, 2001, SCIENCE, V292, P1142, DOI 10.1126/science.1059426; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MOORES EM, 1982, REV GEOPHYS, V20, P735, DOI 10.1029/RG020i004p00735; MUTTER CZ, 1993, EARTH PLANET SC LETT, V117, P295, DOI 10.1016/0012-821X(93)90134-U; SLEEP NH, 1982, J GEOL, V90, P363, DOI 10.1086/628691; WHITE RS, 1992, J GEOPHYS RES-SOL EA, V97, P19683, DOI 10.1029/92JB01749	12	15	15	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1076	+		10.1126/science.1061081	http://dx.doi.org/10.1126/science.1061081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352056				2022-12-28	WOS:000168609200034
J	Surrey, T; Nedelec, F; Leibler, S; Karsenti, E				Surrey, T; Nedelec, F; Leibler, S; Karsenti, E			Physical properties determining self-organization of motors and microtubules	SCIENCE			English	Article							KINESIN; PROTEIN; NCD; LOCALIZATION	In eukaryotic cells, microtubules and their associated motor proteins can be organized into various Large-scale patterns. Using a simplified experimental system combined with computer simulations, we examined how the concentrations and kinetic parameters of the motors contribute to their collective behavior. We observed self-organization of generic steady-state structures such as asters, vortices, and a network of interconnected poles. We identified parameter combinations that determine the generation of each of these structures. In general, this approach may become useful for correlating the morphogenetic phenomena taking place in a biological system with the biophysical characteristics of its constituents.	European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Karsenti, E (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany.	karsenti@embl-heidelberg.de	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019; Surrey, Thomas/AAC-4608-2021	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Surrey, Thomas/0000-0001-9082-1870				BARTON NR, 1995, MOL BIOL CELL, V6, P1563, DOI 10.1091/mbc.6.11.1563; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; FRAENKELCONRAT H, 1955, P NATL ACAD SCI USA, V41, P690, DOI 10.1073/pnas.41.10.690; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; INOUE S, 1982, 40 S SOC DEV BIOL, P30; MITCHISON TJ, 1992, PHILOS T ROY SOC B, V336, P99, DOI 10.1098/rstb.1992.0049; Nedelec F, 2001, METH MOL B, V164, P213; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; NEDELEC F, 1998, THESIS U PARIS 11 OR; NEDELEC F, UNPUB; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Sleigh M. A., 1973, BIOL PROTOZOA; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3	25	422	432	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1167	1171		10.1126/science.1059758	http://dx.doi.org/10.1126/science.1059758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349149				2022-12-28	WOS:000168609200061
J	Carr, A; Morey, A; Mallon, P; Williams, D; Thorburn, DR				Carr, A; Morey, A; Mallon, P; Williams, D; Thorburn, DR			Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia	LANCET			English	Article								Acute hepatitis with lactic acidosis Is a life threatening but reversible toxic effect on mitochondria of HIV-1 nucleoside analogue treatment. We report fatal portal hypertension, liver failure, and persistent mitochondrial dysfunction in a man aged 65 years with HIV-1 Infection who had recovered from nucleoside-analogue-induced acute hepatitis and lactic acidaemia more than 18 months previously. We believe that symptomfree patients who receive nucleoside-analogue therapy should have hepatic function constantly monitored, especially those with past or present lactic acidaemia.	St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia; St Vincents Hosp, Dept Anat Pathol, Sydney, NSW 2010, Australia; St Vincents Hosp, Dept Gastroenterol, Sydney, NSW 2010, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Murdoch Children's Research Institute	Carr, A (corresponding author), St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia.		Thorburn, David R/G-6266-2013	thorburn, david/0000-0002-7725-9470; Morey, Adrienne/0000-0002-7823-8276				Brivet FG, 2000, J HEPATOL, V32, P364, DOI 10.1016/S0168-8278(00)80088-4; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Fromenty Bernard, 1997, Journal of Hepatology, V26, P13, DOI 10.1016/S0168-8278(97)82328-8; Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255; PEZESHKPOUR G, 1991, HUM PATHOL, V22, P1281, DOI 10.1016/0046-8177(91)90112-3	5	60	60	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1412	1414		10.1016/S0140-6736(00)04579-7	http://dx.doi.org/10.1016/S0140-6736(00)04579-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356442				2022-12-28	WOS:000168478200016
J	Ideker, T; Thorsson, V; Ranish, JA; Christmas, R; Buhler, J; Eng, JK; Bumgarner, R; Goodlett, DR; Aebersold, R; Hood, L				Ideker, T; Thorsson, V; Ranish, JA; Christmas, R; Buhler, J; Eng, JK; Bumgarner, R; Goodlett, DR; Aebersold, R; Hood, L			Integrated genomic and proteomic analyses of a systematically perturbed metabolic network	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; OVEREXPRESSION; TRANSCRIPTION; MECHANISMS; PATTERNS; SYSTEM	We demonstrate an integrated approach to build, test, and refine a model of a cellular pathway, in which perturbations to critical pathway components are analyzed using DNA microarrays, quantitative proteomics, and databases of known physical interactions. Using this approach, we identify 997 messenger RNAs responding to 20 systematic perturbations of the yeast galactose-utilization pathway, provide evidence that approximately 15 of 289 detected proteins are regulated posttranscriptionally, and identify explicit physical interactions governing the cellular response to each perturbation. We refine the model through further iterations of perturbation and global measurements, suggesting hypotheses about the regulation of galactose utilization and physical interactions between this and a variety of other metabolic pathways.	Inst Syst Biol, Seattle, WA 98105 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Dept Comp Sci, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ideker, T (corresponding author), Inst Syst Biol, 4225 Roosevelt Way NE,Suite 200, Seattle, WA 98105 USA.		Bumgarner, Roger/AAA-6846-2020; Eng, Jimmy K/I-4202-2012; Bumgarner, Roger E/K-3531-2015	Eng, Jimmy K/0000-0001-6352-6737; Bumgarner, Roger E/0000-0002-8168-6985; Ideker, Trey/0000-0002-1708-8454				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; DOUGLAS HC, 1964, GENETICS, V49, P837; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu LW, 2000, J BIOL CHEM, V275, P5431, DOI 10.1074/jbc.275.8.5431; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Lai K, 2000, BIOCHEM BIOPH RES CO, V271, P392, DOI 10.1006/bbrc.2000.2629; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Mehlhorn K., 1999, LEDA PLATFORM COMBIN; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reece RJ, 2000, CELL MOL LIFE SCI, V57, P1161, DOI 10.1007/PL00000756; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rudoni S, 2000, INT J BIOCHEM CELL B, V32, P215, DOI 10.1016/S1357-2725(99)00121-1; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zheng WJ, 1997, J BIOL CHEM, V272, P30350, DOI 10.1074/jbc.272.48.30350; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	29	1463	1548	4	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					929	934		10.1126/science.292.5518.929	http://dx.doi.org/10.1126/science.292.5518.929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340206				2022-12-28	WOS:000168514900044
J	Shi, SH; Hayashi, Y; Esteban, JA; Malinow, R				Shi, SH; Hayashi, Y; Esteban, JA; Malinow, R			Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons	CELL			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEIN; SILENT SYNAPSES; SYNAPTIC PLASTICITY; POSTSYNAPTIC EXPRESSION; GLUTAMATE RECEPTORS; LTP; POTENTIATION; BINDING; PHOSPHORYLATION	AMPA-type glutamate receptors (AMPA-Rs) mediate a majority of excitatory synaptic transmission in the brain. In hippocampus, most AMPA-Rs are heterooligomers composed of GluR1/GluR2 or GluR2/GluR3 subunits. Here we show that these AMPA-R forms display different synaptic delivery mechanisms. GluR1/ GluR2 receptors are added to synapses during plasticity; this requires interactions between GluR1 and group I PDZ domain proteins. In contrast, GluR2/GluR3 receptors replace existing synaptic receptors continuously; this occurs only at synapses that already have AMPA-Rs and requires interactions by GluR2 with NSF and group I! PDZ domain proteins. The combination of regulated addition and continuous replacement of synaptic receptors can stabilize long-term changes in synaptic efficacy and may serve as a general model for how surface receptor number is established and maintained.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Dept Brain & Cognit Sci, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); RIKEN	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Hayashi, Yasunori/C-2249-2008; Hayashi, Yasunori/AAF-1408-2019; Esteban, Jose/L-4944-2014	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Esteban, Jose/0000-0002-3759-3300				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hayashi Y, 1997, MOL BRAIN RES, V46, P338, DOI 10.1016/S0169-328X(97)00073-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hirai H, 2001, NEUROSCI RES, V39, P261, DOI 10.1016/S0168-0102(00)00237-6; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Inagaki H, 1999, BIOCHEM BIOPH RES CO, V265, P462, DOI 10.1006/bbrc.1999.1723; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 1999, INTRO GREEN FLUORESC; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Racca C, 2000, J NEUROSCI, V20, P2512; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rumpel S, 1998, J NEUROSCI, V18, P8863; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Sudo M, 1999, MOL BRAIN RES, V65, P176, DOI 10.1016/S0169-328X(98)00348-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Ziff EB, 1999, ANN NY ACAD SCI, V868, P465, DOI 10.1111/j.1749-6632.1999.tb11315.x	77	818	847	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					331	343		10.1016/S0092-8674(01)00321-X	http://dx.doi.org/10.1016/S0092-8674(01)00321-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348590	Bronze			2022-12-28	WOS:000168515900003
J	Muggli, P; Lee, S; Katsouleas, T; Assmann, R; Decker, FJ; Hogan, MJ; Iverson, R; Raimondi, P; Siemann, RH; Walz, D; Blue, B; Clayton, CE; Dodd, E; Fonseca, RA; Hemker, R; Joshi, C; Marsh, KA; Mori, WB; Wang, SQ				Muggli, P; Lee, S; Katsouleas, T; Assmann, R; Decker, FJ; Hogan, MJ; Iverson, R; Raimondi, P; Siemann, RH; Walz, D; Blue, B; Clayton, CE; Dodd, E; Fonseca, RA; Hemker, R; Joshi, C; Marsh, KA; Mori, WB; Wang, SQ			Boundary effects - Refractioin of a particle beam	NATURE			English	Article							LASER		Univ So Calif, Los Angeles, CA 90089 USA; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford, CA 94309 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of Southern California; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Los Angeles	Muggli, P (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.		Fonseca, Ricardo A/B-7680-2009; Assmann, Ralph W/L-8457-2016	Fonseca, Ricardo A/0000-0001-6342-6226; Assmann, Ralph W/0000-0003-3440-7717				Chen P., 1987, PART ACCEL, V20, P171; Hemker R. G., 2000, Physical Review Special Topics-Accelerators and Beams, V3, DOI 10.1103/PhysRevSTAB.3.061301; Hogan MJ, 2000, PHYS PLASMAS, V7, P2241, DOI 10.1063/1.874059; Katsouleas T, 2000, NUCL INSTRUM METH A, V455, P161, DOI 10.1016/S0168-9002(00)00724-5; MUGGLI P, UNPUB PHYS REV SP TO; SU JJ, 1990, PHYS REV A, V41, P3321, DOI 10.1103/PhysRevA.41.3321; WHITTUM DH, 1990, PHYS REV LETT, V64, P2511, DOI 10.1103/PhysRevLett.64.2511	7	29	29	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					43	43		10.1038/35075144	http://dx.doi.org/10.1038/35075144			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333969	Bronze			2022-12-28	WOS:000168432800035
J	Schneider, SH				Schneider, SH			What is 'dangerous' climate change?	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Schneider, SH (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							*INT PAN CLIM CHAN, IN PRESS THIRD ASS R; *INT PAN CLIM CHAN, IN PRESS 3 ASS REP W; Intergovernmental Panel on Climate Change, 1996, CLIM CHANG 1995 CONT; Jones RN, 2000, CLIMATIC CHANGE, V45, P403, DOI 10.1023/A:1005551626280; MORGAN MG, 1995, ENVIRON SCI TECHNOL, V29, pA468, DOI 10.1021/es00010a003; MOSS RH, GUIDANCE PAPERSON CR, P33; Nakicenovic N., 2000, SPECIAL REPORT INTER; Schneider S.H., 1983, SOCIAL SCI RES CLIMA, P9	8	217	224	2	29	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					17	19		10.1038/35075167	http://dx.doi.org/10.1038/35075167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333950	Green Submitted			2022-12-28	WOS:000168432800018
J	Yoshida, N; Oeda, K; Watanabe, E; Mikami, T; Fukita, Y; Nishimura, K; Komai, K; Matsuda, K				Yoshida, N; Oeda, K; Watanabe, E; Mikami, T; Fukita, Y; Nishimura, K; Komai, K; Matsuda, K			Protein function - Chaperonin turned insect toxin	NATURE			English	Article							CRYSTAL-STRUCTURE; GROEL		Kinki Univ, Fac Agr, Dept Agr Chem, Nara 6318505, Japan; Sumitomo Chem Co Ltd, Agr Chem Res Lab, Takarazuka, Hyogo 6658555, Japan; Sumitomo Chem Co Ltd, Organ Synth Res Lab, Takarazuka, Hyogo 6658555, Japan; Sumitomo Pharmaceut Co Ltd, Genom Sci Labs, Takarazuka, Hyogo 6658555, Japan; Univ Osaka Prefecture, Adv Sci & Technol Res Inst, Osaka 5998570, Japan	Kindai University (Kinki University); Sumitomo Chem Co Ltd; Sumitomo Chem Co Ltd; Japan Advanced Institute of Science & Technology (JAIST); Osaka Metropolitan University	Yoshida, N (corresponding author), Kinki Univ, Fac Agr, Dept Agr Chem, 3327-204 Nakamachi, Nara 6318505, Japan.							Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Matsura T., 1986, Ecological Research, V1, P15, DOI 10.1007/BF02361201; RANFORD JC, 2000, EXP REV MOL MED; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505	9	87	91	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					44	44		10.1038/35075148	http://dx.doi.org/10.1038/35075148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333970				2022-12-28	WOS:000168432800036
J	Holroyd, KA; O'Donnell, FJ; Stenland, M; Lipchik, GL; Cordingley, GE; Carlson, BW				Holroyd, KA; O'Donnell, FJ; Stenland, M; Lipchik, GL; Cordingley, GE; Carlson, BW			Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEHAVIORAL TREATMENT; FOLLOW-UP; AMITRIPTYLINE; CONTACT; IMPACT	Context Chronic tension-type headaches are characterized by near-daily headaches and often are difficult to manage in primary practice. Behavioral and pharmacological therapies each appear modestly effective, but data are lacking on their separate and combined effects. Objective To evaluate the clinical efficacy of behavioral and pharmacological therapies, singly and combined, far chronic tension-type headaches. Design and Setting Randomized placebo-controlled trial conducted from August 1995 to January 1998 at 2 outpatient sites in Ohio. Participants Two hundred three adults (mean age, 37 years; 76% women) with diagnosis of chronic tension-type headaches (mean, 26 headache d/mo). Interventions Participants were randomly assigned to receive tricyclic antidepressant (amitriptyline hydrochloride, up to 100 mg/d, or nortriptyline hydrochloride, up to 75 mg/d) medication (n=53), placebo (n=48), stress management leg, relaxation, cognitive coping) therapy (3 sessions and 2 telephone contacts) plus placebo (n=49), or stress management therapy plus antidepressant medication (n=53). Main Outcome Measures Monthly headache index scores calculated as the mean of pain ratings (0-10 scale) recorded by participants in a daily diary 4 times per day; number of days per month with at least moderate pain (pain rating greater than or equal to5), analgesic medication use, and Headache Disability Inventory scores, compared by intervention group. Results Tricyclic antidepressant medication and stress management therapy each produced larger reductions in headache activity, analgesic medication use, and headache-related disability than placebo, but antidepressant medication yielded more rapid improvements in headache activity. Combined therapy was more likely to produce clinically significant (greater than or equal to 50%) reductions in headache index scores (64% of participants) than antidepressant medication (38% of participants; P=.006), stress management therapy (35%; P=.003), or placebo (29%; P=.001). On other measures the combined therapy and its 2 component therapies produced similar outcomes. Conclusions Our results indicate that antidepressant medication and stress management therapy are each modestly effective in treating chronic tension-type headaches. Combined therapy may improve outcome relative to monotherapy.	Ohio Univ, Coll Osteopath Med, Athens, OH 45701 USA; Ohio Univ, Dept Psychol, Athens, OH 45701 USA; OrthoNeuro, Headache Treatment & Res, Westerville, OH USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Holroyd, KA (corresponding author), 225 Porter Hall, Athens, OH 45701 USA.	holroyd@ohio.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032374] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beck A.T., 1993, PRINCIPLES PRACTICE, V2nd ed., P333; Bendtsen L, 1996, J NEUROL NEUROSUR PS, V61, P285, DOI 10.1136/jnnp.61.3.285; Bernstein D.A., 1973, PROGR RELAXATION TRA; BERNSTEIN DA, 1993, PRINCIPLES PRACTICE, P53; BLANCHARD EB, 1987, BEHAV THER, V18, P375, DOI 10.1016/S0005-7894(87)80005-9; BLANCHARD EB, 1992, J CONSULT CLIN PSYCH, V60, P537, DOI 10.1037/0022-006X.60.4.537; BLANCHARD EB, 1988, BEHAV ASSESS, V10, P171; BLANCHARD EB, 1988, J CONSULT CLIN PSYCH, V56, P427, DOI 10.1037/0022-006X.56.3.427; BLANCHARD EB, 1981, BEHAV THER, V12, P711, DOI 10.1016/S0005-7894(81)80142-6; BLANCHARD EB, 1987, HEADACHE, V27, P580, DOI 10.1111/j.1526-4610.1987.hed2710580.x; Blanchard EB, 1985, MANAGEMENT CHRONIC H; BOGAARDS MC, 1994, CLIN J PAIN, V10, P174, DOI 10.1097/00002508-199409000-00003; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COUCH JR, 1993, HEADACHE DIAGNOSIS T, P151; COUCH JR, 1993, HEADACHES; COYNE L, 1976, HEADACHE, V16, P70, DOI 10.1111/j.1526-4610.1976.hed1602070.x; D'Zurilla TJ., 1990, J COGN PSYCHOTHER, V4, P327, DOI 10.1891/0889-8391.4.4.327; DIAMOND S, 1992, PRACTICING PHYSICIAN; DZURILLA TJ, 1989, CLIN DECISION MAKING, P371; EDMEADS J, 1993, CAN J NEUROL SCI, V20, P131, DOI 10.1017/S0317167100047697; FRANK E, 1992, PSYCHOTHER RES, V2, P102; GIAMMARCO R, 1998, CRITICAL DECISIONS H; GOBEL H, 1994, PAIN, V59, P241, DOI 10.1016/0304-3959(94)90077-9; Goldfried M. R., 1994, CLIN BEHAV THERAPY; GRANELLA F, 1987, CEPHALALGIA, V7, P15, DOI 10.1046/j.1468-2982.1987.0701015.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOLLON SD, 1981, PSYCHOL BULL, V90, P467, DOI 10.1037/0033-2909.90.3.467; HOLROYD KA, 1986, J BEHAV MED, V9, P515, DOI 10.1007/BF00845282; HOLROYD KA, 1991, J CONSULT CLIN PSYCH, V59, P387, DOI 10.1037/0022-006X.59.3.387; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; HOLROYD KA, 1995, STRESS MANAGEMENT TE; HOLROYD KA, IN PRESS J CONSULT C; HOLROYD KA, 1982, ADV COGNITIVE BEHAV, P276; HOLROYD KA, 2000, HEADACHES, P643; JACOBSON GP, 1995, HEADACHE, V35, P534, DOI 10.1111/j.1526-4610.1995.hed3509534.x; JACOBSON GP, 1994, NEUROLOGY, V44, P837, DOI 10.1212/WNL.44.5.837; JENSEN R, 2000, HEADACHES, P627; KUNKEL RS, 1991, MED CLIN N AM, V75, P595, DOI 10.1016/S0025-7125(16)30435-7; MATHEW NT, 2000, HEADACHES, P667; McCrory DC, 2001, EVIDENCE REPORT BEHA; MCKEE M, 1993, HEADACHE DIAGNOSIS T, P321; Peveler R, 1999, BRIT MED J, V319, P612, DOI 10.1136/bmj.319.7210.612; PFAFFENRATH V, 1994, CEPHALALGIA, V14, P149, DOI 10.1046/j.1468-2982.1994.1402149.x; Rasmussen B. K., 2000, HEADACHES, P545; ROBBINS LD, 2000, MANAGEMENT HEADACHE; SCHOENEN J, 1999, HEADACHE, P177; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Silberstein SD., 1998, HEADACHE CLIN PRACTI; SOLOMON S, 1993, TENSION TYPE HEADACH; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; TOBIN DL, 1988, COGNITIVE THER RES, V12, P325, DOI 10.1007/BF01173301	51	257	264	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2208	2215		10.1001/jama.285.17.2208	http://dx.doi.org/10.1001/jama.285.17.2208			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	424WC	11325322	Green Accepted, Bronze			2022-12-28	WOS:000168256100023
J	Vastag, B				Vastag, B			Mixed message on prescription drug abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2183	2184		10.1001/jama.285.17.2183	http://dx.doi.org/10.1001/jama.285.17.2183			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325305				2022-12-28	WOS:000168256100003
J	Sharpe, M; Carson, A				Sharpe, M; Carson, A			"Unexplained" somatic symptoms, functional syndromes, and somatization: Do we need a paradigm shift?	ANNALS OF INTERNAL MEDICINE			English	Article							FATIGUE SYNDROMES; CHRONIC PAIN; THERAPY; DISORDERS	Medically unexplained functional or somatization symptoms are somatic disorders that are not adequately explained by physical disease processes. The way in which these disorders have been understood and managed has varied over the history of medicine. However, only in the past 100 years has the "mental" explanation predominated. A benefit of this trend has been the development of effective treatments in the form of "antidepressant" drugs and cognitive-behavioral therapies; a cost has been limited integration of these treatments into medical practice and lack of acceptability to patients. We suggest that there is much to learn from physicians of the pre-Freudian era, Their etiologic theories are now supported by new scientific evidence, and their clinical practice provided ways of making psychological treatment acceptable to patients. We propose a paradigm shift in which unexplained symptoms are remedicalized around the notion of a functional disturbance of the nervous system and treatments currently considered "psychiatric" are integrated into general medical care.	Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Sharpe, M (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Kennedy Tower, Edinburgh EH10 5HF, Midlothian, Scotland.	michael.sharpe@ed.ac.uk		sharpe, michael/0000-0002-6474-9980				Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Beard GM., 1869, BOSTON MED SURG J, V3, P217, DOI [10.1056/nejm186904290801301, 10.1056/NEJM186904290801301, DOI 10.1056/NEJM186904290801301]; BERGMAN AB, 1967, NEW ENGL J MED, V276, P1008, DOI 10.1056/NEJM196705042761804; BURDGE DR, 1993, CLIN INFECT DIS, V16, P558, DOI 10.1093/clind/16.4.558; Clauw DJ, 1997, NEUROIMMUNOMODULAT, V4, P134, DOI 10.1159/000097332; CLAUW DJ, 1995, MED HYPOTHESES, V44, P369; Deary IJ, 1999, J PSYCHOSOM RES, V47, P51; Dubois Paul, 1904, PSYCHIC TREATMENT NE; Falret J., 1890, ETUDES CLIN MALADIES; FINK P, 1992, J PSYCHOSOM RES, V36, P439, DOI 10.1016/0022-3999(92)90004-L; Ghaly A. F. F., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P269, DOI 10.3109/01443619409027849; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Kirmayer L. J., 1988, BIOMEDICINE EXAMINED, P57; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Mayou R, 1995, TREATMENT FUNCTIONAL; Mitchell SW., 1904, J NERV MENT DIS, V31, P368; O'Malley PG, 1999, J FAM PRACTICE, V48, P980; POTTS SG, 1995, PSYCHOL MED, V25, P339, DOI 10.1017/S0033291700036242; Price JR, 2000, J PSYCHOSOM RES, V48, P1, DOI 10.1016/S0022-3999(99)00070-7; QUILL TE, 1985, JAMA-J AM MED ASSOC, V254, P3075, DOI 10.1001/jama.254.21.3075; Ringel Y, 1999, J PSYCHOSOM RES, V47, P205; Salmon P, 1999, BRIT MED J, V318, P372, DOI 10.1136/bmj.318.7180.372; Shorter E., 1992, PARALYSIS FATIGUE HI; STEKEL W, 1943, INTERPRETATION DREAM; STRAUS SE, 1991, REV INFECT DIS, V13, pS2; SYDENHAM T, 1848, WORKS THOMAS SYDENHA; THOMAS KB, 1987, BRIT MED J, V294, P1200, DOI 10.1136/bmj.294.6581.1200; TRIMBLE MR, 1982, BMJ-BRIT MED J, V285, P1768, DOI 10.1136/bmj.285.6357.1768; Veith IH, 1965, HIST DIS; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; WILLIS T, ESSAY PATHOLOGY BRAI, P1684	34	134	139	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			926	930		10.7326/0003-4819-134-9_Part_2-200105011-00018	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00018			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346330				2022-12-28	WOS:000168543100018
J	Ahmedzai, SH				Ahmedzai, SH			Window of opportunity for pain control in the terminally ill	LANCET			English	Editorial Material							CANCER PAIN; MORPHINE; ANALGESIA; FENTANYL; RATS		Univ Sheffield, Royal Hallamshire Hosp, Acad Palliat Med Unit, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Ahmedzai, SH (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Acad Palliat Med Unit, Sheffield S10 2JF, S Yorkshire, England.	s.ahmedzai@sheffield.ac.uk		Ahmedzai, Sam/0000-0002-2028-8510				Ahmedzai S, 1997, J PAIN SYMPTOM MANAG, V13, P254, DOI 10.1016/S0885-3924(97)00082-1; BEITBART W, 1998, OXFORD TXB PALLIATIV, P437; Burton AW, 1999, REGION ANESTH PAIN M, V24, P208, DOI 10.1016/S1098-7339(99)90129-3; Dalal S, 1998, J PAIN SYMPTOM MANAG, V16, P245, DOI 10.1016/S0885-3924(98)00084-0; Inturrisi CE, 1998, PROG PAIN RES MANAG, V12, P275; Megens AAHP, 1998, J PAIN SYMPTOM MANAG, V15, P253, DOI 10.1016/S0885-3924(97)00371-0; Mercadante S, 2001, J PAIN SYMPTOM MANAG, V21, P255, DOI 10.1016/S0885-3924(00)00236-0; NUGENT M, IN PRESS J PAIN SYMP; Nurmikko TJ, 1998, BRIT MED J, V317, P1438, DOI 10.1136/bmj.317.7170.1438; Paice JA, 1998, J PAIN SYMPTOM MANAG, V16, P1, DOI 10.1016/S0885-3924(98)00025-6; Ross FB, 2000, PAIN, V84, P421, DOI 10.1016/S0304-3959(99)00230-4; Sapir R, 1999, J PAIN SYMPTOM MANAG, V17, P266, DOI 10.1016/S0885-3924(98)00156-0; Skilbeck J, 1998, PALLIATIVE MED, V12, P245, DOI 10.1191/026921698677124622; *WHO, 1990, WHO TECH REP SER, V804	14	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1304	1305		10.1016/S0140-6736(00)04525-6	http://dx.doi.org/10.1016/S0140-6736(00)04525-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343728				2022-12-28	WOS:000168411400002
J	Fernandez, JM; Chu, S; Oberhauser, AF				Fernandez, JM; Chu, S; Oberhauser, AF			RNA structure - Pulling on hair(pins)	SCIENCE			English	Editorial Material							PROTEIN; HAIRPIN		Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Mayo Clinic; Stanford University	Fernandez, JM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, 200 1st St SW, Rochester, MN 55905 USA.							BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Kortemme T, 1998, SCIENCE, V281, P253, DOI 10.1126/science.281.5374.253; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rief M, 1999, NAT STRUCT BIOL, V6, P346; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0	9	21	25	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					653	654		10.1126/science.1060884	http://dx.doi.org/10.1126/science.1060884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330326				2022-12-28	WOS:000168478300033
J	Solis, RS; Haas, J; Creamer, W				Solis, RS; Haas, J; Creamer, W			Dating caral, a preceramic site in the Supe Valley on the central coast of Peru	SCIENCE			English	Article								Radiocarbon dates from the site of Caral in the Supe Valley of Peru indicate that monumental corporate architecture, urban settlement, and irrigation agriculture began in the Americas by 4090 years before the present (2627 calibrated years B.C.) to 3640 years before the present (1977 calibrated years B.C.). Caral is located 23 kilometers inland from the Pacific coast and contains a central zone of monumental, residential, and nonresidential architecture covering an area of 65 hectares. Caral is one of 18 large preceramic sites in the Supe Valley.	Field Museum Nat Hist, Dept Anthropol, Wheaton, IL 60187 USA; Univ Nacl Mayor San Marcos, Museo Arqueol, Ctr Cultural, Lima 14, Peru; No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA	Field Museum of Natural History (Chicago); Universidad Nacional Mayor de San Marcos; Northern Illinois University	Haas, J (corresponding author), Field Museum Nat Hist, Dept Anthropol, 1400 S Lakeshore Dr, Wheaton, IL 60187 USA.		Shady, Ruth/AAA-8499-2019	Shady, Ruth/0000-0002-1151-941X				ALVA W, 1978, HOMBRE CULTURA ANDIN, V1, P275; DILLEHAY TD, 1989, AM ANTIQUITY, V54, P733, DOI 10.2307/280679; Feldman R.A., 1985, EARLY CEREMONIAL ARC, P71; Feldman Robert, 1980, THESIS HARVARD U; Fung R., 1988, PERUVIAN PREHISTORY, P67; GRIEDER T, 1988, GALGADA PERU PRECERA; Izumi S., 1972, ANDES 4 EXCAVATIONS; KOSOK P, 1985, LIFE LAND WATER ANCI; LEON CW, 1980, REV MUS NAC, V44, P95; MANCO CH, 1977, ARQUEOL PUC, V19, P27; MOSELEY M, 1973, AM ANTIQUITY, V37, P67; Moseley M. E., 1988, ARCHAEOLOGY PREHISTO, P125; Moseley M.E., 1975, MARITIME FDN ANDEAN; Moseley ME, 1985, EARLY CEREMONIAL ARC, P29; POZORSKI S, 1991, AM ANTHROPOL, V93, P454, DOI 10.1525/aa.1991.93.2.02a00150; POZORSKI T, 1979, ANN CARNEGIE MUS NAT, V49, P337; QUILTER J, 1985, J FIELD ARCHAEOL, V12, P279, DOI 10.1179/009346985791169733; Shady R., 1997, CIUDAD SAGRADA CARAL; SHADY R, 2001, ARQUEOL SOC, V13, P13; Shady R., 1999, B ARQUEOLOGIA PUCP, V3, P187; Shady Ruth, 2000, B MUS ARQUEOL ANTROP, V3, P2; Shady Ruth, 1999, B MUSEO ARQUEOLOGIA, V2, P2; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; UHLE M, 1925, U CALIFORNIA PUBLICA, V21, P257; Willey G., 1954, COLUMBIA STUDIES ARC, V3; Williams C., 1979, INVENTARIO CATASTRO; WILLIAMS C, 1972, APUNTES, V2, P1; WILLIAMS C, 1971, APUNTES ARQUEOL, V1, P1; Zechenter Elzbieta., 1988, THESIS U CALIFORNIA	29	106	111	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					723	726		10.1126/science.1059519	http://dx.doi.org/10.1126/science.1059519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	428TX	11326098				2022-12-28	WOS:000168478300050
J	Espinal, MA; Laszlo, A; Simonsen, L; Boulahbal, F; Kim, SJ; Reniero, A; Hoffner, S; Rieder, HL; Binkin, N; Dye, C; Williams, R; Raviglione, MC				Espinal, MA; Laszlo, A; Simonsen, L; Boulahbal, F; Kim, SJ; Reniero, A; Hoffner, S; Rieder, HL; Binkin, N; Dye, C; Williams, R; Raviglione, MC		World Hlth Org	Global trends in resistance to antituberculosis drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHORT-COURSE CHEMOTHERAPY; MYCOBACTERIUM-TUBERCULOSIS; DOTS; PREVALENCE; PROGRAM	Background: Data on global trends in resistance to antituberculosis drugs are lacking. Methods: We expanded the survey conducted by the World Health Organization and the International Union against Tuberculosis and Lung Disease to assess trends in resistance to antituberculosis drugs in countries on six continents. We obtained data using standard protocols from ongoing surveillance or from surveys of representative samples of all patients with tuberculosis. The standard sampling techniques distinguished between new and previously treated patients, and laboratory performance was checked by means of an international program of quality assurance. Results: Between 1996 and 1999, patients in 58 geographic sites were surveyed; 28 sites provided data for at least two years. For patients with newly diagnosed tuberculosis, the frequency of resistance to at least one antituberculosis drug ranged from 1.7 percent in Uruguay to 36.9 percent in Estonia (median, 10.7 percent). The prevalence increased in Estonia, from 28.2 percent in 1994 to 36.9 percent in 1998 (P=0.01), and in Denmark, from 9.9 percent in 1995 to 13.1 percent in 1998 (P=0.04). The median prevalence of multidrug resistance among new cases of tuberculosis was only 1.0 percent, but the prevalence was much higher in Estonia (14.1 percent), Henan Province in China (10.8 percent), Latvia (9.0 percent), the Russian oblasts of Ivanovo (9.0 percent) and Tomsk (6.5 percent), Iran (5.0 percent), and Zhejiang Province in China (4.5 percent). There were significant decreases in multidrug resistance in France and the United States. In Estonia, the prevalence in all cases increased from 11.7 percent in 1994 to 18.1 percent in 1998 (P<0.001). Conclusions: Multidrug-resistant tuberculosis continues to be a serious problem, particularly among some countries of eastern Europe. Our survey also identified areas with a high prevalence of multidrug-resistant tuberculosis in such countries as China and Iran. (N Engl J Med 2001;344:1294-303.) Copyright (C) 2001 Massachusetts Medical Society.	WHO, CH-1211 Geneva, Switzerland; Int Union Against TB & Lung Dis, Paris, France; Lab Ctr Dis Control, Ottawa, ON K1A 0L2, Canada; Inst Pasteur, Algiers, Algeria; Korean Inst TB, Seoul, South Korea; Inst Panamer Protecc Alimentos & Zoonosis, Buenos Aires, DF, Argentina; Swedish Inst Infect Dis Control, Stockholm, Sweden; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; Swedish Institute for Infectious Disease Control; Centers for Disease Control & Prevention - USA	Espinal, MA (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	espinalm@who.int	Simonsen, Lone/K-4531-2014; Dye, Christopher/AIC-4659-2022; ROBERT, Jérôme/C-3993-2011	Simonsen, Lone/0000-0003-1535-8526; ROBERT, Jérôme/0000-0002-9380-0570; RAVIGLIONE, Mario/0000-0002-9331-2067; Dye, Christopher/0000-0002-2957-1793				ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; [Anonymous], 1985, Am Rev Respir Dis, V131, P727; Bloch AB, 1999, INT J TUBERC LUNG D, V3, P273; BORCHARDT J, 1995, EUR RESPIR J, V8, P1076, DOI 10.1183/09031936.95.08071076; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chaisson RE, 1999, INT J TUBERC LUNG D, V3, P1; Chan-Tack KM, 1998, NEW ENGL J MED, V339, P1079, DOI 10.1056/NEJM199810083391511; DAWSON DJ, 1995, MED J AUSTRALIA, V162, P287, DOI 10.5694/j.1326-5377.1995.tb139901.x; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; FARGA V, 1991, REV CHIL ENF RESP, V7, P94; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Hong YP, 1998, INT J TUBERC LUNG D, V2, P365; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; Marrero A, 2000, THORAX, V55, P39, DOI 10.1136/thorax.55.1.39; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Netto EM, 1999, INT J TUBERC LUNG D, V3, P310; PablosMendez A, 1998, NEW ENGL J MED, V339, P139; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; Thomsen VO, 2000, EUR RESPIR J, V16, P203, DOI 10.1183/09031936.00.16220300; Trebucq A, 1999, INT J TUBERC LUNG D, V3, P466; *UN, 1999, WORLD POP PROSP 1998; WHO, 1998, INT J TUBERC LUNG D, V2, P71; *WHO, 1999, WHOCDSCPCTB99259 GLO; *WHO, 1997, WHOTB97225 GLOB TUB; *WHO, 1998, WHOTB98237 GLOB TUB; *WHO, 2000, WHOCDSTB2000275; *WHO IUATLD GLOB P, 1997, WHOTB97229 IUATLD GL; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 1994, WHOTB94179	36	527	553	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1294	1303		10.1056/NEJM200104263441706	http://dx.doi.org/10.1056/NEJM200104263441706			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320389				2022-12-28	WOS:000168252400006
J	Hayashi, F; Smith, KD; Ozinsky, A; Hawn, TR; Yi, EC; Goodlett, DR; Eng, JK; Akira, S; Underhill, DM; Aderem, A				Hayashi, F; Smith, KD; Ozinsky, A; Hawn, TR; Yi, EC; Goodlett, DR; Eng, JK; Akira, S; Underhill, DM; Aderem, A			The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5	NATURE			English	Article							SALMONELLA-TYPHI FLAGELLA; EXPRESSION; PROTEIN; MECHANISMS; INDUCTION; FAMILY; RECOGNITION; ACTIVATION; CLONING; GENES	The innate immune system recognizes pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, but not on the host. Toll-like receptors (TLRs) recognize PAMPs and mediate the production of cytokines necessary for the development of effective immunity(1-4). Flagellin, a principal component of bacterial flagella, is a virulence factor that is recognized by the innate immune system in organisms as diverse as flies, plants and mammals(5-11). Here we report that mammalian TLR5 recognizes bacterial flagellin from both Gram-positive and Gram-negative bacteria, and that activation of the receptor mobilizes the nuclear factor NF-kappaB and stimulates tumour necrosis factor-alpha production. TLR5-stimulating activity was purified from Listeria monocytogenes culture supernatants and identified as flagellin by tandem mass spectrometry. Expression of L. monocytogenes flagellin in non-flagellated Escherichia coli conferred on the bacterium the ability to activate TLR5, whereas deletion of the flagellin genes from Salmonella typhimurium abrogated TLR5-stimulating activity. All known TLRs signal through the adaptor protein MyD88. Mice challenged with bacterial flagellin rapidly produced systemic interleukin-6, whereas MyD88-null mice did not respond to flagellin. Our data suggest that TLR5, a member of the evolutionarily conserved Toll-like receptor family, has evolved to permit mammals specifically to detect flagellated bacterial pathogens.	Inst Syst Biol, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Osaka University	Aderem, A (corresponding author), Inst Syst Biol, 4225 Roosevelt Way NE,Suite 200, Seattle, WA 98195 USA.	aderem@systemsbiology.org	UNDERHILL, DAVID/ABE-2185-2021; Eng, Jimmy K/I-4202-2012; Akira, Shizuo/C-3134-2009	Eng, Jimmy K/0000-0001-6352-6737; Underhill, David/0000-0002-2989-658X				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Ciacci-Wooline F, 1999, INFECT IMMUN, V67, P5176, DOI 10.1128/IAI.67.10.5176-5185.1999; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FUJITA H, 1973, J GEN MICROBIOL, V76, P127, DOI 10.1099/00221287-76-1-127; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Goodlett DR, 2000, ANAL CHEM, V72, P1112, DOI 10.1021/ac9913210; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Luna MD, 2000, RES MICROBIOL, V151, P575, DOI 10.1016/S0923-2508(00)00227-8; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PEEL M, 1988, J GEN MICROBIOL, V134, P2171; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Sebastiani G, 2000, GENOMICS, V64, P230, DOI 10.1006/geno.2000.6115; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Stocker B A, 1994, Int Rev Immunol, V11, P167, DOI 10.3109/08830189409061724; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Wyant TL, 1999, INFECT IMMUN, V67, P1338, DOI 10.1128/IAI.67.3.1338-1346.1999	30	2635	2832	7	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1099	1103		10.1038/35074106	http://dx.doi.org/10.1038/35074106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323673				2022-12-28	WOS:000168285500049
J	Lin, WC; Burgess, RW; Dominguez, B; Pfaff, SL; Sanes, JR; Lee, KF				Lin, WC; Burgess, RW; Dominguez, B; Pfaff, SL; Sanes, JR; Lee, KF			Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; TYROSINE KINASES; TRANSGENIC MICE; ALPHA-SUBUNIT; GROWTH CONES; MUTANT MICE; CRD DOMAIN; AGRIN GENE; JUNCTION; SYNAPTOGENESIS	The development of chemical synapses is regulated by interactions between pre- and postsynaptic cells. At the vertebrate skeletal neuromuscular junction, the organization of an acetylcholine receptor (AChR)-rich postsynaptic apparatus has been well studied. Much evidence suggests that the nerve-derived protein agrin activates muscle-specific kinase (MuSK) to cluster AChRs through the synapse-specific cytoplasmic protein rapsyn. But how postsynaptic differentiation is initiated, or why most synapses are restricted to an 'end-plate band' in the middle of the muscle remains unknown. Here we have used genetic methods to address these issues. We report that the initial steps in postsynaptic differentiation and formation of an end-plate band require MuSK and rapsyn, but are not dependent on agrin or the presence of motor axons. In contrast, the subsequent stages of synaptic growth and maintenance require nerve-derived agrin, and a second nerve-derived signal that disperses ectopic postsynaptic apparatus.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Salk Institute; Washington University (WUSTL)	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	klee@salk.edu	Tuluc, Petronel/C-2527-2011	Burgess, Robert/0000-0002-9229-3407				ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BRAITHWAITE AW, 1979, NATURE, V279, P549, DOI 10.1038/279549a0; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; DAHM LM, 1991, J NEUROSCI, V11, P238; DAVEY DF, 1986, J NEUROSCI, V6, P673; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; Halfter W, 1997, J COMP NEUROL, V383, P1; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; KUES WA, 1995, J CELL BIOL, V130, P949, DOI 10.1083/jcb.130.4.949; KUROMI H, 1984, DEV BIOL, V103, P53, DOI 10.1016/0012-1606(84)90006-X; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; LUPA MT, 1989, J NEUROSCI, V9, P3937; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	43	424	440	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1057	1064		10.1038/35074025	http://dx.doi.org/10.1038/35074025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323662				2022-12-28	WOS:000168285500038
J	Warkentin, TE; Kelton, JG				Warkentin, TE; Kelton, JG			Temporal aspects of heparin-induced thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG PURPURA; ANTIBODIES; PLATELETS; QUINIDINE; EXPLANATION; QUININE; COMPLEX; SERA	Background: Heparin-induced thrombocytopenia is a relatively common antibody-mediated drug reaction. We studied the temporal relation between previous or current heparin therapy and the onset of heparin-induced thrombocytopenia. Methods: We examined the time between the start of heparin therapy and the onset of thrombocytopenia in 243 patients with serologically confirmed heparin-induced thrombocytopenia. We also investigated the persistence of circulating heparin-dependent antibodies by performing a platelet serotonin-release assay and an assay for antibodies against platelet factor 4. The outcome in seven patients who had previously had an episode of heparin-induced thrombocytopenia and were later treated again with heparin was also examined. Results: A fall in the platelet count beginning four or more days after the start of heparin therapy occurred in 170 of the 243 patients (70 percent); in these patients, a history of previous heparin treatment did not influence the timing of the onset of thrombocytopenia. In the remaining 73 patients (30 percent), the onset of thrombocytopenia was rapid (median time of onset, 10.5 hours after the start of heparin administration); all these patients had been treated with heparin within the previous 100 days. During recovery from thrombocytopenia, heparin-dependent antibodies in the serum fell to undetectable levels at a median of 50 to 85 days, depending on the assay performed. In the seven patients who were given heparin again after the disappearance of heparin-dependent antibodies, a new episode of heparin-induced thrombocytopenia did not occur. Conclusions: Heparin-induced thrombocytopenia can begin rapidly in patients who have received heparin within the previous 100 days. Heparin-dependent antibodies do not invariably reappear with subsequent heparin use. (N Engl J Med 2001;344:1286-92.) Copyright (C) 2001 Massachusetts Medical Society.	Hamilton Hlth Sci Corp, Hamilton Reg Lab Med Program, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Warkentin, TE (corresponding author), Hamilton Hlth Sci Corp, Hamilton Reg Lab Med Program, Gen Site,237 Barton St E, Hamilton, ON L8L 2X2, Canada.							Amiral J, 1999, SEMIN HEMATOL, V36, P7; AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; Arepally G, 1997, BLOOD, V89, P370, DOI 10.1182/blood.V89.2.370; BABCOCK RB, 1976, NEW ENGL J MED, V295, P237, DOI 10.1056/NEJM197607292950501; BOLTON FG, 1953, J CLIN PATHOL, V6, P320, DOI 10.1136/jcp.6.4.320; CHONG BH, 1994, BLOOD, V83, P1535; CINES DB, 1980, NEW ENGL J MED, V303, P788, DOI 10.1056/NEJM198010023031404; COLLETT D, 1994, MODELLING SURVIVAL D, P15; Denomme GA, 1997, J LAB CLIN MED, V130, P278, DOI 10.1016/S0022-2143(97)90022-6; GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P247; KELTON JG, 1988, BLOOD, V72, P925; KELTON JG, 1994, BLOOD, V83, P3232; KING DJ, 1984, ANN INTERN MED, V100, P535, DOI 10.7326/0003-4819-100-4-535; LASTER J, 1989, J VASC SURG, V9, P677, DOI 10.1067/mva.1989.vs0090677; MOLLISON PL, 1997, BLOOD TRANSFUSION CL, P60; Newman PM, 2000, BLOOD, V96, P182, DOI 10.1182/blood.V96.1.182.013k18_182_187; PAGANO M, 1993, PRINCIPLES BIOSTATIS, P273; Potzsch B, 2000, NEW ENGL J MED, V343, P515, DOI 10.1056/NEJM200008173430718; POWELL SE, 1988, J BONE JOINT SURG AM, V70A, P1097, DOI 10.2106/00004623-198870070-00022; REID DM, 1988, ANN INTERN MED, V108, P206, DOI 10.7326/0003-4819-108-2-206; RHODES GR, 1973, SURG GYNECOL OBSTET, V136, P409; SHERIDAN D, 1986, BLOOD, V67, P27; SHULMAN NR, 1958, J EXP MED, V107, P711, DOI 10.1084/jem.107.5.711; SILVER D, 1983, ANN SURG, V198, P301, DOI 10.1097/00000658-198309000-00006; VANDERWEERDT CM, 1967, VOX SANG, V12, P265; VISENTIN GP, 1994, J CLIN INVEST, V93, P81, DOI 10.1172/JCI116987; Warkentin T, 2000, FUND CL CAR, P43; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; WARKENTIN TE, 1992, J LAB CLIN MED, V120, P371; WARKENTIN TE, 2000, FUND CL CAR, V39, P211; WEISMANN RE, 1958, ARCH SURG-CHICAGO, V76, P219	33	628	647	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1286	1292		10.1056/NEJM200104263441704	http://dx.doi.org/10.1056/NEJM200104263441704			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320387				2022-12-28	WOS:000168252400004
J	Pascual-Leone, A; Walsh, V				Pascual-Leone, A; Walsh, V			Fast backprojections from the motion to the primary visual area necessary for visual awareness	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; CORTEX V1; BRAIN; DISCRIMINATION; PHOSPHENES; MACAQUE; SYSTEM; PERCEPTION; VISION	Much is known about the pathways from photoreceptors to higher visual areas in the brain. However, how we become aware of what we see or of having seen at all is a problem that has eluded neuroscience. Recordings from macaque V1 during deactivation of MT+/V5 and psychophysical studies of perceptual integration suggest that feedback from secondary visual areas to V1 is necessary for visual awareness. We used transcranial magnetic stimulation to probe the timing and function of feedback from human area MT+/V5 to V1 and found its action to be early and critical for awareness of visual motion.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat, Boston, MA 02115 USA; Univ Oxford, Oxford OX1 3UD, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Oxford	Pascual-Leone, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat, 330 Brookline Ave,Kirstein Hall KS454, Boston, MA 02115 USA.	apleone@caregroup.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382	NEI NIH HHS [R01-EY12873] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012873] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amassian VE, 1998, J CLIN NEUROPHYSIOL, V15, P288, DOI 10.1097/00004691-199807000-00002; BABUR JL, 1993, BRAIN, V116, P1293; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Edelman G.M., 1992, BRIGHT AIR BRILLIANT; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; HUPE JM, 2000, J NEUROPHYSIOL; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; Kammer T, 1999, NEUROPSYCHOLOGIA, V37, P191; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; MERIGAN WH, 1991, J NEUROSCI, V11, P994; Nowak LG, 1997, CEREBR CORT, V12, P205; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; POLLEN DA, 1995, NATURE, V377, P293, DOI 10.1038/377293b0; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Siebner HR, 1998, NEUROREPORT, V9, P943, DOI 10.1097/00001756-199803300-00033; Stewart L, 1999, EEG CL N SU, P334; Stoerig P, 1995, BEHAV BRAIN RES, V71, P147, DOI 10.1016/0166-4328(95)00050-X; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WEISKRANTZ L, 1995, P NATL ACAD SCI USA, V92, P6122, DOI 10.1073/pnas.92.13.6122; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	36	568	574	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					510	512		10.1126/science.1057099	http://dx.doi.org/10.1126/science.1057099			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313497				2022-12-28	WOS:000168187300049
J	Walraven, G; Scherf, C; West, B; Ekpo, G; Paine, K; Coleman, R; Bailey, R; Morison, L				Walraven, G; Scherf, C; West, B; Ekpo, G; Paine, K; Coleman, R; Bailey, R; Morison, L			The burden of reproductive-organ disease in rural women in The Gambia, West Africa	LANCET			English	Article							TRADITIONAL BIRTH ATTENDANTS; SIMPLEX-VIRUS TYPE-2; INFERTILITY; PREVALENCE; MORTALITY; INFECTION; PREGNANCY; MORBIDITY; COMMUNITY; BEHAVIOR	Background Data on the epidemiology of reproductive-organ morbidity are needed to guide effective interventions, to set health-care priorities, and to target future research. This study aimed to find out the prevalence of reproductive-organ disease in a sample of rural Gambian women. Methods A questionnaire on reproductive health was administered by fieldworkers to women aged 15-54 years living in a rural area under demographic surveillance. A female gynaecologist questioned and examined the women (including speculum and bimanual pelvic examinations). Vaginal swabs were taken to test for Trichomonas vaginalis, Candida albicans, and bacterial vaginosis, cervical smears for cytology, cervical swabs for Chlamydia trachomatis PCR and Neisseria gonorrhoeae culture, and venous blood for haemoglobin, HIV, herpes simplex virus 2, and syphilis serology, Findings 1348 (72.0%) of 1871 eligible women took part. Reproductive-organ symptoms were more likely to be reported to the gynaecologist (52.7% of women) than to the fieldworker (26.5%). Menstrual problems, abnormal vaginal discharge, and vaginal itching were the most commonly reported symptoms. A minority of women said they had sought health care for their symptoms. The frequencies of reproductive-organ morbidity were high: menstrual dysfunction 34.1% (95% CI 29.6-39.1), infertility 9.8% (8.2-11.6), reproductive-tract infections 47.3% (43.7-51.0), pelvic tenderness 9.8% ((7.0-13.5), cervical dysplasia 6.7% (5.2-8.4), masses 15.9% (12.5-20.1), and childbirth-related damage to pelvic structures 46.1% (40.1-52.3). 948 (70.3%) women had at least one reproductive-organ disorder. Interpretation For these rural women, whose lives depend heavily on their reproductive function, reproductive-organ disease is a large burden. In inadequately resourced rural areas, with poor education,;heavy agricultural and domestic labour, and limited access to quality health care, many women are not able to attain and maintain reproductive health and wellbeing.	MRC Labs, Farafenni Field Stn, Banjul, Gambia; Cardiff Univ, Dept Obstet & Gynaecol, Cardiff CF4 4XN, S Glam, Wales; London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; Cardiff University; University of London; London School of Hygiene & Tropical Medicine	Walraven, G (corresponding author), MRC Labs, Farafenni Field Stn, POB 273, Banjul, Gambia.	gwalraven@mrc.gm	Morison, Linda A/H-9738-2013; Swaibu, Ramadhani A/H-3164-2011					BAILEY RL, 1994, J INFECT DIS, V170, P709, DOI 10.1093/infdis/170.3.709; BANG RA, 1989, LANCET, V1, P85; *BETH COMM, 1993, ACTA CYTOL, V37, P115; BLEDSOE CH, 1994, POPUL DEV REV, V20, P81, DOI 10.2307/2137631; BRABIN L, 1995, LANCET, V345, P300, DOI 10.1016/S0140-6736(95)90281-3; Bulut A, 1997, STUD FAMILY PLANN, V28, P35, DOI 10.2307/2137969; CATES W, 1985, LANCET, V2, P596; FATHALLA MF, 1988, RES NEEDS HUMAN REPR; Favot I, 1997, INT J EPIDEMIOL, V26, P414, DOI 10.1093/ije/26.2.414; Filippi V, 1997, TROP MED INT HEALTH, V2, P47, DOI 10.1046/j.1365-3156.1997.d01-126.x; GRAHAM WJ, 1995, ASKING QUESTIONS WOM; GREENWOOD AM, 1992, J INFECT DIS, V166, P842, DOI 10.1093/infdis/166.4.842; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P589, DOI 10.1016/0035-9203(89)90362-3; Harrison KA, 1997, LANCET, V349, P644, DOI 10.1016/S0140-6736(97)02192-2; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; HERRERO R, 1997, PAN AM J PUBLIC HLTH, V1, P362; Hill AG, 2000, TROP MED INT HEALTH, V5, P107, DOI 10.1046/j.1365-3156.2000.00528.x; INHORN MC, 1994, SOC SCI MED, V39, P459, DOI 10.1016/0277-9536(94)90089-2; Lancaster EJ, 1999, E AFR MED J, V76, P101; Marsden HS, 1998, J MED VIROL, V56, P79, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;79::AID-JMV13&gt;3.0.CO;2-R; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; TSUI AO, 1997, REPROD HLTH DEV COUN, P178; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walraven G, 2000, B WORLD HEALTH ORGAN, V78, P603; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; WOLFENDALE MR, 1987, BRIT MED J, V294, P33, DOI 10.1136/bmj.294.6563.33; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZURAYK H, 1995, STUD FAMILY PLANN, V26, P14, DOI 10.2307/2138047	34	90	90	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1161	1167		10.1016/S0140-6736(00)04333-6	http://dx.doi.org/10.1016/S0140-6736(00)04333-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423RX	11323043				2022-12-28	WOS:000168192100010
J	Parker, AR; McPhedran, RC; McKenzie, DR; Botten, LC; Nicorovici, NAP				Parker, AR; McPhedran, RC; McKenzie, DR; Botten, LC; Nicorovici, NAP			Photonic engineering - Aphrodite's iridescence	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; Univ Technol Sydney, Sch Math Sci, Sydney, NSW 2007, Australia	University of Oxford; University of Sydney; University of Technology Sydney	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		McPhedran, Ross/ABE-8263-2020; Botten, Lindsay/R-6678-2019; Botten, Lindsay C/G-3160-2017	Botten, Lindsay/0000-0001-6471-6954; Botten, Lindsay C/0000-0001-6471-6954				ATKINS EDT, 1979, INT J BIOL MACROMOL, V1, P29, DOI 10.1016/0141-8130(79)90006-0; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; McPhedran RC, 1999, AUST J PHYS, V52, P791, DOI 10.1071/PH98110; Parker AR, 1995, P ROY SOC B-BIOL SCI, V262, P349, DOI 10.1098/rspb.1995.0216; Parker AR, 1999, FUNCTIONAL MORPHOLOG, P65; ROUSE G, 1998, INVERTEBRATE ZOOLOGY, P174; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794	8	208	216	8	121	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					36	37		10.1038/35051168	http://dx.doi.org/10.1038/35051168			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343102				2022-12-28	WOS:000166175600028
J	Schwetz, BA				Schwetz, BA			New diabetes glucose test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2186	2186		10.1001/jama.285.17.2186	http://dx.doi.org/10.1001/jama.285.17.2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325309				2022-12-28	WOS:000168256100007
J	Schwetz, BA				Schwetz, BA			Famotidine labeling change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2186	2186		10.1001/jama.285.17.2186	http://dx.doi.org/10.1001/jama.285.17.2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325309				2022-12-28	WOS:000168256100009
